Citrus Sinensis ID: 017820
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 365 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S713 | 562 | Serine/threonine-protein | yes | no | 0.947 | 0.615 | 0.762 | 1e-157 | |
| Q84V18 | 754 | Serine/threonine-protein | N/A | no | 0.890 | 0.431 | 0.424 | 4e-71 | |
| Q9LZV4 | 495 | Serine/threonine-protein | no | no | 0.693 | 0.511 | 0.397 | 4e-49 | |
| Q9WV60 | 420 | Glycogen synthase kinase- | yes | no | 0.443 | 0.385 | 0.292 | 2e-09 | |
| P49841 | 420 | Glycogen synthase kinase- | yes | no | 0.443 | 0.385 | 0.292 | 2e-09 | |
| P18266 | 420 | Glycogen synthase kinase- | yes | no | 0.443 | 0.385 | 0.287 | 2e-09 | |
| P18431 | 514 | Protein kinase shaggy OS= | no | no | 0.443 | 0.315 | 0.282 | 3e-09 | |
| Q91757 | 420 | Glycogen synthase kinase- | N/A | no | 0.512 | 0.445 | 0.275 | 6e-09 | |
| Q5YJC2 | 420 | Glycogen synthase kinase- | N/A | no | 0.443 | 0.385 | 0.292 | 1e-08 | |
| P19454 | 339 | Casein kinase II subunit | yes | no | 0.153 | 0.165 | 0.482 | 3e-08 |
| >sp|Q9S713|STT7_ARATH Serine/threonine-protein kinase STN7, chloroplastic OS=Arabidopsis thaliana GN=STN7 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 553 bits (1425), Expect = e-157, Method: Compositional matrix adjust.
Identities = 282/370 (76%), Positives = 321/370 (86%), Gaps = 24/370 (6%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFS--------KNNISSSLTTK 52
MAT++ G A + TP SPFLGK+L KPFS K + + + +
Sbjct: 1 MATISPGGAYI------GTP------SPFLGKKL---KPFSLTSPILSFKPTVKLNSSCR 45
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
A+LIDTV ++F+GVGVGLPCTVMECGD+IYRSTLPKSNGLTITAPGVALAL+A+SYLWAT
Sbjct: 46 AQLIDTVHNLFIGVGVGLPCTVMECGDMIYRSTLPKSNGLTITAPGVALALTALSYLWAT 105
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMFVLAFVERLFR T+RKDDFV+GKKLGEG+FGVVY+ SL+KK S++ +G+
Sbjct: 106 PGVAPGFFDMFVLAFVERLFRPTFRKDDFVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEY 164
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRAC N CADFVYGF + SSKKG EYWL+W+YEGE+TLA L
Sbjct: 165 VLKKATEYGAVEIWMNERVRRACGNSCADFVYGFLDKSSKKGPEYWLLWKYEGESTLAGL 224
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+ILG+VQDLPKG+EREN+IIQTIM QLLFALDGLHSTGI+HRD+KPQN
Sbjct: 225 MQSKEFPYNVETIILGKVQDLPKGLERENKIIQTIMRQLLFALDGLHSTGIIHRDVKPQN 284
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSR+FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA
Sbjct: 285 IIFSEGSRSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAA 344
Query: 353 ALSPVLWQVQ 362
ALSPVLWQ+
Sbjct: 345 ALSPVLWQMN 354
|
Serine/threonine protein kinase required for state transition by phosphorylating light-harvesting complex II outer antennae (LCHII). State transition plays a central role in response to environmental changes and allows to adjust to changing light conditions via the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI). Phosphorylates the minor light harvesting protein LHCB4.2/CP29 and is involved in the light-dependent phosphorylation of TSP9. Acts as a key component of the long-term response (LTR) signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q84V18|STT7_CHLRE Serine/threonine-protein kinase stt7, chloroplastic OS=Chlamydomonas reinhardtii GN=STT7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 150/353 (42%), Positives = 202/353 (57%), Gaps = 28/353 (7%)
Query: 34 LVLIKPFSKNNISSSLTTKAELIDTVRDVFLGV---GVGLPCTVMECGDIIYRSTLPKS- 89
LV +P + + + T E ID + + + + PC VM+CGDI+YRSTL S
Sbjct: 29 LVQRRPGQRRGVPARATP--EFIDALSALVPNLPLEQIAAPCQVMKCGDIVYRSTLDPSL 86
Query: 90 -NGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLG 148
N VAL ++YL+ PGV PG D ++ A ++R K+D VLGK+LG
Sbjct: 87 YNEAGFDEKTVALLAPVLAYLFLPPGVLPGAIDYYIRAPLKRKQTKAIDKNDIVLGKRLG 146
Query: 149 EGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFE 208
G FG V++ L ++ K +++KKA E+G E+WMNER+ R + A+FV F E
Sbjct: 147 TGGFGTVFKGELKEEGGVKTS--IIIKKAKEFGEAEVWMNERMSRVAGHHVAEFVTAFDE 204
Query: 209 N-------------------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ S WL+W YEG+ TL+ LM RE+PYN++ L+ G
Sbjct: 205 SLNVPLPAAAGKRAAPVQPTSPLDANSIWLVWVYEGDNTLSSLMERREWPYNLEPLLFGR 264
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
P+G RE I+ QL+ A+ HS GIVHRDIKP N I SE + K+IDLGA
Sbjct: 265 ELRAPRGPVRELVTIKEAFRQLVQAVAACHSVGIVHRDIKPANCIVSERDKKIKLIDLGA 324
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362
AADLR+GINY+P E+LLDPRYA P+QYIMSTQTP P PVA LSP+LW ++
Sbjct: 325 AADLRIGINYVPNEYLLDPRYAPPQQYIMSTQTPKPPPKPVAAFLSPILWTME 377
|
Serine/threonine protein kinase required for state transition by phosphorylating light-harvesting complex II outer antennae (LCHII). State transition plays a central role in response to environmental changes and allows to adjust to changing light conditions via the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI). Chlamydomonas reinhardtii (taxid: 3055) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LZV4|STN8_ARATH Serine/threonine-protein kinase STN8, chloroplastic OS=Arabidopsis thaliana GN=STN8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 115/289 (39%), Positives = 167/289 (57%), Gaps = 36/289 (12%)
Query: 108 YLWATPGVAPGFFDMFVLA----FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
YL A PGV G D ++LA ++ L ++ DF++ +KLGEG+FGVVY L K
Sbjct: 96 YLTARPGVLIGAIDAYLLAPLQLGLDTLIGRRLKRSDFLVTEKLGEGSFGVVYAGVLLPK 155
Query: 164 PSSKNDG-------------------DLVLKK-------ATEYGAVEIWMNERVRRACAN 197
S+ D ++LKK A E+G E W N R+ RA +
Sbjct: 156 NSTLVDDVRVSKARAKAMDFTGEFKQRVILKKVKVGVRGAEEFGEYEEWFNYRLSRAAPD 215
Query: 198 CCADFVYGFFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
CA+F+ F + + KGG+ WL+WR+EG+ LAD M R FP N+++++ G V
Sbjct: 216 TCAEFLGSFVADKTNTMFTKGGK-WLVWRFEGDRDLADYMKDRSFPSNLESIMFGRVLQG 274
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ ++R II+ IM Q++ +L +H TGIVHRD+KP N++ ++ + K+ID GAAADL
Sbjct: 275 VESVKRRALIIKQIMRQIITSLRKIHGTGIVHRDVKPANLVVTKKGQ-IKLIDFGAAADL 333
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362
R+G NYIP+ LLDP Y PE Y++ +TPS P P+A LSP+LWQ+
Sbjct: 334 RIGKNYIPERTLLDPDYCPPELYVLPEETPSPPPEPIAALLSPILWQLN 382
|
Light-dependent serine/threonine protein kinase that specifically phosphorylates N-terminal threonine residues in psbA/D1, psbD/D2, psbC/CP43 and psbH, which are components of the core antenna complex of photosystem II. Phosphorylation of PSII core components facilitates the exchange of chlorophyll proteins between the grana and the stroma lamellae. Also involved in the phosphorylation of the calcium-sensing receptor (CaS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9WV60|GSK3B_MOUSE Glycogen synthase kinase-3 beta OS=Mus musculus GN=Gsk3b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 63.5 bits (153), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL + V+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPVIYVK----------- 159
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 160 ---LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens GN=GSK3B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 63.5 bits (153), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL + V+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPVIYVK----------- 159
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 160 ---LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18266|GSK3B_RAT Glycogen synthase kinase-3 beta OS=Rattus norvegicus GN=Gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 63.5 bits (153), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPVI-------------- 156
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18431|SGG_DROME Protein kinase shaggy OS=Drosophila melanogaster GN=sgg PE=1 SV=3 | Back alignment and function description |
|---|
Score = 63.5 bits (153), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVV++A L + G+LV K ++ R +C +
Sbjct: 58 KVIGNGSFGVVFQAKLC------DTGELVAIKKVLQDRRFKNRELQIMRKLEHCNIVKLL 111
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R++ QT+ +
Sbjct: 112 YFFYSSGEKRDEVFLNLVLEYIPETVYK---VARQYAKTKQTIPIN-------------- 154
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
I+ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 155 FIRLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPETAVLKLCDFGSAKQLLHGEPNVSY 214
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 215 ICSRY-----YRAPE 224
|
Required for several developmental events such as synctial blastoderm formation and embryonic segmentation. Is involved in transcriptional regulation. Required for Arm phosphorylation. Wg signaling operates by inactivating the Sgg repression of en autoactivation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91757|GSK3B_XENLA Glycogen synthase kinase-3 beta OS=Xenopus laevis GN=gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 62.0 bits (149), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 65/236 (27%), Positives = 97/236 (41%), Gaps = 49/236 (20%)
Query: 104 SAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
S ++ + ATPG P +R TY K +G G+FGVVY+A L
Sbjct: 35 SKVTTVVATPGQGP-----------DRQQEVTYTDT-----KVIGNGSFGVVYQAKLC-- 76
Query: 164 PSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL--IW 221
+ G+LV K ++ R +C + FF +S +K E +L +
Sbjct: 77 ----DTGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281
Y E ++R + Q L + V+ M QL +L +HS
Sbjct: 133 DYVPETVY---RVARHYSRAKQALPIIYVK--------------LYMYQLFRSLAYIHSF 175
Query: 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INYIPKEFLLDPRYAAPE 334
GI HRDIKPQN++ + K+ D G+A L G ++YI + Y APE
Sbjct: 176 GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
|
Plays a role in the organization of the formation of the main body axis of developing embryo. Acts as an inhibitor of differentiation of primary neurons. Inhibits the ability of ectopically expressed NEUROD1 and other bHLH factors to promote early retinal cell differentiation. May participate in the Wnt signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5YJC2|GSK3B_SPECI Glycogen synthase kinase-3 beta OS=Spermophilus citellus GN=GSK3B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 61.2 bits (147), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFV 203
K +G G+FGVVY+A L + G+LV K ++ R +C
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 204 YGFFENSSKKGGEYW-LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
Y F+ + KK Y L+ Y E ++R + QTL + V+
Sbjct: 114 YFFYSSGEKKDVVYLNLVLDYVPETVY---RVARHYSRAKQTLPVIYVK----------- 159
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 160 ---LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Spermophilus citellus (taxid: 9997) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19454|CSK22_YEAST Casein kinase II subunit alpha' OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=CKA2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 60.1 bits (144), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 27/56 (48%), Positives = 35/56 (62%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
IQ +QLL ALD HS GI+HRD+KPQNV+ R ++ID G A G++Y
Sbjct: 144 IQYYFTQLLIALDYCHSMGIMHRDVKPQNVMIDPTERKLRLIDWGLAEFYHPGVDY 199
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. May play a role in cell proliferation. Required for cell viability. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 365 | ||||||
| 224101681 | 574 | predicted protein [Populus trichocarpa] | 0.978 | 0.621 | 0.794 | 1e-167 | |
| 449452072 | 580 | PREDICTED: serine/threonine-protein kina | 0.928 | 0.584 | 0.813 | 1e-163 | |
| 359472994 | 574 | PREDICTED: serine/threonine-protein kina | 0.920 | 0.585 | 0.811 | 1e-161 | |
| 356502478 | 581 | PREDICTED: serine/threonine-protein kina | 0.972 | 0.611 | 0.761 | 1e-160 | |
| 225423883 | 573 | PREDICTED: serine/threonine-protein kina | 0.917 | 0.584 | 0.811 | 1e-159 | |
| 356495992 | 577 | PREDICTED: serine/threonine-protein kina | 0.969 | 0.613 | 0.758 | 1e-159 | |
| 255566845 | 579 | serine/threonine protein kinase, putativ | 0.975 | 0.614 | 0.764 | 1e-159 | |
| 357488271 | 575 | Serine/threonine protein kinase SNT7 [Me | 0.975 | 0.619 | 0.764 | 1e-159 | |
| 388522803 | 575 | unknown [Medicago truncatula] | 0.978 | 0.620 | 0.755 | 1e-158 | |
| 18409136 | 562 | serine/threonine-protein kinase SNT7 [Ar | 0.947 | 0.615 | 0.762 | 1e-155 |
| >gi|224101681|ref|XP_002312380.1| predicted protein [Populus trichocarpa] gi|222852200|gb|EEE89747.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1531), Expect = e-167, Method: Compositional matrix adjust.
Identities = 294/370 (79%), Positives = 321/370 (86%), Gaps = 13/370 (3%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNNISS--------SLTTK 52
MATVASG + I ST + KPPS PFLG++L L P S+ +I++ ++
Sbjct: 1 MATVASGGT--IPIKLHSTHRPKPPS-PFLGRKLNL-NPSSRTSIATLHPKTLAVVASSG 56
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
E D V ++FLGVGVGLPCTVMECGDIIYRSTLPK +GLT+T PG ALAL +SYLWAT
Sbjct: 57 GEFFDAVHNLFLGVGVGLPCTVMECGDIIYRSTLPKPSGLTLTVPGAALALGTLSYLWAT 116
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMF LAFVERLFR T++KDDFVLGKKLGEGAFGVVYRASL KKPSSK +GDL
Sbjct: 117 PGVAPGFFDMFFLAFVERLFRPTFKKDDFVLGKKLGEGAFGVVYRASLTKKPSSK-EGDL 175
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRACAN CADFV+GF ENSSKKG EYWLIWRYEGEATL DL
Sbjct: 176 VLKKATEYGAVEIWMNERVRRACANSCADFVHGFLENSSKKGAEYWLIWRYEGEATLYDL 235
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+I+ EVQDLP+G+ERENRIIQTIM QLLFALDGLHSTGIVHRDIKPQN
Sbjct: 236 MQSKEFPYNVETMIVKEVQDLPRGLERENRIIQTIMRQLLFALDGLHSTGIVHRDIKPQN 295
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT
Sbjct: 296 IIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 355
Query: 353 ALSPVLWQVQ 362
ALSPVLWQ+
Sbjct: 356 ALSPVLWQMN 365
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452072|ref|XP_004143784.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-163, Method: Compositional matrix adjust.
Identities = 283/348 (81%), Positives = 306/348 (87%), Gaps = 9/348 (2%)
Query: 23 KPPSSPFLGKRLVL-IKP-----FSKNNISSSLTTK--AELIDTVRDVFLGVGVGLPCTV 74
K P+SPFLGK+L KP S N + L + A++I V ++F+GVGVGLPCTV
Sbjct: 24 KQPNSPFLGKKLRFKHKPPHLWTVSVQNPRNVLVSALGADMIHMVHNLFVGVGVGLPCTV 83
Query: 75 MECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRT 134
MECGDIIYRSTLPKSNGLT+T PG LAL +SYLWATPGVAPGFFDMF+LAFVER+FR
Sbjct: 84 MECGDIIYRSTLPKSNGLTLTIPGAILALGTLSYLWATPGVAPGFFDMFILAFVERIFRP 143
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
T+RKDDFVLGKKLGEGAFGVVYR SLAK PS K +GDLVLKKATEYGAVEIWMNERVRRA
Sbjct: 144 TFRKDDFVLGKKLGEGAFGVVYRVSLAKNPSDKKEGDLVLKKATEYGAVEIWMNERVRRA 203
Query: 195 CANCCADFVYGFFENSSKKG-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
CAN CADF+YGF ENSSKKG GEYWLIW++EGEATLADLM S+EFPYNV+ +ILGE Q L
Sbjct: 204 CANSCADFIYGFLENSSKKGDGEYWLIWKFEGEATLADLMQSKEFPYNVERMILGEGQQL 263
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
PKG+ERENRIIQTIM QLLFALD LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL
Sbjct: 264 PKGLERENRIIQTIMRQLLFALDSLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 323
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361
RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+
Sbjct: 324 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQM 371
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472994|ref|XP_003631227.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 275/339 (81%), Positives = 299/339 (88%), Gaps = 3/339 (0%)
Query: 27 SPFLGKRL---VLIKPFSKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYR 83
SPFLGK+L L P K + + V DVFLGVGVGLPCTVMECGDIIYR
Sbjct: 28 SPFLGKKLRSQSLSLPSKKAVSNLVCAAGGGFFNLVHDVFLGVGVGLPCTVMECGDIIYR 87
Query: 84 STLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVL 143
STLP+SNGLT+TAPG LAL A+SYLWATPGVAPGFFDMFVLAFVERLFR +++K+DFVL
Sbjct: 88 STLPRSNGLTLTAPGAILALGALSYLWATPGVAPGFFDMFVLAFVERLFRPSFKKEDFVL 147
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFV 203
GKKLGEGAFGVVYR SLAKKP +K +GDLVLKKATEYGAVEIWMNER RRACAN CA FV
Sbjct: 148 GKKLGEGAFGVVYRVSLAKKPGAKREGDLVLKKATEYGAVEIWMNERARRACANSCAYFV 207
Query: 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263
YGF E+SSKKG EYWL+WRYEGE+TL DLM+S+EFPYNV+++ILGEV DLPKG+EREN+I
Sbjct: 208 YGFLESSSKKGSEYWLLWRYEGESTLTDLMLSKEFPYNVESMILGEVPDLPKGLERENKI 267
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
IQTIM QLLFALD LHSTGIVHRDIKPQN+IFSEGSRTFKIIDLGAAADLRVGINYIPKE
Sbjct: 268 IQTIMRQLLFALDSLHSTGIVHRDIKPQNIIFSEGSRTFKIIDLGAAADLRVGINYIPKE 327
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362
FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+
Sbjct: 328 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQMN 366
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502478|ref|XP_003520046.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1466), Expect = e-160, Method: Compositional matrix adjust.
Identities = 287/377 (76%), Positives = 311/377 (82%), Gaps = 22/377 (5%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNNISSSLTT--------- 51
MAT+ G L + PKSK S FLG+RL I PF S
Sbjct: 1 MATIGIGVGVTKL-QQPHRPKSK---SLFLGQRL-RISPFWGEPQCSERRLFGVSNPPRV 55
Query: 52 -------KAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALS 104
E +DTV ++F+GVGVGLPC+VM+CGD+IYRSTLPKSNGLT+T PGV LAL
Sbjct: 56 VQVFALGGGEWLDTVHNLFVGVGVGLPCSVMQCGDVIYRSTLPKSNGLTLTVPGVILALG 115
Query: 105 AISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKP 164
+SYLWATPGVAPGFFDMFVLAFVERLFR TY+KDDFVLGKKLGEG+FGVVYR SLA KP
Sbjct: 116 TLSYLWATPGVAPGFFDMFVLAFVERLFRPTYKKDDFVLGKKLGEGSFGVVYRVSLANKP 175
Query: 165 SSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224
SSK +GDLVLKKATEYGAVEIWMNERVRRACA+ CADFVYGF E+SSKK EYWLIWR+E
Sbjct: 176 SSK-EGDLVLKKATEYGAVEIWMNERVRRACASSCADFVYGFLESSSKKAAEYWLIWRFE 234
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
G+ATLADLM SR+FPYNV+TLILGEVQDLPKG+ERENRIIQTIM Q+LFALDGLHSTGIV
Sbjct: 235 GDATLADLMQSRDFPYNVETLILGEVQDLPKGLERENRIIQTIMRQILFALDGLHSTGIV 294
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 344
HRDIKPQNVIFSE SRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS
Sbjct: 295 HRDIKPQNVIFSEESRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 354
Query: 345 APSAPVATALSPVLWQV 361
APS PVATALSPVLWQ+
Sbjct: 355 APSVPVATALSPVLWQL 371
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225423883|ref|XP_002281563.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1464), Expect = e-159, Method: Compositional matrix adjust.
Identities = 275/339 (81%), Positives = 299/339 (88%), Gaps = 4/339 (1%)
Query: 27 SPFLGKRL---VLIKPFSKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYR 83
SPFLGK+L L P K + + V DVFLGVGVGLPCTVMECGDIIYR
Sbjct: 28 SPFLGKKLRSQSLSLPSKKAVSNLVCAAGGGFFNLVHDVFLGVGVGLPCTVMECGDIIYR 87
Query: 84 STLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVL 143
STLP+SNGLT+TAPG LAL A+SYLWATPGVAPGFFDMFVLAFVERLFR +++K+DFVL
Sbjct: 88 STLPRSNGLTLTAPGAILALGALSYLWATPGVAPGFFDMFVLAFVERLFRPSFKKEDFVL 147
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFV 203
GKKLGEGAFGVVYR SLAKKP +K +GDLVLKKATEYGAVEIWMNER RRACAN CA FV
Sbjct: 148 GKKLGEGAFGVVYRVSLAKKPGAK-EGDLVLKKATEYGAVEIWMNERARRACANSCAYFV 206
Query: 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263
YGF E+SSKKG EYWL+WRYEGE+TL DLM+S+EFPYNV+++ILGEV DLPKG+EREN+I
Sbjct: 207 YGFLESSSKKGSEYWLLWRYEGESTLTDLMLSKEFPYNVESMILGEVPDLPKGLERENKI 266
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
IQTIM QLLFALD LHSTGIVHRDIKPQN+IFSEGSRTFKIIDLGAAADLRVGINYIPKE
Sbjct: 267 IQTIMRQLLFALDSLHSTGIVHRDIKPQNIIFSEGSRTFKIIDLGAAADLRVGINYIPKE 326
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362
FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+
Sbjct: 327 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQMN 365
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495992|ref|XP_003516854.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 286/377 (75%), Positives = 314/377 (83%), Gaps = 23/377 (6%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPF------------SKNN---- 44
MAT+ G L + PKSK S FLG+RL I+PF S +N
Sbjct: 1 MATIGIGVGVTKLQPHK--PKSK---SLFLGQRL-RIRPFWGEPQCSERRLFSVSNPPRV 54
Query: 45 ISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALS 104
+ E +DTV +F+GVGVGLPC+VM+CGD+IYRSTLPKSNGLT+T PGV LAL
Sbjct: 55 VQVFALAGGEWLDTVHSLFVGVGVGLPCSVMQCGDVIYRSTLPKSNGLTLTVPGVILALG 114
Query: 105 AISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKP 164
+SYLWATPGVAPGFFDMFVLAFVERLFR TY+KDDFVLGKKLGEG+FGVVYR SLA KP
Sbjct: 115 TLSYLWATPGVAPGFFDMFVLAFVERLFRPTYKKDDFVLGKKLGEGSFGVVYRVSLANKP 174
Query: 165 SSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224
SSK +GDLVLKKATEYGAVEIWMNERVRRACA+ CADFVYGF E+SSKK EYWLIWR+E
Sbjct: 175 SSK-EGDLVLKKATEYGAVEIWMNERVRRACASSCADFVYGFLESSSKKAAEYWLIWRFE 233
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
G+ATLADLM SR+FPYNV+TLILGEVQDLPKG+ERENRIIQTI+ Q+LFALDGLHSTGIV
Sbjct: 234 GDATLADLMQSRDFPYNVETLILGEVQDLPKGLERENRIIQTIVRQILFALDGLHSTGIV 293
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 344
HRDIKPQN+IFSE SRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS
Sbjct: 294 HRDIKPQNIIFSEESRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 353
Query: 345 APSAPVATALSPVLWQV 361
APS PVATALSPVLWQ+
Sbjct: 354 APSVPVATALSPVLWQL 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566845|ref|XP_002524406.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223536367|gb|EEF38017.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 566 bits (1459), Expect = e-159, Method: Compositional matrix adjust.
Identities = 282/369 (76%), Positives = 308/369 (83%), Gaps = 13/369 (3%)
Query: 3 TVASGSATLVLINRRSTPKSKPPSSP-----FLGKRL---VLIKPFSKNNISSSLTTKA- 53
T+ SG A +V I + KP +S FLGK+L +P N + S+
Sbjct: 4 TITSGGAGIVPIKLHT---QKPITSSLSSSSFLGKKLSPRFSSRPIFSNPRAVSVIASGG 60
Query: 54 -ELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
E D V ++FLGVGVGLPCTVMECGDIIYRSTLPKSNGLT+TAPG LA A+SYLWAT
Sbjct: 61 GEFFDAVHNLFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTLTAPGAVLAFGALSYLWAT 120
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMF LAFVERLFR T+RKDDFVLGKKLGEGAFGVVYR SL KKPSSK +GDL
Sbjct: 121 PGVAPGFFDMFFLAFVERLFRPTFRKDDFVLGKKLGEGAFGVVYRVSLTKKPSSKREGDL 180
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRACA+ CADF+YGF E+SSKK EYWL+WR+EGEATL DL
Sbjct: 181 VLKKATEYGAVEIWMNERVRRACASSCADFLYGFLESSSKKEAEYWLVWRFEGEATLYDL 240
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+ FPYNV+++IL EVQDLPKG+ERENRIIQTIM QLLFALDGLHSTGIVHRDIKPQN
Sbjct: 241 MQSKGFPYNVESMILKEVQDLPKGLERENRIIQTIMRQLLFALDGLHSTGIVHRDIKPQN 300
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSRTFKIIDLGAAADLRVGINYIP EFLLDPRYAAPEQYIMSTQTPSAPS PVAT
Sbjct: 301 IIFSEGSRTFKIIDLGAAADLRVGINYIPNEFLLDPRYAAPEQYIMSTQTPSAPSPPVAT 360
Query: 353 ALSPVLWQV 361
LSPVLWQ+
Sbjct: 361 VLSPVLWQL 369
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357488271|ref|XP_003614423.1| Serine/threonine protein kinase SNT7 [Medicago truncatula] gi|355515758|gb|AES97381.1| Serine/threonine protein kinase SNT7 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 566 bits (1459), Expect = e-159, Method: Compositional matrix adjust.
Identities = 285/373 (76%), Positives = 317/373 (84%), Gaps = 17/373 (4%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNN------ISSSLTTKA- 53
MATVA+ + + R P K S FLG+RL IKP + + +TTKA
Sbjct: 1 MATVATKGIGVTKL-RPYNPNKK---SIFLGQRL-RIKPSNNEQPPQPPCSARFITTKAI 55
Query: 54 ----ELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYL 109
L+++ ++F+GVGVGLPCTVMECGD+IYRSTLPKS+GL +T PGV LA A+SYL
Sbjct: 56 HGAEWLLESAHNLFVGVGVGLPCTVMECGDMIYRSTLPKSSGLNVTVPGVVLAFGALSYL 115
Query: 110 WATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKND 169
WATPGVAPGFFDMFVLAFVERLFR T+RKDDFVLGKKLGEG+FGVVYR +LAKKPSSK +
Sbjct: 116 WATPGVAPGFFDMFVLAFVERLFRPTFRKDDFVLGKKLGEGSFGVVYRVTLAKKPSSK-E 174
Query: 170 GDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229
GDLVLKKATEYGAVEIWMNERVRRACAN CADFVYGF E S+KK EYWLIWR+EG+ATL
Sbjct: 175 GDLVLKKATEYGAVEIWMNERVRRACANSCADFVYGFLERSTKKTPEYWLIWRFEGDATL 234
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
ADL+ SR+FPYNV+TLILGEVQDLPKG+EREN+IIQTI+ QLLFALDGLHSTGIVHRDIK
Sbjct: 235 ADLLQSRDFPYNVETLILGEVQDLPKGLERENKIIQTIIRQLLFALDGLHSTGIVHRDIK 294
Query: 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349
PQN+IFSEGSRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP
Sbjct: 295 PQNIIFSEGSRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 354
Query: 350 VATALSPVLWQVQ 362
VATALSPVLWQ+
Sbjct: 355 VATALSPVLWQLN 367
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388522803|gb|AFK49463.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-158, Method: Compositional matrix adjust.
Identities = 281/372 (75%), Positives = 314/372 (84%), Gaps = 15/372 (4%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVL---------IKPFSKNNISSSLTT 51
MATVA+ + + P + S FLG+RL + P S I++
Sbjct: 1 MATVATKGIGVTKLR----PYNPNKKSIFLGQRLRIKPPNNEQPPQPPCSARFITTKAIH 56
Query: 52 KAE-LIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLW 110
AE L+++ ++F+GVGVGLPCTVMECGD+IYRSTLPKS+GL +T PGV LA A+SYLW
Sbjct: 57 GAEWLLESAHNLFVGVGVGLPCTVMECGDMIYRSTLPKSSGLNVTVPGVVLAFGALSYLW 116
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
ATPGVAPGFFDMFVLAFVERLFR T+RKDDFVLGKKLGEG+FGVVYR +LAKKPSSK +G
Sbjct: 117 ATPGVAPGFFDMFVLAFVERLFRPTFRKDDFVLGKKLGEGSFGVVYRVTLAKKPSSK-EG 175
Query: 171 DLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLA 230
DLVLKKATEYGAVEIWMNERVRRACAN CADFVYGF E S+KK EYWLIWR+EG+ATLA
Sbjct: 176 DLVLKKATEYGAVEIWMNERVRRACANSCADFVYGFLERSTKKTPEYWLIWRFEGDATLA 235
Query: 231 DLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
DL+ SR+FPYNV+TLILGEVQDLPKG+EREN+IIQTI+ QLLFALDGLHSTGIVHRDIKP
Sbjct: 236 DLLQSRDFPYNVETLILGEVQDLPKGLERENKIIQTIIRQLLFALDGLHSTGIVHRDIKP 295
Query: 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350
QN+IFSEGSRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV
Sbjct: 296 QNIIFSEGSRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 355
Query: 351 ATALSPVLWQVQ 362
ATALSPVLWQ+
Sbjct: 356 ATALSPVLWQLN 367
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18409136|ref|NP_564946.1| serine/threonine-protein kinase SNT7 [Arabidopsis thaliana] gi|62901055|sp|Q9S713.1|STT7_ARATH RecName: Full=Serine/threonine-protein kinase STN7, chloroplastic; AltName: Full=Protein STATE TRANSITION 7; AltName: Full=Stt7 homolog; Flags: Precursor gi|12323224|gb|AAG51596.1|AC011665_17 putative protein kinase [Arabidopsis thaliana] gi|12324136|gb|AAG52037.1|AC011914_7 putative protein kinase; 22015-24834 [Arabidopsis thaliana] gi|133778850|gb|ABO38765.1| At1g68830 [Arabidopsis thaliana] gi|332196725|gb|AEE34846.1| serine/threonine-protein kinase SNT7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 282/370 (76%), Positives = 321/370 (86%), Gaps = 24/370 (6%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFS--------KNNISSSLTTK 52
MAT++ G A + TP SPFLGK+L KPFS K + + + +
Sbjct: 1 MATISPGGAYI------GTP------SPFLGKKL---KPFSLTSPILSFKPTVKLNSSCR 45
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
A+LIDTV ++F+GVGVGLPCTVMECGD+IYRSTLPKSNGLTITAPGVALAL+A+SYLWAT
Sbjct: 46 AQLIDTVHNLFIGVGVGLPCTVMECGDMIYRSTLPKSNGLTITAPGVALALTALSYLWAT 105
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMFVLAFVERLFR T+RKDDFV+GKKLGEG+FGVVY+ SL+KK S++ +G+
Sbjct: 106 PGVAPGFFDMFVLAFVERLFRPTFRKDDFVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEY 164
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRAC N CADFVYGF + SSKKG EYWL+W+YEGE+TLA L
Sbjct: 165 VLKKATEYGAVEIWMNERVRRACGNSCADFVYGFLDKSSKKGPEYWLLWKYEGESTLAGL 224
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+ILG+VQDLPKG+EREN+IIQTIM QLLFALDGLHSTGI+HRD+KPQN
Sbjct: 225 MQSKEFPYNVETIILGKVQDLPKGLERENKIIQTIMRQLLFALDGLHSTGIIHRDVKPQN 284
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSR+FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA
Sbjct: 285 IIFSEGSRSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAA 344
Query: 353 ALSPVLWQVQ 362
ALSPVLWQ+
Sbjct: 345 ALSPVLWQMN 354
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 365 | ||||||
| TAIR|locus:2205465 | 562 | STN7 "STT7 homolog STN7" [Arab | 0.901 | 0.585 | 0.750 | 4.1e-136 | |
| TAIR|locus:2181067 | 495 | STN8 "State transition 8" [Ara | 0.517 | 0.381 | 0.397 | 9.7e-46 | |
| TAIR|locus:2136917 | 501 | CPK4 "calcium-dependent protei | 0.216 | 0.157 | 0.354 | 1.8e-07 | |
| UNIPROTKB|K7EQN8 | 153 | STK11 "Serine/threonine-protei | 0.134 | 0.320 | 0.48 | 2.6e-07 | |
| TAIR|locus:2014691 | 495 | CDPK2 "AT1G35670" [Arabidopsis | 0.224 | 0.165 | 0.322 | 6.1e-07 | |
| ZFIN|ZDB-GENE-091116-7 | 311 | si:ch211-193e5.3 "si:ch211-193 | 0.202 | 0.237 | 0.324 | 8.6e-07 | |
| UNIPROTKB|G3N1T2 | 247 | GSK3B "Uncharacterized protein | 0.189 | 0.279 | 0.366 | 8.9e-07 | |
| ZFIN|ZDB-GENE-090312-19 | 340 | si:dkey-45j10.1 "si:dkey-45j10 | 0.202 | 0.217 | 0.363 | 9.2e-07 | |
| UNIPROTKB|F8VYH9 | 170 | CDK4 "Cyclin-dependent kinase | 0.147 | 0.317 | 0.438 | 1.2e-06 | |
| ZFIN|ZDB-GENE-090312-25 | 328 | si:ch211-194c3.4 "si:ch211-194 | 0.232 | 0.259 | 0.358 | 1.4e-06 |
| TAIR|locus:2205465 STN7 "STT7 homolog STN7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1333 (474.3 bits), Expect = 4.1e-136, P = 4.1e-136
Identities = 256/341 (75%), Positives = 292/341 (85%)
Query: 29 FLGKRLVLIKPFS--------KNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDI 80
FLGK+L KPFS K + + + +A+LIDTV ++F+GVGVGLPCTVMECGD+
Sbjct: 17 FLGKKL---KPFSLTSPILSFKPTVKLNSSCRAQLIDTVHNLFIGVGVGLPCTVMECGDM 73
Query: 81 IYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDD 140
IYRSTLPKSNGLTITAPGVALAL+A+SYLWATPGVAPGFFDMFVLAFVERLFR T+RKDD
Sbjct: 74 IYRSTLPKSNGLTITAPGVALALTALSYLWATPGVAPGFFDMFVLAFVERLFRPTFRKDD 133
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
FV+GKKLGEG+FGVVY+ SL+KK S++ +G+ VLKKATEYGAVEIWMNERVRRAC N CA
Sbjct: 134 FVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEYVLKKATEYGAVEIWMNERVRRACGNSCA 192
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
DFVYGF + SSKKG EYWL+W+YEGE+TLA LM S+EFPYNV+T+ILG+VQDLPKG+ERE
Sbjct: 193 DFVYGFLDKSSKKGPEYWLLWKYEGESTLAGLMQSKEFPYNVETIILGKVQDLPKGLERE 252
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI 320
N+IIQTIM QLLFALDGLHSTGI+HRD+KPQN+IFSEGSR+FKIIDLGAAADLRVGINYI
Sbjct: 253 NKIIQTIMRQLLFALDGLHSTGIIHRDVKPQNIIFSEGSRSFKIIDLGAAADLRVGINYI 312
Query: 321 PKEFLLDPRYAAPEQYIMXXXXXXXXXXXXXXXXXXVLWQV 361
PKEFLLDPRYAAPEQYIM VLWQ+
Sbjct: 313 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAAALSPVLWQM 353
|
|
| TAIR|locus:2181067 STN8 "State transition 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 384 (140.2 bits), Expect = 9.7e-46, Sum P(2) = 9.7e-46
Identities = 78/196 (39%), Positives = 117/196 (59%)
Query: 174 LKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK----KGGEYWLIWRYEGEATL 229
++ A E+G E W N R+ RA + CA+F+ F + + KGG+ WL+WR+EG+ L
Sbjct: 192 VRGAEEFGEYEEWFNYRLSRAAPDTCAEFLGSFVADKTNTMFTKGGK-WLVWRFEGDRDL 250
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
AD M R FP N+++++ G V + ++R II+ IM Q++ +L +H TGIVHRD+K
Sbjct: 251 ADYMKDRSFPSNLESIMFGRVLQGVESVKRRALIIKQIMRQIITSLRKIHGTGIVHRDVK 310
Query: 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMXXXXXXXXXXX 349
P N++ ++ + K+ID GAAADLR+G NYIP+ LLDP Y PE Y++
Sbjct: 311 PANLVVTKKGQ-IKLIDFGAAADLRIGKNYIPERTLLDPDYCPPELYVLPEETPSPPPEP 369
Query: 350 XXXXXXXVLWQVQCSP 365
+LWQ+ SP
Sbjct: 370 IAALLSPILWQLN-SP 384
|
|
| TAIR|locus:2136917 CPK4 "calcium-dependent protein kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 116 (45.9 bits), Expect = 1.8e-07, Sum P(2) = 1.8e-07
Identities = 34/96 (35%), Positives = 52/96 (54%)
Query: 248 GEVQD--LPKGI--EREN-RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
GE+ D + KG ERE ++I+TI+ ++ HS G++HRD+KP+N +F S
Sbjct: 109 GELFDRIVSKGCFSEREAAKLIKTILG----VVEACHSLGVMHRDLKPENFLFDSPSDDA 164
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ A D + + Y P ++L D P Y APE
Sbjct: 165 KL----KATDFGLSVFYKPGQYLYDVVGSPYYVAPE 196
|
|
| UNIPROTKB|K7EQN8 STK11 "Serine/threonine-protein kinase STK11" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 110 (43.8 bits), Expect = 2.6e-07, Sum P(2) = 2.6e-07
Identities = 24/50 (48%), Positives = 32/50 (64%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ QL+ L+ LHS GIVH+DIKP N++ + G T KI DLG A L
Sbjct: 95 VKKYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISDLGVAEAL 143
|
|
| TAIR|locus:2014691 CDPK2 "AT1G35670" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 113 (44.8 bits), Expect = 6.1e-07, Sum P(2) = 6.1e-07
Identities = 30/93 (32%), Positives = 48/93 (51%)
Query: 248 GEVQD--LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
GE+ D + KG E ++ I + +L ++ HS G++HRD+KP+N +F K+
Sbjct: 110 GELFDRIVSKGHFSEREAVKLIKT-ILGVVEACHSLGVMHRDLKPENFLFDSPKDDAKL- 167
Query: 306 DLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
A D + + Y P ++L D P Y APE
Sbjct: 168 ---KATDFGLSVFYKPGQYLYDVVGSPYYVAPE 197
|
|
| ZFIN|ZDB-GENE-091116-7 si:ch211-193e5.3 "si:ch211-193e5.3" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 122 (48.0 bits), Expect = 8.6e-07, Sum P(2) = 8.6e-07
Identities = 25/77 (32%), Positives = 44/77 (57%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
+ R+ + ++ QL+ AL S G++HRD+KP+N++ S ++ K++D G L+ Y
Sbjct: 189 DERLAKRVLVQLIAALKHCESRGVLHRDVKPENLLISTETQDIKLLDFGCGDQLKSSA-Y 247
Query: 320 IPKEFLLDPRYAAPEQY 336
+ F P YA PE +
Sbjct: 248 --RYFAGTPAYAPPEWF 262
|
|
| UNIPROTKB|G3N1T2 GSK3B "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 112 (44.5 bits), Expect = 8.9e-07, Sum P(2) = 8.9e-07
Identities = 26/71 (36%), Positives = 38/71 (53%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G +
Sbjct: 133 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 190
Query: 324 FLLDPRYAAPE 334
++ Y APE
Sbjct: 191 YICSRYYRAPE 201
|
|
| ZFIN|ZDB-GENE-090312-19 si:dkey-45j10.1 "si:dkey-45j10.1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 131 (51.2 bits), Expect = 9.2e-07, Sum P(2) = 9.2e-07
Identities = 28/77 (36%), Positives = 46/77 (59%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
+ R+ + ++ QL+ AL S+G++HRD+KP+N++ S+ S+ K++D G DL Y
Sbjct: 190 DERLAKKVLVQLIAALKHCESSGVLHRDVKPENLLISKESQDIKLLDFGCG-DLLKRSAY 248
Query: 320 IPKEFLLDPRYAAPEQY 336
K F P YA PE +
Sbjct: 249 --KYFAGTPAYAPPEWF 263
|
|
| UNIPROTKB|F8VYH9 CDK4 "Cyclin-dependent kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 115 (45.5 bits), Expect = 1.2e-06, Sum P(2) = 1.2e-06
Identities = 25/57 (43%), Positives = 35/57 (61%)
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
P G+ E I+ +M Q L LD LH+ IVHRD+KP+N++ + G T K+ D G A
Sbjct: 109 PPGLPAET--IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLA 162
|
|
| ZFIN|ZDB-GENE-090312-25 si:ch211-194c3.4 "si:ch211-194c3.4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 129 (50.5 bits), Expect = 1.4e-06, Sum P(2) = 1.4e-06
Identities = 33/92 (35%), Positives = 48/92 (52%)
Query: 247 LGEVQDLPKGIER----ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
L QDL E + R+ + ++ QL+ AL S G++HRD+KP+N++ S S+
Sbjct: 161 LAPCQDLQSFCEENGCLDERLAKKVLVQLIAALKHCESRGVLHRDVKPENLLISTESQNI 220
Query: 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
K++D G DL Y K F P YA PE
Sbjct: 221 KLLDFGCG-DLLKRSAY--KYFAGTPAYAPPE 249
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S713 | STT7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7621 | 0.9479 | 0.6156 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 365 | |||
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.0 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-23 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-18 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 0.003 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.004 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 622 bits (1607), Expect = 0.0
Identities = 263/348 (75%), Positives = 296/348 (85%), Gaps = 7/348 (2%)
Query: 19 TPKSKPPSSPFLGKRLV---LIKPFSKNNISSSLTTKA--ELIDTVRDVFLGVGVGLPCT 73
+ S FLG++L L + ++ + + +LT A ELID V ++F+GVGVGLPCT
Sbjct: 7 VAGASGSPSRFLGRKLSSRRLSRAPARRSRARALTAAAGGELIDAVHNLFVGVGVGLPCT 66
Query: 74 VMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFR 133
VMECGD+IYRSTLP+SNGLTITAPG ALAL A +YLWATPGVAPGF DMFVLA +E LFR
Sbjct: 67 VMECGDVIYRSTLPRSNGLTITAPGAALALLAATYLWATPGVAPGFVDMFVLAPLEGLFR 126
Query: 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
+++KDDFVLGKKLGEGAFGVVY+ASL K S K +G VLKKATEYGAVEIWMNERVRR
Sbjct: 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKK-EGKYVLKKATEYGAVEIWMNERVRR 185
Query: 194 ACANCCADFVYGFFENSSKKGG-EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
AC N CADFVYGF E S K EYWL+WRYEGE+TLADLM S+EFPYNV+ +LG+VQD
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQD 245
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
LPKG+EREN+IIQTIM Q+LFALDGLHSTGIVHRD+KPQN+IFSEGS +FKIIDLGAAAD
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAAD 305
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360
LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ
Sbjct: 306 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 96/312 (30%), Positives = 158/312 (50%), Gaps = 48/312 (15%)
Query: 92 LTITAPGVALALSAISY-LWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEG 150
L+ T PG+ L+A+ Y L++ P +D +V A + + + DDF L KLG G
Sbjct: 98 LSPTLPGIG-RLTALYYLLFSKPNPLFNIWDFYVGAPLADGANSRWSSDDFQLRDKLGGG 156
Query: 151 AFGVVYRA-----------SLAKKPSSKNDGDLVLKK---------------------AT 178
FG+ + +K + + +VLK+ +
Sbjct: 157 NFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSA 216
Query: 179 EYGAVEIWMNERVRR--ACANCCADFVYGFFENSSKKG----GEYWLIWRYEGEATLADL 232
E G VE +M +++R A CA+++ G+F +++ G G WL+W++E +ATL D
Sbjct: 217 ETGMVEAYMCAKIKRNPIAAASCAEYL-GYFTSNTADGAFTKGSQWLVWKFESDATLGDA 275
Query: 233 MISR--EFPYNVQTLILGEVQDLPKGIERENR---IIQTIMSQLLFALDGLHSTGIVHRD 287
+ + FP ++ ++ + +P + ++ R +I+ +M Q+L L LH GIVHRD
Sbjct: 276 LDGKLGPFPGCLEEFMMAG-KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRD 334
Query: 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347
IKP+N++ + + KIID GAA D+ GIN+ P +LDPRY+ PE+ +M P AP+
Sbjct: 335 IKPENLLVTVDGQV-KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPA 393
Query: 348 APVATALSPVLW 359
+A LSP W
Sbjct: 394 PAMAALLSPFAW 405
|
Length = 507 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 54/197 (27%), Positives = 82/197 (41%), Gaps = 39/197 (19%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRRACA--NCC 199
LGEG FG VY A K G V +KK +E + E + + N
Sbjct: 1 LGEGGFGTVYLAR------DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54
Query: 200 ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259
+YG FE+ +L+ Y +L DL+ E +
Sbjct: 55 K--LYGVFED----ENHLYLVMEYCEGGSLKDLLKENEGKLS------------------ 90
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
E+ I++ I+ Q+L L+ LHS GI+HRD+KP+N++ + K+ D G + L
Sbjct: 91 EDEILR-ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKS 148
Query: 320 IPKEFLLDPRYAAPEQY 336
+ K + P Y APE
Sbjct: 149 LLKTIVGTPAYMAPEVL 165
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 54/200 (27%), Positives = 81/200 (40%), Gaps = 38/200 (19%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---AN 197
+ L +KLG G+FG VY+A K G +V K + + + ++ RR
Sbjct: 1 YELLRKLGSGSFGTVYKAKH------KGTGKIVAVKILKKRSEKSKKDQTARREIRILRR 54
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ FE+ +L+ Y L D +SR P +
Sbjct: 55 LSHPNIVRLIDAFEDKD----HLYLVMEYCEGGDLFDY-LSRGGPLS------------- 96
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
E E + I Q+L L+ LHS GI+HRD+KP+N++ E KI D G A
Sbjct: 97 ---EDE---AKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV-KIADFGLAK-KL 148
Query: 315 VGINYIPKEFLLDPRYAAPE 334
+ + F+ P Y APE
Sbjct: 149 LKSSSSLTTFVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.6 bits (210), Expect = 2e-18
Identities = 57/207 (27%), Positives = 82/207 (39%), Gaps = 37/207 (17%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA--- 196
+ + +KLGEG+FG VY A K + K VL K E + E+ R + A
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALK-----VLAKKLESKSKEVERFLREIQILASLN 55
Query: 197 --NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
F + S +L+ Y +L DL+ +
Sbjct: 56 HPPNIVKLYDFFQDEGS-----LYLVMEYVDGGSLEDLLKKIGRKGPLS----------- 99
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
I++Q+L AL+ LHS GI+HRDIKP+N++ R K+ID G A L
Sbjct: 100 ------ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153
Query: 315 -----VGINYIPKEFLLDPRYAAPEQY 336
I +P + P Y APE
Sbjct: 154 DPGSTSSIPALPSTSVGTPGYMAPEVL 180
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 60/201 (29%), Positives = 82/201 (40%), Gaps = 42/201 (20%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRACA 196
+ + +KLGEG+FG VY A K G LV +KK E + E +
Sbjct: 1 YEILEKLGEGSFGKVYLAR------DKKTGKLVAIKVIKKKKIKKDRERILREI--KILK 52
Query: 197 NCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ Y FE+ K +L+ Y L DL+ R L
Sbjct: 53 KLKHPNIVRLYDVFEDEDK----LYLVMEYCEGGDLFDLLKKRGR--------------L 94
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
E E + + Q+L AL+ LHS GIVHRD+KP+N++ E K+ D G A L
Sbjct: 95 S---EDE---ARFYLRQILSALEYLHSKGIVHRDLKPENILLDE-DGHVKLADFGLARQL 147
Query: 314 RVGINYIPKEFLLDPRYAAPE 334
G F+ P Y APE
Sbjct: 148 DPGEKL--TTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 44/194 (22%), Positives = 67/194 (34%), Gaps = 61/194 (31%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSS----KNDGDLVLKKA--TEYGAVEIWMNERVR 192
DDF GK +GEG+F V A K+ + K +L K + V+ E+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKE-KETNKEYAIK-----ILDKRQLIKEKKVKYVKIEK-- 52
Query: 193 RACANCCADF-----VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFP 239
+Y F++ GE R G S +
Sbjct: 53 -EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---------SLDEK 102
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
+ +++L AL+ LHS GI+HRD+KP+N++ +
Sbjct: 103 -----------------------CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM 139
Query: 300 RTFKIIDLGAAADL 313
KI D G A L
Sbjct: 140 HI-KITDFGTAKVL 152
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 46/205 (22%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--EIWMNERV 191
F + +K+G+G FG VY+A K G V L+ + + EI
Sbjct: 1 LFEILEKIGKGGFGEVYKAR------HKRTGKEVAIKVIKLESKEKKEKIINEI------ 48
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ C + ++ S K E W++ + +L DL+ S E Q
Sbjct: 49 -QILKKCKHPNIVKYY-GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-------ESQ 99
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAA 310
I + +LL L+ LHS GI+HRDIK N++ S+G K+ID G +
Sbjct: 100 ------------IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLS 145
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQ 335
A L + P + APE
Sbjct: 146 AQLSDTK--ARNTMVGTPYWMAPEV 168
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+ F + +KLGEG++G VY+A +A K + + K EI + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-------EISILK-- 53
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
C + ++ ++ S K + W++ Y G +++D+M +TL
Sbjct: 54 -----QCDSPYIVKYY-GSYFKNTDLWIVMEYCGAGSVSDIMKITN-----KTLT----- 97
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
E E I I+ Q L L+ LHS +HRDIK N++ +E K+ D G +
Sbjct: 98 ------EEE---IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSG 147
Query: 312 DLRVGINYIPKEFLLDPRYAAPE 334
L + P + APE
Sbjct: 148 QL-TDTMAKRNTVIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 48/208 (23%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-RVR 192
++ G+ LG G+FG VY A K+ G+L+ L +E + E R+
Sbjct: 1 EWTRGELLGRGSFGSVYLAL------DKDTGELMAVKSVELSGDSEEELEAL-EREIRIL 53
Query: 193 RA--CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-FPYNVQTLILGE 249
+ N YG + K + Y +L+ L+ P V
Sbjct: 54 SSLQHPNIVR--YYGSERDEEKNT--LNIFLEYVSGGSLSSLLKKFGKLPEPV------- 102
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
I+ Q+L L LHS GIVHRDIK N++ K+ D G
Sbjct: 103 --------------IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVV-KLADFGC 147
Query: 310 AADLRVGINYIPKEFLL---DPRYAAPE 334
A R+G + P + APE
Sbjct: 148 AK--RLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 39/196 (19%)
Query: 146 KLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+GEGA+GVV + +A K +++ D +KK E+ + ++R N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHE--NI 62
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ + ++ G +L++ Y +L ++ P G+
Sbjct: 63 VN------LKEAFRRKGRLYLVFEY--------------VERT----LLELLEASPGGLP 98
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
+ +++ + QLL A+ HS I+HRDIKP+N++ SE S K+ D G A LR
Sbjct: 99 PD--AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPA 155
Query: 319 YIPKEFLLDPRYAAPE 334
+++ Y APE
Sbjct: 156 SPLTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 41/187 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC 195
F L + +GEG +G VY+A K G LV K + EI + R
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKT------GQLVAIKIMDIIEDEEEEIKEEYNILRKY 59
Query: 196 AN--CCADFVYGFFENSSKKGG--EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+N A F YG F + G + WL+ G G V
Sbjct: 60 SNHPNIATF-YGAFIKKNPPGNDDQLWLVMELCGG---------------------GSVT 97
Query: 252 DLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
DL KG+ ++ + I I+ + L L LH ++HRDIK QN++ ++ + K++D
Sbjct: 98 DLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV-KLVD 156
Query: 307 LGAAADL 313
G +A L
Sbjct: 157 FGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 55/186 (29%), Positives = 74/186 (39%), Gaps = 60/186 (32%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDLV-LKK----ATEYGAV-----EIWMNERVRR-AC 195
+GEGA+G VY+A N G V LKK +E G EI + +++
Sbjct: 7 IGEGAYGTVYKAR------DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 196 ANCCA--DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV-QD 252
N D +G R + E L TL+ V QD
Sbjct: 61 PNIVRLLDVCHG---------------PRTDRELKL--------------TLVFEHVDQD 91
Query: 253 L--------PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L G+ E I+ +M QLL +D LHS IVHRD+KPQN++ + KI
Sbjct: 92 LATYLSKCPKPGLPPE--TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS-DGQVKI 148
Query: 305 IDLGAA 310
D G A
Sbjct: 149 ADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 51/188 (27%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D K LG+G+ GVVY+ K G + LKK + + +E R+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH------KPTGKIYALKK------IHVDGDEEFRKQLLR 48
Query: 198 -------CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
C + +V YG F K GE ++ Y +LAD +L
Sbjct: 49 ELKTLRSCESPYVVKCYGAFY----KEGEISIVLEYMDGGSLAD--------------LL 90
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV-IFSEGSRTFKII 305
+V +P+ ++ I Q+L LD LH+ I+HRDIKP N+ I S+G KI
Sbjct: 91 KKVGKIPE------PVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIA 142
Query: 306 DLGAAADL 313
D G + L
Sbjct: 143 DFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 30/198 (15%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVR--RACA 196
DF + K+G+G+FGVV++ K D + +K+ E + R A
Sbjct: 1 DFEILNKIGKGSFGVVFKVV------RKADKRVYAMKQIDLSKMNRREREEAIDEARVLA 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ ++ ++E S G+ ++ Y L L+ + + LP
Sbjct: 55 KLDSSYIIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQR------------GRPLP-- 99
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
E+++ + Q+L L LHS I+HRDIK N+ KI DLG A L
Sbjct: 100 ---EDQVWR-FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV-KIGDLGVAKLLSDN 154
Query: 317 INYIPKEFLLDPRYAAPE 334
N+ + P Y +PE
Sbjct: 155 TNF-ANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 21/121 (17%)
Query: 236 REFPYNVQTLILGEVQDLPKGIERENR----IIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
E Y V L+LG DL + ++ + ++ + +++ AL+ LHS GI+HRDIKP
Sbjct: 72 EENMYLVVDLLLG--GDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPD 129
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPEQYIMSTQTPSAP 346
N++ E I D A + + L P Y APE ++ Q S
Sbjct: 130 NILLDEQGHV-HITDFNIATKV-------TPDTLTTSTSGTPGYMAPE--VLCRQGYSVA 179
Query: 347 S 347
Sbjct: 180 V 180
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (144), Expect = 6e-10
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---- 195
+ + K++G+G+FG VY K+DG L + K + M+E+ R
Sbjct: 1 KYEIIKQIGKGSFGKVYLVR------RKSDGKLYVLKEIDLSN----MSEKEREDALNEV 50
Query: 196 ---ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ ++E S ++ G+ ++ Y L+ + ++
Sbjct: 51 KILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQK---KEGKPF------ 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLG 308
E +I+ QL AL LHS I+HRDIKPQN+ + S G K+ D G
Sbjct: 101 ------PEEQILD-WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFG 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 55/190 (28%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKK----PSSKNDGDLVLKKATEYGAVEIWM 187
+ F L + +G+G+FG VY+A +A K ++++ + + + EI
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ--------EIQF 52
Query: 188 NERVRRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQT 244
+ C + ++ YG F SK W+I Y G + DL+ +
Sbjct: 53 -------LSQCRSPYITKYYGSFLKGSK----LWIIMEYCGGGSCLDLLKPGKLD----- 96
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
I I+ ++L L+ LH G +HRDIK N++ SE K+
Sbjct: 97 ----------------ETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE-EGDVKL 139
Query: 305 IDLGAAADLR 314
D G + L
Sbjct: 140 ADFGVSGQLT 149
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 59/218 (27%), Positives = 73/218 (33%), Gaps = 74/218 (33%)
Query: 143 LGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATE---------------- 179
G K+G G FG VY A +A K D D K
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 180 YGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFP 239
Y VE+ + VY F E Y TL +L
Sbjct: 64 YYGVEVHREK-------------VYIFME--------------YCSGGTLEEL------- 89
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
L G + D +I+ QLL L LHS GIVHRDIKP N IF + +
Sbjct: 90 -----LEHGRILDE--------HVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN-IFLDHN 135
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLL---DPRYAAPE 334
K+ D G A L+ + +E P Y APE
Sbjct: 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 38/202 (18%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR------- 192
DF + KKLG+G++G VY+ K+ S D K + G+ M+++ R
Sbjct: 1 DFKVLKKLGKGSYGSVYKV---KRLS---DNQFYALKEVDLGS----MSQKEREDAVNEI 50
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
R A+ + + E + G + ++ Y A DL + + +
Sbjct: 51 RILASVNHPNIISYKE-AFLDGNKLCIVMEY---APFGDL-------SKAIS----KRKK 95
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
K I + I I QLL L LH I+HRD+K N++ KI DLG +
Sbjct: 96 KRKLIPEQ--EIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGIS-- 150
Query: 313 LRVGINYIPKEFLLDPRYAAPE 334
+V + K + P Y APE
Sbjct: 151 -KVLKKNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 43/177 (24%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-------LKKATEYGAVEIWMNERVRRACAN 197
+K+GEGA G VY+A+ + G V K+ E EI + + C +
Sbjct: 25 EKIGEGASGEVYKAT------DRATGKEVAIKKMRLRKQNKELIINEI----LIMKDCKH 74
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ +++ S G E W++ Y +L D++ N E Q
Sbjct: 75 ---PNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-------EPQ------ 117
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAADL 313
I + ++L L+ LHS ++HRDIK N+ + +GS K+ D G AA L
Sbjct: 118 ------IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQL 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (137), Expect = 5e-09
Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 251 QDLPKGIEREN-----RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
DL K +++ +I++IM QLL L HS I+HRD+KPQN++ + K+
Sbjct: 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR-DGVLKLA 140
Query: 306 DLGAA 310
D G A
Sbjct: 141 DFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 222 RYEGEATLADLMIS-REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280
R+E +L+D+ IS E Y V L+ ++ L E + IQ + Q+L L +HS
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
G+VHRD+KP N++ +E KI D G A
Sbjct: 127 AGVVHRDLKPSNILINENC-DLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 57/218 (26%)
Query: 141 FVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAV---EI 185
+ LG +G G+FGVVY A + + P KN L++K + +
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+ E ++ N + V F + K +++ +R N L
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY----------------AR----NNHAL 167
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
L +++ QL AL +HS I HRD+KPQN++ + T K+
Sbjct: 168 PL--------------FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213
Query: 306 DLGAAADLRVG---INYIPKEFLLDPRYAAPEQYIMST 340
D G+A +L G ++YI F Y APE + +T
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGAT 246
|
Length = 440 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR--RACA 196
DD+ L + +G GA VVY A + V K + + ++E + +A +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPN------NEKVAIKRIDLEKCQTSVDELRKEVQAMS 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
C V ++ S G E WL+ Y +L D+M S P+G
Sbjct: 55 QCNHPNVVKYY-TSFVVGDELWLVMPYLSGGSLLDIMKSS----------------YPRG 97
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-GSRTFKIIDLGAAADLRV 315
E II T++ ++L L+ LHS G +HRDIK N++ E GS KI D G +A L
Sbjct: 98 GLDEA-IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLAD 154
Query: 316 GINYIP---KEFLLDPRYAAPE 334
G + K F+ P + APE
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 51/209 (24%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA---- 200
+ +G+G+FG V K K+DG +++ K +YG M E+ ++ +
Sbjct: 6 ETIGKGSFGTVR------KVRRKSDGKILVWKEIDYGN----MTEKEKQQLVSEVNILRE 55
Query: 201 ---DFVYGFFE---NSSKKGGEYWLIWRYEGEATLADLMISR---EFPYNVQTLILGEVQ 251
+ +++ + S + +++ Y LA L I + E Y
Sbjct: 56 LKHPNIVRYYDRIIDRSNQ--TLYIVMEYCEGGDLAQL-IQKCKKERKY----------- 101
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLH-----STGIVHRDIKPQNVIFSEGSRTFKIID 306
IE E I + I++QLL AL H ++HRD+KP N IF + + K+ D
Sbjct: 102 -----IE-EEFIWR-ILTQLLLALYECHNRSDPGNTVLHRDLKPAN-IFLDANNNVKLGD 153
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQ 335
G A L + K ++ P Y +PEQ
Sbjct: 154 FGLAKILGHD-SSFAKTYVGTPYYMSPEQ 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 53/198 (26%), Positives = 79/198 (39%), Gaps = 72/198 (36%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK-ATEYGAVEIWMNER-------- 190
+ + K+LG+G FG VY LA+ K G+LV +KK ++ + E MN R
Sbjct: 1 YKVIKQLGDGTFGSVY---LARN---KETGELVAIKKMKKKFYSWEECMNLREVKSLRKL 54
Query: 191 -----------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-- 237
V R N FV+ + E + L LM R+
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYMEGN------------------LYQLMKDRKGK 94
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
F +V I++I+ Q+L L +H G HRD+KP+N++ S
Sbjct: 95 PFSESV---------------------IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133
Query: 297 EGSRTFKIIDLGAAADLR 314
G KI D G A ++R
Sbjct: 134 -GPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK--KATEYGAVEIWMNE-RVRR 193
++D+ L +++G G +G VY+A G+LV +K K EI E + +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKAR------DIATGELVAIKVIKLEPGDDFEIIQQEISMLK 55
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
C + +G S + + W++ Y G +L D+ Y V L E+Q
Sbjct: 56 ECRHPNIVAYFG----SYLRRDKLWIVMEYCGGGSLQDI-------YQVTRGPLSELQ-- 102
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
I + + L L LH TG +HRDIK N++ +E K+ D G +A L
Sbjct: 103 ----------IAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDV-KLADFGVSAQL 151
Query: 314 RVGINYIPKEFLLDPRYAAPE 334
I K F+ P + APE
Sbjct: 152 TATIAK-RKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 35/173 (20%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA----TEYGAVEIWMNERVRRACAN 197
+ ++GEGA G+V++A + G+ V LKK E G + E +A
Sbjct: 4 ILGRIGEGAHGIVFKAK------DRETGETVALKKVALRRLEGGIPNQALREI--KALQA 55
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
C +V + G + L+ Y L++++ E P LP+
Sbjct: 56 CQHPYVVKLLD-VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-------------LPE-- 98
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+++ M LL + +H+ GI+HRD+KP N++ S KI D G A
Sbjct: 99 ----AQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA-DGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+++G+G+FG V++ + + L++A + EI ++ + C + +V
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S KG + W+I Y G + DL+ R P++ E Q I
Sbjct: 66 KYY-GSYLKGTKLWIIMEYLGGGSALDLL--RAGPFD-------EFQ------------I 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
T++ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 57/204 (27%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-VRRACANCC 199
LG+G+FG V L +K K+ G L VLKK + VE + ER + +
Sbjct: 1 LGKGSFGKVL---LVRK---KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-- 52
Query: 200 ADFV----YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
F+ Y F + E Y V G +L
Sbjct: 53 -PFIVKLHYAF---------------------------QTEEKLYLVLEYAPG--GELFS 82
Query: 256 GIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAA 310
+ +E R + ++++ AL+ LHS GI++RD+KP+N++ ++G K+ D G A
Sbjct: 83 HLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLA 140
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
+L + F P Y APE
Sbjct: 141 KELSSEGSRT-NTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 36/122 (29%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 251 QDLPKGIERENR---------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301
DL K ++ R I++ M QLL + H G++HRD+KPQN++ +
Sbjct: 90 SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149
Query: 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361
KI DLG + + E ++ Y APE + ST S PV +W V
Sbjct: 150 LKIADLGLGRAFSIPVKSYTHE-IVTLWYRAPEVLLGSTHY----STPVD------IWSV 198
Query: 362 QC 363
C
Sbjct: 199 GC 200
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 32/87 (36%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLGAAA------DLRVGIN 318
+M Q+L AL H+ GIVHRD+KPQN++ S K++D G D V
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSA 345
E L P Y APEQ TP++
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNS 170
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 31/169 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKAT--EYGAVEIWMNERVRRACANCCAD 201
K+GEG +GVVY+A K G++V +KK R +
Sbjct: 5 GKIGEGTYGVVYKAR------DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
+ + KG Y L++ + + L L+ R+ LP
Sbjct: 59 NIIKLLDVFRHKGDLY-LVFEFM-DTDLYKLIKDRQRG-------------LP------E 97
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+I++ + QLL L HS GI+HRD+KP+N++ + K+ D G A
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 49/199 (24%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANC 198
LG+GAFG VY+A K G K + + VEI + C
Sbjct: 13 LGDGAFGKVYKAQ------HKETGLFAAAKIIQIESEEELEDFMVEI-------DILSEC 59
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ G +E + + W++ + L +M+ E L E Q
Sbjct: 60 KHPNIVGLYEAYFYEN-KLWILIEFCDGGALDSIMLELERG-------LTEPQ------- 104
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGI 317
I+ + Q+L AL+ LHS ++HRD+K N++ +G K+ D G +A +
Sbjct: 105 -----IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNK--- 154
Query: 318 NYIPKE--FLLDPRYAAPE 334
+ + K F+ P + APE
Sbjct: 155 STLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 9e-08
Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 9/76 (11%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR-VGINYIPK 322
IQ + Q+L L LHS ++HRD+KP N++ + KI D G A R V + K
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLA---RGVDPDEDEK 160
Query: 323 EFLLD---PR-YAAPE 334
FL + R Y APE
Sbjct: 161 GFLTEYVVTRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 8/71 (11%)
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
N+ LI G + LP E R+ ++ M QLL +LD +H GI HRDIKP+N++ +
Sbjct: 85 NLYELIKGRKRPLP-----EKRV-KSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-- 136
Query: 301 TFKIIDLGAAA 311
K+ D G+
Sbjct: 137 ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 23/71 (32%), Positives = 40/71 (56%), Gaps = 6/71 (8%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+ +++++ ++ LH GI+HRDIKP+N++ + K+ D G + R G K+
Sbjct: 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-LKLTDFGLS---RNG--LENKK 152
Query: 324 FLLDPRYAAPE 334
F+ P Y APE
Sbjct: 153 FVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT--FKIIDLGAAADLRVGI 317
+ + Q +++L+ A+ +H G VHRDIKP+NV+ RT K+ D G+AA L
Sbjct: 100 DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156
Query: 318 NYIPKEFLLDPRYAAPE 334
K + P Y APE
Sbjct: 157 MVNSKLPVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 28/89 (31%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+L +++ P G++ E+R+ + + Q+L ++ HS I+HRDIKP+N++ S+ S K+
Sbjct: 86 VLDDLEKYPNGLD-ESRV-RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ-SGVVKLC 142
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A L + +++ Y APE
Sbjct: 143 DFGFARTL-AAPGEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 38/126 (30%), Positives = 62/126 (49%), Gaps = 15/126 (11%)
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
F Y V+ +L ++++P G+ E +++ + QL+ A+ H IVHRDIKP+N++ S
Sbjct: 79 FEY-VEKNMLELLEEMPNGVPPEK--VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357
K+ D G A +L G N E++ Y +PE + AP A+
Sbjct: 136 ND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL---------GAPYGKAVD-- 183
Query: 358 LWQVQC 363
+W V C
Sbjct: 184 MWSVGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 55/184 (29%), Positives = 79/184 (42%), Gaps = 48/184 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIW--MNERVRRAC 195
+F + KK+G+G F VVY+A DG +V LKK V+I+ M+ + R+ C
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI------CLLDGRVVALKK------VQIFEMMDAKARQDC 49
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI---LGEVQD 252
E K ++ + +Y LA F N + I L + D
Sbjct: 50 LK----------EIDLLKQLDHPNVIKY-----LA------SFIENNELNIVLELADAGD 88
Query: 253 LPKGIER--------ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L + I+ R I QL AL+ +HS I+HRDIKP NV F + K+
Sbjct: 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV-FITATGVVKL 147
Query: 305 IDLG 308
DLG
Sbjct: 148 GDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 17/106 (16%)
Query: 244 TLILGEV-QDLPKGIER------ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
TL+ V QDL +++ I+ +M QLL LD LHS +VHRD+KPQN++ +
Sbjct: 85 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 144
Query: 297 EGSRTFKIIDLGAA---------ADLRVGINYIPKEFLLDPRYAAP 333
+ K+ D G A + V + Y E LL YA P
Sbjct: 145 SSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 51/189 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAV---------EIWMN 188
D+ + KLGEG FG VY+A G +V LKK + EI +
Sbjct: 8 RDYEILGKLGEGTFGEVYKAR------QIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 189 ERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
++++ D + S +K G +++ PY L
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV-----------------TPYMDHDL--- 101
Query: 249 EVQDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRT 301
G+ + I+ M QLL ++ LH I+HRDIK N+ I ++G
Sbjct: 102 ------SGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--I 153
Query: 302 FKIIDLGAA 310
KI D G A
Sbjct: 154 LKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+++G+G+FG VY+ + + L++A + EI ++ + C + ++
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYIT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S KG + W+I Y G + DL+ K E I
Sbjct: 66 RYY-GSYLKGTKLWIIMEYLGGGSALDLL---------------------KPGPLEETYI 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 10/76 (13%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLG----AAADLRVGINYIP 321
+++++ AL+ LHS GI+HRD+KP N++ S G K+ D G ++ +N
Sbjct: 98 YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 322 KE---FLLDPRYAAPE 334
KE + P Y APE
Sbjct: 156 KEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AG 170
Query: 317 INYIPKEFLLDPRYAAPE 334
+++ +++ Y APE
Sbjct: 171 TSFMMTPYVVTRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 23/144 (15%)
Query: 204 YGFFENSSKKG--GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
YG F S G + WL+ + G ++ DL+ + KG +
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN------------------TKGNALKE 120
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
I I ++L L LH+ ++HRDIK QNV+ +E + K++D G +A L +
Sbjct: 121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGR-R 178
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSA 345
F+ P + APE I + P A
Sbjct: 179 NTFIGTPYWMAPE-VIACDENPDA 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 38/108 (35%), Positives = 51/108 (47%), Gaps = 21/108 (19%)
Query: 244 TLILGEV-QDL--------PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
TL+ V QDL P G+ E I+ +M Q L LD LH+ IVHRD+KP+N++
Sbjct: 83 TLVFEHVDQDLRTYLDKVPPPGLPAET--IKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140
Query: 295 FSEGSRTFKIIDLG---------AAADLRVGINYIPKEFLLDPRYAAP 333
+ G K+ D G A + V + Y E LL YA P
Sbjct: 141 VTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AG 177
Query: 317 INYIPKEFLLDPRYAAPE 334
+++ +++ Y APE
Sbjct: 178 TSFMMTPYVVTRYYRAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 23/144 (15%)
Query: 204 YGFF--ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
YG F +N + WL+ + G ++ DL+ + KG +
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN------------------TKGNTLKE 110
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
I I ++L L LH ++HRDIK QNV+ +E + K++D G +A L +
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGR-R 168
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSA 345
F+ P + APE I + P A
Sbjct: 169 NTFIGTPYWMAPE-VIACDENPDA 191
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 23/48 (47%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+ M QLL L LHS GI+HRDIK N+ I ++G K+ D G A
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/210 (28%), Positives = 84/210 (40%), Gaps = 49/210 (23%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--------EYGAVEIWM 187
+F L + LG GA+G V+ L +K + G L VLKKAT E+ E +
Sbjct: 1 NFELLRVLGTGAYGKVF---LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57
Query: 188 NERVRRACANCCADFVYGF--FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
E VRR C V F+ +K LI Y L + RE
Sbjct: 58 LEAVRR-----CPFLVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQRE-------- 100
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKI 304
E E R+ +++++ ALD LH GI++RDIK +N++ SEG +
Sbjct: 101 ---------HFTESEVRVY---IAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVL 146
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G + + F Y APE
Sbjct: 147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+K+G+G+FG V++ + + L++A + EI ++ + C + +V
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S K + W+I Y G + DL+ + L E Q I
Sbjct: 66 KYY-GSYLKDTKLWIIMEYLGGGSALDLL---------EPGPLDETQ------------I 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ IM QLL AL +HS ++HRD+KP N++ + R K+ D G A
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV-KLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 25/78 (32%), Positives = 43/78 (55%), Gaps = 3/78 (3%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AC 174
Query: 317 INYIPKEFLLDPRYAAPE 334
N++ +++ Y APE
Sbjct: 175 TNFMMTPYVVTRYYRAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 60/217 (27%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNER---- 190
++ LG +G GAFGVVY+ + GD V K A++ M E
Sbjct: 1 NYQLGDLIGRGAFGVVYKGL------NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLK 54
Query: 191 -------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
V+ G E S ++I Y +L + I + P+
Sbjct: 55 NLKHPNIVK----------YIGSIETS----DSLYIILEYAENGSLRQI-IKKFGPFP-- 97
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTF 302
E+ + + Q+L L LH G++HRDIK N+ +G
Sbjct: 98 ----------------ESLVA-VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VV 138
Query: 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 339
K+ D G A L ++ + P + APE MS
Sbjct: 139 KLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 53/208 (25%), Positives = 78/208 (37%), Gaps = 51/208 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSK--------NDGDLVLKKATEYGAVEIWMNER 190
DD +LG G GVV + +P+ K + + ++K I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAIQKQ-------ILRELD 51
Query: 191 VRRACANC--CADFVYG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
+ C N F YG F+ N G+ + Y +L IL
Sbjct: 52 ILHKC-NSPYIVGF-YGAFYNN-----GDISICMEYMDGGSLDK--------------IL 90
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIID 306
EVQ I RI+ I +L L LH I+HRD+KP N++ + K+ D
Sbjct: 91 KEVQ---GRI--PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCD 144
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPE 334
G + L +N + K F+ Y APE
Sbjct: 145 FGVSGQL---VNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 32/199 (16%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRAC 195
+ D+ L +++G G +G VY+A + L+ ++ + EI+M + C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM----VKEC 63
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+C +G + + K W+ Y G +L D+ Y+V T L E+Q
Sbjct: 64 KHCNIVAYFGSYLSREK----LWICMEYCGGGSLQDI-------YHV-TGPLSELQ---- 107
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
I + + L L LHS G +HRDIK N++ ++ K+ D G AA +
Sbjct: 108 --------IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV-KLADFGVAAKITA 158
Query: 316 GINYIPKEFLLDPRYAAPE 334
I K F+ P + APE
Sbjct: 159 TIAK-RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +HS GI+HRD+KP N+ +E KI+D G A
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 47/208 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERV--- 191
++FV+ K + GAFG VY L +K KN+ L V+KKA + M +V
Sbjct: 4 EEFVIVKPISRGAFGKVY---LGRK---KNNSKLYAVKVVKKAD---MINKNMVHQVQAE 54
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
R A A + F+ + S + +L+ Y LI G+V+
Sbjct: 55 RDALALSKSPFIVHLYY-SLQSANNVYLVMEY---------------------LIGGDVK 92
Query: 252 DLPK--GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLG 308
L G E ++ I S++ ALD LH GI+HRD+KP N++ S EG K+ D G
Sbjct: 93 SLLHIYGYFDEEMAVKYI-SEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFG 149
Query: 309 -AAADLRVGINYIPKEFLLDPRYAAPEQ 335
+ L +N + + L P A P+
Sbjct: 150 LSKVTLNRELNMM--DILTTPSMAKPKN 175
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G V+ L K + I I+ ++L AL +H G++HRDIK N++ + K+ D
Sbjct: 87 GSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNV-KLCDF 145
Query: 308 GAAADL 313
G AA L
Sbjct: 146 GVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 13/82 (15%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAAADLRVGIN 318
++++++ Q+L + LHS ++HRD+KP N+ + EG KI DLG A R+ N
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA---RL-FN 163
Query: 319 YIPKEFL-LDPR-----YAAPE 334
K LDP Y APE
Sbjct: 164 APLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 25/71 (35%), Positives = 41/71 (57%), Gaps = 1/71 (1%)
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
Y V L+ ++ ++ K + + +Q ++ QLL L +HS GI+HRD+KP NV +E
Sbjct: 96 YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC 155
Query: 300 RTFKIIDLGAA 310
+I+D G A
Sbjct: 156 E-LRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 22/169 (13%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+ +G GAFG+V+ L ++ K D LV+ K VE M + R A N C
Sbjct: 6 RVVGRGAFGIVH---LCRR---KADQKLVIIKQIP---VE-QMTKDERLAAQNEC----- 50
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
K +I YE LMI E Y + +Q + E+ I+
Sbjct: 51 ----QVLKLLSHPNIIEYYENFLEDKALMIVME--YAPGGTLAEYIQKRCNSLLDEDTIL 104
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ Q+L AL +H+ I+HRD+K QN++ + KI D G + L
Sbjct: 105 HFFV-QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
+ R+I+T + Q+L + HS ++HRD+KPQN++ + K+ D G A + +
Sbjct: 99 KNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363
E ++ Y APE + S S PV +W V C
Sbjct: 159 TFTHE-VVTLWYRAPEILLGSRHY----STPVD------IWSVGC 192
|
Length = 294 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 26/70 (37%), Positives = 35/70 (50%), Gaps = 13/70 (18%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPR 329
Q+L + LHS GI+HRD+KP N++ T KI+D G A R F++ P
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA---RTAGT----SFMMTPY 177
Query: 330 -----YAAPE 334
Y APE
Sbjct: 178 VVTRYYRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 28/65 (43%), Positives = 34/65 (52%), Gaps = 1/65 (1%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPR 329
Q+L L LH IVHRDIK NV+ + S KI D G + L GIN + F +
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 330 YAAPE 334
Y APE
Sbjct: 175 YMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR-RACANCCADFVY 204
+LG+GAFG VY+A +K G L K E + E + V A C ++
Sbjct: 19 ELGDGAFGKVYKAK------NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV 72
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREF-PYNVQTLILGEVQDLPKGIERENRI 263
G YW +G+ L I EF P I+ E L +G+
Sbjct: 73 KLL------GAFYW-----DGK-----LWIMIEFCPGGAVDAIMLE---LDRGLTEPQ-- 111
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPK 322
IQ I Q+L AL LHS I+HRD+K NV+ + +G K+ D G +A + + +
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAK---NVKTLQR 166
Query: 323 E--FLLDPRYAAPEQYIMST 340
F+ P + APE + T
Sbjct: 167 RDSFIGTPYWMAPEVVMCET 186
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 44/205 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--EIWMNE 189
++DF L +++G G +G VY+A + N G+L L+ ++ V EI M +
Sbjct: 8 QEDFELIQRIGSGTYGDVYKAR------NVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK 61
Query: 190 RVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+C + +F S + + W+ + G +L D+ Y+V T L E
Sbjct: 62 -------DCKHSNIVAYF-GSYLRRDKLWICMEFCGGGSLQDI-------YHV-TGPLSE 105
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
Q I + + L L LHS G +HRDIK N++ ++ K+ D G
Sbjct: 106 SQ------------IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHV-KLADFGV 152
Query: 310 AADLRVGINYIPKEFLLDPRYAAPE 334
+A + I K F+ P + APE
Sbjct: 153 SAQITATIAK-RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 38/178 (21%)
Query: 140 DFVLGKKLGEGAFGVVYRAS--LAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRAC 195
+F + KK+G G F VYRA+ L +KP + LKK V+I+ M+ + R+ C
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKP-------VALKK------VQIFEMMDAKARQDC 49
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
E K + + +Y L + E ++ G++ + K
Sbjct: 50 VK----------EIDLLKQLNHPNVIKY-----LDSFIEDNELNIVLELADAGDLSQMIK 94
Query: 256 GIERENRII--QTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+++ R+I +T+ QL A++ +HS ++HRDIKP NV F + K+ DLG
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV-FITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I++ M L L+ LHS I+HRD+KP N++ + K+ D G A
Sbjct: 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 46/208 (22%), Positives = 69/208 (33%), Gaps = 64/208 (30%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDL-VLKK-----ATEYGAVEIWMNERVRRACANCCA 200
LG G FG V K+ LK E G E +E+ C
Sbjct: 1 LGVGGFGRVE------LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK--EILEECNH 52
Query: 201 DFV-----------YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
F+ Y + GGE W I R G L
Sbjct: 53 PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG------LF---------------- 90
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + ++ ++ A + LH+ GI++RD+KP+N++ K++D G
Sbjct: 91 ----------DEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV-KLVDFGF 139
Query: 310 AADLRVGINYIPKEFLL--DPRYAAPEQ 335
A L+ G K + P Y APE
Sbjct: 140 AKKLKSG----QKTWTFCGTPEYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 29/175 (16%)
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANC 198
G K+G G +G VY+A K+ K+D D LK+ G EI + ++
Sbjct: 6 GCKVGRGTYGHVYKA---KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS 62
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
F ++ +K WL++ Y + R N + + LP+G+
Sbjct: 63 LQKV---FLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV------QLPRGM- 109
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAA 310
+++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 110 -----VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 40/184 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
DDF + K +G GAFG V+ L + K+ G + VL+K+ + + ER
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRD---KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI 54
Query: 193 RACANC--CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
A A+ Y F + +L+ Y L +L+I
Sbjct: 55 LADADSPWIVKLYYSFQDEEH-----LYLVMEYMPGGDLMNLLIR--------------- 94
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
K + E + +++L+ ALD +H G +HRDIKP N++ K+ D G
Sbjct: 95 ----KDVFPEE-TARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA-DGHIKLADFGLC 148
Query: 311 ADLR 314
+
Sbjct: 149 KKMN 152
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 4/74 (5%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
+++ I +L L LHS I+HRDIKP N++ + + K+ D G + +L +N +
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV-KLCDFGVSGEL---VNSLA 160
Query: 322 KEFLLDPRYAAPEQ 335
F Y APE+
Sbjct: 161 GTFTGTSFYMAPER 174
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 22/66 (33%), Positives = 36/66 (54%), Gaps = 7/66 (10%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
I ++ K ++I+ IM +L L+ +H GI H DIKP+N++ +R + II
Sbjct: 116 IFKRIKCKNK------KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-II 168
Query: 306 DLGAAA 311
D G A+
Sbjct: 169 DYGIAS 174
|
Length = 294 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 52/179 (29%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRRACA-NCC 199
K LG+G+FG V+ L +K + + G L VLKKAT + + +RVR +
Sbjct: 2 KVLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKAT------LKVRDRVRTKMERDIL 52
Query: 200 ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259
A+ + F L + ++ E L LIL D +G +
Sbjct: 53 AEVNHPFIVK---------LHYAFQTEGKL--------------YLIL----DFLRGGDL 85
Query: 260 ENRIIQTIM----------SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
R+ + +M ++L ALD LHS GI++RD+KP+N++ E K+ D G
Sbjct: 86 FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFG 143
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 251 QDLPK-----GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
QDL K + + I+++ M QLL L HS ++HRD+KPQN++ + + K+
Sbjct: 83 QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLA 141
Query: 306 DLGAA 310
D G A
Sbjct: 142 DFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 248 GEVQDLPKG-IERENR----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
G V DL KG ++R R II I+ + L L LH +HRD+K N++ +
Sbjct: 105 GSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GV 163
Query: 303 KIIDLGAAADL---RVGINY-IPKEFLLDPRYAAPEQYIMST 340
K++D G +A L R+ N + F + P A EQ + ST
Sbjct: 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 7/68 (10%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
M+++ A+D LH G +HRD+KP+N +I + G K+ D G + GI +
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSK----GIVTYANSVVG 160
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 161 SPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRI----IQTIMSQLLFALDGLHSTGI 283
L D+ + +F V ++ DL K ++R+ R+ ++ I+ Q+L L+ LH
Sbjct: 84 GLVDVYVEGDFINLVMDIMAS---DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYF 140
Query: 284 VHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
+HRD+ P N+ I S+G KI D G A
Sbjct: 141 MHRDLSPANIFINSKG--ICKIADFGLA 166
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 252 DLPK--GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
DL K G +Q ++ Q+L L +HS GI+HRD+KP N+ +E KI+D G
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGL 163
Query: 310 A 310
A
Sbjct: 164 A 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 46/177 (25%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRRACANCC- 199
K LG+G +G V+ +K + + G + VLKKAT + + + R
Sbjct: 2 KVLGKGGYGKVF---QVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK 58
Query: 200 ----ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
D +Y F + GG+ +LI Y L GE L
Sbjct: 59 HPFIVDLIYAF-----QTGGKLYLILEY---------------------LSGGE---LFM 89
Query: 256 GIERENRIIQTI----MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ERE ++ +S++ AL+ LH GI++RD+KP+N++ K+ D G
Sbjct: 90 HLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV-KLTDFG 145
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
F Y T+ L E++ P+G+ +I+ I+ Q L A++ H +HRD+KP+N++ ++
Sbjct: 79 FEYCDHTV-LNELEKNPRGVPEH--LIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135
Query: 298 GSRTFKIIDLGAAADL-RVGINYIPKEFLLDPRYAAPEQYIMSTQ 341
+ K+ D G A L G +Y +++ Y APE + TQ
Sbjct: 136 QGQ-IKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQ 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 25/66 (37%), Positives = 37/66 (56%), Gaps = 3/66 (4%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
+Q++ L+ LH IV+RD+KP+NV+ + +I DLG A +L+ G K P
Sbjct: 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV-RISDLGLAVELKGGKK--IKGRAGTP 158
Query: 329 RYAAPE 334
Y APE
Sbjct: 159 GYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 41/181 (22%)
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
TY+K D KLGEG++ VY+ SK G LV K EI +
Sbjct: 6 TYKKLD-----KLGEGSYATVYKGR------SKLTGQLVALK-------EIRLEHE---E 44
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGE 249
A A E S K ++ TL D++ +++ F Y + T +
Sbjct: 45 GAPFTA-----IREASLLKD------LKHANIVTLHDIIHTKKTLTLVFEY-LDTDLKQY 92
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ D G+ N ++ + QLL L H ++HRD+KPQN++ SE K+ D G
Sbjct: 93 MDDCGGGLSMHN--VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE-LKLADFGL 149
Query: 310 A 310
A
Sbjct: 150 A 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 36/179 (20%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA 196
+ D + +KLGEG++ VY K SK +G LV K E +R A
Sbjct: 3 KADSYEKLEKLGEGSYATVY------KGKSKVNGKLVALKVIRLQEEEGTPFTAIREA-- 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGEVQ 251
S KG ++ L D++ ++E F Y V T + +
Sbjct: 55 -------------SLLKG------LKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMD 94
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
P G+ EN ++ + QLL L +H I+HRD+KPQN++ S+ + K+ D G A
Sbjct: 95 KHPGGLHPEN--VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD-TGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 20/50 (40%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
+I++ + QLL + HS ++HRD+KPQN+ I EG K+ D G A
Sbjct: 99 PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 22/51 (43%), Positives = 33/51 (64%), Gaps = 2/51 (3%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
E+RI Q ++ Q+L L +H+ GI+HRD+KP N+ +E KI+D G A
Sbjct: 117 EDRI-QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC 195
D + + + +G+G +G VY+ + +K DG L K + + EI + ++
Sbjct: 22 DTWEIIETIGKGTYGKVYKVT------NKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75
Query: 196 AN--CCADFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
N F YG F + K GG+ WL+ ++ +L+ LI G+ D
Sbjct: 76 PNHPNVVKF-YGMFYKADKLVGGQLWLVLELCNGGSVTELVKG--------LLICGQRLD 126
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAA 311
+I I+ L L LH+ I+HRD+K N++ + EG K++D G +A
Sbjct: 127 EA--------MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSA 176
Query: 312 DL---RVGINY-IPKEFLLDPRYAAPEQ 335
L R+ N + F + P A EQ
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-05
Identities = 16/42 (38%), Positives = 24/42 (57%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
I+ QL+ AL+ LH I+H DIK +NV++ + D G
Sbjct: 114 IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYG 155
|
Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 43/204 (21%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKN-------DGDLVLKKATEYGAVEIWMNERVRR 193
+ + KK+GEG+FG +Y LAK S D + K E E+ + +++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLM--ISREFPYNVQTLILGEV 250
N F S ++ G +++ Y +G DLM I+R+
Sbjct: 59 P--NIVT------FFASFQENGRLFIVMEYCDG----GDLMKRINRQ------------- 93
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+G+ I + Q+ L +H I+HRDIK QN+ S+ K+ D G A
Sbjct: 94 ----RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
L + + + P Y +PE
Sbjct: 150 RQLNDSME-LAYTCVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 44/206 (21%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
++L ++LG+G+FG VY K + LK E E+ NE V+ AN A
Sbjct: 2 YILQQRLGKGSFGTVYLVK-----DKKAVAEERLKVLKEIPVGELNPNETVQ---ANQEA 53
Query: 201 D------------FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
F F E + + +I Y L + E + +TL
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDA-----FCIITEYCEGRDLDCKL--EELKHTGKTL--- 103
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
EN++ + + QLL + +H I+HRD+K +N+ + KI D G
Sbjct: 104 ----------SENQVCEWFI-QLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFG 150
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPE 334
+ L +G + F P Y +PE
Sbjct: 151 VSR-LLMGSCDLATTFTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ + QLL L +HS ++HRD+KP N++ +E +I D G A
Sbjct: 109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMA 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 20/54 (37%), Positives = 28/54 (51%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ +I QLL L LH I+HRD+K N++ + +I D GAAA L
Sbjct: 101 KEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 11/69 (15%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLL- 326
S+++ AL+ LHS IV+RD+KP+N++ EG K+ D G A LR + + L
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR------DRTWTLC 159
Query: 327 -DPRYAAPE 334
P Y APE
Sbjct: 160 GTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 2/66 (3%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
+Q++ L+ LH I++RD+KP+NV+ +I DLG A +L+ G + K + P
Sbjct: 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV-RISDLGLAVELKDGQSKT-KGYAGTP 161
Query: 329 RYAAPE 334
+ APE
Sbjct: 162 GFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 252 DLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
DL K I + ++ + Q+L L LHS GI+HRDIKP N++ + KI D
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDF 147
Query: 308 GAA 310
G A
Sbjct: 148 GLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 23/71 (32%), Positives = 40/71 (56%), Gaps = 1/71 (1%)
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
Y V L+ ++ ++ K + + +Q ++ Q+L L +HS I+HRD+KP N+ +E
Sbjct: 98 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 300 RTFKIIDLGAA 310
KI+D G A
Sbjct: 158 E-LKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 26/79 (32%), Positives = 36/79 (45%), Gaps = 13/79 (16%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA-----ADLRVGIN 318
I++ M QLL L+ H +HRDIK N++ + K+ D G A + R N
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTN 176
Query: 319 ------YIPKEFLL-DPRY 330
Y P E LL + RY
Sbjct: 177 KVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 24/73 (32%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
I T+ +L AL LH+ G++HRDIK +++ + R K+ D G A + +P+
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV-KLSDFGFCAQVSKE---VPRR 172
Query: 324 FLL--DPRYAAPE 334
L P + APE
Sbjct: 173 KSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 45/202 (22%), Positives = 73/202 (36%), Gaps = 39/202 (19%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+D LGK LGEGAFG V +A + + +K + A
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------------DATEK 57
Query: 198 CCADFV--------YGFFEN------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
+D V G +N + G +++ Y L D + +R P
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 244 TLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
+ E + ++S Q+ ++ L S +HRD+ +NV+ +E
Sbjct: 118 SPDDPRPP-------EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH- 169
Query: 301 TFKIIDLGAAADLRVGINYIPK 322
KI D G A D+ I+Y K
Sbjct: 170 VMKIADFGLARDIH-HIDYYRK 190
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 19/47 (40%), Positives = 25/47 (53%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ M QLL L +HS ++HRD+KP NV + KI D G A
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 43/145 (29%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISR-EFPYNVQTLILGEVQDLPKGIERENRI 263
G+ + S + +Y + +G AD+ S E PY+ Q LP ER R
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYD---------QYLPSAPERTRRD 227
Query: 264 IQTIMSQLLFALD-------------GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
S L +D L S VHRD+ +NV+ EG + KI D G A
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVKICDFGLA 286
Query: 311 ADLRVGINYIPKEFLLDP-RYAAPE 334
D+ NYI K P ++ APE
Sbjct: 287 RDIMRDSNYISKGSTFLPLKWMAPE 311
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 36/177 (20%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIW--MNERVRRACA 196
+F + KK+G G F VYRA+ DG V LKK V+I+ M+ + R C
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLL------DGVPVALKK------VQIFDLMDAKARADCI 50
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
E K + + +Y A + E ++ G++ + K
Sbjct: 51 K----------EIDLLKQLNHPNVIKYY-----ASFIEDNELNIVLELADAGDLSRMIKH 95
Query: 257 IERENRII--QTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+++ R+I +T+ QL AL+ +HS ++HRDIKP NV F + K+ DLG
Sbjct: 96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV-FITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC 195
+ +D LGK LGEG FG V A K K AV++ ++ +
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-------PKEAVTVAVKMLKDDATEKDL 64
Query: 196 ANCCADF----VYGFFEN------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
++ ++ + G +N + + G ++I Y + L + + +R P +
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+ V D + + + Q+ ++ L S +HRD+ +NV+ +E + KI
Sbjct: 125 DIARVPDEQMTFKD----LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIA 179
Query: 306 DLGAAADLRVGINYIPKEF--LLDPRYAAPE 334
D G A D+ I+Y K L ++ APE
Sbjct: 180 DFGLARDVN-NIDYYKKTTNGRLPVKWMAPE 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 45/208 (21%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--------EYGAVEIWM 187
+F L K LG GA+G V+ L +K S + G L VLKKAT E+ E +
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57
Query: 188 NERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-FPYNVQTLI 246
E +R++ + F+ +K LI Y L + RE F +
Sbjct: 58 LEHIRQSPFLVTLHYA---FQTDTK----LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
GE+ + AL+ LH GI++RDIK +N++ + D
Sbjct: 111 SGEI---------------------VLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTD 148
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPE 334
G + + F Y AP+
Sbjct: 149 FGLSKEFHEDEVERAYSFCGTIEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
++ +M QLL + LH I+HRD+K N++ + KI D G A
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-- 313
G E E + +++L L+ LH V+RD+KP+N++ + +I DLG A +
Sbjct: 98 GFEEERALFYA--AEILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPE 154
Query: 314 ------RVG-INYIPKEFLLDPRYAAPEQY 336
RVG + Y+ E L + RY Y
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDY 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
+Q++ AL+ LHS IV+RD+KP+N+ + S+G KI D G A
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 33/105 (31%), Positives = 47/105 (44%), Gaps = 19/105 (18%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPK 322
IQ + Q+L L +HS ++HRD+KP N++ + KI D G A R+ +
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLA---RIADPEHDHT 163
Query: 323 EFLLD---PR-YAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363
FL + R Y APE IM S A+ +W V C
Sbjct: 164 GFLTEYVATRWYRAPE--IMLN------SKGYTKAID--IWSVGC 198
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
R +D VLGK LGEG FG V A K + + T+ AV++ ++
Sbjct: 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPN------RVTKV-AVKMLKSDATE 64
Query: 193 RACANCCADF----VYGFFEN------SSKKGGEYWLIWRYEGEATLADLMISR-----E 237
+ ++ ++ + G +N + + G ++I Y + L + + +R E
Sbjct: 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVI 294
+ YN P + E + ++S Q+ ++ L S +HRD+ +NV+
Sbjct: 125 YCYN------------PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172
Query: 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEF--LLDPRYAAPE 334
+E KI D G A D+ I+Y K L ++ APE
Sbjct: 173 VTE-DNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPE 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 6/71 (8%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
I I L L LHS +HRDIK N++ +E T K+ D G+A+ +
Sbjct: 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSAS-----LVSPANS 170
Query: 324 FLLDPRYAAPE 334
F+ P + APE
Sbjct: 171 FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 35/117 (29%), Positives = 48/117 (41%), Gaps = 11/117 (9%)
Query: 220 IWRYEGEATLAD-LMISREF-PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG 277
I +Y G D L I E P +L + P+ +I+ Q+L L+
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE------PVIRLYTRQILLGLEY 117
Query: 278 LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
LH VHRDIK N I + + K+ D G A +V K F P + APE
Sbjct: 118 LHDRNTVHRDIKGAN-ILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP--- 321
Q + QLL AL +H+ + HRD+KP+N I + KI D G A RV N P
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKN-ILANADCKLKICDFGLA---RVAFNDTPTAI 161
Query: 322 --KEFLLDPRYAAPE 334
+++ Y APE
Sbjct: 162 FWTDYVATRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 12/88 (13%)
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL- 313
+G+E E I + +Q+ + LHS IV+RD+KP+NV+ + ++ DLG A +L
Sbjct: 90 RGLEMERVIHYS--AQITCGILHLHSMDIVYRDMKPENVLLDDQGNC-RLSDLGLAVELK 146
Query: 314 -------RVGIN-YIPKEFLLDPRYAAP 333
R G N Y+ E L + Y+ P
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYP 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 16/85 (18%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN----- 318
I+ +M LL L +H I+HRD+K N++ ++ K+ D G A + N
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNR 179
Query: 319 ---------YIPKEFLLDPR-YAAP 333
Y P E LL R Y P
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G +HRD+KP N++ + S K+ D G
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 9/68 (13%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL-- 326
++L+ A + LHS I++RD+KP+N++ + K+ D G A + + F L
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLL-DNKGHVKVTDFGFAKKVP------DRTFTLCG 177
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 178 TPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G +HRD+KP N++ + S K+ D G
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYI 320
+I ++ L + + I+HRDIKP N++ S G K+ D G + +L IN I
Sbjct: 107 KIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQ--IKLCDFGVSGEL---INSI 158
Query: 321 PKEFLLDPRYAAPEQ 335
F+ Y +PE+
Sbjct: 159 ADTFVGTSTYMSPER 173
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 20/110 (18%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA----------ADL 313
++ M QLL L H I+HRD+KPQN++ +E K+ D G A ++
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE-LKLADFGLARAKSVPTKTYSNE 163
Query: 314 RVGINYIPKEFLL-DPRYAAPEQ--------YIMSTQTPSAPSAPVATAL 354
V + Y P + LL Y+ P Y M+T P P + V L
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 33/122 (27%)
Query: 252 DLPKGIER--------ENRIIQTIMSQLLFAL-------DGLHSTGIVHRDIKPQNVIFS 296
DL + I++ E I I QLL AL DG + ++HRD+KPQN+ S
Sbjct: 100 DLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159
Query: 297 EGSRTF----------------KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST 340
G R KI D G + + +GI + + P Y +PE + T
Sbjct: 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKN--IGIESMAHSCVGTPYYWSPELLLHET 217
Query: 341 QT 342
++
Sbjct: 218 KS 219
|
Length = 1021 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 6e-04
Identities = 49/201 (24%), Positives = 74/201 (36%), Gaps = 35/201 (17%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNE-RVRRA--CANCCA 200
KKLGEGAFG VY+ L K + + LK+ + ++ E RV + N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
+ G + +L+ Y DL + P +
Sbjct: 61 --LLGV----CTEEEPLYLVLEY---MEGGDL----------LDYLRKSRPVFPS--PEK 99
Query: 261 NRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ + ++ L FA+ G L S VHRD+ +N + E KI D G + D+
Sbjct: 100 STL--SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156
Query: 315 VGINYIPKEFLLDP-RYAAPE 334
Y K P R+ APE
Sbjct: 157 DDDYYRKKTGGKLPIRWMAPE 177
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 36/171 (21%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+KLGEG++ VY K S+ +G LV K E +R A
Sbjct: 11 EKLGEGSYATVY------KGISRINGQLVALKVISMKTEEGVPFTAIREA---------- 54
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGEVQDLPKGIER 259
S KG ++ I L D++ ++E F Y + T + + P G+
Sbjct: 55 -----SLLKGLKHANI------VLLHDIIHTKETLTFVFEY-MHTDLAQYMIQHPGGLHP 102
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
N ++ M QLL L +H I+HRD+KPQN++ S K+ D G A
Sbjct: 103 YN--VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVIF 295
P + + EV++L E ++S Q+ ++ L S VHRD+ +NV+
Sbjct: 211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++G + KI D G A D+ NY+ K P ++ APE
Sbjct: 271 AQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 35/199 (17%)
Query: 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRAC--ANCCADF 202
+LG+GAFG VY+A K+ ++ K+ E +E +M E + +C N
Sbjct: 12 ELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 68
Query: 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
++EN+ W++ + + +M+ E P L E Q
Sbjct: 69 DAFYYENN------LWILIEFCAGGAVDAVMLELERP-------LTEPQ----------- 104
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIP 321
I+ + Q L AL+ LH I+HRD+K N++F+ +G K+ D G +A I
Sbjct: 105 -IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQR-R 160
Query: 322 KEFLLDPRYAAPEQYIMST 340
F+ P + APE + T
Sbjct: 161 DSFIGTPYWMAPEVVMCET 179
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 22/71 (30%), Positives = 39/71 (54%), Gaps = 10/71 (14%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL--------RVG-INY 319
+++ L+ LH IV+RD+KP+N++ + +I DLG A ++ RVG + Y
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHI-RISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 320 IPKEFLLDPRY 330
+ E + + RY
Sbjct: 168 MAPEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G + D+ I T+ +L AL LHS G++HRDIK +++ + R K+ D
Sbjct: 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV-KLSDF 161
Query: 308 GAAADLRVGINYIPKEFLL--DPRYAAPE 334
G A + +PK L P + APE
Sbjct: 162 GFCAQIS---KDVPKRKSLVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 21/51 (41%), Positives = 28/51 (54%), Gaps = 1/51 (1%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ + QLL A+D +H GI+HRDIK +NV G + D GAA R
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENV-LVNGPEDICLGDFGAACFAR 311
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 32/120 (26%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI---FSEGSRTFKIIDLGAA-------- 310
I I + + + HS G++HRD+KP N++ F E I+D GAA
Sbjct: 117 SIFHKICATIEYV----HSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEE 168
Query: 311 --ADLRVGINY-------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361
D+ V IP + + P Y APE+ + P++ S + AL +L+Q+
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL---GVPASESTDI-YALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E +++ + Q+L L+ LH+ GI+HRDIK N I + KI D G + L
Sbjct: 104 EETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN-ILVDNKGGIKISDFGISKKLEANS 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANC 198
G K+G G +G VY+ AK+ K++ + LK+ G EI + ++ N
Sbjct: 6 GCKVGRGTYGHVYK---AKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKH--PNV 60
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
A F +S +K WL++ Y + R N + + LP+
Sbjct: 61 IA-LQKVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPM------QLPRS-- 108
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAA 310
++++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 109 ----MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 44/211 (20%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
+ L K+LG+GA+G+V A+ + + + +KK T + +I +R
Sbjct: 2 YELIKELGQGAYGIV---CSARNAETSEEETVAIKKITNVFSKKILAKRALR-------- 50
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGE---ATLADLMISREFPYNVQTLILGEVQ--DLPK 255
E L+ + G L D+ I +N + + E+ DL +
Sbjct: 51 ---------------ELKLLRHFRGHKNITCLYDMDIVFPGNFN-ELYLYEELMEADLHQ 94
Query: 256 GIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA- 310
I + Q+ + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 95 IIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLAR 153
Query: 311 ---ADLRVGINYIPKEFLLDPRYAAPEQYIM 338
+ ++ E++ Y APE IM
Sbjct: 154 GFSENPGENAGFM-TEYVATRWYRAPE--IM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+++ QLL + H ++HRD+KPQN++ ++ K+ D G A + +N E
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNE 160
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G + D+ I T+ +L AL LH+ G++HRDIK +++ + R K+ D
Sbjct: 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDF 162
Query: 308 GAAADLRVGINYIPKEFLL--DPRYAAPE 334
G A + +PK L P + APE
Sbjct: 163 GFCAQVS---KEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 28/90 (31%)
Query: 268 MSQLLFA-----LDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAADLRVGI---- 317
M+++ FA L+ LH+ GIVHRD+KP N +I S G K+ D G + ++G+
Sbjct: 102 MARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLS---KIGLMSLT 156
Query: 318 -----NYIPKEF--LLD------PRYAAPE 334
+I K+ LD P Y APE
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 43/216 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERV-RRA 194
D+F+ K+GEG+ G+V A++ K+ G LV K + E+ NE V R
Sbjct: 23 DNFI---KIGEGSTGIVCIATV------KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ +Y NS G E W++ + L D++ + E Q
Sbjct: 74 YQHENVVEMY----NSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNEEQ--- 117
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
I + +L AL LH+ G++HRDIK +++ + R K+ D G A +
Sbjct: 118 ---------IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV-KLSDFGFCAQVS 167
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350
+ K + P + APE + ++ P P +
Sbjct: 168 KEVPR-RKSLVGTPYWMAPE---LISRLPYGPEVDI 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 2/70 (2%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
Q + QLL L +HS ++HRD+KP N++ + KI D G A +++ E+
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM-TEY 168
Query: 325 LLDPRYAAPE 334
++ Y APE
Sbjct: 169 VVTRWYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 19/88 (21%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG-- 308
+ ++R + + +++ LL L L +VH D+ P N++ G R +ID
Sbjct: 136 LVAAELLDRLAELWERLLAALLALLPALP-LVLVHGDLHPGNLLVDPGGRVTGVIDFEDA 194
Query: 309 ----AAADLRVGINYIPKEFLLDPRYAA 332
A DL + + +E A
Sbjct: 195 GLGDPAYDLASLLRSLGEEL--GAELLA 220
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLD 327
Q+L ++ LHS IVHRDIK N I + + K+ D GA+ L+ + K
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 328 PRYAAPE 334
P + +PE
Sbjct: 171 PYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
EN++++ + Q+ AL LH I+HRD+K QNV + + K+ DLG A L
Sbjct: 101 ENQVVEWFV-QIAMALQYLHEKHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLE-NQCD 157
Query: 320 IPKEFLLDPRYAAPEQY 336
+ + P Y +PE +
Sbjct: 158 MASTLIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 44/198 (22%)
Query: 147 LGEGAFG--VVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA---- 200
LG+GAFG +YR D LV+ K E ++E+ RR N
Sbjct: 8 LGKGAFGEATLYR--------RTEDDSLVVWK--EVNLTR--LSEKERRDALNEIVILSL 55
Query: 201 ---DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ ++ N + Y TL D I R+ KG
Sbjct: 56 LQHPNIIAYY-NHFMDDNTLLIEMEYANGGTLYD-KIVRQ-----------------KGQ 96
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E ++ + Q++ A+ +H GI+HRDIK N IF + K+ D G + L G
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN-IFLTKAGLIKLGDFGISKIL--GS 153
Query: 318 NYIPKEFLL-DPRYAAPE 334
Y E ++ P Y +PE
Sbjct: 154 EYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 57/225 (25%), Positives = 81/225 (36%), Gaps = 73/225 (32%)
Query: 138 KDDFVLGKKLGEGAFGVVYRAS---LAKKPSSKNDGDLVLKKATEYGAVEIWMNE----- 189
+++ GK LG GAFG V A+ L+K + +LK E M+E
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 190 ---------RVRRACAN----------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLA 230
+ AC CC YG N ++ E +L TL
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCC----YGDLLNFLRRKRESFL--------TLE 141
Query: 231 DLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
DL+ F Y V KG+ F L S +HRD+
Sbjct: 142 DLL---SFSYQVA-----------KGMA--------------F----LASKNCIHRDLAA 169
Query: 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPE 334
+NV+ + G + KI D G A D+ NY+ K L ++ APE
Sbjct: 170 RNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 15/40 (37%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G++HRD+KP N++ + K+ D G
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 39/212 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADF-- 202
++LGEGAFG VY+ L + + +K E ++ + R+ A +D
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE-AELMSDLQH 67
Query: 203 -----VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ G +++ Y L + ++ +V G
Sbjct: 68 PNIVCLLGVCTKEQP----TCMLFEYLAHGDLHEFLVRNSPHSDV-------------GA 110
Query: 258 ERENRIIQTIMSQLLF---------ALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
E + +++ + F ++ L S VHRD+ +N + EG T KI D G
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-LTVKISDFG 169
Query: 309 AAADLRVGINY-IPKEFLLDPRYAAPEQYIMS 339
+ D+ Y + + LL R+ PE I+
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEA-ILY 200
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 15/41 (36%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
M++ + A++ +H G +HRDIKP N++ G K+ D G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 17/39 (43%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
Q+L + LH IVHRDIKP N++ + KI D G
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNV-KIADFG 213
|
Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 6/68 (8%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLL 326
++++ AL LHS +V+RD+K +N++ + KI D G + GI+ K F
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKE---GISDGATMKTFCG 157
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 158 TPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
++ +M QLL L LH I+HRD+K N++ ++ KI D G A
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 22/48 (45%), Positives = 28/48 (58%), Gaps = 1/48 (2%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
TI +LL AL LH GI+HRD+K +N IF + + D GAA L
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLGDFGAACKL 235
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I Q+L L LH+ I+HRD+K +N IF I DLGAA
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTEN-IFINDVDQVCIGDLGAA 204
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 2/67 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLD 327
SQ+ +D L S +HRD+ +NV+ ++G R KI D G A D+ NY+ K L
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 328 PRYAAPE 334
++ APE
Sbjct: 278 VKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDP 328
Q+ + L S +HRD+ +N++ + G R KI D G A D+R NY+ K L
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 329 RYAAPE 334
++ APE
Sbjct: 281 KWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.003
Identities = 20/52 (38%), Positives = 25/52 (48%), Gaps = 6/52 (11%)
Query: 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE 189
LGKKLGEGAFG VY+ L K V LK+ +E ++ E
Sbjct: 2 TLGKKLGEGAFGEVYKGKL--KGKGGKKKVEVAVKTLKEDASEQQIEEFLRE 51
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 15/44 (34%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
++++ L+ +H+ +V+RD+KP N++ E +I DLG A D
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACD 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 233 MISREFPYNVQTLILGEV---QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
MI++++ +++ + + E +D P + ++ R IM QLL A++ +H ++HRDIK
Sbjct: 240 MITQKYDFDLYSFMYDEAFDWKDRP--LLKQTR---AIMKQLLCAVEYIHDKKLIHRDIK 294
Query: 290 PQNVIFSEGSRTFKIIDLGAA 310
+N IF + D G A
Sbjct: 295 LEN-IFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 16/50 (32%), Positives = 27/50 (54%), Gaps = 1/50 (2%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
Q +++ + A+D +H G +HRDIKP N++ K+ D G L+
Sbjct: 104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHV-KLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 23/66 (34%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
++++ L LHS GI++RD+K NV+ KI D G + G N F P
Sbjct: 103 AEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNR-ASTFCGTP 160
Query: 329 RYAAPE 334
Y APE
Sbjct: 161 DYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 365 | |||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.33 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.71 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.15 | |
| PLN02236 | 344 | choline kinase | 96.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.89 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.84 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.46 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.49 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.45 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.4 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.98 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 93.47 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.09 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=406.58 Aligned_cols=346 Identities=71% Similarity=1.158 Sum_probs=284.9
Q ss_pred CCCCCCCCCCccccccccccCCC-----CCCCccccchhhHHHHHHHhhhhhhcccccccccccccceeecCCCCCCCCc
Q 017820 18 STPKSKPPSSPFLGKRLVLIKPF-----SKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGL 92 (365)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~l~~~~~~ 92 (365)
....+...+++|+|++....+.. ++......+++..++.+.++.+++++|+|+|||+|+|||.+++++++.++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~ 85 (566)
T PLN03225 6 AVAGASGSPSRFLGRKLSSRRLSRAPARRSRARALTAAAGGELIDAVHNLFVGVGVGLPCTVMECGDVIYRSTLPRSNGL 85 (566)
T ss_pred ccccccCCCCcccccccccccccccccccchhhccccccchhHHHHhhhccccccccCceeeeeccceeeeccCCcccCc
Confidence 34445666778889887755521 3344556667777999999999999999999999999999999999999999
Q ss_pred ccCcchhhHHHhhhhhhhccCCCCCchhHHHHHHHHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcce
Q 017820 93 TITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172 (365)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~v 172 (365)
.++.++.........|++..|+..|+.++++.....+....+.+..++|++.++||+|+||.||+|++..+.. .....+
T Consensus 86 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~v 164 (566)
T PLN03225 86 TITAPGAALALLAATYLWATPGVAPGFVDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKY 164 (566)
T ss_pred cccCchHHHHHHHHHHhccCCccccccchheeechhhhccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEE
Confidence 9999999999888999999999999999999888888888899999999999999999999999999988711 112789
Q ss_pred eehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc-cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccc
Q 017820 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251 (365)
Q Consensus 173 avK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~ 251 (365)
++|++......+.+.++++.+.+.......+..+..... ..+..+++|+||+++++|.+++....+++.+++++.+...
T Consensus 165 AvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~ 244 (566)
T PLN03225 165 VLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQ 244 (566)
T ss_pred EEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchh
Confidence 999988777777776666555444333333333322221 4567899999999999999999999999999999988877
Q ss_pred cCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcC
Q 017820 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYA 331 (365)
Q Consensus 252 ~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~ 331 (365)
.++++..+.+..+..++.|++.||.|||+++|+||||||+|||++++...+||+|||+|+.+..+.++.+....+|+.||
T Consensus 245 ~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~ 324 (566)
T PLN03225 245 DLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYA 324 (566)
T ss_pred hccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCcc
Confidence 77877778888899999999999999999999999999999999975449999999999987766666677889999999
Q ss_pred CccccccCCCCCCC------------------CCchhhhhhhhhheecccC
Q 017820 332 APEQYIMSTQTPSA------------------PSAPVATALSPVLWQVQCS 364 (365)
Q Consensus 332 APE~l~~~~~~~~~------------------d~~s~~~slg~vlw~lGc~ 364 (365)
|||++.....++.. +...|+||||++||||-++
T Consensus 325 APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~ 375 (566)
T PLN03225 325 APEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP 375 (566)
T ss_pred ChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhC
Confidence 99988766554432 2345899999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=318.39 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=166.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|.+.++||+|+||+||+|+.+.++ ..||+|.+.... .........++..+....|+||+.+++.. ...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~-----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSG-----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-EDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCC-----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-ecC
Confidence 4579999999999999999999999998 667777665542 22333334566777778899999998877 566
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
+..|+|||||++|+|.+|++.++ .+++..++.++.|++.||++||+++||||||||+|||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~--------------------~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG--------------------RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 79999999999999999999886 5689999999999999999999999999999999999
Q ss_pred EecC--C---CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEG--S---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~--~---~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+.. . ..+||+|||+|+.+..+. ...+.+|+|.|||||++....|+.++| .||+|.+||++-+
T Consensus 142 Ls~~~~~~~~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKAD----LWSiG~Ilyq~l~ 209 (429)
T KOG0595|consen 142 LSTTARNDTSPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKAD----LWSIGTILYQCLT 209 (429)
T ss_pred eccCCCCCCCceEEecccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhh----HHHHHHHHHHHHh
Confidence 9864 1 379999999999987543 346899999999999999999988888 9999999999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=308.87 Aligned_cols=196 Identities=20% Similarity=0.308 Sum_probs=169.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...++|++.++||+|+||+||.++.++|+ +.+|+|.++...- .+......++..+...+||+|+.+...+ +
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~-----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-Q 95 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTG-----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-Q 95 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccC-----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-c
Confidence 35689999999999999999999999998 8888888765432 2334444556667778999999998877 6
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
++..+|+|++|++||.|...+++.+ .+++..++.++.+|+.||.|||++|||||||||+|
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg--------------------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREG--------------------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC--------------------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 7789999999999999999999776 56889999999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||++| +++|+|||+|+..-.. +....+++||+.|||||++.+..++...| +||||+++|+|-|
T Consensus 156 ILLd~~G-Hi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vD----WWsLGillYeML~ 220 (357)
T KOG0598|consen 156 ILLDEQG-HIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVD----WWSLGILLYEMLT 220 (357)
T ss_pred eeecCCC-cEEEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccc----hHhHHHHHHHHhh
Confidence 9999998 9999999999954333 22346799999999999999998888887 9999999999855
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.08 Aligned_cols=194 Identities=22% Similarity=0.270 Sum_probs=169.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++.+.++.||+|..|+||+++++.|+ +.+|+|.+....+. -..+..++...++.+++++|+.+++.+...+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~-----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTG-----KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 34467888999999999999999999998 89999999543332 2334445667777789999999999996665
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NI 293 (365)
....++||||++|+|.+++...+ .+++..+.+++.+|++||.|||. ++||||||||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--------------------~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--------------------RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 57999999999999999998654 56889999999999999999995 9999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.+| ++||||||.++.+..+ .+++++||..|||||.+.+..++.++| +||||+.+||+.
T Consensus 211 LvNskG-eVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sD----IWSLGLsllE~a 271 (364)
T KOG0581|consen 211 LVNSKG-EVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSD----IWSLGLSLLELA 271 (364)
T ss_pred eeccCC-CEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccc----eecccHHHHHHh
Confidence 999988 9999999999988654 568999999999999999999999877 999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.94 Aligned_cols=193 Identities=21% Similarity=0.296 Sum_probs=168.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHH---HHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMN---ERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+..++|++.+.||.|+||.|.+++.+.++ ..+|+|.+....-....+. ..+.+.+....||+++.++..+ .
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g-----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSG-----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-K 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCC-----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-c
Confidence 56789999999999999999999999988 7788888775544333322 2345667777799999988776 6
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+...+++||||++||.|..+++..+ .+++..++.++.||+.||+|||+++|++||+||+|
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~--------------------rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN 174 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG--------------------RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN 174 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC--------------------CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence 6689999999999999999998865 67889999999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||.+| .+||+|||.|+..... .-+.+|||.|+|||.+....++...| +|+|||++|||-|
T Consensus 175 iLlD~~G-~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavD----WWalGVLIYEMla 236 (355)
T KOG0616|consen 175 LLLDQNG-HIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVD----WWALGVLIYEMLA 236 (355)
T ss_pred eeeccCC-cEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchh----HHHHHHHHHHHHc
Confidence 9999998 9999999999987643 45799999999999999999988888 9999999999966
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=289.81 Aligned_cols=198 Identities=24% Similarity=0.288 Sum_probs=163.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-------HHHHHHHHHHHhhccCCCceeeeecc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-------EIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
..+.|.+.+.||+|+||.|-+|..+.|+ +.||+|.+...... .....+++...+...+||+|+.+.+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tg-----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTG-----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccC-----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 4578999999999999999999999999 88999887643221 12223466778888999999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ...+..|+||||++||+|.+.+-.++ .+.+..-+.+++|++.|+.|||++||+|||||
T Consensus 245 f-~~~ds~YmVlE~v~GGeLfd~vv~nk--------------------~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK 303 (475)
T KOG0615|consen 245 F-EVPDSSYMVLEYVEGGELFDKVVANK--------------------YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK 303 (475)
T ss_pred e-ecCCceEEEEEEecCccHHHHHHhcc--------------------ccccchhHHHHHHHHHHHHHHHHcCcccccCC
Confidence 7 55677899999999999999998776 33556667899999999999999999999999
Q ss_pred CCceEEecC--CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEG--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~--~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||+..+ ...+||+|||+|+....+ ..+.+++|||.|.|||++.+...+... ...|+||||++||-+-|
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~-~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYP-SKVDIWSLGCVLFVCLS 376 (475)
T ss_pred cceEEeccCCcceEEEecccchhhccccc--eehhhhcCCccccChhheecCCeeccc-chheeeeccceEEEEec
Confidence 999999865 238999999999987633 346899999999999999887766655 35668888888887644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=287.24 Aligned_cols=198 Identities=20% Similarity=0.238 Sum_probs=168.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..+|++.++||+|+||+||+++...++ +.+|.|++.-. ...+......+...++..+|+||+.++...+.++.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g-----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDG-----KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCc-----chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 368999999999999999999999998 88999998722 23344445566788899999999999985545554
Q ss_pred e-EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH--CC--CcccCCCC
Q 017820 216 E-YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS--TG--IVHRDIKP 290 (365)
Q Consensus 216 ~-~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~--~~--IiHrDIKp 290 (365)
+ ++||||+|+.|+|.++++..+ ..+..++++.+++++.|++.||..+|+ .. |+||||||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K----------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFK----------------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHH----------------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 4 999999999999999998654 123467899999999999999999999 44 99999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.||+|+.+| .+||+|||+++.+...... ....+|||.||+||.+....++.++| +||+|.++|||-
T Consensus 157 aNIFl~~~g-vvKLGDfGL~r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSD----iWslGCllyEMc 222 (375)
T KOG0591|consen 157 ANIFLTANG-VVKLGDFGLGRFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSD----IWSLGCLLYEMC 222 (375)
T ss_pred hheEEcCCC-ceeeccchhHhHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchh----HHHHHHHHHHHH
Confidence 999999988 9999999999998765443 45789999999999999999999888 899999999884
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.69 Aligned_cols=196 Identities=21% Similarity=0.231 Sum_probs=163.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
.+|..++.||+|||+.||++++..+++.++.+.|..|.+......+ ...+++...+...|+||+.++..+ ++....|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~re--Kv~~EIeIHr~L~HpnIV~f~~~F-EDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQRE--KVLNEIEIHRSLKHPNIVQFYHFF-EDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHH--HHHHHHHHHHhcCCCcEEeeeeEe-ecCCceE
Confidence 6799999999999999999999999844443333333333333333 333447778888999999999887 6678999
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|.|+|..++|..+++... .++|..++.++.||+.||.|||+++|||||||..|++|+++
T Consensus 95 ivLELC~~~sL~el~Krrk--------------------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~ 154 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRK--------------------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN 154 (592)
T ss_pred EEEEecCCccHHHHHHhcC--------------------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc
Confidence 9999999999999998654 56888899999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
. ++||+|||||..+.... ....+.+|||.|+|||++........+| +||+|++||.|-+
T Consensus 155 ~-~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvD----iWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 155 M-NVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVD----IWSLGCVMYTLLV 213 (592)
T ss_pred C-cEEecccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchh----hhhhhhHHHhhhh
Confidence 7 99999999999876442 3457899999999999999888888777 9999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=302.45 Aligned_cols=195 Identities=23% Similarity=0.276 Sum_probs=165.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc-----cccHHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT-----EYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.+..++|.+.++||+|+||.|+++..+.++ ..+|+|.++ ...+.+..+.|+-+..+.. .||+++.++..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~-----e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~ 437 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTN-----EYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSC 437 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCC-----cEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccc
Confidence 567789999999999999999999999998 667777665 3445666666654444444 89999999888
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ++..+++.||||++||++..+.+.. .+++..++.++..|+.||.|||++||||||||
T Consensus 438 f-QT~~~l~fvmey~~Ggdm~~~~~~~---------------------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK 495 (694)
T KOG0694|consen 438 F-QTKEHLFFVMEYVAGGDLMHHIHTD---------------------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLK 495 (694)
T ss_pred c-ccCCeEEEEEEecCCCcEEEEEecc---------------------cccHHHHHHHHHHHHHHHHHHHhcCceeeecc
Confidence 7 6678999999999999955544433 46889999999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+|||||.+| ++||+|||+++...... ..+.+++|||.|||||++.+..|+...| +|+|||+||||-+
T Consensus 496 LdNiLLD~eG-h~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVD----WW~lGVLlyeML~ 563 (694)
T KOG0694|consen 496 LDNLLLDTEG-HVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVD----WWGLGVLLYEMLV 563 (694)
T ss_pred hhheEEcccC-cEEecccccccccCCCC-CccccccCChhhcChhhhccCcccchhh----HHHHHHHHHHHHc
Confidence 9999999998 99999999999754333 3568999999999999999999999988 9999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.76 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=168.8
Q ss_pred HHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH---HHHHHHHHHhhccCCCceeee
Q 017820 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI---WMNERVRRACANCCADFVYGF 206 (365)
Q Consensus 130 ~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~ 206 (365)
++.+..+..++|++++.||+|+||+||+|+-+.|+ ..+|+|+++....... .....++..+.....++++.+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg-----~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTG-----EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCC-----cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEE
Confidence 44456778899999999999999999999999999 8899999987655433 233334556666788999999
Q ss_pred ecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
+..+ ++...+||||||++||++..+|...+ .++++.++.++.+++.|++-+|+.|+|||
T Consensus 207 yYsF-QD~~~LYLiMEylPGGD~mTLL~~~~--------------------~L~e~~arfYiaE~vlAI~~iH~~gyIHR 265 (550)
T KOG0605|consen 207 YYSF-QDKEYLYLIMEYLPGGDMMTLLMRKD--------------------TLTEDWARFYIAETVLAIESIHQLGYIHR 265 (550)
T ss_pred EEEe-cCCCeeEEEEEecCCccHHHHHHhcC--------------------cCchHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 8887 66789999999999999999998876 56888899999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEeccccccccc---------------C------Cccc-------------------------
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRV---------------G------INYI------------------------- 320 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~---------------~------~~~~------------------------- 320 (365)
||||+|+|||..| ++||+|||||+-+.. . ....
T Consensus 266 DIKPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~ 344 (550)
T KOG0605|consen 266 DIKPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQL 344 (550)
T ss_pred cCChhheeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhh
Confidence 9999999999998 999999999863311 0 0000
Q ss_pred cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 321 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 321 ~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
....+|||.|||||++.+..++..+| +||||++||||
T Consensus 345 a~StVGTPDYiAPEVll~kgY~~~cD----wWSLG~ImyEm 381 (550)
T KOG0605|consen 345 AYSTVGTPDYIAPEVLLGKGYGKECD----WWSLGCIMYEM 381 (550)
T ss_pred hhcccCCccccchHHHhcCCCCcccc----HHHHHHHHHHH
Confidence 11368999999999999999988888 99999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.20 Aligned_cols=201 Identities=20% Similarity=0.288 Sum_probs=162.2
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
+.+..+++.+.+.||+|+||+||+|.+.++ ..+++|.+....... .....++...+...+|+||+.+++.+.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGT------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCc------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 334456777788899999999999999985 338888887543222 334445666777799999999999885
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC-CcccCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKP 290 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~-IiHrDIKp 290 (365)
.....+.+||||+++|+|.++++... ...++...+..++.||++||.|||+++ ||||||||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~------------------~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~ 171 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKR------------------KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS 171 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcc------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence 54447999999999999999998731 125678889999999999999999999 99999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc--CCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM--STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++.++||+|||+++...... ...+...||+.|||||++.+ ..++.++| +||||++||||-+
T Consensus 172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~D----vySFgIvlWEl~t 241 (362)
T KOG0192|consen 172 DNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSD----VYSFGIVLWELLT 241 (362)
T ss_pred hhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccch----hhhHHHHHHHHHH
Confidence 999999975599999999998765432 23344799999999999994 46666666 9999999999854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=292.62 Aligned_cols=191 Identities=27% Similarity=0.337 Sum_probs=159.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..+.|+.+++||+|.||.||+|++..++ +.||+|+++-+... ......+++..++...|+||+.+.+.....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tg-----kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETG-----KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccC-----cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 5578999999999999999999999999 99999999866533 233445667888999999999998877655
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+|+|+|||+. +|.-++...+ ..+++.+|+.+++|++.||+|+|++||+|||||.+||
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~-------------------vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi 249 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPG-------------------VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI 249 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCC-------------------cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence 5799999999996 7777776543 4678899999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||.+| .+||+|||+|+.+.......-+..+-|.+|.|||.+.|... |..+|.||+.||
T Consensus 250 Lidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~----------Yg~aVDlWS~GC 308 (560)
T KOG0600|consen 250 LIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS----------YGTAVDLWSVGC 308 (560)
T ss_pred EEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc----------cccceeehhhhH
Confidence 999988 99999999999887665544566788999999999998743 223333677776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=275.45 Aligned_cols=180 Identities=23% Similarity=0.342 Sum_probs=150.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH--HHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++.|+.+.++|+|+||+||+++++.|+ ..||+|+..+..+.+. ....++++++....|+|++.+.+.+ .+..
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~Tg-----qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-rrkr 74 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTG-----QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-RRKR 74 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcc-----cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-Hhcc
Confidence 367888999999999999999999999 9999999987765432 3444678889999999999999988 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++|+|||+. ++.+-++... ...+.+.++.++.|++.|+.|+|+++||||||||+||||
T Consensus 75 klhLVFE~~dh-TvL~eLe~~p-------------------~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi 134 (396)
T KOG0593|consen 75 KLHLVFEYCDH-TVLHELERYP-------------------NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI 134 (396)
T ss_pred eeEEEeeecch-HHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE
Confidence 89999999997 4444454432 245778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccc-cCCccccccccCCCCcCCccccccCCC-CCCCC
Q 017820 296 SEGSRTFKIIDLGAAADLR-VGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAP 346 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d 346 (365)
+.++ .+||||||+|+.+. .+..+ +..+-|.+|.|||.+.|... ....|
T Consensus 135 t~~g-vvKLCDFGFAR~L~~pgd~Y--TDYVATRWYRaPELLvGDtqYG~pVD 184 (396)
T KOG0593|consen 135 TQNG-VVKLCDFGFARTLSAPGDNY--TDYVATRWYRAPELLVGDTQYGKPVD 184 (396)
T ss_pred ecCC-cEEeccchhhHhhcCCcchh--hhhhhhhhccChhhhcccCcCCCccc
Confidence 9988 99999999999887 44444 56788999999999999644 44445
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=290.09 Aligned_cols=193 Identities=25% Similarity=0.356 Sum_probs=158.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-----cHHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
...||.+++.||+|+|++|++|++..++ +++|+|.+... ........|+. .+.....|+.++.++..+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~-----keYAiKVl~K~~Iike~KvkYV~~Ek~-~l~~L~~hPgivkLy~TF- 143 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATG-----KEYAIKVLDKRYIIKEKKVKYVTREKE-ALTQLSGHPGIVKLYFTF- 143 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCC-----ceeeHhhhhHHHHHhhcccchhhHHHH-HHHHhhCCCCeEEEEEEe-
Confidence 5579999999999999999999999998 77787776432 22222222221 122333899999999887
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
+++..+|+|+||.++|+|.++++..+ .+++.-.+.++.||+.||+|||++|||||||||+
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G--------------------sfde~caR~YAAeIldAleylH~~GIIHRDlKPE 203 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG--------------------SFDETCARFYAAEILDALEYLHSNGIIHRDLKPE 203 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC--------------------cchHHHHHHHHHHHHHHHHHHHhcCceeccCChh
Confidence 66678999999999999999999876 5688889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc------------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhe
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~------------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw 359 (365)
|||||+|+ ++||+|||.|+.+...... ....++||..|.+||++.....++.+| +|+||++||
T Consensus 204 NILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD----iWAlGCily 278 (604)
T KOG0592|consen 204 NILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD----LWALGCILY 278 (604)
T ss_pred heeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc----hHHHHHHHH
Confidence 99999998 9999999999987643211 124599999999999998888877777 999999999
Q ss_pred ec
Q 017820 360 QV 361 (365)
Q Consensus 360 ~l 361 (365)
+|
T Consensus 279 Qm 280 (604)
T KOG0592|consen 279 QM 280 (604)
T ss_pred HH
Confidence 87
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.08 Aligned_cols=283 Identities=29% Similarity=0.472 Sum_probs=202.2
Q ss_pred cccccceeecCCCCCCCCcccCcchhhHHHhhhhhhhccCCCCCchhHHHHHHHHHHHhhccccCCCeEEeeeeecCCCe
Q 017820 74 VMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFG 153 (365)
Q Consensus 74 ~~~~~~~~~~s~l~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG 153 (365)
-..|||+.+.++|. ++.||..+..+.+.|++++|++.++.+|+|...+........+..++|++.++||+|+||
T Consensus 86 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~r~~~d~F~i~~~LG~GgFG 159 (507)
T PLN03224 86 ATIGGDLAALATLS------PTLPGIGRLTALYYLLFSKPNPLFNIWDFYVGAPLADGANSRWSSDDFQLRDKLGGGNFG 159 (507)
T ss_pred HHhhhhhhhhhhcC------CCCccHHHHHHHHHHhhcCCccccchhHHhhcccccccCCCCccccCceEeeEeecCCCe
Confidence 44588988887765 456888888888888999999999999999999998888888899999999999999999
Q ss_pred eEEEEEecCCCCC-----------CCCcceeehhhccccHHH--HHHH------------HHHHHHhhccCCCc-----e
Q 017820 154 VVYRASLAKKPSS-----------KNDGDLVLKKATEYGAVE--IWMN------------ERVRRACANCCADF-----V 203 (365)
Q Consensus 154 ~Vy~a~~~~~~~~-----------~~~~~vavK~~~~~~~~~--~~~~------------~~~~~~~~~~~~~~-----i 203 (365)
+||+|.+..++.. ...+.|++|++....... ...+ ..+...+....|.+ +
T Consensus 160 ~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~ 239 (507)
T PLN03224 160 ITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASC 239 (507)
T ss_pred EEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhh
Confidence 9999986433211 112568999876432211 0000 00111122122221 2
Q ss_pred eeeecccc-------cCCCeEEEEEEecCCCcHHHHHHhcC--CCcchhhhhccc--cccCcccccccHHHHHHHHHHHH
Q 017820 204 YGFFENSS-------KKGGEYWLIWRYEGEATLADLMISRE--FPYNVQTLILGE--VQDLPKGIERENRIIQTIMSQLL 272 (365)
Q Consensus 204 ~~~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~i~~qi~ 272 (365)
..+++.+. ...+..|+||||+++++|.++++... ++.++++++... ..+......+++..++.++.|++
T Consensus 240 ~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~ 319 (507)
T PLN03224 240 AEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVL 319 (507)
T ss_pred hhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHH
Confidence 22222221 12356899999999999999998643 445555555432 22222344567888999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC------
Q 017820 273 FALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP------ 346 (365)
Q Consensus 273 ~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d------ 346 (365)
.+|.|||+++|+||||||+|||++.++ .+||+|||+++....+.........+|+.|+|||++.....++..+
T Consensus 320 ~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~ 398 (507)
T PLN03224 320 TGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA 398 (507)
T ss_pred HHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhh
Confidence 999999999999999999999999987 9999999999876544333333345589999999987655443332
Q ss_pred ------------Cchhhhhhhhhheeccc
Q 017820 347 ------------SAPVATALSPVLWQVQC 363 (365)
Q Consensus 347 ------------~~s~~~slg~vlw~lGc 363 (365)
...|+||+|+++++|-+
T Consensus 399 ~l~~~~~~yg~~~~~DvwSlGvil~em~~ 427 (507)
T PLN03224 399 LLSPFAWLYGRPDLFDSYTAGVLLMQMCV 427 (507)
T ss_pred hhhhhHHhcCCCCccchhhHHHHHHHHHh
Confidence 23589999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=285.87 Aligned_cols=195 Identities=26% Similarity=0.347 Sum_probs=165.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-cHHHHHHHHHHHHHhhccC-CCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCC-ADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~ 214 (365)
..++|.+.++||.|+||+||+|+...++ ..||+|+++.. ...+..++.++...+...+ |+||+.+++...+..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~-----~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCC-----ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 4578999999999999999999999998 77999998744 4567778888888887777 999999999986666
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++|||||+. +|++++++++. .+++..++.|+.||++||+|+|.+|+.|||+||||||
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r-------------------~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNR-------------------LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCC-------------------cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence 699999999985 99999998764 4577889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+..+. .+||+|||+||.+.....+ +..+.|.+|.|||++....+.... .|+||+|.++.|+-
T Consensus 143 i~~~~-~iKiaDFGLARev~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~p---vD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 143 ISGND-VIKIADFGLAREVRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSP---VDMWAVGCIMAELY 204 (538)
T ss_pred ecccc-eeEecccccccccccCCCc--chhhhcccccchHHhhhccccCCc---hHHHHHHHHHHHHH
Confidence 99766 9999999999988755444 467889999999999876443332 24788887777753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=284.51 Aligned_cols=198 Identities=23% Similarity=0.318 Sum_probs=159.3
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc----cH-HHHHHHHHHHHHhhccC-CCceeeeecc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY----GA-VEIWMNERVRRACANCC-ADFVYGFFEN 209 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~~~~~~~~~~-~~~i~~~~~~ 209 (365)
...+.|.+++.||+|+||.|++|....++ ..||+|.+... .. .......++...+.... |+||+.+++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~-----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG-----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCC-----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 35689999999999999999999999998 66777744332 11 11122223444555555 9999999988
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
.... ..+++||||+.+|+|++++.+.+ .+.+..++++++|+++|++|||++||+|||||
T Consensus 89 ~~t~-~~~~ivmEy~~gGdL~~~i~~~g--------------------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 89 FATP-TKIYIVMEYCSGGDLFDYIVNKG--------------------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred EecC-CeEEEEEEecCCccHHHHHHHcC--------------------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 8444 55999999999999999998854 45778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.+..++||+|||++.... .......+.+||+.|+|||++.+.. ++ ....|+||+||+||-|-|
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~---g~~aDvWS~GViLy~ml~ 218 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYS---GKAADVWSLGVILYVLLC 218 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcC---CchhhhhhhHHHHHHHHh
Confidence 9999999982399999999999874 3334567899999999999999876 54 334569999999998865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=271.78 Aligned_cols=196 Identities=26% Similarity=0.329 Sum_probs=158.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC-eE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG-EY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~ 217 (365)
.+|..++.||+|+||.||++.+..++ ...++|.+...........+++...+...+|++|+.+++.....+. .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g-----~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTG-----ELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCC-----cceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 57889999999999999999999876 6788888765543334445566777777779999999997545544 79
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
.+.|||+.+|+|.+++...+ + .+++..++.+.+||++||.|||++|||||||||+|||++.
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g------------------~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~ 152 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYG------------------G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP 152 (313)
T ss_pred EeeeeccCCCcHHHHHHHcC------------------C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC
Confidence 99999999999999998875 2 4688999999999999999999999999999999999999
Q ss_pred -CCCcEEEEeccccccccc--CCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 -GSRTFKIIDLGAAADLRV--GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 -~~~~ikL~DFGla~~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||+++.... ........+.||+.|||||++..+.. .+..+|+||||.++-||.
T Consensus 153 ~~~-~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~---~~~~sDiWSlGCtVvEM~ 216 (313)
T KOG0198|consen 153 SNG-DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV---ARRESDIWSLGCTVVEML 216 (313)
T ss_pred CCC-eEEeccCccccccccccccccccccccCCccccCchhhcCCCc---CCccchhhhcCCEEEecc
Confidence 56 999999999987653 11222346899999999999985221 223455888888888774
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=282.72 Aligned_cols=205 Identities=21% Similarity=0.306 Sum_probs=175.7
Q ss_pred HHHHHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCce
Q 017820 124 VLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFV 203 (365)
Q Consensus 124 ~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i 203 (365)
....+............|...++||+|+.|.||.|+...++ +.||+|++.............+...+...+|+|+
T Consensus 258 ~~~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~-----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~Ni 332 (550)
T KOG0578|consen 258 ILAKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTK-----QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNI 332 (550)
T ss_pred HHHHhheeccCCChhhhhcchhhhccccccceeeeeeccCC-----ceEEEEEEEeccCCchhhhHHHHHHHHhccchHH
Confidence 33344444455666678999999999999999999999998 7788888876555444444455677788889999
Q ss_pred eeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC
Q 017820 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (365)
Q Consensus 204 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I 283 (365)
+.|++.+... +.+|+||||+++|+|.|.+.... +++.+|..|+++++.||+|||.+||
T Consensus 333 Vnfl~Sylv~-deLWVVMEym~ggsLTDvVt~~~---------------------~~E~qIA~Icre~l~aL~fLH~~gI 390 (550)
T KOG0578|consen 333 VNFLDSYLVG-DELWVVMEYMEGGSLTDVVTKTR---------------------MTEGQIAAICREILQGLKFLHARGI 390 (550)
T ss_pred HHHHHHhccc-ceeEEEEeecCCCchhhhhhccc---------------------ccHHHHHHHHHHHHHHHHHHHhcce
Confidence 9999988554 89999999999999999987653 5889999999999999999999999
Q ss_pred cccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||||.+|||++.++ .+||+|||+|..+..... ...+.+|||.|||||++....+.++.| +||||+++|||
T Consensus 391 iHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVD----IWSLGIMaIEM 462 (550)
T KOG0578|consen 391 IHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVD----IWSLGIMAIEM 462 (550)
T ss_pred eeeccccceeEeccCC-cEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCcccc----chhhhhHHHHH
Confidence 9999999999999998 899999999998866554 457899999999999999999999999 99999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=257.73 Aligned_cols=175 Identities=24% Similarity=0.275 Sum_probs=145.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|...++||+|.||.||+|++..++ +.||+|+++-....+ .....+++..++...|+||+.+.+.+ ...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~-----~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETG-----KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-PHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCC-----cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-cCCCc
Confidence 57888999999999999999999999 788888887543332 22334567778888899999998887 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+.+|+||++. +|+..+++... .++...++.++.++++||+|||++.|+||||||.|+|++
T Consensus 76 l~lVfEfm~t-dLe~vIkd~~i-------------------~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis 135 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKDKNI-------------------ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS 135 (318)
T ss_pred eEEEEEeccc-cHHHHhccccc-------------------ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc
Confidence 9999999995 89999988764 346788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
++| .+||+|||+|+.+........ ..+-|.+|.|||.+.|...
T Consensus 136 ~~g-~lKiADFGLAr~f~~p~~~~~-~~V~TRWYRAPELLfGsr~ 178 (318)
T KOG0659|consen 136 SDG-QLKIADFGLARFFGSPNRIQT-HQVVTRWYRAPELLFGSRQ 178 (318)
T ss_pred CCC-cEEeecccchhccCCCCcccc-cceeeeeccChHHhccchh
Confidence 998 999999999998765433222 2367999999999998754
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=278.50 Aligned_cols=207 Identities=18% Similarity=0.274 Sum_probs=164.2
Q ss_pred HHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCcee
Q 017820 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 128 ~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~ 204 (365)
.+.+.......++|++.+.||+|+||.||+|++..++ +.+|+|.+..... .......++...+....|++++
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv 106 (370)
T cd05621 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106 (370)
T ss_pred HHHHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEe
Confidence 3444556667789999999999999999999999887 7788887653211 1122233455666778899999
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+++.+ ..+..+++||||+++|+|.+++.... +++..++.++.||+.||.|||+++|+
T Consensus 107 ~~~~~~-~~~~~~~lv~Ey~~gg~L~~~l~~~~---------------------~~~~~~~~~~~qil~aL~~LH~~~Iv 164 (370)
T cd05621 107 QLFCAF-QDDKYLYMVMEYMPGGDLVNLMSNYD---------------------VPEKWAKFYTAEVVLALDAIHSMGLI 164 (370)
T ss_pred eEEEEE-EcCCEEEEEEcCCCCCcHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 998776 55678999999999999999986543 35677889999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||||||+|||+++++ .+||+|||+|+.+............||+.|||||++.+...+...+..+|+||+|+++|+|-
T Consensus 165 HrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 165 HRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred ecCCCHHHEEECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 999999999999987 99999999998765433333456789999999999976653333444566999999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=283.51 Aligned_cols=201 Identities=20% Similarity=0.240 Sum_probs=164.5
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
..|.+..+++.+++.||+|+||+||+|.|. +.||||.++... .......+.++..++..+|.||+-|.++
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 456778889999999999999999999999 569999887543 3344455567788899999999999998
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+... .+.||+.+|+|-+|+.+++-.+ -+++....+.|++||++||.|||.++|||||||
T Consensus 457 ~~~p--~~AIiTqwCeGsSLY~hlHv~e-------------------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK 515 (678)
T KOG0193|consen 457 CMNP--PLAIITQWCEGSSLYTHLHVQE-------------------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK 515 (678)
T ss_pred hcCC--ceeeeehhccCchhhhhccchh-------------------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence 7443 4599999999999999997654 245777889999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEeccccccccc-CCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
..||++.+++ ++||+|||++..-.. .....-....|...|||||++++....+.+. .||+||||+|+|||-|
T Consensus 516 SnNIFl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~-qSDVYaFGiV~YELlt 588 (678)
T KOG0193|consen 516 SNNIFLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSF-QSDVYAFGIVWYELLT 588 (678)
T ss_pred ccceEEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCc-ccchhhhhHHHHHHHh
Confidence 9999999987 999999999864221 1122234567788899999999777655554 8889999999999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.07 Aligned_cols=227 Identities=21% Similarity=0.239 Sum_probs=162.1
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+++..++|++.++||+|+||.||+|.+.........+.||+|.+..... .+.....++...+... .|+|++.+++.+.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4556789999999999999999999875433333336789998865432 2222222333444444 7999999988776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchh-hh--------------------h--------ccc-------------
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQ-TL--------------------I--------LGE------------- 249 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-~~--------------------~--------~~~------------- 249 (365)
..+..++++|||+++|+|.+++....-..... +. . ...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 66677999999999999999997643110000 00 0 000
Q ss_pred cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCC
Q 017820 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDP 328 (365)
Q Consensus 250 ~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~ 328 (365)
.........+++..+..++.||++||.|||++||+||||||+|||++.++ .+||+|||+++.+...... ......+++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence 00000123467788899999999999999999999999999999999987 9999999999876433222 223345678
Q ss_pred CcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 329 RYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 329 ~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
.|+|||++.+..++.++| +||||+++|+| |.+|
T Consensus 241 ~y~aPE~~~~~~~~~~sD----iwslG~il~el~~~g~~p 276 (338)
T cd05102 241 KWMAPESIFDKVYTTQSD----VWSFGVLLWEIFSLGASP 276 (338)
T ss_pred cccCcHHhhcCCCCcccC----HHHHHHHHHHHHhCCCCC
Confidence 999999998877776665 99999999996 5554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.23 Aligned_cols=191 Identities=23% Similarity=0.346 Sum_probs=166.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+++|.+.+.||+|+||.||+|+-+.+. +.||+|.+.+.+ ..+.....++.+..+...|+||+.+++++ +...
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~-----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~ 74 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTI-----QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSA 74 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccce-----eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccc
Confidence 368999999999999999999998887 888998886544 34555566778888899999999999988 6668
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
++|+|+||+.+ +|..+++..+ .++++.++.++.|++.||.|||+++|+|||+||+|||+
T Consensus 75 ~~~vVte~a~g-~L~~il~~d~--------------------~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl 133 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILEQDG--------------------KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL 133 (808)
T ss_pred eEEEEehhhhh-hHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee
Confidence 99999999998 9999998766 67899999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+..+ ++|+||||+|+....+.. .-..+.|||.|||||++.+..++..+| .||||+++||+
T Consensus 134 ~~~~-~~KlcdFg~Ar~m~~~t~-vltsikGtPlYmAPElv~e~pyd~~sD----lWslGcilYE~ 193 (808)
T KOG0597|consen 134 EKGG-TLKLCDFGLARAMSTNTS-VLTSIKGTPLYMAPELVEEQPYDHTSD----LWSLGCILYEL 193 (808)
T ss_pred cCCC-ceeechhhhhhhcccCce-eeeeccCcccccCHHHHcCCCccchhh----HHHHHHHHHHH
Confidence 9977 999999999998765433 235689999999999999888887777 89999999886
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=267.74 Aligned_cols=200 Identities=21% Similarity=0.257 Sum_probs=170.8
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+..+.+++|..+++||+|.||.|-+++.+.++ +.+|+|.++.. ...|...-..+.+.+..+.||++..+...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~-----k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATG-----KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccC-----ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 45567899999999999999999999999998 77888877643 23444444456778888999998777665
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ +.++.++.||||.+||.|+-.+.... .+++...+.+..+|+.||.|||+++||+||+|
T Consensus 237 F-Qt~drlCFVMeyanGGeLf~HLsrer--------------------~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK 295 (516)
T KOG0690|consen 237 F-QTQDRLCFVMEYANGGELFFHLSRER--------------------VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK 295 (516)
T ss_pred h-ccCceEEEEEEEccCceEeeehhhhh--------------------cccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence 5 67789999999999999988887654 56788899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecccC
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQCS 364 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc~ 364 (365)
.+|+|+|.+| ++||+|||+++.- .......++++|||.|.|||++....+....| +|.+|||||||-|-
T Consensus 296 LENLlLDkDG-HIKitDFGLCKE~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVD----WWG~GVVMYEMmCG 364 (516)
T KOG0690|consen 296 LENLLLDKDG-HIKITDFGLCKEE-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVD----WWGVGVVMYEMMCG 364 (516)
T ss_pred hhhheeccCC-ceEeeecccchhc-ccccceeccccCChhhcCchhhccccccceee----hhhhhHHHHHHHhc
Confidence 9999999998 9999999999852 22234567899999999999999999888888 99999999999983
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.23 Aligned_cols=192 Identities=20% Similarity=0.329 Sum_probs=154.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||+||+|.+..++ +.+++|.+......+ ......+...+....|++++.++..+ ..+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTG-----HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-QDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-ecCC
Confidence 58999999999999999999998887 788888876433221 12223344556667889998888776 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi 134 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD--------------------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence 8999999999999999987654 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc----------------------------------cccccccCCCCcCCccccccCCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
+.++ .+||+|||+|+.+..... ......+||+.|+|||++.+..+
T Consensus 135 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 213 (363)
T cd05628 135 DSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213 (363)
T ss_pred CCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC
Confidence 9987 999999999976532110 00124589999999999988776
Q ss_pred CCCCCCchhhhhhhhhheec
Q 017820 342 TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 342 ~~~~d~~s~~~slg~vlw~l 361 (365)
+.++| +||||+++|+|
T Consensus 214 ~~~~D----vwSlGvil~el 229 (363)
T cd05628 214 NKLCD----WWSLGVIMYEM 229 (363)
T ss_pred CCchh----hhhhHHHHHHH
Confidence 66555 99999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=274.80 Aligned_cols=220 Identities=18% Similarity=0.256 Sum_probs=168.6
Q ss_pred CCCchhHHHHHH---HHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHH
Q 017820 115 VAPGFFDMFVLA---FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMN 188 (365)
Q Consensus 115 ~~p~~~~~~~~~---~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~ 188 (365)
..+.-++.+... .+..........++|++.+.||+|+||.||+|.+..++ +.+++|.+..... ......
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~ 90 (371)
T cd05622 16 RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFF 90 (371)
T ss_pred cccchHHHHHHHhhhHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEEEHHHhhhhHHHHHH
Confidence 344444444433 23334456677799999999999999999999999887 7788887653221 112222
Q ss_pred HHHHHHhhccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHH
Q 017820 189 ERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (365)
Q Consensus 189 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 268 (365)
.++...+....|++++.+++.+ ..+..+++||||+++|+|.+++.... +++..++.++
T Consensus 91 ~~e~~i~~~~~hp~iv~~~~~~-~~~~~~~lv~Ey~~gg~L~~~~~~~~---------------------~~~~~~~~~~ 148 (371)
T cd05622 91 WEERDIMAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYD---------------------VPEKWARFYT 148 (371)
T ss_pred HHHHHHHHhCCCCCCCeEEEEE-EcCCEEEEEEcCCCCCcHHHHHHhcC---------------------CCHHHHHHHH
Confidence 3345566677899999888776 45678999999999999999986543 3567788899
Q ss_pred HHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCc
Q 017820 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (365)
Q Consensus 269 ~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~ 348 (365)
.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.+............||+.|||||++.+.......+..
T Consensus 149 ~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~ 227 (371)
T cd05622 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227 (371)
T ss_pred HHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCc
Confidence 9999999999999999999999999999987 999999999987654433334567899999999999766543334456
Q ss_pred hhhhhhhhhheecc
Q 017820 349 PVATALSPVLWQVQ 362 (365)
Q Consensus 349 s~~~slg~vlw~lG 362 (365)
+|+||||+++|+|-
T Consensus 228 ~DiwSlGvilyell 241 (371)
T cd05622 228 CDWWSVGVFLYEML 241 (371)
T ss_pred cceeehhHHHHHHH
Confidence 67999999999983
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.14 Aligned_cols=198 Identities=18% Similarity=0.241 Sum_probs=161.9
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..+.+.+.+.||+|-||+||+|.+..+ ..|++|.++.......... ++...+....|++++.+++.+..
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m~~~~f~-~Ea~iMk~L~H~~lV~l~gV~~~- 272 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSMSPEAFL-REAQIMKKLRHEKLVKLYGVCTK- 272 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC------CcccceEEeccccChhHHH-HHHHHHHhCcccCeEEEEEEEec-
Confidence 344445566678899999999999999986 5788888876544322222 45677788889999999998844
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
++.++|||||+..|+|.++++..+ +..++..+...++.|||+||+||+++++|||||...||
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~------------------~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi 334 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTRE------------------GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI 334 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcC------------------CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence 448999999999999999998733 33557788889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++++. .+||+|||+|+.+.++.........-...|.|||.+..+.++.++| +|||||+|||+-
T Consensus 335 LV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSD----VWSFGVlL~E~f 398 (468)
T KOG0197|consen 335 LVDEDL-VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSD----VWSFGVLLWELF 398 (468)
T ss_pred eeccCc-eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccc----eeehhhhHHHHh
Confidence 999988 9999999999965544443333445567999999999999998888 999999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=265.99 Aligned_cols=178 Identities=25% Similarity=0.316 Sum_probs=146.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|+...+|++|+||.||+|+++.|+ ..||+|+++.....+.. ...+++..+...+|+||+.+.+......
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~-----eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTD-----EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcc-----eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 4578999999999999999999999998 89999999866544322 2334566777778999998876654333
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..|+|||||+. +|..++.....+ +....++.++.|+++|+.|||.+.|+||||||+|+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~-------------------F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNL 208 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQP-------------------FLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNL 208 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCC-------------------CchHHHHHHHHHHHHHHHHHhhceeEecccchhhe
Confidence 779999999996 899999887644 35566889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
|++.+| .+||+|||+|+.+..... ..+..+-|.+|.|||.+.+.+.
T Consensus 209 Lm~~~G-~lKiaDFGLAR~ygsp~k-~~T~lVVTLWYRaPELLLG~~t 254 (419)
T KOG0663|consen 209 LLSHKG-ILKIADFGLAREYGSPLK-PYTPLVVTLWYRAPELLLGAKT 254 (419)
T ss_pred eeccCC-cEEecccchhhhhcCCcc-cCcceEEEeeecCHHHhcCCcc
Confidence 999988 999999999998865422 2345677999999999998743
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=273.47 Aligned_cols=205 Identities=18% Similarity=0.288 Sum_probs=162.5
Q ss_pred HHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceee
Q 017820 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYG 205 (365)
Q Consensus 129 ~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~ 205 (365)
..........++|++.+.||+|+||.||+|.+..++ +.+|+|.+..... .......++...+...+|++++.
T Consensus 33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~ 107 (370)
T cd05596 33 EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK-----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107 (370)
T ss_pred HhhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcce
Confidence 333455667789999999999999999999999887 7888888754321 11122233455677778999998
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+.+.+ ..+..+++||||+++|+|.+++.... +++..+..++.|++.||.|||++||+|
T Consensus 108 ~~~~~-~~~~~~~lv~Ey~~gg~L~~~l~~~~---------------------l~~~~~~~~~~qi~~aL~~LH~~~ivH 165 (370)
T cd05596 108 LHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYD---------------------IPEKWARFYTAEVVLALDAIHSMGFIH 165 (370)
T ss_pred EEEEE-ecCCEEEEEEcCCCCCcHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 88765 55678999999999999999986543 356778889999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||||+|||+++++ .+||+|||+++..............||+.|+|||++.+.......+..+|+||||+++|+|
T Consensus 166 rDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 166 RDVKPDNMLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred cCCCHHHEEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 99999999999987 9999999999876543333334678999999999987665444445567799999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=265.72 Aligned_cols=193 Identities=19% Similarity=0.265 Sum_probs=167.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
...+|++.+.||+|.||.|-+|+.+..+ +.||+|.++.+. .++.....++++.+...+|++|+.+++.+ ..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sg-----R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-EN 124 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSG-----REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-EN 124 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCC-----cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-cC
Confidence 3468999999999999999999998887 889999887553 33444556678888999999999999988 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+.+.|||||..+|.|+||+.+.+ .+++..++++++||++|+.|+|.++++|||||.+||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--------------------~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI 184 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--------------------SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI 184 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--------------------cccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence 678999999999999999998876 678899999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|.++ ++||+|||++..+..... -++++|+|.|.+||.+.|.++.... .|.||||++||.|
T Consensus 185 LLD~N~-NiKIADFGLSNly~~~kf--LqTFCGSPLYASPEIvNG~PY~GPE---VDsWsLGvLLYtL 246 (668)
T KOG0611|consen 185 LLDQNN-NIKIADFGLSNLYADKKF--LQTFCGSPLYASPEIVNGTPYKGPE---VDSWSLGVLLYTL 246 (668)
T ss_pred eecCCC-CeeeeccchhhhhccccH--HHHhcCCcccCCccccCCCCCCCCc---cchhhHHHHHHHH
Confidence 999988 999999999987765432 3689999999999999988775443 4599999999976
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=295.04 Aligned_cols=209 Identities=20% Similarity=0.268 Sum_probs=174.3
Q ss_pred HHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCcee
Q 017820 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 128 ~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~ 204 (365)
+.....-....+||.+.++||+|+||+|.+++.+.++ +.+|+|.+.... ..+.....+++..+.+.+.++|+
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~-----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTE-----KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccc-----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 3444556677899999999999999999999999998 999999987632 22333334456677777788888
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+...+ +++.++|+||+|++||+|..++...+ .+++..++.++..|+.||+-||+.|+|
T Consensus 139 ~LhyAF-QD~~~LYlVMdY~pGGDlltLlSk~~--------------------~~pE~~ArFY~aEiVlAldslH~mgyV 197 (1317)
T KOG0612|consen 139 QLHYAF-QDERYLYLVMDYMPGGDLLTLLSKFD--------------------RLPEDWARFYTAEIVLALDSLHSMGYV 197 (1317)
T ss_pred HHHHHh-cCccceEEEEecccCchHHHHHhhcC--------------------CChHHHHHHHHHHHHHHHHHHHhccce
Confidence 777666 77789999999999999999998765 457888999999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCC-CCCCCchhhhhhhhhheeccc
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT-PSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~d~~s~~~slg~vlw~lGc 363 (365)
||||||+|||||..| ++||+|||.|-.+..+..-.....+|||.|++||++.....+ .......|+||+||++|||-|
T Consensus 198 HRDiKPDNvLld~~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly 276 (1317)
T KOG0612|consen 198 HRDIKPDNVLLDKSG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY 276 (1317)
T ss_pred eccCCcceeEecccC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc
Confidence 999999999999998 999999999988776656667788999999999999855444 444455669999999999966
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=273.96 Aligned_cols=193 Identities=21% Similarity=0.340 Sum_probs=155.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|++..++ +.+|+|.+..... .......++...+...+|++++.+++.+ ..+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTG-----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-QDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-EcCC
Confidence 47999999999999999999999887 7889998864321 1122233345566677799999888776 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~ 134 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD--------------------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL 134 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence 8999999999999999987654 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-------------------------------------ccccccCCCCcCCcccccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-------------------------------------IPKEFLLDPRYAAPEQYIM 338 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-------------------------------------~~~~~~gt~~Y~APE~l~~ 338 (365)
+.++ .+||+|||+++.+...... .....+||+.|+|||++.+
T Consensus 135 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (364)
T cd05599 135 DAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213 (364)
T ss_pred CCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC
Confidence 9987 9999999999765322100 1113579999999999987
Q ss_pred CCCCCCCCCchhhhhhhhhheecc
Q 017820 339 STQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 339 ~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
..++.++| +||||+++|+|-
T Consensus 214 ~~~~~~~D----iwSlG~il~el~ 233 (364)
T cd05599 214 TGYNKECD----WWSLGVIMYEML 233 (364)
T ss_pred CCCCCeee----eecchhHHHHhh
Confidence 77766665 999999999983
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=267.67 Aligned_cols=195 Identities=23% Similarity=0.357 Sum_probs=161.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC---C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (365)
.+..+.+.||+|.||+||+|.|++ ..||||...... ...|.+|.++......+|+||.+|......+. .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccC-------CceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 578899999999999999999998 669999876544 45566666777777888999999987754443 7
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC--------CCcccC
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRD 287 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~--------~IiHrD 287 (365)
++|||++|.+.|||+||+.+.. ++.+...+++..++.||.+||.. .|.|||
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t---------------------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT---------------------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc---------------------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 8999999999999999998753 46677889999999999999954 599999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCC--Cchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAP--SAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d--~~s~~~slg~vlw~lG 362 (365)
||..|||+..++ .+-|+|+|+|.......+ ...+..+||-+|||||++...-.....+ ...|+||||.|+||+.
T Consensus 342 lKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 342 LKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred cccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 999999999988 999999999987655432 2345789999999999987654443333 3788999999999986
Q ss_pred c
Q 017820 363 C 363 (365)
Q Consensus 363 c 363 (365)
|
T Consensus 421 r 421 (513)
T KOG2052|consen 421 R 421 (513)
T ss_pred H
Confidence 4
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.37 Aligned_cols=193 Identities=20% Similarity=0.220 Sum_probs=158.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.+++|.-...||+|+||.||+|...++ ..||+|++...... +.. ...+...+...+|+|++.+++.+...+.
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~------~~vAVK~~~~~~~~~~~e-F~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG------TVVAVKRLSSNSGQGERE-FLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC------CEEEEEEecCCCCcchhH-HHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 448899899999999999999999876 67999988765543 222 3445666777779999999999865554
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCc
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG---IVHRDIKPQN 292 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~---IiHrDIKp~N 292 (365)
+.+||+||+.+|+|.+.+..... . .++|.+..+|+.++|+||+|||... |||||||++|
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~-----------------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKG-----------------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCC-----------------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 79999999999999999987641 1 5588999999999999999999854 9999999999
Q ss_pred eEEecCCCcEEEEeccccccccc-CCccccccc-cCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRV-GINYIPKEF-LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~-~~~~~~~~~-~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||++. ++||+|||+|+.... ... ..+. .||.+|+|||++..+..+.++| +||||++|-|+
T Consensus 208 ILLD~~~-~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsD----VySFGVvllEl 271 (361)
T KOG1187|consen 208 ILLDEDF-NAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSD----VYSFGVVLLEL 271 (361)
T ss_pred eeECCCC-CEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccc----cccchHHHHHH
Confidence 9999987 999999999976654 221 1222 8999999999999888888888 89999998776
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=266.91 Aligned_cols=201 Identities=21% Similarity=0.248 Sum_probs=159.8
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--------------HHHHHHHHHHHHhhccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------------VEIWMNERVRRACANCCA 200 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~~~~~~~~ 200 (365)
....++|++++.||+|.||.|-+|++..++ +.||+|.+..... .+.....+++..+..+.|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~-----~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDG-----KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCC-----cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 446689999999999999999999999998 7777776642211 123344556777888899
Q ss_pred Cceeeeeccccc-CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH
Q 017820 201 DFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (365)
Q Consensus 201 ~~i~~~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH 279 (365)
+|++.+.+.... ....+|+|+|||..|.+...- +....+++.++++++++++.||+|||
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--------------------~d~~els~~~Ar~ylrDvv~GLEYLH 227 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--------------------PDKPELSEQQARKYLRDVVLGLEYLH 227 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCC--------------------CCcccccHHHHHHHHHHHHHHHHHHH
Confidence 999998877543 348899999999988753321 12233789999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCcEEEEecccccccccCCcc----ccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 280 ~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
.+|||||||||+|+||++++ ++||+|||.+..+..+... .-....|||.|||||.+.++.....+-...|+||+|
T Consensus 228 ~QgiiHRDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 228 YQGIIHRDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred hcCeeccccchhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 99999999999999999997 9999999999876443221 112368999999999998876566666688999999
Q ss_pred hhheec
Q 017820 356 PVLWQV 361 (365)
Q Consensus 356 ~vlw~l 361 (365)
|.||+|
T Consensus 307 VTLYCl 312 (576)
T KOG0585|consen 307 VTLYCL 312 (576)
T ss_pred hhHHHh
Confidence 999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.28 Aligned_cols=196 Identities=27% Similarity=0.321 Sum_probs=147.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccCCCc-eeeeecccccCC-
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADF-VYGFFENSSKKG- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~-i~~~~~~~~~~~- 214 (365)
..|...++||+|+||+||+|+...++ +.||+|+++-..+.|.. ...+++..+....|.+ ++.+.+.....+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g-----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTG-----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCC-----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 56777888999999999999999998 88999998755442211 1122333344444444 776666654444
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++|+||+.. +|..++.....+ ....+...++.++.||+.||+|||+++|+||||||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~----------------~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKP 148 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKK----------------PQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKP 148 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhcccc----------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCc
Confidence 388999999985 899999876521 02345588999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||||+++| .+||+|||+|+........ -...++|.+|.|||++.+. .+....| +||+|.++-||-
T Consensus 149 QNlLi~~~G-~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vD----iWs~GcIfaEm~ 215 (323)
T KOG0594|consen 149 QNLLISSSG-VLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVD----IWSLGCIFAEMF 215 (323)
T ss_pred ceEEECCCC-cEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcc----hHhHHHHHHHHH
Confidence 999999987 9999999999976533221 2456889999999999988 4444444 677777666653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=272.17 Aligned_cols=193 Identities=20% Similarity=0.343 Sum_probs=153.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... ........+...+....|++++.+++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTG-----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-QDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-EcCC
Confidence 47999999999999999999999887 7788887754321 1122223345566777899999988776 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll 134 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD--------------------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 8999999999999999987643 34677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc------------c----------------------------------ccccccCCCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN------------Y----------------------------------IPKEFLLDPR 329 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~------------~----------------------------------~~~~~~gt~~ 329 (365)
+.++ .+||+|||+|+.+..... . .....+||+.
T Consensus 135 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 135 DRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred CCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 9887 999999999964321000 0 0012579999
Q ss_pred cCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 330 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 330 Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.+..++.++| +||||+++|+|-
T Consensus 214 y~aPE~~~~~~~~~~~D----iwSlGvil~ell 242 (377)
T cd05629 214 YIAPEIFLQQGYGQECD----WWSLGAIMFECL 242 (377)
T ss_pred ccCHHHHccCCCCCcee----eEecchhhhhhh
Confidence 99999998877776665 999999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=266.90 Aligned_cols=190 Identities=19% Similarity=0.312 Sum_probs=155.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... +......+...+....|++++.++..+ ..+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG-----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-QDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-EcCC
Confidence 47999999999999999999999887 77888887643221 222223344556666799999888766 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 134 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG--------------------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 8999999999999999997654 34678888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++.... ......||+.|+|||++.+..++.++| +||||+++|+|-+
T Consensus 135 ~~~~-~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~ell~ 193 (333)
T cd05600 135 DASG-HIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVD----YWSLGCMLYEFLC 193 (333)
T ss_pred CCCC-CEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccc----eecchHHHhhhhh
Confidence 9987 999999999986543 234578999999999998876666555 9999999999843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=275.04 Aligned_cols=188 Identities=19% Similarity=0.230 Sum_probs=162.4
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.|++..+...-++-||.|+.|.||+|+.++ ..|||||+++... ..+..++...|+||+.|.+.+ .
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~n-------etVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVC-t 182 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLHN-------ETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVC-T 182 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeeccC-------ceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeee-c
Confidence 344555555667789999999999999987 7899999876543 345667778899999999998 6
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+...|+||||||..|-|+.+++... .........|..+|+.||.|||.+.|||||||.-|
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~--------------------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPN 242 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGR--------------------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPN 242 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccC--------------------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCc
Confidence 7789999999999999999998765 44667788899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+.++ .+||+|||.++.+.... +.-.++||..|||||++++.+...+.| +||||||||||-
T Consensus 243 iLIs~~d-~VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVD----IwSfGVVLWEmL 305 (904)
T KOG4721|consen 243 ILISYDD-VVKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVD----IWSFGVVLWEML 305 (904)
T ss_pred eEeeccc-eEEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccc----eehhHHHHHHHH
Confidence 9999988 99999999999875442 223689999999999999999999998 999999999984
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=270.70 Aligned_cols=193 Identities=20% Similarity=0.336 Sum_probs=153.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.+|++.+.||+|+||.||+|.+..++ +.+|+|.+...... ......++...+....|++++.++..+ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTN-----ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-QDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-EcCC
Confidence 37999999999999999999999887 78888877543211 122223345566677889998888776 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill 134 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG--------------------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE
Confidence 8999999999999999997654 34677888899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCC------------------------------------------ccccccccCCCCcCCc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGI------------------------------------------NYIPKEFLLDPRYAAP 333 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~------------------------------------------~~~~~~~~gt~~Y~AP 333 (365)
+.++ .+||+|||+|..+.... ........||+.||||
T Consensus 135 ~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 135 DRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred CCCC-CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 9987 99999999986432100 0011235799999999
Q ss_pred cccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 334 EQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 334 E~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.+..++.++| +||||+++|+|-
T Consensus 214 E~~~~~~~~~~~D----iwSlGvilyell 238 (376)
T cd05598 214 EVLLRTGYTQLCD----WWSVGVILYEML 238 (376)
T ss_pred HHHcCCCCCccee----eeeccceeeehh
Confidence 9998877766655 999999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=270.82 Aligned_cols=198 Identities=20% Similarity=0.251 Sum_probs=171.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|..++++|+|+||.+++++.+..+ +.+++|++.-.. ..+......++..+....||+|+.+.+.+..++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~-----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDD-----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCC-----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 3578999999999999999999998887 789999987443 223334455667777799999999999997777
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..++|||+|++||+|.+.+.+.+ +..++++.+..++.|++.|+.|||+++|+|||||+.||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k------------------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nif 138 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK------------------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIF 138 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh------------------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhh
Confidence 77999999999999999998764 456789999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++.++ .+||.|||+|+.+..... ...+.+||+.||+||.+.+.++..++| +|+||.++|||-|
T Consensus 139 ltk~~-~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSD----iWsLGC~~yEm~~ 201 (426)
T KOG0589|consen 139 LTKDK-KVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSD----IWSLGCCLYEMCT 201 (426)
T ss_pred ccccC-ceeecchhhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCc----chhhcchHHHHHh
Confidence 99988 889999999998865542 356789999999999999999999999 8888888888865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=270.69 Aligned_cols=192 Identities=22% Similarity=0.345 Sum_probs=153.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|++.+.||+|+||+||+|++..++ +.+|+|.+..... ........+...+....|++++.++..+ ..+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTH-----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-QDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-ecCCE
Confidence 6899999999999999999998887 7888888764322 1222233445566777899999988777 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~ 135 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME--------------------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID 135 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC
Confidence 999999999999999987654 346778888999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc----------------------------------------------cccccccCCCCc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN----------------------------------------------YIPKEFLLDPRY 330 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~----------------------------------------------~~~~~~~gt~~Y 330 (365)
.++ ++||+|||+++.+..... ......+||+.|
T Consensus 136 ~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 136 LDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 887 999999999864321100 011245799999
Q ss_pred CCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 331 AAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 331 ~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.+..++.++| +||||+++|+|-
T Consensus 215 ~aPE~~~~~~~~~~~D----iwSlG~il~ell 242 (381)
T cd05626 215 IAPEVLLRKGYTQLCD----WWSVGVILFEML 242 (381)
T ss_pred cCHHHHcCCCCCCccc----eeehhhHHHHHH
Confidence 9999998877766665 999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=266.19 Aligned_cols=193 Identities=18% Similarity=0.293 Sum_probs=157.3
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..+..++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 87 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTG-----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF 87 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3446689999999999999999999999887 77888877643221 112223344556667899999988776
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+..+++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||
T Consensus 88 -~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp 146 (329)
T PTZ00263 88 -QDENRVYFLLEFVVGGELFTHLRKAG--------------------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKP 146 (329)
T ss_pred -EcCCEEEEEEcCCCCChHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 45678999999999999999987654 346777888999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||++.++ .+||+|||+++..... .....||+.|+|||++.+...+.++| +||||+++|+|
T Consensus 147 ~NIll~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el 208 (329)
T PTZ00263 147 ENLLLDNKG-HVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVD----WWTMGVLLYEF 208 (329)
T ss_pred HHEEECCCC-CEEEeeccCceEcCCC----cceecCChhhcCHHHHcCCCCCCcce----eechHHHHHHH
Confidence 999999987 9999999999876432 23468999999999998877665555 99999999997
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=265.00 Aligned_cols=199 Identities=19% Similarity=0.256 Sum_probs=154.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||+||++++..++ +.+++|.+.... ..+.....++...+....|+++..+...+ ..+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE-----RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-QDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCC
Confidence 58999999999999999999998887 778888775422 11222223344556667788888887766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill 135 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE
Confidence 8999999999999999997642 134677788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCC-CCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT-PSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++.+............||+.|+|||++.+.... ...+..+|+||||+++|+|-+
T Consensus 136 ~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 136 DMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred cCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence 9887 999999999987654333333346799999999998763221 122345669999999999843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=260.85 Aligned_cols=189 Identities=22% Similarity=0.254 Sum_probs=154.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.. ..+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISE-----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-HDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-ccCC
Confidence 47999999999999999999999887 7788888753321 1222233455667777899999888766 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli 134 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG--------------------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL 134 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence 8999999999999999987654 34677788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++..... .....||+.|+|||++.+...+.++ |+||||+++|+|-
T Consensus 135 ~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~----DiwSlG~il~~l~ 192 (291)
T cd05612 135 DKEG-HIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEML 192 (291)
T ss_pred CCCC-CEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchh----hHHHHHHHHHHHH
Confidence 9887 9999999999876432 2346799999999999877665555 5999999999983
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=271.01 Aligned_cols=192 Identities=21% Similarity=0.336 Sum_probs=152.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
+|++.++||+|+||+||+|++..++ +.+++|.+..... .......++...+....|++++.++..+ ..+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTK-----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-EeCCE
Confidence 6899999999999999999998887 7788888764322 1222333445566777899999988876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~ 135 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG--------------------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999987654 346778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCC----------------------------------------------ccccccccCCCCc
Q 017820 297 EGSRTFKIIDLGAAADLRVGI----------------------------------------------NYIPKEFLLDPRY 330 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~----------------------------------------------~~~~~~~~gt~~Y 330 (365)
.++ .+||+|||+|+.+.... ........||+.|
T Consensus 136 ~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 136 RDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred CCC-CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 987 99999999986432100 0001235799999
Q ss_pred CCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 331 AAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 331 ~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.+..++.++| +||||+++|+|-
T Consensus 215 ~aPE~~~~~~~~~~~D----iwSlGvil~ell 242 (382)
T cd05625 215 IAPEVLLRTGYTQLCD----WWSVGVILYEML 242 (382)
T ss_pred CCHHHhcCCCCCCeee----EEechHHHHHHH
Confidence 9999998877766555 999999999983
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=267.31 Aligned_cols=194 Identities=20% Similarity=0.337 Sum_probs=155.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... .......+...+....|++++.++..+ ..+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTG-----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-QDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCC
Confidence 57999999999999999999999887 78888887643211 122223344556667889999888776 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli 134 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD--------------------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE
Confidence 8999999999999999987654 35778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc----------------------------------cccccccCCCCcCCccccccCCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
+.++ .+||+|||+++.+..... ......+||+.|+|||++.+..+
T Consensus 135 ~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 135 DAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred CCCC-CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 9987 999999999875432110 01124579999999999988777
Q ss_pred CCCCCCchhhhhhhhhheeccc
Q 017820 342 TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 342 ~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++| +||||+++|+|-+
T Consensus 214 ~~~~D----iwSlGvilyel~t 231 (360)
T cd05627 214 NKLCD----WWSLGVIMYEMLI 231 (360)
T ss_pred CCcce----eccccceeeeccc
Confidence 76665 9999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=267.22 Aligned_cols=193 Identities=22% Similarity=0.346 Sum_probs=157.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.++..+ ..+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTG-----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-QDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-ecCC
Confidence 47999999999999999999999887 7888888764321 1222233445566777799999887766 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll 134 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRKD--------------------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 8999999999999999997653 35678888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCC----------------------------ccccccccCCCCcCCccccccCCCCCCCCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGI----------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~----------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~ 347 (365)
+.++ .+||+|||+++.+.... ........||+.|+|||++.+..++.++|
T Consensus 135 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D- 212 (350)
T cd05573 135 DADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD- 212 (350)
T ss_pred CCCC-CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCcee-
Confidence 9987 99999999998665432 11233567999999999998886666665
Q ss_pred chhhhhhhhhheecc
Q 017820 348 APVATALSPVLWQVQ 362 (365)
Q Consensus 348 ~s~~~slg~vlw~lG 362 (365)
+||||+++|+|-
T Consensus 213 ---iwSlG~il~ell 224 (350)
T cd05573 213 ---WWSLGVILYEML 224 (350)
T ss_pred ---eEecchhhhhhc
Confidence 999999999983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=266.36 Aligned_cols=194 Identities=19% Similarity=0.269 Sum_probs=155.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.....++|++.+.||+|+||.||+|.+..++. ..+++|.+..... .......++...+....|++++.+++.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDF----PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCC----eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 34466899999999999999999999765431 4678887653321 1122223345666777899999988776
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+..+++||||+.+|+|.+++.... .+++..++.++.|++.||.|||++||+||||||
T Consensus 101 -~~~~~~~lv~Ey~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 159 (340)
T PTZ00426 101 -KDESYLYLVLEFVIGGEFFTFLRRNK--------------------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKP 159 (340)
T ss_pred -EeCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH
Confidence 55678999999999999999997654 357788889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||++.++ ++||+|||+++.+... .....||+.|||||++.+..++.++| +||||+++|+|
T Consensus 160 ~NILl~~~~-~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~D----iwSlGvil~el 221 (340)
T PTZ00426 160 ENLLLDKDG-FIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAAD----WWTLGIFIYEI 221 (340)
T ss_pred HHEEECCCC-CEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCcccc----ccchhhHHHHH
Confidence 999999887 9999999999875422 24568999999999998877666555 99999999998
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=263.92 Aligned_cols=198 Identities=21% Similarity=0.266 Sum_probs=155.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|.+.+.||+|+||.||+|.+..++ +.+++|.++.... ......+++...+....|++++.+...+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATG-----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-QDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-ecCC
Confidence 47999999999999999999999887 7788888764422 1222333445566667889988887665 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll 135 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYE-------------------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE
Confidence 8999999999999999997653 135778888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCC--CCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT--PSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~--~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+|+.+............||+.|+|||++...... ...+..+|+||||+++|+|-
T Consensus 136 ~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 203 (330)
T cd05601 136 DRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203 (330)
T ss_pred CCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence 9987 999999999987654433333456799999999998743222 12234556999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=262.91 Aligned_cols=191 Identities=21% Similarity=0.217 Sum_probs=147.0
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCC-CceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCA-DFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~ 215 (365)
+|++.+.||+|+||.||+|.+..++ +.+|+|.+..... .+......+...+....| +++..+...+ ...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCC
Confidence 5899999999999999999998887 7788887764321 111112222333344434 4455555444 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 134 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (324)
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 8999999999999999887643 34677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++...... .......||+.|+|||++.+..++.++| +||+|+++|+|-
T Consensus 135 ~~~~-~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslGvil~ell 195 (324)
T cd05587 135 DAEG-HIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVD----WWAFGVLLYEML 195 (324)
T ss_pred cCCC-CEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccc----hhhhHHHHHHHH
Confidence 9987 99999999987532221 1234568999999999998877766555 999999999984
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=256.57 Aligned_cols=192 Identities=20% Similarity=0.205 Sum_probs=153.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+...+ ..+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-~~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-ETKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCC-----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-ccCCe
Confidence 4788999999999999999999888 77888876533211 112223345666777889998887766 45568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++|+||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~ 136 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMG------------------NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 999999999999998876432 11357788889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||+++....... .....||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 137 ~~~-~~kl~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~D----vwslGvil~el~ 195 (285)
T cd05631 137 DRG-HIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPD----WWGLGCLIYEMI 195 (285)
T ss_pred CCC-CEEEeeCCCcEEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccC----chhHHHHHHHHH
Confidence 887 999999999987543322 23467999999999998887777665 999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=244.89 Aligned_cols=200 Identities=22% Similarity=0.252 Sum_probs=166.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHH---HHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWM---NERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.++..++|++++.||+|-||.||+|+.+.+. ..+++|.+....-..... ..++...-.+..|+||...++.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~-----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSL-----FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCC-----cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 4457789999999999999999999999887 788899886554333222 22334456778899999998887
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.+....|+++||..+|+|+..+++.. ...+++.....++.|++.||.|+|.++||||||||
T Consensus 92 -hd~~riyLilEya~~gel~k~L~~~~------------------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 92 -HDSKRIYLILEYAPRGELYKDLQEGR------------------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred -eccceeEEEEEecCCchHHHHHHhcc------------------cccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 56678999999999999999998543 23567888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
+|+|++.++ .+||+|||-+.... .....+.+||..|.+||+..+...+...| +|++|++.||+ ||+|
T Consensus 153 enlLlg~~~-~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd----~w~lgvl~yeflvg~pp 221 (281)
T KOG0580|consen 153 ENLLLGSAG-ELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVD----LWSLGVLCYEFLVGLPP 221 (281)
T ss_pred HHhccCCCC-CeeccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhh----HHHHHHHHHHHHhcCCc
Confidence 999999988 99999999987644 23356899999999999999888877776 99999999885 6665
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=262.18 Aligned_cols=195 Identities=19% Similarity=0.248 Sum_probs=147.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH----HHHHHHHHHHHhhcc-CCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (365)
+|++.+.||+|+||.||+++........ +.+++|.+...... .......+...+... .|++++.+...+ ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~ 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTG--KLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-QTE 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCC--CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-ecC
Confidence 5899999999999999999875321111 67888876543211 111122223333333 578888777655 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRD--------------------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 78999999999999999987654 3567888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .+||+|||+++..............||+.|||||++.+.. .+.+ +|+||||+++|+|-
T Consensus 138 i~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----~DiwslG~il~ell 201 (332)
T cd05614 138 LDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA----VDWWSLGILIFELL 201 (332)
T ss_pred ECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCc----cccccchhhhhhhh
Confidence 99987 9999999999875444333334578999999999987643 4444 45999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=269.16 Aligned_cols=192 Identities=27% Similarity=0.364 Sum_probs=166.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc-cccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT-EYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..|...++||+|+||.||+|.+..++ +.||+|.+. +....++...++++..+..+.++++..+++.+ ..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~-----k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-l~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTK-----KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-LKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecccc-----ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-eecccH
Confidence 57888899999999999999999998 889999987 34445566666677778888889998888877 667789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
|++|||+++|++.+.++... .+++..+..++++++.||.|||.++.+|||||+.|||+..
T Consensus 87 wiiMey~~gGsv~~lL~~~~--------------------~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~ 146 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGN--------------------ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE 146 (467)
T ss_pred HHHHHHhcCcchhhhhccCC--------------------CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec
Confidence 99999999999999997654 2255667789999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||.+..+...... ..+++|||.|||||++.+..++.++| +||||+..+||.
T Consensus 147 ~g-~vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KAD----IWSLGITaiEla 205 (467)
T KOG0201|consen 147 SG-DVKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKAD----IWSLGITAIELA 205 (467)
T ss_pred cC-cEEEEecceeeeeechhhc-cccccccccccchhhhccccccchhh----hhhhhHHHHHHh
Confidence 87 9999999999988765544 38899999999999999888988888 999999998873
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=262.25 Aligned_cols=191 Identities=20% Similarity=0.219 Sum_probs=148.0
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHh-hccCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~ 215 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+...... .......+...+ ....|+++..+...+ ...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-QTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-ecCC
Confidence 5889999999999999999998887 77888876643211 111111122222 233567776666554 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill 134 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE
Confidence 8999999999999999887643 34677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 135 ~~~~-~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwSlGvil~ell 195 (323)
T cd05616 135 DSEG-HIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVD----WWAFGVLLYEML 195 (323)
T ss_pred CCCC-cEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccc----hhchhHHHHHHH
Confidence 9987 99999999997543221 2234578999999999998877766655 999999999983
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=257.49 Aligned_cols=199 Identities=21% Similarity=0.244 Sum_probs=163.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-cHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
...++|++.++||.|..++||+|+...++ ..|++|++.-+ ...+.....++.+.+...+||||+.++..+ ..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~-----e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-vv~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTN-----EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-VVD 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccC-----CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-Eec
Confidence 35589999999999999999999999988 78889988633 334445666778889999999999999888 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+|+||.||.+|++.+++...- ...+++..|..|++++++||.|||++|.||||||+.|||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~------------------~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYY------------------PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHc------------------cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 79999999999999999998752 124788999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+++| .+||+|||.+..+-.... ...++++||+.|||||++..... -.|.++|+||||+...||
T Consensus 159 i~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~--GYdfKaDIwSfGITA~EL 225 (516)
T KOG0582|consen 159 IDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH--GYDFKADIWSFGITACEL 225 (516)
T ss_pred EcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc--CccchhhhhhhhHHHHHH
Confidence 99998 999999998776544322 11256899999999999643322 234455699999988776
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=263.15 Aligned_cols=198 Identities=20% Similarity=0.289 Sum_probs=153.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||++++..++ +.+|+|.+..... .+.....++...+....|+++..++..+ ..+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTG-----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-QDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-ecCC
Confidence 58999999999999999999999887 7888888764221 1222223344555666788888887766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 135 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE
Confidence 8999999999999999987532 135677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||++..+............||+.|||||++.+... ....+..+|+||+|+++|+|-
T Consensus 136 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 136 DKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred CCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 9887 99999999998765443333334579999999999874321 112233556999999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=262.85 Aligned_cols=198 Identities=19% Similarity=0.267 Sum_probs=153.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.++||+|+||+||++.+..++ +.+++|.+..... .+.....++...+....|+++..+...+ ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-QDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-ecCC
Confidence 57999999999999999999998887 7788887653221 1122223344556667888888887766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-------------------~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili 135 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-------------------RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 89999999999999999976431 34677788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++.+............||+.|+|||++.+... ....+..+|+||||+++|+|-
T Consensus 136 ~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 136 DMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred CCCC-CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 9887 99999999998654433333344689999999999874321 112233556999999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=262.40 Aligned_cols=186 Identities=20% Similarity=0.194 Sum_probs=149.5
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~ 221 (365)
+.||+|+||.||+|.+..++ +.+++|.+..... .+.....++...+....|++++.+.+.+ ..+..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-QTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-EcCCEEEEEE
Confidence 46999999999999998887 7788887764321 1222233345566777899998887765 5567899999
Q ss_pred EecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCc
Q 017820 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (365)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ 301 (365)
||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 75 e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~ 133 (323)
T cd05571 75 EYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-H 133 (323)
T ss_pred eCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-C
Confidence 9999999999987654 347788889999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 302 ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||+|||+|+..... ........||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwSlG~il~ell 189 (323)
T cd05571 134 IKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVD----WWGLGVVMYEMM 189 (323)
T ss_pred EEEeeCCCCcccccC-CCcccceecCccccChhhhcCCCCCcccc----Ccccchhhhhhh
Confidence 999999999754222 12234578999999999998877766665 999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=249.43 Aligned_cols=199 Identities=24% Similarity=0.317 Sum_probs=164.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|.|+.||++....+++..+.+.+-+|++... .....+++.+.|+...||+|+.+.... ...+.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti-~~~~~ 84 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSI-QEESF 84 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhh-cccce
Confidence 45789999999999999999999999995544444444454444 455566778899999999999998877 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+|++.|++|..-+-.+. -.++..+..+++||+++|.|+|.++|||||+||+|+|+-
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~--------------------~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA 144 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA 144 (355)
T ss_pred eEEEEecccchHHHHHHHHHH--------------------HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence 899999999999876554432 237788999999999999999999999999999999996
Q ss_pred c--CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 297 E--GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 297 ~--~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
+ ++.-+||+|||+|..+..+ .....+.|||.|||||+++..++....| +|+.||+||-| ||+|
T Consensus 145 SK~~~A~vKL~~FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvD----iW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 145 SKAKGAAVKLADFGLAIEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVD----IWACGVILYILLVGYPP 211 (355)
T ss_pred eccCCCceeecccceEEEeCCc--cccccccCCCcccCHHHhhcCCCCCcch----hhhhhHHHHHHHhCCCC
Confidence 4 3448999999999998733 3346789999999999999999988887 99999998865 7877
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=259.98 Aligned_cols=198 Identities=20% Similarity=0.263 Sum_probs=161.8
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc-----cccHHHHHHHHHHHHHhhccCCCceee
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT-----EYGAVEIWMNERVRRACANCCADFVYG 205 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~~~~~~~~~~i~~ 205 (365)
+....+..+.|..-++||+||||+||-++...|+ +.+|.|++. .........++ ..++...+.++|+.
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTG-----KMYAcKkL~KKRiKkr~ge~maLnE--k~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATG-----KMYACKKLDKKRIKKRKGETMALNE--KQILEKVSSPFIVS 249 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecch-----hhHHHHHHHHHHHHHhhhhHHhhHH--HHHHHHhccCcEEE
Confidence 3345677789999999999999999999999999 666666553 33333333333 34444455567777
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+-..+ .+.+.+++|+..|+||+|.-.+...+ ...++++.++.++.+|+.||++||..+||+
T Consensus 250 laYAf-eTkd~LClVLtlMNGGDLkfHiyn~g------------------~~gF~e~ra~FYAAEi~cGLehlH~~~iVY 310 (591)
T KOG0986|consen 250 LAYAF-ETKDALCLVLTLMNGGDLKFHIYNHG------------------NPGFDEQRARFYAAEIICGLEHLHRRRIVY 310 (591)
T ss_pred Eeeee-cCCCceEEEEEeecCCceeEEeeccC------------------CCCCchHHHHHHHHHHHhhHHHHHhcceee
Confidence 65555 66789999999999999988776655 246799999999999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+||+|||+|+.| +++|+|+|+|..+..+... ...+||.+|||||++.+..++.+.| +|+||.+||+|
T Consensus 311 RDLKPeNILLDd~G-hvRISDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~D----wf~lGCllYem 379 (591)
T KOG0986|consen 311 RDLKPENILLDDHG-HVRISDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPD----WFSLGCLLYEM 379 (591)
T ss_pred ccCChhheeeccCC-CeEeeccceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCcc----HHHHHhHHHHH
Confidence 99999999999998 9999999999998766543 4569999999999999999888888 89999999987
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=256.50 Aligned_cols=199 Identities=20% Similarity=0.242 Sum_probs=166.1
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..+..++|++++.||.|.-|+||++.+.+++ ..+|+|.+.+..... ....+.++..+....||++..++..+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~-----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTN-----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCC-----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 3456678999999999999999999999998 788999887654432 22333456678888999999888877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
+.....+++||||+||+|+.+.+... +..++++.++.++.+++.||+|||..|||+|||||
T Consensus 147 -et~~~~cl~meyCpGGdL~~LrqkQp------------------~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 147 -ETDKYSCLVMEYCPGGDLHSLRQKQP------------------GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred -eccceeEEEEecCCCccHHHHHhhCC------------------CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 66689999999999999999998764 55778999999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEeccccccccc---------------------------------C-C-------------------
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRV---------------------------------G-I------------------- 317 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~---------------------------------~-~------------------- 317 (365)
+||||.++| ++.|+||.++..... . .
T Consensus 208 ENILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 208 ENILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred ceeEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 999999998 999999999753211 0 0
Q ss_pred --ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 318 --NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 318 --~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+.....++||..|.|||++.|...+...| +|+||+++|||
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgsAVD----WWtfGIflYEm 328 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGSAVD----WWTFGIFLYEM 328 (459)
T ss_pred CCCccccccccccccccceeeecCCCCchhh----HHHHHHHHHHH
Confidence 01123479999999999999999888877 99999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=265.12 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=173.2
Q ss_pred HhhhhhhhccCCCCCchhHHHHHHHHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH
Q 017820 103 LSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA 182 (365)
Q Consensus 103 ~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~ 182 (365)
..+..|.+..+...|. .-.+.+..++|++.+.||+|+||.||+|.+..++.......|++|.+.....
T Consensus 14 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~ 81 (374)
T cd05106 14 AEGNNYTFIDPTQLPY------------NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81 (374)
T ss_pred ccCCcceeeCCccccc------------cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC
Confidence 3455666666655553 1134456789999999999999999999987766555556799998875432
Q ss_pred H-HHHHHHHHHHHhhcc-CCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhh---------------
Q 017820 183 V-EIWMNERVRRACANC-CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL--------------- 245 (365)
Q Consensus 183 ~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~--------------- 245 (365)
. ......++...+... .|++++.+++.+ ..+...++||||+.+|+|.+++............
T Consensus 82 ~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (374)
T cd05106 82 TDEREALMSELKILSHLGQHKNIVNLLGAC-THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNI 160 (374)
T ss_pred HHHHHHHHHHHHHHHhhccCCceeeEeeEe-cCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccccccccccccccccc
Confidence 2 222222334445444 799999998876 4556899999999999999998754211000000
Q ss_pred --------------------------hc---------cccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 246 --------------------------IL---------GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 246 --------------------------~~---------~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.. ...........+++..+++++.||+.||.|||++||+||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 240 (374)
T cd05106 161 TLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAA 240 (374)
T ss_pred chhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCch
Confidence 00 0000111223467888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
+|||+++++ ++||+|||+++.+....... .....+++.|||||++.+..++.++| +||||+++|+| |.+|
T Consensus 241 ~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----vwSlGvil~ellt~G~~P 314 (374)
T cd05106 241 RNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSD----VWSYGILLWEIFSLGKSP 314 (374)
T ss_pred heEEEeCCC-eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCcccc----HHHHHHHHHHHHhCCCCC
Confidence 999999877 99999999998764433221 12334567899999998877776666 99999999996 5554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=259.73 Aligned_cols=187 Identities=21% Similarity=0.212 Sum_probs=149.6
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~ 221 (365)
+.||+|+||.||++++..++ +.+++|.+..... .+.....++...+....|++++.+.+.+ ..+..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-ecCCEEEEEE
Confidence 46999999999999998887 7888888764321 1222223345666777899998887766 4557899999
Q ss_pred EecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCc
Q 017820 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (365)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ 301 (365)
||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 75 E~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~ 133 (323)
T cd05595 75 EYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-H 133 (323)
T ss_pred eCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-C
Confidence 9999999998886543 357788999999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 302 ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-+
T Consensus 134 ~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwSlGvil~ell~ 190 (323)
T cd05595 134 IKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVD----WWGLGVVMYEMMC 190 (323)
T ss_pred EEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhc----hhhhHHHHHHHHh
Confidence 9999999987542221 2224567999999999998777666555 9999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=276.43 Aligned_cols=217 Identities=21% Similarity=0.298 Sum_probs=183.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..++...+.++.+.||+|.||+||+|+..+.........|+||.+++.... .....+++...+....|+||+.+++.+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC- 558 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC- 558 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-
Confidence 445677889999999999999999999987766666688999999988776 667777888999999999999999998
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..++.+++|+|||..|+|.+||..+...-... +.+. + ....++..+...|+.||+.||+||-++.+|||||...
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~--~~g~--~--~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKL--ASGQ--D--TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccc--cCCC--C--CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 66778999999999999999998876322111 0010 0 1345788999999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccc-cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+||.++- .+||+|||+++++-..+.|... .-....+|||||.+..++++..+| +||+||||||+
T Consensus 633 NCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSD----VWs~GVvLWEI 698 (774)
T KOG1026|consen 633 NCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESD----VWSFGVVLWEI 698 (774)
T ss_pred hceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhh----hhhhhhhhhhh
Confidence 99999976 9999999999998777666544 445577999999999999988888 99999999996
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=257.19 Aligned_cols=190 Identities=26% Similarity=0.281 Sum_probs=143.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC----C
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG----G 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 215 (365)
.|.-.+++|+|+||.||+|....++ +.+|+|+...+...... +...+....|+||+.+...+.... -
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~-----~~vAIKKv~~d~r~knr----El~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE-----EEVAIKKVLQDKRYKNR----ELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC-----ceeEEEEecCCCCcCcH----HHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 6888999999999999999999987 88999998766542221 222333677888887765554333 2
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
...+||||++. +|+++++... ..+...+.-.++-+..||++||.|||+.||+||||||+|+|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~----------------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv 158 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYT----------------RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV 158 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHh----------------hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE
Confidence 45689999996 8999988521 011233445577899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~l 361 (365)
|.+.+.+||||||.|+.+..++.. .....|..|.|||.+.|.+. +.+.| +||.|.|+=||
T Consensus 159 D~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~ID----iWSaGCV~aEL 219 (364)
T KOG0658|consen 159 DPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSID----IWSAGCVMAEL 219 (364)
T ss_pred cCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeE----EhhhhHHHHHH
Confidence 998779999999999988765433 45677899999999998854 44444 55555555443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=259.15 Aligned_cols=191 Identities=20% Similarity=0.208 Sum_probs=146.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhc-cCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 215 (365)
+|++.+.||+|+||.||+|.+..++ +.||+|.+..... ........+...+.. .+|+++..+...+ ...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-QTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-ecCC
Confidence 4788999999999999999999887 7788887764321 111111112222332 3455555555544 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill 134 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 8999999999999999887643 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++...... .......||+.|+|||++.+..++.++| +||+|+++|+|-
T Consensus 135 ~~~~-~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslGvil~ell 195 (323)
T cd05615 135 DSEG-HIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVD----WWAYGVLLYEML 195 (323)
T ss_pred CCCC-CEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccc----hhhhHHHHHHHH
Confidence 9987 99999999998643222 1234567999999999998777666555 999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=259.39 Aligned_cols=186 Identities=21% Similarity=0.197 Sum_probs=148.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~ 221 (365)
+.||+|+||.||++.+..++ +.+|+|.+..... .+.....++...+....|++++.+...+ ..+..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-QTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-EcCCEEEEEE
Confidence 46999999999999998887 7888888764321 1222233345566777889988877665 4567899999
Q ss_pred EecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCc
Q 017820 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (365)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ 301 (365)
||+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .
T Consensus 75 Ey~~~g~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~ 133 (328)
T cd05593 75 EYVNGGELFFHLSRER--------------------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-H 133 (328)
T ss_pred eCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-c
Confidence 9999999998886543 357788889999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 302 ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslGvil~ell 189 (328)
T cd05593 134 IKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVD----WWGLGVVMYEMM 189 (328)
T ss_pred EEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCC----ccccchHHHHHh
Confidence 9999999997643221 1234568999999999998877766665 999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=257.47 Aligned_cols=183 Identities=19% Similarity=0.245 Sum_probs=147.5
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|++++.++..+ ..+...++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ-----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-QSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-ecCCeEEEEEcC
Confidence 799999999999998887 778888775432 12222223344556667899999887766 456789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+|
T Consensus 75 ~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~k 133 (312)
T cd05585 75 INGGELFHHLQREG--------------------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIA 133 (312)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEE
Confidence 99999999987653 346778889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++...... .......||+.|+|||++.+..++.++| +||+|+++|+|
T Consensus 134 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslGvil~el 186 (312)
T cd05585 134 LCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVD----WWTLGVLLYEM 186 (312)
T ss_pred EEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccc----eechhHHHHHH
Confidence 99999998643222 2234568999999999998877766665 99999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=258.79 Aligned_cols=186 Identities=19% Similarity=0.223 Sum_probs=146.6
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---H-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---E-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||+||+|.+..++ +.+++|.+...... + .....+....+....|++++.++..+ .....+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-~~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG-----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-QTTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-ecCCEEEEE
Confidence 46999999999999998887 77888877543211 1 11111222345667899999887766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+++++
T Consensus 75 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~- 133 (325)
T cd05604 75 LDFVNGGELFFHLQRER--------------------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG- 133 (325)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-
Confidence 99999999998886543 357788889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|||||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~el~ 190 (325)
T cd05604 134 HVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVD----WWCLGAVLYEML 190 (325)
T ss_pred CEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCc----cccccceehhhh
Confidence 99999999997543222 2234568999999999998877766655 999999999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=258.28 Aligned_cols=185 Identities=23% Similarity=0.274 Sum_probs=145.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
+.||+|+||.||+|.+..++ +.||+|.++.... .+....+ .........|++++.+++.+ ..+..+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~hp~i~~~~~~~-~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN-----EFFAIKALKKDVVLEDDDVECTMVE-RRVLALAWEHPFLTHLFCTF-QTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHH-HHHHHhccCCCCccceeeEE-EcCCEEEE
Confidence 46999999999999998887 7788887764321 1111111 11222345788998887766 45678999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 74 v~e~~~gg~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~ 133 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG--------------------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133 (316)
T ss_pred EEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC
Confidence 999999999999887653 357778889999999999999999999999999999999987
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+|+...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 -~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~ell 190 (316)
T cd05592 134 -HIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVD----WWSFGVLLYEML 190 (316)
T ss_pred -CEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCccc----chhHHHHHHHHH
Confidence 99999999998653322 2234578999999999998877766665 999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=267.59 Aligned_cols=194 Identities=22% Similarity=0.235 Sum_probs=161.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..+-|++++.||.|+-|.|.+|++..|+ +..|+|.+... ......-.++++..++...|+|++.+++.+ ..
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TG-----qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-e~ 83 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETG-----QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-EN 83 (786)
T ss_pred cccceeccccccCCCCceehhhhccccc-----ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-cc
Confidence 4578999999999999999999999999 55555555432 222233445556677788899999999887 66
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
..++|+|.||+++|.|++++-.++ .+.+..++++++||+.|+.|+|..+|+|||+||+|+
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG--------------------~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl 143 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKG--------------------PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL 143 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence 689999999999999999998876 567888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||.++ ++||+|||+|..-..+. .-.+-||+|.|.|||++.|.+|+... +|+||.||+||+|-
T Consensus 144 LLd~~~-nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~---sDVWSCGVILfALL 206 (786)
T KOG0588|consen 144 LLDVKN-NIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRP---SDVWSCGVILFALL 206 (786)
T ss_pred hhhccc-CEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCc---cccchhHHHHHHHH
Confidence 999988 79999999998644432 33578999999999999999886654 46999999999873
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=258.03 Aligned_cols=189 Identities=20% Similarity=0.222 Sum_probs=150.2
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----HH-HHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
|++.+.||+|+||.||+|.+..++ +.+++|.+..... .+ ...+.++...+....|++++.+++.+ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG-----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-QTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-EcC
Confidence 678999999999999999998887 7788888764321 11 11122223334566799999888766 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|..++... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nil 133 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIHTD---------------------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE
Confidence 7899999999999998887543 2477788899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .+||+|||+++..... ........||+.|||||++.+..++.++| +||||+++|+|-
T Consensus 134 l~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~D----iwslG~il~el~ 195 (324)
T cd05589 134 LDTEG-FVKIADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVD----WWGLGVLIYEML 195 (324)
T ss_pred ECCCC-cEEeCcccCCccCCCC-CCcccccccCccccCHhHhcCCCCCcccc----hhhHHHHHHHHH
Confidence 99987 9999999998754322 22234578999999999998877666555 999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=258.75 Aligned_cols=187 Identities=20% Similarity=0.221 Sum_probs=146.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||+||+|.+..++ +.+++|.+..... .+.....++...+....|++++.++..+ .....+++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE-----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-EcCCeEEEE
Confidence 46999999999999998887 6788887654321 1111222223345567889998887766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~- 133 (325)
T cd05602 75 LDYINGGELFYHLQRER--------------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 133 (325)
T ss_pred EeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999999987643 345677888999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+|+...... .......||+.|+|||++.+..++.++| +||||+++|+|-+
T Consensus 134 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el~~ 191 (325)
T cd05602 134 HIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVD----WWCLGAVLYEMLY 191 (325)
T ss_pred CEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccc----cccccHHHHHHhc
Confidence 99999999998643222 2234578999999999998877766655 9999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=257.33 Aligned_cols=187 Identities=21% Similarity=0.216 Sum_probs=148.0
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~ 221 (365)
+.||+|+||.||++.+..++ +.+++|.+..... ........+...+....|++++.+...+ ..+..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-EcCCEEEEEE
Confidence 46999999999999998887 7788887764321 1222223344556667889988877665 5567899999
Q ss_pred EecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEecCCC
Q 017820 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~~~~~ 300 (365)
||+++++|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 75 E~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~- 133 (325)
T cd05594 75 EYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG- 133 (325)
T ss_pred eCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-
Confidence 9999999998886543 35778889999999999999997 7999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-+
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el~t 191 (325)
T cd05594 134 HIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVD----WWGLGVVMYEMMC 191 (325)
T ss_pred CEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccc----cccccceeeeecc
Confidence 99999999997543221 1224567999999999998877766665 9999999999843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=263.62 Aligned_cols=192 Identities=19% Similarity=0.117 Sum_probs=153.6
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...+..++|++.+.||+|+||.||+|.+..++ +.+|+|+..... ..++...+....|++|+.+++.+ .
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~-----~~vaiK~~~~~~------~~~E~~il~~l~HpnIv~~~~~~-~ 153 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTC-----EHVVIKAGQRGG------TATEAHILRAINHPSIIQLKGTF-T 153 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECCCC-----CEEEEechhhhh------hHHHHHHHHhCCCCCCCCEeEEE-E
Confidence 34456689999999999999999999999887 788888754321 12345566677899999988776 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+...++|+|++. ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 154 ~~~~~~lv~e~~~-~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~N 212 (391)
T PHA03212 154 YNKFTCLILPRYK-TDLYCYLAAKR--------------------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212 (391)
T ss_pred ECCeeEEEEecCC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHh
Confidence 4567899999986 68888876543 34667788999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+|+..............||+.|+|||++.+..++.+ +|+||||+++|+|-
T Consensus 213 Ill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----~DiwSlGvil~ell 277 (391)
T PHA03212 213 IFINHPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPA----VDIWSAGIVLFEMA 277 (391)
T ss_pred EEEcCCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcH----HHHHHHHHHHHHHH
Confidence 9999987 99999999997543322222345689999999999987766554 45999999999983
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=257.22 Aligned_cols=186 Identities=19% Similarity=0.238 Sum_probs=146.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HH-HHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EI-WMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||+||+|.+..++ +.+++|.+...... +. ....+....+....|++++.++..+ .....+++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-~~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG-----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-QTADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-EeCCEEEEE
Confidence 47999999999999998887 77888887543211 11 1111222344567789999887766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~- 133 (323)
T cd05575 75 LDYVNGGELFFHLQRER--------------------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG- 133 (323)
T ss_pred EcCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-
Confidence 99999999999887654 346778889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~ell 190 (323)
T cd05575 134 HVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVD----WWCLGAVLYEML 190 (323)
T ss_pred cEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCcccc----ccccchhhhhhh
Confidence 99999999997643222 2234568999999999998877666555 999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=269.12 Aligned_cols=197 Identities=19% Similarity=0.265 Sum_probs=158.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCC-CCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKK-PSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..|.+.+.||+|+||.||+|....+ + ..+++|++............++...+....|++++.+++.+ ..++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~-----~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPK-----EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-KSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCC-----eEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-EECCEE
Confidence 4599999999999999999998766 4 56777766544444444444566777888999999998877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+.+|+|.+++.... .....+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~----------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~ 204 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRL----------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204 (478)
T ss_pred EEEEECCCCCCHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC
Confidence 99999999999999886431 11224577888899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||+|+.+..... .......||+.|+|||++.+..++.++ |+||||+++|+|-
T Consensus 205 ~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----Dv~slG~~l~el~ 265 (478)
T PTZ00267 205 TG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA----DMWSLGVILYELL 265 (478)
T ss_pred CC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHH----hHHHHHHHHHHHH
Confidence 87 999999999987654322 123456799999999999877666554 5999999999983
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=252.03 Aligned_cols=194 Identities=22% Similarity=0.295 Sum_probs=152.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|++..++ ..+++|.+...... ......++...+....|++++.+++.+ ...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCC-----cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCE
Confidence 47999999999999999999998887 77888877643221 112222345566667889998887766 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||++++.+..+..... .+++..++.++.|++.||.|||+++|+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPN--------------------GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 999999999877765543221 357778899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||+++.+............||+.|+|||++.+..++.++ |+||+|+++|+|-+
T Consensus 135 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----DiwslGvil~el~~ 196 (287)
T cd07848 135 HND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV----DMWSVGCILGELSD 196 (287)
T ss_pred CCC-cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCch----hHHhHHHHHHHHHh
Confidence 987 999999999987654433333456789999999999877665544 59999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=257.08 Aligned_cols=196 Identities=24% Similarity=0.325 Sum_probs=161.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
..+..++.+.||+|.||.||+|+..+ +.||||...... .+.+..|+.+.......|+||+.|++.....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC-------ceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 34677888999999999999999887 779999877554 4455666677778889999999998775221
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC---------CCc
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---------GIV 284 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~---------~Ii 284 (365)
..++|||++|.+.|+|.+|+..+- .++....+++..+++||+|||+. .|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~nt---------------------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANT---------------------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhcc---------------------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 358999999999999999998764 57888999999999999999964 599
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCC--CCCCCchhhhhhhhhheec
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQT--PSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~--~~~d~~s~~~slg~vlw~l 361 (365)
|||||.+|||+.+|. ++-|+|||+|..+..+.... .-..+||.+|||||++.+...- ..+-...|+||+|.||||+
T Consensus 339 HRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi 417 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI 417 (534)
T ss_pred cccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999988 99999999999887553321 2247999999999999887443 3334488999999999997
Q ss_pred c
Q 017820 362 Q 362 (365)
Q Consensus 362 G 362 (365)
-
T Consensus 418 ~ 418 (534)
T KOG3653|consen 418 A 418 (534)
T ss_pred H
Confidence 3
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=256.51 Aligned_cols=186 Identities=21% Similarity=0.244 Sum_probs=144.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHh-hccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+++|.+..... .+......+...+ ....|++++.+++.+ .....+++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG-----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-QTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-EeCCEEEEE
Confidence 47999999999999999887 7788887764321 1111111122222 334688888887766 455789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 75 ~E~~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~- 133 (316)
T cd05620 75 MEFLNGGDLMFHIQDKG--------------------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG- 133 (316)
T ss_pred ECCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999999887643 346777889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslGvil~el~ 190 (316)
T cd05620 134 HIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVD----WWSFGVLLYEML 190 (316)
T ss_pred CEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccc----hhhhHHHHHHHH
Confidence 99999999997533222 2234578999999999998877776665 999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=261.03 Aligned_cols=201 Identities=23% Similarity=0.260 Sum_probs=161.7
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.|.+..++..+.++||+|.||+||+|.....+.... ..||+|..+... .......-.+.+.++..+|+|++.+++.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~-~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKV-VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCcee-eeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 466777888889999999999999999987654221 128888887522 3334444456677788999999999998
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
. .....+++|||+|.||+|.++|+..+- .++..+...++.+.+.||+|||++++|||||-
T Consensus 230 a-~~~~Pl~ivmEl~~gGsL~~~L~k~~~-------------------~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIA 289 (474)
T KOG0194|consen 230 A-VLEEPLMLVMELCNGGSLDDYLKKNKK-------------------SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIA 289 (474)
T ss_pred E-cCCCccEEEEEecCCCcHHHHHHhCCC-------------------CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHh
Confidence 7 555789999999999999999998751 34667778899999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccc-cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+|+|++.++ .+||+|||+++.-. ...... .-.-..+|+|||.+....++.++| +||+|+++||+
T Consensus 290 ARNcL~~~~~-~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTD----V~sfGV~~~Ei 355 (474)
T KOG0194|consen 290 ARNCLYSKKG-VVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTD----VWSFGVLLWEI 355 (474)
T ss_pred HHHheecCCC-eEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccc----hhheeeeEEee
Confidence 9999999987 89999999997643 111112 123467999999999998888888 99999999996
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=255.86 Aligned_cols=186 Identities=20% Similarity=0.239 Sum_probs=144.5
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhh-ccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|++..++ +.+++|.+..... ........+...+. ...|++++.+++.+ ..+..+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-~~~~~~~lv 74 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-QTKDRLFFV 74 (321)
T ss_pred CccccCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCeEEEE
Confidence 46999999999999998887 7788887764321 11111111222222 34688888887766 455789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 75 ~E~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~- 133 (321)
T cd05591 75 MEYVNGGDLMFQIQRSR--------------------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG- 133 (321)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-
Confidence 99999999999887543 346777889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~el~ 190 (321)
T cd05591 134 HCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVD----WWALGVLMYEMM 190 (321)
T ss_pred CEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccc----eechhHHHHHHh
Confidence 99999999997643222 2234567999999999998877766655 999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=255.16 Aligned_cols=186 Identities=18% Similarity=0.212 Sum_probs=145.7
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH----HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|++..++ ..+++|.+...... ......++...+....|++++.+.+.+ ......++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG-----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-QTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-EcCCEEEEE
Confidence 47999999999999998887 77888876533211 111122223345667899999887665 556789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~- 133 (321)
T cd05603 75 LDYVNGGELFFHLQRER--------------------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG- 133 (321)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-
Confidence 99999999988886543 346677888999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el~ 190 (321)
T cd05603 134 HVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVD----WWCLGAVLYEML 190 (321)
T ss_pred CEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCc----ccccchhhhhhh
Confidence 99999999997532222 2234568999999999998777666555 999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=267.42 Aligned_cols=201 Identities=21% Similarity=0.265 Sum_probs=157.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||+||+|.+..++ +.+|+|.+.... ..+.....++...+....|++++.+...+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDG-----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4579999999999999999999998887 788999875432 233333444556667778888887765443221
Q ss_pred -------CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 215 -------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 215 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
..+++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+++|+|||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~----------------~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK----------------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 246899999999999999875431 123467788999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+..++.++ |+||||+++|+|-+
T Consensus 169 LKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~----DVwSlGvilyeLlt 240 (496)
T PTZ00283 169 IKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA----DMFSLGVLLYELLT 240 (496)
T ss_pred CCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHH----HHHHHHHHHHHHHH
Confidence 999999999987 99999999998764332 1223457899999999999877666554 59999999999843
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=242.52 Aligned_cols=198 Identities=22% Similarity=0.327 Sum_probs=160.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcc-----ccHHHHHHH----HHHHHHhhccCCCceeeeecc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVEIWMN----ERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+.|.-.+.||+|..+.|-++..+.++ +.+++|++.. .......+. .++........||+|+.+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~-----~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETG-----KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccc-----cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 56777889999999999999999998 7777777631 111111111 122233455679999998877
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ +....+++|+|.++.|.|+|++.+.- .++++..++|++|+++|+.|||.++|||||||
T Consensus 92 y-es~sF~FlVFdl~prGELFDyLts~V--------------------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLK 150 (411)
T KOG0599|consen 92 Y-ESDAFVFLVFDLMPRGELFDYLTSKV--------------------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLK 150 (411)
T ss_pred c-cCcchhhhhhhhcccchHHHHhhhhe--------------------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccC
Confidence 6 56678999999999999999998764 67889999999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC--Cchhhhhhhhhheec--ccCC
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP--SAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d--~~s~~~slg~vlw~l--Gc~~ 365 (365)
|+|||+|++. ++||+|||.|..+..+.. -...+|||+|.|||.+...-+..... ...|.|++||+||.| ||+|
T Consensus 151 pENILlddn~-~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpP 227 (411)
T KOG0599|consen 151 PENILLDDNM-NIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPP 227 (411)
T ss_pred hhheeecccc-ceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCc
Confidence 9999999988 999999999998876654 35789999999999988665544332 367899999999986 8988
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=256.79 Aligned_cols=223 Identities=22% Similarity=0.238 Sum_probs=162.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
|.+..++|++.+.||+|+||.||+|.+..++.....+.|++|++...... +......+...+... .|++++.+++.+.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 44566799999999999999999998776655445578999988643322 222222233344444 7889999888776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccc-----------------------------------------c
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE-----------------------------------------V 250 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~-----------------------------------------~ 250 (365)
..+..+++++||+.+++|.+++................ .
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 66778999999999999999987543111000000000 0
Q ss_pred ccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCC
Q 017820 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPR 329 (365)
Q Consensus 251 ~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~ 329 (365)
........+++..+..++.||+.||.|||+++|+||||||+|||+++++ .+||+|||+++.+...... ......++..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 0000123568888999999999999999999999999999999999887 9999999999876433222 1233456778
Q ss_pred cCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 330 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 330 Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||++.+..++.++| +||||+++|+|
T Consensus 241 y~aPE~~~~~~~~~~~D----i~SlGv~l~el 268 (337)
T cd05054 241 WMAPESIFDKVYTTQSD----VWSFGVLLWEI 268 (337)
T ss_pred ccCcHHhcCCCCCcccc----HHHHHHHHHHH
Confidence 99999998888877766 99999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=255.63 Aligned_cols=185 Identities=18% Similarity=0.230 Sum_probs=145.4
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHh-hccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+|+|.++..... .......+...+ ....|++++.+++.+ .....+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-~~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR-----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-QTESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-EcCCEEEEE
Confidence 46999999999999999887 77888887643211 111122223333 333688998887766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~- 133 (329)
T cd05588 75 IEFVSGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG- 133 (329)
T ss_pred EeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999998886543 357788999999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+||+|||+++..... ........||+.|+|||++.+..++.++| +||||+++|+|
T Consensus 134 ~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~~l~el 189 (329)
T cd05588 134 HIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVD----WWALGVLMFEM 189 (329)
T ss_pred CEEECcCccccccccC-CCccccccCCccccCHHHHcCCCCCCccc----eechHHHHHHH
Confidence 9999999999753221 22234578999999999998877766655 99999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=254.97 Aligned_cols=186 Identities=19% Similarity=0.232 Sum_probs=145.2
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHH-HhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRR-ACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+++|.+..... ........+.. ......|++++.+++.+ .....+++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~~~~iv 74 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG-----RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-QTPDRLFFV 74 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-EcCCEEEEE
Confidence 46999999999999998887 7788887764321 11111111222 22334688988887766 556789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 75 ~Ey~~~g~L~~~i~~~~--------------------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~- 133 (320)
T cd05590 75 MEFVNGGDLMFHIQKSR--------------------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG- 133 (320)
T ss_pred EcCCCCchHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-
Confidence 99999999999887654 356788889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++..... ........||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 134 ~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el~ 190 (320)
T cd05590 134 HCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEMLYGPSVD----WWAMGVLLYEML 190 (320)
T ss_pred cEEEeeCCCCeecCcC-CCcccccccCccccCHHHHcCCCCCCccc----hhhhHHHHHHHh
Confidence 9999999999764322 22234568999999999998777666555 999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=250.07 Aligned_cols=218 Identities=19% Similarity=0.194 Sum_probs=157.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCC-----------CCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCcee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS-----------SKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----------~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 204 (365)
..++|++.++||+|+||.||+|.+..... ......+++|.+...... ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45799999999999999999998754321 011135888887654322 222233345566667899999
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+++.+. .....++||||+.+++|.+++............ ............+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCV-DEDPLCMITEYMENGDLNQFLSSHHLDDKEENG-NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEe-cCCceEEEEecCCCCcHHHHHHhcccccccccc-ccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9988764 456789999999999999998765321110000 00011122234567788999999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||||+|||+++++ .+||+|||+++.+...... ......++..|||||++.+..++.++ |+||||+++|+|
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~~l~el 233 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS----DVWAFGVTLWEI 233 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchh----hhHHHHHHHHHH
Confidence 999999999999987 9999999999876443322 12334567899999999877666555 499999999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=277.35 Aligned_cols=208 Identities=18% Similarity=0.240 Sum_probs=175.1
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..+..++.+.||+|.||+||+|+............|++|.+++.. ..+.....++...+....|+||+.+++.+..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD- 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-
Confidence 35567899999999999999999999876644434668999988664 3455556667788899999999999999866
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++++|||.+|+|..|+++.... .-....++...+..++.||++|++||+++++|||||...|+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~-------------~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNC 833 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPA-------------PFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNC 833 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccc-------------cCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhhe
Confidence 77899999999999999999887410 11234567788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccc-cCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEF-LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||++.. .+||+|||+|+++-....++.... ....+|||||.++...++.++| +|||||+|||+
T Consensus 834 LL~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSD----vWsFGVllWEi 897 (1025)
T KOG1095|consen 834 LLDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSD----VWSFGVLLWEI 897 (1025)
T ss_pred eecccC-cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccc----hhhhHHHHHHH
Confidence 999986 999999999998877777665554 4456999999999999999988 99999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=252.32 Aligned_cols=194 Identities=20% Similarity=0.219 Sum_probs=150.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+....... .....++...+....|++++.+.+.. ..+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~ 76 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNG-----KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-HTKE 76 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCC-----CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-ecCC
Confidence 3479999999999999999999998877 778888876432211 11222345556667889998887766 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHP-------------------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 8999999996 57888776543 134667788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++...... .......||+.|+|||++.+.. ..+..+|+||+|+++|+|
T Consensus 137 ~~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l 197 (303)
T cd07869 137 SDTG-ELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGST---EYSTCLDMWGVGCIFVEM 197 (303)
T ss_pred CCCC-CEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCC---CCCcHHHHHHHHHHHHHH
Confidence 9987 99999999997643222 1223467899999999986542 223456799999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=259.46 Aligned_cols=222 Identities=19% Similarity=0.234 Sum_probs=158.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+.+..++|++.++||+|+||.||+|++...........+++|.++.... .+.....++...+... .|+|++.+++.+
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~- 108 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC- 108 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-
Confidence 3445679999999999999999999864332222236789998864332 2222222334444444 799999998877
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchh--------------------------hhhccc---------cc-----
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQ--------------------------TLILGE---------VQ----- 251 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~--------------------------~~~~~~---------~~----- 251 (365)
..+...++||||+++|+|.+++......+... +++... ..
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 55568899999999999999997654211110 000000 00
Q ss_pred ---------------cCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccC
Q 017820 252 ---------------DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316 (365)
Q Consensus 252 ---------------~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~ 316 (365)
....+..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRND 267 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCc
Confidence 001123567888999999999999999999999999999999999876 9999999999876543
Q ss_pred Cccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 317 INYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 317 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.... .....++..|+|||++.+..++.++| +||||+++|+|
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD----i~slG~~l~el 309 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESD----VWSYGILLWEI 309 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCC----HHHHHHHHHHH
Confidence 3221 12334567899999998877776665 99999999996
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=253.37 Aligned_cols=186 Identities=21% Similarity=0.270 Sum_probs=144.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHh-hccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||+||+|++..++ +.+|+|.+..... ........+...+ ....|++++.+++.+ .....+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv 74 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-QTKENLFFV 74 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-EeCCEEEEE
Confidence 47999999999999999887 7788887764321 1111111112222 335789998888776 455789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 75 ~ey~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~- 133 (316)
T cd05619 75 MEYLNGGDLMFHIQSCH--------------------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG- 133 (316)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-
Confidence 99999999999987643 346677888999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++....... ......||+.|+|||++.+..++.++| +||+|+++|+|-
T Consensus 134 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslG~il~el~ 190 (316)
T cd05619 134 HIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQKYNTSVD----WWSFGVLLYEML 190 (316)
T ss_pred CEEEccCCcceECCCCCC-ceeeecCCccccCHHHHcCCCCCchhh----hhhHHHHHHHHH
Confidence 999999999975432221 234568999999999998777666655 999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=253.95 Aligned_cols=191 Identities=19% Similarity=0.226 Sum_probs=147.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccC----
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK---- 213 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---- 213 (365)
+|++.++||+|+||.||+|.+..++ ..|++|++..... .......++...+....|++++.+++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 5899999999999999999998887 7888988763211 1222233445566777899998887654322
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||++ ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAND--------------------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhcc--------------------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 245899999996 58988886543 357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCcccccc--CCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIM--STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~--~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++. .+|+||||+++|+|
T Consensus 135 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~----~~DvwSlGvvl~el 201 (338)
T cd07859 135 LANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP----AIDIWSIGCIFAEV 201 (338)
T ss_pred EECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCc----hhHHHHHHHHHHHH
Confidence 999987 999999999986432211 11234679999999999865 33333 55699999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=254.23 Aligned_cols=184 Identities=19% Similarity=0.258 Sum_probs=140.9
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHH---HHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIW---MNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
||+|+||+||+|.+..++ +.+++|.+...... +.. .+..+........|++++.+...+ .....+++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-~~~~~~~lv 74 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR-----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-QTDSDLYLV 74 (330)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-ecCCeEEEE
Confidence 799999999999998887 77888876532211 111 111122222223688888887665 455789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~- 133 (330)
T cd05586 75 TDYMSGGELFWHLQKEG--------------------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG- 133 (330)
T ss_pred EcCCCCChHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-
Confidence 99999999999887644 357788999999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheecc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++...... .......||+.|+|||++.+.. ++.+ +|+||||+++|+|-
T Consensus 134 ~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~----~DvwslGvil~ell 191 (330)
T cd05586 134 HIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKH----VDFWSLGVLVFEMC 191 (330)
T ss_pred CEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCc----cceeccccEEEEec
Confidence 99999999997643222 2234578999999999987543 4444 45999999999984
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=253.57 Aligned_cols=185 Identities=19% Similarity=0.243 Sum_probs=145.2
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHh-hccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+++|.+...... +.....++...+ ....|++++.+.+.+ .....+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND-----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-QTTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-EeCCEEEEE
Confidence 47999999999999998887 77888887643221 111122222332 334688888887765 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~- 133 (327)
T cd05617 75 IEYVNGGDLMFHMQRQR--------------------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG- 133 (327)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-
Confidence 99999999999886543 357788999999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+||+|||+++..... ........||+.|+|||++.+..++.++| +||||+++|+|
T Consensus 134 ~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslGvil~el 189 (327)
T cd05617 134 HIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVD----WWALGVLMFEM 189 (327)
T ss_pred CEEEeccccceeccCC-CCceecccCCcccCCHHHHCCCCCCchhe----eehhHHHHHHH
Confidence 9999999999753221 12234578999999999998877766555 99999999987
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.37 Aligned_cols=193 Identities=19% Similarity=0.249 Sum_probs=156.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.+.||+|+||.||++++..++ ..+++|.+..... .......++...+....|++++.+++.+ ..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 75 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSD 75 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EEC
Confidence 35689999999999999999999999887 7788887764322 2222333455666777899999988776 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NI 293 (365)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni 135 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAK--------------------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence 68999999999999999987643 346788899999999999999986 699999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++.+... ......||+.|+|||++.+..++.++ |+||||+++|+|-
T Consensus 136 l~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~----DiwslG~il~el~ 196 (331)
T cd06649 136 LVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS----DIWSMGLSLVELA 196 (331)
T ss_pred EEcCCC-cEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchH----hHHHHHHHHHHHH
Confidence 999987 9999999999866432 22456799999999999877666554 5999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.56 Aligned_cols=191 Identities=19% Similarity=0.274 Sum_probs=147.2
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.+.||+|+||.||++++....... +.+++|.+..... ........+...+....|++++.+++.+ ..++.+++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-~~~~~~~l 77 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTG--KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-QTGGKLYL 77 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCC--CEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-ecCCeEEE
Confidence 368999999999999875422111 6788887764321 1112223345566777899999888776 45578999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
||||+.+++|.+++...+ .+.+..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 78 v~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 137 (323)
T cd05584 78 ILEYLSGGELFMHLEREG--------------------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG 137 (323)
T ss_pred EEeCCCCchHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 999999999999987654 235677888999999999999999999999999999999987
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+++...... .......||+.|+|||++.+...+.++ |+||||+++|+|-+
T Consensus 138 -~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~----DiwslG~il~ell~ 195 (323)
T cd05584 138 -HVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAV----DWWSLGALMYDMLT 195 (323)
T ss_pred -CEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcc----eecccHHHHHHHhc
Confidence 99999999997543222 223456899999999999877665555 49999999999843
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=253.86 Aligned_cols=185 Identities=19% Similarity=0.233 Sum_probs=145.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHH-hhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRA-CANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+++|.+.... .........+... .....|++++.+++.+ ..+..+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QTESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-EeCCEEEEE
Confidence 46999999999999999887 778888776432 1111111222222 3344789999888766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 75 ~E~~~~~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~- 133 (329)
T cd05618 75 IEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 133 (329)
T ss_pred EeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-
Confidence 99999999998886543 357788889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+||+|||+++..... ........||+.|+|||++.+..++.++| +||||+++|+|
T Consensus 134 ~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwslG~il~el 189 (329)
T cd05618 134 HIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVD----WWALGVLMFEM 189 (329)
T ss_pred CEEEeeCCccccccCC-CCccccccCCccccCHHHHcCCCCCCccc----eecccHHHHHH
Confidence 9999999999754322 12234578999999999998877766655 99999999987
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=255.83 Aligned_cols=194 Identities=22% Similarity=0.305 Sum_probs=160.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccC-CCceeeeeccccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCC-ADFVYGFFENSSK 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~ 212 (365)
..+.|++.+.||+|.||.||+++.+.++ +.+|+|.+...... .....+++...+.... |+|++.+.+.+ .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg-----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-e 106 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTG-----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-E 106 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCC-----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-E
Confidence 4468999999999999999999999998 66776666543321 2233444455555555 99999998887 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++|||++.||.|.+.+.... +++..+..++.|++.++.|||+.||+||||||+|
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~~---------------------~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN 165 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKKH---------------------YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPEN 165 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHcc---------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHH
Confidence 5569999999999999999987651 3778899999999999999999999999999999
Q ss_pred eEEecCC---CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGS---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~---~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|+.... ..+|++|||+|..... .....+.+||+.|+|||++....++...| +||+|+++|-|-|
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~D----iWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVD----VWSIGVILYILLS 233 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccc----hhHHHHHHHHHhh
Confidence 9997543 2799999999998766 44457899999999999999888888888 9999999998865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=249.47 Aligned_cols=196 Identities=20% Similarity=0.225 Sum_probs=151.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.++||+|+||.||+|.+..++ ..+++|.+...... ......++...+....|++++.+++.. ..+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~ 76 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-HTER 76 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCC-----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-cCCC
Confidence 4578999999999999999999998887 77888876532211 111222345566677899999988776 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++ +|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNCG-------------------NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 89999999985 8998886543 124667788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++++ .+||+|||+++....... ......+|+.|+|||++.+.. ..+..+|+||+|+++|+|-+
T Consensus 137 ~~~~-~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 137 NEKG-ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGST---EYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred CCCC-CEEECcCcceeeccCCCc-cccCceecccccChHHhcCCc---ccCcHHHHHHHHHHHHHHHh
Confidence 9987 999999999986543221 223457899999999986532 12345679999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=256.99 Aligned_cols=223 Identities=21% Similarity=0.255 Sum_probs=161.8
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (365)
++++..++|+++++||+|+||.||+|.+...........|++|++...... ......++...+... .|+|++.+++.+
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 455677899999999999999999999876554444467899988644322 222233344455555 499999999877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchh---------------------------hhh-----------------
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQ---------------------------TLI----------------- 246 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~---------------------------~~~----------------- 246 (365)
......++||||+++|+|.+++.......... ..-
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 55678999999999999999987642110000 000
Q ss_pred -----------------------------ccccc---cCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 247 -----------------------------LGEVQ---DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 247 -----------------------------~~~~~---~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
.+.+. .......+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 00000 0001234677888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .+||+|||+++.+...... ......+++.|+|||++.+..++.++| +||||+++|+|
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----iwSlGvil~el 332 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD----VWSYGILLWEI 332 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh----HHHHHHHHHHH
Confidence 99987 9999999999876433222 223456778999999998877766555 99999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=258.77 Aligned_cols=178 Identities=19% Similarity=0.267 Sum_probs=144.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhh---ccCCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACA---NCCADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~ 214 (365)
+|++.+.||+|+||.|-+|.+..|+ ..||+|.++....- +...+.++.+.+. ...-.+++.+++.+ .-.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~-----e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTG-----EIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-YFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCC-----cEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-ccc
Confidence 7899999999999999999999999 88999998865433 2222223333333 33345677887777 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
++++||+|.++. +|+++++.+.|. .++...++.++.||+.||.+||+.+|||+||||||||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~------------------Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENIL 321 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFR------------------GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENIL 321 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhhee
Confidence 799999998875 999999998752 4678889999999999999999999999999999999
Q ss_pred EecCC-CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC
Q 017820 295 FSEGS-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346 (365)
Q Consensus 295 l~~~~-~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d 346 (365)
|.+.+ ..+||+|||.|....... .+.+-+..|.|||++.|.+++.+.|
T Consensus 322 L~~~~r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~ID 370 (586)
T KOG0667|consen 322 LKDPKRSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAID 370 (586)
T ss_pred eccCCcCceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccc
Confidence 97533 389999999998764332 2567788999999999999999999
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=245.47 Aligned_cols=188 Identities=21% Similarity=0.248 Sum_probs=147.8
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||+||++.+..++ +.+++|++....... ......+...+...+|++++.+...+ ..+..+++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATG-----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-QTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCC-----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-cCCCeEEEEEeC
Confidence 699999999999999887 788888876432211 11222344556677889998887665 455789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... .....+++..++.++.|++.||.|||+++|+||||||+||++++++ .+|
T Consensus 75 ~~~g~L~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~ 137 (280)
T cd05608 75 MNGGDLRYHIYNVD----------------EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVR 137 (280)
T ss_pred CCCCCHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEE
Confidence 99999998875422 1123467888999999999999999999999999999999999877 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||+++.+..... ......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 138 l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~D----vwslG~il~el~ 191 (280)
T cd05608 138 ISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVD----YFALGVTLYEMI 191 (280)
T ss_pred EeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCcccc----HHHHHHHHHHHH
Confidence 999999987654332 234568999999999998877665555 999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=247.62 Aligned_cols=193 Identities=22% Similarity=0.294 Sum_probs=147.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----HHHHHHHHHHHHhhccCCCceeeeecccc--
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VEIWMNERVRRACANCCADFVYGFFENSS-- 211 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-- 211 (365)
++|++.+.||+|+||.||+|.+..++. +.+++|.+..... .....+..+...+....|++++.+++.+.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCC----eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 479999999999999999999864321 5677887653221 11222223334445557899988876543
Q ss_pred --cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 212 --KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 212 --~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
.....+++|+||++ ++|.+++.... ...+++..++.++.|++.||.|||++||+|||||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVP------------------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 23467899999997 58999886543 1235778889999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++| +||||+++|+|
T Consensus 138 p~Nil~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D----iwslG~il~el 202 (290)
T cd07862 138 PQNILVTSSG-QIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVD----LWSVGCIFAEM 202 (290)
T ss_pred HHHEEEcCCC-CEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccc----hHHHHHHHHHH
Confidence 9999999987 9999999999875433 2234567899999999998776665554 99999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=243.81 Aligned_cols=198 Identities=14% Similarity=0.157 Sum_probs=153.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+....... ..+++|..+.... .......++...+....|++++.+++.+ ..+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~--~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRE--LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-TRGN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCce--eeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-ecCC
Confidence 4578999999999999999999876433221 6788888775432 2223333445566667899999988776 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili 140 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-------------------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV 140 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE
Confidence 8999999999999999987643 134677889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+.++ .++++|||.+...............++..|+|||++.+..++.++| +||+|+++|++
T Consensus 141 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~~l~el 201 (266)
T cd05064 141 NSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD----VWSFGIVMWEV 201 (266)
T ss_pred cCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhH----HHHHHHHHHHH
Confidence 9987 9999999988754332222222344567899999998776665554 99999999994
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=261.65 Aligned_cols=194 Identities=23% Similarity=0.264 Sum_probs=146.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
..++|++.+.||+|+||.||+|.+..++ +.||+|++....... .++...+....|++++.+.+.+..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~----~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTS-----EKVAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEecCcchH----HHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 4578999999999999999999998887 788998875443221 223445566678888776443211
Q ss_pred ---CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 213 ---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 213 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
....+++||||+++ +|.+++.... ..+..+++..++.++.||+.||.|||+++|+|||||
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK 197 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYA----------------RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence 12357799999985 7777765421 112345778889999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++..+||+|||+|+.+.... ......||+.|+|||++.+. .++ ..+|+||||+++|+|-
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~----~~~DiwSlGvil~ell 265 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYT----THIDLWSLGCIIAEMI 265 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCC----cHHHHHHHHHHHHHHH
Confidence 9999999776589999999998765432 22356789999999998654 333 3566999999999983
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=252.45 Aligned_cols=223 Identities=21% Similarity=0.215 Sum_probs=159.4
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhc-cCCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACAN-CCADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 211 (365)
+.+..++|++.+.||+|+||.||+|.+...+.....+.+++|.++..... +.....++...+.. .+|++++.+++.+.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 44566899999999999999999999765544444478999988653322 22222223333333 36889998888776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhcc------------------c------------------------
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG------------------E------------------------ 249 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~------------------~------------------------ 249 (365)
..+..++++|||+++|+|.+++......+.......+ .
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 6667889999999999999999764321111000000 0
Q ss_pred -----cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCcc-cccc
Q 017820 250 -----VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKE 323 (365)
Q Consensus 250 -----~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~ 323 (365)
.........+++..+..++.|++.||.|||+++|+||||||+|||+++++ .+||+|||+++........ ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence 00000112467788899999999999999999999999999999999887 9999999999865433221 1223
Q ss_pred ccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 324 ~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
..+++.|+|||++.+..++.++| +|+||+++|++
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~D----i~slG~~l~el 274 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSD----VWSFGVLLWEI 274 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhh----HHHHHHHHHHH
Confidence 45567899999998777666655 99999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=251.25 Aligned_cols=194 Identities=19% Similarity=0.256 Sum_probs=154.8
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.++||+|+||.||+|.+..++ ..+++|.+..... .......++...+....|++++.+++.+ ..+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 75 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSD 75 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-EEC
Confidence 35589999999999999999999998887 6677776654322 2222233445566667899999988876 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NI 293 (365)
+.+++||||+.+++|.+++...+ .+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni 135 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 135 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence 78999999999999999987654 346778889999999999999985 799999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ .+||+|||++..+... ......||..|+|||++.+..++.+ +|+||||+++|+|-+
T Consensus 136 li~~~~-~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~----~DvwslG~il~~l~~ 197 (333)
T cd06650 136 LVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQ----SDIWSMGLSLVEMAI 197 (333)
T ss_pred EEcCCC-CEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcH----HHHHHHHHHHHHHHH
Confidence 999987 9999999999765432 1234678999999999987655544 559999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.47 Aligned_cols=193 Identities=19% Similarity=0.185 Sum_probs=149.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.++||+|+||.||+|.+..++ +.|++|.+...... ......++...+....|++++.+++.+ ..++.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTG-----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCC-----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCCe
Confidence 367888999999999999999998877 78899887544322 222333455666777899999988776 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+++|.+.. ..++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 147 ~~lv~e~~~~~~L~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------------------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202 (353)
T ss_pred EEEEEecCCCCcccccc------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 99999999999885421 124566788999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCC-CCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS-APSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||+++.+..... ......||..|+|||++........ ....+|+||||+++|+|-
T Consensus 203 ~~~-~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~ 267 (353)
T PLN00034 203 SAK-NVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY 267 (353)
T ss_pred CCC-CEEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH
Confidence 987 999999999987643322 2245689999999999865432222 223577999999999974
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=241.46 Aligned_cols=210 Identities=19% Similarity=0.255 Sum_probs=155.9
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.+.||+|+||.||+|.+...........+++|++...... ......++...+....|++++.+++.+ ..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cCC
Confidence 355789999999999999999999865432233367899887643321 212222334556667899999888776 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|.+++........ ..+....+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil 151 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEME----------NNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCcccc----------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence 689999999999999999976431100 0111224567788899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcccc-ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .++|+|||+++.+........ ....+++.|||||++.+..++.++ |+||||+++|+|
T Consensus 152 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~~l~el 214 (277)
T cd05062 152 VAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS----DVWSFGVVLWEI 214 (277)
T ss_pred EcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchh----HHHHHHHHHHHH
Confidence 99987 999999999986544332211 223557889999999876665554 599999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=261.10 Aligned_cols=193 Identities=19% Similarity=0.225 Sum_probs=143.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhh---ccCCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACA---NCCADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~---~~~~~~i~~~~~~~~ 211 (365)
..++|++.++||+|+||+||+|.+..++ +.||+|.++..... +...+.++...+. ...+.+++.+...+.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRK-----EYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCC-----eEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4578999999999999999999998877 77888887542211 1111112222222 223344555555554
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKP 290 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp 290 (365)
.....+++|||++ +++|.+++...+ .+++..++.++.||+.||.|||+ .|||||||||
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP 260 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--------------------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKP 260 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCH
Confidence 5557899999988 467888776543 35677888999999999999998 5999999999
Q ss_pred CceEEecCCC---------------cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 291 QNVIFSEGSR---------------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 291 ~NILl~~~~~---------------~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
+|||++.++. .+||+|||.+.... .......||+.|||||++.+..++.++ |+||||
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~----DiwSlG 332 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYST----DMWSMG 332 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHH----HHHHHH
Confidence 9999987652 49999999886432 123457899999999999887776554 599999
Q ss_pred hhheeccc
Q 017820 356 PVLWQVQC 363 (365)
Q Consensus 356 ~vlw~lGc 363 (365)
+++|+|-+
T Consensus 333 vil~ellt 340 (467)
T PTZ00284 333 CIIYELYT 340 (467)
T ss_pred HHHHHHHh
Confidence 99999843
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=241.91 Aligned_cols=192 Identities=19% Similarity=0.206 Sum_probs=152.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|++.+.||+|+||+||++.+..++ +.+++|++....... .....++...+....|++++.+++.+ ..+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC-----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-cCCCe
Confidence 4889999999999999999998877 778888775432211 11122344566677899999887776 44568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMG------------------NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC
Confidence 999999999999998876532 12357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .++|+|||+++....... .....|++.|+|||++.+..++.++| +||+|+++|+|-
T Consensus 137 ~~~-~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D----iws~G~~l~el~ 195 (285)
T cd05605 137 DYG-HIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPD----WWGLGCLIYEMI 195 (285)
T ss_pred CCC-CEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCcccc----chhHHHHHHHHH
Confidence 887 999999999987543322 23457899999999998777666555 999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=240.64 Aligned_cols=191 Identities=19% Similarity=0.215 Sum_probs=150.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|+..+.||+|+||+||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.+ ..++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATG-----KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-ETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCC-----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-ecCCE
Confidence 3778899999999999999999887 7788887753321 1112222344556666788888876665 44578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++++||+.+++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~ 136 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMG------------------NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEeccCccHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC
Confidence 999999999999998886533 12457888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .++|+|||++........ .....|+..|+|||++.+..++.++| +||+|+++|+|
T Consensus 137 ~~~-~~kl~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~D----i~slG~~l~~l 194 (285)
T cd05632 137 DYG-HIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPD----YWGLGCLIYEM 194 (285)
T ss_pred CCC-CEEEecCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccc----hHHHHHHHHHH
Confidence 887 999999999976543222 23467899999999998777766665 99999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=246.38 Aligned_cols=199 Identities=18% Similarity=0.168 Sum_probs=153.1
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+...+|++.+.||+|+||.||+|.+..++... ...+++|....... .......++...+....|+|++.+++.+..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-- 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCcc-ceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--
Confidence 45579999999999999999999987654322 13478888764332 222223334556677789999999887643
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+.+|+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil 141 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD-------------------NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc-------------------cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 357799999999999999876531 2456778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .+||+|||+++.+...... ......++..|+|||++.+..++.++| +||||+++|+|
T Consensus 142 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D----i~slGv~l~el 204 (316)
T cd05108 142 VKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD----VWSYGVTVWEL 204 (316)
T ss_pred ecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh----hHHHHHHHHHH
Confidence 99987 9999999999876543221 112234467899999998777666555 99999999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=249.55 Aligned_cols=190 Identities=19% Similarity=0.268 Sum_probs=148.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLG-----INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCC-----ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 479999999999999999999998887 788888875332 111222223455666778999998877654332
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 151 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIHM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 151 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHhc----------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 457999999986 55555532 235677888999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 152 ~NIl~~~~~-~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~D----iwSlG~il~el~ 216 (359)
T cd07876 152 SNIVVKSDC-TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVD----IWSVGCIMGELV 216 (359)
T ss_pred HHEEECCCC-CEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchh----hHHHHHHHHHHH
Confidence 999999987 9999999999864332 2234568899999999998877766655 999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=247.81 Aligned_cols=187 Identities=21% Similarity=0.272 Sum_probs=145.4
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhh-ccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ ..+++|.+..... .+......+...+. ...|++++.+++.+ .....+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-~~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD-----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-QTKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCEEEEE
Confidence 46999999999999998887 7788887764321 11111111222222 23688998888766 455789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+++++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~- 133 (318)
T cd05570 75 MEYVNGGDLMFHIQRSG--------------------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG- 133 (318)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-
Confidence 99999999999887653 357788899999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+++...... .......||+.|+|||++.+..++.++| +||||+++|+|-+
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~D----iwslGvil~~l~~ 191 (318)
T cd05570 134 HIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVD----WWALGVLLYEMLA 191 (318)
T ss_pred cEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchh----hhhHHHHHHHHhh
Confidence 99999999997532221 2234567999999999998877766555 9999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=241.93 Aligned_cols=191 Identities=20% Similarity=0.273 Sum_probs=148.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHhhccCCCceeeeeccccc--
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSK-- 212 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-- 212 (365)
+|++.+.||+|+||+||+|.+..++ +.+++|.+.... ......+..+...+....|++++.+++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 5899999999999999999999887 778888765321 1122222233444555678999888765432
Q ss_pred --CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 213 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....++++||+.+ +|.+++.... ...+++..++.++.|++.||.|||++||+||||||
T Consensus 76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp 136 (288)
T cd07863 76 TDRETKVTLVFEHVDQ-DLRTYLDKVP------------------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP 136 (288)
T ss_pred CCCCceEEEEEccccc-CHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 23568999999985 8888886543 12357788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||+++++ .+||+|||+++...... ......||+.|+|||++.+..++.++| +||+|+++|+|
T Consensus 137 ~Nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D----iwslG~~l~~l 200 (288)
T cd07863 137 ENILVTSGG-QVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVD----MWSVGCIFAEM 200 (288)
T ss_pred HHEEECCCC-CEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcch----hhhHHHHHHHH
Confidence 999999987 99999999998764322 223467899999999998776665555 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=246.83 Aligned_cols=189 Identities=22% Similarity=0.292 Sum_probs=147.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
+.||+|+||.||++.+....... +.+++|.+...... +......+...+....|++++.+++.+ ..++.+++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAG--QLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-QTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCC--CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-EcCCEEEEEEc
Confidence 67999999999999874321111 67888877643221 122223345566777899999887776 45678999999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcE
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~i 302 (365)
|+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||+++++ .+
T Consensus 79 ~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~ 137 (318)
T cd05582 79 FLRGGDLFTRLSKEV--------------------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HI 137 (318)
T ss_pred CCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cE
Confidence 999999999986543 357788999999999999999999999999999999999987 99
Q ss_pred EEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||+++....... ......||+.|+|||++.+...+.++| +||||+++|+|-
T Consensus 138 kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~D----iwslG~il~el~ 192 (318)
T cd05582 138 KLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSAD----WWSFGVLMFEML 192 (318)
T ss_pred EEeeccCCcccCCCCC-ceecccCChhhcCHHHHcCCCCCCccc----eeccceEeeeec
Confidence 9999999986543321 234568999999999998776665555 999999999984
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=252.27 Aligned_cols=193 Identities=23% Similarity=0.265 Sum_probs=149.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
+|++.+.||+|+||.||+|.+..++ +.+|+|++..... .......++...+....|+|++.+++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCC-----CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 5789999999999999999998877 7889998764321 22222334455666778999988877664333
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...++|+||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSPQ--------------------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHE
Confidence 37899999997 57877775433 457788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+|+..............+|+.|+|||++.+... .+..+|+||+|+++|+|-
T Consensus 135 li~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~il~el~ 199 (372)
T cd07853 135 LVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH---YTSAVDIWSVGCIFAELL 199 (372)
T ss_pred EECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCC---CCcHHHHHhHHHHHHHHH
Confidence 999987 99999999998654433333344578999999999876432 233566999999999973
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=240.09 Aligned_cols=181 Identities=24% Similarity=0.331 Sum_probs=145.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccCCCceeeeeccccc----
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
..|...+.||+|+||.|..|.+..++ ..||+||+......... ...++...+++..|+|++.++.....
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~-----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTG-----EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCC-----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 46666899999999999999999999 89999999855544433 33356677888889999888766544
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.-...|+|+|+|+ .+|.+.++... .+++..+..++.|++.||.|+|+.+|+|||+||.|
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~--------------------~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsN 155 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQ--------------------DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSN 155 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCc--------------------cccHHHHHHHHHHHHHhcchhhcccccccccchhh
Confidence 2377899999995 58999998765 46788899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccC-CCCCCCC
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMS-TQTPSAP 346 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d 346 (365)
+|++.+- .+||+|||+|+...... ....+..+-|.+|.|||.+... .++...|
T Consensus 156 ll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiD 210 (359)
T KOG0660|consen 156 LLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAID 210 (359)
T ss_pred eeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhh
Confidence 9999986 99999999999875321 1123456779999999998654 4455555
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=241.77 Aligned_cols=215 Identities=20% Similarity=0.271 Sum_probs=160.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH-HHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+...+.......+++|.+........ ....++...+....|++++.+++.. ....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-TKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-cCCC
Confidence 4468999999999999999999987766555557789998875443222 2223344556667789998888766 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++++|.+++............ .........+++..++.++.|++.||.|||+++++||||||+||++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAE----SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccc----cccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 789999999999999999865321110000 0001112356788889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .++|+|||+++....... .......+++.|+|||++.+..++.+ +|+||||+++|+|
T Consensus 158 ~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----sDv~slG~il~el 219 (283)
T cd05048 158 GEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE----SDIWSFGVVLWEI 219 (283)
T ss_pred cCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh----hhHHHHHHHHHHH
Confidence 9987 999999999986543322 22334567889999999987766655 4599999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=249.81 Aligned_cols=191 Identities=19% Similarity=0.265 Sum_probs=148.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|++++.+++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCC-----ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 3479999999999999999999998877 778888876432 11222222334555666789988887655332
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 214 ----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 214 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
....++||||+++ +|.+.+... +++..++.++.|++.||.|||++||+|||||
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------------l~~~~~~~~~~qi~~aL~~LH~~givHrDik 146 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQME----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhhc----------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 2467999999985 566665432 3567788899999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 147 p~Nill~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~D----iwslG~il~el~ 212 (355)
T cd07874 147 PSNIVVKSDC-TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVD----IWSVGCIMGEMV 212 (355)
T ss_pred hHHEEECCCC-CEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhh----HHHHHHHHHHHH
Confidence 9999999987 9999999999865432 2234568899999999998777666555 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=237.43 Aligned_cols=197 Identities=19% Similarity=0.224 Sum_probs=153.1
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++.++||+|+||.||+|.+..+ ..+++|.+...... .....++...+....|++++.+++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 73 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV-TKE 73 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCC------ceEEEEEccCCchh-HHHHHHHHHHHHhCCCCCeeeEEEEE-cCC
Confidence 34568999999999999999999997644 56888876643322 22223344555666789999887766 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+.+++|.+++.... +...++..+..++.|++.||.|||+++++||||||+||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 135 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDE------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 67899999999999999987542 123466778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .++|+|||+++..............++..|+|||++.+...+.+. |+||||+++|+|-
T Consensus 136 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~~l~~l~ 198 (261)
T cd05072 136 VSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS----DVWSFGILLYEIV 198 (261)
T ss_pred ecCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhh----hhhhhHHHHHHHH
Confidence 99987 999999999987654332222334567789999999877666655 4999999999973
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=255.97 Aligned_cols=187 Identities=23% Similarity=0.227 Sum_probs=150.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
...|.+.+.||+|+||.||+|.+..++ +.|++|...... ..++...+....|+||+.+++.. ..++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~-----~~vavK~~~~~~------~~~E~~iL~~L~HpnIv~l~~~~-~~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP-----QRVVVKAGWYAS------SVHEARLLRRLSHPAVLALLDVR-VVGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC-----CEEEEecccccC------HHHHHHHHHHCCCCCCCcEEEEE-EECCEE
Confidence 458999999999999999999999887 778888643221 12344556667899999888765 445688
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+|++. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARL-------------------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred EEEEEccC-CCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 99999996 68888876542 13577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||+++.+...... ......||+.|+|||++.+..++.+ +|+||||+++|||
T Consensus 296 ~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~----sDvwSlGviL~El 355 (461)
T PHA03211 296 PE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPS----VDIWSAGLVIFEA 355 (461)
T ss_pred CC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCch----HHHHHHHHHHHHH
Confidence 87 9999999999876443221 1234679999999999987766554 5599999999997
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=239.52 Aligned_cols=199 Identities=16% Similarity=0.195 Sum_probs=152.3
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.+.||+|+||+||+|.+..++...+ ..+++|........ .......+...+....|++++.+++.. .+
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~--~~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIK-IPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC--PG 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCcee-eEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE--CC
Confidence 355799999999999999999999976653221 24677776543322 222223334445667899999988764 34
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+.+|+|.+++..... .+++..+..++.|++.||.|||+++++||||||+|||
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil 141 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-------------------SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 567899999999999999976431 3467788899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .+||+|||+++.+..... .......++..|+|||++.+..++.++| +||||+++|++
T Consensus 142 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D----v~slG~il~el 204 (279)
T cd05111 142 LKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD----VWSYGVTVWEM 204 (279)
T ss_pred EcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhh----HHHHHHHHHHH
Confidence 99977 999999999986543322 2223456778999999998776665555 99999999997
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=256.81 Aligned_cols=190 Identities=23% Similarity=0.248 Sum_probs=153.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--H-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--E-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.-|.-++.||.|+||.||-|++..+. ..|++|++.-.+.. + .....++++.+....|||.+.|.+++ ..+.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~-----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-Lre~ 99 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-LREH 99 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCcc-----ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-eccc
Confidence 35666889999999999999999988 88999999754432 2 23344567788889999999998877 6667
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..|||||||-| +-.|++.-... .+.+..|..|..+.+.||.|||+++.||||||..|||+
T Consensus 100 TaWLVMEYClG-SAsDlleVhkK-------------------plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 100 TAWLVMEYCLG-SASDLLEVHKK-------------------PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred hHHHHHHHHhc-cHHHHHHHHhc-------------------cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 89999999985 77777766553 34566788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.+ .+||+|||.|.... ..+.++|||.|||||++......- .|...|+||||+..-||
T Consensus 160 se~g-~VKLaDFGSAsi~~-----PAnsFvGTPywMAPEVILAMDEGq-YdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 160 SEPG-LVKLADFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIEL 218 (948)
T ss_pred cCCC-eeeeccccchhhcC-----chhcccCCccccchhHheeccccc-cCCccceeeccchhhhh
Confidence 9988 99999999998754 346799999999999987553322 33355689999876655
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=237.18 Aligned_cols=196 Identities=16% Similarity=0.239 Sum_probs=153.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+...+|++.+.||+|+||.||+|.+..++ +.+++|........ .....++...+....|++++.+++.+ ..+.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 75 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC-TREP 75 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCC-----ceEEEEEecCCchH-HHHHHHHHHHHHhCCCCChhheEEEE-cCCC
Confidence 45578999999999999999999998876 77888877644322 12222344455566788988888766 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.++++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++++||||||+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~ 137 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECN------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence 8899999999999999987543 1234677788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++..............+++.|+|||.+.+...+.++ |+||||+++|+|
T Consensus 138 ~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~il~el 198 (263)
T cd05052 138 GENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS----DVWAFGVLLWEI 198 (263)
T ss_pred cCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchh----HHHHHHHHHHHH
Confidence 9887 999999999987654332222233456789999998777666554 599999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=266.24 Aligned_cols=205 Identities=22% Similarity=0.250 Sum_probs=155.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.++||+|+||.||+|.+..++ +.|++|++...... ......++...+....|++++.+++.. ..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg-----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS-----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-SDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC-----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-eeCC
Confidence 68999999999999999999998887 78999987643211 111222345566677899999888766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+++++|.+++......... ........+...+..++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l---------~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL 146 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESL---------SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL 146 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhcccc---------chhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE
Confidence 899999999999999998753210000 00011234566788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCC-----------------ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhh
Q 017820 296 SEGSRTFKIIDLGAAADLRVGI-----------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~-----------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vl 358 (365)
+.++ .+||+|||+|+...... ...+....||+.|||||++.+...+.++ |+||||+++
T Consensus 147 d~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS----DIWSLGVIL 221 (932)
T PRK13184 147 GLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST----DIYALGVIL 221 (932)
T ss_pred cCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh----HHHHHHHHH
Confidence 9987 99999999998662110 0112346799999999999877665554 599999999
Q ss_pred eeccc
Q 017820 359 WQVQC 363 (365)
Q Consensus 359 w~lGc 363 (365)
|+|-+
T Consensus 222 yELLT 226 (932)
T PRK13184 222 YQMLT 226 (932)
T ss_pred HHHHH
Confidence 99743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=255.22 Aligned_cols=193 Identities=24% Similarity=0.350 Sum_probs=159.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
..|...+.||+|+||.||+++++.++ +.||+|..+.. ...+.|..| ...++..+|+||+.+++......
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG-----~~vAvK~~~~~~~~r~~e~~~~E--ieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETG-----RLVAVKTFNKESSLRPRERWCRE--IEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccc-----cchhHHhhhhhcccchHHHHHHH--HHHHHHcCchhhhhhcccCCcccc
Confidence 56778899999999999999999999 89999999873 444555444 45566666999999988764433
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
....++||||.+|+|...+++.+ ....+++..++.++.++..||.|||++||+||||||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PE-----------------N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP 148 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPE-----------------NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKP 148 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcc-----------------cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Confidence 45689999999999999997654 344678889999999999999999999999999999
Q ss_pred CceEEecC--C-CcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEG--S-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~--~-~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.||++-.. | ..-||+|||+|+.+.++. ....+.||+.|.+||++.. ..++...| -||+|+.+|+.
T Consensus 149 ~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVD----LWS~GvtlY~c 217 (732)
T KOG4250|consen 149 GNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVD----LWSFGVTLYEC 217 (732)
T ss_pred CcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceee----hhhhhhHHHHH
Confidence 99998532 2 267999999999988766 4578999999999999994 77777777 78888888875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=236.09 Aligned_cols=193 Identities=14% Similarity=0.225 Sum_probs=149.9
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||++.+..+ ..+++|........+.. ..++...+....|++++.+++.+ ......
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~------~~~a~K~~~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ------IKVAIKAINEGAMSEED-FIEEAKVMMKLSHPKLVQLYGVC-TQQKPL 74 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC------ceEEEEecccCCccHHH-HHHHHHHHHHCCCCCceeEEEEE-ccCCCE
Confidence 36899999999999999999988654 56888876643322222 22244556667789999888766 455679
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++|+||||||+||++++
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQG-------------------KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 999999999999999875431 2467788899999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||.++..............++..|+|||++.+..++.+ +|+||+|+++|+|-
T Consensus 136 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~s~G~~l~el~ 195 (256)
T cd05114 136 TG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK----SDVWSFGVLMWEVF 195 (256)
T ss_pred CC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchh----hhhHHHHHHHHHHH
Confidence 87 99999999998654333222223345678999999977665554 55999999999973
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=238.90 Aligned_cols=191 Identities=21% Similarity=0.213 Sum_probs=151.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|++.+.||+|+||.||++.+..++ +.+++|.+..... ........+...+....|++++.+.+.+ ..+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-ETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCC-----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-ecCCE
Confidence 4788899999999999999999988 7888887653321 1111222334556667788888887766 44568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~ 136 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMG------------------EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 999999999999999886543 12357788889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .++|+|||++.....+.. .....||+.|+|||++.+..++.++| +||+|+++|+|
T Consensus 137 ~~~-~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~D----iwslG~~l~~l 194 (285)
T cd05630 137 DHG-HIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPD----WWALGCLLYEM 194 (285)
T ss_pred CCC-CEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccc----cHHHHHHHHHH
Confidence 987 999999999976543322 23457899999999998877776665 99999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=248.67 Aligned_cols=189 Identities=19% Similarity=0.271 Sum_probs=147.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|++++.+++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCC-----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 479999999999999999999998887 778888876432 11122222344556667788888877654322
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
....++||||+++ +|.+++... +++..++.++.|++.||.|||++||+||||||
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~~----------------------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 154 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQME----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 154 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHhc----------------------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCH
Confidence 2468999999985 676666432 35677889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++ |+||||+++|+|
T Consensus 155 ~NIll~~~~-~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~----DiwSlG~il~el 218 (364)
T cd07875 155 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENV----DIWSVGCIMGEM 218 (364)
T ss_pred HHEEECCCC-cEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchh----hHHhHHHHHHHH
Confidence 999999987 99999999998654322 22456789999999999877666555 599999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=238.56 Aligned_cols=212 Identities=19% Similarity=0.250 Sum_probs=154.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.++||+|+||.||+|.............+++|.+....... .....++...+....|++++.+++.. ..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-SK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cC
Confidence 34568999999999999999999987643222223578888776443221 11222334455666788888888765 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++||||+.+|+|.+++...... ..........+...+..++.|++.||.|||+++|+||||||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~ni 150 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPE----------AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNC 150 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccc----------cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheE
Confidence 56789999999999999999764310 00111123446677889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++++ .++|+|||+++.+....... .....++..|+|||++.+...+.++ |+||||+++|+|-
T Consensus 151 li~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~----DvwslG~~l~el~ 215 (288)
T cd05061 151 MVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS----DMWSFGVVLWEIT 215 (288)
T ss_pred EEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHh----HHHHHHHHHHHHH
Confidence 999987 99999999998654332221 1223457789999999877665554 5999999999983
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=237.26 Aligned_cols=191 Identities=27% Similarity=0.354 Sum_probs=153.4
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHH--HHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMN--ERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
|++.+.||+|+||+||++.+..++ +.+++|............. .++........|++++.+++.... ....+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG-----QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT-----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC-----eEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-ccccc
Confidence 789999999999999999999987 7899999876654443322 223444555578888888777633 67888
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
++|||+.+++|.+++.... .+++..+..++.|+++||.+||+++|+|+||||+||+++++
T Consensus 75 ~v~~~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~ 134 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK--------------------PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN 134 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS--------------------SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT
T ss_pred ccccccccccccccccccc--------------------ccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999998433 45788899999999999999999999999999999999987
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccc-cCCCCCCCCCchhhhhhhhhheeccc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI-MSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ .++|+|||.+..... .........+|..|+|||++. +... +..+|+||||+++|+|-+
T Consensus 135 ~-~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~~Di~slG~il~~l~~ 194 (260)
T PF00069_consen 135 G-EVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKY----TRKSDIWSLGIILYELLT 194 (260)
T ss_dssp S-EEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSB----STHHHHHHHHHHHHHHHH
T ss_pred c-ccccccccccccccc-cccccccccccccccccccccccccc----cccccccccccccccccc
Confidence 7 999999999986421 122334578899999999987 4444 445569999999999844
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=239.48 Aligned_cols=196 Identities=21% Similarity=0.323 Sum_probs=156.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.++.....+.....++...+....|++++.+++.. .....
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-~~~~~ 80 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTG-----ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-LRRDK 80 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCC-----cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCE
Confidence 4468999999999999999999998877 77888887654433333334445566777899999998876 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++++||+++++|.+++...+ .+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 140 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG--------------------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 999999999999999987654 357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .++|+|||++........ ......|++.|+|||++...... ..+..+|+||||+++|+|
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 141 DNG-HVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKG-GYNQLCDIWAVGITAIEL 202 (267)
T ss_pred CCC-CEEECcceeeeEccCccc-ccccccCcccccChhhhccccCC-CCCchhhhHHHHHHHHHH
Confidence 887 999999999976543221 22346789999999997532211 123466799999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=237.71 Aligned_cols=185 Identities=19% Similarity=0.200 Sum_probs=145.0
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||.||++.+..++ +.+++|.+...... .......+...+....|++++.+...+ ..+..+++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG-----KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-ESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCC-----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-ecCCeEEEEEec
Confidence 799999999999999887 77887776532211 111122234456667899999887766 456789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||++++++ .++
T Consensus 75 ~~g~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~ 135 (277)
T cd05607 75 MNGGDLKYHIYNVG------------------ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCR 135 (277)
T ss_pred CCCCCHHHHHHhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEE
Confidence 99999998886543 12356777888999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++........ .....||+.|+|||++.+..++.++| +||+|+++|+|-
T Consensus 136 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D----vwslGv~l~el~ 188 (277)
T cd05607 136 LSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVD----WFAMGCSIYEMV 188 (277)
T ss_pred EeeceeeeecCCCce--eeccCCCCCccCHHHHccCCCCCchh----HHHHHHHHHHHH
Confidence 999999987654322 23457899999999998777665555 999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=243.88 Aligned_cols=194 Identities=23% Similarity=0.268 Sum_probs=157.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc-----cccHHHHHHHHHHHHHhhccC-CCceeeeec
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT-----EYGAVEIWMNERVRRACANCC-ADFVYGFFE 208 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~ 208 (365)
.+...+|.++.+||+|+||.|-+|..+.+. ..+|+|.++ ++.+.|..+.++ +.+.... .++++.+ .
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtd-----ELyAiKiLkKDViiQdDDvectm~EK--rvLAL~~kppFL~ql-H 416 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEK--RVLALPGKPPFLVQL-H 416 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcc-----hhhhhhhhccceeeecCcccceehhh--hheecCCCCchHHHH-H
Confidence 456679999999999999999999999988 566666665 445556555554 3333333 4444444 4
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+++.-+.+|.||||++||+|.-.++.-+ .+.+..+..++.+|+-||-+||++|||+|||
T Consensus 417 ScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--------------------kFKEp~AvFYAaEiaigLFFLh~kgIiYRDL 476 (683)
T KOG0696|consen 417 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL 476 (683)
T ss_pred HHhhhhhheeeEEEEecCchhhhHHHHhc--------------------ccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence 44466789999999999999988887765 5577788899999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|.+|||+|.+| ++||+|||+++.-..+ ..+..+++|||.|+|||.+.-.++..+.| +|++||+||||-
T Consensus 477 KLDNvmLd~eG-HiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvD----WWa~GVLLyEml 544 (683)
T KOG0696|consen 477 KLDNVMLDSEG-HIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVD----WWAFGVLLYEML 544 (683)
T ss_pred cccceEeccCC-ceEeeecccccccccC-CcceeeecCCCcccccceEEecccccchh----HHHHHHHHHHHH
Confidence 99999999998 9999999999863322 33457899999999999999888888887 999999999984
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=234.57 Aligned_cols=201 Identities=17% Similarity=0.208 Sum_probs=154.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.+.||+|+||.||+|.+..++... ..+++|........ .......+...+....|++++.+++.. ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKE--IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-TKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCc--ceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-ecCCc
Confidence 468999999999999999999987653221 56888877644322 222223344556667789998888766 45577
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~ 140 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG-------------------KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN 140 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 8999999999999999876431 346778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
+++ .++|+|||+++....... .......+++.|+|||.+.+..++.++| +|+||+++|+| |..|
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~D----v~slG~~l~~l~~~g~~p 208 (266)
T cd05033 141 SNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASD----VWSFGIVMWEVMSYGERP 208 (266)
T ss_pred CCC-CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccc----hHHHHHHHHHHHccCCCC
Confidence 987 999999999987752211 1122234567899999998776665555 99999999995 6655
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=236.51 Aligned_cols=196 Identities=21% Similarity=0.299 Sum_probs=154.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.............+++...+....|++++.+++.+ ..+..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-~~~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTG-----ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-LSREK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCC-----eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-EeCCE
Confidence 3468999999999999999999998877 77888877644332223333445566777899999888776 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++|+||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG--------------------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 999999999999999886543 346778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .+||+|||+++.+..... ......|++.|+|||.+....... .+..+|+||+|+++|+|
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~-~~~~~Dvws~G~il~el 202 (267)
T cd06646 141 DNG-DVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGG-YNQLCDIWAVGITAIEL 202 (267)
T ss_pred CCC-CEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCC-CcchhhHHHHHHHHHHH
Confidence 887 899999999986643221 123457889999999885432221 23456799999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=234.85 Aligned_cols=198 Identities=20% Similarity=0.251 Sum_probs=162.3
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcc-----ccHHHHHHHHHHHHHhhccCCCceeee
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVEIWMNERVRRACANCCADFVYGF 206 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~ 206 (365)
..+.+...+|.++++||+|+|+.|-+++...|. +.+++|.+++ +.+......++ .-.-...++++++++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~-----qiyamkvvkkel~nddedidwvqtek-~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----QIYAMKVVKKELVNDDEDIDWVQTEK-HVFEQASNNPFLVGL 316 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccc-----eeeehhhHHHHhcCCcccchhHHhhH-HHHHhccCCCeEEeh
Confidence 356677889999999999999999999999998 6666665542 22222222222 122345678999988
Q ss_pred ecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
...+ +.+..++.|.||+++|+|.-.++... +++++.++.+..+|..||.|||++|||+|
T Consensus 317 hscf-qtesrlffvieyv~ggdlmfhmqrqr--------------------klpeeharfys~ei~lal~flh~rgiiyr 375 (593)
T KOG0695|consen 317 HSCF-QTESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEICLALNFLHERGIIYR 375 (593)
T ss_pred hhhh-cccceEEEEEEEecCcceeeehhhhh--------------------cCcHHHhhhhhHHHHHHHHHHhhcCeeee
Confidence 7666 67789999999999999988777654 56888899999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|.+|+|+|..| ++||+|+|+++.-- .......+++|||.|+|||.+++..+..+.| +|+|||+|+||-
T Consensus 376 dlkldnvlldaeg-hikltdygmcke~l-~~gd~tstfcgtpnyiapeilrgeeygfsvd----wwalgvlmfemm 445 (593)
T KOG0695|consen 376 DLKLDNVLLDAEG-HIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVD----WWALGVLMFEMM 445 (593)
T ss_pred eccccceEEccCC-ceeecccchhhcCC-CCCcccccccCCCcccchhhhcccccCceeh----HHHHHHHHHHHH
Confidence 9999999999988 99999999998632 2234567899999999999999999999988 999999999983
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.07 Aligned_cols=189 Identities=17% Similarity=0.166 Sum_probs=149.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..+|++.+.||+|+||.||+|....... .+.+++|.+...... .++...+....|++++.+++.+ ......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~---~~~v~vK~~~~~~~~-----~~E~~il~~l~h~~iv~~~~~~-~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQ---RKKVIVKAVTGGKTP-----GREIDILKTISHRAIINLIHAY-RWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCcc---ceeEEEEeccccccH-----HHHHHHHHhcCCCCccceeeeE-eeCCEE
Confidence 4689999999999999999998654322 166888877643221 2344555666789998887765 445689
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+++||++. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~--------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~ 220 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSG--------------------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE 220 (392)
T ss_pred EEEehhcC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC
Confidence 99999987 58888874332 3577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++| +||||+++|+|
T Consensus 221 ~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D----vwslGvil~el 280 (392)
T PHA03207 221 PE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTD----IWSAGLVLFEM 280 (392)
T ss_pred CC-CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhh----HHHHHHHHHHH
Confidence 87 9999999999876543222 223568999999999998877766555 99999999998
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=238.26 Aligned_cols=216 Identities=21% Similarity=0.257 Sum_probs=163.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|.+.+.||+|+||.||+|.+...........+++|..............++...+....|++++.+.+.+ ..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-GDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-ccCCc
Confidence 45789999999999999999999765443333466888888765554444444456667777899999988776 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++......... ... .........+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMI--LVD--GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCccccc--ccc--cccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 99999999999999999876532110 000 01111223568888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .++|+|||+++....... .......++..|+|||++.+...+.+ +|+||||+++|+|-
T Consensus 158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~el~ 219 (291)
T cd05094 158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWSFGVILWEIF 219 (291)
T ss_pred cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch----hhHHHHHHHHHHHH
Confidence 987 999999999986543322 12234566789999999887666555 45999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=247.43 Aligned_cols=187 Identities=21% Similarity=0.168 Sum_probs=148.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
...+|++.+.||+|+||.||+|.+..++ ..+++|........ .+...+....|++++.+++.+ ..+..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~valK~~~~~~~~------~E~~~l~~l~h~~iv~~~~~~-~~~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQP-----DPVVLKIGQKGTTL------IEAMLLQNVNHPSVIRMKDTL-VSGAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCC-----ceEEEEeCCccccH------HHHHHHHhCCCCCCcChhheE-EeCCe
Confidence 3368999999999999999999998876 67888865433221 123445566789999888776 44567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+|++. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRS-------------------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred eEEEEEccC-CcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 899999996 58888876543 1356788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||+++...... ......||+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 192 ~~~-~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D----iwSlGvvl~ell 250 (357)
T PHA03209 192 DVD-QVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKAD----IWSAGIVLFEML 250 (357)
T ss_pred CCC-CEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhh----HHHHHHHHHHHH
Confidence 987 99999999997533221 123567999999999998877666554 999999999984
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.76 Aligned_cols=195 Identities=17% Similarity=0.225 Sum_probs=150.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|.+.++||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.. ..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 77 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-HTDK 77 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCC-----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-eeCC
Confidence 4578999999999999999999998877 77888877533221 111122344556666789999888776 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++ +|.+++...+ ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill 137 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCG-------------------NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI 137 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 89999999985 8888776543 134667788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++....... ......+|+.|+|||++.+.. ..+..+|+||+|+++|+|-
T Consensus 138 ~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~ 199 (309)
T cd07872 138 NERG-ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSS---EYSTQIDMWGVGCIFFEMA 199 (309)
T ss_pred CCCC-CEEECccccceecCCCcc-ccccccccccccCCHHHhCCC---CCCcHHHHHHHHHHHHHHH
Confidence 9987 999999999976433222 123457799999999986532 2334677999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=252.47 Aligned_cols=192 Identities=22% Similarity=0.232 Sum_probs=158.2
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC-CeEEEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG-GEYWLI 220 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~lV 220 (365)
++..+||+|+|-+||+|.|..++-+++...+-+..+..... +......+.+.+....|+||+.|+..+.... ....+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~-~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPE-ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChH-HHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 34678999999999999999998555554444444443322 2233444678889999999999998876543 568899
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCceEEecC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKPQNVIFSEG 298 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDIKp~NILl~~~ 298 (365)
+|.+..|+|..|.++.+ ..+.+.++.|++||+.||.|||++. |||||||-+||+|+.+
T Consensus 122 TEL~TSGtLr~Y~kk~~--------------------~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR--------------------RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred eecccCCcHHHHHHHhc--------------------cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 99999999999999876 5577899999999999999999984 9999999999999988
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+.+||+|+|+|+..+... ...++|||.|||||++. ..|+...| +||||.||.||-
T Consensus 182 ~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VD----VYaFGMCmLEMv 237 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVD----VYAFGMCMLEMV 237 (632)
T ss_pred cCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhh----hhhhhHHHHHHH
Confidence 8899999999999876543 34589999999999987 67777777 999999999884
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=234.61 Aligned_cols=212 Identities=19% Similarity=0.239 Sum_probs=160.8
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.+.||+|+||.||+|.+.........+.+++|....... .......++...+....|++++.+++.. ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-ST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-cC
Confidence 345689999999999999999999987655344447799998764432 2222222344556667899999988876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+++++|.+++........ .......+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~ni 150 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAE----------NNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNC 150 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchh----------hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheE
Confidence 5789999999999999999976431100 001223457788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++++ .+||+|||+++.+...... ......++..|+|||++.+...+.++| +||||+++|++-
T Consensus 151 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~il~el~ 215 (277)
T cd05032 151 MVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD----VWSFGVVLWEMA 215 (277)
T ss_pred EEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccc----hHHHHHHHHHhh
Confidence 999987 9999999999876543322 223456788999999997776666555 999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=235.18 Aligned_cols=194 Identities=15% Similarity=0.198 Sum_probs=149.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.++||+|+||.||+|.+..+ ..+++|++........ ...++...+....|++++.+++.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~~~~~-~~~~E~~~l~~l~~~~i~~~~~~~--~~~ 73 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV--SEE 73 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC------ceEEEEecccCccCHH-HHHHHHHHHHhCCCCCcceEEEEE--CCC
Confidence 3457899999999999999999988665 4588888764332211 122334455556788888887654 335
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... +..+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEM------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 6799999999999999997532 1234677788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .++|+|||.++.+............++..|+|||++.+...+.+ +|+||||+++|++
T Consensus 136 ~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~----~DvwslG~~l~el 196 (262)
T cd05071 136 GENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTEL 196 (262)
T ss_pred cCCC-cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCch----hhHHHHHHHHHHH
Confidence 9987 99999999998765443322234456778999999876665544 5599999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=237.02 Aligned_cols=213 Identities=20% Similarity=0.265 Sum_probs=159.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|.+.+.||+|+||.||++.............+++|.+............++...+....|++++.+++.+ ..+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-VEGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCc
Confidence 45789999999999999999998654322222256788887655444333334445566667789999888776 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++|+||+++++|.+++.........+. +..+...+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMA-------EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCcccccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999999999986543211110 111223478889999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||+++....... .......+++.|+|||++.+...+.+ +|+||||+++|+|-
T Consensus 155 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----sDiwslG~il~~l~ 216 (288)
T cd05093 155 ENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWSLGVVLWEIF 216 (288)
T ss_pred cCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch----hhHHHHHHHHHHHH
Confidence 987 999999999986543322 11223455788999999977665555 45999999999884
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=254.87 Aligned_cols=199 Identities=22% Similarity=0.283 Sum_probs=158.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..+-|.|+..||.|+||.||+|..+.++ -..+.|.+......+.....-++..+..+.||+++.++..+.. ++.
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~-----~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enk 103 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETK-----LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENK 103 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccch-----hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCc
Confidence 3467889999999999999999999774 3334555543333333333334667888889999999988754 468
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+|++.|||+||....++-+-+ ..+.+.+|..+++|++.||.|||++.|||||||..|||+.
T Consensus 104 LwiliEFC~GGAVDaimlEL~-------------------r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELG-------------------RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT 164 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhc-------------------cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE
Confidence 999999999999999887654 3568899999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
-+| .++|+|||.+....... .....++|||.|||||++....+ +...|..+|+||||+.|-+|.
T Consensus 165 ldG-dirLADFGVSAKn~~t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA 229 (1187)
T KOG0579|consen 165 LDG-DIRLADFGVSAKNKSTR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA 229 (1187)
T ss_pred ecC-cEeeecccccccchhHH-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence 998 99999999986543222 23467999999999999886644 334455788999999998874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=236.56 Aligned_cols=196 Identities=20% Similarity=0.188 Sum_probs=151.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEec----CCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc-c
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLA----KKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-K 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 212 (365)
..+|++.+.||+|+||.||+|... .++ ..+++|++............++...+....|++++.+.+... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTG-----EVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCC-----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 358999999999999999999853 233 678999887655444444444556677778999998877543 3
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++|+||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n 138 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-------------------ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN 138 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence 3457899999999999999987543 134677888999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccc--cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++++++ .+||+|||+++.+....... .....++..|+|||++.+..++. .+|+||||+++|+|-
T Consensus 139 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~el~ 205 (284)
T cd05081 139 ILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELF 205 (284)
T ss_pred EEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcCh----HHHHHHHHHHHHHHh
Confidence 9999987 99999999998765432211 11223345699999997766554 455999999999983
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=239.17 Aligned_cols=212 Identities=18% Similarity=0.229 Sum_probs=150.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (365)
.+..++|++.+.||+|+||.||+|.+..++.. ..+++|....... .......++...+... .|++++.+++.+ .
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-~ 78 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-E 78 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCce---eeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-C
Confidence 34668999999999999999999998766522 2346666553221 1222222233344444 788998888776 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++|+||+++++|.+++........-... ......+..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF----AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccc----cccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 556899999999999999999765411000000 0001123356888899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+++++ .+||+|||+++..... .......++..|+|||++.+...+.++ |+||||+++|+|
T Consensus 155 ili~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~il~el 216 (303)
T cd05088 155 ILVGENY-VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNS----DVWSYGVLLWEI 216 (303)
T ss_pred EEecCCC-cEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccc----cchhhhhHHHHH
Confidence 9999987 9999999999643211 111122346789999998776665554 499999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=246.29 Aligned_cols=199 Identities=21% Similarity=0.335 Sum_probs=163.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+-...+.-|..++.||-|+||+|.++.-.+|. ..+|+|.+++..-.. ......++..+.....++++.++..
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~-----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTR-----ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchh-----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 33445568999999999999999999998887 888999887654322 2223334566677777888888877
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .+.+.+|+||+|++||++-.+|...+ .+++..++.++.++..|+++.|..|+||||||
T Consensus 698 F-QDkdnLYFVMdYIPGGDmMSLLIrmg--------------------IFeE~LARFYIAEltcAiesVHkmGFIHRDiK 756 (1034)
T KOG0608|consen 698 F-QDKDNLYFVMDYIPGGDMMSLLIRMG--------------------IFEEDLARFYIAELTCAIESVHKMGFIHRDIK 756 (1034)
T ss_pred e-ccCCceEEEEeccCCccHHHHHHHhc--------------------cCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence 7 66689999999999999999998876 46888999999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccC---------Cc--------------------------------cccccccCCC
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVG---------IN--------------------------------YIPKEFLLDP 328 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~---------~~--------------------------------~~~~~~~gt~ 328 (365)
|+|||||.+| ++||+|||||+-++-. .. ......+||+
T Consensus 757 PDNILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~ 835 (1034)
T KOG0608|consen 757 PDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTP 835 (1034)
T ss_pred ccceEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCC
Confidence 9999999998 9999999999754311 00 0012368999
Q ss_pred CcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 329 RYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 329 ~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.|+|||++....++..+| +|+.||+||||-
T Consensus 836 nyiapevl~r~g~~q~cd----wws~gvil~em~ 865 (1034)
T KOG0608|consen 836 NYIAPEVLARTGYTQLCD----WWSVGVILYEML 865 (1034)
T ss_pred cccChHHhcccCccccch----hhHhhHHHHHHh
Confidence 999999999999998888 999999999983
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=244.82 Aligned_cols=186 Identities=21% Similarity=0.228 Sum_probs=150.9
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~ 221 (365)
.+.||+|.||+||-|..+.++ +.||+|.+.+.. .......+.+...+...+|+-|+.+...+ +..+..++||
T Consensus 569 devLGSGQFG~VYgg~hRktG-----rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTG-----RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-ETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccC-----ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-cCCceEEEEe
Confidence 468999999999999999999 778887765321 12223444556778888999998886666 6667999999
Q ss_pred EecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC--C
Q 017820 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG--S 299 (365)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~--~ 299 (365)
|-+.|.-|...+.+.. ..+++..-+.++.||+.||.|||.++|+|+||||+|||+.+. .
T Consensus 643 EKl~GDMLEMILSsEk-------------------gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEK-------------------GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPF 703 (888)
T ss_pred hhhcchHHHHHHHhhc-------------------ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCC
Confidence 9998755555554432 356888888999999999999999999999999999999854 3
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhee
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~ 360 (365)
.++||||||.|+.+..... ...++|||.|.|||+++...++..-| +||+||++|-
T Consensus 704 PQvKlCDFGfARiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLD----MWSVGVIiYV 758 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLD----MWSVGVIIYV 758 (888)
T ss_pred Cceeeccccceeecchhhh--hhhhcCCccccCHHHHhhcccccccc----ceeeeEEEEE
Confidence 4999999999999875543 35789999999999999999999998 8889988873
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=251.78 Aligned_cols=188 Identities=23% Similarity=0.293 Sum_probs=156.0
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEecC
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEG 225 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~ 225 (365)
+||+|.||+||-|+|..|. .++|+|.+.+....+..-..+++......+|.||+.+++.+ .+++.+-|.||.++
T Consensus 582 VLGKGTYG~VYA~RD~~tq-----vrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQ-----VRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-SENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccce-----eEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-CCCCeEEEEeecCC
Confidence 6999999999999999998 89999999888777777777778888899999999999997 55668889999999
Q ss_pred CCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEE
Q 017820 226 EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305 (365)
Q Consensus 226 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~ 305 (365)
||+|.+++++.=.| .+-++..+-.+.+||++||.|||++.|||||||-+|+|++.-.+.+||+
T Consensus 656 GGSLSsLLrskWGP-----------------lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKIS 718 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGP-----------------LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKIS 718 (1226)
T ss_pred CCcHHHHHHhccCC-----------------CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEec
Confidence 99999999875321 1226778889999999999999999999999999999999765699999
Q ss_pred ecccccccccCCccccccccCCCCcCCccccccCC--CCCCCCCchhhhhhhhhheec
Q 017820 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST--QTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 306 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~d~~s~~~slg~vlw~l 361 (365)
|||.++.+. +.+....++.||..|||||++..+. +...+| +||||..+-||
T Consensus 719 DFGTsKRLA-ginP~TETFTGTLQYMAPEvIDqG~RGYG~aAD----IWS~GCT~vEM 771 (1226)
T KOG4279|consen 719 DFGTSKRLA-GINPCTETFTGTLQYMAPEVIDQGPRGYGKAAD----IWSFGCTMVEM 771 (1226)
T ss_pred ccccchhhc-cCCccccccccchhhhChHhhccCCcCCCchhh----hhhccceeEee
Confidence 999999864 3445567899999999999998663 344444 55555554444
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=240.29 Aligned_cols=190 Identities=23% Similarity=0.348 Sum_probs=160.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+-|.+.++||+|+||.||+|..+.++ ..+++|++.-..+.+.... ++..+..+..++++.+++.++ +...+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG-----~v~AIK~VPV~sDLQEIIK--EISIMQQC~S~yVVKYYGSYF-K~sDLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESG-----HVLAIKKVPVDTDLQEIIK--EISIMQQCKSKYVVKYYGSYF-KHSDLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccC-----cEEEEEecCccchHHHHHH--HHHHHHHcCCchhhhhhhhhc-cCCceE
Confidence 34667889999999999999999998 8899999886655544333 345566777888899998874 557899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|||||+.|+..|.+.-++. .++++.+..+++..+.||+|||...-||||||..|||++.+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K-------------------~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~ 165 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRK-------------------PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD 165 (502)
T ss_pred eehhhcCCCcHHHHHHHhcC-------------------CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc
Confidence 99999999999999987653 56788899999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
| +.||+|||.|-.+.+.-. ..++++|||.|||||++..-.++.++| +||||+.--||
T Consensus 166 G-~AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVI~EIGY~~~AD----IWSLGITaIEM 222 (502)
T KOG0574|consen 166 G-IAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIEEIGYDTKAD----IWSLGITAIEM 222 (502)
T ss_pred c-hhhhhhccccchhhhhHH-hhCccccCcccccHHHHHHhccchhhh----Hhhhcchhhhh
Confidence 8 999999999987754432 346899999999999999888888888 88888876665
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=233.97 Aligned_cols=191 Identities=19% Similarity=0.270 Sum_probs=147.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
.+|++.+.||+|+||.||+|.+..+ +.+++|............. ++...+....|++++.+++.. ......+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~------~~~~iK~~~~~~~~~~~~~-~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGK------IDVAIKMIREGAMSEDDFI-EEAKVMMKLSHPNLVQLYGVC-TKQRPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCC------ccEEEEEeccCCCCHHHHH-HHHHHHHhCCCCCEEEEEEEE-cCCCceE
Confidence 5789999999999999999988643 5688887654322221111 234455556789999887765 4556789
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|+||+++++|.+++..... .+++..++.++.|++.||.|||+++|+||||||+||+++++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~ 136 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKG-------------------KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED 136 (256)
T ss_pred EEEecCCCCCHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC
Confidence 99999999999999876431 34678889999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ .+||+|||+++..............++..|+|||.+.+..++.++ |+||||+++|++
T Consensus 137 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~----Di~slG~il~~l 194 (256)
T cd05059 137 N-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS----DVWSFGVLMWEV 194 (256)
T ss_pred C-cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchh----hHHHHHHHHHHH
Confidence 7 999999999986543322222223345689999999877666554 599999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=235.54 Aligned_cols=218 Identities=20% Similarity=0.282 Sum_probs=158.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
..+..++|++.+.||+|+||.||++.+...........+++|........ +.....++...+... .|++++.+++.+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~- 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC- 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-
Confidence 34456799999999999999999999876543333467888877643322 222222233334444 689999988766
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+..++++|||+.+++|.++++........... .........+++..++.++.|++.||.|||+++|+||||||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP----DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccc----ccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 4556899999999999999999865311100000 001123446788899999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||++++++ .+||+|||+++.+....... .....++..|+|||++.+..++.++| +||||+++|++
T Consensus 162 Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~il~el 227 (293)
T cd05053 162 NVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD----VWSFGVLLWEI 227 (293)
T ss_pred eEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccc----eeehhhHHHHH
Confidence 99999987 99999999998765432211 12234567899999987776666555 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=237.10 Aligned_cols=214 Identities=21% Similarity=0.261 Sum_probs=160.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|.+.+.||+|+||.||+|.+.........+.+++|........ ......++...+....|++++.+++.+ ..+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-TEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-ecCC
Confidence 45689999999999999999999866533333477899988654433 222333345556667788888888776 4457
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+++++|.+++...+....... ........+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili 155 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLK------SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhc------ccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence 89999999999999999987652111100 011223456788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++.+...... ......+++.|+|||++.+..++.++| +||||+++|+|-
T Consensus 156 ~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~il~e~~ 218 (280)
T cd05049 156 GYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD----VWSFGVVLWEIF 218 (280)
T ss_pred cCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhh----HHHHHHHHHHHH
Confidence 9987 9999999999865433221 123345678999999998877766555 999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=222.17 Aligned_cols=203 Identities=22% Similarity=0.222 Sum_probs=162.9
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc---
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (365)
+..++|++.+.||+|||+.||+++...++ +.+|+|++.-....+.....+++...+..+++|++..+.....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~-----~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTG-----HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcc-----cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 35679999999999999999999988888 8899999887666666666677888888889998877544322
Q ss_pred -CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCCC
Q 017820 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIK 289 (365)
Q Consensus 213 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDIK 289 (365)
.....|+++.|...|+|.+.++... .++..+++.++.+|+.+|++||++||+.. ++|||||
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k----------------~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiK 156 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLK----------------IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIK 156 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHh----------------hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCC
Confidence 2357899999999999999998765 35667899999999999999999999998 9999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCcccc--------ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIP--------KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~--------~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|.|||+++++ .++|.|||.++..+....... .....|.-|.|||.+.-. ....-+.+.|+||||++||+|
T Consensus 157 P~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-~~~ti~ertDIWSLGCtLYa~ 234 (302)
T KOG2345|consen 157 PANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-SHCTITERTDIWSLGCTLYAM 234 (302)
T ss_pred cceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc-cCcccccccchhhhhHHHHHH
Confidence 9999999977 999999999986543211110 123558899999987543 333344567799999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=231.54 Aligned_cols=194 Identities=20% Similarity=0.214 Sum_probs=154.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
++|.+.+.||+|+||.||+|.+..++ +.+++|.+..... .+....+++...+....|++++.+++... .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG-----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-D 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC-----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-c
Confidence 57999999999999999999998877 7788887653321 12223334455667778999999888774 4
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++++||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG--------------------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 569999999999999999987653 346777889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcccc--ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++++++ .++|+|||+++.......... ....++..|+|||++.+...+.+ +|+||+|+++|++-+
T Consensus 136 lv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~el~~ 202 (263)
T cd06625 136 LRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK----ADVWSVGCTVVEMLT 202 (263)
T ss_pred EEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCch----hhhHHHHHHHHHHHh
Confidence 999877 999999999986543222111 34567889999999987665544 559999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=233.25 Aligned_cols=192 Identities=17% Similarity=0.224 Sum_probs=149.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+... ..+++|.+......+.. ..++...+....|++++.+++.+ ......
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~------~~~aik~~~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSEDE-FIEEAKVMMKLSHEKLVQLYGVC-TKQRPI 74 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCC------CcEEEEEcCCCcccHHH-HHHHHHHHhcCCCCCeeeEEEEE-ccCCCc
Confidence 46899999999999999999987653 45888877644322211 22234455666799999988776 445678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+++|||+.+++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK-------------------RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 999999999999999876431 3467888999999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||.++..............++..|+|||++.+..++.+ +|+||||+++|+|
T Consensus 136 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~----~Di~slG~~l~~l 194 (256)
T cd05113 136 QG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK----SDVWAFGVLMWEV 194 (256)
T ss_pred CC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccch----hHHHHHHHHHHHH
Confidence 87 99999999998654432222223345678999999977665554 5599999999997
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=231.04 Aligned_cols=196 Identities=22% Similarity=0.337 Sum_probs=156.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|..............++...+....|++++.+++.. ..+..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATG-----ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-LRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCC-----CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-EeCCEE
Confidence 478999999999999999999998876 67888877654433333444455667777899999988766 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||++++
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTR-------------------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 99999999999999987652 13567888999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||.+..+..... ......++..|+|||++.+... ...+..+|+|+||+++|+|
T Consensus 137 ~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 137 DG-DVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CC-CEEECccccchhhhhhhh-ccccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHH
Confidence 87 999999999986543221 2244678899999999876521 2233456699999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=233.96 Aligned_cols=203 Identities=20% Similarity=0.284 Sum_probs=151.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccc----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSS---- 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~---- 211 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.............. +...+... .|++++.+++.+.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~-e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNG-----SKAAVKILDPIHDIDEEIEA-EYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCC-----ceeEEEeeccccchHHHHHH-HHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4589999999999999999999998877 77888876543222211111 22223333 5888888876543
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+..+++||||+++++|.+++.... ..+..+++..++.++.|++.||.|||+++|+||||||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 153 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFL----------------KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhh----------------ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHH
Confidence 23467899999999999999876421 11234577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++++++ .+||+|||+++.+.... .......|++.|+|||++..... ....+..+|+||+|+++|+|.+
T Consensus 154 nili~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 154 NILLTTEG-GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred hEEECCCC-CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 99999987 89999999998764322 22344578999999999864321 2223445679999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=256.06 Aligned_cols=203 Identities=17% Similarity=0.171 Sum_probs=147.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCC--------------CcceeehhhccccHHHHHHHHHHHHHhhccCCCc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKN--------------DGDLVLKKATEYGAVEIWMNERVRRACANCCADF 202 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (365)
..++|++.++||+|+||+||+|.......... ...++.|++..... .....+++...+....|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSR-AAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchH-HHHHHHHHHHHHHhCCCCC
Confidence 34789999999999999999998654321110 11122333322221 2223334556677778999
Q ss_pred eeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC
Q 017820 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (365)
Q Consensus 203 i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~ 282 (365)
++.+++.+ ...+..++|++++. ++|.+++......+ ........++.++.||+.||.|||++|
T Consensus 225 Iv~l~~~~-~~~~~~~lv~e~~~-~~l~~~l~~~~~~~---------------~~~~~~~~~~~i~~ql~~aL~yLH~~g 287 (501)
T PHA03210 225 ILKIEEIL-RSEANTYMITQKYD-FDLYSFMYDEAFDW---------------KDRPLLKQTRAIMKQLLCAVEYIHDKK 287 (501)
T ss_pred cCcEeEEE-EECCeeEEEEeccc-cCHHHHHhhccccc---------------cccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 99888776 44567889999886 47777776543211 111234567789999999999999999
Q ss_pred CcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 283 IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||||||||+|||++.++ .+||+|||+|+.+............||+.|+|||++.+..++.+ +|+||||+++|+|-
T Consensus 288 IiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----~DiwSlGvil~ell 362 (501)
T PHA03210 288 LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI----TDIWSCGLILLDML 362 (501)
T ss_pred eecCCCCHHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH----HHHHHHHHHHHHHH
Confidence 99999999999999987 99999999998775443333445789999999999987766555 45999999999984
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=232.59 Aligned_cols=195 Identities=16% Similarity=0.222 Sum_probs=149.5
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.++||+|+||.||+|.+... ..+++|.......... ...++...+....|++++.++... ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~k~~~~~~~~~~-~~~~E~~~l~~l~~~~i~~~~~~~--~~~ 73 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGN------TKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVV--SEE 73 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCC------ceeEEEEecCCCCCHH-HHHHHHHHHHhcCCCceEEEEeEE--CCC
Confidence 4557899999999999999999987654 5678887764332221 122334455666788888887654 235
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili 135 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGE------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence 6789999999999999987542 1235778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .++|+|||++..+............++..|+|||++.+...+.++| +||||+++|+|-
T Consensus 136 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~~l~~l~ 197 (260)
T cd05070 136 GDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD----VWSFGILLTELV 197 (260)
T ss_pred eCCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhh----hHHHHHHHHHHH
Confidence 9987 9999999999876443322222344567899999987766655554 999999999983
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=238.15 Aligned_cols=218 Identities=20% Similarity=0.242 Sum_probs=153.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCC--CCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
++...++|.+++.||+|+||.||+|.+...+.. .....+++|....... ........+...+... .|++++.+++.
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 344558999999999999999999987653321 1224688888775322 2222222223333333 68899888877
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+...++||||+++++|.+++........ ..+.+. .......+++..++.++.|++.||.|||++|++|||||
T Consensus 93 ~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~--~~~~~~--~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 93 C-TQDGPLYVIVEYASKGNLREYLRARRPPGM--EYCYNP--TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred E-ecCCceEEEEecCCCCcHHHHHHhcCCccc--cccccc--ccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 6 445688999999999999999976542100 000000 00112346778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+||+++.++ .+||+|||+++......... .....+++.|+|||++.+...+.+ +|+||||+++|+|
T Consensus 168 p~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~DvwslG~~l~el 235 (307)
T cd05098 168 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ----SDVWSFGVLLWEI 235 (307)
T ss_pred HHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH----HHHHHHHHHHHHH
Confidence 9999999987 99999999998654322111 112234578999999987666554 5599999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=232.48 Aligned_cols=195 Identities=21% Similarity=0.265 Sum_probs=153.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|++..++ +.+++|.+.... .........+...+....|++++.+++.+ ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR-----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-IEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC-----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-EECC
Confidence 68999999999999999999998887 778888664321 12222223345566777899999888766 3456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++++|.+++..... +...++++.+..++.|++.||.|||+++++|+||||+||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKK----------------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhh----------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 88999999999999998864320 12235778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+.++ .++|+|||++........ ......|++.|+|||.+.+...+.+ +|+|++|+++|+|
T Consensus 140 ~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~----~Di~slG~~l~el 199 (267)
T cd08228 140 TATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFK----SDIWSLGCLLYEM 199 (267)
T ss_pred cCCC-CEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCch----hhHHHHHHHHHHH
Confidence 9987 999999999987643322 1234578899999999977655544 5599999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=235.41 Aligned_cols=199 Identities=23% Similarity=0.287 Sum_probs=156.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..+.|++.++||+|+||.||+|.+..++ +.+++|..............++...+....|++++.+.+.+ ..+..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-YWDGK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCC-----ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-EeCCe
Confidence 4478999999999999999999998887 77888887655444444344445566777899999888776 34568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|..++.... ..+++..+..++.|++.+|.|||+++|+||||||+||+++
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~ 144 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD-------------------RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc
Confidence 999999999999988876543 1346788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||++...... ........+++.|+|||++.+... ....+..+|+||||+++|+|-
T Consensus 145 ~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~ 209 (292)
T cd06644 145 LDG-DIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209 (292)
T ss_pred CCC-CEEEccCccceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence 877 9999999998764322 122345678899999999864332 222344677999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=243.68 Aligned_cols=189 Identities=22% Similarity=0.281 Sum_probs=147.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
.++|++.+.||+|+||.||+|.+..++ +.|++|++...... ......++...+....|++++.+++.+...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCC-----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 378999999999999999999998887 78889887643221 112222345566777889988877654322
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
....+++++++ +++|.+++... .+++..++.++.|++.||.|||++||+||||||
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp 146 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQ---------------------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKP 146 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 24578999987 56888877543 247788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||+++++ .+||+|||+++..... .....||+.|+|||++.+. .++.+ +|+||||+++|+|-
T Consensus 147 ~Nil~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~----~DiwslG~il~el~ 210 (343)
T cd07878 147 SNVAVNEDC-ELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAELL 210 (343)
T ss_pred hhEEECCCC-CEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCch----hhhHhHHHHHHHHH
Confidence 999999987 9999999999865432 2346789999999998763 34444 45999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=231.59 Aligned_cols=191 Identities=17% Similarity=0.235 Sum_probs=150.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.+.||+|+||.||++...+ ..+++|........+. ...+...+....|++++.+++.....+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~~~~~--~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCchHHH--HHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 355799999999999999999998764 5688888765443322 2223445566678899888876656667
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 135 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGR------------------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE
Confidence 88999999999999999876541 134677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++...... ....++..|+|||++.+...+.+ +|+|+||+++|+|-
T Consensus 136 ~~~~-~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~i~~~l~ 193 (256)
T cd05082 136 SEDN-VAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTK----SDVWSFGILLWEIY 193 (256)
T ss_pred cCCC-cEEecCCccceeccccC----CCCccceeecCHHHHccCCCCch----hhhHHHHHHHHHHH
Confidence 9987 99999999998653321 23445678999999877665554 55999999999883
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=237.52 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=155.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+.+..++|++.+.||+|+||.||+|.+...........+++|........ ......++...+... .|++++.+++.+
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC- 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-
Confidence 44566799999999999999999998754433333467888877644322 222223334455555 689999888766
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+..++++||+.+++|.+++..... ..+++..+..++.|++.||.|||+++|+|+||||+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~ 170 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE------------------SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 170 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccc
Confidence 455679999999999999999876431 12577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||++.++ .++|+|||+++.+...... ......+++.|+|||++.+...+.++ |+||+|+++|+|
T Consensus 171 Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----DiwslGvil~el 236 (302)
T cd05055 171 NVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFES----DVWSYGILLWEI 236 (302)
T ss_pred eEEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHh----HHHHHHHHHHHH
Confidence 99999877 9999999999876543221 12234567889999999877766655 499999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=231.99 Aligned_cols=195 Identities=14% Similarity=0.177 Sum_probs=149.9
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.+.||+|+||.||+|.+..+ +.+++|.+........ ...++...+....|++++.++..+ ..+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~v~iK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 74 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNT------TPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC-TLEE 74 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCC------eEEEEEeeCCCcccHH-HHHHHHHHHHHCCCCCccceeEEE-ecCC
Confidence 4557899999999999999999997654 5688888765432211 122234455566788888887765 4556
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+.+++|.+++.... +..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 136 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGA------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV 136 (261)
T ss_pred CeeeeeecccCCcHHHHHhccC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE
Confidence 7899999999999999987542 1245778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++...............+..|+|||++.+...+.++| +||||+++|+|
T Consensus 137 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~~l~el 197 (261)
T cd05068 137 GENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD----VWSFGILLTEI 197 (261)
T ss_pred cCCC-CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhh----HHHHHHHHHHH
Confidence 9987 9999999999876533221111223345899999988766665555 99999999987
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=228.64 Aligned_cols=194 Identities=20% Similarity=0.266 Sum_probs=154.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||++.+..++ +.+++|++.... .......+++...+....|++++.+.+.+......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG-----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC-----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 5899999999999999999998877 778888875332 222223344455666677899988877654455678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+++++|.+++.... +..+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~------------------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~ 137 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQK------------------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137 (257)
T ss_pred EEEecccCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec
Confidence 99999999999999987532 123577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++........ ......+++.|+|||++.+...+.++ |+|++|+++|+|-
T Consensus 138 ~~-~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~il~~l~ 196 (257)
T cd08223 138 TN-IIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKS----DVWALGCCVYEMA 196 (257)
T ss_pred CC-cEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchh----hhHHHHHHHHHHH
Confidence 87 999999999987643222 23456789999999999877666554 4999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=234.17 Aligned_cols=198 Identities=17% Similarity=0.163 Sum_probs=149.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.++||+|+||+||+|++..++... ...|++|........ ......++...+....|+++..+++.+. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENV-KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL--TS 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCcc-ceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc--CC
Confidence 4579999999999999999999987665322 134788877643322 2222333445566677888888877653 24
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~ 142 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-------------------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 5779999999999999987643 134677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++.+...... ......+++.|+|||++.+...+.+ +|+||||+++|+|
T Consensus 143 ~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~----~Di~slG~~l~el 204 (279)
T cd05109 143 KSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ----SDVWSYGVTVWEL 204 (279)
T ss_pred cCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCch----hHHHHHHHHHHHH
Confidence 8877 9999999999876433221 1122345678999999977665554 4599999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=228.70 Aligned_cols=193 Identities=17% Similarity=0.255 Sum_probs=152.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+|++.+.||+|+||.||++.+..++ +.+++|.++... .........+...+....|++++.+.+.+ ..+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD-----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC-----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-EECCEEE
Confidence 5889999999999999999998887 778888765322 22222223344456666788988887766 5567899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+++||+++++|.+++.... +..+++..++.++.|++.||.|||++||+|+||||+||+++++
T Consensus 75 lv~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQR------------------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred EEEeeCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 9999999999999886532 1235678888999999999999999999999999999999988
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .++|+|||+++....... ......|++.|+|||++.+...+.++| +||+|+++|+|-
T Consensus 137 ~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~D----v~slG~i~~~l~ 194 (255)
T cd08219 137 G-KVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSD----IWSLGCILYELC 194 (255)
T ss_pred C-cEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhh----hhhhchhheehh
Confidence 7 999999999986643222 223467899999999998776665555 999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=230.35 Aligned_cols=195 Identities=21% Similarity=0.193 Sum_probs=152.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-----cHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+... ...+.....++...+....|++++.+.+.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTG-----RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCC-----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 68999999999999999999998887 77888876421 122233334445566777899999888765433
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 214 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+..+++++||+++++|.+++.... .+++..+..++.|++.+|.|||+++|+|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--------------------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN 136 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 356889999999999999987643 23567788899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++.++ .++|+|||+++....... .......|+..|+|||++.+...+.+ +|+||||+++|+|-+
T Consensus 137 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~il~el~~ 204 (265)
T cd06652 137 ILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK----ADIWSVGCTVVEMLT 204 (265)
T ss_pred EEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcc----hhHHHHHHHHHHHhh
Confidence 9999877 999999999986542211 11234568899999999977655544 559999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=245.97 Aligned_cols=223 Identities=22% Similarity=0.272 Sum_probs=159.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccC-CCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCC-ADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~-~~~i~~~~~~~~ 211 (365)
+.+..++|.+.++||+|+||.||+|++.........+.|++|++....... .....++...+.... |+|++.+++.+
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~- 110 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC- 110 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE-
Confidence 455667899999999999999999998754433344679999987543222 212223444455554 89999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcch---------hhhhc-----------------------------------
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNV---------QTLIL----------------------------------- 247 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~---------~~~~~----------------------------------- 247 (365)
..+...++|+||+.+|+|.+++........- ...+.
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4456899999999999999999765321000 00000
Q ss_pred --------------------------------cc--cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 248 --------------------------------GE--VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 248 --------------------------------~~--~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.. .........+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 00 00001123467788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+++++ .+||+|||+++.+...... ......+++.|||||++.+..++.+ +|+||||+++|||-
T Consensus 271 Ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~DvwslGvil~e~l 335 (401)
T cd05107 271 LICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL----SDVWSFGILLWEIF 335 (401)
T ss_pred EEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH----hHHHHHHHHHHHHH
Confidence 999877 9999999999865433221 1223467889999999987666554 45999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=227.77 Aligned_cols=193 Identities=25% Similarity=0.345 Sum_probs=155.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|.+.+.||+|+||.||+|.+..++ +.+++|.+... ...+......+...+....|++++.+++.+ ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK-----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-LDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC-----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-ccCCEE
Confidence 5889999999999999999998887 77888876532 222233333345566777899999988776 445789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... +..+++..++.++.|++.||.|||++|++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~ 136 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQR------------------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA 136 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC
Confidence 99999999999999987642 124577888899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||+++.+...... .....|++.|+|||++.+...+.++| +||||+++|+|-
T Consensus 137 ~~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~il~~l~ 195 (256)
T cd08529 137 YD-NVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSD----VWALGVVLYECC 195 (256)
T ss_pred CC-CEEEcccccceeccCccch-hhccccCccccCHHHhcCCCCCCccc----hHHHHHHHHHHH
Confidence 87 9999999999876543322 23457889999999998777665555 999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=237.07 Aligned_cols=216 Identities=19% Similarity=0.238 Sum_probs=158.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH-HHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
...+|++.+.||+|+||.||+|.+..+......+.+++|.+........ ....++........|++++.+++.. ....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-TKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-cCCC
Confidence 3457888999999999999999987654333447799998875543321 2223344555667789999888776 4446
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+.+++|.+++............ .........+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGST----DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCcccccc----ccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 789999999999999998654322211110 0111123346778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++........ ......+++.|+|||++.+..++.++ |+||||+++|+|-
T Consensus 158 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~~l~el~ 220 (283)
T cd05091 158 FDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS----DIWSYGVVLWEVF 220 (283)
T ss_pred cCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch----hHHHHHHHHHHHH
Confidence 9877 9999999999865433221 12334567899999999877666555 5999999999963
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=234.17 Aligned_cols=214 Identities=21% Similarity=0.257 Sum_probs=157.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
...+|++.++||+|+||.||++.............+++|..............++...+....|++++.+++.+ ..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 81 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-TEGRP 81 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-ecCCc
Confidence 44689999999999999999998654322222266788877655544444444455666777899999888766 44567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++++||+.+++|.+++........... .........+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILA-----GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhc-----ccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 8999999999999999976542100000 00111223567888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .+||+|||+++.......+. .....+++.|+|||++.+...+.++ |+||||+++|+|
T Consensus 157 ~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~il~el 217 (280)
T cd05092 157 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES----DIWSFGVVLWEI 217 (280)
T ss_pred CCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchh----hHHHHHHHHHHH
Confidence 877 99999999998654332211 2234457889999999877665554 599999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=250.22 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=168.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
..+.|+|.+.||.|.+|.||+++...++ ...++|.+....+.+...+.+.......+.|+|+..+++.+..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~-----~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTG-----QLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecC-----ceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 5578999999999999999999999887 6677777665555544444444455566778888777766542
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.++++|||||||++||.-|+++... +..++|..|..|++.++.||.+||.+.+||||||-.|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~------------------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~N 153 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK------------------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQN 153 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc------------------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCce
Confidence 3489999999999999999997642 5677899999999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecccC
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQCS 364 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lGc~ 364 (365)
||++.++ .+||.|||++..+..... ..++.+|||.|||||++... ..+..-|..+|+||||+.--|||-.
T Consensus 154 iLLT~e~-~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 154 VLLTENA-EVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred EEEeccC-cEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 9999988 999999999998765443 35789999999999999865 4456667799999999999999853
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=233.97 Aligned_cols=195 Identities=17% Similarity=0.259 Sum_probs=155.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
...+|++.++||+|+||.||+|.+.. + +.+++|.+.............+...+....|++++.+++.. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 76 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-R-----VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-SVGEP 76 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-C-----CcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-ecCCC
Confidence 34689999999999999999999987 4 77888887765543333344455566777899998887766 45567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++.+.. +..+++..+..++.|++.||.|||++||+|+||||+||+++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPE------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred eEEEEeecccCCHHHHHhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 899999999999999997643 12357788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||.+........ ......++..|+|||++.+..++.++ |+|+||+++|+|-
T Consensus 139 ~~~-~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~----DiwslG~~l~~l~ 198 (261)
T cd05148 139 EDL-VCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKS----DVWSFGILLYEMF 198 (261)
T ss_pred CCc-eEEEccccchhhcCCccc-cccCCCCceEecCHHHHccCCCCchh----hHHHHHHHHHHHH
Confidence 987 999999999987643322 22344567789999999876666554 5999999999983
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=234.11 Aligned_cols=200 Identities=19% Similarity=0.277 Sum_probs=156.9
Q ss_pred HHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeec
Q 017820 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 129 ~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
+.....+....+|++.+.||+|+||.||+|.+..++ +.+++|.+............++...+....|++++.+.+
T Consensus 10 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~ 84 (296)
T cd06654 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84 (296)
T ss_pred HhccccCCcccceeeEEEecCCCCeEEEEEEECCCC-----cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344444556679999999999999999999988777 778888776443332222333344556678899998887
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ ..+...++|+||+.+++|.+++.... +++..+..++.|++.||.|||++||+||||
T Consensus 85 ~~-~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~i~~ql~~aL~~LH~~gi~H~dL 142 (296)
T cd06654 85 SY-LVGDELWVVMEYLAGGSLTDVVTETC---------------------MDEGQIAAVCRECLQALEFLHSNQVIHRDI 142 (296)
T ss_pred EE-EeCCEEEEeecccCCCCHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 66 44678999999999999999986532 356678899999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+|||++.++ .+||+|||++......... .....+++.|+|||.+.+...+.+ +|+|++|+++|+|
T Consensus 143 kp~Nill~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~s~Gvil~~l 209 (296)
T cd06654 143 KSDNILLGMDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPK----VDIWSLGIMAIEM 209 (296)
T ss_pred CHHHEEEcCCC-CEEECccccchhccccccc-cCcccCCccccCHHHHcCCCCCcc----chHHHHHHHHHHH
Confidence 99999999887 9999999998865433221 234578999999999987666554 4599999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=242.17 Aligned_cols=195 Identities=22% Similarity=0.266 Sum_probs=167.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH--HHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
+=|.+.+.||+|.|++|-+|+..-|+ .+||+|.+......+. -..-++.+.+....|+||+.+++.. .....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTG-----ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhccc-----ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccce
Confidence 56889999999999999999999998 8888888865544332 2333456778888899999999887 56688
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+|||+|.-.+|+|+||+-.++ ..+++..+++++.||+.|+.|+|+.++|||||||+|+.+-
T Consensus 92 lyLiLELGD~GDl~DyImKHe-------------------~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF 152 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-------------------EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF 152 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-------------------ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe
Confidence 999999999999999997765 3578899999999999999999999999999999999998
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.-+-+||+|||++..+..+.. -.+.+|+..|-|||.+.|..++..+ .|+|||||+||-|=|
T Consensus 153 EKlGlVKLTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPA---VDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 153 EKLGLVKLTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPA---VDIWSLGVILYMLVC 214 (864)
T ss_pred eecCceEeeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcc---hhhhHHHHHHHHHHh
Confidence 8777999999999988776654 3678999999999999998886544 469999999999887
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=234.71 Aligned_cols=218 Identities=21% Similarity=0.265 Sum_probs=157.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+|++.+.||+|+||.||+|.+...........+++|....... .+.....++...+....|++++.+++.+ ..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-SQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-ecCCCcE
Confidence 5788999999999999999986544443446678887764432 2223333445566677899999988776 4456789
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhcc-----c-cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILG-----E-VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+++||+.+++|.+++........ ..... . .........+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGP--SYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccc--cccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999876431100 00000 0 0011122357888899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
||+++++ .+||+|||+++.......+. .....++..|+|||++.+...+.+ +|+||||+++|+| |++|
T Consensus 158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~----~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ----SDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH----hHHHHHHHHHHHHHhcCCCC
Confidence 9999877 99999999998654332221 223455678999999877665554 5599999999996 6554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=235.19 Aligned_cols=212 Identities=19% Similarity=0.203 Sum_probs=155.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCC---------CCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceee
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPS---------SKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYG 205 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---------~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 205 (365)
+..++|++.+.||+|+||.||+|++..++. ......+++|........ ......++...+....|++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 355799999999999999999998865421 111235788887654322 2222334455667778899988
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+++.+ ......++||||+.+++|.+++......-.. .........++..+..++.|++.||.|||+++++|
T Consensus 82 ~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 82 LLGVC-VSDDPLCMITEYMENGDLNQFLSQREIESTF--------THANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred EEEEE-cCCCccEEEEecCCCCcHHHHHHhccccccc--------cccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 88776 4456889999999999999998764311000 00011123567888899999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||||+||++++++ .+||+|||+++........ ......++..|+|||++.+..++.++ |+||||+++|+|
T Consensus 153 ~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----DvwSlG~~l~el 224 (295)
T cd05097 153 RDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS----DVWAFGVTLWEM 224 (295)
T ss_pred cccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh----hHHHHHHHHHHH
Confidence 99999999999877 9999999999865433221 12234557789999998877665554 599999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=230.47 Aligned_cols=200 Identities=18% Similarity=0.224 Sum_probs=149.6
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC----
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG---- 214 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 214 (365)
|++++.||+|+||.||+|.+..++... ..+++|.+.... ..+......+...+....|++++.+++......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQ--LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCc--ceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 568899999999999999986543221 668888776432 222222233445566677899988876653322
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...++++||+.+++|.+++...... .....+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~--------------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Ni 144 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLG--------------GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNC 144 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhcc--------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheE
Confidence 2479999999999999998664311 0122467788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcccc-ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++++ .+||+|||+++.......+.. ....++..|+|||++.+...+.++| +||||+++|+|
T Consensus 145 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D----v~SlG~il~el 208 (273)
T cd05035 145 MLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSD----VWAFGVTMWEI 208 (273)
T ss_pred EECCCC-eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccc----hHHHHHHHHHH
Confidence 999987 999999999987654432221 2234567899999987777766655 99999999997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=243.70 Aligned_cols=195 Identities=21% Similarity=0.278 Sum_probs=166.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH--HHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
....|.+.+.||+|.|+.|.+|+...++ ..||+|.+.+...... ....++...+...+|+||+.++... ...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~-----~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-~t~ 127 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTG-----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-ETE 127 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCC-----ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-eec
Confidence 5579999999999999999999999998 8899998876544332 2344567778889999999999887 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||..+|.+++++..++ ...+..++.++.|++++++|||+++|+|||||++|||
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g--------------------r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNil 187 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG--------------------RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENIL 187 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc--------------------cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcc
Confidence 78999999999999999999876 3355778899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+.+. ++||+|||++..+..+. .-.+.+|++-|.|||++.+..++. ...|+|++|+++|.|=|
T Consensus 188 L~~~m-nikIaDfgfS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~g---pe~D~Wslgvvly~LV~ 250 (596)
T KOG0586|consen 188 LDENM-NIKIADFGFSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDG---PEVDIWSLGVVLYALVE 250 (596)
T ss_pred ccccc-ceeeeccccceeecccc--cccccCCCCCccChHhhcCcccCC---cceehhhhhhhheeeee
Confidence 99987 89999999999886433 346899999999999998887533 34569999999999865
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=235.86 Aligned_cols=191 Identities=21% Similarity=0.242 Sum_probs=153.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||++.+..++ ..+++|.+......+ .....++...+....|++++.+++.+ ..++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSG-----LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-YSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCC-----eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCEE
Confidence 47999999999999999999998887 667777765432221 22233345566667899999998776 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEe
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~ 296 (365)
++|+||+++++|.+++...+ .+++..+..++.|+++||.|||+ ++++||||||+|||++
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG--------------------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 99999999999999997653 34677888999999999999998 5899999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++ .+||+|||++...... ......|++.|+|||++.+..++.++ |+||||+++|+|-+
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~----DiwslG~~l~~l~~ 193 (308)
T cd06615 135 SRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQS----DIWSLGLSLVEMAI 193 (308)
T ss_pred cCC-cEEEccCCCccccccc---ccccCCCCcCccChhHhcCCCCCccc----hHHHHHHHHHHHHh
Confidence 987 9999999999765432 12456889999999998776666555 49999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=233.94 Aligned_cols=192 Identities=22% Similarity=0.316 Sum_probs=151.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||++.+..++ +.+++|.+..... .+.....++...+....|++++.+++.+ ..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETR-----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-ETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCC-----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-ecCC
Confidence 47999999999999999999998887 7888887764432 1122222344566677889999888766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll 134 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG--------------------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE
Confidence 8999999999999999997654 34677788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCC--------------ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGI--------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~--------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++...... ........++..|+|||++.+...+.++| +||||+++|+|
T Consensus 135 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~vl~el 209 (305)
T cd05609 135 TSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVD----WWAMGIILYEF 209 (305)
T ss_pred CCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhh----HHHHHHHHHHH
Confidence 9887 99999999987421110 01112346788999999988766665555 99999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=233.23 Aligned_cols=190 Identities=23% Similarity=0.301 Sum_probs=153.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||++.+..++ +.+++|.+...... ......++...+....|++++.+++.. ..+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG-----KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-QDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-EcCC
Confidence 47999999999999999999998877 77888877543221 122223344556666799998888776 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||++
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili 134 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG--------------------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 8999999999999999987654 34677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++++ .+||+|||+++..... .....+++.|+|||.+.+...+.+ +|+|+||+++|+|-+
T Consensus 135 ~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~~l~~ 193 (290)
T cd05580 135 DSDG-YIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKA----VDWWALGILIYEMLA 193 (290)
T ss_pred CCCC-CEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCcc----ccHHHHHHHHHHHHh
Confidence 9987 9999999999876433 234678999999999877655554 459999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=233.47 Aligned_cols=201 Identities=22% Similarity=0.342 Sum_probs=151.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC----
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK---- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---- 213 (365)
.+.|++.+.||+|+||.||+|.+..++ +.+++|........+.....++........|++++.+.+.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCC-----cEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 367889999999999999999998877 77888877543322222222222222333688888887765432
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 214 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
...+++++||+++++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~n 141 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK------------------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 256899999999999999987642 1235678888999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++++++ .++|+|||+++....... ......|++.|+|||++.+... ....+..+|+||+|+++|+|-+
T Consensus 142 ili~~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~ 211 (272)
T cd06637 142 VLLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211 (272)
T ss_pred EEECCCC-CEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999987 999999999986543222 2345678999999999874321 2233446779999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=234.97 Aligned_cols=200 Identities=20% Similarity=0.279 Sum_probs=158.8
Q ss_pred HHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeec
Q 017820 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 129 ~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
++....+-..++|++.+.||+|+||.||+|.+..++ +.+++|.+............++...+....|++++.+++
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 83 (297)
T cd06656 9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83 (297)
T ss_pred HhhcccCChhhhceeeeeeccCCCeEEEEEEECCCC-----CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344444556689999999999999999999988777 788888876443333333334455667778999999887
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ ..+...++|+||+++++|.+++.+.. +++..+..++.|++.+|.|||+.+|+||||
T Consensus 84 ~~-~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL 141 (297)
T cd06656 84 SY-LVGDELWVVMEYLAGGSLTDVVTETC---------------------MDEGQIAAVCRECLQALDFLHSNQVIHRDI 141 (297)
T ss_pred EE-ecCCEEEEeecccCCCCHHHHHHhCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 76 45678999999999999999986532 356778899999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+|||++.++ .++|+|||++........ ......+++.|+|||.+.+...+.+ +|+||+|+++|++
T Consensus 142 ~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slGvil~~l 208 (297)
T cd06656 142 KSDNILLGMDG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK----VDIWSLGIMAIEM 208 (297)
T ss_pred CHHHEEECCCC-CEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcH----HHHHHHHHHHHHH
Confidence 99999999887 999999999986543322 1234578899999999987666554 5599999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=231.00 Aligned_cols=209 Identities=16% Similarity=0.205 Sum_probs=159.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|+...+......+.+++|........ ......++.+.+....|++++.++..+ ....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-REAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-CCCC
Confidence 34789999999999999999999887665556678888887654433 122233345566667789988887765 4556
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++....-. ....+...+++..+..++.|++.+|.|||+++|+||||||+||++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~-----------~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili 150 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSK-----------DEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccc-----------cccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE
Confidence 789999999999999998765310 000112246788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .++|+|||+++..............++..|+|||.+.+...+.+ +|+||||+++|++-
T Consensus 151 ~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~----~Di~slG~~l~~l~ 212 (275)
T cd05046 151 SSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK----SDVWSFGVLMWEVF 212 (275)
T ss_pred eCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCch----hhHHHHHHHHHHHH
Confidence 9987 99999999987654333323334566788999999877665554 45999999999873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=237.57 Aligned_cols=198 Identities=21% Similarity=0.266 Sum_probs=143.2
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc-CCCeEEEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-KGGEYWLIWR 222 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lV~e 222 (365)
+++||+|+||+||+|.+...... +.+++|.+........ ..++...+....|++++.+.+.+.. .+...++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~---~~~aiK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDD---RDYALKQIEGTGISMS--ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCC---ceEEEEEECCCCCcHH--HHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 57899999999999997642211 6788888765432222 1233455666789999888776533 3467899999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec---CC
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE---GS 299 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~---~~ 299 (365)
|+++ +|.+++....... ...+...+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 81 ~~~~-~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 81 YAEH-DLWHIIKFHRASK-----------ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred ccCC-CHHHHHHhccccc-----------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc
Confidence 9875 8888876543110 0112234688889999999999999999999999999999999942 22
Q ss_pred CcEEEEecccccccccCCc--cccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheecc
Q 017820 300 RTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lG 362 (365)
..+||+|||+|+.+..... .......||+.|+|||++.+.. ++. .+|+||+|+++|+|-
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~----~~DiwslG~il~el~ 210 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK----AIDIWAIGCIFAELL 210 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCc----hhhHHHHHHHHHHHH
Confidence 3899999999987643321 1223568899999999987643 444 455999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=232.09 Aligned_cols=199 Identities=20% Similarity=0.273 Sum_probs=152.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.|++|.+.... ..+.....++........|++++.+++.. ..+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-~~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTG-----TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-FREGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCC-----cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-ecCCc
Confidence 57999999999999999999999887 888888776432 22222222333345667889999888776 44567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCceEE
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF 295 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NILl 295 (365)
.++++||++ ++|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||++
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVY----------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhc----------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 999999997 68888876532 1123568889999999999999999998 99999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++.+.... ......++..|+|||++.+.......+..+|+|+||+++|+|-+
T Consensus 138 ~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 202 (283)
T cd06617 138 NRNG-QVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202 (283)
T ss_pred CCCC-CEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh
Confidence 9987 99999999998654322 12335788999999998764332333445669999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=231.82 Aligned_cols=202 Identities=19% Similarity=0.259 Sum_probs=159.4
Q ss_pred HHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeee
Q 017820 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFF 207 (365)
Q Consensus 128 ~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 207 (365)
+.+....+....+|++.+.||.|+||.||+|.+..++ +.+++|.+............++...+....|++++.+.
T Consensus 8 ~~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 82 (296)
T cd06655 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATG-----QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL 82 (296)
T ss_pred HHHHHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCC-----cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeee
Confidence 3445555556678999999999999999999998887 77888877543322222223344556667889998888
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
+.+ ..+..+++|+||+.+++|.+++.... +++..+..++.|++.||.|||++|++|+|
T Consensus 83 ~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------l~~~~~~~i~~~l~~al~~LH~~~i~H~d 140 (296)
T cd06655 83 DSF-LVGDELFVVMEYLAGGSLTDVVTETC---------------------MDEAQIAAVCRECLQALEFLHANQVIHRD 140 (296)
T ss_pred eeE-ecCceEEEEEEecCCCcHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 766 45678999999999999999886532 46778899999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+||+++.++ .+||+|||++......... .....++..|+|||.+.+..++.++ |+||||+++|+|-
T Consensus 141 L~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slGvil~~ll 209 (296)
T cd06655 141 IKSDNVLLGMDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV----DIWSLGIMAIEMV 209 (296)
T ss_pred CCHHHEEECCCC-CEEEccCccchhccccccc-CCCcCCCccccCcchhcCCCCCchh----hHHHHHHHHHHHH
Confidence 999999999877 9999999999865433221 2345788999999998876665554 5999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=230.94 Aligned_cols=216 Identities=18% Similarity=0.220 Sum_probs=156.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH-HHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+..++.. ....+++|.+......+. ....++...+....|++++.+++.. ..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMD-HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-TQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCC-CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-ecCC
Confidence 457899999999999999999997433211 126788888864332222 2233345566777899999888765 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+++++|.+++............ ..........+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCS---SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 789999999999999998654322111100 00001112346788889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++....... .......++..|+|||++.+...+.+ +|+||||+++|+|-
T Consensus 158 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~il~el~ 220 (283)
T cd05090 158 GEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD----SDIWSFGVVLWEIF 220 (283)
T ss_pred cCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch----hhhHHHHHHHHHHH
Confidence 9987 999999999986543321 11233456778999999977665555 45999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=253.09 Aligned_cols=202 Identities=22% Similarity=0.256 Sum_probs=153.8
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc-cCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~ 213 (365)
++..-++++.+.|.+|||+.||+|++...+ +.+|+|++.-..........+++..+.. ..|+||+.|++.....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 345568899999999999999999999887 7899999876655555555555555544 4599999999832211
Q ss_pred ------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 017820 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVH 285 (365)
Q Consensus 214 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiH 285 (365)
.-+++|.||||.+|.|.|+|..+. ...+++..+++|+.|+++|+.+||... |||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl------------------q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH 169 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRL------------------QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH 169 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHH------------------hccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence 256789999999999999998653 123788999999999999999999987 999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCC-c-cc----cc--cccCCCCcCCccccccCCCCCCCCCchhhhhhhhh
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-N-YI----PK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~-~-~~----~~--~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~v 357 (365)
||||-|||||+.++ +.||||||.|....... . .. .. ..-.|+-|+|||++.-..- ...+.++|+|+||++
T Consensus 170 RDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg-~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 170 RDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG-LPIGEKSDIWALGCL 247 (738)
T ss_pred hhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC-CCCcchhHHHHHHHH
Confidence 99999999999988 99999999987432211 0 00 00 1244899999999753222 223345569999999
Q ss_pred heec
Q 017820 358 LWQV 361 (365)
Q Consensus 358 lw~l 361 (365)
||-|
T Consensus 248 LYkL 251 (738)
T KOG1989|consen 248 LYKL 251 (738)
T ss_pred HHHH
Confidence 8854
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=231.13 Aligned_cols=197 Identities=16% Similarity=0.195 Sum_probs=143.5
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|...... ....+++|.+......+ .....++...+....|+|++.+++.+ .....+++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM---SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-IESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCC---CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCceEEEEEe
Confidence 36899999999999765432 12567888765433222 22222334455667899999998876 455789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++...... .....++..+..++.||+.||.|||+++|+||||||+|||+++++ .+|
T Consensus 77 ~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~k 140 (269)
T cd05042 77 CPLGDLKNYLRSNRGM---------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVK 140 (269)
T ss_pred CCCCcHHHHHHhcccc---------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEE
Confidence 9999999999765411 011235677889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCcc-ccccccCCCCcCCccccccCCC---CCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQ---TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~---~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++........ ......+++.|+|||++..... ....+..+|+||||+++|+|
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05042 141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202 (269)
T ss_pred EeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence 9999999754332221 1223456778999999864322 22334577899999999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.94 Aligned_cols=204 Identities=21% Similarity=0.264 Sum_probs=154.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
....++|++.+.||+|+||+||+|.+..++ ..+++|.+.... .........+...+....|++|+.+++.+..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg-----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ-----EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCC-----eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 346689999999999999999999998877 677777765322 2222233345566777789999998876643
Q ss_pred C-CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-------CCc
Q 017820 213 K-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-------GIV 284 (365)
Q Consensus 213 ~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-------~Ii 284 (365)
. ...+|+||||+.+++|.+++.... .....+++..++.|+.||+.||.|||+. +||
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~----------------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IV 147 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCY----------------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCce
Confidence 3 467899999999999999987532 0112467888999999999999999984 499
Q ss_pred ccCCCCCceEEecCC----------------CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCc
Q 017820 285 HRDIKPQNVIFSEGS----------------RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (365)
Q Consensus 285 HrDIKp~NILl~~~~----------------~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~ 348 (365)
||||||+||||+.+. ..+||+|||+++.+.... ......||+.|+|||++.+... ..+..
T Consensus 148 HRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~--~~s~K 223 (1021)
T PTZ00266 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETK--SYDDK 223 (1021)
T ss_pred eccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCC--CCCch
Confidence 999999999996421 258999999998764332 2345689999999999865321 12335
Q ss_pred hhhhhhhhhheeccc
Q 017820 349 PVATALSPVLWQVQC 363 (365)
Q Consensus 349 s~~~slg~vlw~lGc 363 (365)
+|+||||++||+|-+
T Consensus 224 SDVWSLG~ILYELLT 238 (1021)
T PTZ00266 224 SDMWALGCIIYELCS 238 (1021)
T ss_pred hHHHHHHHHHHHHHH
Confidence 569999999999854
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=232.19 Aligned_cols=198 Identities=18% Similarity=0.190 Sum_probs=151.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC-CCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-GGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~ 216 (365)
.-|++.+.||+|+||.||+|.+...+ ....+.+++|.+..... .......++...+....|++++.+.+.+... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 46788999999999999999864211 01116789998764432 2223344455567777899998887765444 367
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++..... ..++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~-------------------~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKN-------------------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc
Confidence 8999999999999999865431 246677889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .++|+|||+++.+...... ......++..|+|||++.+..++.++| +||||+++|+|
T Consensus 144 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D----i~slG~il~el 205 (284)
T cd05079 144 SEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASD----VWSFGVTLYEL 205 (284)
T ss_pred CCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcccc----chhhhhhhhhh
Confidence 987 9999999999876543221 122456677899999998777666555 99999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=231.37 Aligned_cols=211 Identities=17% Similarity=0.206 Sum_probs=155.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|.+.+.||+|+||.||+|.+...........+++|........ ......++...+....|++++.+++... ...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-ERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCC
Confidence 45789999999999999999999976221112267888877644322 2222233445566678899998887664 445
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+.+++|.+++...... ......+++..+..++.||+.||.|||+++++||||||+||++
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~-------------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~ 149 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPR-------------PERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL 149 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEE
Confidence 778999999999999999775411 0112356788899999999999999999999999999999999
Q ss_pred ecCC--CcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 296 SEGS--RTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 296 ~~~~--~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
+.++ ..+||+|||+++.+....... ......+..|+|||++.+..++.++| +||||+++|+| |+.|
T Consensus 150 ~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----iwslG~il~el~~~g~~p 221 (277)
T cd05036 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTD----VWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred eccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhH----HHHHHHHHHHHHcCCCCC
Confidence 8654 369999999998764322211 11233456899999998777766555 99999999995 5554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=229.51 Aligned_cols=201 Identities=15% Similarity=0.149 Sum_probs=153.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..+|++.+.||+|+||.||+|.+..++... ..+++|...... .........+...+....|++++.+++.. ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCc--eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-CCCCc
Confidence 357999999999999999999998765322 458888876432 22222333445566677899999988776 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~ 140 (269)
T cd05065 80 VMIITEFMENGALDSFLRQND-------------------GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN 140 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc
Confidence 899999999999999987643 1346777889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcccc--cccc--CCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIP--KEFL--LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~--~~~~--gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
.++ .+||+|||+++.......... .... .+..|+|||++.+...+.++| +||+|+++|++ |..|
T Consensus 141 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D----vwslG~~l~e~l~~g~~p 211 (269)
T cd05065 141 SNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD----VWSYGIVMWEVMSYGERP 211 (269)
T ss_pred CCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhh----hhhhHHHHHHHhcCCCCC
Confidence 877 999999999986543322111 1111 245799999998776665554 99999999994 6554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=234.06 Aligned_cols=218 Identities=19% Similarity=0.247 Sum_probs=155.5
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCC--CCCCCcceeehhhcccc-HHHHHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKP--SSKNDGDLVLKKATEYG-AVEIWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
+++..++|.+.+.||+|+||.||+|++.... .......+++|...... ..+.....++...+... .|++++.+.+.
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 4456689999999999999999999864321 11112468888876432 22222223333444444 68888888776
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ......+++|||+++++|.+++............ .........++...+..++.|++.||.|||++||+|||||
T Consensus 90 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 90 C-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY----DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred E-ecCCceEEEEecCCCCcHHHHHHhcCCccccccc----ccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 6 4456789999999999999999875421100000 0001123356778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+||++++++ .+||+|||+++.+...... ......+++.|+|||++.+..++.++ |+||||+++|++
T Consensus 165 p~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~~l~el 232 (304)
T cd05101 165 ARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLMWEI 232 (304)
T ss_pred cceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchh----hHHHHHHHHHHH
Confidence 9999999887 9999999999876433221 12234567789999999877666555 599999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=225.99 Aligned_cols=195 Identities=22% Similarity=0.278 Sum_probs=156.9
Q ss_pred ccCCCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeee---ecccc
Q 017820 136 YRKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGF---FENSS 211 (365)
Q Consensus 136 ~~~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~---~~~~~ 211 (365)
-..++|.+. ++||-|-.|.|-.+..+.|+ .++|+|.+.+...... ++........|++|+.+ ++...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~-----ekfALKvL~Ds~KARr----EVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQ-----EKFALKVLLDSPKARR----EVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccch-----hhhHHHHHhcCHHHHh----HhhhhhhhcCCCceEEeehhhhhhc
Confidence 355788886 57999999999999999999 8999999886543322 22223334445665555 55555
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+.+|||.++||.|++-+++++ ...++++.+..|+.||+.|+.|||+.+|.||||||+
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g------------------~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpE 190 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRG------------------DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPE 190 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcc------------------cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChh
Confidence 56688999999999999999999876 235688999999999999999999999999999999
Q ss_pred ceEEecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|....+ ..+||+|||+|+.... ...-.+.+-||.|.|||++...+++...| .||+||++|-|-|
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscd----mwSlgVimYIlLC 258 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCD----MWSLGVIMYILLC 258 (400)
T ss_pred heeeecCCCCcceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCC----ccchhHHHHHhhc
Confidence 99997533 4899999999997543 22345678899999999998888777777 9999999999988
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=232.53 Aligned_cols=210 Identities=16% Similarity=0.142 Sum_probs=157.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCC-----------CCcceeehhhccccHH-HHHHHHHHHHHhhccCCCcee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSK-----------NDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~-----------~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 204 (365)
..++|++.+.||+|+||.||+|.+..++... ....+++|.+...... ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4579999999999999999999987655322 2245788887654322 222223344556666789998
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+++.+ ..+...++++||+.+++|.+++......... .......+++..++.++.|++.||.|||+++|+
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 83 RLLGVC-TVDPPLCMIMEYMENGDLNQFLQKHVAETSG---------LACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred EEEEEE-ecCCCcEEEEecCCCCCHHHHHHhccccccc---------ccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 888766 4457899999999999999998765311000 011223568888999999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||||+||++++++ .++|+|||+++....... .......+++.|+|||++.+...+.++| +||||+++|+|
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----v~slG~~l~el 225 (296)
T cd05051 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD----VWAFGVTLWEI 225 (296)
T ss_pred ccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccch----hhhhHHHHHHH
Confidence 999999999999987 999999999986543322 1223456678999999988766665555 99999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=234.63 Aligned_cols=195 Identities=21% Similarity=0.255 Sum_probs=153.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... .......+...+....|++++.+++.. ..+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG-----KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-QTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC-----cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-ecCC
Confidence 47999999999999999999998877 78888887644322 222333445566667789998887766 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+.+++|.+++.... +..+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili 136 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQP------------------GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL 136 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCC------------------CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE
Confidence 8999999999999999987542 1245778888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc----------------------------cccccccCCCCcCCccccccCCCCCCCCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~----------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~ 347 (365)
+.++ .++|+|||++........ .......||..|+|||++.+...+.
T Consensus 137 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---- 211 (316)
T cd05574 137 HESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS---- 211 (316)
T ss_pred cCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc----
Confidence 9987 999999999875532211 1112357899999999998766554
Q ss_pred chhhhhhhhhheecc
Q 017820 348 APVATALSPVLWQVQ 362 (365)
Q Consensus 348 ~s~~~slg~vlw~lG 362 (365)
.+|+||||+++|+|-
T Consensus 212 ~~Di~slG~ll~~l~ 226 (316)
T cd05574 212 AVDWWTLGILLYEML 226 (316)
T ss_pred hHHHHHHHHHHHHHh
Confidence 455999999999984
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=232.30 Aligned_cols=208 Identities=18% Similarity=0.226 Sum_probs=146.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHh-hccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++.. ..+++|.++.... .......++...+ ....|++++.+++.+ .....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK---MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-ENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCc---ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-ccCCc
Confidence 6899999999999999999998776532 2356665553221 1111122223333 333688888887765 44567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++++||+++++|.+++........ .... .........+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~---~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLET-DPAF---AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG 153 (297)
T ss_pred ceEEEEecCCCcHHHHHHhcccccc-cccc---ccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence 9999999999999999976431100 0000 00011223567888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .+||+|||++....... .......+..|+|||++.+..++.++ |+||||+++|+|
T Consensus 154 ~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~----DvwSlG~il~el 211 (297)
T cd05089 154 ENL-ASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKS----DVWSFGVLLWEI 211 (297)
T ss_pred CCC-eEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchh----hHHHHHHHHHHH
Confidence 877 99999999986432111 11122335679999998776666554 599999999998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=226.58 Aligned_cols=195 Identities=23% Similarity=0.273 Sum_probs=153.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.++... ........++...+....|++++.++..+. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG-----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-ENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC-----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-cCC
Confidence 68999999999999999999998777 778888765321 121222333455666678899988887764 457
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+++++|.+++.... ..+..++++.++.++.|++.||.|||++||+|+||||+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~ 139 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhc----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence 8899999999999999986532 112345778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+.++ .++|+|||+++.+..... ......+++.|+|||.+.+..++.++| +|++|+++|+|
T Consensus 140 ~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~D----i~slG~il~~l 199 (267)
T cd08224 140 TATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSD----IWSLGCLLYEM 199 (267)
T ss_pred CCCC-cEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhc----HHHHHHHHHHH
Confidence 9887 999999999986543321 123457889999999998766665555 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=230.61 Aligned_cols=196 Identities=20% Similarity=0.256 Sum_probs=153.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+++.+ ..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-IEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC-----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-EeCC
Confidence 57899999999999999999998877 77888876543221 112222344556667789998888776 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++++|.+++..... ....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKK----------------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhc----------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 88999999999999998875321 12345788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .++|+|||++......... .....|+..|+|||++.+...+.+ +|+||+|+++|+|-
T Consensus 140 ~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~----~Dv~slG~il~~l~ 200 (267)
T cd08229 140 TATG-VVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFK----SDIWSLGCLLYEMA 200 (267)
T ss_pred cCCC-CEEECcchhhhccccCCcc-cccccCCcCccCHHHhcCCCccch----hhHHHHHHHHHHHH
Confidence 9887 9999999999876433221 234578999999999977666555 45999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=227.82 Aligned_cols=194 Identities=21% Similarity=0.215 Sum_probs=152.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-----cHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+|++.+.||+|+||.||+|.+..++ +.+++|.+... ...+.....++...+....|++++.+++.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTG-----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCC-----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 58999999999999999999998877 77888865421 122223334455666777899998888765433
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 214 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+..+++++||+++++|.+++.... .+++..++.++.|++.||.|||+++++|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~n 136 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--------------------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 357889999999999999987643 24667788999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+++.++ .++|+|||+++....... .......++..|+|||++.+...+.+ +|+||||+++|+|-
T Consensus 137 i~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~~l~ 203 (264)
T cd06653 137 ILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK----ADVWSVACTVVEML 203 (264)
T ss_pred EEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCcc----ccHHHHHHHHHHHH
Confidence 9999877 999999999986543211 11224578999999999977655554 45999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=227.89 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=151.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|.+.+.||+|+||.||+|.+....... ..+++|...... ........++...+....|++++.+++.+. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEK--IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--EN 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCC--cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--CC
Confidence 4578999999999999999999986552211 567888776544 222223333455666677899998887653 34
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili 140 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-------------------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence 5789999999999999997643 134678888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+.++ .+||+|||+++.......+......++..|+|||++.+..++.++| +||||+++|++
T Consensus 141 ~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~il~el 201 (270)
T cd05056 141 SSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASD----VWMFGVCMWEI 201 (270)
T ss_pred ecCC-CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhh----hHHHHHHHHHH
Confidence 9987 9999999999876544333223334567899999987766665555 99999999994
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=226.32 Aligned_cols=196 Identities=18% Similarity=0.230 Sum_probs=150.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++.++||+|+||.||++.+... ..+++|......... ....++...+....|++++.+.+....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~------~~~~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK-- 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCC------ccEEEEecCCChhHH-HHHHHHHHHHHhcCCCCcceEEEEEcC--
Confidence 44668999999999999999999986544 558888776443222 222233445666778888888776543
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...+++|||+++++|.+++.... +...++..+..++.|++.||.|||++|++||||||+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~ 134 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 67899999999999999997643 123466778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .+||+|||+++.+............++..|+|||++.....+.++| +||||+++|++-
T Consensus 135 i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D----i~slG~~l~~l~ 197 (260)
T cd05073 135 VSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD----VWSFGILLMEIV 197 (260)
T ss_pred EcCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCcccc----chHHHHHHHHHH
Confidence 99877 9999999999876543322222345567899999998766655555 999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=229.74 Aligned_cols=199 Identities=17% Similarity=0.201 Sum_probs=146.0
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc-----C
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK-----K 213 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~ 213 (365)
|.+++.||+|+||.||+|.+..++.. ..+++|...... ..+.....++...+....|++++.+++.+.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSI---LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCe---eeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 35788999999999999998776521 357777665331 2222222333445566678888887764322 1
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++++||+.+++|.+++...... .+...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 143 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLG--------------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhccc--------------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhe
Confidence 23578999999999999988543210 0122467888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+++++ .+||+|||+++.+....... .....+++.|+|||++.+..++.++ |+||||+++|+|
T Consensus 144 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~----Di~slG~il~el 207 (272)
T cd05075 144 MLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKS----DVWSFGVTMWEI 207 (272)
T ss_pred EEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHH----HHHHHHHHHHHH
Confidence 999887 99999999998765432211 1223456789999999876666554 599999999998
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=228.44 Aligned_cols=197 Identities=17% Similarity=0.234 Sum_probs=144.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|.+..... ...+++|+++..... ......++...+....|++++.+++.+ ......++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYT---PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-TEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCC---ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCCcEEEEEC
Confidence 468999999999998754321 156888887654322 222333345666777899999988776 445678999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++...... .....++..+..++.|++.||.|||+++++||||||+||+++.++ ++|
T Consensus 77 ~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~k 140 (269)
T cd05087 77 CPLGDLKGYLRSCRKA---------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVK 140 (269)
T ss_pred CCCCcHHHHHHHhhhc---------------ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEE
Confidence 9999999999764310 112335667788999999999999999999999999999999977 999
Q ss_pred EEecccccccccCCcc-ccccccCCCCcCCccccccCCCC---CCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQT---PSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~---~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++........ ......+++.|+|||++.+.... ...+..+|+||||+++|+|
T Consensus 141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05087 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202 (269)
T ss_pred ECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHH
Confidence 9999999754332221 12345678899999998643211 1223456799999999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=232.74 Aligned_cols=189 Identities=14% Similarity=0.106 Sum_probs=147.7
Q ss_pred CCeEEe--eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccccc-
Q 017820 139 DDFVLG--KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK- 212 (365)
Q Consensus 139 ~~y~l~--~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 212 (365)
++++.. ..||+|++|.||+|.+.+ +.|++|.+....... .....++...+....|+|++.+++.+..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIFNN-------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEECC-------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 444444 679999999999999853 779999886543222 2333455667777889999999876543
Q ss_pred -C-CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCC
Q 017820 213 -K-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIK 289 (365)
Q Consensus 213 -~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIK 289 (365)
. ...+++||||+++|+|.+++.... .+++.....++.|++.||.|||+. +++|||||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~--------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk 150 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKEK--------------------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhCC--------------------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence 2 357899999999999999997653 345677788999999999999985 99999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc--CCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM--STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||+++++ .+||+|||+++..... .....||..|+|||++.+ ..++.+ +|+||||+++|+|-+
T Consensus 151 p~nill~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k----~Di~SlGvil~el~~ 217 (283)
T PHA02988 151 SVSFLVTENY-KLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIK----DDIYSLGVVLWEIFT 217 (283)
T ss_pred hhhEEECCCC-cEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccch----hhhhHHHHHHHHHHH
Confidence 9999999987 9999999999865432 234578899999999875 444444 459999999999843
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=228.70 Aligned_cols=196 Identities=18% Similarity=0.214 Sum_probs=152.1
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++.++||+|+||.||+|.+... +.+++|.+........ ...++...+....|++++.+++.. ..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~--~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVV--TQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCC------ceEEEEEecCCCCcHH-HHHHHHHHHHhcCCcCeeeEEEEE--cc
Confidence 34568999999999999999999987653 6688887765433221 222334555666788888887654 34
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+.+++|.+++.... +..+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~ 134 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPE------------------GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence 56899999999999999986543 224577788899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .++|+|||++...............++..|+|||++.+...+.++| +||||+++|++-
T Consensus 135 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D----i~slG~~l~el~ 197 (260)
T cd05067 135 VSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD----VWSFGILLTEIV 197 (260)
T ss_pred EcCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccc----hHHHHHHHHHHH
Confidence 99987 9999999999876533222223345677899999998777666655 999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=229.13 Aligned_cols=197 Identities=15% Similarity=0.157 Sum_probs=150.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.+.||+|+||.||+|.+..++... ..+++|.+..... ........+...+....|++++.+.+.+ ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKRE--IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCc--eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCc
Confidence 368999999999999999999987554222 4688887764332 2222233344555666799999887766 45568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++..... .+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~ 140 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDG-------------------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC
Confidence 8999999999999999876431 346677889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcccc--ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .++|+|||+++.+........ ....++..|+|||++.+...+.++| +|+||+++|++
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D----v~slG~~l~el 202 (267)
T cd05066 141 SNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD----VWSYGIVMWEV 202 (267)
T ss_pred CCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhh----hHHHHHHHHHH
Confidence 887 999999999987654322111 1233456899999998766666555 99999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=248.40 Aligned_cols=208 Identities=15% Similarity=0.150 Sum_probs=170.7
Q ss_pred HHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceee
Q 017820 127 FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYG 205 (365)
Q Consensus 127 ~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~ 205 (365)
+.-+.+..++......|.++||.|.||+||+|+.+..++.. ..||+|.++.... ........+...+.+..||||+.
T Consensus 617 qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre--~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 617 QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKRE--ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcc--eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEE
Confidence 34455667778889999999999999999999999877665 7799999985443 33334445667788999999999
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+.+.. .+.....||+|||++|+|..||..++-.| ..-++.-+++.|+.||+||-+.+.||
T Consensus 695 LEGVV-Tks~PvMIiTEyMENGsLDsFLR~~DGqf-------------------tviQLVgMLrGIAsGMkYLsdm~YVH 754 (996)
T KOG0196|consen 695 LEGVV-TKSKPVMIITEYMENGSLDSFLRQNDGQF-------------------TVIQLVGMLRGIASGMKYLSDMNYVH 754 (996)
T ss_pred EEEEE-ecCceeEEEhhhhhCCcHHHHHhhcCCce-------------------EeehHHHHHHHHHHHhHHHhhcCchh
Confidence 87776 66788999999999999999999887444 44556679999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccC--CCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||...|||++.+- .+|++|||+++.+.++.....++.-| ..+|.|||.+...++|..+| +||+|+||||.
T Consensus 755 RDLAARNILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASD----VWSyGIVmWEV 827 (996)
T KOG0196|consen 755 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASD----VWSYGIVMWEV 827 (996)
T ss_pred hhhhhhheeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhh----ccccceEEEEe
Confidence 99999999999986 99999999999876554222223333 56999999999888888777 99999999996
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=228.09 Aligned_cols=191 Identities=19% Similarity=0.241 Sum_probs=143.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|.+....... ..+++|....... .+.....++...+....|++++.+++.+...+...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQK--IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCce--EEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999976543222 5688888754322 22222223344566678999999888665556678899999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+.+++|.+++..... ..++..+..++.|++.||.|||+++++||||||+|||+++++ .+|
T Consensus 79 ~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~k 138 (262)
T cd05058 79 MKHGDLRNFIRSETH-------------------NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVK 138 (262)
T ss_pred CCCCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEE
Confidence 999999999875431 224556778999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++.+...... ......++..|+|||++.+..++.+ +|+||||+++|+|
T Consensus 139 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~~l~el 195 (262)
T cd05058 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK----SDVWSFGVLLWEL 195 (262)
T ss_pred ECCccccccccCCcceeecccccCcCCccccChhHhccCccchH----HHHHHHHHHHHHH
Confidence 9999999865432111 1123456778999999877665554 5599999999997
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=244.43 Aligned_cols=198 Identities=20% Similarity=0.263 Sum_probs=168.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH-HHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.++......+.++||+|-||+|.+++.... .+||+|++++...... ....++++.+..+.||||+.+++.+ .
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC-~ 605 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGP------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC-V 605 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCc------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee-e
Confidence 345667889999999999999999998773 7899999997665443 5566677888888999999999998 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.++.+++|+||+++|+|.+|+..+..|. .+.....+|+.||+.||.||.+.++|||||.+.|
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt------------------~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPT------------------AETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcc------------------cccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 5678999999999999999999887543 1334455699999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccc-cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|++.++ ++||+|||+++.+-.+..+... ..+...+|||+|.+..++++.++| +|++|+.|||+
T Consensus 668 cLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSD----vWafgvTlwE~ 732 (807)
T KOG1094|consen 668 CLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASD----VWAFGVTLWEV 732 (807)
T ss_pred eeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhh----hhhhHHHHHHH
Confidence 9999988 9999999999987666665443 456678999999999999998888 99999999996
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=230.09 Aligned_cols=186 Identities=20% Similarity=0.228 Sum_probs=148.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|........ ......++...+....|++++.+++.+ ......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTR-----RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-FVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-EECCEE
Confidence 47889999999999999999998887 77888877543221 112222344456667899999988876 445678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 75 SICTEFMDGGSLDVYR------------------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred EEEEecCCCCChHHhh------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 8999999999986542 1256678889999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++..+.... .....||..|+|||++.+..++.++| +||||+++|+|-
T Consensus 131 ~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~D----vwslG~~l~~l~ 187 (279)
T cd06619 131 RG-QVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSD----VWSLGISFMELA 187 (279)
T ss_pred CC-CEEEeeCCcceeccccc---ccCCCCChhhcCceeecCCCCCCcch----HHHHHHHHHHHH
Confidence 87 99999999998654322 23468899999999998776666555 999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=232.16 Aligned_cols=198 Identities=19% Similarity=0.218 Sum_probs=136.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHH--------HHHHHHHhhccCCCcee
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWM--------NERVRRACANCCADFVY 204 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~--------~~~~~~~~~~~~~~~i~ 204 (365)
+..++|++.+.||+|+||.||+|.+..++... ..+++|....... .+... ............|.++.
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~--~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCIN--NQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccc--cceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34579999999999999999999987763211 4455554321111 11110 01112233445677777
Q ss_pred eeecccccCC---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC
Q 017820 205 GFFENSSKKG---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (365)
Q Consensus 205 ~~~~~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~ 281 (365)
.+++...... ...+++++++.. ++.+.+.... ..++..++.++.|++.||.|||++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~ 145 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--------------------CKNKKLIKNIMKDMLTTLEYIHEH 145 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc--------------------cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 7665433222 133567776653 5555554322 125667889999999999999999
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
+|+||||||+|||++.++ .++|+|||+|+.+..... .......||+.|+|||++.+..++.++| +||||
T Consensus 146 ~iiHrDiKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~D----iwSlG 220 (294)
T PHA02882 146 GISHGDIKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGD----LESLG 220 (294)
T ss_pred CeecCCCCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHH----HHHHH
Confidence 999999999999999877 999999999987643221 1112357999999999998877766655 99999
Q ss_pred hhheec
Q 017820 356 PVLWQV 361 (365)
Q Consensus 356 ~vlw~l 361 (365)
+++|+|
T Consensus 221 ~~l~el 226 (294)
T PHA02882 221 YCMLKW 226 (294)
T ss_pred HHHHHH
Confidence 999987
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=225.89 Aligned_cols=189 Identities=18% Similarity=0.239 Sum_probs=150.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|...+ +.+++|+...... .......+...+....|++++.+++.... +..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 74 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRG-------QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNP 74 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecC-------cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCC
Confidence 45789999999999999999998763 6789998876654 22222334455666678899888877643 678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++++|+||||+||+++
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~ 136 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGR------------------AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe
Confidence 9999999999999999876531 1357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .+||+|||.++...... ....++..|+|||++.+..++. .+|+||||+++|++
T Consensus 137 ~~~-~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~----~~Di~slG~il~~l 192 (256)
T cd05039 137 EDL-VAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFST----KSDVWSFGILLWEI 192 (256)
T ss_pred CCC-CEEEccccccccccccc----ccCCCcccccCchhhcCCcCCc----HHHHHHHHHHHHHH
Confidence 987 99999999998763221 1234466899999987766554 45699999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=231.98 Aligned_cols=198 Identities=22% Similarity=0.281 Sum_probs=156.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+..++ ..+++|...............+...+....|++++.+.+.+ ..+...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETG-----LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-FYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCC-----cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-ecCCeE
Confidence 368999999999999999999998776 77888887654443333333344556666799999998876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++...+. .+++..++.++.|++.||.|||+++|+|+||||+||+++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-------------------~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER-------------------GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 999999999999999876431 3577888999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++....... .......+|+.|+|||++..... ....+..+|+||||+++|+|-
T Consensus 139 ~~-~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 139 DG-DVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred CC-CEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 87 99999999987653322 12234678999999999865432 222345677999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=235.64 Aligned_cols=219 Identities=19% Similarity=0.236 Sum_probs=155.4
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCC--CCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeec
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSK--NDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFE 208 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~ 208 (365)
.+++...+|++++.||+|+||.||+|++...+... ....+++|........ ......++...+... .|++++.+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 35556678999999999999999999876533221 1135788877643222 222222333444444 6899998887
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ ..+...++++||+++++|.+++........ ..... ........+++..+..++.|++.||.|||++||+||||
T Consensus 86 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~--~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 86 AC-TQDGPLYVLVEYASKGNLREYLRARRPPGM--DYSFD--TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred EE-ccCCceEEEEecCCCCcHHHHHHhcCCccc--ccccc--cccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 76 445678999999999999999976531100 00000 00012335677888899999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+|||+++++ .+||+|||+++......... .....++..|+|||++.+..++.++ |+||||+++|+|
T Consensus 161 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~il~el 229 (334)
T cd05100 161 AARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLLWEI 229 (334)
T ss_pred ccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchh----hhHHHHHHHHHH
Confidence 99999999887 99999999998764432221 1223445689999999877766655 499999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=229.95 Aligned_cols=182 Identities=19% Similarity=0.261 Sum_probs=139.6
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----H-HHHHHHH-HHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----A-VEIWMNE-RVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~-~~~~~~~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.||+|+||.||++.+..++ +.+++|.+.... . ......+ .+........|+++..+...+ ..++..++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-HTPDKLCF 74 (279)
T ss_pred CcccCCCeEEEEEEECCCC-----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-ecCCeEEE
Confidence 4899999999999998877 778888664321 1 1111122 223344455688887776655 44568999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
||||+.+++|.+++...+ .+++..+..++.|++.||.|||+++|+||||||+|||+++++
T Consensus 75 v~e~~~~~~L~~~i~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~ 134 (279)
T cd05633 75 ILDLMNGGDLHYHLSQHG--------------------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134 (279)
T ss_pred EEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC
Confidence 999999999999887554 357788999999999999999999999999999999999887
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheec
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++|+|||++....... .....||+.|+|||++.+ ..++. .+|+||+|+++|+|
T Consensus 135 -~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~----~~Di~slG~~l~~l 189 (279)
T cd05633 135 -HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDS----SADWFSLGCMLFKL 189 (279)
T ss_pred -CEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCc----hhhhHHHHHHHHHH
Confidence 99999999997654321 234578999999999864 23343 45699999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=227.66 Aligned_cols=196 Identities=17% Similarity=0.222 Sum_probs=152.5
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.+.||+|+||.||+|.+..+ +.+++|.+........ ...++...+....|+++..+++.. ....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 74 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVC-SEEE 74 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC------ceEEEEEecCCccCHH-HHHHHHHHHhhCCCCCEeeeeeee-ecCC
Confidence 4668999999999999999999997654 5688887764432221 122334455667789998888765 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++|||+.+++|.+++.... +..+++..+..++.|++.||.|||+++++|+||||+||++
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili 136 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGE------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccc------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE
Confidence 7899999999999999987643 1235677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++.+............++..|+|||.+.+...+.++| +||+|+++|++-
T Consensus 137 ~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D----i~slG~il~~l~ 198 (261)
T cd05034 137 GENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD----VWSFGILLTEIV 198 (261)
T ss_pred cCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhH----HHHHHHHHHHHH
Confidence 9987 9999999999876543222222334567899999998776665554 999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=232.85 Aligned_cols=219 Identities=20% Similarity=0.248 Sum_probs=153.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCC--CCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeeccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENS 210 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (365)
....++|.+.++||+|+||.||+|++..... ......+++|.+...... .......+...+... .|++++.+++.+
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3455799999999999999999998754221 112256788877643322 222222233344434 589999988766
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+..+++++||+.+++|.+++............. ........+++..+..++.|++.||.|||++||+||||||
T Consensus 88 -~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 88 -TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD----ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred -ccCCceEEEEecCCCCcHHHHHHhcCCCccccccc----ccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 44567899999999999999997753211000000 0011223567888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||+++++ .+||+|||+++......... .....++..|||||++.+..++.++| +||||+++|+|-|
T Consensus 163 ~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----iwslG~~l~el~~ 231 (314)
T cd05099 163 RNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD----VWSFGILMWEIFT 231 (314)
T ss_pred eeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccch----hhHHHHHHHHHHh
Confidence 999999887 99999999998664322211 11223456899999998776666555 9999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=224.19 Aligned_cols=194 Identities=20% Similarity=0.236 Sum_probs=155.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||.+++..++ ..+++|.+.... ........++...+....|++++.+++.+ ..+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD-----SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-MDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC-----cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-ecCCeE
Confidence 5899999999999999999998887 778888765332 22222233445566677899999998887 446789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+++++|.+++.... +..+++..+..++.|++.+|.|||+.+++|+||||+||++++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~ 136 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK 136 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC
Confidence 99999999999999987642 124577888999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .+||+|||+++....... ......+++.|+|||++.+...+.++ |+||+|+++|+|-+
T Consensus 137 ~~-~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~----Dv~slG~i~~~l~~ 196 (256)
T cd08221 137 AG-LIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKS----DIWALGCVLYELLT 196 (256)
T ss_pred CC-CEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcc----hhHHHHHHHHHHHH
Confidence 87 999999999987644332 23456789999999998876665555 49999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=229.60 Aligned_cols=196 Identities=22% Similarity=0.275 Sum_probs=151.3
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
-|++.+.||+|+||.||+|.+..++ ..+++|..............++...+....|++++.+.+.+ ..+...++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETG-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCC-----eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-eeCCEEEE
Confidence 4678899999999999999998877 67777777544433333333344556667899999888766 44578999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
|+||+++++|.+++..... .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 80 v~e~~~~~~l~~~~~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~ 140 (282)
T cd06643 80 LIEFCAGGAVDAVMLELER-------------------PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140 (282)
T ss_pred EEEecCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC
Confidence 9999999999988765331 356778899999999999999999999999999999999887
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||++....... .......+|+.|+|||++..... ....+..+|+||+|+++|+|-
T Consensus 141 -~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 141 -DIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred -CEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 99999999997653322 12344678999999999853321 122334667999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=227.42 Aligned_cols=193 Identities=15% Similarity=0.219 Sum_probs=148.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+..+ ..+++|.......... ...++...+....|++++.++... ....
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~lK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 74 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVV--SEEP 74 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC------ceEEEEEcccCCccHH-HHHHHHHHHHhCCCCCeeeEEEEE--cCCC
Confidence 447899999999999999999998765 4578887764433221 122234455666788888877654 2456
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.+++|||+.+++|.+++.... +...++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 789999999999999997543 11346777889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .++|+|||+++..............++..|+|||++.+...+. .+|+||||+++|+|
T Consensus 137 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~----~~Di~slG~~l~el 196 (260)
T cd05069 137 DNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTEL 196 (260)
T ss_pred CCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcCh----HHHHHHHHHHHHHH
Confidence 987 9999999999876443322222345677899999887665544 45599999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=224.12 Aligned_cols=193 Identities=21% Similarity=0.260 Sum_probs=153.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ ..+++|.+.... ..+......+...+....|++++.+++.. ..+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ-----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-LEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-ecCCEE
Confidence 5899999999999999999998877 778888775432 22233333445566667789988887765 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... +..+++..++.++.|++.+|.|||+++|+|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~ 136 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRC------------------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK 136 (256)
T ss_pred EEEEecCCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 99999999999999997643 123577888999999999999999999999999999999987
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++..+||+|||.++...... ......++..|+|||.+.+...+.++ |+||+|+++|+|-
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~~l~~l~ 195 (256)
T cd08220 137 HKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKS----DIWALGCVLYELA 195 (256)
T ss_pred CCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCccc----chHHHHHHHHHHH
Confidence 66578999999998764332 22346789999999999876666555 4999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=229.32 Aligned_cols=200 Identities=18% Similarity=0.187 Sum_probs=149.6
Q ss_pred CCe-EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC-CC
Q 017820 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-GG 215 (365)
Q Consensus 139 ~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 215 (365)
++| ++.+.||+|+||+||++...... ......+++|....... .......++...+....|++++.+.+.+... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 89999999999999987653221 11115688888764432 1122222345566777899999888765433 35
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.++++|||+++++|.+++.... +++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~---------------------l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili 140 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHK---------------------LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL 140 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE
Confidence 6899999999999999986543 4778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
++++ .+||+|||+++.+..+... ......++..|+|||++.+...+.++| +||||+++|+| ||.|
T Consensus 141 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~D----i~slG~~l~el~tg~~p 209 (283)
T cd05080 141 DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASD----VWSFGVTLYELLTHCDS 209 (283)
T ss_pred cCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccc----cHHHHHHHHHHHhCCCC
Confidence 9987 9999999999876543221 112234566799999998776666555 99999999998 5544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=228.41 Aligned_cols=202 Identities=21% Similarity=0.313 Sum_probs=151.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
..+.|++.+.||+|+||.||+|.+..++ ..+++|..............++........|++++.+++.+..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCC-----cEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3378999999999999999999998877 6788887654332222222222222233368999988776642
Q ss_pred -CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 213 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.+..++++|||+++++|.+++.... +..+++..++.++.|++.||.|||+++|+|+||||+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTK------------------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 2467899999999999999987543 123467778899999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++++++ .++|+|||++........ ......|++.|+|||++.... .....+..+|+||||+++|+|-+
T Consensus 151 nili~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 151 NVLLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred HEEECCCC-CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 99999987 999999999986543221 234567899999999986321 12233445679999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=225.68 Aligned_cols=187 Identities=14% Similarity=0.218 Sum_probs=143.0
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|++..++ +.+++|........ ......++...+....|++++.+++.+ ......++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN-----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCC-----ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCeEEEEee
Confidence 46999999999999998877 77888876543222 112223344456667899999888776 445678999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+.+++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+|
T Consensus 75 ~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~k 134 (252)
T cd05084 75 VQGGDFLTFLRTEG-------------------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLK 134 (252)
T ss_pred ccCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEE
Confidence 99999999986543 1346778889999999999999999999999999999999887 999
Q ss_pred EEecccccccccCCcccc-ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++.......... .....+..|+|||.+.+...+.+ +|+||||+++|+|
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~il~e~ 189 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE----SDVWSFGILLWEA 189 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcCCCCChH----HHHHHHHHHHHHH
Confidence 999999986543221111 11223457999999977765554 5599999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=230.20 Aligned_cols=211 Identities=18% Similarity=0.209 Sum_probs=154.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCC-----------CCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCcee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS-----------SKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----------~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 204 (365)
..++|++.++||+|+||.||++.+..... ......+++|........ ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 44789999999999999999997654211 111145788887654322 122222344556666789998
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+++.+ ..+...+++|||+.+++|.+++........ ........+++..+..++.|++.||.|||++||+
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 83 RLLAVC-ITSDPLCMITEYMENGDLNQFLSRHEPQEA---------AEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred eEEEEE-ecCCccEEEEEeCCCCcHHHHHHhcCcccc---------cccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 888766 445678999999999999999976542110 0012233567788999999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||||||+|||+++++ .++|+|||+++.+....... .....+++.|+|||+..+..++.++| +||||+++|+|-
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D----iwSlG~~l~el~ 226 (296)
T cd05095 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASD----VWAFGVTLWEIL 226 (296)
T ss_pred cccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhh----hhHHHHHHHHHH
Confidence 999999999999877 99999999998654332211 12234567899999988777766655 999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=231.31 Aligned_cols=195 Identities=19% Similarity=0.261 Sum_probs=148.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|++++.+++.. .....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g-----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-HSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC-----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-ccCCce
Confidence 5889999999999999999998887 677888765322111 11112234455566789999888776 455789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+++ +|.+++.... ..+++..++.++.||++||.|||+++|+||||||+||+++.
T Consensus 75 ~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~ 134 (284)
T cd07839 75 TLVFEYCDQ-DLKKYFDSCN-------------------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134 (284)
T ss_pred EEEEecCCC-CHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC
Confidence 999999984 7888776533 13577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
++ .+||+|||+++........ .....+++.|+|||++.+... .+..+|+||||+++|+| |+.|
T Consensus 135 ~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~il~~l~tg~~p 199 (284)
T cd07839 135 NG-ELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRP 199 (284)
T ss_pred CC-cEEECccchhhccCCCCCC-cCCCccccCCcChHHHhCCcc---cCcHHHHHHHHHHHHHHHhcCCC
Confidence 87 9999999999865433221 234567899999999866432 23456799999999998 5544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=232.87 Aligned_cols=195 Identities=17% Similarity=0.230 Sum_probs=150.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.++||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+.+.+ ..+.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-~~~~ 77 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEK 77 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCC-----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-ecCC
Confidence 4589999999999999999999998877 77888877533211 111122344556666789999888876 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++|+||++ ++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+|||+
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~ 137 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCG-------------------NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE
Confidence 8999999998 58988886543 134667788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++....... ......+++.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 138 ~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 138 NERG-ELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred CCCC-cEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCC---CCccHHHHHHHHHHHHHHH
Confidence 9987 999999999976433221 123456789999999986532 1234567999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=226.84 Aligned_cols=188 Identities=15% Similarity=0.146 Sum_probs=140.8
Q ss_pred eeeecCCCeeEEEEEecCCCC-------CCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 145 KKLGEGAFGVVYRASLAKKPS-------SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+.||+|+||.||+|+...+.. ......+++|.+............++...+....|++++.+++.+ ......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVC-VRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCCC
Confidence 468999999999998653321 111235777876554333333333445566777899999998876 345678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+++|||+++++|..++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS-------------------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred EEEEecccCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 99999999999998876543 13467778899999999999999999999999999999987
Q ss_pred CCC------cEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSR------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~------~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++. .++++|||++..... .....++..|+|||++.+ ..++. .+|+||||+++|+|
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~----~~DiwslG~~l~el 202 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSI----AADKWSFGTTLWEI 202 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCc----hhHHHHHHHHHHHH
Confidence 552 389999999876532 234567889999998863 33443 45699999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=225.86 Aligned_cols=194 Identities=21% Similarity=0.202 Sum_probs=151.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+|+..+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|++++.+.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTG-----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCC-----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 47899999999999999999998887 778888765321 12222333445566677899998888765433
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 214 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+..+++++||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n 136 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYG--------------------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN 136 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 467889999999999999987643 24667788899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+++.++ .+||+|||+++.+..... .......++..|+|||++.+..++.++ |+||+|+++|+|-
T Consensus 137 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slG~i~~el~ 203 (266)
T cd06651 137 ILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKA----DVWSLGCTVVEML 203 (266)
T ss_pred EEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchh----hhHHHHHHHHHHH
Confidence 9999887 999999999986543211 111235688999999999876665555 4999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=227.88 Aligned_cols=189 Identities=21% Similarity=0.270 Sum_probs=147.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..|++.+.||+|.||.||+|.-.+++... .+.+|+|+++...+.. ....-+++..++...|+|++.+...+-..+..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 57999999999999999999766654321 3589999998663321 11222456677788899999887777665789
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.|+++||.+. +|.+.++-+.- ++...++...++.|+.||+.|+.|||++=|+||||||.|||+.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~---------------~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRA---------------SKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVM 166 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhcc---------------chhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEe
Confidence 9999999985 88888876542 2334667888999999999999999999999999999999998
Q ss_pred cC----CCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCC
Q 017820 297 EG----SRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSA 345 (365)
Q Consensus 297 ~~----~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~ 345 (365)
.+ | .+||+|||+|+.+...-. +....++-|.+|.|||.+.|.....++
T Consensus 167 gdgperG-~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~A 220 (438)
T KOG0666|consen 167 GDGPERG-RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKA 220 (438)
T ss_pred ccCCccC-eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccch
Confidence 77 5 999999999998765422 233457779999999999988554443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=232.45 Aligned_cols=198 Identities=20% Similarity=0.270 Sum_probs=143.0
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc-cCCCeEEEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-KKGGEYWLIWR 222 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~lV~e 222 (365)
+.+||+|+||.||+|........ +.+++|.+........ ..++...+....|++++.+.+.+. ..+...++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~---~~~a~k~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMS--ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCcc---ceEEEEEecCCCCcHH--HHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 46899999999999997643211 6788888765433222 223455566677899988877653 33467899999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe----cC
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS----EG 298 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~----~~ 298 (365)
|+++ +|.+++....... .......+++..++.++.|++.||.|||+++|+||||||+|||+. .+
T Consensus 81 ~~~~-~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK-----------ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred eeCC-cHHHHHHhhhccc-----------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC
Confidence 9885 7888776432100 011223467888999999999999999999999999999999994 33
Q ss_pred CCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .+||+|||+|+.+..... .......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 149 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 149 G-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred C-cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCC---ccCcHHHHHhHHHHHHHHH
Confidence 4 899999999987644322 1123467899999999987532 1233566999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=228.00 Aligned_cols=183 Identities=19% Similarity=0.227 Sum_probs=141.9
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----H-HH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----A-VE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~-~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.||+|+||.||+|.+..++ +.+++|.+.... . .. ...+..+........|++++.+...+ ..++.+++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HTPDKLSF 74 (278)
T ss_pred CcccCCCeEEEEEEEecCC-----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-ecCCEEEE
Confidence 4899999999999998877 778888765321 1 11 11222233445556788888777665 45578999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
|+||+.+++|.+++...+ .+++..++.++.|++.||.|||+++|+||||||+||+++.++
T Consensus 75 v~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~ 134 (278)
T cd05606 75 ILDLMNGGDLHYHLSQHG--------------------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134 (278)
T ss_pred EEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC
Confidence 999999999999886543 357788999999999999999999999999999999999987
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++.+.... .....|+..|+|||++.+. .++.++ |+||+|+++|+|-
T Consensus 135 -~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~----Di~s~G~~l~~l~ 190 (278)
T cd05606 135 -HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLL 190 (278)
T ss_pred -CEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCccc----chHhHHHHHHHHH
Confidence 99999999998654322 2345789999999998754 344444 5999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=227.91 Aligned_cols=209 Identities=14% Similarity=0.229 Sum_probs=158.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.+.||+|+||.||+|.+..++ ......+++|.+..... .+.....++...+....|++++.+.+.....+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34589999999999999999999987632 11116678887764422 22333334455566678999999888766667
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...+++++|+.+++|.+++...... ....+..+++..++.++.|++.||.|||+++++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil 149 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLG------------EANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhcccc------------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEE
Confidence 7889999999999999998764310 0112345788889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .+||+|||+++.+...... ......++..|+|||++.+..++.++ |+||||+++|++-
T Consensus 150 ~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~----Di~slG~~l~el~ 213 (280)
T cd05043 150 IDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSAS----DVWSFGVLLWELM 213 (280)
T ss_pred EcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchh----hHHHhHHHHHHHh
Confidence 99887 9999999999866433221 12234567789999999877666555 5999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=228.26 Aligned_cols=191 Identities=21% Similarity=0.286 Sum_probs=149.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|........ ......++...+....|++++.+.+.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-RRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC-----cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-eeCCE
Confidence 57999999999999999999998877 77888876533211 111222344556667789999888776 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|..++.... .+++..++.++.|++.+|.|||+++|+|+||||+||+++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~ 134 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR--------------------GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc
Confidence 999999999988887765432 357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .++|+|||++..+..... ......++..|+|||++.+. .++. .+|+||+|+++|+|
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~----~~Di~slG~i~~~l 194 (286)
T cd07847 135 KQG-QIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGP----PVDVWAIGCVFAEL 194 (286)
T ss_pred CCC-cEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCc----hhhhHHHHHHHHHH
Confidence 987 999999999987654322 12345678899999998653 2333 45699999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=225.79 Aligned_cols=198 Identities=16% Similarity=0.161 Sum_probs=150.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|+..+.||+|+||.||+|.+..++... ..+++|.+.... .........+...+....|++++.+.+.. ....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKE--VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-TKFK 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCc--eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-ccCC
Confidence 3468999999999999999999987655322 468888876442 22222233344556677889998888776 4556
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili 140 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-------------------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV 140 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE
Confidence 7899999999999999987543 134667788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccc--cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||++............ ....++.|+|||++.+..++.+ +|+||||+++|++
T Consensus 141 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~----~Dv~slG~il~el 203 (268)
T cd05063 141 NSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA----SDVWSFGIVMWEV 203 (268)
T ss_pred cCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChH----hHHHHHHHHHHHH
Confidence 9877 9999999999866433221111 1223457999999877665555 4599999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=226.66 Aligned_cols=204 Identities=21% Similarity=0.271 Sum_probs=151.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|..............+.........|++++.+.+.+...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDG-----SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCC-----CEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4589999999999999999999998877 77888877543322222222222222233688888877665332
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 214 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
...+++|+||+++++|.++++... ..+..+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~----------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n 158 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLL----------------ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 256899999999999999886421 112345778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++++++ .+||+|||+++.+..... ......|+..|+|||++..... ....+..+|+||||+++|+|-+
T Consensus 159 ili~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 159 ILLTTEG-GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred EEEcCCC-CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 9999987 999999999986543322 2234578999999999865431 2223446669999999999853
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=258.39 Aligned_cols=198 Identities=23% Similarity=0.271 Sum_probs=147.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
.+|+..+.||+||||.||+++++-++ +.+|+|++.-... .......++...+...+|+|++.|+..+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDG-----r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDG-----REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccc-----hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 68999999999999999999999999 7888888875542 23334445677888899999998876553310
Q ss_pred --------------------------------------------------------------------------------
Q 017820 215 -------------------------------------------------------------------------------- 214 (365)
Q Consensus 215 -------------------------------------------------------------------------------- 214 (365)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccc
Q 017820 215 -----------------------------------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259 (365)
Q Consensus 215 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (365)
..+||-||||+..+|.+++..+.+. .
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-------------------~ 694 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-------------------S 694 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-------------------h
Confidence 1234444555544444444433311 0
Q ss_pred cHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEeccccccccc----------------CCc-cccc
Q 017820 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV----------------GIN-YIPK 322 (365)
Q Consensus 260 ~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~----------------~~~-~~~~ 322 (365)
.....+++++||++||.|+|++|||||||||.||++++++ .+||+|||+|+.... +.+ ...+
T Consensus 695 ~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 695 QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 3566889999999999999999999999999999999987 999999999987220 011 1234
Q ss_pred cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 323 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 323 ~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
..+||..|+|||++.+... .+.+.+.|+||||+|++||-
T Consensus 774 s~VGTalYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEML 812 (1351)
T ss_pred cccceeeeecHHHhccccc-ccccchhhhHHHHHHHHHHh
Confidence 5799999999999876652 34455666999999999984
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=224.92 Aligned_cols=186 Identities=16% Similarity=0.156 Sum_probs=142.0
Q ss_pred eeeecCCCeeEEEEEecCCCC-----CCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPS-----SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
+.||+|+||.||+|.+..++. ......+++|........ .....++...+....|++++.+++.+.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 469999999999999987652 122234667765544332 2233334456667789999988887644 56799
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
|+||+++++|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 78 v~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN-------------------NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc-------------------CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence 9999999999999876541 346677889999999999999999999999999999999765
Q ss_pred C------cEEEEecccccccccCCccccccccCCCCcCCccccccC--CCCCCCCCchhhhhhhhhheec
Q 017820 300 R------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS--TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~------~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~d~~s~~~slg~vlw~l 361 (365)
. .+||+|||+++.... .....++..|+|||++.+. ..+. .+|+||||+++|+|
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~----~~Di~slG~~~~~l 199 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTI----AADKWSFGTTLLEI 199 (259)
T ss_pred cccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcch----hhHHHHHHHHHHHH
Confidence 2 599999999987543 2234667789999998765 3443 45699999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=228.94 Aligned_cols=195 Identities=21% Similarity=0.287 Sum_probs=149.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ ..+++|++......+ .....++...+....|++++.+.+.+ ..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-MQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC-----cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-eeCCeE
Confidence 5899999999999999999998877 778888775332111 11222334455556699999988876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||++ ++|.+++.... .+..+++..++.++.|++.||.|||+++|+||||||+||++++
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLP-----------------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred EEEEecCC-CCHHHHHhcCC-----------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence 99999998 58888876532 2235678889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .+||+|||++........ ......+++.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 137 KG-VIKLADFGLARAFGIPVR-VYTHEVVTLWYRAPEVLLGSP---RYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred CC-cEEECcccceeecCCCcc-cccCCcccccccChHHhcCCC---CcCcHHHHHHHHHHHHHHHH
Confidence 87 999999999976533221 122346788999999886542 22346779999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=223.55 Aligned_cols=194 Identities=24% Similarity=0.302 Sum_probs=152.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+...... .......+...+....|++++.+++.. .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG-----ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-VHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC-----cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-ecCCEE
Confidence 5889999999999999999998776 77888887644332 233333445566667889988888765 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+.+++|.+++.... ..++..++.++.|++.||.|||++||+|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~ 134 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGR--------------------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH 134 (264)
T ss_pred EEEEecCCCCcHHHHHhhcC--------------------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 99999999999999987643 2366778889999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCcccc---ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIP---KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||++........... ....+++.|+|||++.+.. ....+..+|+|+||+++|++
T Consensus 135 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l 199 (264)
T cd06626 135 NG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEM 199 (264)
T ss_pred CC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHH
Confidence 77 999999999987654332211 2357788999999987665 11233355699999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=225.28 Aligned_cols=193 Identities=21% Similarity=0.274 Sum_probs=152.2
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----H--HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----A--VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+|+.++.||+|+||.||+|.+..++ ..+++|.+.... . ........+...+....|++++.+++.+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG-----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-CE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC-----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-cc
Confidence 4788899999999999999998887 778888775322 1 1122233345566667899999998876 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
++.+++|+||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni 134 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG--------------------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL 134 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 678999999999999999987643 346778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++.++..+||+|||.+..+..... .......+|..|+|||++.+..++.++| +|++|+++|+|-
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~D----v~slG~~l~~l~ 202 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCD----VWSVGCVIIEMA 202 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccc----hHHHHHHHHHHH
Confidence 9988765799999999987643311 1123457889999999987766655554 999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=232.47 Aligned_cols=190 Identities=20% Similarity=0.273 Sum_probs=149.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+.|.....||+|+||.||++.+..++ +.+++|++............++...+....|++++.+.+.+ ..++..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTG-----KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-LVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCC-----CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-ecCCeEE
Confidence 44555678999999999999998877 77888887544333333333344556667899988887765 4567899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+||||+++++|.+++.... +++..++.++.||+.||.|||+++|+||||||+||+++++
T Consensus 96 lv~e~~~~~~L~~~~~~~~---------------------l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTR---------------------MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred EEEeCCCCCcHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 9999999999999875432 3667788999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ .++|+|||++........ ......|+..|+|||++.+..++.+ +|+||+|+++|+|
T Consensus 155 ~-~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slGvil~el 211 (292)
T cd06658 155 G-RIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTE----VDIWSLGIMVIEM 211 (292)
T ss_pred C-CEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCch----hhHHHHHHHHHHH
Confidence 7 999999999976543322 2234678999999999877666554 5599999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=227.65 Aligned_cols=193 Identities=22% Similarity=0.300 Sum_probs=150.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.+ ..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG-----ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-PHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC-----ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-ecCCee
Confidence 5899999999999999999998877 7788887764331 1112223334455566689988887766 446789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+ +++|.+++..... .+++..++.++.|++.+|.|||+++++|+||||+||++++
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~ 134 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEER-------------------PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA 134 (286)
T ss_pred EEEeccc-CCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC
Confidence 9999999 9999999876431 3577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++...............++..|+|||++.+... .+..+|+|++|+++|+|-
T Consensus 135 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~~l~~l~ 195 (286)
T cd07832 135 DG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195 (286)
T ss_pred CC-cEEEeeeeecccccCCCCCccccccCcccccCceeeecccc---CCchhHHHHHHHHHHHHH
Confidence 77 99999999998765433222234678999999999865322 234567999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=223.30 Aligned_cols=194 Identities=16% Similarity=0.174 Sum_probs=151.1
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|.+..++... ..+++|.+..... .......++...+....|++++.+++.... ..+++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKV--IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCc--eEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEe
Confidence 46899999999999987643211 4588898876555 333334445566777789999988877644 789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++..... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++ .+|
T Consensus 77 ~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~k 137 (257)
T cd05040 77 APLGSLLDRLRKDAL------------------GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVK 137 (257)
T ss_pred cCCCcHHHHHHhccc------------------ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEE
Confidence 999999999876531 2357788899999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 304 IIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 304 L~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
|+|||+++.+...... ......++..|+|||++.+...+.++ |+||||+++|+| |-+|
T Consensus 138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~----Di~slG~~l~el~t~g~~p 200 (257)
T cd05040 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHAS----DVWMFGVTLWEMFTYGEEP 200 (257)
T ss_pred eccccccccccccccceecccCCCCCceecCHHHhcccCcCchh----hhHHHHHHHHHHHhCCCCC
Confidence 9999999876543221 11234677899999998776665555 499999999998 5544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=223.21 Aligned_cols=198 Identities=23% Similarity=0.273 Sum_probs=150.7
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|.+..... ....+++|.+....... .....++...+....|++++.+++.... ...++++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDG--KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCC--CCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEe
Confidence 469999999999999986511 11778888887654432 2233334455555668999888877644 6789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++....... ....+..+++..++.++.|++.||.|||+++|+|+||||+||++++++ .+|
T Consensus 78 ~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~ 145 (262)
T cd00192 78 MEGGDLLDYLRKSRPVF-----------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVK 145 (262)
T ss_pred ccCCcHHHHHhhccccc-----------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEE
Confidence 99999999998752100 001123568889999999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||.++....... .......+++.|+|||++.....+.++ |+||||+++|+|
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~il~~l 200 (262)
T cd00192 146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS----DVWSFGVLLWEI 200 (262)
T ss_pred EcccccccccccccccccccCCCcCccccCHHHhccCCcchhh----ccHHHHHHHHHH
Confidence 999999987654332 122345678899999998877555554 499999999987
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=224.00 Aligned_cols=187 Identities=17% Similarity=0.221 Sum_probs=140.8
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEec
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~ 224 (365)
.||+|+||.||+|.+...+.. ..+++|......... .....++...+....|++++.+++.+ .....++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~---~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQ---IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCc---eeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--cCCCeEEEEEeC
Confidence 489999999999987643211 457888776543322 12233344556667899999888765 345789999999
Q ss_pred CCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEE
Q 017820 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304 (365)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL 304 (365)
++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||
T Consensus 77 ~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl 136 (257)
T cd05115 77 SGGPLNKFLSGKK-------------------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKI 136 (257)
T ss_pred CCCCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEe
Confidence 9999999987543 1357788999999999999999999999999999999999887 9999
Q ss_pred EecccccccccCCcccc--ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 305 IDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 305 ~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||+++.+........ ....+++.|+|||++.+...+.++ |+||||+++|++
T Consensus 137 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~~l~el 191 (257)
T cd05115 137 SDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS----DVWSYGITMWEA 191 (257)
T ss_pred ccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchh----hHHHHHHHHHHH
Confidence 99999986543322111 112335789999998776665554 599999999985
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=228.15 Aligned_cols=195 Identities=20% Similarity=0.206 Sum_probs=146.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+....... .....++...+....|++++.+.+.. ..+..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRING-----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-HTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCC-----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-ecCCe
Confidence 478999999999999999999998887 778888775332111 11222334455666789998887776 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+||+. ++|.+++.... ..+.+..++.++.|++.||.|||+++|+|+||||+|||++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~ 137 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP-------------------GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS 137 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc
Confidence 999999996 67777665432 1235566788999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||+++....... ......+++.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 138 ~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 138 YLG-ELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGAT---DYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred CCC-cEEEeccccccccCCCCC-CCCCccccccccCCceeecCC---CCCcHHHHHHHHHHHHHHHh
Confidence 887 999999999976432211 123456789999999986532 12234679999999999843
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=225.45 Aligned_cols=192 Identities=20% Similarity=0.252 Sum_probs=150.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---------HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---------VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
+|.+.+.||+|+||.||+|.+..++ +.+++|.+..... ......+++...+....|++++.+++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG-----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC-----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 4788999999999999999988776 6788886643211 1112233445556677899999988776
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
......++++||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||
T Consensus 76 -~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p 134 (267)
T cd06628 76 -LDADHLNIFLEYVPGGSVAALLNNYG--------------------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134 (267)
T ss_pred -EeCCccEEEEEecCCCCHHHHHHhcc--------------------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCH
Confidence 44578899999999999999997653 346677889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc-----cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||++++++ .++|+|||.++.+..... .......|+..|+|||++.+...+.++ |+|++|+++|+|-
T Consensus 135 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~----Dv~slG~il~~l~ 206 (267)
T cd06628 135 ANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA----DIWSLGCLVVEML 206 (267)
T ss_pred HHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchh----hhHHHHHHHHHHh
Confidence 999999887 999999999987653211 111235688999999999876665554 5999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=224.47 Aligned_cols=191 Identities=17% Similarity=0.273 Sum_probs=148.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||++...+ +.+++|........+.. .++...+....|++++.+++.... ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~iK~~~~~~~~~~~--~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTG-------QKVAVKNIKCDVTAQAF--LEETAVMTKLHHKNLVRLLGVILH--NG 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCC-------CceEEEeecCcchHHHH--HHHHHHHHhCCCCCcCeEEEEEcC--CC
Confidence 34689999999999999999987533 66888887654433322 223445666778999888877533 34
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~ 134 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRG------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 789999999999999997643 12346777889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec---ccCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV---QCSP 365 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l---Gc~~ 365 (365)
.++ .+||+|||+++...... .....+..|+|||++.+..++.+. |+||||+++|+| |..|
T Consensus 135 ~~~-~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~----Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 135 EDG-VAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKS----DVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred CCC-cEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchh----hHHHHHHHHHHHHhCCCCC
Confidence 987 99999999997643221 223445689999998876666555 499999999997 5554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=223.16 Aligned_cols=192 Identities=15% Similarity=0.246 Sum_probs=147.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..+|++.+.||+|+||.||+|.+... +.+++|.+......+.. ...+...+....|++++.+++.. ......
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~------~~~~~k~~~~~~~~~~~-~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGVC-TERSPI 74 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCC------CeEEEEECCCCCCCHHH-HHHHHHHHHhCCCCCeeeEEEEE-ccCCce
Confidence 46899999999999999999988643 56888877643322221 22234455566788888887765 445688
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+.+++|.+++..... .++++.++.++.|++.+|.|||+++++|+||||+||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRG-------------------KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 999999999999999875431 2466778899999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||+++..............++..|+|||++.+...+.+ +|+|+||+++|+|
T Consensus 136 ~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~----~Dv~slG~~l~el 194 (256)
T cd05112 136 NQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK----SDVWSFGVLMWEV 194 (256)
T ss_pred CC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChH----HHHHHHHHHHHHH
Confidence 77 99999999998654332222223345678999999977665544 5599999999996
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=222.13 Aligned_cols=187 Identities=16% Similarity=0.218 Sum_probs=142.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|.... + +.+++|........+ .....++...+....|++++.+++.+ ......++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~-----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-K-----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-TQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEecC-C-----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-ecCCccEEEEEC
Confidence 468999999999998653 3 678888876543222 11222344455666789988887765 445678999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||++++++ .+|
T Consensus 74 ~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~ 133 (250)
T cd05085 74 VPGGDFLSFLRKKK-------------------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLK 133 (250)
T ss_pred CCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEE
Confidence 99999999886543 1246778889999999999999999999999999999999887 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.....+.........+++.|+|||++.+...+.+ +|+||||+++|++-
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~ll~~~~ 188 (250)
T cd05085 134 ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE----SDVWSYGILLWETF 188 (250)
T ss_pred ECCCccceeccccccccCCCCCCcccccCHHHhccCCCCch----hHHHHHHHHHHHHh
Confidence 99999997654332222223344678999999977665555 45999999999873
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=225.91 Aligned_cols=190 Identities=14% Similarity=0.157 Sum_probs=143.9
Q ss_pred eeeecCCCeeEEEEEecCCCCC--CCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
+.||+|+||.||+|.+..++.. .....+++|..............++...+....|++++.+++.+. .+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-CGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-eCCCcEEEEe
Confidence 4699999999999998665422 223567788776443332223333445566677899988887764 4467889999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCc-
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT- 301 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~- 301 (365)
|+++|+|.+++...+. .+++..++.++.||+.||.|||+++|+||||||+|||++.++..
T Consensus 80 ~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 80 YVKFGSLDTYLKKNKN-------------------LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred cCCCCcHHHHHhcCCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccc
Confidence 9999999999976541 34677788999999999999999999999999999999877632
Q ss_pred ------EEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheeccc
Q 017820 302 ------FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 302 ------ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++++|||++..... .....++..|+|||++.+. ..+.+ +|+||||+++|+|-+
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~----~DiwslG~~l~~l~~ 200 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLA----ADKWSFGTTLWEIFS 200 (258)
T ss_pred cCCCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCch----hhHHHHHHHHHHHHc
Confidence 79999999875432 2345788899999998753 23444 559999999999844
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=230.57 Aligned_cols=199 Identities=17% Similarity=0.143 Sum_probs=151.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|+..+.||+|+||.||+|.+..++... ...+++|......... .....++........|++++.+++.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETV-KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcc-eeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 45679999999999999999999998766332 2356778776443221 1122233455666789999988876533
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+||||||+||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~-------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil 141 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKD-------------------NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL 141 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence 346789999999999999876431 3466778899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .+||+|||+++.+...... ......++..|+|||++.+...+.++ |+||||+++|++
T Consensus 142 l~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~----DiwslG~~l~el 204 (303)
T cd05110 142 VKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS----DVWSYGVTIWEL 204 (303)
T ss_pred ecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHH----HHHHHHHHHHHH
Confidence 99877 9999999999876433221 12234557789999998776655554 599999999996
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=228.07 Aligned_cols=197 Identities=18% Similarity=0.260 Sum_probs=152.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+ .....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTG-----VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-FIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-ecCCeE
Confidence 47899999999999999999998777 778888775432 22222233345556667889999888866 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEe
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~ 296 (365)
++|+||+++++|.+++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVA-----------------TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred EEEEeecCCCCHHHHHHhccc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 999999999999998875320 1235778899999999999999997 5999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCC--CCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT--PSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~--~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||++..+... ......+++.|+|||++.+.... ......+|+||||+++|+|-
T Consensus 138 ~~~-~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~ 201 (286)
T cd06622 138 GNG-QVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201 (286)
T ss_pred CCC-CEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence 977 9999999999865432 22345688899999998665431 12234667999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=225.64 Aligned_cols=198 Identities=18% Similarity=0.162 Sum_probs=151.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+..++... ...+++|........ ......++...+....|++++.+++.+.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~-~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCc-ceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 4578999999999999999999987765322 245788877654322 22223334455566678998888876643 6
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++|+||+.+++|.+++..... .+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~ 142 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKD-------------------NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence 88999999999999999876431 24677889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++.+....... .....++..|+|||.+....++.+ +|+||||+++|++
T Consensus 143 ~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~----~Di~slG~~l~el 204 (279)
T cd05057 143 KTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK----SDVWSYGVTVWEL 204 (279)
T ss_pred cCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch----hhHHHHHHHHHHH
Confidence 9887 99999999998765433211 112234568999999876655554 5599999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=227.58 Aligned_cols=197 Identities=20% Similarity=0.251 Sum_probs=148.0
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
.+.+.||.|.||.||+|.+.. ........|++|.+...... +.....++...+....|++++.+++.+. .....++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-cccccccc
Confidence 578999999999999999983 11222277889988654332 2333333455566669999999998885 55669999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
+||+.+|+|.+++.... ...+++..+..|+.|+++||.|||+++++|+||+++||++++++
T Consensus 80 ~e~~~~g~L~~~L~~~~------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~- 140 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKN------------------KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG- 140 (259)
T ss_dssp EE--TTEBHHHHHHHTC------------------TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-
T ss_pred ccccccccccccccccc------------------cccccccccccccccccccccccccccccccccccccccccccc-
Confidence 99999999999998862 12457788899999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+++....... .......+...|+|||.+.+...+. .+|+||||+++||+-+
T Consensus 141 ~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~----ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 141 QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTK----KSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESH----HHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc----cccccccccccccccc
Confidence 999999999987632211 1223345677899999998877444 5559999999999753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=210.69 Aligned_cols=187 Identities=20% Similarity=0.302 Sum_probs=147.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHH--HHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMN--ERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.+|...++||+|.||+||+|++..+. ..|++|.++-+.+.+..-. .+++-.+....|.||+.+.... ..+..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~-----eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-hsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCcc-----ceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-ccCce
Confidence 35667889999999999999999998 8899999886555443222 2334455666788888887765 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+-+|+|||.. +|..++.+-+ ..++.+.++.++.|+++||.++|+++++|||+||+|+||+
T Consensus 76 ltlvfe~cdq-dlkkyfdsln-------------------g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin 135 (292)
T KOG0662|consen 76 LTLVFEFCDQ-DLKKYFDSLN-------------------GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN 135 (292)
T ss_pred eEEeHHHhhH-HHHHHHHhcC-------------------CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec
Confidence 9999999986 7888776654 3567888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+| ++|++|||+|+.+...... -...+-|.+|.+|.++.+.+....+ +.||+.||
T Consensus 136 ~ng-elkladfglarafgipvrc-ysaevvtlwyrppdvlfgakly~ts----------idmwsagc 190 (292)
T KOG0662|consen 136 RNG-ELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTS----------IDMWSAGC 190 (292)
T ss_pred cCC-cEEecccchhhhcCCceEe-eeceeeeeeccCcceeeeeehhccc----------hHhhhcch
Confidence 998 9999999999987544321 1234669999999999987554333 23777777
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=226.40 Aligned_cols=193 Identities=24% Similarity=0.304 Sum_probs=150.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|+++..+.+.+ ..++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-RRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC-----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-EECCE
Confidence 47999999999999999999998887 788888876432211 12223344555566688888888776 44678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++++||++++.+..+..... .+++..++.++.|++.||.|||+++++|+||||+||+++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~ 134 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG--------------------GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS 134 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 999999999877766554322 357788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||++...............++..|+|||++.+. ..+. .+|+||||+++|+|-
T Consensus 135 ~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~----~~Dv~slG~~l~~l~ 196 (288)
T cd07833 135 ESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK----PVDVWAIGCIMAELL 196 (288)
T ss_pred CCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCc----hhhHHHHHHHHHHHH
Confidence 977 999999999987654433223456788999999999776 4444 556999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=222.02 Aligned_cols=196 Identities=24% Similarity=0.305 Sum_probs=151.7
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
+++.+.||+|+||.||++.+...+. .....+++|........ .......+...+....|++++.+++.... ....++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEE
Confidence 4578899999999999999986431 12266888888755443 22233334455555688999888877644 478999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
+|||+.+++|.+++..... ..+++..+..++.|++.||.|||+++++|+||||+||++++++
T Consensus 79 i~e~~~~~~l~~~~~~~~~------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~ 140 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP------------------KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL 140 (258)
T ss_pred EEeccCCCCHHHHHHhhhh------------------ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC
Confidence 9999999999999876431 1157888999999999999999999999999999999999987
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++|+|||+++..............+++.|+|||.+.+...+.+ +|+|++|+++|+|
T Consensus 141 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~----~Di~slG~i~~~l 197 (258)
T smart00219 141 -VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSK----SDVWSFGVLLWEI 197 (258)
T ss_pred -eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcc----hhHHHHHHHHHHH
Confidence 99999999998776543332223347889999999866655555 4599999999987
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=222.61 Aligned_cols=199 Identities=21% Similarity=0.214 Sum_probs=152.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.+.+.....||+|+||.||+|.+..++ ..+++|..............++...+....|++++.+++.+ ..+...
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 80 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQ-----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-SENGFF 80 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-ccCCEE
Confidence 345555678999999999999988776 77888877655444444444455666777899999988776 455789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+.+++|.+++.....+ ...++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~ 143 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGP-----------------LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143 (268)
T ss_pred EEEEecCCCCCHHHHHHHhccc-----------------CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence 9999999999999998764211 11256678889999999999999999999999999999987
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+...++|+|||++..+..... ......|++.|+|||++.+... ..+..+|+||+|+++|+|-
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~~Dv~slGvvl~~l~ 205 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPR--GYGAPADIWSLGCTIVEMA 205 (268)
T ss_pred CCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccc--cCCchhhhHHHHHHHHHHH
Confidence 445999999999976543221 2233568899999999865432 1234567999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=224.35 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=152.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccccc-CCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK-KGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 216 (365)
++|+..+.||.|++|.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.+.. ....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG-----MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC-----eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence 47999999999999999999998876 7788887764322 122222334556667789999998876533 3457
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~ 139 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVK----------------KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 899999999999999876432 1123457778899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .++|+|||++....... .....++..|+|||.+.+..++.++ |+|+||+++|+|
T Consensus 140 ~~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~----Dv~slG~il~~l 196 (287)
T cd06621 140 RKG-QVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITS----DVWSLGLTLLEV 196 (287)
T ss_pred cCC-eEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchh----hHHHHHHHHHHH
Confidence 987 99999999987654322 2245678899999999877666555 599999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=235.66 Aligned_cols=190 Identities=26% Similarity=0.360 Sum_probs=158.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHH----------HHHHHhhccCCCceeeee
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNE----------RVRRACANCCADFVYGFF 207 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~i~~~~ 207 (365)
.+|..++.+|+|+||.|++|.++... ..|++|.+.+..- .+-|++. .++..+....|+||+.++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~-----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENN-----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ccceeeeeccccccceEEEeeecccc-----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 57999999999999999999999876 8899998864432 2333322 344555666699999988
Q ss_pred cccccCCCeEEEEEEecC-CCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 208 ENSSKKGGEYWLIWRYEG-EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
..+ ++++.+||+||-.+ +.+|+++++.+. .+++..++.|++||+.|+++||++|||||
T Consensus 636 dfF-Eddd~yyl~te~hg~gIDLFd~IE~kp--------------------~m~E~eAk~IFkQV~agi~hlh~~~ivhr 694 (772)
T KOG1152|consen 636 DFF-EDDDYYYLETEVHGEGIDLFDFIEFKP--------------------RMDEPEAKLIFKQVVAGIKHLHDQGIVHR 694 (772)
T ss_pred hee-ecCCeeEEEecCCCCCcchhhhhhccC--------------------ccchHHHHHHHHHHHhccccccccCceec
Confidence 766 66789999999766 458999997664 56888899999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||-+|++++.+| -+||+|||.|.....+. -..++||..|.|||++.|.++-.+.. |+|+||++||..
T Consensus 695 dikdenvivd~~g-~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~q---diwalgillyti 762 (772)
T KOG1152|consen 695 DIKDENVIVDSNG-FVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQ---DIWALGILLYTI 762 (772)
T ss_pred ccccccEEEecCC-eEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcc---hhhhhhheeeEE
Confidence 9999999999998 99999999998766443 35789999999999999999988776 599999999864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=223.16 Aligned_cols=196 Identities=15% Similarity=0.189 Sum_probs=140.6
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
+.||+|+||.||+|....... ...+++|...... ..+.....++........|++++.+++.+ ......++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-VEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCC---cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-cCCCccEEEEec
Confidence 369999999999998654331 1345566554332 22222223334455567899999988876 445688999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++...... ....+...++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 77 ~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~ 139 (268)
T cd05086 77 CELGDLKSYLSQEQWH----------------RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVK 139 (268)
T ss_pred CCCCcHHHHHHhhhcc----------------cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEE
Confidence 9999999999765311 11235567788999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCc-cccccccCCCCcCCccccccCCC---CCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQ---TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~---~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||++........ .......++..|+|||++..... ....+..+|+||||+++|+|
T Consensus 140 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (268)
T cd05086 140 VGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201 (268)
T ss_pred ecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHH
Confidence 999999864322111 11234578899999999864322 12223456799999999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=222.41 Aligned_cols=190 Identities=18% Similarity=0.207 Sum_probs=148.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc------HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+|++.+.||+|+||+||+|.+. ++ ..+++|.+.... ........++...+....|++++.+.+.+ ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~-----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QG-----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-LD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CC-----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-ec
Confidence 5888999999999999999864 33 668888765321 11122233445566777889999988876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++++||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+|+|+||||+||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 133 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG--------------------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence 578999999999999999997643 346778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCC-----ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++++ .++|+|||+++...... ........|+..|+|||++.+...+.+ +|+|+||+++|+|
T Consensus 134 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~----~Dv~slG~~~~~l 201 (265)
T cd06631 134 MLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK----SDIWSIGCTVFEM 201 (265)
T ss_pred EECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcch----hhHHHHHHHHHHH
Confidence 999887 99999999998653211 111234568999999999987666555 4599999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=222.01 Aligned_cols=196 Identities=27% Similarity=0.360 Sum_probs=154.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||.|+||+||+|.+..++ ..+++|...... ........++...+....|++++.+++.. .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN-----EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC-----cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-eeCCEE
Confidence 57999999999999999999988776 678888775332 22333333444556667889999888766 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++|++.+++|.+++..... ...+++..++.++.|++.||.|||++||+|+||||+||++++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP-----------------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 999999999999999976431 124577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++..+...... ......|+..|+|||++... ..+. .+|+|+||+++|+|-
T Consensus 138 ~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~----~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 DG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF----KADIWSFGITAIELA 201 (267)
T ss_pred CC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCc----ccchHhHhHHHHHHH
Confidence 87 9999999999876543222 22345789999999998766 4444 455999999999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=221.09 Aligned_cols=189 Identities=20% Similarity=0.246 Sum_probs=144.4
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
++||+|+||.||+|.+..++... ..+++|........ .......+...+....|++++.+++.. ....++++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKE--VEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC--KGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCc--ceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--cCCceEEEEEe
Confidence 47999999999999886654222 57888887755432 122222334455666789999888754 34568999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+.+++|.+++.... .+++..+..++.|++.+|.|||+++++|+||||+|||++.++ .+|
T Consensus 77 ~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~k 135 (257)
T cd05060 77 APLGPLLKYLKKRR--------------------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAK 135 (257)
T ss_pred CCCCcHHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEE
Confidence 99999999997653 346778899999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccc--cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||+++........... ...++..|+|||.+.+...+.++| +||||+++|++-
T Consensus 136 l~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----i~slG~~l~~~~ 192 (257)
T cd05060 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD----VWSYGVTLWEAF 192 (257)
T ss_pred eccccccceeecCCcccccccCccccccccCHHHhcCCCCCccch----HHHHHHHHHHHH
Confidence 9999999876544322111 223356899999997776665555 999999999873
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=227.58 Aligned_cols=192 Identities=20% Similarity=0.290 Sum_probs=151.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|.+.+.||+|+||.||++.+..++ +.+++|.+............++...+....|++++.+.+.+ .....
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~ 90 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-LVGDE 90 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCC-----CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-eeCCc
Confidence 4579999999999999999999988776 77888887543322222222334455666789998887766 44568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+||+++++|.+++.+.. +++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~---------------------l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTETC---------------------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred EEEEEecCCCCcHHHHHhhcC---------------------CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 899999999999999987543 35667888999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .++|+|||++........ ......+++.|+|||.+.+...+.+ +|+|++|+++|++
T Consensus 150 ~~~-~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~----~Dv~slG~ll~~l 208 (293)
T cd06647 150 MDG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK----VDIWSLGIMAIEM 208 (293)
T ss_pred CCC-CEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCch----hhHHHHHHHHHHH
Confidence 887 999999999876544322 2234578899999999987666555 4599999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=228.26 Aligned_cols=191 Identities=18% Similarity=0.234 Sum_probs=151.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||+||++.+..++ +.+++|........+ .....++...+....|++++.+++.+. ...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 76 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTG-----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-NEN 76 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCC-----cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-cCC
Confidence 4578999999999999999999998877 777887765432211 122223445556667999998887764 447
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVI 294 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NIL 294 (365)
.+++|+||+++++|.+++...+ .+++..+..++.|++.+|.|||+ ++++||||||+||+
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGG--------------------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 8999999999999999886643 34677788999999999999997 68999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++++ .++|+|||++....... .....|+..|+|||++.+...+.++| +||+|+++|++
T Consensus 137 ~~~~~-~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~D----i~slG~~l~~l 195 (284)
T cd06620 137 VNSRG-QIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSD----VWSLGISIIEL 195 (284)
T ss_pred ECCCC-cEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccch----HHHHHHHHHHH
Confidence 99887 99999999987653221 23467899999999987776655555 99999999988
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=226.43 Aligned_cols=194 Identities=21% Similarity=0.279 Sum_probs=150.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|......... .....++...+....|++++.+.+.+ ..+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG-----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC-----CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCCe
Confidence 47999999999999999999998777 778888765432221 11122334556667789988888776 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+||+++++|.++..... .+++..++.++.|++.||.|||+++|+|+||||+||+++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~ 134 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN--------------------GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS 134 (286)
T ss_pred EEEEEecCCccHHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 999999999998887765432 357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++ .++|+|||++..+.... .......++..|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 135 QSG-VVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT---KYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred CCC-cEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhcccc---ccCchHhHHHHHHHHHHHHc
Confidence 987 99999999998764432 2223456889999999986532 22345679999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=225.53 Aligned_cols=188 Identities=16% Similarity=0.109 Sum_probs=137.7
Q ss_pred eeecCCCeeEEEEEecCCCC-------------------CCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeee
Q 017820 146 KLGEGAFGVVYRASLAKKPS-------------------SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGF 206 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~-------------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 206 (365)
.||+|+||.||+|....++. ......+++|.+............++...+....|+|++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998643221 11123477777754333222222233455677789999999
Q ss_pred ecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
++.+ ..+...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||
T Consensus 82 ~~~~-~~~~~~~lv~ey~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 141 (274)
T cd05076 82 HGVC-VRGSENIMVEEFVEHGPLDVCLRKEK-------------------GRVPVAWKITVAQQLASALSYLEDKNLVHG 141 (274)
T ss_pred EEEE-EeCCceEEEEecCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHcCCccCC
Confidence 8876 45568899999999999999886533 134667788999999999999999999999
Q ss_pred CCCCCceEEecCC------CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhee
Q 017820 287 DIKPQNVIFSEGS------RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 287 DIKp~NILl~~~~------~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~ 360 (365)
||||+|||++..+ ..+|++|||++...... ....++..|+|||++.+. ...+..+|+||||+++|+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~---~~~~~~~Dv~slG~~l~e 213 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGG---NSLSTAADKWSFGTTLLE 213 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCC---CCCCcHHHHHHHHHHHHH
Confidence 9999999998643 14899999998653221 234678889999988653 122345569999999999
Q ss_pred c
Q 017820 361 V 361 (365)
Q Consensus 361 l 361 (365)
+
T Consensus 214 l 214 (274)
T cd05076 214 I 214 (274)
T ss_pred H
Confidence 7
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=221.51 Aligned_cols=190 Identities=22% Similarity=0.333 Sum_probs=154.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .....++........|++++.+.+.+ ..+..++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG-----QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-FKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC-----cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-ecCCcEE
Confidence 78999999999999999999998876 7788888765543 22223334455556899999988876 4457899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+|+|+||+|+||+++++
T Consensus 75 l~~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~ 135 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-------------------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE 135 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC
Confidence 9999999999999987543 235778889999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ .++|+|||++........ ......++..|+|||++.+...+.+ +|+|+||+++|+|
T Consensus 136 ~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~----~Di~s~G~il~~l 192 (256)
T cd06612 136 G-QAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNK----ADIWSLGITAIEM 192 (256)
T ss_pred C-cEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCch----hhHHHHHHHHHHH
Confidence 7 999999999987654321 2234568899999999987765554 4599999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=223.07 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=152.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc-cCCCceeeeecccccC--
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKK-- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~-- 213 (365)
..++|++.+.||+|+||.||+|.+..++ ..+++|.............. +...+.. ..|++++.+++.+...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~-e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTG-----QLVAIKIMDIIEDEEEEIKE-EYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCC-----cEEEEEEEecCchhHHHHHH-HHHHHHHhcCCCChheEEEEEEecCC
Confidence 4489999999999999999999998776 67888877654433222222 2333333 3688888877665332
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
+..+++||||+++++|.+++.... ..+..+++..++.++.|++.||.|||+++++|+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p 141 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLR----------------KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 356899999999999999886532 0123457788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
+||++++++ .+||+|||++........ ......|++.|+|||++..... ....+..+|+|+||+++|+|-
T Consensus 142 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 142 QNILLTKNA-EVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred HHEEEccCC-eEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 999999987 999999999986543322 2234678999999999865432 233345677999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=225.45 Aligned_cols=198 Identities=22% Similarity=0.292 Sum_probs=149.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|++++.+++.+ ..+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-HSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC-----cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-ecCCe
Confidence 68999999999999999999998877 778888875432211 11122234455666789999888876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||++ ++|.+++.... ....++..++.++.||+.||.|||+++|+||||||+||+++
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSP------------------DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCC------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 999999997 47888775433 11236677888999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
.++..+||+|||+++....... ......+++.|+|||++.+.. ..+..+|+||+|+++|+| |++|
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~i~~~l~tg~~p 203 (294)
T PLN00009 137 RRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSR---HYSTPVDIWSVGCIFAEMVNQKPL 203 (294)
T ss_pred CCCCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 7655899999999976543221 113346788999999986532 233456799999999998 5544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=238.05 Aligned_cols=216 Identities=18% Similarity=0.216 Sum_probs=169.7
Q ss_pred hhHHHHHHHHHHHhhc-----cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHH
Q 017820 119 FFDMFVLAFVERLFRT-----TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVR 192 (365)
Q Consensus 119 ~~~~~~~~~~~~~~~~-----~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~ 192 (365)
..|.|..-..+.+..+ ++..+...+.++||+|.||.||+|.+........ -.||+|..+.+...+ ......+.
T Consensus 364 etDdYAEI~dety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~-iaVAvKtCK~d~t~d~tekflqEa 442 (974)
T KOG4257|consen 364 ETDDYAEIGDETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGER-IAVAVKTCKTDCTPDDTEKFLQEA 442 (974)
T ss_pred ccchhhhcccccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcc-eeeeeehhccCCChhhHHHHHHHH
Confidence 3455554444443333 2344556667789999999999999876532221 348888887644332 22223345
Q ss_pred HHhhccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHH
Q 017820 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (365)
Q Consensus 193 ~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~ 272 (365)
..+++..|++|+.+.+.+. ....|+|||.++-|.|..|++.+.. .++......++.||+
T Consensus 443 ~iMrnfdHphIikLIGv~~--e~P~WivmEL~~~GELr~yLq~nk~-------------------sL~l~tL~ly~~Qi~ 501 (974)
T KOG4257|consen 443 SIMRNFDHPHIIKLIGVCV--EQPMWIVMELAPLGELREYLQQNKD-------------------SLPLRTLTLYCYQIC 501 (974)
T ss_pred HHHHhCCCcchhheeeeee--ccceeEEEecccchhHHHHHHhccc-------------------cchHHHHHHHHHHHH
Confidence 6678889999999998864 4579999999999999999998763 445666778999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhh
Q 017820 273 FALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (365)
Q Consensus 273 ~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~ 352 (365)
.+|.|||++.+|||||...|||+.+.. -+||+|||+++-+.+...+..........|||||.+.-..++..+| +|
T Consensus 502 talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASD----VW 576 (974)
T KOG4257|consen 502 TALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASD----VW 576 (974)
T ss_pred HHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccccchhhccccccceeecCccccchhcccchhh----HH
Confidence 999999999999999999999999987 9999999999999888888777667778999999998887777666 99
Q ss_pred hhhhhheec
Q 017820 353 ALSPVLWQV 361 (365)
Q Consensus 353 slg~vlw~l 361 (365)
.|||++||.
T Consensus 577 MFgVCmWEI 585 (974)
T KOG4257|consen 577 MFGVCMWEI 585 (974)
T ss_pred HHHHHHHHH
Confidence 999999985
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=226.84 Aligned_cols=195 Identities=19% Similarity=0.224 Sum_probs=149.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+....... .....++...+....|++++.+.+.. ..+.
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 76 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTG-----QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-HTKK 76 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCC-----cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-ecCC
Confidence 3579999999999999999999998777 778888875432111 11122345556666789999888776 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||++
T Consensus 77 ~~~lv~e~~~~-~L~~~~~~~~-------------------~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~ 136 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMDDCG-------------------GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136 (291)
T ss_pred eEEEEEecCCC-CHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE
Confidence 89999999985 8999887543 134677889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++....... ......++..|+|||++.+.. ..+..+|+||+|+++|+|-
T Consensus 137 ~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~il~~l~ 198 (291)
T cd07844 137 SERG-ELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGST---EYSTSLDMWGVGCIFYEMA 198 (291)
T ss_pred cCCC-CEEECccccccccCCCCc-cccccccccccCCcHHhhcCc---ccCcHHHHHHHHHHHHHHH
Confidence 9987 999999999875432211 112345688999999986532 1233566999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=220.80 Aligned_cols=191 Identities=20% Similarity=0.258 Sum_probs=150.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+|+..+.||+|+||.||+|.+..++ ..+++|.+.... .........+...+....|++++.+.+.. ..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG-----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-REE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC-----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-ecC
Confidence 4778899999999999999998776 778888765332 11222333445566677889998888765 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++++||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~ 134 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG--------------------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 78999999999999999987643 3467778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .+||+|||++....... ......|+..|+|||.+.... ..+..+|+|+||+++|+|-
T Consensus 135 ~~~~~-~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~---~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 135 VDTNG-VVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQG---GYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred ECCCC-CEEEccCccceeccccc--cccccCCCcceeCHHHhcCCC---CCCchhhhHHHHHHHHHHH
Confidence 99887 99999999998754332 224567899999999986554 2334566999999999873
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=225.18 Aligned_cols=219 Identities=17% Similarity=0.193 Sum_probs=156.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+.........+.+++|.+...... ......++...+....|++++.+++.+ ..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-AVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-cCCC
Confidence 45789999999999999999999754211112267888887654322 222233345556666889999888766 4556
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhc--cccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLIL--GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+++++||+++++|.+++.............. ...........+++..++.++.|++.||.|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 78999999999999999986532111000000 0000111223567888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++++ .++|+|||+++.+....... .....++..|+|||++.+..++.++| +||||+++|+|
T Consensus 162 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----v~slG~il~el 225 (288)
T cd05050 162 LVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESD----VWAYGVVLWEI 225 (288)
T ss_pred EecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhH----HHHHHHHHHHH
Confidence 999987 99999999998654332211 12334567899999988776666555 99999999998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=224.48 Aligned_cols=192 Identities=25% Similarity=0.394 Sum_probs=154.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||.|+||.||+|.+..++ ..+++|...... ........++...+....|++++.+.+.+ ..+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN-----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-LKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC-----eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-EECCeE
Confidence 47889999999999999999998877 778888775433 22222233345556666799998888765 455789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||++++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG---------------------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 9999999999999998754 2367788999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .++|+|||+++.+..... ......+++.|+|||++.+..++.++| +|+||+++|+|-+
T Consensus 134 ~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sD----v~slG~il~~l~t 193 (274)
T cd06609 134 EG-DVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKAD----IWSLGITAIELAK 193 (274)
T ss_pred CC-CEEEcccccceeeccccc-ccccccCCccccChhhhccCCCCchhh----HHHHHHHHHHHHh
Confidence 87 999999999987754322 234567889999999998777555555 9999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=220.84 Aligned_cols=181 Identities=20% Similarity=0.339 Sum_probs=142.7
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HH-HHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IW-MNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
+.||+|+||.||+|.+..++ +.+++|......... .. ...+.........|++++.+++.+ ..+..+++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG-----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-QSKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC-----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-EcCCeEEEE
Confidence 57999999999999998877 778888876433211 11 111122233444788888888766 456789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
+||+++++|.+++...+ .+++..+..++.|++.||.|||+++++|+||||+||++++++
T Consensus 76 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~- 134 (260)
T cd05611 76 MEYLNGGDCASLIKTLG--------------------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG- 134 (260)
T ss_pred EeccCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-
Confidence 99999999999987654 346778889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++|+|||+++.... .....+++.|+|||++.+...+.+ +|+|+||+++|+|
T Consensus 135 ~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~----~Dv~slG~il~~l 186 (260)
T cd05611 135 HLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKM----SDWWSLGCVIFEF 186 (260)
T ss_pred cEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcch----hhhHHHHHHHHHH
Confidence 999999999976432 234578899999999887665444 5599999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=219.06 Aligned_cols=192 Identities=23% Similarity=0.322 Sum_probs=153.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||++.+..++ +.+++|.+... ...+.....++...+....|++++.+.+.+ ......
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG-----KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-EENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC-----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-cCCCeE
Confidence 5899999999999999999998877 77888876532 122222333445566777899999888776 556789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+.+++|.+++.... ....++..+..++.|++.||.|||+++++|+||+|+||+++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~ 136 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQR------------------GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136 (256)
T ss_pred EEEEecCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 99999999999999887542 123467788899999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .++|+|||++........ ......|++.|+|||++.+...+.++| +|++|+++|+|
T Consensus 137 ~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~D----v~slG~i~~~l 194 (256)
T cd08218 137 DG-TIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSD----IWALGCVLYEM 194 (256)
T ss_pred CC-CEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccc----hhHHHHHHHHH
Confidence 87 999999999986543221 223456889999999998776665555 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=224.59 Aligned_cols=198 Identities=22% Similarity=0.293 Sum_probs=142.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|........+ .....++.......+|++++.+.+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCC-----cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 47999999999999999999998887 778888765432211 111112222222234577777765543322
Q ss_pred ---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 215 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...++||||+++ +|.+++..... ..+..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ 139 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGR---------------GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcc---------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChH
Confidence 248999999996 88888865431 01234678889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+++.++..+||+|||+++.+...... .....+++.|+|||++.+.. ..+..+|+|+||+++|+|
T Consensus 140 nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 140 NLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGST---HYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred HEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCC---CCCchHHHHHHHHHHHHH
Confidence 9999984449999999999865332211 12235688999999886432 223456699999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=221.22 Aligned_cols=190 Identities=20% Similarity=0.273 Sum_probs=153.3
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.++..+ ..+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK-----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC-----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCe
Confidence 5899999999999999999998877 7788887764321 1222233344566677899999887766 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++|+||+.+++|.+++.... .+++..+..++.|+++||.|||+++++|+||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 134 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKV--------------------KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--------------------CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc
Confidence 999999999999999987652 346778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .++|+|||.+....... ......|+..|+|||++.+...+.++| +|+||+++|+|-
T Consensus 135 ~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~D----i~slG~~l~~l~ 193 (258)
T cd05578 135 EQG-HVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVD----WWSLGVTAYECL 193 (258)
T ss_pred CCC-CEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCccc----chhhHHHHHHHH
Confidence 987 99999999998765432 123467888999999998777665555 999999999874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=229.38 Aligned_cols=191 Identities=20% Similarity=0.247 Sum_probs=149.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
..|.....||+|+||.||+|.+..++ +.+++|.+............++...+....|++++.+++.+ ..+...+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-LVGEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCC-----CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-eeCCeEE
Confidence 44555668999999999999998777 77888887543322222233344556667789988888766 4567899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+++||+++++|.+++.... +++..++.++.|++.||.|||+++|+||||||+||+++.+
T Consensus 95 iv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~ 153 (297)
T cd06659 95 VLMEFLQGGALTDIVSQTR---------------------LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153 (297)
T ss_pred EEEecCCCCCHHHHHhhcC---------------------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC
Confidence 9999999999999875432 3677888999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .+||+|||+++.+..... ......|+..|+|||++.+..++.+ +|+||+|+++|+|-
T Consensus 154 ~-~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~il~el~ 211 (297)
T cd06659 154 G-RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTE----VDIWSLGIMVIEMV 211 (297)
T ss_pred C-cEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCch----hhHHHHHHHHHHHH
Confidence 7 999999999976543322 1234678999999999987666554 45999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=222.75 Aligned_cols=185 Identities=20% Similarity=0.167 Sum_probs=144.6
Q ss_pred CCeEEeeee--ecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKL--GEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~L--G~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.+ |+|+||.||++....++ ..+++|........+.... ... ....|++++.+++.+. .+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~e~~---~~~-~~~~h~~iv~~~~~~~-~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNAIEPM---VHQ-LMKDNPNFIKLYYSVT-TLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCC-----cEEEEEEEehhhcchhhHH---HHH-HhhcCCCEEEEEEEEe-cCCe
Confidence 566676665 99999999999998887 6677777654321111111 111 1125888888887763 4568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++.... .+++..++.++.|+++||.|||+.|++||||||+||+++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--------------------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 999999999999999997653 357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++..++|+|||+++..... ....++..|+|||++.+..++.++ |+||+|+++|+|-
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~----DvwslG~il~~l~ 200 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSF----DWWAVGVLTYELL 200 (267)
T ss_pred CCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchh----hHHHHHHHHHHHH
Confidence 87668999999999865422 235689999999999877766554 5999999999874
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=223.04 Aligned_cols=189 Identities=22% Similarity=0.345 Sum_probs=146.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHH---HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVE---IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+ ...+..+...+....|++++.+.+.+ ..+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG-----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-LKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC-----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-eeCC
Confidence 4778899999999999999998877 778888765321 111 11122223333334589999888765 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+++|.+++... .+++..++.++.|++.+|.|||+.||+|+||+|+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~---------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG---------------------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 899999999999999988653 24677788999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .++|+|||++........ ......|+..|+|||++.+.. ++. .+|+|+||+++|+|
T Consensus 135 ~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~~Dv~slG~~l~~l 195 (277)
T cd06917 135 TNTG-NVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDT----KADIWSLGITIYEM 195 (277)
T ss_pred cCCC-CEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCcccc----chhHHHHHHHHHHH
Confidence 9977 999999999987654432 223457899999999986532 334 45599999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=221.22 Aligned_cols=186 Identities=18% Similarity=0.237 Sum_probs=139.9
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
.||+|+||.||+|.+...+.. +.+++|.+....... ......+...+....|++++.+++.. ....+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSE---KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--EAESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCc---eEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCcEEEEec
Confidence 689999999999976533221 678888775432211 11222334455666789998887764 34567899999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++++++ .+|
T Consensus 77 ~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~k 135 (257)
T cd05116 77 AELGPLNKFLQKNK--------------------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAK 135 (257)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEE
Confidence 99999999986543 346778889999999999999999999999999999999977 999
Q ss_pred EEecccccccccCCccc--cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++.+....... .....+++.|+|||++.+...+. .+|+||||+++|+|
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~el 191 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS----KSDVWSFGVLMWEA 191 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCc----hhHHHHHHHHHHHH
Confidence 99999998765432211 12234467999999987655554 45599999999997
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=219.79 Aligned_cols=196 Identities=21% Similarity=0.296 Sum_probs=153.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc-CCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK-KGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 216 (365)
+|++.+.||.|+||.||+|.+..++ ..+++|.+.... ..+......+...+....|++++.+++.... .+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence 5889999999999999999998887 778888765322 2222223334456667788999888765543 4467
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH-----HCCCcccCCCCC
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH-----STGIVHRDIKPQ 291 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH-----~~~IiHrDIKp~ 291 (365)
.++++||+++++|.+++.... .....+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCK----------------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred EEEEehhccCCCHHHHHHHHh----------------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 899999999999999987642 11234677889999999999999999 899999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++++++ .+||+|||+++........ .....+++.|+|||++.+...+.+ +|+|+||+++|+|-
T Consensus 140 nili~~~~-~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~----~Dv~slG~il~~l~ 204 (265)
T cd08217 140 NIFLDANN-NVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEK----SDIWSLGCLIYELC 204 (265)
T ss_pred HEEEecCC-CEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCch----hHHHHHHHHHHHHH
Confidence 99999987 9999999999876543321 234578999999999877665544 55999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=222.69 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=144.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH----HHHHHHHHHHhhcc-CCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE----IWMNERVRRACANC-CADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (365)
+|++.+.||+|+||.||+|.+....... +.+++|.+....... .....++...+... +|++++.+...+ ..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g--~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~ 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSG--KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTD 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCC--ceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-ecC
Confidence 4889999999999999999985321111 668888775432111 11112223333333 578887776555 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQRE--------------------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 68899999999999999987643 3467778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .+||+|||+++..............|+..|+|||++.+... ..+..+|+|+||+++|+|-
T Consensus 138 ~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~~l~~ll 202 (290)
T cd05613 138 LDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG--GHDKAVDWWSMGVLMYELL 202 (290)
T ss_pred ECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCC--CCCccccHHHHHHHHHHHh
Confidence 99987 99999999998765433333345678999999999865321 1123456999999999884
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=220.81 Aligned_cols=194 Identities=17% Similarity=0.182 Sum_probs=148.3
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-------HH---HHHHHHHHHHhhccCCCceeeeecc
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VE---IWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+|.+.+.||+|+||.||+|.+..++ +.+++|.+..... .. ......+...+....|++++.+++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG-----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC-----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 5889999999999999999988777 6777776542111 11 1112233445666678999888876
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+...++|+||+.+++|.+++.... .+++..++.++.|++.||.|||+++++|+|||
T Consensus 77 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 135 (272)
T cd06629 77 E-TTEEYLSIFLEYVPGGSIGSCLRTYG--------------------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK 135 (272)
T ss_pred e-ccCCceEEEEecCCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCC
Confidence 5 45678999999999999999987653 34677788899999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+||++++++ .++|+|||+++....... .......|+..|+|||++.... ...+..+|+||||+++|++-
T Consensus 136 ~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 136 ADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred hhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHHH
Confidence 9999999887 999999999976543211 1123457889999999987654 11233456999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=229.28 Aligned_cols=191 Identities=14% Similarity=0.129 Sum_probs=146.1
Q ss_pred EeeeeecC--CCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 143 LGKKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 143 l~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+.++||+| +|++||++.+..++ +.|++|++.... ........++...+....|++++.+++.+ ..+...+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG-----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-IADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccC-----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EECCEEE
Confidence 56789999 78999999999988 888999876432 22222333345566777899999988776 4557899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|+||+++++|.+++..... ..+++..++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFM------------------DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137 (327)
T ss_pred EEEeccCCCcHHHHHHhhcc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC
Confidence 99999999999999865421 135678889999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCc------cccccccCCCCcCCccccccC--CCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMS--TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~--~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .++++|||.+........ .......++..|+|||++.+. .++. .+|+||+|+++|+|-
T Consensus 138 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----~~DiwslG~il~el~ 204 (327)
T cd08227 138 G-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA----KSDIYSVGITACELA 204 (327)
T ss_pred C-cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCc----hhhHHHHHHHHHHHH
Confidence 7 999999987654321111 011234567789999998753 2333 456999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=229.76 Aligned_cols=190 Identities=19% Similarity=0.269 Sum_probs=147.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTG-----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCC-----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 378999999999999999999999887 788888875321 11111222344556667788888877654322
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
....++|+||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~----------------------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQMD----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhhc----------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 2457999999975 788776532 36677888999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||+++.++ .+||+|||+++...... ......+|+.|+|||++.+..++.++| +||||+++|+|-
T Consensus 147 ~Nil~~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D----vwslG~~l~~l~ 211 (353)
T cd07850 147 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVD----IWSVGCIMGEMI 211 (353)
T ss_pred HHEEECCCC-CEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchh----hHhHHHHHHHHH
Confidence 999999987 99999999998654322 234457889999999998877766655 999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=218.41 Aligned_cols=193 Identities=26% Similarity=0.321 Sum_probs=154.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|++..... ........+...+....|++++.+++.+ .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTG-----KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-YKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-ccCCeE
Confidence 47899999999999999999999877 7888888765543 2222233344455555689999888776 445789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEe
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~ 296 (365)
++|+||+++++|.+++.... .+++..+..++.|++++|.|||+ ++++|+||+|+||+++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVG--------------------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred EEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 99999999999999997643 34778889999999999999999 9999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .++|+|||.+......... .....++..|+|||.+.+...+.+ +|+|+||+++|+|-+
T Consensus 135 ~~~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~----~Dv~slG~il~~l~t 195 (264)
T cd06623 135 SKG-EVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYA----ADIWSLGLTLLECAL 195 (264)
T ss_pred CCC-CEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCch----hhHHHHHHHHHHHHh
Confidence 987 9999999999876543322 234578899999999877655444 559999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=222.73 Aligned_cols=192 Identities=25% Similarity=0.349 Sum_probs=152.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..|+..+.||+|+||.||+|.+..++ ..+++|.+.... ..+.....++...+....|++++.+.+.+ ..+..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-LKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCC-----EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCEE
Confidence 46778899999999999999998877 778888765332 22333333445566667899999888876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++.... +++..+..++.|++.||.|||+++++|+||+|+||+++.
T Consensus 78 ~lv~e~~~~~~L~~~i~~~~---------------------l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAGP---------------------FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEecCCCCcHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 99999999999999886532 356678889999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .++|+|||++..+..... ......++..|+|||++.+...+.+ +|+||||+++|+|-+
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~----~Dv~slG~il~el~t 196 (277)
T cd06640 137 QG-DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSK----ADIWSLGITAIELAK 196 (277)
T ss_pred CC-CEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccH----HHHHHHHHHHHHHHH
Confidence 87 999999999987643321 2234568889999999877665555 459999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=256.36 Aligned_cols=195 Identities=22% Similarity=0.306 Sum_probs=154.9
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|+-+..||.|.||.||-|.+..++ ...|+|.++-... .......+++..+...+|+|++.+++.... .+..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tG-----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTG-----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCcc-----chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHH
Confidence 5677889999999999999999998 6677776653322 122233345677788899999999988744 4678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+|.||||.+|+|.++++..+ ..++...+.+..|++.|+.|||++|||||||||+||+|+.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr--------------------i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~ 1369 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR--------------------IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF 1369 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc--------------------hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec
Confidence 89999999999999998754 3467778889999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccc---cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPK---EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+| .+|+.|||.|..+.......++ ...||+.|||||++.+......- -+.|+||||.|+-||-
T Consensus 1370 ~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~-~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1370 NG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHG-GAADIWSLGCVVLEMA 1435 (1509)
T ss_pred CC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCC-cchhhhcccceEEEee
Confidence 88 9999999999988765432222 47899999999999766433222 2456888888887774
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=225.16 Aligned_cols=191 Identities=26% Similarity=0.364 Sum_probs=151.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+.|+..+.||+|+||.||+|.+..++ ..+++|...... ........++...+....|++++.+.+.+ ..+..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-LKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCC-----eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-ccCCce
Confidence 45667888999999999999998776 678888776333 22222333445566667899999888776 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||||+||++++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~ 136 (277)
T cd06642 78 WIIMEYLGGGSALDLLKPG---------------------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEEccCCCcHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence 9999999999999988543 2466788899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||++..+..... ......++..|+|||++.+..++.+ +|+||||+++|+|-
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~Dv~slG~il~el~ 195 (277)
T cd06642 137 QG-DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFK----ADIWSLGITAIELA 195 (277)
T ss_pred CC-CEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchh----hhHHHHHHHHHHHH
Confidence 87 999999999987643321 2234578899999999987765554 55999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=218.18 Aligned_cols=193 Identities=23% Similarity=0.326 Sum_probs=152.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|++++.+++.+ ..+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS-----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC-----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeE
Confidence 5889999999999999999999887 678888765431 11222223345566677789999888765 556789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+.+++|.+++.... +..+++..+..++.|++.||.|||+++++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~ 136 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQR------------------GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK 136 (257)
T ss_pred EEEEecCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC
Confidence 99999999999999987543 123477888999999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++..+||+|||.+........ ......|++.|+|||++.+...+.+ +|+|++|+++|++
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~----~Dv~slG~il~~l 195 (257)
T cd08225 137 NGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNK----TDIWSLGCVLYEL 195 (257)
T ss_pred CCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCch----hhHHHHHHHHHHH
Confidence 865689999999987653322 2234568999999999877666555 4599999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=216.31 Aligned_cols=195 Identities=23% Similarity=0.306 Sum_probs=154.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||++.+..++ ..+++|.+..... .......++...+....|++++.+.+.. ..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG-----KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-EEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC-----cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-ecCCEE
Confidence 5889999999999999999998776 7788888764432 2222233344556666688888887766 344789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... ..+..+++..+..++.|++.||.|||++|++|+||+|+||++++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~ 138 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQK----------------KEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS 138 (258)
T ss_pred EEEEEecCCCcHHHHHHHhh----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC
Confidence 99999999999999987642 12235678889999999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||.+....... .......|++.|+|||.+.+...+.+.| +|++|+++|+|-
T Consensus 139 ~~-~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~D----v~slG~~~~~l~ 197 (258)
T cd08215 139 NG-LVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSD----IWSLGCVLYELC 197 (258)
T ss_pred CC-cEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCcccc----HHHHHHHHHHHH
Confidence 77 99999999998764432 2234567899999999988777666555 999999999883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=228.28 Aligned_cols=192 Identities=21% Similarity=0.269 Sum_probs=145.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
.++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ......++...+....|++++.+.+....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTG-----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCC-----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 378999999999999999999998887 78899987643221 11222234455566668888877654322
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.....++++||+++ +|.+++... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~~---------------------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~N 136 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKTQ---------------------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSN 136 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 22468999999985 787777543 34677889999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+++.++ .+||+|||+++........ ......||+.|+|||++.+. .++. .+|+||+|+++|+|
T Consensus 137 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~~DvwslGvil~el 203 (336)
T cd07849 137 LLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTK----AIDIWSVGCILAEM 203 (336)
T ss_pred EEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCc----HHHHHHHHHHHHHH
Confidence 9999987 9999999999865433221 11345789999999987543 3333 45699999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=215.04 Aligned_cols=195 Identities=18% Similarity=0.214 Sum_probs=149.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH--HHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE--RVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++.++...||.|+.|+|++++...++ ...|+|+++.....+....- .+.-.+....-++|+..++.+ ..+.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~-----~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-i~n~ 164 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTG-----HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-ITNT 164 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccc-----eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-eeCc
Confidence 456777788999999999999999998 89999999877665543222 122223333468888888887 4455
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCceE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVI 294 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NIL 294 (365)
..++.||.+.. -+..++..... .+++..+-++...++.||.||.++ |||||||||+|||
T Consensus 165 dV~IcMelMs~-C~ekLlkrik~-------------------piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL 224 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKRIKG-------------------PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 224 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHHhcC-------------------CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence 67777777653 23344443332 357788888999999999999865 7999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|+.| ++||||||.+-.+.++... +...|-+.|||||.+.- +..++-|..+|+||||+.|+||.
T Consensus 225 lDe~G-niKlCDFGIsGrlvdSkAh--trsAGC~~YMaPERidp-~~~~kYDiRaDVWSlGITlveLa 288 (391)
T KOG0983|consen 225 LDERG-NIKLCDFGISGRLVDSKAH--TRSAGCAAYMAPERIDP-PDKPKYDIRADVWSLGITLVELA 288 (391)
T ss_pred EccCC-CEEeecccccceeeccccc--ccccCCccccCccccCC-CCCCccchhhhhhhhccchhhhh
Confidence 99998 9999999999877655433 44678899999999753 33677888999999999999984
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=217.05 Aligned_cols=194 Identities=18% Similarity=0.210 Sum_probs=151.7
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHH-hhccCCCceeeeecccccCCCeEEEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRA-CANCCADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
.+.||+|+|+.|--+....++ ..+++|.+.+.........-++... ..-..|+||+.+++.+ +++..+|||+|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~-----~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTG-----KEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccc-----hhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEEEEe
Confidence 357999999999999999998 8889998876654443333333333 4445699999988877 66789999999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC--C
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS--R 300 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~--~ 300 (365)
-+.||+|.+.++.+. .+++..+.++.++|+.||++||.+||.|||+||+|||-...+ .
T Consensus 157 Km~GGplLshI~~~~--------------------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRK--------------------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred cccCchHHHHHHHhh--------------------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC
Confidence 999999999998876 468888999999999999999999999999999999987544 2
Q ss_pred cEEEEecccccccccCCccc------cccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINYI------PKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~~------~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
-+|||||.++.-+..+.... -.+.+|+..|||||++.-- ......|...|.||||+++|-|-|
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 68999999987554332211 1247888899999997532 223344557779999999998854
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=224.17 Aligned_cols=191 Identities=21% Similarity=0.273 Sum_probs=148.2
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-----HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|++...... .......+...+....|++++.+++.+.. +
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG-----RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-K 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC-----cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-C
Confidence 4889999999999999999998877 78888887644322 11112223445556678898888877644 6
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+ +++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+||+
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~-------------------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 134 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKS-------------------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence 7899999999 889999987543 13577888899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.++ .++|+|||+++....... ......+++.|+|||++.+.. .....+|+|+||+++|+|
T Consensus 135 l~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 135 IASDG-VLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGAR---HYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred EcCCC-CEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCC---CCCcHHHHHHHHHHHHHH
Confidence 99987 999999999987654321 123346688999999885432 123456799999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=220.27 Aligned_cols=192 Identities=26% Similarity=0.352 Sum_probs=151.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+-|++.+.||+|+||.||+|.+..++ ..+++|....... .......++...+....|++++.+++.+ ..+..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-LKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCC-----cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-EeCCeE
Confidence 35778899999999999999988776 7788887653322 2222333445566667899999998876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++... .+++..+..++.|++.+|.|||+++++|+||||+||+++.
T Consensus 78 ~lv~e~~~~~~l~~~i~~~---------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG---------------------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC
Confidence 9999999999999988643 2367778899999999999999999999999999999998
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .++|+|||++..+.... .......++..|+|||++.+...+.+ +|+||||+++|+|-+
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~----~Dv~slG~~l~~l~~ 196 (277)
T cd06641 137 HG-EVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSK----ADIWSLGITAIELAK 196 (277)
T ss_pred CC-CEEEeecccceecccch-hhhccccCCccccChhhhccCCCCch----hhHHHHHHHHHHHHc
Confidence 87 99999999997654322 11234578899999999877655544 559999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=235.50 Aligned_cols=195 Identities=20% Similarity=0.298 Sum_probs=161.2
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..+...++++...||-||||.|-++..+... ..+|+|.++..-- .+......+.+.+..++.++|+.++..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccc-----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 4456678889999999999999999988765 3477776654322 2222222334555666688898888776
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.++...|++||-|-||.|...+.+++ .+++...+.++..+++|++|||++|||+|||||
T Consensus 490 -rd~kyvYmLmEaClGGElWTiLrdRg--------------------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 490 -RDSKYVYMLMEACLGGELWTILRDRG--------------------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred -ccchhhhhhHHhhcCchhhhhhhhcC--------------------CcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 66678999999999999999998876 567788899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|+|++.+| -+||.|||.|+.+..+. ...+++|||.|.|||++.+...+...| .|+||+++|||
T Consensus 549 ENllLd~~G-y~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avD----yWaLGIli~EL 612 (732)
T KOG0614|consen 549 ENLLLDNRG-YLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVD----YWALGILIYEL 612 (732)
T ss_pred hheeeccCC-ceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhH----HHHHHHHHHHH
Confidence 999999998 99999999999987654 346899999999999999888877777 99999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=206.06 Aligned_cols=200 Identities=21% Similarity=0.268 Sum_probs=156.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH--HHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++..-+..||+|++|.|-+-+...++ ...|+|.+...-..+. ....++-...+...-++++.|++.. .+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg-----~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-~re 117 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSG-----TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-FRE 117 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCC-----eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-hcc
Confidence 4467777889999999999999999888 8889998874433221 1222223334555678899999977 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NI 293 (365)
...|+.||.+.. ||..+..+- +.++...++..+-+|+..+++||.|||++ .|||||+||+||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v----------------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKV----------------LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI 180 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHH----------------HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence 689999999874 665554332 34566788999999999999999999987 899999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+.+| ++||||||.+-.+.++... +--.|---|||||.+........-+..||+||||+.+.||.
T Consensus 181 LIn~~G-qVKiCDFGIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 181 LINYDG-QVKICDFGISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred EEccCC-cEEEcccccceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 999998 9999999999877654332 12466778999999987777767778999999999999985
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=219.98 Aligned_cols=203 Identities=18% Similarity=0.230 Sum_probs=141.8
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecccccCCCeEEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
+.||+|+||.||+|.+..++.. ..+++|....... .......++...+... .|++++.+++.+ .....++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCe---eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-ecCCCceEEEE
Confidence 3689999999999999876522 2456776664322 1112222233333333 788998888776 44567899999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcE
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~i 302 (365)
|+.+++|.+++............ .........++++.++.++.|++.||.|||++|++||||||+|||+++++ .+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~ 151 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAF----AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA 151 (270)
T ss_pred eCCCCcHHHHHHhcccccccccc----ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eE
Confidence 99999999999765321000000 00111223567888999999999999999999999999999999999987 99
Q ss_pred EEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++...... ........+..|+|||++.+..++.++ |+||||+++|+|-
T Consensus 152 kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~----Di~slG~il~el~ 205 (270)
T cd05047 152 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNS----DVWSYGVLLWEIV 205 (270)
T ss_pred EECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchh----hHHHHHHHHHHHH
Confidence 99999998642211 111122345689999998766665554 5999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=232.98 Aligned_cols=200 Identities=17% Similarity=0.228 Sum_probs=162.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+|++...+.....+||-|.||+||.|.|+.-. -.|++|.++++...-. ...++...+....|+|++.+++.+ .
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkys-----lTvAVKtLKEDtMeve-EFLkEAAvMKeikHpNLVqLLGVC-T 333 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC-T 333 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccc-----eeeehhhhhhcchhHH-HHHHHHHHHHhhcCccHHHHhhhh-c
Confidence 45556678888999999999999999998866 6789999987654322 222334556677899999999988 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+|||+|||..|+|.+|+.+.+ ....+.-.+..++.||..||+||..+++|||||...|
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecn------------------r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN 395 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECN------------------RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 395 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhc------------------hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 6678999999999999999998765 2234556677899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|+.++. .+|++|||+++.+..+...-.....-...|.|||-+.-..+..++| +|+|||+|||+.
T Consensus 396 CLVgEnh-iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSD----VWAFGVLLWEIA 460 (1157)
T KOG4278|consen 396 CLVGENH-IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD----VWAFGVLLWEIA 460 (1157)
T ss_pred ccccccc-eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchh----hHHHHHHHHHHH
Confidence 9999987 9999999999988765443222334467899999998888877777 999999999973
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=218.04 Aligned_cols=182 Identities=22% Similarity=0.314 Sum_probs=146.1
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||.|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.. ..+..+++++||
T Consensus 1 lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN-----RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-KDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-EcCCccEEEEec
Confidence 699999999999998776 7888888754321 1222233345566677899999988765 456789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~ 133 (262)
T cd05572 75 CLGGELWTILRDRG--------------------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVK 133 (262)
T ss_pred CCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEE
Confidence 99999999997653 246777889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+|||+++...... ......+++.|+|||++.+..++.+ +|+|++|+++|++
T Consensus 134 l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~----~Di~slG~il~~l 185 (262)
T cd05572 134 LVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFS----VDYWSLGILLYEL 185 (262)
T ss_pred EeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCCh----hhhhhhHHHHHHH
Confidence 99999998765432 2234578999999999877666554 4599999999987
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=214.83 Aligned_cols=191 Identities=21% Similarity=0.298 Sum_probs=152.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||++.+..++ +.+++|....... .......++...+....|+++..+.+.. ..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG-----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-ETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC-----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-EeCCEE
Confidence 5889999999999999999998777 7788888765543 2223333444555566788888877665 445789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++++||+++++|.+++.... .+++..+..++.|++.+|.|||++||+|+||||+||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 134 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG--------------------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC
Confidence 99999999999999987653 3577888999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .++|+|||.+......... .....++..|+|||.+.+... +..+|+|++|+++|+|-
T Consensus 135 ~~-~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~----~~~~Dv~~lG~~l~~l~ 193 (254)
T cd06627 135 DG-VVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGA----STASDIWSLGCTVIELL 193 (254)
T ss_pred CC-CEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCC----CcchhHHHHHHHHHHHH
Confidence 77 9999999999876543322 234678999999999876553 34566999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.07 Aligned_cols=187 Identities=16% Similarity=0.222 Sum_probs=144.4
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
++||+|+||.||+|.+.. + +.+++|........ .......+...+....|+++..+++.+ ......++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~-----~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N-----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-VQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-C-----CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-ecCCCeEEEEEc
Confidence 469999999999999877 5 78899887654332 222233345566777899998887766 455688999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++..... .+++..+..++.|++.+|.|||+++++||||||+||+++.++ .+|
T Consensus 74 ~~~~~l~~~l~~~~~-------------------~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~ 133 (251)
T cd05041 74 VPGGSLLTFLRKKKN-------------------RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLK 133 (251)
T ss_pred CCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEE
Confidence 999999999865431 346677888999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCcccc-ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||+++.......... ....++..|+|||++.+...+.++| +||||+++|+|-
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D----i~slG~i~~~l~ 189 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD----VWSYGILLWETF 189 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchh----HHHHHHHHHHHH
Confidence 999999986543221111 1223456799999988776665555 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=219.26 Aligned_cols=200 Identities=21% Similarity=0.203 Sum_probs=151.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc-CCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK-KGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~ 215 (365)
.++|++.+.||+|+||.||+|.+...+ ....+.+++|.+...... ......++...+....|++++.+.+.... .+.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 468889999999999999999975431 111267889888755442 22223334445566678888887765433 245
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-------------------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~ 142 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-------------------DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-------------------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 7899999999999999997653 135777888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-c-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-I-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .++|+|||++......... . .....++..|+|||++.+...+.++| +||||+++|+|-
T Consensus 143 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D----i~slG~~l~el~ 206 (284)
T cd05038 143 ESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD----VWSFGVTLYELF 206 (284)
T ss_pred cCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccc----hHHHhhhhheee
Confidence 9987 9999999999876533221 1 11234566799999998776655555 999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=220.65 Aligned_cols=192 Identities=19% Similarity=0.242 Sum_probs=150.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
.+|.-.+.||+|+||.||++.+..++ ..+++|+.............++...+....|++++.+++.+ ..+...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-~~~~~~~ 92 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTG-----RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-LVGDELW 92 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-EcCCeEE
Confidence 35666789999999999999988776 77888877543332222223334455666788988888765 4567889
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+++||+.+++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 93 ~v~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 93 VVMEFLEGGALTDIVTHT---------------------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred EEEeccCCCCHHHHHHhC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 999999999999988763 23667788999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ .++|+|||.+........ ......|++.|+|||++.+..++.++ |+|+||+++|+|-+
T Consensus 152 ~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~----Dv~slGv~l~ell~ 210 (285)
T cd06648 152 G-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEV----DIWSLGIMVIEMVD 210 (285)
T ss_pred C-cEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcc----cHHHHHHHHHHHHh
Confidence 7 999999999876543322 12345789999999998776665554 59999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=219.71 Aligned_cols=194 Identities=21% Similarity=0.255 Sum_probs=147.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecC-CCCCCCCcceeehhhcccc----------HHHHHHHHHHHH-HhhccCCCceeeee
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAK-KPSSKNDGDLVLKKATEYG----------AVEIWMNERVRR-ACANCCADFVYGFF 207 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~-~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~i~~~~ 207 (365)
+|++.+.||+|+||.||+|.+.. ++ +.+++|.+.... .........+.. ......|++++.++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~-----~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQ-----NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCC-----ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence 47889999999999999999987 44 567777654221 111111112222 23346789999888
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHR 286 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHr 286 (365)
+.+ ..++..++++||+++++|.+++.... ..+..+++..++.++.|++.+|.|||+ .+++|+
T Consensus 76 ~~~-~~~~~~~lv~e~~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~ 138 (269)
T cd08528 76 KTF-LENDRLYIVMDLIEGAPLGEHFNSLK----------------EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR 138 (269)
T ss_pred eeE-ccCCeEEEEEecCCCCcHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHhccCCceeec
Confidence 876 45678999999999999999886422 112346778899999999999999996 689999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||||+||++++++ .+||+|||++....... ......|+..|+|||++.+..++. .+|+||||+++|+|-
T Consensus 139 dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~----~~Dv~slG~ll~~l~ 207 (269)
T cd08528 139 DLTPNNIMLGEDD-KVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGE----KADVWAFGCILYQMC 207 (269)
T ss_pred CCCHHHEEECCCC-cEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCch----HHHHHHHHHHHHHHH
Confidence 9999999999987 99999999998654332 224567899999999998765544 455999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=221.10 Aligned_cols=192 Identities=22% Similarity=0.289 Sum_probs=151.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|+++..+++.+ ..+..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTG-----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-YNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCC-----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-ecCCEE
Confidence 47888999999999999999998877 77888877654322 222222334445556689988887766 445789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEe
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~ 296 (365)
++++||+++++|.+++.... ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-------------------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-------------------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 99999999999999987652 134677788999999999999999 9999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++ .++|+|||.+..+..... ....++..|+|||++.+..++.+ +|+||||+++|+|-+
T Consensus 136 ~~~-~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~----~Dv~slG~~l~~l~~ 194 (265)
T cd06605 136 SRG-QIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVK----SDIWSLGLSLIELAT 194 (265)
T ss_pred CCC-CEEEeecccchhhHHHHh---hcccCChhccCHHHHcCCCCCch----hhHHHHHHHHHHHHh
Confidence 977 999999999976643222 22678899999999987755554 559999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=220.22 Aligned_cols=197 Identities=20% Similarity=0.249 Sum_probs=146.2
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH----HHHHHHHHHHHhhcc-CCCceeeeecccccCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (365)
+|++.+.||+|+||.||++.+....... ..+++|.+...... .......+...+... +|+++..+.+.+ ..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~--~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~~~ 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAG--KLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-QTD 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCC--cEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-ecC
Confidence 4889999999999999999875432211 56788876533211 111112223333333 588888776655 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.+++.... .+++..++.++.|++++|.|||+.+++||||||+||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQRE--------------------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC--------------------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 78899999999999999886543 3467778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .++|+|||+++.+............|+..|+|||.+.+... ..+..+|+|+||+++|+|-
T Consensus 138 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~il~el~ 202 (288)
T cd05583 138 LDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG--GHDKAVDWWSLGVLTFELL 202 (288)
T ss_pred ECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCC--CCcchhhhHHHHHHHHHHH
Confidence 99987 99999999998765443333344678999999999876541 1233566999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=220.20 Aligned_cols=192 Identities=22% Similarity=0.270 Sum_probs=148.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|++......+ ......+...+....|++++.+++.. ..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCC-----CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-ccCCcE
Confidence 5889999999999999999998877 778888775332111 11222345566667899999988876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+. ++|.+++.... +..+++..++.++.|++.||.|||+++++|+||||+||++++
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~ 135 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASP------------------LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 135 (284)
T ss_pred EEEeeccc-cCHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 99999996 58888876532 224577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++ .+||+|||+++.+..... ......+++.|+|||++.+... .+..+|+|+||+++|+|
T Consensus 136 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~---~~~~~Dv~slG~il~~l 194 (284)
T cd07860 136 EG-AIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEM 194 (284)
T ss_pred CC-CEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCC---CCcHHHHHHHHHHHHHH
Confidence 87 999999999986543321 1223467889999998865432 23457799999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=214.93 Aligned_cols=194 Identities=25% Similarity=0.308 Sum_probs=152.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|++.++||+|+||.||++.+..++ +.+++|.+.... ..+.....++...+....|++++.+.+.+ ..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN-----QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-LDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC-----CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-ccCCEE
Confidence 5889999999999999999998877 778888775432 22222222334555666688888887666 445789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... ..+..+++..++.++.|++.||.|||+.|++|+||||+||++++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~ 138 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRK----------------KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA 138 (256)
T ss_pred EEEehhcCCCCHHHHHHHHH----------------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec
Confidence 99999999999999987632 11234577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .+||+|||+++..... ......+++.|+|||.+.+...+.++ |+|++|+++|+|-+
T Consensus 139 ~~-~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~----D~~slG~~~~~l~~ 196 (256)
T cd08530 139 ND-LVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKS----DIWSLGCLLYEMAT 196 (256)
T ss_pred CC-cEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchh----hHHHHHHHHHHHHh
Confidence 77 9999999999876544 22345688999999999876665554 59999999999843
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=224.65 Aligned_cols=199 Identities=19% Similarity=0.234 Sum_probs=148.3
Q ss_pred CeEEeeeeecCCCeeEEEEEecC--CCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAK--KPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~--~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
+|++.++||+|+||.||+|.+.. ++ +.+++|.+.... ........++...+....|++++.+.+.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDG-----KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCC-----CeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 48899999999999999999987 55 788888877522 11111122234456666788888887776443
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++||||+++ +|.+++..... .....+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Ni 139 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQ---------------AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhcc---------------CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 2689999999985 67776654321 1113567888999999999999999999999999999999
Q ss_pred EEec----CCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSE----GSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~----~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++. ++ .+||+|||+++.+..... .......+|..|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 140 l~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 140 LVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred EEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHh
Confidence 9998 76 999999999987643322 1233567899999999886532 12345669999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=222.22 Aligned_cols=196 Identities=21% Similarity=0.283 Sum_probs=145.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.++||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|++++.+.+.+...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTK-----QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCC-----cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 4578999999999999999999998887 778888765332111 11112234455566788887776543222
Q ss_pred ------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 214 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
....++|+||+++ +|.+++.... ..+++..++.++.|++.||.|||++|++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 144 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-------------------VKFTLSEIKKVMKMLLNGLYYIHRNKILHRD 144 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 2467999999985 7887776542 1357788999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||+||+++.++ .+||+|||++..+...... ......++..|+|||++.+... .+..+|+||+|+++|+|
T Consensus 145 l~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~~l~el 217 (310)
T cd07865 145 MKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YGPPIDMWGAGCIMAEM 217 (310)
T ss_pred CCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcc---cCchhhhHHHHHHHHHH
Confidence 999999999987 9999999999866433221 1123567889999998865421 23356699999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=212.56 Aligned_cols=190 Identities=23% Similarity=0.331 Sum_probs=153.6
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
+|++.+.||+|+||.||++.+..++ ..+++|+.............++...+....|+++..+.+.+ ......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-LKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCC-----cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-ecCCeEEE
Confidence 5889999999999999999998776 77889988765542333333344556666688888887765 44578999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
++||+++++|.+++.... ..+++..+..++.|++.+|.|||+++++|+||+|+||++++++
T Consensus 75 ~~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-------------------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135 (253)
T ss_pred EEecCCCCcHHHHHhhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC
Confidence 999999999999987652 1347788889999999999999999999999999999999977
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++|+|||.+........ .....++..|+|||++.+...+.+ +|+|+||+++|+|
T Consensus 136 -~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~----~Dv~slG~il~~l 190 (253)
T cd05122 136 -EVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYK----ADIWSLGITAIEL 190 (253)
T ss_pred -eEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCcc----ccHHHHHHHHHHH
Confidence 999999999987654332 345678899999999987665544 5599999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=223.59 Aligned_cols=196 Identities=24% Similarity=0.258 Sum_probs=148.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.+.||+|+||.||+|.+..++ ..|++|.+......+ .....++...+....|++++.+.+.....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSG-----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 4579999999999999999999998887 778888765332111 11112234455566788888877665433
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++|+||+++ +|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 139 (309)
T cd07845 80 LDSIFLVMEYCEQ-DLASLLDNMP-------------------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139 (309)
T ss_pred CCeEEEEEecCCC-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 2578999999985 8888876532 1357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++++ .+||+|||++......... .....+++.|+|||++.+... .+..+|+||+|+++|+|-
T Consensus 140 l~~~~~-~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~---~~~~~DvwslG~il~el~ 203 (309)
T cd07845 140 LLTDKG-CLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCTT---YTTAIDMWAVGCILAELL 203 (309)
T ss_pred EECCCC-CEEECccceeeecCCccCC-CCcccccccccChhhhcCCCC---cCchHHHHHHHHHHHHHH
Confidence 999987 9999999999876543221 123355788999999865321 234566999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=218.83 Aligned_cols=185 Identities=22% Similarity=0.229 Sum_probs=144.1
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||+||+|.+..++ +.+++|.+..... ........+...+...+|++++.+.+.+ ...+.+++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATG-----KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-ETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCC-----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-ecCCeEEEEEec
Confidence 699999999999998887 6788877653221 1111112234555666789988887665 455789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++++++ .++
T Consensus 75 ~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~ 135 (277)
T cd05577 75 MNGGDLKYHIYNVGE------------------PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVR 135 (277)
T ss_pred CCCCcHHHHHHHcCc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEE
Confidence 999999999876541 2357788889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||.+....... ......++..|+|||++.+..++.++ |+|+||+++|+|-
T Consensus 136 l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~----Di~slG~il~~l~ 188 (277)
T cd05577 136 ISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSV----DWFALGCTLYEMI 188 (277)
T ss_pred EccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchh----hhHHHHHHHHHHh
Confidence 99999998654322 22345778899999998876655554 4999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=217.81 Aligned_cols=200 Identities=19% Similarity=0.233 Sum_probs=146.1
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC----
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG---- 214 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 214 (365)
|++.+.||+|+||.||+|.+...+... ..+++|.+.... ........++...+....|++++.+++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSF--QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCc--eEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567889999999999999876432211 678888776432 222222233445666778999988887543321
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++++|..+++|.+++...... .+...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~--------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ni 144 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIG--------------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNC 144 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhE
Confidence 2347889999999999887543210 0112357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++++ .+||+|||+++....+... ......+++.|++||.+.+...+.++ |+||||+++|+|
T Consensus 145 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~s----Di~slG~il~el 208 (273)
T cd05074 145 MLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHS----DVWAFGVTMWEI 208 (273)
T ss_pred EEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhh----hhHHHHHHHHHH
Confidence 999877 9999999999876433221 12234556789999998777666554 599999999997
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=223.16 Aligned_cols=194 Identities=22% Similarity=0.258 Sum_probs=148.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccCCCceeeeecccccC-CC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADFVYGFFENSSKK-GG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.++.....+.. ...++...+....|++++.+.+..... ..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTG-----EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCC-----cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 68999999999999999999998877 77888887643322111 112234455556689998887665333 27
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++|+||+++ +|.+++..... .+++..++.++.|++.||.|||+++++|+||||+||++
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQ-------------------PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 89999999985 99998876431 35778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+++....... ......+++.|+|||.+.+... .+..+|+||+|+++|+|-
T Consensus 140 ~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~ 201 (293)
T cd07843 140 NNRG-ILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKE---YSTAIDMWSVGCIFAELL 201 (293)
T ss_pred CCCC-cEEEeecCceeeccCCcc-ccccccccccccCchhhcCCcc---ccchhhHHHHHHHHHHHH
Confidence 9987 999999999987654321 1234567889999999865432 234566999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=223.51 Aligned_cols=189 Identities=21% Similarity=0.257 Sum_probs=144.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|++..... .......++...+....|++++.+++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCC-----eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3489999999999999999999998877 7888888764321 1112222344566667889988877654321
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 214 ----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 214 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
....+++++++ +++|.+++.... +++..++.++.|++.||.|||++||+|||||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~---------------------l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 147 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQK---------------------LTDDHVQFLIYQILRGLKYIHSADIIHRDLK 147 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 24467888876 578888776432 4677788999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+||++++++ .+||+|||+++..... .....++..|+|||++.+. ..+. .+|+||+|+++|+|
T Consensus 148 p~NIll~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~----~~DvwslG~il~el 211 (345)
T cd07877 148 PSNLAVNEDC-ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAEL 211 (345)
T ss_pred hHHEEEcCCC-CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCc----hhhHHHHHHHHHHH
Confidence 9999999987 9999999999865322 2345788999999998652 3333 45699999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=225.22 Aligned_cols=191 Identities=20% Similarity=0.290 Sum_probs=147.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC--
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (365)
++|.+.+.||+|+||+||+|.+..++ +.+++|.+.... ........++...+....|++++.+.+......
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETN-----EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCC-----CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 68999999999999999999998887 788888775421 111112223344556667899988876543322
Q ss_pred --CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 215 --GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 215 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
...++++||++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~N 138 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQ--------------------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 45899999997 68888876543 45778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|+++.++ .+||+|||+++...... .......++..|+|||++.+. ..+. .+|+|+||+++|+|
T Consensus 139 il~~~~~-~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~----~~DiwslG~il~~l 202 (337)
T cd07858 139 LLLNANC-DLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTT----AIDVWSVGCIFAEL 202 (337)
T ss_pred EEEcCCC-CEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCC----cccHHHHHHHHHHH
Confidence 9999987 99999999998764332 223345788999999988653 3444 45699999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=221.81 Aligned_cols=196 Identities=22% Similarity=0.253 Sum_probs=147.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.++..... .......+...+....|++++.+.+.....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTG-----ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCC-----cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 4578999999999999999999998877 67888877533211 111222334555666788988887665332
Q ss_pred --------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 214 --------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 214 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+..+++|+||+++ ++.+++.... ..+++..++.++.|++.||.|||+.+|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~i~H 139 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-------------------VHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 2478999999986 7777765432 13577889999999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+||||+||++++++ .+||+|||++..+............++..|+|||++.+... .+..+|+|++|+++|+|
T Consensus 140 ~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~~Di~slG~~~~el 211 (302)
T cd07864 140 RDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEER---YGPAIDVWSCGCILGEL 211 (302)
T ss_pred CCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHhcCCCC---CCchhHHHHHHHHHHHH
Confidence 99999999999987 99999999998765433222223456788999998864321 23456799999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=218.00 Aligned_cols=193 Identities=22% Similarity=0.333 Sum_probs=150.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccC-CCceeeeecccccCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCC-ADFVYGFFENSSKKG 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~ 214 (365)
++|.+.+.||+|+||.||+|.+..++ ..+++|...... ........++...+.... |+++..+++.+ ..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN-----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-QDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC-----CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-cCC
Confidence 47999999999999999999998877 677777665321 111112222233344444 89998887766 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~ 134 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKYG--------------------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL 134 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 78999999999999999987654 4577889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCc-------------------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGIN-------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~-------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
++.++ .++|+|||++........ .......++..|+|||++.+...+.+ +|+|+||
T Consensus 135 i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~----~Di~slG 209 (280)
T cd05581 135 LDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS----SDLWALG 209 (280)
T ss_pred ECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh----hhHHHHH
Confidence 99887 999999999986643321 12234577899999999877665554 5599999
Q ss_pred hhheecc
Q 017820 356 PVLWQVQ 362 (365)
Q Consensus 356 ~vlw~lG 362 (365)
+++|++-
T Consensus 210 ~~l~~l~ 216 (280)
T cd05581 210 CIIYQML 216 (280)
T ss_pred HHHHHHH
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=224.35 Aligned_cols=191 Identities=22% Similarity=0.310 Sum_probs=148.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
+|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|++++.+.+......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG-----RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC-----cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 5899999999999999999998877 788888776533 122222233444555666888888877654432
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
..++++|||+++ +|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~l~~~~--------------------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~ni 134 (330)
T cd07834 76 FNDVYIVTELMET-DLHKVIKSPQ--------------------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134 (330)
T ss_pred ccceEEEecchhh-hHHHHHhCCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 478999999984 7888876543 457788889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|++.++ .++|+|||++........ .......+|..|+|||++.+. ..+. .+|+|+||+++|+|
T Consensus 135 li~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~sDi~slG~il~~l 200 (330)
T cd07834 135 LVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK----AIDIWSVGCIFAEL 200 (330)
T ss_pred EEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCc----chhHHHHHHHHHHH
Confidence 999987 999999999987654431 112345778999999999876 4444 45699999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=219.33 Aligned_cols=200 Identities=17% Similarity=0.216 Sum_probs=151.0
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+..++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++........|++++.+++.+ .
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~ 84 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTG-----HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-I 84 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCC-----eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-e
Confidence 446689999999999999999999998876 77888887643221 111222222333444588888888776 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQ 291 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~ 291 (365)
.....+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~-------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ 144 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQ-------------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHH
Confidence 56689999999864 7777765532 135677888999999999999997 59999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++++++ .+||+|||++..+...... ....+++.|+|||++.+.......+..+|+||||+++|+|-+
T Consensus 145 nill~~~~-~~kL~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~ 213 (296)
T cd06618 145 NILLDASG-NVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213 (296)
T ss_pred HEEEcCCC-CEEECccccchhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence 99999877 9999999999866433222 234678899999999766533334456679999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=218.52 Aligned_cols=194 Identities=18% Similarity=0.245 Sum_probs=148.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+|++.++||+|++|.||+|++..++ ..+++|.+...... ......++...+....|+++..+.+.+ ...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG-----EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-HTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC-----eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-eeCCcEE
Confidence 5899999999999999999998877 77888877643211 111112234455566789998888776 4456889
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|+||+++ +|.+++.... ....+++..+..++.|++.||.|||+++++||||||+||+++++
T Consensus 75 lv~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHG-----------------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred EEEecCCc-cHHHHHHhcC-----------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 99999995 8888876543 11245788899999999999999999999999999999999988
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .++|+|||+++....... ......++..|+|||++.+.. ..+..+|+|+||+++|+|-
T Consensus 137 ~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~~l~ 195 (284)
T cd07836 137 G-ELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSR---TYSTSIDIWSVGCIMAEMI 195 (284)
T ss_pred C-cEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCC---CCCcHHHHHHHHHHHHHHH
Confidence 7 999999999986543222 123346788999999986532 2344677999999999873
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=218.99 Aligned_cols=197 Identities=21% Similarity=0.234 Sum_probs=150.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
......+.|.+.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+.+.
T Consensus 9 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~ 83 (307)
T cd06607 9 SKDDPEKLFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGC 83 (307)
T ss_pred cCCCcchhhhhheeecCCCCeEEEEEEEcCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34445578999999999999999999998777 778888775322 1122222334456667789999998887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+...++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+++|+||||+
T Consensus 84 ~-~~~~~~~lv~e~~~-g~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~ 142 (307)
T cd06607 84 Y-LREHTAWLVMEYCL-GSASDILEVHK-------------------KPLQEVEIAAICHGALQGLAYLHSHERIHRDIK 142 (307)
T ss_pred E-EeCCeEEEEHHhhC-CCHHHHHHHcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 6 44567899999998 57777765432 134778888999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+||++++++ .++|+|||++..... .....+++.|+|||++.+... ...+..+|+|++|+++|+|-
T Consensus 143 p~nIl~~~~~-~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 143 AGNILLTEPG-TVKLADFGSASLVSP-----ANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred cccEEECCCC-CEEEeecCcceecCC-----CCCccCCccccCceeeeccCC-CCCCcccchHHHHHHHHHHH
Confidence 9999999987 999999999976432 234578889999999853211 22333566999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=216.78 Aligned_cols=190 Identities=22% Similarity=0.317 Sum_probs=141.7
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccC-CCeE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK-GGEY 217 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 217 (365)
|++.+.||+|+||.||+|.+..++ +.+++|....... .......++........|++++.+.+.+... .+.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG-----KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC-----cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 678999999999999999998877 7788887664321 1111122222233333588888777665433 2688
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||++ ++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+||+++.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~ 135 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-------------------RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC
Confidence 99999998 48888776532 13477889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .+||+|||+++.+...... ....++..|+|||++.+... .+..+|+||+|+++|+|-
T Consensus 136 -~-~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slGv~l~el~ 193 (282)
T cd07831 136 -D-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY---YGPKMDIWAVGCVFFEIL 193 (282)
T ss_pred -C-CeEEEecccccccccCCCc--CCCCCCcccCChhHhhcCCC---CCcchhHHHHHHHHHHHH
Confidence 6 9999999999876433222 34567899999998754321 233566999999999883
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=215.34 Aligned_cols=185 Identities=21% Similarity=0.317 Sum_probs=144.8
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||.||++.+..++ +.+++|.+..... .......++...+....|++++.+.+.. ..+...++++||
T Consensus 1 lg~g~~~~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG-----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-QGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-ecCcEEEEEEec
Confidence 689999999999998877 7788887754432 1222223334455666789988887665 556789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||++++++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~ 133 (265)
T cd05579 75 LPGGDLASLLENVG--------------------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLK 133 (265)
T ss_pred CCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEE
Confidence 99999999997643 347778889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCc-------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 304 IIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 304 L~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++........ .......++..|+|||++.+...+.+ +|+|+||+++|++-
T Consensus 134 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~----~Dv~slG~~~~~l~ 195 (265)
T cd05579 134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT----VDWWSLGCILYEFL 195 (265)
T ss_pred EEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcc----hhhHHHHHHHHHHH
Confidence 999999876433211 11234567889999999877665544 55999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=224.87 Aligned_cols=194 Identities=21% Similarity=0.235 Sum_probs=145.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC----
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 214 (365)
.+|.+.+.||+|+||.||+|.+..++ +.+++|++............++...+....|++++.+++.....+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~-----~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCD-----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCC-----cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 78999999999999999999999887 778888775443333333333455566667888887765543322
Q ss_pred ---------CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 215 ---------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 215 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
...++|+||++ ++|.+++... .+++..++.++.|++.||.|||++||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~aL~~LH~~givH 137 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQG---------------------PLSEEHARLFMYQLLRGLKYIHSANVLH 137 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 35789999998 4888877543 2467788899999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||||+||+++.++..+||+|||+++.+...... ......++..|+|||++.... ..+..+|+||||+++|+|-
T Consensus 138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCcc---ccCchhhHHHHHHHHHHHH
Confidence 9999999999866658999999999865322111 112346788999999875422 1234567999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.26 Aligned_cols=198 Identities=18% Similarity=0.304 Sum_probs=150.7
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH---HHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI---WMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+....|+++++||+||.+.||++...+. +.+++|++........ -...++........+..|+.+++..
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~------~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE- 429 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDK------QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE- 429 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCC------cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-
Confidence 34556899999999999999999987765 5677777653322211 1112233344555678888888776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..++.+|+|||| +..+|..+++.... ....-.++.+..|++.++.+.|++||||.||||.
T Consensus 430 v~d~~lYmvmE~-Gd~DL~kiL~k~~~-------------------~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPA 489 (677)
T KOG0596|consen 430 VTDGYLYMVMEC-GDIDLNKILKKKKS-------------------IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPA 489 (677)
T ss_pred ccCceEEEEeec-ccccHHHHHHhccC-------------------CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcc
Confidence 446799999995 55799999987641 1121267889999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCC-------Cchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAP-------SAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d-------~~s~~~slg~vlw~l 361 (365)
|+|+-. | .+||+|||.|..+..... ......+||+.||+||.+.....+...+ ..||+||||.+||+|
T Consensus 490 NFLlVk-G-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 490 NFLLVK-G-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred cEEEEe-e-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 999987 5 999999999998876543 3344679999999999998776653333 478899999999987
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=218.56 Aligned_cols=192 Identities=21% Similarity=0.237 Sum_probs=146.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..+.|...+.||+|+||.||+|.+..++ ..+++|.+.... .........+...+....|++++.+.+.+ ..
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 96 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-LR 96 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ee
Confidence 3356888999999999999999998877 778888775322 11122223344556667799999988876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 97 ~~~~~lv~e~~~g-~l~~~~~~~~-------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 97 EHTAWLVMEYCLG-SASDLLEVHK-------------------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 5678999999975 7777765433 1356788889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++.++ .++|+|||++..... .....|++.|+|||++.+.. ....+..+|+||||+++|+|
T Consensus 157 l~~~~~-~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 157 LLTEPG-QVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred EECCCC-CEEEecCCCccccCC-----cccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHH
Confidence 999887 999999999875432 23457889999999975321 12233456699999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=215.64 Aligned_cols=190 Identities=28% Similarity=0.388 Sum_probs=146.2
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccC-CCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCC-ADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 218 (365)
|++.+.||+|+||+||+|.+..++ +.+++|+...... .+.....++...+.... |+++..+++.+. .+...+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-ENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC-----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-cCCcEE
Confidence 678999999999999999998876 7788887754322 12212222333444445 889988887764 467899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+||||+ +++|.+++.... +..+++..++.++.|++.+|.|||+++++|+||||+||+++++
T Consensus 75 lv~e~~-~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRK------------------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred EEEecC-CCCHHHHHHhcc------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 999999 789998887643 1245778899999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ .++|+|||+++....... .....++..|+|||++.+.. ..+..+|+||||+++|+|
T Consensus 136 ~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~s~G~~l~el 192 (283)
T cd07830 136 E-VVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRST---SYSSPVDIWALGCIMAEL 192 (283)
T ss_pred C-CEEEeecccceeccCCCC--cCCCCCcccccCceeeecCc---CcCCccchhhHHHHHHHH
Confidence 7 999999999987643322 23456888999999885432 123356699999999988
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=215.85 Aligned_cols=190 Identities=23% Similarity=0.271 Sum_probs=145.6
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-----HHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----IWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
|++.+.||+|+||.||+|.+..++ +.+++|.+......+ ...+..+...+....|++++.+.+.+....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC-----CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 678999999999999999998766 778888776322211 111112333445556888888877664332
Q ss_pred ---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 215 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..++++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+++++|+||||+
T Consensus 76 ~~~~~~~l~~e~~~~-~l~~~l~~~~------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ 136 (287)
T cd07838 76 DRELKLTLVFEHVDQ-DLATYLSKCP------------------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136 (287)
T ss_pred CCCceeEEEehhccc-CHHHHHHHcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 248999999985 7888886543 113577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||++++++ .+||+|||++..+..... .....++..|+|||++.+...+.++| +||+|+++|+|
T Consensus 137 nili~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~D----i~s~G~~l~~l 199 (287)
T cd07838 137 NILVTSDG-QVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVD----MWSVGCIFAEL 199 (287)
T ss_pred hEEEccCC-CEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcch----hhhHHHHHHHH
Confidence 99999987 999999999987644322 23345788999999998776665554 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=223.42 Aligned_cols=193 Identities=20% Similarity=0.267 Sum_probs=147.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccc---cC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSS---KK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~ 213 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.+. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSG-----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 78999999999999999999999887 7788887764321 11111222345556666888887765442 23
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++|+||++ ++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSDQ--------------------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 467899999996 58888876543 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++++ .+||+|||+++....... .......|+..|+|||++.+.. ..+..+|+|++|+++|+|
T Consensus 139 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~l~el 205 (334)
T cd07855 139 LVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP---EYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred EEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCc---ccccccchHHHHHHHHHH
Confidence 999987 999999999976543221 1123457899999999986532 133455699999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=224.38 Aligned_cols=195 Identities=23% Similarity=0.290 Sum_probs=147.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhcc-CCCceeeeecccccC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC-CADFVYGFFENSSKK- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~- 213 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+... .|++++.+++.+...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTK-----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCC-----eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 378999999999999999999998776 778888764321 11111122234445555 899999988765433
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++|+||++ ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN---------------------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 457899999998 4898887653 235667778999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc----ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++.++ .+||+|||+++.+...... ......||..|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 139 ll~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~~l~el~t 208 (337)
T cd07852 139 LLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST---RYTKGVDMWSVGCILGEMLL 208 (337)
T ss_pred EEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceeeeccc---cccccchHHHHHHHHHHHHh
Confidence 999988 9999999999876543221 223457899999999886532 22335669999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=221.79 Aligned_cols=191 Identities=23% Similarity=0.294 Sum_probs=140.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCC--CCCCCCcceeehhhccccHHH--HHHHHHHHHHhhc-cCCCceeeeecccc---
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKK--PSSKNDGDLVLKKATEYGAVE--IWMNERVRRACAN-CCADFVYGFFENSS--- 211 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~--~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~-~~~~~i~~~~~~~~--- 211 (365)
+|++.+.||+|+||.||++.+..+ + ..+++|.+....... .....++...+.. ..|++++.+++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEE-----ETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcC-----ceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 588999999999999999999876 5 678888776422111 1111112223333 35888888776432
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
......+++++|++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~ 134 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSGQ--------------------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 22345788889887 58888876543 3567888999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||+++++ .+||+|||+++.+...... ......||+.|+|||++.+. ..+ ..+|+||+|+++|+|
T Consensus 135 Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~----~~~Di~slGv~l~~l 203 (332)
T cd07857 135 NLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYT----KAIDVWSVGCILAEL 203 (332)
T ss_pred HeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCC----cHHHHHHHHHHHHHH
Confidence 99999987 9999999999876533221 12345789999999987653 333 456699999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=224.94 Aligned_cols=200 Identities=19% Similarity=0.251 Sum_probs=160.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc--cccHHH---HHHH--HHHHHHhhccCCCceeeeecc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE---IWMN--ERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~--~~~~~~---~~~~--~~~~~~~~~~~~~~i~~~~~~ 209 (365)
..++|-++.+||+|||++||+|.+.... +.|++|.-. .....| .... -++.+......|+.|+..+..
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~Eq-----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQ-----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchh-----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 3468888999999999999999998776 555655433 222221 1111 134455667789999999999
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC--CCcccC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--GIVHRD 287 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~--~IiHrD 287 (365)
+..+.+.++-|+|||+|.+|.-|++.+. ..++..++.|+.||+.||.||.+. .|||-|
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhk--------------------lmSEKEARSIiMQiVnAL~YLNEikpPIIHYD 595 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHK--------------------LMSEKEARSIIMQIVNALKYLNEIKPPIIHYD 595 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhh--------------------hhhHHHHHHHHHHHHHHHHHHhccCCCeeeec
Confidence 9889999999999999999999998776 457888999999999999999976 599999
Q ss_pred CCCCceEEecCC--CcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhe
Q 017820 288 IKPQNVIFSEGS--RTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (365)
Q Consensus 288 IKp~NILl~~~~--~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw 359 (365)
|||.|||+-+.. +.+||+|||+++.+.+.... ......||.+|++||.+.-++..++..-..|+||+||++|
T Consensus 596 LKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 596 LKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred cCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 999999996532 38999999999988765432 2345799999999999998877888878888999999998
Q ss_pred ec
Q 017820 360 QV 361 (365)
Q Consensus 360 ~l 361 (365)
..
T Consensus 676 QC 677 (775)
T KOG1151|consen 676 QC 677 (775)
T ss_pred hh
Confidence 74
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=216.67 Aligned_cols=193 Identities=24% Similarity=0.277 Sum_probs=147.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC-CCeE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-GGEY 217 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 217 (365)
|++.+.||+|+||.||+|.+..++ +.+++|.+.... .........+...+....|++++.+.+..... ....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG-----ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC-----eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence 678999999999999999998877 778888887543 11111122234455555688888887776444 3789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++ +|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||++++
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~ 135 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPE-------------------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135 (287)
T ss_pred EEEeccccc-cHHHHHhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC
Confidence 999999985 8888876542 14577888999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||++...............++..|+|||.+.+... ....+|+|+||+++|+|-
T Consensus 136 ~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 136 DG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR---YGPEVDMWSVGCILAELF 196 (287)
T ss_pred CC-CEEEccccceeeccCCCcccccccccccccCCceeeEcccc---CChHHHHHHHHHHHHHHH
Confidence 87 99999999998765443222234567889999998765321 233567999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=218.64 Aligned_cols=197 Identities=19% Similarity=0.209 Sum_probs=143.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~ 216 (365)
++|+..+.||+|+||.||++.+..++ +.+++|.+..... ........+...+... .|++++.+++... .+..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-~~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSG-----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-REGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCC-----CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-cCCc
Confidence 57778889999999999999998887 7888988764322 1222222223333344 4889998888664 4567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCceEE
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF 295 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NILl 295 (365)
.+++|||+.. ++.++..... ......+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~ 141 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVY---------------EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141 (288)
T ss_pred EEEEEecccC-CHHHHHHHHH---------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE
Confidence 8899999874 5555443210 00112457788999999999999999975 99999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++++ .+||+|||+++.+..... .....|+..|+|||++.+.. ....+..+|+||+|+++|+|
T Consensus 142 ~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 142 DRNG-NIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred ccCC-cEEEeecchhHHhccCCc--cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHHH
Confidence 9987 999999999986543221 23346889999999987652 11223345699999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=215.61 Aligned_cols=196 Identities=22% Similarity=0.328 Sum_probs=154.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.-..+.|++.+.||+|+||.||+|.+..++ ..+++|.+..... .......+...+....|++++.+++.+ ..+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~ 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATG-----KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-LVG 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCC-----cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-EEC
Confidence 345578999999999999999999998766 7788888765443 122222334456666789998888776 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~ 148 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF-------------------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL 148 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEE
Confidence 78999999999999999998753 13466778899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .++|+|||++........ ......++..|+|||++.+...+.+ +|+|+||+++|+|-
T Consensus 149 i~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~----~Dv~slGvil~~l~ 210 (286)
T cd06614 149 LSKDG-SVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPK----VDIWSLGIMCIEMA 210 (286)
T ss_pred EcCCC-CEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCc----cccHHHHHHHHHHH
Confidence 99877 999999999876543221 2234567889999999877666555 45999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=219.23 Aligned_cols=187 Identities=20% Similarity=0.282 Sum_probs=146.6
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEE
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
...+||+|+||.||++....++ ..+++|++............++...+....|++++.+++.+ ..+...+++||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 97 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVME 97 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCC-----eEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-EeCCEEEEEEe
Confidence 3467999999999999998877 78888877543333322233334455666788888887765 45678999999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcE
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~i 302 (365)
|+++++|.+++.... +++..++.++.|++.+|.|||++|++|+||||+||++++++ .+
T Consensus 98 ~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~ 155 (292)
T cd06657 98 FLEGGALTDIVTHTR---------------------MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RV 155 (292)
T ss_pred cCCCCcHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CE
Confidence 999999999875432 36677889999999999999999999999999999999987 99
Q ss_pred EEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|+|||++..+..... ......|++.|+|||++.+..++.++ |+|++|+++|+|-
T Consensus 156 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~----Dv~slGvil~el~ 210 (292)
T cd06657 156 KLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEV----DIWSLGIMVIEMV 210 (292)
T ss_pred EEcccccceecccccc-cccccccCccccCHHHhcCCCCCchh----hHHHHHHHHHHHH
Confidence 9999999876543322 12345788999999998776665554 5999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=213.34 Aligned_cols=198 Identities=21% Similarity=0.292 Sum_probs=147.2
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
+|.+.+.||+|+||.||++.+..++... ...++|.+... ...+......+...+....|++++.+++.. ......
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEE--RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-LERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcc--eEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-hcCCce
Confidence 5889999999999999999988765222 22334433211 111222222234456667799998888776 445678
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... ..+..+++..++.++.|++.||.|||++|++|+||||+||++++
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELK----------------HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHh----------------hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 99999999999999886532 11235688889999999999999999999999999999999976
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ .++|+|||+++....... ......|++.|+|||.+.+...+.+ +|+|++|+++|+|-+
T Consensus 142 -~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~----~Dv~slG~~~~~l~~ 200 (260)
T cd08222 142 -N-LLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSK----SDIWSLGCILYEMCC 200 (260)
T ss_pred -C-CEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCch----hhHHHHHHHHHHHHh
Confidence 4 799999999987643322 2345678999999999876665555 459999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=211.15 Aligned_cols=173 Identities=16% Similarity=0.227 Sum_probs=138.0
Q ss_pred CCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEecCCCcH
Q 017820 150 GAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229 (365)
Q Consensus 150 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL 229 (365)
|.||.||++.+..++ +.+++|++........ +........|++++.+++.+ ......+++|||+++++|
T Consensus 4 g~~~~v~~~~~~~~~-----~~~~~K~i~~~~~~~~-----~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQ-----QTFILKGLRKSSEYSR-----ERLTIIPHCVPNMVCLHKYI-VSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCC-----cEEEEEeecchhhhhh-----HHHHHHhcCCCceeehhhhe-ecCCeEEEEEecCCCCCH
Confidence 899999999999988 7899998875432211 12222334578888888766 455789999999999999
Q ss_pred HHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEeccc
Q 017820 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309 (365)
Q Consensus 230 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGl 309 (365)
.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++++|||.
T Consensus 73 ~~~l~~~~--------------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~ 131 (237)
T cd05576 73 WSHISKFL--------------------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSR 131 (237)
T ss_pred HHHHHHhc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccc
Confidence 99987643 246788899999999999999999999999999999999987 999999998
Q ss_pred ccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 310 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+...... .....++..|+|||++.+...+.++ |+||+|+++|+|-
T Consensus 132 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~----DvwslG~il~el~ 176 (237)
T cd05576 132 WSEVEDS----CDGEAVENMYCAPEVGGISEETEAC----DWWSLGAILFELL 176 (237)
T ss_pred hhccccc----cccCCcCccccCCcccCCCCCCchh----hHHHHHHHHHHHH
Confidence 8765432 1234567789999998776666555 4999999999874
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=221.37 Aligned_cols=192 Identities=22% Similarity=0.287 Sum_probs=147.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|.+..++ ..+++|....... .......++...+....|++++.+.+.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 3578999999999999999999998887 7788887753221 11112223455667778899888877654332
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 215 -----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 215 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
..+++|+||+ +++|.+++... .+++..++.++.|++.||.|||++||+|||||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---------------------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk 145 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE---------------------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK 145 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 3568999999 56888887643 24677889999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+||++++++ .++|+|||++...... .....+++.|+|||++.+.. .....+|+||||+++|++-+
T Consensus 146 p~Nill~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~ 211 (343)
T cd07880 146 PGNLAVNEDC-ELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWM---HYTQTVDIWSVGCIMAEMLT 211 (343)
T ss_pred HHHEEEcCCC-CEEEeecccccccccC----ccccccCCcccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHh
Confidence 9999999887 9999999999865322 23457789999999986532 13345679999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=208.79 Aligned_cols=194 Identities=23% Similarity=0.261 Sum_probs=155.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCC-Ce
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG-GE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~ 216 (365)
+|++.+.||+|++|.||+|.+..++ +.+++|....... .+.....++...+....|+++..+++...... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG-----ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCe
Confidence 5888999999999999999998776 7788887765442 23333344555666677999999887764432 68
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++++||+++++|.+++.... .+++..++.++.|++.+|.|||+++++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~ 135 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--------------------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 999999999999999987653 357788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .++|+|||.+......... ......++..|+|||.+.+...+.+ +|+|+||+++|+|-+
T Consensus 136 ~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~----~Dv~slG~il~~l~~ 198 (260)
T cd06606 136 SDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA----ADIWSLGCTVIEMAT 198 (260)
T ss_pred CCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCch----hhHHHHHHHHHHHHh
Confidence 977 9999999999876554321 1234678899999999877765444 459999999999744
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=212.15 Aligned_cols=200 Identities=19% Similarity=0.188 Sum_probs=146.6
Q ss_pred eeeecCCCeeEEEEEecCCCCC-CCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSS-KNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
+.||+|+||.||+|++...... .....+++|.+..... .......++...+....|++++.+++.+ ......++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-LLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-cCCCCeEEEEe
Confidence 3689999999999998653311 1114577787654321 1222333345566777899999988776 44567899999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC---
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS--- 299 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~--- 299 (365)
|+++++|.+++...... ......+++..+..++.|++.||.|||+++++|+||||+||+++.++
T Consensus 80 ~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~ 146 (269)
T cd05044 80 LMEGGDLLSYLRDARVE-------------RFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146 (269)
T ss_pred ccCCCcHHHHHHHhhhc-------------ccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCC
Confidence 99999999999764310 00123457788889999999999999999999999999999998754
Q ss_pred -CcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 300 -RTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 -~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
..++|+|||+++.+...... ......++..|+|||++.+...+.++| +||||+++|+|-
T Consensus 147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D----v~slG~il~ell 207 (269)
T cd05044 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSD----VWSFGVLMWEIL 207 (269)
T ss_pred CcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchh----HHHHHHHHHHHH
Confidence 27999999999866433221 122345678999999998877766555 999999999973
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=219.85 Aligned_cols=195 Identities=23% Similarity=0.285 Sum_probs=144.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
.++|++.++||+|+||.||+|.+..++ ..+++|.+......+ .....++...+....|++++.+.+.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG-----RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 589999999999999999999998887 677888764322111 11112234455566788888776554322
Q ss_pred -----CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 214 -----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 214 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
...+++|+||+.+ +|.+.+.... ..+++..++.++.|+++||.|||++||+|+||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-------------------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl 141 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPS-------------------VKLTESQIKCYMLQLLEGINYLHENHILHRDI 141 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 2457999999885 5666665432 24578889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCcc----------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhh
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~----------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vl 358 (365)
||+||++++++ .++|+|||+++........ ......+++.|+|||++.+.. ..+..+|+||+|+++
T Consensus 142 ~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il 217 (311)
T cd07866 142 KAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER---RYTTAVDIWGIGCVF 217 (311)
T ss_pred CHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC---ccCchhHhHHHHHHH
Confidence 99999999987 9999999999865432211 112346788999999886532 233456699999999
Q ss_pred eec
Q 017820 359 WQV 361 (365)
Q Consensus 359 w~l 361 (365)
|+|
T Consensus 218 ~el 220 (311)
T cd07866 218 AEM 220 (311)
T ss_pred HHH
Confidence 987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=212.74 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=153.5
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HH-HHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EI-WMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++..++.+-+..||.|+||+|++-..+.++ +..|+|+++..... +. ....+..-.....+-++|+.|++..+.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg-----~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSG-----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccC-----cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 345567777888999999999999999988 89999999865542 22 222223344566778999999999865
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~ 291 (365)
+ +..|+.||.|.- +|..+.+.- |.+ +...++++.+-+|..-.+.||.||... .||||||||+
T Consensus 135 E-GdcWiCMELMd~-SlDklYk~v---y~v------------q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPS 197 (361)
T KOG1006|consen 135 E-GDCWICMELMDI-SLDKLYKRV---YSV------------QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPS 197 (361)
T ss_pred C-CceeeeHHHHhh-hHHHHHHHH---HHH------------HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChh
Confidence 5 578999999974 554433211 111 234668888889999999999999865 7999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++..| .+||||||.+-.+.++... +.-.|-.-|||||.+..... -.|..||+||||+.|+|+.
T Consensus 198 NILldr~G-~vKLCDFGIcGqLv~SiAk--T~daGCrpYmAPERi~p~~~--gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 198 NILLDRHG-DVKLCDFGICGQLVDSIAK--TVDAGCRPYMAPERIDPSDK--GYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred heEEecCC-CEeeecccchHhHHHHHHh--hhccCCccccChhccCCccC--CcchhhhhhhhcceEeeee
Confidence 99999988 9999999999887655432 33477788999999864432 4677899999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=218.35 Aligned_cols=190 Identities=23% Similarity=0.266 Sum_probs=146.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|++.... .........+...+....|++++.+.+.+...+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTG-----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCC-----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3478999999999999999999999887 778888764321 111122223445566667999999888775556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++++||++ ++|.+++.... +++..+..++.|+++||.|||+++|+||||||+||+
T Consensus 83 ~~~~lv~e~~~-~~L~~~~~~~~---------------------~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil 140 (328)
T cd07856 83 EDIYFVTELLG-TDLHRLLTSRP---------------------LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140 (328)
T ss_pred CcEEEEeehhc-cCHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence 78899999985 58888876432 356667889999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .++|+|||+++..... .....+++.|+|||++.+ ...+ ..+|+|++|+++|+|-
T Consensus 141 i~~~~-~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~----~~~Dv~slG~il~el~ 200 (328)
T cd07856 141 INENC-DLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYD----VEVDIWSAGCIFAEML 200 (328)
T ss_pred ECCCC-CEEeCccccccccCCC----cCCCcccccccCceeeeccCCcC----cHHHHHHHHHHHHHHH
Confidence 99877 9999999999754321 234567889999998765 2333 4566999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=216.23 Aligned_cols=196 Identities=20% Similarity=0.241 Sum_probs=147.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..+.|...+.||+|+||.||+|.+..++ ..+++|.+... .........++...+....|++++.+.+.+ ..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 86 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LR 86 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCC-----cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-Ec
Confidence 4456888899999999999999998776 67888876532 111112222334556666788888887765 34
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++|+||+. ++|.+++..... .+++..++.++.|++.||.|||+++++||||||+||
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKK-------------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 578899999997 588777754331 246777889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec--ccCC
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
+++.++ .++|+|||++..... .....+++.|+|||++.+... ...+..+|+||||+++|+| |+.|
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~~~~Di~slG~il~el~~g~~p 213 (308)
T cd06634 147 LLSEPG-LVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPP 213 (308)
T ss_pred EECCCC-cEEECCcccceeecC-----cccccCCccccCHHHHhhccc-CCCCcccchHHHHHHHHHHHcCCCC
Confidence 999887 999999999976542 234578899999999754211 1123356699999999998 5544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=212.49 Aligned_cols=192 Identities=21% Similarity=0.267 Sum_probs=145.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
|++.+.||+|++|.||+|.+..++ +.+++|++......+ ......+...+....|++++.+.+.. ..+...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG-----EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-HSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC-----CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-ccCCeEE
Confidence 577899999999999999998877 778888775332111 01112234455666788888887776 4557899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+++||++ ++|.+++.... ...+++..+..++.|++.||.|||+++++|+||+|+||+++++
T Consensus 75 iv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~ 135 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSP------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE 135 (283)
T ss_pred EEEeccC-cCHHHHHhhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC
Confidence 9999996 68999887543 1245788899999999999999999999999999999999997
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .++|+|||+++........ .....+++.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 136 ~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~ 194 (283)
T cd07835 136 G-ALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSR---QYSTPVDIWSIGCIFAEMV 194 (283)
T ss_pred C-cEEEeecccccccCCCccc-cCccccccCCCCCceeecCc---ccCcHHHHHHHHHHHHHHH
Confidence 7 9999999999765332211 12335688999999886532 1234577999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=219.40 Aligned_cols=192 Identities=19% Similarity=0.218 Sum_probs=145.3
Q ss_pred CCeE-EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH--------------HHHHHHHHHhhccCCCce
Q 017820 139 DDFV-LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--------------WMNERVRRACANCCADFV 203 (365)
Q Consensus 139 ~~y~-l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i 203 (365)
++|. +.+.||+|+||+||+|.+..++ +.+++|++........ ....++...+....|+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCC-----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 5665 4678999999999999998877 7788887653322110 012234445666778999
Q ss_pred eeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC
Q 017820 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (365)
Q Consensus 204 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I 283 (365)
+.+++.+ ..+...+++|||+. ++|.+++.... .+++..+..++.|++.||.|||++||
T Consensus 83 v~~~~~~-~~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~ql~~aL~~LH~~~i 140 (335)
T PTZ00024 83 MGLVDVY-VEGDFINLVMDIMA-SDLKKVVDRKI--------------------RLTESQVKCILLQILNGLNVLHKWYF 140 (335)
T ss_pred eeeeEEE-ecCCcEEEEEeccc-cCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 8888766 45578999999997 58998886543 34678888999999999999999999
Q ss_pred cccCCCCCceEEecCCCcEEEEecccccccccCC-------------ccccccccCCCCcCCccccccCCCCCCCCCchh
Q 017820 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~ 350 (365)
+|+||||+||+++.++ .++|+|||+++...... ........+++.|+|||++.+.. ..+..+|
T Consensus 141 ~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~D 216 (335)
T PTZ00024 141 MHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---KYHFAVD 216 (335)
T ss_pred ecccccHHHeEECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC---CCCcHHH
Confidence 9999999999999987 99999999998654111 01112345688999999986543 2244677
Q ss_pred hhhhhhhheec
Q 017820 351 ATALSPVLWQV 361 (365)
Q Consensus 351 ~~slg~vlw~l 361 (365)
+||||+++|+|
T Consensus 217 v~slG~~l~el 227 (335)
T PTZ00024 217 MWSVGCIFAEL 227 (335)
T ss_pred HHHHHHHHHHH
Confidence 99999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=232.78 Aligned_cols=173 Identities=23% Similarity=0.319 Sum_probs=138.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.++|++.++||+|+||.||+|.+..++ +.|++|.+.... .........+...+....|++++.++... ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNS-----KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-QSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-EEC
Confidence 479999999999999999999999877 788888876432 11222333345556667889998887665 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~--------------------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL 136 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG--------------------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML 136 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence 78999999999999999987643 2466778899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 338 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 338 (365)
++.++ .+||+|||+++....... ......+|+.|++||....
T Consensus 137 l~~~g-~vkL~DFGls~~~~~~~~-~~~~~~~t~~~~~pe~~~~ 178 (669)
T cd05610 137 ISNEG-HIKLTDFGLSKVTLNREL-NMMDILTTPSMAKPKNDYS 178 (669)
T ss_pred EcCCC-CEEEEeCCCCccccCCcc-cccccccCccccCcccccc
Confidence 99887 999999999987643322 2345789999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=212.66 Aligned_cols=191 Identities=22% Similarity=0.255 Sum_probs=145.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+-|...++||+|+||.||+|.+..++ ..+++|.+.... ........++...+....|++++.+.+.+ ..+.
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 94 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTN-----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-LKEH 94 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-EeCC
Confidence 34777888999999999999998777 778888775321 12222222344556666789988888776 4457
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..|+|+||+. ++|.+++..... .+++..+..++.|++.+|.|||++||+|+||||+||++
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~~-------------------~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHKK-------------------PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 8899999997 577777764331 34677788899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||++.... ......|+..|+|||++.+... ...+..+|+||||+++|+|.
T Consensus 155 ~~~~-~~kL~dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-~~~~~~sDv~slGvil~el~ 214 (313)
T cd06633 155 TEPG-QVKLADFGSASKSS-----PANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELA 214 (313)
T ss_pred CCCC-CEEEeecCCCcccC-----CCCCccccccccChhhccccCC-CCCCchhhHHHHHHHHHHHH
Confidence 9887 99999999986432 1234678999999999854211 22344667999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=217.44 Aligned_cols=188 Identities=22% Similarity=0.307 Sum_probs=141.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|.+.+.||+|+||.||+|.+..++ ..+++|++......+ .....++...+....|++++.+++.+....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTG-----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCC-----cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 368999999999999999999998877 778888775322111 111223345566667888888776653322
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++|+||+.. +|.++... .+++..+..++.|++.||.|||+++|+||||||
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp 145 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIMGH----------------------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP 145 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 457999999874 66555421 246677889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+||+++.++ .+||+|||+++..... .....+|..|+|||++.+.. ..+..+|+||||+++|+|
T Consensus 146 ~NIll~~~~-~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slGvil~el 208 (342)
T cd07879 146 GNLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWM---HYNQTVDIWSVGCIMAEM 208 (342)
T ss_pred HHEEECCCC-CEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCcc---ccCchHHHHHHHHHHHHH
Confidence 999999987 9999999999865322 23457788999999986532 123456699999999997
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-28 Score=213.97 Aligned_cols=181 Identities=22% Similarity=0.274 Sum_probs=130.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCC--
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (365)
-+.+-.+.||-|.||.||.++|..++ +++++|++......- ....-++..++....|.|+...++......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdg-----rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSG-----KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCc-----cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 45566789999999999999999998 899999987554332 222223445566667888776655432222
Q ss_pred --CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 215 --GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 215 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.++|+++|.+.. +|+..+-+. ..++..-++-++.||++||.|||+.+|+||||||.|
T Consensus 128 fFqEiYV~TELmQS-DLHKIIVSP--------------------Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGN 186 (449)
T KOG0664|consen 128 FFQELYVLTELMQS-DLHKIIVSP--------------------QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGN 186 (449)
T ss_pred HHHHHHHHHHHHHh-hhhheeccC--------------------CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCcc
Confidence 223444444432 344433322 255667788899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCC
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAP 346 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d 346 (365)
+|++++- .+||||||+|+....+.....+..+-|-.|.|||.++|... +...|
T Consensus 187 LLVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvD 240 (449)
T KOG0664|consen 187 LLVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVD 240 (449)
T ss_pred EEeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccc
Confidence 9999975 99999999999766555444555667889999999998744 44444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=228.61 Aligned_cols=197 Identities=17% Similarity=0.198 Sum_probs=158.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++.++.++||+|.||.|++|.|..-+... ..||||.++..... ......++...+....|++++.+++..-. .
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~--V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--q 183 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKH--VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--Q 183 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcE--EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--c
Confidence 3457778899999999999999998754333 67899999876654 33344455666777889999999887533 6
Q ss_pred eEEEEEEecCCCcHHHHHHh-cCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 216 EYWLIWRYEGEATLADLMIS-REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...+|+|.+..|+|.+-+.. ..-.+ -...+..++.||+.||.||.++++|||||...|+|
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~l-------------------lv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAIL-------------------LVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccce-------------------eHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 78899999999999999987 33333 33456789999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccc-cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~-~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+-... .+||+|||+.+.+..+.++ ... ...-...|+|||.+...+++-.+| +|++||.||||
T Consensus 245 laspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSD----vWmyGVTiWEM 308 (1039)
T KOG0199|consen 245 LASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASD----VWMYGVTIWEM 308 (1039)
T ss_pred ecccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccch----hhhhhhhHHhh
Confidence 98865 9999999999998776542 222 234456899999999999888877 99999999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=232.17 Aligned_cols=218 Identities=21% Similarity=0.281 Sum_probs=167.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCC--CCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeec
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
.+++..++..+.+.||+|.||.|++|........ .....||+|..+..... ......++..+.....|+|++.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 4556667778888999999999999997643322 12467899988755433 2333344555667778999999999
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCccc-ccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG-IERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
.+.. .+.+++|+||+..|+|.++++.... ...+.+.- ..... ..++......++.||+.|++||++..+||||
T Consensus 370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~----~~~~~~~~-~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRV----TESIDGSG-VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred eecc-CCceEEEEEeccCCcHHHHHHhccc----cccccccC-CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 8855 7889999999999999999988760 00000000 00000 3478889999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcccccccc--CCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFL--LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|-..|||+.++. .+||+|||+|+.......+..+.-. ....|||||.+....++.++| +||+|++|||+
T Consensus 444 LAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSD----VWSfGI~L~Ei 514 (609)
T KOG0200|consen 444 LAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSD----VWSFGILLWEI 514 (609)
T ss_pred hhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccch----hhHHHHHHHHH
Confidence 999999999987 9999999999987666665534333 345799999999988888887 99999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=215.62 Aligned_cols=192 Identities=14% Similarity=0.097 Sum_probs=141.9
Q ss_pred eeeecC--CCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 145 KKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 145 ~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
..||+| +||+||+|.+..++ +.|++|...... .......+++........|++++.+++.+ ..+...++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTG-----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-TTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCC-----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-ecCCceEEE
Confidence 456666 99999999998887 788888765322 22223333445556667899999988877 445788999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
+||+.+++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 78 ~e~~~~~~l~~~l~~~~~------------------~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~- 138 (328)
T cd08226 78 SPFMAYGSANSLLKTYFP------------------EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG- 138 (328)
T ss_pred EecccCCCHHHHHHhhcc------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-
Confidence 999999999999876431 1357788889999999999999999999999999999999887
Q ss_pred cEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++++|||.+......... .+....++..|+|||++.+.... .+..+|+||+|+++|+|-+
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~DiwslG~~l~el~~ 205 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG--YNVKSDIYSVGITACELAT 205 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCC--CCchhhHHHHHHHHHHHHh
Confidence 9999999865433221110 01112346679999998764221 2335669999999999843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=212.88 Aligned_cols=191 Identities=15% Similarity=0.137 Sum_probs=138.9
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.+++.+|.|++ ||.++...++ +.+++|++... ........+++...+....|++++.+++.+ ......++
T Consensus 5 ~i~~~~~~~~~--v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-~~~~~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMI--VHLAKHKPTN-----TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IVDSELYV 76 (314)
T ss_pred hhhHhhcCCce--EEEEEecCCC-----CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-ecCCeEEE
Confidence 34444555544 5555555555 78899887643 222333344445566667799999888766 45578899
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
+|||+++++|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++
T Consensus 77 ~~e~~~~~~l~~~l~~~~------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~ 138 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHF------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG 138 (314)
T ss_pred EEeccCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC
Confidence 999999999999987642 11346778889999999999999999999999999999999887
Q ss_pred CcEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 300 RTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+||+|||.+..+..... .......++..|+|||++.+.... .+..+|+||+|+++|+|
T Consensus 139 -~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~Diws~G~il~el 203 (314)
T cd08216 139 -KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACEL 203 (314)
T ss_pred -ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCC--CCcchhHHHHHHHHHHH
Confidence 999999999875532211 112345678889999998753211 12346699999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=209.44 Aligned_cols=191 Identities=21% Similarity=0.304 Sum_probs=145.8
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
|++.+.||+|++|.||+|.+..++ ..+++|.+...... ......++...+....|++++.+.+.. ..+...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG-----EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-RHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC-----cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-ccCCCEE
Confidence 567889999999999999998777 77888877543322 112222334445555688888887766 4457899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|+||+++ +|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++++
T Consensus 75 ~v~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 134 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQ-------------------RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134 (283)
T ss_pred EEEeccCC-CHHHHHHhhc-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC
Confidence 99999985 8888876643 134677889999999999999999999999999999999987
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .++|+|||.+........ ......++..|+|||.+.+. ...+..+|+|++|+++|+|-
T Consensus 135 ~-~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~ 193 (283)
T cd05118 135 G-VLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGD---KGYSTPVDIWSVGCIFAELL 193 (283)
T ss_pred C-cEEEeeeeeeEecCCCcc-cccCccCcccccCcHHHhcC---CCCCchhHHHHHHHHHHHHH
Confidence 7 999999999987654331 12235678899999998764 12334566999999999873
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=208.73 Aligned_cols=189 Identities=25% Similarity=0.307 Sum_probs=145.1
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
|++.+.||+|+||.||+|....++ +.+++|........+ ......+...+....|++++.+.+.. ......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG-----EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-HTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC-----cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-hcCCceE
Confidence 567889999999999999998877 778888776542111 11112233444555688888887766 3447899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+|+||++ ++|.+++.... ..+++..++.++.|++.||.|||++||+|+||+|+||+++++
T Consensus 75 ~v~e~~~-~~l~~~i~~~~-------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~ 134 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP-------------------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD 134 (282)
T ss_pred EEecCcC-cCHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC
Confidence 9999998 48999997652 135778889999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ .++|+|||+++....... ......++..|+|||++.+. ..+. .+|+|+||+++|++
T Consensus 135 ~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~----~~Dv~slG~~l~~l 192 (282)
T cd07829 135 G-VLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYST----AVDIWSVGCIFAEM 192 (282)
T ss_pred C-CEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCc----cccHHHHHHHHHHH
Confidence 7 999999999987644322 12234567889999998765 4444 45599999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=223.38 Aligned_cols=188 Identities=19% Similarity=0.254 Sum_probs=151.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|.+...+|.|+|+.|-.+.+..++ +..++|.+.+..... .++..-......|+|++.....+ ..+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~-----~~~~vkii~~~~~~~---~~e~~~~~~~~~h~niv~~~~v~-~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTD-----QEPAVKIISKRADDN---QDEIPISLLVRDHPNIVKSHDVY-EDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccc-----cchhheecccccccc---ccccchhhhhcCCCcceeeccee-cCCce
Confidence 4578999999999999999999999988 677777776551111 11122334556789999888776 66789
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.|+|||.+.++.|.+-+..... .. ..+..|+.||+.+++|||++||||||+||+|||++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~--------------------~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPE--------------------FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred eeeeehhccccHHHHHHHhcch--------------------hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 9999999999988887765542 12 45667999999999999999999999999999995
Q ss_pred -cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 -EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 -~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.+ +++|+|||.++..... ..+.+-|..|.|||++....+++.+| +||||++||+|-|
T Consensus 450 ~~~g-~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD----~WSLGvlLy~ML~ 508 (612)
T KOG0603|consen 450 GSAG-HLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACD----WWSLGVLLYEMLT 508 (612)
T ss_pred CCCC-cEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchh----hHHHHHHHHHHHh
Confidence 655 9999999999977544 23557789999999999888888887 9999999999965
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=202.80 Aligned_cols=198 Identities=18% Similarity=0.246 Sum_probs=155.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.+.|.+.+.||+|-||.+-+++.+.++ ..+++|.+...........++.-.......|.+|+.-++..++..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~-----t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSK-----TRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCc-----eEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 378999999999999999999999988 889999887654443333333444456667888888888777888899
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe-
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS- 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~- 296 (365)
+.++||++.|+|.+-+...+ +-+...++++.|+++|+.|+|++++||||||.+||||-
T Consensus 98 vF~qE~aP~gdL~snv~~~G---------------------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG---------------------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred EEeeccCccchhhhhcCccc---------------------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 99999999999988776654 34566778999999999999999999999999999985
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheec--ccCC
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQV--QCSP 365 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~l--Gc~~ 365 (365)
.|...+||||||+.+..... .....-+..|.+||...... .....+..+|+|.||+++|-. ||+|
T Consensus 157 ~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P 224 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP 224 (378)
T ss_pred CCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCc
Confidence 44459999999999865322 22344566799999876542 234556678899999998754 7776
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-28 Score=208.51 Aligned_cols=192 Identities=21% Similarity=0.318 Sum_probs=142.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccCCCceeeeecccccC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
..|+-..+||+|.||+||+|+..+++ ++|++|++.-....+.. ...++...+....|++++.+.+.+...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~-----kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTG-----KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCcc-----chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 56777889999999999999999998 78888887543333221 222344555666666666554443221
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 214 ----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 214 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
...+++|+.+|+. +|.-++..... .++...|.+++.++++||.|+|+..|+|||+|
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~v-------------------r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKV-------------------RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccc-------------------cccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 2458999999985 78777766542 45667799999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCcccc---ccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhhee
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIP---KEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~ 360 (365)
++|+||+.++ .+||+|||+|+.+....+... +..+-|.+|.+||.+.|... +++.| +|+-|.++=|
T Consensus 152 aaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iD----iWgAgCimae 221 (376)
T KOG0669|consen 152 AANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPID----IWGAGCIMAE 221 (376)
T ss_pred HhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcch----hHhHHHHHHH
Confidence 9999999988 999999999987765544222 24566999999999998754 44445 5555555433
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=214.89 Aligned_cols=189 Identities=23% Similarity=0.308 Sum_probs=144.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.+.||+|+||.||+|.+..++ ..+++|.+.... ........++...+....|++++.+.+.....+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTG-----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCC-----cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 478999999999999999999998877 778888775321 111111222344556667888877765543222
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
...++|+||++ ++|.+++... .+++..++.++.|++.||.|||+.||+||||||
T Consensus 89 ~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (343)
T cd07851 89 LEDFQDVYLVTHLMG-ADLNNIVKCQ---------------------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146 (343)
T ss_pred ccccccEEEEEecCC-CCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 34899999985 5899888653 246778899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+||++++++ .++|+|||++...... .....++..|+|||.+.+.. ..+..+|+||||+++|+|
T Consensus 147 ~Nill~~~~-~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslGv~l~el 209 (343)
T cd07851 147 SNIAVNEDC-ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHeEECCCC-CEEEcccccccccccc----ccCCcccccccCHHHHhCCC---CCCchHhHHHHHHHHHHH
Confidence 999999987 9999999999865432 23457788999999986532 223345699999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=212.07 Aligned_cols=170 Identities=21% Similarity=0.186 Sum_probs=122.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecC-CCCCCCCcceeehhhccc-----cHHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAK-KPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..++|.+.+.||+|+||+||+|++.. ++ ..+++|+.... .........++...+....|++++..+...
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPG-----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCC-----eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 45789999999999999999999876 33 44688775422 121223344556666667777776432221
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC-C
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI-K 289 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI-K 289 (365)
+..++||||+++++|... ...+ ...++.|++++|.|||++||+|||| |
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~~~--------------------------~~~~~~~i~~aL~~lH~~gIiHrDL~K 139 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RPHG--------------------------DPAWFRSAHRALRDLHRAGITHNDLAK 139 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cccc--------------------------hHHHHHHHHHHHHHHHHCCCeeCCCCC
Confidence 357999999999999632 1100 1357889999999999999999999 9
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc-cc------cccccCCCCcCCccccccCCCCC
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN-YI------PKEFLLDPRYAAPEQYIMSTQTP 343 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~-~~------~~~~~gt~~Y~APE~l~~~~~~~ 343 (365)
|+|||++.++ .+||+|||+|+.+..... +. -.+..+++.|+|||.+.-.....
T Consensus 140 P~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~ 199 (365)
T PRK09188 140 PQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKI 199 (365)
T ss_pred cceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhcc
Confidence 9999998877 999999999997654321 11 13567899999999987554433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=229.95 Aligned_cols=195 Identities=22% Similarity=0.329 Sum_probs=162.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
-..++|++..++|.|+||.||+|++..++ +..++|.++-..........+++...+.+.|+||+.+++.+ ....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~-----elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~d 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSG-----ELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRD 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccC-----chhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhc
Confidence 35689999999999999999999999998 67777777766555555556667778889999999999988 6668
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+|++||||++|+|.+.-+-.+ .+++.++....+..+.||.|||++|=+|||||-.|||+
T Consensus 86 klwicMEycgggslQdiy~~Tg--------------------plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTG--------------------PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred CcEEEEEecCCCcccceeeecc--------------------cchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 8999999999999999876655 56889999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC---CCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS---TQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.+ .+|++|||.+..+...... .+.++||+.|||||+--.. .+...+| +|++|+.--|+|
T Consensus 146 td~g-DvklaDfgvsaqitati~K-rksfiGtpywmapEvaaverkggynqlcd----iwa~gitAiel~ 209 (829)
T KOG0576|consen 146 TDEG-DVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCD----IWALGITAIELG 209 (829)
T ss_pred cccC-ceeecccCchhhhhhhhhh-hhcccCCccccchhHHHHHhccccccccc----ccccccchhhhh
Confidence 9988 9999999999887654433 4679999999999986533 4445555 777776655544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=202.63 Aligned_cols=185 Identities=21% Similarity=0.287 Sum_probs=144.6
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEe
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
||+|+||.||++.+..++ +.+++|.+...... .......+...+....|+++..+...+ ..+...+++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG-----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-ecCCeeEEEEec
Confidence 699999999999998766 77888876543221 111222333455666688888887665 556789999999
Q ss_pred cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEE
Q 017820 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (365)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ik 303 (365)
+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~ 133 (250)
T cd05123 75 APGGELFSHLSKEG--------------------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIK 133 (250)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEE
Confidence 99999999987653 346788889999999999999999999999999999999987 999
Q ss_pred EEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++....... .......++..|+|||.+.+...+.+ +|+|+||+++|++.+
T Consensus 134 l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~----~D~~slG~~~~~l~~ 188 (250)
T cd05123 134 LTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKA----VDWWSLGVLLYEMLT 188 (250)
T ss_pred EeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCch----hhHHHHHHHHHHHHH
Confidence 99999998764332 12345678899999999877665444 559999999998754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=199.75 Aligned_cols=170 Identities=24% Similarity=0.335 Sum_probs=136.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc-cCCCceeeeecccccC-C
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKK-G 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~-~ 214 (365)
..++|++.+++|+|-+++||.|....++ .++++|.+++-....+..+ ...+.+ ..++||+.++...... .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~-----eK~ViKiLKPVkkkKIkRE---ikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNN-----EKCVIKILKPVKKKKIKRE---IKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCC-----ceEEEeeechHHHHHHHHH---HHHHHhccCCCCeeehhhhhcCccc
Confidence 5689999999999999999999988777 7889998887665554433 333333 3589999887765433 3
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
....+|+||+++.+...+... ++...++.++.|++.||+|+|+.||+|||+||.|++
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t-----------------------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT-----------------------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred cCchhHhhhhccccHHHHhhh-----------------------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 567899999999887776543 344568899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 339 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 339 (365)
||....+++|+|+|+|-+...+..+ +..+.+..|--||.+..-
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy 207 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDY 207 (338)
T ss_pred echhhceeeeeecchHhhcCCCcee--eeeeehhhcCCchheeec
Confidence 9988789999999999988776655 445667788999998654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=203.27 Aligned_cols=192 Identities=19% Similarity=0.249 Sum_probs=142.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHH--HHHhhcc--CCCc-eeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERV--RRACANC--CADF-VYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~~~~~~~--~~~~-i~~~~~~~~ 211 (365)
..++|.+.+.+|+|.||.|-++.+..++ ..+|+|.++.-.........++ ...+... .-.+ .+.+.+++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~-----~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETK-----EHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCC-----ceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-
Confidence 4579999999999999999999999886 7788888765443322221111 1111111 1112 23333333
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
+-.++.++|+|.++ -++++++..+++ ..++...++.+..|+++++.+||+.+++|.||||+
T Consensus 161 dyrghiCivfellG-~S~~dFlk~N~y------------------~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPE 221 (415)
T KOG0671|consen 161 DYRGHICIVFELLG-LSTFDFLKENNY------------------IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPE 221 (415)
T ss_pred hccCceEEEEeccC-hhHHHHhccCCc------------------cccchHHHHHHHHHHHHHHHHHHhcceeecCCChh
Confidence 45678999999886 489999988764 24567789999999999999999999999999999
Q ss_pred ceEEecC-------------------CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhh
Q 017820 292 NVIFSEG-------------------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (365)
Q Consensus 292 NILl~~~-------------------~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~ 352 (365)
|||+.+. ...++|+|||.|+.-... ..+++.|..|.|||++.+-.++..+| +|
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCD----vW 293 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCD----VW 293 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccC----ce
Confidence 9998421 237999999999875432 25678899999999999999999999 66
Q ss_pred hhhhhheec
Q 017820 353 ALSPVLWQV 361 (365)
Q Consensus 353 slg~vlw~l 361 (365)
|+|.+|.|+
T Consensus 294 SiGCIL~El 302 (415)
T KOG0671|consen 294 SIGCILVEL 302 (415)
T ss_pred eeeeEEEEe
Confidence 666666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=239.19 Aligned_cols=178 Identities=15% Similarity=0.189 Sum_probs=141.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.|...+.||+|+||.||+|++..++ ..|++|++........ .+...+....|++++.+++.+ ..+...++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~----~~~~~l~~l~HpnIv~~~~~~-~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNG-----MQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLC-RSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCC-----cEEEEEEccCCccccH----HHHHHHhhCCCCCcceEEEEE-EcCCCCEE
Confidence 4556778999999999999998777 7889998764432221 123445566899999999887 44567899
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH---HCCCcccCCCCCceEEe
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH---STGIVHRDIKPQNVIFS 296 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH---~~~IiHrDIKp~NILl~ 296 (365)
||||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 761 v~Ey~~~g~L~~~l~~-----------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~ 817 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----------------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817 (968)
T ss_pred EEeCCCCCcHHHHHhc-----------------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC
Confidence 9999999999999853 255677899999999999999 66999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ ..++. ||.+..... .....+|+.|||||++.+..++.++| +||+|+++|||
T Consensus 818 ~~~-~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sD----v~S~Gvvl~el 871 (968)
T PLN00113 818 GKD-EPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSD----IYGFGLILIEL 871 (968)
T ss_pred CCC-ceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccc----hhhHHHHHHHH
Confidence 876 77765 666654321 12347899999999998877776665 99999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=191.57 Aligned_cols=191 Identities=26% Similarity=0.303 Sum_probs=148.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
|.+.+.||+|++|.||++....++ +.+++|........ ......++........|+++..+++.. ......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG-----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-EDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC-----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-ecCCceEE
Confidence 567899999999999999998866 77888888755432 222333334445555778888777665 44478899
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
++||+++++|.+++..... ..++..+..++.|++.++.+||+++++|+||+|+||+++.++
T Consensus 75 v~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGG-------------------KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred EEeccCCCCHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9999999999999876541 046778889999999999999999999999999999999986
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccc-cCCCCCCCCCchhhhhhhhhheec
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI-MSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++|+|||.+...............++..|++||++. ....+. .+|+|+||+++|+|
T Consensus 136 -~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~----~~Dv~~lG~~~~~l 193 (225)
T smart00221 136 -LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGE----AVDIWSLGVILYEL 193 (225)
T ss_pred -CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCc----hhhHHHHHHHHHHH
Confidence 9999999999876544211224467788999999984 333333 56699999999988
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=216.65 Aligned_cols=195 Identities=17% Similarity=0.173 Sum_probs=155.2
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
..+..++||+|+||+||+|.+...++.+ .-.|++|.+.+.... ......++...+....|+|++.+++.+... .+.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~v-KipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENV-KIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCcee-cceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHH
Confidence 4445678999999999999998775444 346788877654433 222233345567778899999998876443 388
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
||++|++.|+|.|+++.++- .+-.+....|..||++||.|||.++++||||-..|+|+.+-
T Consensus 774 lvtq~mP~G~LlDyvr~hr~-------------------~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP 834 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD-------------------NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP 834 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc-------------------cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC
Confidence 99999999999999988652 33446677899999999999999999999999999999997
Q ss_pred CCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 299 SRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+ ++||.|||+|+.+..... +......-.+.|||-|.+....++..+| +||+||.+||+
T Consensus 835 ~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSD----VWsfGVtiWEl 893 (1177)
T KOG1025|consen 835 N-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSD----VWSFGVTIWEL 893 (1177)
T ss_pred C-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhh----hhhhhhhHHHH
Confidence 7 999999999998765533 3333444467899999999999999888 99999999996
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=195.91 Aligned_cols=220 Identities=17% Similarity=0.226 Sum_probs=174.8
Q ss_pred HHHHHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCcee
Q 017820 126 AFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 126 ~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~ 204 (365)
+.-.+....++..+++++...+-+|.||.||+|.++..+.....+.+.+|.+++... .+..+...+...+....|+|+.
T Consensus 271 e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 271 EFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred HHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 334455566677789999999999999999999998777777778899998876543 3444444555566677799999
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+.+.........+.++.+.+-|+|..|+...+. .+..........++..++.|++.|++|||.+|||
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~------------~~~~~aqtvtt~qlV~masQla~am~hlh~~~Vi 418 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRG------------DDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVI 418 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhcc------------CCCccccchhHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 9998888888899999999999999999984321 0111123456677888999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccccc-cccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|.||...|++||+.- ++||+|=.+++++-.+....-+ ..-....||+||.+.+..++..+| +|||||+||||-
T Consensus 419 HkDiAaRNCvIdd~L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasD----vWsfGVllWELm 492 (563)
T KOG1024|consen 419 HKDIAARNCVIDDQL-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASD----VWSFGVLLWELM 492 (563)
T ss_pred cchhhhhcceehhhe-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhh----hHHHHHHHHHHH
Confidence 999999999999975 9999999999987665443222 233456899999999999988777 999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=208.48 Aligned_cols=189 Identities=23% Similarity=0.239 Sum_probs=141.1
Q ss_pred eEEeeeeecCCCe-eEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 141 FVLGKKLGEGAFG-VVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 141 y~l~~~LG~G~fG-~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
|.-.+.+|.|+-| .||+|...+ +.||+|++......-. ..++......-.|+|++.+++.. ......||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-------R~VAVKrll~e~~~~A--~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-------REVAVKRLLEEFFDFA--QREIQLLQESDEHPNVIRYYCSE-QDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-------ceehHHHHhhHhHHHH--HHHHHHHHhccCCCceEEEEeec-cCCceEEE
Confidence 3334568999887 599999987 7899999875543222 22233344556799999999876 55578899
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec--
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-- 297 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~-- 297 (365)
..|.|.. +|.++++..... ...... ...+.++.|+++||++||+.+||||||||+||||+.
T Consensus 581 alELC~~-sL~dlie~~~~d-------------~~~~~~---i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESSGLD-------------VEMQSD---IDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred EehHhhh-hHHHHHhccccc-------------hhhccc---ccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 9999985 999999874110 000111 234578999999999999999999999999999987
Q ss_pred -CC-CcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhee
Q 017820 298 -GS-RTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 298 -~~-~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~ 360 (365)
++ ..++|+|||+++.+..+.. ....+..||.+|+|||++.....+...| +++||.++|-
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avD----iFslGCvfyY 706 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVD----IFSLGCVFYY 706 (903)
T ss_pred CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccc----hhhcCceEEE
Confidence 23 4899999999998876643 2345688999999999999888877666 6666666553
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=184.47 Aligned_cols=180 Identities=24% Similarity=0.317 Sum_probs=141.9
Q ss_pred CCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEecCCCcH
Q 017820 151 AFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229 (365)
Q Consensus 151 ~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL 229 (365)
+||.||+|.+..++ ..+++|......... .....++........|+++..+.+.. ......++++||+++++|
T Consensus 1 ~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTG-----KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVF-EDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhe-eeCCEEEEEEeCCCCCCH
Confidence 68999999998876 778888886544322 22222334444555888888887766 344789999999999999
Q ss_pred HHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEeccc
Q 017820 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309 (365)
Q Consensus 230 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGl 309 (365)
.+++.... .+++..+..++.+++.++.|||+.+++|+||+|+||++++++ .++|+|||.
T Consensus 75 ~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~ 133 (244)
T smart00220 75 FDLLKKRG--------------------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGL 133 (244)
T ss_pred HHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccc
Confidence 99987653 146788899999999999999999999999999999999987 999999999
Q ss_pred ccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 310 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+....... ......++..|+|||++.+...+.+ +|+|++|+++|++-|
T Consensus 134 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~----~Di~slG~~l~~l~~ 181 (244)
T smart00220 134 ARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKA----VDVWSLGVILYELLT 181 (244)
T ss_pred eeeecccc--ccccccCCcCCCCHHHHccCCCCch----hhHHHHHHHHHHHHh
Confidence 98765432 2345678899999999876555554 459999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=174.48 Aligned_cols=185 Identities=25% Similarity=0.343 Sum_probs=141.9
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEEEEecC
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEG 225 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~ 225 (365)
||+|++|.||++.+..++ +.+++|........ ......++...+....++++..+..... .....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG-----KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-DENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCC-----cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeEEEEEecCC
Confidence 689999999999998766 78899988766542 1122223344445555677877776663 3478999999999
Q ss_pred CCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec-CCCcEEE
Q 017820 226 EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-GSRTFKI 304 (365)
Q Consensus 226 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~-~~~~ikL 304 (365)
+++|.+++.... ..+++..++.++.+++++|.+||+++++|+||+|.||+++. ++ .++|
T Consensus 75 ~~~l~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l 134 (215)
T cd00180 75 GGSLKDLLKENE-------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKL 134 (215)
T ss_pred CCcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEE
Confidence 999999987652 13467788899999999999999999999999999999998 66 9999
Q ss_pred EecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||.+........ ......+...|++||.+... ...+...|+|++|.++|++
T Consensus 135 ~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 135 ADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ecCCceEEccCCcc-hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH
Confidence 99999987654321 12345678899999998765 2333455699999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=187.70 Aligned_cols=182 Identities=23% Similarity=0.361 Sum_probs=143.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCC--
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (365)
.+|.-.+.+|.|.- .|-.|.|..++ ..|++|++...... ......++...+...+|.|++..+..+..+.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~-----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLG-----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhcc-----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 58888999999988 78888888887 77888877543221 1222234455667778999998887765443
Q ss_pred ---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 215 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...++|||++.. +|.+.+.. .++-+.+..++.|++.|++|||+.||+||||||+
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~----------------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPs 147 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM----------------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPS 147 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH----------------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 556888888874 77776652 3466789999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++..+. .+||.|||+|+.-... ...+..+.|..|.|||++.+..+.+..| +|++||
T Consensus 148 nivv~~~~-~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vd-----------iwSvGc 205 (369)
T KOG0665|consen 148 NIVVNSDC-TLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVD-----------IWSVGC 205 (369)
T ss_pred cceecchh-heeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccch-----------hhhhhh
Confidence 99999987 9999999999864432 4566788899999999999999888888 677776
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=192.40 Aligned_cols=194 Identities=24% Similarity=0.310 Sum_probs=147.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..+.|.+.++||+|+|++||+|.+... ....+.|++|.+...........| +........+.++....+.. ..+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~p~ri~~E-l~~L~~~gG~~ni~~~~~~~-rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSSPSRILNE-LEMLYRLGGSDNIIKLNGCF-RNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccCchHHHHH-HHHHHHhccchhhhcchhhh-ccCCe
Confidence 447899999999999999999999872 111278999998866554443333 33334445567777777665 66789
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
..+|+||.+..+..++..+. +-..++.+++.++.||.++|.+|||||||||+|+|.+
T Consensus 110 v~ivlp~~~H~~f~~l~~~l-----------------------~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSL-----------------------SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN 166 (418)
T ss_pred eEEEecccCccCHHHHHhcC-----------------------CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc
Confidence 99999999999999988654 3466889999999999999999999999999999999
Q ss_pred cCCCcEEEEeccccccccc-------------------C--------------Cccc----------cccccCCCCcCCc
Q 017820 297 EGSRTFKIIDLGAAADLRV-------------------G--------------INYI----------PKEFLLDPRYAAP 333 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~-------------------~--------------~~~~----------~~~~~gt~~Y~AP 333 (365)
.....-.|+|||+|..... + .++. .-...||++|.||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 8777999999999972110 0 0000 0136899999999
Q ss_pred cccccC-CCCCCCCCchhhhhhhhhheec
Q 017820 334 EQYIMS-TQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 334 E~l~~~-~~~~~~d~~s~~~slg~vlw~l 361 (365)
|++... .++++. |+||.||++.++
T Consensus 247 EvL~k~~~Qttai----Diws~GVI~Lsl 271 (418)
T KOG1167|consen 247 EVLFRCPRQTTAI----DIWSAGVILLSL 271 (418)
T ss_pred HHHhhccCcCCcc----ceeeccceeehh
Confidence 998754 344444 499999988764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-23 Score=192.61 Aligned_cols=195 Identities=19% Similarity=0.289 Sum_probs=145.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH------HHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA------VEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+..++|.+....|+|-|++|-+|.+...+ ..||||.++.... .|....+++...-..- .-+.+.++..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~-----~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Ed-k~Hclrl~r~ 502 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARG-----QEVAIKIIRNNEVMHKTGLKELEILKKLNDADPED-KFHCLRLFRH 502 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCC-----CeeEEEEeecchHHhhhhhHHHHHHHHhhccCchh-hhHHHHHHHH
Confidence 35578999999999999999999999887 6899999875433 2222222222111110 1112333333
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .-..++|||+|-+. .+|.++++..+ +...+....++.++.|++-||..|...||+|.|||
T Consensus 503 F-~hknHLClVFE~Ls-lNLRevLKKyG-----------------~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK 563 (752)
T KOG0670|consen 503 F-KHKNHLCLVFEPLS-LNLREVLKKYG-----------------RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK 563 (752)
T ss_pred h-hhcceeEEEehhhh-chHHHHHHHhC-----------------cccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence 3 23468999999776 58899988765 34466778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||+++....+||||||.|.....+. . +...-+..|.|||++.|-+++...| .||+|++||||-
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~ene--i-tPYLVSRFYRaPEIiLG~~yd~~iD----~WSvgctLYElY 629 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENE--I-TPYLVSRFYRAPEIILGLPYDYPID----TWSVGCTLYELY 629 (752)
T ss_pred ccceEeccCcceeeeccCcccccccccc--c-cHHHHHHhccCcceeecCcccCCcc----ceeeceeeEEee
Confidence 9999999988899999999998765432 1 2334466899999999999988887 788888888763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=185.51 Aligned_cols=135 Identities=24% Similarity=0.364 Sum_probs=102.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHh-hccCCCceeeeecc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRAC-ANCCADFVYGFFEN 209 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~-~~~~~~~i~~~~~~ 209 (365)
..++|.+.++||-|.|++||+|.|.... +.||+|..+..... |+.....+...- .......++.++..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~-----r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNK-----RYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCC-----eEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 4489999999999999999999999987 88888888755432 333333222221 12334456666655
Q ss_pred cc---cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 017820 210 SS---KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVH 285 (365)
Q Consensus 210 ~~---~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiH 285 (365)
+. ..+.+.++|+|+++. +|..++....+ ..++...++.|++||+.||.|||.+ ||||
T Consensus 151 FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~Y------------------rGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNY------------------RGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred ceecCCCCcEEEEEehhhhh-HHHHHHHHhCC------------------CCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 54 445889999999975 78888877664 2456678999999999999999976 8999
Q ss_pred cCCCCCceEE
Q 017820 286 RDIKPQNVIF 295 (365)
Q Consensus 286 rDIKp~NILl 295 (365)
-||||+|||+
T Consensus 212 TDlKPENvLl 221 (590)
T KOG1290|consen 212 TDLKPENVLL 221 (590)
T ss_pred cCCCcceeee
Confidence 9999999997
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=182.98 Aligned_cols=192 Identities=24% Similarity=0.290 Sum_probs=135.0
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhc-cCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACAN-CCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 215 (365)
+|.+.++||+|+||.||++.+..++ ...+|+|........ ....+..+...+.. .....+..+.......+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 8999999999999999999998764 146777766543211 12222222222221 111223333333223456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..|+||+.++ .+|.++..... ...++...+..++.|++.+|+++|+.|++||||||+|+++
T Consensus 95 ~~~iVM~l~G-~sL~dl~~~~~------------------~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 95 FNFIVMSLLG-PSLEDLRKRNP------------------PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVV 155 (322)
T ss_pred eeEEEEeccC-ccHHHHHHhCC------------------CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeee
Confidence 7889998776 59999875543 2356777889999999999999999999999999999999
Q ss_pred ecCC----CcEEEEeccccc--ccccCCc-----cc--cccccCCCCcCCccccccCCCCCCCCCchhhhhh
Q 017820 296 SEGS----RTFKIIDLGAAA--DLRVGIN-----YI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (365)
Q Consensus 296 ~~~~----~~ikL~DFGla~--~~~~~~~-----~~--~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~sl 354 (365)
.... ..+.|.|||+|+ .+....+ .. ...+.||.+|++++...+...+..+|..|..|.+
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l 227 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYML 227 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHH
Confidence 8653 479999999999 3322221 11 2346799999999999999999999966644444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=170.31 Aligned_cols=134 Identities=16% Similarity=0.194 Sum_probs=92.9
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---------------------------HHHH--HHHHHHH
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---------------------------EIWM--NERVRRA 194 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~--~~~~~~~ 194 (365)
.+.||+|+||.||+|.+. ++ +.||+|.++..... +.+. +.+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g-----~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG-----EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC-CC-----CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999999986 56 78899987643210 0000 1111112
Q ss_pred hhccC--CCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHH
Q 017820 195 CANCC--ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (365)
Q Consensus 195 ~~~~~--~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~ 272 (365)
+.... ++.++. . ...++||||++++++........ .++...+..++.|++
T Consensus 76 l~~~~v~~p~~~~------~--~~~~iVmE~i~g~~l~~~~~~~~--------------------~~~~~~~~~i~~qi~ 127 (190)
T cd05147 76 LVTAGIPCPEPIL------L--KSHVLVMEFIGDDGWAAPRLKDA--------------------PLSESKARELYLQVI 127 (190)
T ss_pred HHHCCCCCCcEEE------e--cCCEEEEEEeCCCCCcchhhhcC--------------------CCCHHHHHHHHHHHH
Confidence 22111 222211 1 12389999999987765432221 346677889999999
Q ss_pred HHHHHH-HHCCCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 273 FALDGL-HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 273 ~aL~yL-H~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
.+|.|+ |+.||+||||||+|||+++ + .++|+|||+|...
T Consensus 128 ~~L~~l~H~~giiHrDlkP~NIli~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 128 QIMRILYQDCRLVHADLSEYNLLYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHhCCcccCCCCHHHEEEEC-C-cEEEEEccccccC
Confidence 999999 7999999999999999985 5 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=166.87 Aligned_cols=190 Identities=20% Similarity=0.270 Sum_probs=141.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH-HHHHHHHHHhhc-cCCCceeeeecccccC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACAN-CCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~-~~~~~i~~~~~~~~~~ 213 (365)
+..+.|.+.++||.|+||.+|+|.....+ ..||+|.......... ..+.++-+.+.. ...|.+..+. .+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~g-----e~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~----~e 82 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSG-----EEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG----TE 82 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCC-----ceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc----cc
Confidence 35689999999999999999999999888 8899998765544433 233344444433 2344444332 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...-.+||+..+ .+|.+++.-..- .++...+.-++.|++.-++|+|.+++|||||||+|+
T Consensus 83 ~~ynvlVMdLLG-PsLEdLfnfC~R-------------------~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 83 KDYNVLVMDLLG-PSLEDLFNFCSR-------------------RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred cccceeeeeccC-ccHHHHHHHHhh-------------------hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 567789999886 588888764432 345666778999999999999999999999999999
Q ss_pred EEecC--CCcEEEEecccccccccCCc-----c-ccccccCCCCcCCccccccCCCCCCCCCchhhhhh
Q 017820 294 IFSEG--SRTFKIIDLGAAADLRVGIN-----Y-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (365)
Q Consensus 294 Ll~~~--~~~ikL~DFGla~~~~~~~~-----~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~sl 354 (365)
|..-+ -.++.|+|||+|+.+.+... + ......||.+|.+-....+-.++..+|..|.+|.|
T Consensus 143 LMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 143 LMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred eeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 98632 23899999999997754322 1 12357899999999999999999999854444443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=163.18 Aligned_cols=140 Identities=17% Similarity=0.158 Sum_probs=93.5
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-----H---------------------HHHHHHHHHHhh
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----E---------------------IWMNERVRRACA 196 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----~---------------------~~~~~~~~~~~~ 196 (365)
+.+.||+|+||.||+|.+. ++ +.||+|..+..... + ....+.+...+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DG-----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK 74 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CC-----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999999987 56 78888887643210 0 000011112222
Q ss_pred ccCCCceeeeecccccCCCeEEEEEEecCCCcHHHH-HHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHH
Q 017820 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL-MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL 275 (365)
Q Consensus 197 ~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL 275 (365)
...++++....... . ...++||||++++++... +... ..+...+..++.|++.++
T Consensus 75 ~l~~~~i~~p~~~~-~--~~~~lVmE~~~g~~~~~~~l~~~---------------------~~~~~~~~~i~~~l~~~l 130 (190)
T cd05145 75 RLYEAGVPVPEPIL-L--KKNVLVMEFIGDDGSPAPRLKDV---------------------PLEEEEAEELYEQVVEQM 130 (190)
T ss_pred HHHhCCCCCceEEE-e--cCCEEEEEEecCCCchhhhhhhc---------------------cCCHHHHHHHHHHHHHHH
Confidence 22222221110000 1 124799999998865433 3221 235567888999999999
Q ss_pred HHHHH-CCCcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 276 DGLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 276 ~yLH~-~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
.++|+ +||+||||||+|||++ ++ .++|+|||+|+.+.
T Consensus 131 ~~lH~~~givHrDlkP~NIll~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 131 RRLYQEAGLVHGDLSEYNILYH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHhCCEecCCCChhhEEEE-CC-CEEEEEcccceecC
Confidence 99999 9999999999999998 55 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-21 Score=169.79 Aligned_cols=186 Identities=23% Similarity=0.311 Sum_probs=140.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH-HHHHHh-hccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRAC-ANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~~-~~~~~~~i~~~~~~~~~~~~~ 216 (365)
-.|+++++||+|+||+.++|.+.-++ ..||+|......+......| +.-..+ .....|+++- |+ ..+.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nn-----e~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYY-FG---qeG~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNN-----EPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYY-FG---QEGKY 98 (449)
T ss_pred ccceeccccccCcceeeecccccccC-----ceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceee-ec---cccch
Confidence 47999999999999999999998887 88999987644433322222 222222 2334454432 22 44666
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
-.||+|.++ .+|.|++.-.+- .++.+.+.-++.|++.-++|+|++.+|+|||||+|+||.
T Consensus 99 NiLVidLLG-PSLEDLFD~CgR-------------------~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 99 NILVIDLLG-PSLEDLFDLCGR-------------------RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred hhhhhhhhC-cCHHHHHHHhcC-------------------cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 789999876 588888765543 456677888999999999999999999999999999996
Q ss_pred cC----CCcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhh
Q 017820 297 EG----SRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357 (365)
Q Consensus 297 ~~----~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~v 357 (365)
.. ...+.|+|||+|+.+.+.... ..+...||.+||+-.-..|.+++..+| .=|||-+
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDD----LEaLGHv 225 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDD----LEALGHV 225 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhh----HHHhhhh
Confidence 32 238999999999987665321 234689999999999999999999998 6666644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=202.76 Aligned_cols=126 Identities=16% Similarity=0.193 Sum_probs=94.1
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..++.++||++ ++|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||
T Consensus 53 ~~~~~~~e~~~-~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 53 DSIVRALECED-VSLRQWLDNPD-------------------RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred chhhhhhccCC-ccHHHHHhccc-------------------ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 45777888774 59999996432 23577889999999999999999999999999999999
Q ss_pred EecCC------------------CcEEEEecccccccccCCc---------------cccccccCCCCcCCccccccCCC
Q 017820 295 FSEGS------------------RTFKIIDLGAAADLRVGIN---------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 295 l~~~~------------------~~ikL~DFGla~~~~~~~~---------------~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
|+..+ ..+||+|||+++....... .......||+.|||||++.+..+
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 192 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS 192 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCC
Confidence 96432 2566677776654211000 00112468999999999988777
Q ss_pred CCCCCCchhhhhhhhhheecccC
Q 017820 342 TPSAPSAPVATALSPVLWQVQCS 364 (365)
Q Consensus 342 ~~~~d~~s~~~slg~vlw~lGc~ 364 (365)
+.++| +||||++||||-|.
T Consensus 193 ~~~sD----VwSlGviL~ELl~~ 211 (793)
T PLN00181 193 NCASD----VYRLGVLLFELFCP 211 (793)
T ss_pred Cchhh----hhhHHHHHHHHhhC
Confidence 66555 99999999999763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-21 Score=193.97 Aligned_cols=197 Identities=21% Similarity=0.263 Sum_probs=154.3
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..+.|.|.+.||+|+||.||+|...+ + +.+|+|.-++...+|..+..+++..+.....+.+..+.... .-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~-----~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~-~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-G-----KLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAH-VFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-C-----cEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHH-ccCC
Confidence 445699999999999999999999887 4 89999999999999988888777666622222233332222 2234
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.-++|+||.+.|||.+++...+ ..++..+..+..|++.-++.||..+|||+||||+|+||
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~--------------------~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll 827 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNK--------------------VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLL 827 (974)
T ss_pred cceeeeeccccccHHHhhccCC--------------------CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEe
Confidence 5679999999999999998554 34777889999999999999999999999999999999
Q ss_pred ec------CCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhe
Q 017820 296 SE------GSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (365)
Q Consensus 296 ~~------~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw 359 (365)
.. +..-++|+|||.|.++.--. +..-+..++|-.+-.+|+..|..++...|.+..+..+.++|+
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 52 23379999999998764322 223456788999999999999999999996655555555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=162.63 Aligned_cols=140 Identities=16% Similarity=0.112 Sum_probs=99.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHH---------HHHHHHHhhccCCCceeeee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWM---------NERVRRACANCCADFVYGFF 207 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~~ 207 (365)
..++|++.+.||+|+||.||++.+. + +.+++|...+........ .+++.+.+....|+++....
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~--~-----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD--Y-----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC--C-----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 4589999999999999999997652 3 679999886443221111 23343333444445444333
Q ss_pred cccccC-------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH
Q 017820 208 ENSSKK-------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280 (365)
Q Consensus 208 ~~~~~~-------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~ 280 (365)
...... ....+++|||++|.+|.++... ++ ....+++.+|..+|+
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~------------------------~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI------------------------SE----DVKAKIKASIESLHQ 153 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhhc------------------------cH----HHHHHHHHHHHHHHH
Confidence 222111 2468999999999999887321 11 245699999999999
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
.|++|||+||+||++++++ ++|+|||..+..
T Consensus 154 ~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~ 184 (232)
T PRK10359 154 HGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCT 184 (232)
T ss_pred cCCccCCCChHHEEEeCCC--EEEEECCCcccc
Confidence 9999999999999999865 999999988765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=162.61 Aligned_cols=190 Identities=28% Similarity=0.350 Sum_probs=138.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCC-ceeeeecccccCCCe
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCAD-FVYGFFENSSKKGGE 216 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~ 216 (365)
|.+.+.||.|+||.||++.+. ..+++|.+....... .....++........++ ++..+.... .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~ 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGS 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCE
Confidence 788999999999999999988 345555554332221 22222233344444555 577776665 44455
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.+++++++.++++.+++...... ..........++.|++.++.|+|+.+++|||+||+||+++
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~ 135 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRK-----------------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD 135 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 89999999999999777654311 2346777889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-----ccccccCCCCcCCccccccC---CCCCCCCCchhhhhhhhhhee
Q 017820 297 EGSRTFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMS---TQTPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~---~~~~~~d~~s~~~slg~vlw~ 360 (365)
..+..++++|||.++........ ......||..|+|||.+.+. ..... .|+|++|+++++
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~----~D~~s~g~~~~~ 203 (384)
T COG0515 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS----SDIWSLGITLYE 203 (384)
T ss_pred CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCch----HhHHHHHHHHHH
Confidence 87646999999999865544322 23578999999999998763 34444 458888877665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=154.15 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=94.0
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-----CCCceeeeecccccCC--Ce
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-----CADFVYGFFENSSKKG--GE 216 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-----~~~~i~~~~~~~~~~~--~~ 216 (365)
.+.||+|+||.||. +..+. . .++|++............++...+... .|++|+.+++...++. +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~-----~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDA-----Q-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCc-----C-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 57899999999995 44442 2 357765533111111222233333333 5799999988876653 34
Q ss_pred -EEEEEEec--CCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCc
Q 017820 217 -YWLIWRYE--GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL-DGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 217 -~~lV~e~~--~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL-~yLH~~~IiHrDIKp~N 292 (365)
+.+|+||. .+++|.+++.+.. +++. ..++.|++.++ +|||+++|+||||||+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~---------------------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~N 135 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCR---------------------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQN 135 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHccc---------------------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 44889994 4899999997543 1223 25678888888 99999999999999999
Q ss_pred eEEecC---CCcEEEEe-ccccccc
Q 017820 293 VIFSEG---SRTFKIID-LGAAADL 313 (365)
Q Consensus 293 ILl~~~---~~~ikL~D-FGla~~~ 313 (365)
||++.. +..++|+| ||....+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~~~~i 160 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGESTFI 160 (210)
T ss_pred EEEeccCCCCCcEEEEECCCCccee
Confidence 999742 23899999 5555443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=150.47 Aligned_cols=176 Identities=14% Similarity=0.101 Sum_probs=113.4
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH----HHHHHHHHHhhcc-CCCceeeeecccccCCCe
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI----WMNERVRRACANC-CADFVYGFFENSSKKGGE 216 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~ 216 (365)
.+...|++|+||+||++...+ .+++.+.+........ +..+++...+... +++++..++.. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~-------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~ 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGE-------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DG 72 (218)
T ss_pred ccceeecCCCcceEEEeecCC-------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cC
Confidence 357789999999999877633 6677666654443221 2233344444444 22334444332 34
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCceEE
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI-KPQNVIF 295 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI-Kp~NILl 295 (365)
.+++|||+.|.+|.+..... ...++.|++.+|.++|++||+|||| ||+|||+
T Consensus 73 ~~lvmeyI~G~~L~~~~~~~---------------------------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv 125 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPRG---------------------------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV 125 (218)
T ss_pred EEEEEeeecCccHHhhhhhh---------------------------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE
Confidence 68999999999886543210 1246789999999999999999999 7999999
Q ss_pred ecCCCcEEEEecccccccccCCcc----c--------cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhe
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY----I--------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~----~--------~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw 359 (365)
+.++ .++|+|||+|......... . ..-...++.|++|+.-.. ...++-...+.++.|--+|
T Consensus 126 ~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~--l~~~~~~~~~w~~~g~~~~ 198 (218)
T PRK12274 126 QEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV--LKRTSWIRELWFATGKPVY 198 (218)
T ss_pred cCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh--hccchhHHHHHHHhcchHH
Confidence 9877 9999999999855432210 0 011246888999986543 2233333444555554433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=155.10 Aligned_cols=143 Identities=17% Similarity=0.150 Sum_probs=97.0
Q ss_pred CeEEeeeeecCCCeeEEEEE-ecCCCCCCCCcceeehhhccccHH----------------------H--HHHHHHHHHH
Q 017820 140 DFVLGKKLGEGAFGVVYRAS-LAKKPSSKNDGDLVLKKATEYGAV----------------------E--IWMNERVRRA 194 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~-~~~~~~~~~~~~vavK~~~~~~~~----------------------~--~~~~~~~~~~ 194 (365)
.|.+.+.||+|+||.||+|. +..++ ..|++|.++..... + ....+.+...
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSG-----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCC-----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 58899999999999999998 55566 77888877633110 0 0001111222
Q ss_pred hhccCC--CceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHH
Q 017820 195 CANCCA--DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (365)
Q Consensus 195 ~~~~~~--~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~ 272 (365)
+....+ ..+...+.. ...++||||+++.+|........ ..+...+..++.|++
T Consensus 104 L~~L~~~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~ 158 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKDV--------------------EPEEEEEFELYDDIL 158 (237)
T ss_pred HHHHHhcCCCCCeeeEe-----cCceEEEEEecCCcccccccccC--------------------CcchHHHHHHHHHHH
Confidence 211111 111222221 23589999999988766542211 224455678999999
Q ss_pred HHHHHHHHCC-CcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 273 FALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 273 ~aL~yLH~~~-IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
.+|.+||++| |+||||||+||+++ ++ .++|+|||.|....
T Consensus 159 ~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~~~~ 199 (237)
T smart00090 159 EEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSVELD 199 (237)
T ss_pred HHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhhccC
Confidence 9999999999 99999999999999 55 99999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-18 Score=171.68 Aligned_cols=194 Identities=22% Similarity=0.208 Sum_probs=138.0
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHH---HHHhhccCCCceeeeecccccCCCeEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERV---RRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
...+.+|.|.+|.|+.+...........+.+.++ .. ....+......+ .-.-....|++++..+...... ....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-DGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-ccch
Confidence 4567899999998888887766644333444433 21 222222222211 1122334566665554444222 3334
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
-.|||++. +|+.++.+.. .+....+..+++|++.|+.|+|+.||.|||+|++|+++..+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~--------------------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~ 456 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNG--------------------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN 456 (601)
T ss_pred hhhhcccH-HHHHHHhccc--------------------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC
Confidence 44999999 9999998763 22445577899999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 299 SRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ .+||+|||.+..+..... .....++|+..|+|||++.+..+.+..- |+|+.|+++..|-+
T Consensus 457 g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~v---DiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 457 G-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAV---DVWSCGIIYICMIL 520 (601)
T ss_pred C-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchh---hhhhccceEEEEec
Confidence 8 999999999986654422 3445789999999999999888877665 59999999887754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=144.37 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=93.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--H--------------------HHHHHHHHHHhhc
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--E--------------------IWMNERVRRACAN 197 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~--------------------~~~~~~~~~~~~~ 197 (365)
.|.+.+.||+|+||.||++... ++ +.+++|........ + ......+...+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DG-----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CC-----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3888999999999999999875 44 77888865432100 0 0001111111111
Q ss_pred cCCC--ceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHH
Q 017820 198 CCAD--FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL 275 (365)
Q Consensus 198 ~~~~--~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL 275 (365)
..+. .+...+. ....++||||+++++|.++... .....++.+++.++
T Consensus 90 l~~~~i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~--------------------------~~~~~~~~~i~~~l 138 (198)
T cd05144 90 LYEEGFPVPKPID-----WNRHAVVMEYIDGVELYRVRVL--------------------------EDPEEVLDEILEEI 138 (198)
T ss_pred HHHcCCCCCceee-----cCCceEEEEEeCCcchhhcccc--------------------------ccHHHHHHHHHHHH
Confidence 1122 1111111 2345899999999998765321 11446888999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 276 DGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 276 ~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
.++|+.||+||||||+||++++++ .++|+|||.|....
T Consensus 139 ~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~~~ 176 (198)
T cd05144 139 VKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccccCC
Confidence 999999999999999999999877 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=144.24 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=91.6
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HH----HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VE----IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
+.||+|++|.||+|.+.+ ..+++|+...... .. .....++...+....+.++....... .....
T Consensus 2 ~~l~~G~~~~vy~~~~~~-------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG-------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYF-VDPEN 73 (211)
T ss_pred cccccCceEEEEEEeeCC-------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEE-EeCCC
Confidence 579999999999998743 5577776442210 00 11111122222222222221111111 12346
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.+++|||+++++|.+++.... . ....++.+++.+|.++|+.+++|+|++|+|||++
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~-----------------------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG-----------------------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc-----------------------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 789999999999999886532 1 4667899999999999999999999999999999
Q ss_pred cCCCcEEEEeccccccc
Q 017820 297 EGSRTFKIIDLGAAADL 313 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~ 313 (365)
++ .++|+|||.++..
T Consensus 130 -~~-~~~liDf~~a~~~ 144 (211)
T PRK14879 130 -GG-KIYLIDFGLAEFS 144 (211)
T ss_pred -CC-CEEEEECCcccCC
Confidence 45 8999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=142.92 Aligned_cols=98 Identities=26% Similarity=0.273 Sum_probs=82.2
Q ss_pred CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEe
Q 017820 227 ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306 (365)
Q Consensus 227 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~D 306 (365)
|+|.+++...+ ..+++..++.++.|++.||.|||+++ ||+|||++.++ .+|+
T Consensus 1 GsL~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~-- 52 (176)
T smart00750 1 VSLADILEVRG-------------------RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL-- 52 (176)
T ss_pred CcHHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--
Confidence 67888887643 24688899999999999999999999 99999999987 8998
Q ss_pred cccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 307 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+++..... ...||+.|||||++.+..++.++| +||||+++|+|-
T Consensus 53 fG~~~~~~~~------~~~g~~~y~aPE~~~~~~~~~~~D----iwSlG~il~ell 98 (176)
T smart00750 53 DGSVAFKTPE------QSRVDPYFMAPEVIQGQSYTEKAD----IYSLGITLYEAL 98 (176)
T ss_pred ccceEeeccc------cCCCcccccChHHhcCCCCcchhh----HHHHHHHHHHHH
Confidence 9999875432 236899999999998887776555 999999999984
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-17 Score=162.07 Aligned_cols=142 Identities=17% Similarity=0.142 Sum_probs=93.5
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.|...+.||+|+||.||+|.+.... ...+..+.|....... .......++...+....++++....... .....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-~~~~~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD-VDPEE 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE-EeCCC
Confidence 4456889999999999999876542 1111111121111110 1111222333344444444443322222 22345
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++.. ...++.|++.+|.|||+++|+||||||+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~~----------------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~ 462 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEG----------------------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462 (535)
T ss_pred CEEEEEecCCCcHHHHHHH----------------------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence 7899999999999988752 346889999999999999999999999999994
Q ss_pred cCCCcEEEEecccccccc
Q 017820 297 EGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~ 314 (365)
++ .++|+|||+|+...
T Consensus 463 -~~-~~~liDFGla~~~~ 478 (535)
T PRK09605 463 -DD-RLYLIDFGLGKYSD 478 (535)
T ss_pred -CC-cEEEEeCcccccCC
Confidence 44 89999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.7e-17 Score=140.16 Aligned_cols=129 Identities=17% Similarity=0.230 Sum_probs=86.6
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----HH-HH---HHHHHHHHHhhccCCCc--eeeeecccccCCC
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AV-EI---WMNERVRRACANCCADF--VYGFFENSSKKGG 215 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~-~~---~~~~~~~~~~~~~~~~~--i~~~~~~~~~~~~ 215 (365)
.||+|+||.||+|.+.+ +.+++|...... .. .. ....++...+....+.+ +...+. ....
T Consensus 1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~---~~~~ 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD---VDPD 70 (199)
T ss_pred CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE---EECC
Confidence 38999999999998543 567777643211 11 11 11111222222211111 111111 1234
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... . .++.|++.+|.+||+.|++|+|+||+||++
T Consensus 71 ~~~lv~e~~~g~~l~~~~~~~~--------------------------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~ 123 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKDVIEEGN--------------------------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIV 123 (199)
T ss_pred CCEEEEEEECCccHHHHHhhcH--------------------------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEE
Confidence 5689999999999998875432 0 588999999999999999999999999999
Q ss_pred ecCCCcEEEEeccccccc
Q 017820 296 SEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~ 313 (365)
+ ++ .++++|||+++..
T Consensus 124 ~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 124 R-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred E-CC-cEEEEECCCCcCC
Confidence 9 55 9999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-17 Score=140.29 Aligned_cols=136 Identities=18% Similarity=0.178 Sum_probs=86.7
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH----HHHH--------------------HHHHHHHhhccC
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWM--------------------NERVRRACANCC 199 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~--------------------~~~~~~~~~~~~ 199 (365)
.+.||+|+||.||+|.+. ++ ..|++|..+..... .... .+.+...+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG-----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC-CC-----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 578999999999999987 44 77899876543211 0000 000011110000
Q ss_pred CC--ceeeeecccccCCCeEEEEEEecCCCcHHH-HHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHH
Q 017820 200 AD--FVYGFFENSSKKGGEYWLIWRYEGEATLAD-LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (365)
Q Consensus 200 ~~--~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~ 276 (365)
.. .+...+.. ...++||||++++++.. .+.... ....+..++.+++.++.
T Consensus 76 ~~~~~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~----------------------~~~~~~~~~~~~~~~l~ 128 (187)
T cd05119 76 EAGVPVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR----------------------LLEDPEELYDQILELMR 128 (187)
T ss_pred HcCCCCCceEec-----CCCEEEEEEeCCCCccChhhhhhh----------------------hcccHHHHHHHHHHHHH
Confidence 00 01111111 24589999999955321 111110 00346789999999999
Q ss_pred HHHH-CCCcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 277 GLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 277 yLH~-~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
++|. ++|+|+||||+||+++ ++ .++|+|||.|....
T Consensus 129 ~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a~~~~ 165 (187)
T cd05119 129 KLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQAVEID 165 (187)
T ss_pred HHhhccCcCcCCCChhhEEEE-CC-cEEEEECccccccc
Confidence 9999 9999999999999999 55 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.6e-17 Score=146.82 Aligned_cols=202 Identities=17% Similarity=0.183 Sum_probs=114.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHh--------------hccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRAC--------------ANCC 199 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~--------------~~~~ 199 (365)
..+..++.||.|+|+.||++++..|+ ..+++|...... ..+...++.+.... +...
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~-----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETG-----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred eEEEEccccccCCceEEEEEEEccCC-----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 36778899999999999999999999 666666543221 22222222211111 1111
Q ss_pred CCceeeeecc-----cccCCCe-----EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHH
Q 017820 200 ADFVYGFFEN-----SSKKGGE-----YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMS 269 (365)
Q Consensus 200 ~~~i~~~~~~-----~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 269 (365)
.--++.+-+. ....... .+++|+-. .++|.+++..-.... + ............+..
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-----------~--~~~~l~~~arl~lT~ 152 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-----------Q--THSPLAFAARLSLTV 152 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-----------T--TSHHHHHHHHHHHHH
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-----------c--ccchhHHHHHHHHHH
Confidence 1111111100 0011112 35566655 468887765321000 0 011122233345668
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC----CCCCC
Q 017820 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST----QTPSA 345 (365)
Q Consensus 270 qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~ 345 (365)
|+++.+.+||++|++|+||||+|++++.+| .++|+||+....... .... ...+..|.+||...... .....
T Consensus 153 Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~ 227 (288)
T PF14531_consen 153 QMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPY 227 (288)
T ss_dssp HHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE
T ss_pred HHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCccccee
Confidence 999999999999999999999999999998 999999988765432 2211 34457899999765431 11222
Q ss_pred CCchhhhhhhhhheecccC
Q 017820 346 PSAPVATALSPVLWQVQCS 364 (365)
Q Consensus 346 d~~s~~~slg~vlw~lGc~ 364 (365)
....|+|+||+++|.++|.
T Consensus 228 t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 228 TFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHS
T ss_pred eeccCHHHHHHHHHHHHHc
Confidence 3366799999999999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=161.57 Aligned_cols=181 Identities=20% Similarity=0.196 Sum_probs=130.8
Q ss_pred eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccC-CCceeeeecccccCCCeEEEEEE
Q 017820 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCC-ADFVYGFFENSSKKGGEYWLIWR 222 (365)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~lV~e 222 (365)
.+|+|.||.|++++-....... .-+++|..+...... ......++..+...+ +++++.....+ ......+++.+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~--~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-qt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAG--HLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-QTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhcccccc--chhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-ccccchhHhhh
Confidence 3799999999988654322221 445655554322110 001122333344444 77777776655 56678899999
Q ss_pred ecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcE
Q 017820 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (365)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~i 302 (365)
|..+|+|...+.... .+++...+.+...++-+++.+|+.+|+|||+|++||+++.+| ++
T Consensus 78 ~~rgg~lft~l~~~~--------------------~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi 136 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEV--------------------MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HI 136 (612)
T ss_pred hcccchhhhccccCC--------------------chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-cc
Confidence 999998877665543 446677788999999999999999999999999999999998 99
Q ss_pred EEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.|||+++..-.... .+||..|||||++. .. +...|+|++|+++++|
T Consensus 137 ~~tdfglske~v~~~~-----~cgt~eymApEI~~--gh----~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 137 KLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--GH----LSAADWWSFGVLAFEL 184 (612)
T ss_pred ccCCchhhhHhHhhhh-----cccchhhhhhHhhh--cc----CCcccchhhhhhHHHH
Confidence 9999999997643322 29999999999987 23 3345599999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-16 Score=161.14 Aligned_cols=156 Identities=24% Similarity=0.368 Sum_probs=112.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..+|..+|.|..|++|.||.++++.+. .++++ ++++....- + ||..+-+ ..
T Consensus 82 e~df~~IklisngAygavylvrh~~tr-----qrfa~-kiNkq~lil-------R---------nilt~a~-------np 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETR-----QRFAM-KINKQNLIL-------R---------NILTFAG-------NP 132 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccc-----cchhh-cccccchhh-------h---------ccccccC-------Cc
Confidence 369999999999999999999999887 77888 444322110 0 1222211 12
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+.| |+-...++..+. + =.+++.+++|||+.||+|||+||+|.+|..
T Consensus 133 fvv------gDc~tllk~~g~--------------------l--------Pvdmvla~Eylh~ygivhrdlkpdnllIT~ 178 (1205)
T KOG0606|consen 133 FVV------GDCATLLKNIGP--------------------L--------PVDMVLAVEYLHSYGIVHRDLKPDNLLITS 178 (1205)
T ss_pred cee------chhhhhcccCCC--------------------C--------cchhhHHhHhhccCCeecCCCCCCcceeee
Confidence 222 333333333220 1 122378899999999999999999999999
Q ss_pred CCCcEEEEecccccccccC--------------CccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 298 GSRTFKIIDLGAAADLRVG--------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~--------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
=| ++|++|||+++..-.. .....+.++|||.|+|||++....|....| +|+||+++|+.
T Consensus 179 mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvd----wwamGiIlyeF 251 (1205)
T KOG0606|consen 179 MG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVD----WWAMGIILYEF 251 (1205)
T ss_pred cc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCcc----HHHHHHHHHHH
Confidence 77 9999999999854211 123345689999999999999999988888 99999999984
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=138.53 Aligned_cols=207 Identities=19% Similarity=0.271 Sum_probs=131.7
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCC------------------------------CcceeehhhccccH
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKN------------------------------DGDLVLKKATEYGA 182 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~------------------------------~~~vavK~~~~~~~ 182 (365)
...+..++|+|++.||+|--..||.|+...+++... .-..++|.+.....
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 345678899999999999999999998765321100 11245565532211
Q ss_pred ---HHHHHHH---HH---------------------HHHhhccCCCceeeeeccccc-----------------------
Q 017820 183 ---VEIWMNE---RV---------------------RRACANCCADFVYGFFENSSK----------------------- 212 (365)
Q Consensus 183 ---~~~~~~~---~~---------------------~~~~~~~~~~~i~~~~~~~~~----------------------- 212 (365)
.+...+. ++ ........|+||+.++..+..
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1111000 00 001233579999887665432
Q ss_pred ---CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 213 ---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 213 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
.+..+|+||.-... +|.+++..+. ++....+-++.|+++|+.|||.+||.|||+|
T Consensus 311 g~g~~~tlylvMkrY~~-tLr~yl~~~~---------------------~s~r~~~~~laQlLEav~hL~~hgvAhRDlK 368 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQ-TLREYLWTRH---------------------RSYRTGRVILAQLLEAVTHLHKHGVAHRDLK 368 (598)
T ss_pred ccCCCceEEEehhcchh-hHHHHHhcCC---------------------CchHHHHHHHHHHHHHHHHHHHccchhhccc
Confidence 23556777765553 7777776553 3555667789999999999999999999999
Q ss_pred CCceEEecCC---CcEEEEecccccccccC---Ccccc--ccccCCCCcCCccccccCCCCC--CCCCchhhhhhhhhhe
Q 017820 290 PQNVIFSEGS---RTFKIIDLGAAADLRVG---INYIP--KEFLLDPRYAAPEQYIMSTQTP--SAPSAPVATALSPVLW 359 (365)
Q Consensus 290 p~NILl~~~~---~~ikL~DFGla~~~~~~---~~~~~--~~~~gt~~Y~APE~l~~~~~~~--~~d~~s~~~slg~vlw 359 (365)
.+|||+.-++ ..+.|+|||++-.-..- -.+.. -..-|.-.-||||+....+-.. -.-...|.|+.|.+-|
T Consensus 369 SDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaY 448 (598)
T KOG4158|consen 369 SDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAY 448 (598)
T ss_pred ccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHH
Confidence 9999985332 27889999988532211 01111 1356788899999875442211 1123567899998888
Q ss_pred ec
Q 017820 360 QV 361 (365)
Q Consensus 360 ~l 361 (365)
|+
T Consensus 449 EI 450 (598)
T KOG4158|consen 449 EI 450 (598)
T ss_pred HH
Confidence 75
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-14 Score=131.08 Aligned_cols=72 Identities=14% Similarity=0.216 Sum_probs=59.5
Q ss_pred EEEEEEecCC-CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 217 YWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 217 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.++|+|++++ .+|.+++.... +++. .+.|++.+|.+||++||+||||||+|||+
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~~~---------------------l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 121 ADILIERIEGARDLVALLQEAP---------------------LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred eeEEEEecCCCCCHHHHHhcCC---------------------CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 3599999997 68988876432 1222 35789999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccc
Q 017820 296 SEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~ 314 (365)
+.++ .++|+|||.++...
T Consensus 176 ~~~~-~v~LIDfg~~~~~~ 193 (239)
T PRK01723 176 DPDG-KFWLIDFDRGELRT 193 (239)
T ss_pred cCCC-CEEEEECCCcccCC
Confidence 9877 99999999998643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-16 Score=151.49 Aligned_cols=123 Identities=24% Similarity=0.316 Sum_probs=104.6
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++.|++|...+|.+++.... .+...+......++.|++.+++| ++.+|||+||.||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-----------------~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif 388 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-----------------TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIF 388 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-----------------cccccchhHHHHHHHhhccchhh---ccchhhhccccccc
Confidence 35889999999999999997553 23345667788999999999999 99999999999999
Q ss_pred EecCCCcEEEEecccccccccCC-----ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+..+. ++||.|||+........ ....+.-.||..||+||++.+..++.+.| +|+||++|+||-
T Consensus 389 ~~~d~-q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvd----IyaLGlil~EL~ 456 (516)
T KOG1033|consen 389 FSDDD-QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVD----IYALGLILAELL 456 (516)
T ss_pred cccch-hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcc----hhhHHHHHHHHH
Confidence 99887 99999999998765544 22345679999999999999999999998 999999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=119.68 Aligned_cols=131 Identities=23% Similarity=0.210 Sum_probs=93.0
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhc--cCCCceeeeecccccCCCeEEE
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACAN--CCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l 219 (365)
+.+.||+|.++.||++.... +.+++|....... .....+......+.. ...+.++... ..++..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~----~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG----ESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc----CCCCccEE
Confidence 45789999999999999865 5688887765442 122222223333333 2344443332 23367899
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCceEEe
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---GIVHRDIKPQNVIFS 296 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~---~IiHrDIKp~NILl~ 296 (365)
++||++++++..+ +......++.+++++|.++|.. +++|+|+||+||+++
T Consensus 71 v~e~~~g~~~~~~---------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~ 123 (155)
T cd05120 71 LMEWIEGETLDEV---------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123 (155)
T ss_pred EEEecCCeecccC---------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE
Confidence 9999998776543 1123456789999999999985 699999999999999
Q ss_pred cCCCcEEEEecccccc
Q 017820 297 EGSRTFKIIDLGAAAD 312 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~ 312 (365)
+.+ .++++|||.++.
T Consensus 124 ~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 124 DGK-ILGIIDWEYAGY 138 (155)
T ss_pred CCc-EEEEEecccccC
Confidence 866 999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=127.68 Aligned_cols=193 Identities=13% Similarity=0.134 Sum_probs=138.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+...+..+..+|.+...|+.|+|++.+. .+++|.+.-..-. -.....++--.++...|+|+..+++.+ .+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn-------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-ns 258 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN-------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-NS 258 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc-------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-cC
Confidence 3445667778899999999999999874 4666655422111 011111223456677899999999887 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC-Cc-ccCCCCC
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IV-HRDIKPQ 291 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~-Ii-HrDIKp~ 291 (365)
...+.++..|++-|+|+.++++.. +...+..++.+++.++++|+.|||+.. +| ---+...
T Consensus 259 ppnlv~isq~mp~gslynvlhe~t------------------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 259 PPNLVIISQYMPFGSLYNVLHEQT------------------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred CCCceEeeeeccchHHHHHHhcCc------------------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 578999999999999999998764 234466788899999999999999874 33 3468888
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++||++- +.+|. .+-+++ .++.....-.|.||+||.++..+.+..- ...|.|||++++|||.
T Consensus 321 hvmidedl-taris-mad~kf-----sfqe~gr~y~pawmspealqrkped~n~-raadmwsfaillwel~ 383 (448)
T KOG0195|consen 321 HVMIDEDL-TARIS-MADTKF-----SFQEVGRAYSPAWMSPEALQRKPEDLNI-RAADMWSFAILLWELN 383 (448)
T ss_pred eEEecchh-hhhee-ccccee-----eeeccccccCcccCCHHHHhcCchhcch-hhhhHHHHHHHHHHhh
Confidence 99999876 66653 121221 1223345668899999999876554433 3678999999999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=134.14 Aligned_cols=78 Identities=19% Similarity=0.293 Sum_probs=59.6
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHH-HHHHHHHCCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF-ALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~-aL~yLH~~~IiHrDIKp~NI 293 (365)
...++||||++|++|.++...... ..+ ...++.+++. .+..+|..|++|+|+||.||
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~-------------------~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNi 288 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEA-------------------GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNI 288 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhc-------------------CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccE
Confidence 346899999999999887653210 001 2235555555 46788999999999999999
Q ss_pred EEecCCCcEEEEeccccccccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRV 315 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~ 315 (365)
++++++ .++++|||++..+..
T Consensus 289 lv~~~g-~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 289 FVLKDG-KIIALDFGIVGRLSE 309 (437)
T ss_pred EECCCC-cEEEEeCCCeeECCH
Confidence 999887 999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9e-14 Score=141.57 Aligned_cols=193 Identities=20% Similarity=0.150 Sum_probs=127.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++...+.||.+.|=.|.+|++.. +.|++|..-... ..+.....+.++ .....++|...|.... ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-------G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-~t~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-------GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-VTDK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-------ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-HhhH
Confidence 78899999999999999999877 456666654332 222222222222 5556677777664432 3334
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..|+|-+|... +|+|-+..+.| +..-..++|+.|++.||.-+|..||+|+|||.+||||
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPF--------------------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPF--------------------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchH--------------------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 45566666654 77777765543 2344466899999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCC-CCC-C-----CCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMST-QTP-S-----APSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~-~~~-~-----~d~~s~~~slg~vlw~lG 362 (365)
+.-+ =+.|+||..-+..--..+. --.+...-..|+|||.+.... .+. . -....|++|+|.++-||-
T Consensus 154 TSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 154 TSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred eeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 9876 7899999876532111110 011112223599999987532 111 1 223568999999988775
Q ss_pred c
Q 017820 363 C 363 (365)
Q Consensus 363 c 363 (365)
|
T Consensus 233 ~ 233 (1431)
T KOG1240|consen 233 L 233 (1431)
T ss_pred h
Confidence 5
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.5e-12 Score=108.14 Aligned_cols=126 Identities=18% Similarity=0.138 Sum_probs=84.2
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhh-ccCCCceeeeecccccCCCeEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
.+.|+.|.++.||+++... +.+++|....... .....+.+....+. ....+.++.+. ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~-------~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~------~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN-------KKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD------PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECC-------eEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe------CCCCeEE
Confidence 4678999999999998763 6788888754431 11111111222221 12234343321 1234799
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCceEE
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI-----VHRDIKPQNVIF 295 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I-----iHrDIKp~NILl 295 (365)
|||+++.++.+.. . ....++.+++++|..||+.++ +|+|++|.||++
T Consensus 70 ~e~i~G~~l~~~~--~--------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~ 121 (170)
T cd05151 70 TEFIEGSELLTED--F--------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL 121 (170)
T ss_pred EEecCCCcccccc--c--------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE
Confidence 9999998875430 0 012356899999999999985 999999999999
Q ss_pred ecCCCcEEEEecccccc
Q 017820 296 SEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~ 312 (365)
+ ++ .++++|||.|..
T Consensus 122 ~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 122 D-DG-RLWLIDWEYAGM 136 (170)
T ss_pred E-CC-eEEEEecccccC
Confidence 9 45 899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.9e-12 Score=125.05 Aligned_cols=148 Identities=18% Similarity=0.168 Sum_probs=89.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--------------------------------
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW-------------------------------- 186 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------- 186 (365)
.+|+. +.||+|++|+||+|+.+.++ +.||+|..++.....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G-----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNG-----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCC-----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 45666 78999999999999998866 78999988644211100
Q ss_pred ---HHH-----HH----HHHhhccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHH--HhcCCCcchhhhhcccccc
Q 017820 187 ---MNE-----RV----RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLM--ISREFPYNVQTLILGEVQD 252 (365)
Q Consensus 187 ---~~~-----~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~ 252 (365)
... ++ .+...+..+...+.+-..+..-....++||||+.|+.+.++- ...+.
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-------------- 259 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-------------- 259 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC--------------
Confidence 000 00 000111111111111111111123467999999999998752 22221
Q ss_pred CcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC---CcEEEEeccccccccc
Q 017820 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS---RTFKIIDLGAAADLRV 315 (365)
Q Consensus 253 ~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~---~~ikL~DFGla~~~~~ 315 (365)
....+.+..+..++.|++ ..|++|+|+||.||+++.++ +.++++|||++..+..
T Consensus 260 --d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 260 --DMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --CHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 011223344455555654 58999999999999998765 3899999999987653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-12 Score=126.13 Aligned_cols=144 Identities=17% Similarity=0.231 Sum_probs=111.9
Q ss_pred ccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHH
Q 017820 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (365)
Q Consensus 197 ~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~ 276 (365)
...|.|+..|.+..... ...++|++||..|+|.|.+....+ ..++.....++++++.||.
T Consensus 3 ~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~-------------------~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDI-------------------KLDYFFILSFIRDISKGLA 62 (484)
T ss_pred ccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcccc-------------------CccHHHHHHHHHHHHHHHH
Confidence 44578888888877444 889999999999999999987542 4577778889999999999
Q ss_pred HHHHCCC-cccCCCCCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCC---CCCchhh
Q 017820 277 GLHSTGI-VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPS---APSAPVA 351 (365)
Q Consensus 277 yLH~~~I-iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~---~d~~s~~ 351 (365)
|||.-.| .|+.++..|+++|... .+||+|||+........... .....-..-|.|||.+........ .....|+
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred HHhcCcceeeeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 9998876 8999999999999976 99999999987664211110 111223456999999988644444 4556779
Q ss_pred hhhhhhheec
Q 017820 352 TALSPVLWQV 361 (365)
Q Consensus 352 ~slg~vlw~l 361 (365)
||+|++++|+
T Consensus 142 Ys~~ii~~ei 151 (484)
T KOG1023|consen 142 YSFGIIMYEI 151 (484)
T ss_pred ehHHHHHHHH
Confidence 9999999886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-13 Score=137.60 Aligned_cols=197 Identities=24% Similarity=0.282 Sum_probs=137.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--H-HHHHHHHhhccCCCceeeeecccccCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--M-NERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~-~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
...|.+.+.||+|+|+.|-......... ..++.|.+......+.. . ..+.........|.+++.+++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~----~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPE----SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCc----ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-CCC
Confidence 3578888999999999999887754431 44555555433211111 1 11111112222388888888776 555
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH-STGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH-~~~IiHrDIKp~NI 293 (365)
...+++++|..++++.+.+..... ...+......++.|+..++.|+| ..++.||||||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~------------------~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~ 155 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS------------------TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNS 155 (601)
T ss_pred cccccccCcccccccccccccCCc------------------cCCCCcchhhhhhhhccCccccCcccccccCCCCCccc
Confidence 788999999999998887732211 01233345579999999999999 99999999999999
Q ss_pred EEecCCCcEEEEeccccccccc--CCccccccccC-CCCcCCccccccCCC-CCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRV--GINYIPKEFLL-DPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~--~~~~~~~~~~g-t~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~l 361 (365)
+++..+..+++.|||+|..+.. +........+| ++.|+|||...+..+ .+..| +|+.|+++-.+
T Consensus 156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d----~~S~g~~l~~~ 223 (601)
T KOG0590|consen 156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVD----VWSLGIVLSAM 223 (601)
T ss_pred hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcc----ccccccccccc
Confidence 9998765899999999998766 33344456788 999999999988533 33444 77777766544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-10 Score=99.93 Aligned_cols=76 Identities=14% Similarity=0.300 Sum_probs=57.6
Q ss_pred CeEEEEEEecCCCcHHH-HHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCc
Q 017820 215 GEYWLIWRYEGEATLAD-LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL-HSTGIVHRDIKPQN 292 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yL-H~~~IiHrDIKp~N 292 (365)
...++||||+++..+.. .+.+. .++.+....+..|++.+|..| |+.||||+|+++.|
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~---------------------~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDA---------------------KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhcc---------------------ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 35679999998754321 12111 123345567789999999998 89999999999999
Q ss_pred eEEecCCCcEEEEeccccccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~ 313 (365)
||+++ + .++|+|||.|...
T Consensus 156 IL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-C-cEEEEECCCceeC
Confidence 99975 4 8999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-10 Score=97.61 Aligned_cols=126 Identities=21% Similarity=0.306 Sum_probs=84.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhh-----ccccHHHHHHHH------HHHHHhhc--cCCCceeeeecccc
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA-----TEYGAVEIWMNE------RVRRACAN--CCADFVYGFFENSS 211 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~-----~~~~~~~~~~~~------~~~~~~~~--~~~~~i~~~~~~~~ 211 (365)
..+++|+-+.+|.+.+.+. .+++|.- +.....+....+ ++...+.. .+.|.++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----- 69 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----- 69 (204)
T ss_pred chhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----
Confidence 4578999999999977542 3343322 211112211111 22222222 223333322
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
+.....|+|||++|..|.+++.+.. ..++..+-.-+.-||..||+|+|+.++
T Consensus 70 -D~~~~~I~me~I~G~~lkd~l~~~~---------------------------~~~~r~vG~~vg~lH~~givHGDLTts 121 (204)
T COG3642 70 -DPDNGLIVMEYIEGELLKDALEEAR---------------------------PDLLREVGRLVGKLHKAGIVHGDLTTS 121 (204)
T ss_pred -cCCCCEEEEEEeCChhHHHHHHhcc---------------------------hHHHHHHHHHHHHHHhcCeecCCCccc
Confidence 2356779999999999999887652 136777788888999999999999999
Q ss_pred ceEEecCCCcEEEEecccccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~ 312 (365)
||+++.+ .+.++|||++..
T Consensus 122 NiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 122 NIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred eEEEeCC--cEEEEECCcccc
Confidence 9999874 599999999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.2e-11 Score=116.10 Aligned_cols=194 Identities=19% Similarity=0.170 Sum_probs=135.7
Q ss_pred CCeEEeeeeec--CCCeeEEEEEe--cCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 139 DDFVLGKKLGE--GAFGVVYRASL--AKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 139 ~~y~l~~~LG~--G~fG~Vy~a~~--~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..|.+.+.+|. |.+|.||.+.. ..+. ..+++|+-..... .......+.........|.+.+.... .+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~-----~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~-~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESP-----HKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP-AW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCC-----cccccccccCCCCCccccccccchhhcccccCccccccccCc-cc
Confidence 45667888999 99999999998 5554 6677776332211 11111112222233344666666333 33
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHH----HHHHHHHCCCcccC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF----ALDGLHSTGIVHRD 287 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~----aL~yLH~~~IiHrD 287 (365)
..++..++-+|+++ .+|..+..... ..++...++..+.+... ||..+|+.+++|-|
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~-------------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~ 247 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPC-------------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDD 247 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhccc-------------------ccCCchhhhhHHhhhhhcccccccccCCCcccccc
Confidence 66788999999998 57777776543 12355667788888888 99999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCc----cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||+||++..+...++++|||+...+..+.- .......|...|++||..++. ++..+ |+++||.++-+.+|
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~----di~sl~ev~l~~~l 322 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFAS----DIFSLGEVILEAIL 322 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHh----hhcchhhhhHhhHh
Confidence 9999999999845999999999998876531 111234778899999987543 44444 49999998877665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-09 Score=90.05 Aligned_cols=139 Identities=17% Similarity=0.233 Sum_probs=88.9
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhh-----ccccHHHHHHH------HHHHHHhhc--cCCCceeeeecc
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA-----TEYGAVEIWMN------ERVRRACAN--CCADFVYGFFEN 209 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~-----~~~~~~~~~~~------~~~~~~~~~--~~~~~i~~~~~~ 209 (365)
....|-+|+-+.|+++.+.+ +..++|.- +-......... .+....+.. ...|.++ +.
T Consensus 11 ~l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-~~-- 80 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-FI-- 80 (229)
T ss_pred cceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-EE--
Confidence 57789999999999999876 44455433 21111111111 111111221 1223222 21
Q ss_pred cccCCCeEEEEEEecCC-CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 210 SSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
+...-.|+|||+++ .++.+++.+...+ ..+.+....++++|-+.+.-||.++|||+||
T Consensus 81 ---D~~~~~i~ME~~~g~~~vk~~i~~~~~~------------------~~~d~~~~~~~~~iG~~igklH~ndiiHGDL 139 (229)
T KOG3087|consen 81 ---DTYGGQIYMEFIDGASTVKDFILSTMED------------------ESEDEGLAELARRIGELIGKLHDNDIIHGDL 139 (229)
T ss_pred ---ecCCCeEEEEeccchhHHHHHHHHHccC------------------cccchhHHHHHHHHHHHHHHhhhCCeecccc
Confidence 12344688999987 5788888765421 1122233678899999999999999999999
Q ss_pred CCCceEEecCCCcE--EEEecccccc
Q 017820 289 KPQNVIFSEGSRTF--KIIDLGAAAD 312 (365)
Q Consensus 289 Kp~NILl~~~~~~i--kL~DFGla~~ 312 (365)
..+||++.+++..+ .++|||++..
T Consensus 140 TTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 140 TTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccceEEecCCCcCceEEEeecchhc
Confidence 99999998877654 8999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-08 Score=91.32 Aligned_cols=80 Identities=18% Similarity=0.231 Sum_probs=63.6
Q ss_pred CeEEEEEEecCCC-cHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
..-++|||++++. +|.+++..... ...+......++.+++..+.-||+.||+|+|+++.||
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~------------------~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~Ni 169 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT------------------NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHF 169 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc------------------cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhE
Confidence 4578999999986 89998853210 0123455668999999999999999999999999999
Q ss_pred EEecC------CCcEEEEecccccc
Q 017820 294 IFSEG------SRTFKIIDLGAAAD 312 (365)
Q Consensus 294 Ll~~~------~~~ikL~DFGla~~ 312 (365)
|++.+ +..+.|+||+.++.
T Consensus 170 Ll~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 170 LLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred EEeccccCCCCCceEEEEECCcccc
Confidence 99852 34899999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.3e-09 Score=105.85 Aligned_cols=187 Identities=19% Similarity=0.129 Sum_probs=126.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEec-CCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...+|.+...||.|.|+.|+..... .++ ..+++|.+.+... .++....+.........|.+.++++..+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~-----~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGD-----CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCC-----ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 4568999999999999999998755 333 6677777654322 222222233333334445556666555533
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
..+.++=.||+.++++........ .+++...+++..|++.++.++|+..++|+|+||+|
T Consensus 338 -~r~~~ip~e~~~~~s~~l~~~~~~--------------------~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psn 396 (524)
T KOG0601|consen 338 -LRQGYIPLEFCEGGSSSLRSVTSQ--------------------MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSN 396 (524)
T ss_pred -cccccCchhhhcCcchhhhhHHHH--------------------hcCcchhhhhHHHHHhccccccchhhhcccccccc
Confidence 345568889999988766552211 23556678899999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcC--CccccccCCCCCCCCCchhhhhhhhh
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYA--APEQYIMSTQTPSAPSAPVATALSPV 357 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~--APE~l~~~~~~~~~d~~s~~~slg~v 357 (365)
|++..++...++.|||+++.+... ......+-+++ +++.........+.| +++|+.-
T Consensus 397 i~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~----~~sl~~~ 455 (524)
T KOG0601|consen 397 ILISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKAD----IFSLGLS 455 (524)
T ss_pred eeeccchhhhhcccccccccccee----cccccccccccccchhhccccccccccc----ccccccc
Confidence 999987569999999999753221 12233344444 566666666666666 5666543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=90.33 Aligned_cols=82 Identities=20% Similarity=0.200 Sum_probs=47.3
Q ss_pred eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhcc--CCCceeeeecccccCCCeEE
Q 017820 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANC--CADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 218 (365)
+.|+.|.++.||+++..+ + +.+++|....... .....+.+....+... ..+.++.+.... ...+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g-----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~-~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-G-----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP-SVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecC-C-----cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC-CccCCce
Confidence 578999999999998754 2 5688887654321 1222222223333221 234444433221 1113568
Q ss_pred EEEEecCCCcHHHHH
Q 017820 219 LIWRYEGEATLADLM 233 (365)
Q Consensus 219 lV~e~~~~gsL~~~l 233 (365)
+||||+++.++.+.+
T Consensus 77 ~v~e~i~G~~l~~~~ 91 (223)
T cd05154 77 YVMERVDGRVLRDRL 91 (223)
T ss_pred EEEEEeCCEecCCCC
Confidence 999999998886654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7e-10 Score=113.47 Aligned_cols=197 Identities=17% Similarity=0.124 Sum_probs=138.8
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH---HHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE---RVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...+++.+.+-+-+|.|+.++.+.-..++... ..|.............+ ..........++.++..+..+ .
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~-----~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~ 874 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTR-----PSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-P 874 (1205)
T ss_pred CCCccceecccccCCCCcccccCCcccccccc-----chhhhccchhhccccccccCCccCccccCCCCceecccCCC-C
Confidence 35678999999999999999998877666332 22222111111110001 111122234456666555542 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
......++++|.++++|...++..+ ..+++..+.....+..+++|||+..++|||+||.|
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~--------------------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~ 934 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG--------------------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDS 934 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC--------------------CcccccccchhHHHHhhhhccccchhhcccccccc
Confidence 5678899999999999999988765 23445566678889999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccC------------------------------CccccccccCCCCcCCccccccCCCC
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVG------------------------------INYIPKEFLLDPRYAAPEQYIMSTQT 342 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~ 342 (365)
+++..++ +.++.|||+......- .........||+.|.+||.+.+....
T Consensus 935 ~l~~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 935 LLIAYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred hhhcccC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 9999988 9999999843321100 00112346889999999999999888
Q ss_pred CCCCCchhhhhhhhhheeccc
Q 017820 343 PSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 343 ~~~d~~s~~~slg~vlw~lGc 363 (365)
..+| +|+.|+++++..|
T Consensus 1014 s~ad----~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 1014 SAAD----WWSSGVCLFEVLT 1030 (1205)
T ss_pred Ccch----hhhhhhhhhhhhc
Confidence 8888 9999999999765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.7e-08 Score=96.31 Aligned_cols=139 Identities=14% Similarity=0.157 Sum_probs=101.4
Q ss_pred HHHHHHhhccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHH
Q 017820 189 ERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (365)
Q Consensus 189 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 268 (365)
.+-.+.+...+||+|+.|+... ...+..|+|+|-+. .|..++++.+ ...+...+
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~-e~~~~~ylvTErV~--Pl~~~lk~l~-----------------------~~~v~~Gl 110 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTT-EEEGTLYLVTERVR--PLETVLKELG-----------------------KEEVCLGL 110 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhh-cccCceEEEeeccc--cHHHHHHHhH-----------------------HHHHHHHH
Confidence 3445667778899999999887 44568999999886 6666666543 34566789
Q ss_pred HHHHHHHHHHH-HCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCC
Q 017820 269 SQLLFALDGLH-STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (365)
Q Consensus 269 ~qi~~aL~yLH-~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~ 347 (365)
.||+.||.||| +.+++|++|.-+.|++++.| +.||++|-++........ .......-..|..||.+.- ++-
T Consensus 111 ~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~------s~~ 182 (690)
T KOG1243|consen 111 FQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP------SEW 182 (690)
T ss_pred HHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc------ccc
Confidence 99999999998 56899999999999999988 999999998865432221 1111222234677775422 223
Q ss_pred chhhhhhhhhheec
Q 017820 348 APVATALSPVLWQV 361 (365)
Q Consensus 348 ~s~~~slg~vlw~l 361 (365)
..|.|.||.++|++
T Consensus 183 s~D~~~Lg~li~el 196 (690)
T KOG1243|consen 183 SIDSWGLGCLIEEL 196 (690)
T ss_pred chhhhhHHHHHHHH
Confidence 55789999999986
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.1e-08 Score=84.05 Aligned_cols=95 Identities=23% Similarity=0.266 Sum_probs=70.8
Q ss_pred CCceeeeecccccCCCeEEEEEEecCCC-cHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHH
Q 017820 200 ADFVYGFFENSSKKGGEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL 278 (365)
Q Consensus 200 ~~~i~~~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yL 278 (365)
.|..+.+...........++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--------------------~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--------------------LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--------------------cchhhHHHHHHHHHHHHHHH
Confidence 3444444433222224568999999874 89999876321 23345667899999999999
Q ss_pred HHCCCcccCCCCCceEEecCC--CcEEEEecccccccc
Q 017820 279 HSTGIVHRDIKPQNVIFSEGS--RTFKIIDLGAAADLR 314 (365)
Q Consensus 279 H~~~IiHrDIKp~NILl~~~~--~~ikL~DFGla~~~~ 314 (365)
|+.||+|+|+++.|||++.++ ..+.++||+.++...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999999999864 379999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.1e-09 Score=94.35 Aligned_cols=148 Identities=15% Similarity=0.102 Sum_probs=98.5
Q ss_pred HHHhhccCCCceeeeeccccc----CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHH
Q 017820 192 RRACANCCADFVYGFFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTI 267 (365)
Q Consensus 192 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i 267 (365)
.+.+....|.+++.+...+.. +.....+++||+..|+|.++|++..+ ....+.....++|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~----------------~~~a~~~~~wkkw 181 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK----------------NQKALFQKAWKKW 181 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH----------------hhhhhhHHHHHHH
Confidence 334444556666665443322 23667899999999999999988752 2334566778899
Q ss_pred HHHHHHHHHHHHHC--CCcccCCCCCceEEecCCCcEEEEecccccccccC----CccccccccCCCCcCCccccccCCC
Q 017820 268 MSQLLFALDGLHST--GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG----INYIPKEFLLDPRYAAPEQYIMSTQ 341 (365)
Q Consensus 268 ~~qi~~aL~yLH~~--~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~ 341 (365)
+.||+.||.|||+. -|+|+++..+-|++..++ -+||.- +.-...... .........+-++|.|||.=.....
T Consensus 182 ~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~ 259 (458)
T KOG1266|consen 182 CTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT 259 (458)
T ss_pred HHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCccccc
Confidence 99999999999987 499999999999999776 666642 111111100 0111112345689999997544444
Q ss_pred CCCCCCchhhhhhhhhheec
Q 017820 342 TPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 342 ~~~~d~~s~~~slg~vlw~l 361 (365)
+. .+|+|++|.+-.+|
T Consensus 260 ~~----a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 260 TG----ASDIYKFGMCALEM 275 (458)
T ss_pred cc----chhhhhhhHHHHHH
Confidence 44 45599999776554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.2e-07 Score=76.92 Aligned_cols=140 Identities=14% Similarity=0.120 Sum_probs=89.7
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhc---------cccHHHHHHHHHHHHHhhccCCC--ceeeeecccc-cCC
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT---------EYGAVEIWMNERVRRACANCCAD--FVYGFFENSS-KKG 214 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~---------~~~~~~~~~~~~~~~~~~~~~~~--~i~~~~~~~~-~~~ 214 (365)
-|+||.+-|++....+ +.+-+|+.. +........+-.....+.....+ .++ +.+... ...
T Consensus 26 ~~rgG~SgV~r~~~~g-------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~ 97 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE 97 (216)
T ss_pred cCCCCcceEEEEEeCC-------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence 4678999999987655 346666654 22222333333333333333333 222 222111 112
Q ss_pred CeEEEEEEecCC-CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
-..+||+|-+++ .+|.+++.+... ...+......++.+++..+.-||+.|+.|+|+.+.||
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~------------------~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khI 159 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAV------------------SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHI 159 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCc------------------CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhhe
Confidence 446799996664 588888865431 1224455567899999999999999999999999999
Q ss_pred EEecCCC-cEEEEecccccc
Q 017820 294 IFSEGSR-TFKIIDLGAAAD 312 (365)
Q Consensus 294 Ll~~~~~-~ikL~DFGla~~ 312 (365)
+++.++. .++++||--++.
T Consensus 160 ll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 160 YVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eecCCCCeeEEEEEhhccch
Confidence 9986551 499999988764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.3e-07 Score=81.48 Aligned_cols=74 Identities=27% Similarity=0.425 Sum_probs=49.9
Q ss_pred EEEEEEecC--CCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCce
Q 017820 217 YWLIWRYEG--EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG-LHSTGIVHRDIKPQNV 293 (365)
Q Consensus 217 ~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~y-LH~~~IiHrDIKp~NI 293 (365)
..+||||++ +..+..+....- +......++.+++..+.. +|..||+|+|+.+.||
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~----------------------~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NI 138 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDL----------------------SPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNI 138 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGG----------------------GGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSE
T ss_pred CEEEEEecCCCccchhhHHhccc----------------------cchhHHHHHHHHHHHHHHHHHhcCceecCCChhhE
Confidence 469999999 666655443220 112245677788885555 5799999999999999
Q ss_pred EEecCCCcEEEEecccccccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~ 314 (365)
|++++ .+.|+|||.|....
T Consensus 139 lv~~~--~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 139 LVDDG--KVYIIDFGQAVDSS 157 (188)
T ss_dssp EEETT--CEEE--GTTEEETT
T ss_pred Eeecc--eEEEEecCcceecC
Confidence 99985 89999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.5e-07 Score=78.19 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=87.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH---------HHH---HHhhccCCCcee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE---------RVR---RACANCCADFVY 204 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~i~ 204 (365)
..++|.+.+.+-......|.+-.... +.+++|..++.......... ++. ..+.........
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 45789999999888877777776655 67888877644322111111 111 111111111111
Q ss_pred eeecc----cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH
Q 017820 205 GFFEN----SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280 (365)
Q Consensus 205 ~~~~~----~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~ 280 (365)
.++.. ...-....+++|||++|..|.++..- ++ .+...+.+++.-+|+
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i------------------------~e----~~~~ki~~~ikqlH~ 153 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDI------------------------DE----DLAEKIVEAIKQLHK 153 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchhc------------------------CH----HHHHHHHHHHHHHHH
Confidence 11111 00112566799999999888765421 11 244567778999999
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.|+.|+|..|.|++++++ .++++||+..+.
T Consensus 154 ~G~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 154 HGFYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred cCCccCCCCcCcEEEECC--cEEEEECccccc
Confidence 999999999999999964 699999988765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=84.79 Aligned_cols=150 Identities=18% Similarity=0.183 Sum_probs=110.7
Q ss_pred eeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc---CCCeEEEEEEecCC-Cc
Q 017820 153 GVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---KGGEYWLIWRYEGE-AT 228 (365)
Q Consensus 153 G~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~lV~e~~~~-gs 228 (365)
.+.|++....++ ..+++|++.............+.+.....+|.|++.+.+.+.. ....+++|+.|.++ ++
T Consensus 290 ~Ttyk~~s~~DG-----~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVDG-----NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccCC-----ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 578999999888 8899999965555444444556777788889999988666542 23678899999875 58
Q ss_pred HHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecc
Q 017820 229 LADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308 (365)
Q Consensus 229 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFG 308 (365)
|.++.........- ........+....++.+|.++.|+..||.++|+.|+..+-|.|.+||++.+. .++|..-|
T Consensus 365 L~d~~F~~~~~t~~-----~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~ 438 (655)
T KOG3741|consen 365 LYDLYFANPPFTKR-----TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCG 438 (655)
T ss_pred HHHHHccCCccccc-----cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEeccc
Confidence 88876544321100 0011234566788999999999999999999999999999999999999866 77777655
Q ss_pred ccccc
Q 017820 309 AAADL 313 (365)
Q Consensus 309 la~~~ 313 (365)
..-.+
T Consensus 439 i~Dvl 443 (655)
T KOG3741|consen 439 IMDVL 443 (655)
T ss_pred ceeee
Confidence 54433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=77.67 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=84.3
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc----------cH------------HHHHHHHHHHHHhhcc
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY----------GA------------VEIWMNERVRRACANC 198 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----------~~------------~~~~~~~~~~~~~~~~ 198 (365)
..++..||-|--+.||.|.+... .++++|.-+.. .+ ......+++...+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g------~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG------RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECCCC------CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 44688999999999999998854 67777753211 00 0111112222222221
Q ss_pred CCC--ceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHH
Q 017820 199 CAD--FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (365)
Q Consensus 199 ~~~--~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~ 276 (365)
... .+-.- ...+...+||||+++..|...-- +.+....++..|++-+.
T Consensus 167 ~~~G~~VP~P-----~~~nRHaVvMe~ieG~eL~~~r~-------------------------~~en~~~il~~il~~~~ 216 (304)
T COG0478 167 YPEGVKVPKP-----IAWNRHAVVMEYIEGVELYRLRL-------------------------DVENPDEILDKILEEVR 216 (304)
T ss_pred hhcCCCCCCc-----cccccceeeeehcccceeecccC-------------------------cccCHHHHHHHHHHHHH
Confidence 111 01111 12356789999999977765431 11113345556666666
Q ss_pred HHHHCCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 277 GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 277 yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
-+-..||||+|+.+=||++++|+ .+.++||--+..
T Consensus 217 ~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v~ 251 (304)
T COG0478 217 KAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQAVP 251 (304)
T ss_pred HHHHcCccccCCchheEEEecCC-CEEEEeCccccc
Confidence 66689999999999999999988 999999976654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.2e-06 Score=79.55 Aligned_cols=102 Identities=15% Similarity=0.104 Sum_probs=78.1
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccc
Q 017820 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 336 (365)
Q Consensus 257 ~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 336 (365)
...+++.+.+..+.++.+...||..|-+-+|++++|+|+++++ .+.|.|=..-.....+..+ --.+|...|.+||.-
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng~~~--~cpVg~~eftPPElQ 188 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANGTLH--LCPVGVSEFTPPELQ 188 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCCceE--ecccCccccCCHHHh
Confidence 4568889999999999999999999999999999999999988 9999885433222222222 246889999999976
Q ss_pred c-cCCCCCCCCCchhhhhhhhhheec
Q 017820 337 I-MSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 337 ~-~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
. +.-.....+.-+|.+.|+++++++
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~l 214 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHL 214 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHH
Confidence 5 222333344567799999999876
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.8e-06 Score=85.33 Aligned_cols=76 Identities=20% Similarity=0.339 Sum_probs=53.5
Q ss_pred CeEEEEEEecCCCcHHHH--HHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHH-HHHHHHCCCcccCCCCC
Q 017820 215 GEYWLIWRYEGEATLADL--MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFA-LDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~a-L~yLH~~~IiHrDIKp~ 291 (365)
+.-.++|||++|..+.+. ++..+. +.+. ++..++++ +.-+-..|+.|.|..|.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~---------------------d~k~---ia~~~~~~f~~q~~~dgffHaDpHpG 294 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKSAGI---------------------DRKE---LAELLVRAFLRQLLRDGFFHADPHPG 294 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHhcCC---------------------CHHH---HHHHHHHHHHHHHHhcCccccCCCcc
Confidence 456799999999999887 444331 2222 22222221 22233489999999999
Q ss_pred ceEEecCCCcEEEEeccccccccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRV 315 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~ 315 (365)
||+++.++ ++.+.|||+...+..
T Consensus 295 Ni~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 295 NILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred ceEEecCC-cEEEEcCcceecCCH
Confidence 99999997 999999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=79.59 Aligned_cols=139 Identities=21% Similarity=0.251 Sum_probs=84.0
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc------------------------------------------
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------------------------------------------ 181 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------------------------------------------ 181 (365)
.+.||.-+.|.||+|+.+. + ..||+|..++.-
T Consensus 166 ~~piaaASlaQVhrA~L~~-G-----~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-G-----EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred cchhhhcchhheEEEEecC-C-----CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 4679999999999999998 3 778888753221
Q ss_pred --HHHHHHHHHHHHHhhccC---CCceeeeecccccCCCeEEEEEEecCCCcHHHH--HHhcCCCcchhhhhccccccCc
Q 017820 182 --AVEIWMNERVRRACANCC---ADFVYGFFENSSKKGGEYWLIWRYEGEATLADL--MISREFPYNVQTLILGEVQDLP 254 (365)
Q Consensus 182 --~~~~~~~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~~~ 254 (365)
..|....++..+...... -..+-.++... ...-.|+|||++|..+.|. +.+.+
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~~g----------------- 299 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDKRG----------------- 299 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHHcC-----------------
Confidence 112222223333333332 11122222222 2457899999999887665 33333
Q ss_pred ccccccHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCceEEec---CCCcEEEEeccccccccc
Q 017820 255 KGIERENRIIQTIMSQLLFAL-DGLHSTGIVHRDIKPQNVIFSE---GSRTFKIIDLGAAADLRV 315 (365)
Q Consensus 255 ~~~~~~~~~i~~i~~qi~~aL-~yLH~~~IiHrDIKp~NILl~~---~~~~ikL~DFGla~~~~~ 315 (365)
.+...+ +..+.++. +-+=..|++|+|-.|.||+++. .+..+.+.|||+.+.+..
T Consensus 300 ----i~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 300 ----ISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----CCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 122222 22222221 1223568999999999999994 345999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.3e-05 Score=67.67 Aligned_cols=80 Identities=26% Similarity=0.230 Sum_probs=48.2
Q ss_pred eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccC--CCceeeeecccccCCCeEEEE
Q 017820 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCC--ADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~lV 220 (365)
.+.|+.|..+.||+....+ +.+++|...... ......+..+.+.+.... .+.++... .........+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~-~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD-TSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-------SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE-EETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-------cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec-ccccccccceEE
Confidence 4679999999999999776 478888876651 122222222333333322 34444322 121333558999
Q ss_pred EEecCCCcHHH
Q 017820 221 WRYEGEATLAD 231 (365)
Q Consensus 221 ~e~~~~gsL~~ 231 (365)
|+++++.++.+
T Consensus 74 ~~~i~g~~~~~ 84 (239)
T PF01636_consen 74 MEYIPGRPLDD 84 (239)
T ss_dssp EEEESSEEHHH
T ss_pred EEEeccccccc
Confidence 99999998877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.1e-07 Score=88.23 Aligned_cols=171 Identities=18% Similarity=0.139 Sum_probs=119.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCc-eeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADF-VYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~ 215 (365)
+...+.....+++|+.+.+|+.+...+ +....+.+... .+ ..-....+...++++ .+.+++.. +.+.
T Consensus 240 k~kws~~fh~fvK~altknpKkRptae------klL~h~fvs~~--l~---~rl~~eLLdK~n~P~~~v~~~~d~-~~E~ 307 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAE------KLLQHPFVSQT--LS---RRLAIELLDKVNNPNPVVRYLEDY-DGED 307 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChh------hheeceeeccc--hh---hHHHHHHHHHccCCCCcccccccC-Cccc
Confidence 334566677899999999999988765 44444444433 11 222345566666777 55555554 5567
Q ss_pred eEEEEEEecCCC-cHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 216 EYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 216 ~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..|+.++++.++ +-...+. .....+...+...+.+.-+++|+|+|+-.=+||| ||+
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~-------------------~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l 364 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMT-------------------VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NIL 364 (829)
T ss_pred ccchhhhhhcCCccccccCC-------------------hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccc
Confidence 889999999987 2211111 1111233344566777888899999998778999 888
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d 346 (365)
..+ + ..+..||+.+..+.... .+.+..+|+.++|||+........+.+
T Consensus 365 ~s~-~-~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~ 412 (829)
T KOG0576|consen 365 GSE-E-EVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPD 412 (829)
T ss_pred ccc-c-ccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCC
Confidence 877 4 89999999998776543 467889999999999999998888888
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.5e-06 Score=84.72 Aligned_cols=89 Identities=18% Similarity=0.345 Sum_probs=69.2
Q ss_pred HHHHHHHHHHHHHC-CCcccCCCCCceEEecCCCcEEEEecccccccccCCccccc--------cccCCCCcCCcccccc
Q 017820 268 MSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK--------EFLLDPRYAAPEQYIM 338 (365)
Q Consensus 268 ~~qi~~aL~yLH~~-~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~--------~~~gt~~Y~APE~l~~ 338 (365)
+.+++.||.|+|.. ++||++|.|++|.++.++ .+||+.|+.+........+... -..-...|.|||++.+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34566999999976 899999999999999987 9999999998766553222111 1233568999999988
Q ss_pred CCCCCCCCCchhhhhhhhhheec
Q 017820 339 STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 339 ~~~~~~~d~~s~~~slg~vlw~l 361 (365)
...++.+| ++|+|+++|.+
T Consensus 184 ~~~~~~sd----~fSlG~li~~i 202 (700)
T KOG2137|consen 184 TTNTPASD----VFSLGVLIYTI 202 (700)
T ss_pred cccccccc----ceeeeeEEEEE
Confidence 77777777 89999888764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=7e-05 Score=66.69 Aligned_cols=29 Identities=31% Similarity=0.284 Sum_probs=25.2
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG--TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC--cEEEechhcCc
Confidence 478999999999998854 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.3e-06 Score=88.41 Aligned_cols=73 Identities=21% Similarity=0.207 Sum_probs=54.1
Q ss_pred cccCCCCC-ceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 284 VHRDIKPQ-NVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 284 iHrDIKp~-NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
-|++.+|. |++++.++ ..++.|||.++....+.. ......+||+.|||||++.+..++. .+|+||||+++|||
T Consensus 499 ~~~~~~p~~~~~~~p~~-~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~----~~DiwSlG~il~El 573 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQ-VKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGP----AVDWWALGVCLFEF 573 (669)
T ss_pred CCCCCCCCCceeECCcc-ccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCc----HHHHHHHHHHHHHH
Confidence 45666677 55555555 788999999987654422 2234578999999999998766544 45699999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.7e-05 Score=66.74 Aligned_cols=31 Identities=29% Similarity=0.322 Sum_probs=26.9
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|+.|.|||+++++ ...|+||+.|..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGK-FSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCc-EEEEEEcccccc
Confidence 3589999999999999865 788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.5e-05 Score=63.57 Aligned_cols=131 Identities=22% Similarity=0.298 Sum_probs=83.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH-HHHHHhhc-cCCCceeeeecccccCCCeEE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACAN-CCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 218 (365)
....+.|++|.+|.||++.+.+ ..+++|..+.+........+ ++.+.+.. ...|.++.+ +.-+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~-------~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG-------GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC-------ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 3446779999999999999987 57888887766554433333 33333332 223444333 2234
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC-CCceEEec
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK-PQNVIFSE 297 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK-p~NILl~~ 297 (365)
+.|||..|-.|.+.-.... . +-...+++.---|-..||-|..|. |...+|-.
T Consensus 89 i~me~i~G~~L~~~~~~~~-----------------------r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~ 141 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGGD-----------------------R----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN 141 (201)
T ss_pred hhhhhhcCcchhhhhhccc-----------------------H----HHHHHHHHHHHHHHHhccchhhhcCCceeEEec
Confidence 5699999988877654211 1 233445555444666799999886 55455555
Q ss_pred CCCcEEEEecccccccc
Q 017820 298 GSRTFKIIDLGAAADLR 314 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~ 314 (365)
++ .+.|+||..|+.-.
T Consensus 142 ~~-~~~iIDFd~At~k~ 157 (201)
T COG2112 142 DR-DVYIIDFDSATFKK 157 (201)
T ss_pred CC-cEEEEEccchhhcc
Confidence 45 89999999998543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=65.30 Aligned_cols=50 Identities=20% Similarity=0.330 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 263 IIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 263 ~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
....+..++++.+.-|-. .++||+||..=|||+. ++ .+.|+|||-|....
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~~~ 217 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVTID 217 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECccccccC
Confidence 566778888888888776 8999999999999999 45 99999999887654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00044 Score=64.54 Aligned_cols=30 Identities=37% Similarity=0.619 Sum_probs=27.0
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
.+++|+|+++.||++++++ ...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 5899999999999999876 67899999985
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00039 Score=62.25 Aligned_cols=30 Identities=27% Similarity=0.493 Sum_probs=25.5
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
+++|+|+.+.|||+++++ ...|+||+.|..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence 589999999999998754 567999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0013 Score=61.66 Aligned_cols=30 Identities=30% Similarity=0.463 Sum_probs=25.9
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
.++||+|+.|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 3899999999999998654 56899999885
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00076 Score=71.48 Aligned_cols=31 Identities=32% Similarity=0.548 Sum_probs=25.6
Q ss_pred CCcccCCCCCceEEecCC-CcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGS-RTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~-~~ikL~DFGla~~ 312 (365)
.+||+|+++.|||++.++ ...-|+||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 599999999999998543 2467999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0023 Score=55.59 Aligned_cols=87 Identities=20% Similarity=0.212 Sum_probs=55.9
Q ss_pred CCceeeeecccccCCCeEEEEEEecCC------CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHH
Q 017820 200 ADFVYGFFENSSKKGGEYWLIWRYEGE------ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF 273 (365)
Q Consensus 200 ~~~i~~~~~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~ 273 (365)
+..+..+++.. +++...-+|+|.+.+ .||.+++.+..+ +. . +...+-+
T Consensus 76 ~~~i~r~~G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~---------------------~~-~---~~~~L~~ 129 (199)
T PF10707_consen 76 WSHIPRFYGFV-ETNLGLGLVVELIRDADGNISPTLEDYLKEGGL---------------------TE-E---LRQALDE 129 (199)
T ss_pred ccccccEeEEE-ecCCceEEEEEEEECCCCCcCccHHHHHHcCCc---------------------cH-H---HHHHHHH
Confidence 44455555555 344456777776542 357777755442 22 2 3333444
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCC--C-cEEEEe-cccccc
Q 017820 274 ALDGLHSTGIVHRDIKPQNVIFSEGS--R-TFKIID-LGAAAD 312 (365)
Q Consensus 274 aL~yLH~~~IiHrDIKp~NILl~~~~--~-~ikL~D-FGla~~ 312 (365)
-.+||-+++|+.+|++|+||++..++ . .+.|+| ||....
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCccc
Confidence 56788999999999999999997433 2 688888 665544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0013 Score=56.99 Aligned_cols=38 Identities=39% Similarity=0.562 Sum_probs=32.4
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccc
Q 017820 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310 (365)
Q Consensus 267 i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla 310 (365)
-+.+|.+-|..+|..||+-+|+|+.|.. .=||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLGIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCCeeeccCcccccc------CCEEEecccC
Confidence 4677888899999999999999999985 3389999865
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0011 Score=61.37 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=26.8
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.+++|+|+.|.|||+++++ .+.|+||+.|..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 3799999999999999865 678999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00068 Score=60.49 Aligned_cols=31 Identities=29% Similarity=0.437 Sum_probs=26.6
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
+++|+|+.+.|||+++++..+.|+||-.|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999998323899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0016 Score=62.75 Aligned_cols=30 Identities=23% Similarity=0.348 Sum_probs=25.8
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|+.+.|||+.++ .++++||-.|..
T Consensus 223 ~~l~HgDl~~gni~~~~~--~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE--ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC--CcEEEecccccc
Confidence 469999999999999874 699999987753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0063 Score=56.55 Aligned_cols=81 Identities=11% Similarity=0.087 Sum_probs=45.9
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-cHHHHHHHHHHHHHhhc---cCCCceeeeecccccCCCe
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACAN---CCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~ 216 (365)
..-.+.||+|..+.||+....+ .++++|..+.. .......+.+..+.+.. ...|.++.+.... ...+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-------~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~-~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-------GNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE-QSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-------CCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC-CcCCC
Confidence 3346789999999999987544 34555554432 11122222222222222 3455565544332 22356
Q ss_pred EEEEEEecCCCcH
Q 017820 217 YWLIWRYEGEATL 229 (365)
Q Consensus 217 ~~lV~e~~~~gsL 229 (365)
.++|||++++.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0026 Score=57.63 Aligned_cols=29 Identities=28% Similarity=0.477 Sum_probs=25.4
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.|.|||+++++ +.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence 589999999999999864 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0006 Score=62.82 Aligned_cols=135 Identities=15% Similarity=0.191 Sum_probs=82.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----------------HHHHHH-------HHHHHHHhh
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----------------AVEIWM-------NERVRRACA 196 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~-------~~~~~~~~~ 196 (365)
=+.+++.||-|--+-||.+-+... +..++|.-+-.. ....|+ ..+...+-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G------~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEG------NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred hhhhccccccccccceEEEecCCC------CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 356789999999999999998754 456666432000 000011 011111111
Q ss_pred ccCCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHH
Q 017820 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (365)
Q Consensus 197 ~~~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~ 276 (365)
...+.+-+ ....+....++|||++.+-.|.+.-+-.+ +..+...+..-+.
T Consensus 167 L~e~gfpV----PkpiD~~RH~Vvmelv~g~Pl~~v~~v~d--------------------------~~~ly~~lm~~Iv 216 (465)
T KOG2268|consen 167 LYERGFPV----PKPIDHNRHCVVMELVDGYPLRQVRHVED--------------------------PPTLYDDLMGLIV 216 (465)
T ss_pred HHHcCCCC----CCcccccceeeHHHhhcccceeeeeecCC--------------------------hHHHHHHHHHHHH
Confidence 11111000 00122366788999988877665543222 2245556666677
Q ss_pred HHHHCCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 277 GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 277 yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
-|-.+|+||+|..-=||++++++ .++++||--..
T Consensus 217 ~la~~GlIHgDFNEFNimv~dd~-~i~vIDFPQmv 250 (465)
T KOG2268|consen 217 RLANHGLIHGDFNEFNIMVKDDD-KIVVIDFPQMV 250 (465)
T ss_pred HHHHcCceecccchheeEEecCC-CEEEeechHhh
Confidence 78899999999999999999877 99999997543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0019 Score=55.70 Aligned_cols=89 Identities=19% Similarity=0.192 Sum_probs=64.2
Q ss_pred ceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-
Q 017820 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS- 280 (365)
Q Consensus 202 ~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~- 280 (365)
++..+++.+ ..++++||.+.+++...... +..-...++....+|+.++++.+++|+.
T Consensus 21 ~~pk~lG~C-----G~~~v~E~~~~~~~~~~~~~-----------------l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 21 PFPKLLGSC-----GRFYVVEYVGAGSLYGIYRP-----------------LSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred CCCCeeeEC-----CCEEEEEeecCccccccccc-----------------cccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 445555554 13578999998766432000 0011234778888999999999999987
Q ss_pred --CCCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 281 --TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 281 --~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
..+.-.|++++|+-+++++ ++|++|...+...
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 3477799999999999887 9999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.027 Score=52.38 Aligned_cols=29 Identities=21% Similarity=0.492 Sum_probs=25.5
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999987 4 78999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.014 Score=54.25 Aligned_cols=30 Identities=20% Similarity=0.358 Sum_probs=26.7
Q ss_pred CCcccCCCCCceEEecC----CCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEG----SRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~----~~~ikL~DFGla~~ 312 (365)
.++|+|+.+.|||++++ + .++++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETK-KLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCCC
Confidence 58999999999999975 5 899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.012 Score=55.70 Aligned_cols=31 Identities=26% Similarity=0.336 Sum_probs=25.9
Q ss_pred HCCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 280 ~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
...++|+|+.+.||+++++ .++++||..+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~--~~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH--ETKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCC--CCEEEcCccccc
Confidence 3469999999999999874 588999987754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.025 Score=53.36 Aligned_cols=30 Identities=20% Similarity=0.375 Sum_probs=26.2
Q ss_pred CcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 283 IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
++|.|+-+.|||+++++..++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999986544899999999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.025 Score=53.21 Aligned_cols=51 Identities=16% Similarity=0.219 Sum_probs=43.1
Q ss_pred cHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 260 ENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 260 ~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..+++..++++.+.-++-+..+ ..=|||+...||||+ +| ++.|+||-+++.
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeec
Confidence 4566778888888877777755 689999999999999 56 999999999983
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.024 Score=53.85 Aligned_cols=32 Identities=31% Similarity=0.499 Sum_probs=27.4
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
.++|+|+++.|||+++++..+.++||..|..-
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 58999999999999875448999999998743
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.034 Score=51.91 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=27.3
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
+++|+|+.++|+|++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999999877 899999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.088 Score=49.79 Aligned_cols=136 Identities=15% Similarity=0.213 Sum_probs=85.2
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc---------------------------cccHHHHHHHHHHHHHh
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT---------------------------EYGAVEIWMNERVRRAC 195 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~---------------------------~~~~~~~~~~~~~~~~~ 195 (365)
|-.+|..|--+.||.|+.... ..+|+|..+ +......|.+.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG------~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk 221 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDG------SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK 221 (520)
T ss_pred cccccccCccceeEeeecCCC------ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence 456788999999999987665 446776541 22234455555444332
Q ss_pred hccC--CCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHH
Q 017820 196 ANCC--ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF 273 (365)
Q Consensus 196 ~~~~--~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~ 273 (365)
+... .|---.++ -....|||+|++... ++ ....+...++...+..+-.|++.
T Consensus 222 Rl~~aGIP~PePIl------Lk~hVLVM~FlGrdg---------w~-----------aPkLKd~~ls~~ka~~~Y~~~v~ 275 (520)
T KOG2270|consen 222 RLNNAGIPCPEPIL------LKNHVLVMEFLGRDG---------WA-----------APKLKDASLSTSKARELYQQCVR 275 (520)
T ss_pred HHHhcCCCCCCcee------eecceEeeeeccCCC---------Cc-----------CcccccccCChHHHHHHHHHHHH
Confidence 2211 11000000 034579999998532 11 12223344555567777778888
Q ss_pred HHHHHH-HCCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 274 ALDGLH-STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 274 aL~yLH-~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
-|.-|- ..++||.||.-=|+|+.+ | .+.|+|-+-+..
T Consensus 276 ~MR~lY~~c~LVHADLSEfN~Lyhd-G-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 276 IMRRLYQKCRLVHADLSEFNLLYHD-G-KLYIIDVSQSVE 313 (520)
T ss_pred HHHHHHHHhceeccchhhhhheEEC-C-EEEEEEcccccc
Confidence 787764 568999999999999987 4 999999887754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.13 Score=48.31 Aligned_cols=29 Identities=34% Similarity=0.698 Sum_probs=25.7
Q ss_pred CcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 283 IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
+||+|+.|.||+++.+...+.++|||-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999876248999999886
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.083 Score=49.32 Aligned_cols=31 Identities=29% Similarity=0.404 Sum_probs=27.8
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
.++|+|+.+.|||++.++ -+-++||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence 589999999999999988 6999999999753
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.11 Score=47.56 Aligned_cols=46 Identities=22% Similarity=0.319 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHHHHHC--CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 266 TIMSQLLFALDGLHST--GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 266 ~i~~qi~~aL~yLH~~--~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..+..+-..+.-.|.. -++|.|+.|+|+|.++++ .++|+||--|..
T Consensus 136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 3444444444444444 589999999999999977 999999988864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.089 Score=48.57 Aligned_cols=76 Identities=14% Similarity=0.111 Sum_probs=34.1
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHh---hccCCCceeeeecccccCCCeE
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---ANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.+-.+.++.|....+|+..... +.+.+|.-..........+.+-.+.+ .....|.++.+... .+..
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~-------~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~----~~~~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDG-------GSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY----DDDA 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS--------EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-----SSCC
T ss_pred eeeeEecCCCChhheEEEECCC-------ccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee----cCCc
Confidence 4446779989999999988333 67888876633221111111111222 23334444444322 2344
Q ss_pred EEEEEecCCC
Q 017820 218 WLIWRYEGEA 227 (365)
Q Consensus 218 ~lV~e~~~~g 227 (365)
++++||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 8999998876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.16 Score=48.92 Aligned_cols=31 Identities=23% Similarity=0.350 Sum_probs=25.9
Q ss_pred HCCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 280 ~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.+..+|+|+.|.|||++++ ..|++|.-.|-.
T Consensus 226 ~~aLlHGDlHtGSI~v~~~--~~kvIDpEFAfy 256 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND--STKVIDPEFAFY 256 (409)
T ss_pred chhhccCcCCCCCEEecCC--ceEEEccccccc
Confidence 3469999999999999985 699999777643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.4 Score=52.16 Aligned_cols=32 Identities=25% Similarity=0.503 Sum_probs=26.0
Q ss_pred CCCcccCCCCCceEEecCC--CcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGS--RTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~--~~ikL~DFGla~~ 312 (365)
+++||.|+.+.|||++.++ ...-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999764 2345999998753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.3 Score=47.04 Aligned_cols=30 Identities=20% Similarity=0.141 Sum_probs=25.0
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
...+|.|+-+.|||.++ + .++++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~-~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-Q-GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-C-CEEEEEeccccC
Confidence 35789999999999765 3 799999988863
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.69 Score=43.48 Aligned_cols=29 Identities=24% Similarity=0.344 Sum_probs=24.4
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 3689999999999994 3 578999998863
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.05 Score=50.80 Aligned_cols=52 Identities=17% Similarity=0.293 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHH---H-HCCCcccCCCCCceEEecCCC-----------------cEEEEeccccccc
Q 017820 262 RIIQTIMSQLLFALDGL---H-STGIVHRDIKPQNVIFSEGSR-----------------TFKIIDLGAAADL 313 (365)
Q Consensus 262 ~~i~~i~~qi~~aL~yL---H-~~~IiHrDIKp~NILl~~~~~-----------------~ikL~DFGla~~~ 313 (365)
+-++.++.||+.-.--. - -..++|-||||+|||+-++.. .++|.||.+|+.-
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 45777888887543112 2 336899999999999854321 5678899888743
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.0054 Score=66.83 Aligned_cols=116 Identities=11% Similarity=-0.021 Sum_probs=81.0
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-----CCcccC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-----GIVHRD 287 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-----~IiHrD 287 (365)
...+.|..++|+..|.+++.+.+.- .+...+++..+.....+.+.+..-.|+. -.+|++
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~----------------ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGL----------------EESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhcc----------------ccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 3466788999999999999886532 1112223333333444446666666654 278999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d 346 (365)
+|+-|.+|..+. .+|+.++|+.+.... .....+...+++-|++|++...-.++.++|
T Consensus 1366 Lkf~lpmIVtny-~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNY-NVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred hhhhccceecCC-cccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHH
Confidence 999999999987 999999999993221 122235567888999999988878877765
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.13 Score=44.55 Aligned_cols=32 Identities=19% Similarity=0.325 Sum_probs=26.8
Q ss_pred CCCcccCCCCCceEEecCCC----cEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSR----TFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~----~ikL~DFGla~~ 312 (365)
..++|+|+.+.||++..++. .+.|+||..++.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 46899999999999986532 689999998875
|
subfamily of choline kinases |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.11 Score=55.49 Aligned_cols=153 Identities=18% Similarity=0.087 Sum_probs=95.2
Q ss_pred HHHHHHHHHHHHHhhccCCCceeeeecccccCCCe---EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCccccc
Q 017820 182 AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE---YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258 (365)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (365)
..++...+.+...+....|+++..++.+...+... ..+..+++...++.+.+++.. .
T Consensus 223 k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--------------------~ 282 (1351)
T KOG1035|consen 223 KKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--------------------S 282 (1351)
T ss_pred HHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--------------------c
Confidence 34556666666777777889888887765444322 223456777777777776654 3
Q ss_pred ccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC---ceEEecCCCcEEEE--ecccccccccCCccccccccCCCCcCCc
Q 017820 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ---NVIFSEGSRTFKII--DLGAAADLRVGINYIPKEFLLDPRYAAP 333 (365)
Q Consensus 259 ~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~---NILl~~~~~~ikL~--DFGla~~~~~~~~~~~~~~~gt~~Y~AP 333 (365)
.+....+.+..+..+||.|+|+....|.-+..+ +-..+.++ ...+. ||+..+.+...... .....+..|.++
T Consensus 283 i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~ 359 (1351)
T KOG1035|consen 283 IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNAD 359 (1351)
T ss_pred cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccc--hhhcCccccccc
Confidence 456778889999999999999996555444433 22233333 56666 89888876543321 233445678888
Q ss_pred cccccCCCCCCCCCchhhhhhhhhhe
Q 017820 334 EQYIMSTQTPSAPSAPVATALSPVLW 359 (365)
Q Consensus 334 E~l~~~~~~~~~d~~s~~~slg~vlw 359 (365)
|.+........- ..+.|.+|...-
T Consensus 360 e~~~~~~~~~~r--~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 360 EDLKENTAKKSR--LTDLWCLGLLLL 383 (1351)
T ss_pred cccccccchhhh--hhHHHHHHHHHh
Confidence 887655443331 234666665443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.075 Score=45.64 Aligned_cols=30 Identities=27% Similarity=0.418 Sum_probs=25.3
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
..+|+|+.|.||+++++ .++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~~~--~~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS--GLRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECC--CEEEEeCCcccCC
Confidence 36899999999999875 4889999998653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.24 E-value=1.3 Score=42.84 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=24.1
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
...+|+|+.|.|||++++ ..+++|.-.|-
T Consensus 230 ~~L~HGDl~~g~i~~~~~--~~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPD--STQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCC--CceEecchhhc
Confidence 369999999999999985 58999966553
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.067 Score=49.13 Aligned_cols=32 Identities=28% Similarity=0.437 Sum_probs=26.5
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
.++|+|++|.|||+++++...-|+||+.|..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 58999999999999975534679999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 365 | ||||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-07 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 7e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-04 |
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 44/221 (19%), Positives = 76/221 (34%), Gaps = 67/221 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNER--- 190
++L LG+GA V+R K GDL + V++ M E
Sbjct: 8 NHLWLLSDILGQGATANVFRGR------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 191 --------VRRACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISREFPY 240
V+ ++ E ++ + LI + G L ++ Y
Sbjct: 62 KKLNHKNIVK----------LFAIEEETTTR--HKVLIMEFCPCGS--LYTVLEEPSNAY 107
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS---E 297
+ E E I+ + ++ ++ L GIVHR+IKP N++ +
Sbjct: 108 GLP--------------ESEFLIV---LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
G +K+ D GAA +L E + Y P+
Sbjct: 151 GQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPD 185
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 43/221 (19%), Positives = 75/221 (33%), Gaps = 67/221 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNER--- 190
++L LG+GA V+R K GDL + V++ M E
Sbjct: 8 NHLWLLSDILGQGATANVFRGR------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 191 --------VRRACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISREFPY 240
V+ ++ E ++ + LI + G L ++ Y
Sbjct: 62 KKLNHKNIVK----------LFAIEEETTTR--HKVLIMEFCPCGS--LYTVLEEPSNAY 107
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS---E 297
+ E E ++ ++ ++ L GIVHR+IKP N++ +
Sbjct: 108 GLP--------------ESE---FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
G +K+ D GAA +L E + Y P+
Sbjct: 151 GQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPD 185
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 43/230 (18%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEI 185
+ + L +G+G++GVV A + K + + V + TE V +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE---VRL 81
Query: 186 WMNERVRRACANCCADFVYGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISR 236
+ + +Y +E+ GG + + ++T M
Sbjct: 82 M------KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 237 EFPYNVQTLILGEVQDLPKGIEREN-------RIIQTIMSQLLFALDGLHSTGIVHRDIK 289
+ E + RE+ ++I IM Q+ AL LH+ GI HRDIK
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 290 PQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
P+N +F + S K++D G + + N + P + APE
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKL-NNGEYYGMTTKAGTPYFVAPE 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 39/215 (18%), Positives = 71/215 (33%), Gaps = 41/215 (19%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ LGEGAF VY A+ +KN VLK E ++ ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
Y + L+ TL + + + + +P
Sbjct: 124 SMQHMFMKFYSAHLFQNG----SVLVGELYSYGTLLNAINLYKNTPE---------KVMP 170
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF----------SEGSRTFKI 304
++ + ++L+ ++ +H I+H DIKP N I + S +
Sbjct: 171 ------QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 305 IDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
IDLG + D+++ PK + + E
Sbjct: 225 IDLGQSIDMKL----FPKGTIFTAKCETSGFQCVE 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 47/216 (21%), Positives = 74/216 (34%), Gaps = 37/216 (17%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
DF LG+GAFG V A+ D K + ++ A+
Sbjct: 5 ASDFEEIAVLGQGAFGQVV---KARN---ALDSRYYAIKKIRHTEEKLSTILSEVMLLAS 58
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL- 253
+V Y + + L I E+ N G + DL
Sbjct: 59 LNHQYVVRYYAAWLERRNFV------KPMTAVKKKSTLFIQMEYCEN------GTLYDLI 106
Query: 254 -PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ + ++ + Q+L AL +HS GI+HRD+KP N+ E SR KI D G A +
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKN 165
Query: 313 LRVGINYIPKEFLLD-------------PRYAAPEQ 335
+ ++ + + Y A E
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 45/216 (20%), Positives = 73/216 (33%), Gaps = 56/216 (25%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE----- 189
+ + ++LG G FG V R ++ G+ V ++ E W E
Sbjct: 14 GPWEMKERLGTGGFGYVLRWI------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 190 RVRRACANCCADFVYGFFENSSK--KGGEYWLIWRY--EGEATLADLMISREFPYNVQTL 245
++ N + + K L Y G+ L + E ++
Sbjct: 68 KLN--HPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGD--LRKYLNQFENCCGLK-- 119
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFK 303
E R + +S + AL LH I+HRD+KP+N++ K
Sbjct: 120 ------------EGPIRTL---LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK 164
Query: 304 IIDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
IIDLG A + + L +Y APE
Sbjct: 165 IIDLGYA-------KELDQGELCTEFVGTLQYLAPE 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 44/227 (19%), Positives = 69/227 (30%), Gaps = 60/227 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRACAN 197
DF + LG G FGVV+ A +K D +K+ + + E R
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAK------NKVDDCNYAIKR------IRLPNRELAREKVMR 52
Query: 198 ------------------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFP 239
+ S ++ + + L D M R
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-- 110
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
ERE + I Q+ A++ LHS G++HRD+KP N+ F+
Sbjct: 111 ---------------TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-D 154
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD-----------PRYAAPEQ 335
K+ D G + + Y +PEQ
Sbjct: 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 30/213 (14%), Positives = 71/213 (33%), Gaps = 51/213 (23%)
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE 189
+ + + + K++G G V++ + + + ++ + NE
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 190 -----RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNV 242
++++ +Y + +++ + L + ++
Sbjct: 77 IAYLNKLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID--- 125
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
E ++ +L A+ +H GIVH D+KP N + +G
Sbjct: 126 ---------------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG--ML 165
Query: 303 KIIDLGAAADLRVGINYIPKEFLL-DPRYAAPE 334
K+ID G A ++ + K+ + Y PE
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 47/207 (22%), Positives = 73/207 (35%), Gaps = 36/207 (17%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLK--KATEYGAVEIWMNE 189
++ + F +LG G++G V++ SK DG L +K + G +
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVR------SKEDGRLYAVKRSMSPFRGPKDRARKL 104
Query: 190 RVRRACANCCA-DFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLIL 247
+ + + ++GG +L +Q
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELCGPS---------------LQQHCE 148
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
LP E ++ + L AL LHS G+VH D+KP N IF K+ D
Sbjct: 149 AWGASLP-----EAQV-WGYLRDTLLALAHLHSQGLVHLDVKPAN-IFLGPRGRCKLGDF 201
Query: 308 GAAADLRVGINYIPKEFLLDPRYAAPE 334
G +L G + DPRY APE
Sbjct: 202 GLLVEL--GTAGAGEVQEGDPRYMAPE 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 32/209 (15%), Positives = 68/209 (32%), Gaps = 53/209 (25%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE---- 189
+ + K++G G V++ + L++A NE
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSY-RNEIAYL 61
Query: 190 -RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNVQTLI 246
++++ +Y + +++ + L + ++
Sbjct: 62 NKLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID------- 106
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
E ++ +L A+ +H GIVH D+KP N + +G K+ID
Sbjct: 107 -----------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG--MLKLID 150
Query: 307 LGAAADLRVGINYIPKEFLL-DPRYAAPE 334
G A ++ + K+ + Y PE
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 39/209 (18%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKK--ATEYGAVEIWMNE-RVRRAC 195
++ +KLGEG F V L + +DG LK+ E E E + R
Sbjct: 30 HYLFIQKLGEGGFSYVD---LVE---GLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 196 A--NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
N + + E WL+ + TL + + + L
Sbjct: 84 NHPNILR--LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL----------KDKGNFL 131
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
E + I ++ + L+ +H+ G HRD+KP N++ + ++DLG+
Sbjct: 132 T---EDQ---ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQA 184
Query: 314 RVGINYIPKEFLLD--------PRYAAPE 334
+ + + L Y APE
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 30/211 (14%), Positives = 70/211 (33%), Gaps = 51/211 (24%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-- 189
+ + + K++G G V++ + + + ++ + NE
Sbjct: 54 KGRIYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 190 ---RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNVQT 244
++++ +Y + +++ + L + ++
Sbjct: 107 YLNKLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID----- 153
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
E ++ +L A+ +H GIVH D+KP N + +G K+
Sbjct: 154 -------------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKL 195
Query: 305 IDLGAAADLRVGINYIPKEFLL-DPRYAAPE 334
ID G A ++ + K+ + Y PE
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 25/208 (12%), Positives = 57/208 (27%), Gaps = 16/208 (7%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRA-------SLAKK---PSSKNDGDLVLKKATEYGAVEIW 186
R V G LG+ A S + + + + + E + +
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 187 MNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ ++ +K + L+ + N+QT
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
+ + + Q++ L LH G+VH ++P +++ + +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTG 249
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPE 334
+R G + + PE
Sbjct: 250 FEHL--VRDGARV---VSSVSRGFEPPE 272
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 33/216 (15%), Positives = 57/216 (26%), Gaps = 26/216 (12%)
Query: 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVR 192
+ + L + L G VV+ + LK T ER+
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVR------DVERLEDFALKVFTMGAENSRSELERLH 110
Query: 193 RACANCCADFVYGFFENSSKKGGEYWL-IWRYEGEATLADLMISREFPYNVQTLILGEV- 250
A E ++ + + A L ++ L+L
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170
Query: 251 -QDLPKGIERENRIIQT-----------IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298
DL + + + +QL+ L S G+VH P N+
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
R + D+ A + + YA E
Sbjct: 231 GR-LMLGDVSAL----WKVGTRGPASSVPVTYAPRE 261
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 26/233 (11%), Positives = 57/233 (24%), Gaps = 13/233 (5%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKK---PSSKNDGDLVLKKA 177
VE R V G LG+ A S + + + + +
Sbjct: 69 VESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 126
Query: 178 TEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE 237
E + + + ++ +K + L+ +
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
N+QT + + + Q++ L LH G+VH ++P +++ +
Sbjct: 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 246
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350
+ P A P+ +
Sbjct: 247 RGG-VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 45/203 (22%), Positives = 76/203 (37%), Gaps = 38/203 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC--- 195
+ +V +K+GEG+FG S DG + K M+ + R
Sbjct: 24 EKYVRLQKIGEGSFGKAILVK------STEDGRQYVIKEINISR----MSSKEREESRRE 73
Query: 196 ----ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
AN + + E S ++ G +++ Y L + +++
Sbjct: 74 VAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVL----------- 121
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
E++I+ Q+ AL +H I+HRDIK QN IF T ++ D G A
Sbjct: 122 -FQ-----EDQILD-WFVQICLALKHVHDRKILHRDIKSQN-IFLTKDGTVQLGDFGIAR 173
Query: 312 DLRVGINYIPKEFLLDPRYAAPE 334
L + + + P Y +PE
Sbjct: 174 VLNSTVELA-RACIGTPYYLSPE 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 44/223 (19%), Positives = 72/223 (32%), Gaps = 70/223 (31%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ + +G LG G FG VY + +D V ++K E+ RV
Sbjct: 41 LESQYQVGPLLGSGGFGSVY---SGIR---VSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 193 R----------ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
+ + +FE + LI + E P V
Sbjct: 95 MEVVLLKKVSSGFSGVIR--LLDWFERPDS----FVLI------------L---ERPEPV 133
Query: 243 QTLILGEVQD-------LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
++ D L E R + Q+L A+ H+ G++HRDIK +N++
Sbjct: 134 -----QDLFDFITERGALQ---EELAR---SFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G+ + D Y+ PE
Sbjct: 183 DLNRGELKLIDFGSG-------ALLKDTVYTDFDGTRVYSPPE 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 41/226 (18%), Positives = 68/226 (30%), Gaps = 64/226 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+F +K+G G FG V++ + DG + A + E V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV------KRLDGCIYAIKRSKKPLAGSVDEQNA-LRE-V 61
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
V +F + + + Y +LAD + E +
Sbjct: 62 YAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISE----NYRIMSYFKEAE 116
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV------------------ 293
++ ++ Q+ L +HS +VH DIKP N+
Sbjct: 117 ------------LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164
Query: 294 IFSEGSRTFKIIDLGAAADL-----RVGINYIPKEFLLDPRYAAPE 334
++ FKI DLG + G D R+ A E
Sbjct: 165 DWASNKVMFKIGDLGHVTRISSPQVEEG----------DSRFLANE 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 37/204 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRAC-- 195
+F + KK+G G F VYRA+ DG LKK + M+ + R C
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAA------CLLDGVPVALKKVQIFDL----MDAKARADCIK 81
Query: 196 -----ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V ++ S + E ++ L+ ++ + F + +
Sbjct: 82 EIDLLKQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLI----- 133
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
E + + QL AL+ +HS ++HRDIKP N +F + K+ DLG
Sbjct: 134 --------PERTVWK-YFVQLCSALEHMHSRRVMHRDIKPAN-VFITATGVVKLGDLGLG 183
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
+ P Y +PE
Sbjct: 184 RFFSSKTTA-AHSLVGTPYYMSPE 206
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 43/209 (20%), Positives = 85/209 (40%), Gaps = 41/209 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC--- 195
+D+ + +G G++G + K+DG +++ K +YG+ M E ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIR------RKSDGKILVWKELDYGS----MTEAEKQMLVSE 55
Query: 196 ----ANCCADFVYGFFEN-SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ +++ + +++ Y LA ++ + Q L
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYL----- 108
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHS-----TGIVHRDIKPQNVIFSEGSRTFKII 305
E +++ +M+QL AL H ++HRD+KP N +F +G + K+
Sbjct: 109 --------DEEFVLR-VMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQNVKLG 158
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A L ++ K F+ P Y +PE
Sbjct: 159 DFGLARILNHDTSFA-KTFVGTPYYMSPE 186
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 51/223 (22%), Positives = 82/223 (36%), Gaps = 79/223 (35%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKK--PSSKNDGDLVLKKATEYGAVEIWMN 188
+ +++ + LG G FG+V+R + K D LV K E + I +N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---E---ISI-LN 56
Query: 189 ----ERVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
+ ++ FE+ + G + + + + +
Sbjct: 57 IARHRNILH---------LHESFESMEELVMIFEFISGLD------------IFERINTS 95
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
F N ERE I + + Q+ AL LHS I H DI+P+N+I+
Sbjct: 96 AFELN----------------ERE---IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ S T KII+ G A L+ P + P Y APE
Sbjct: 137 TRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPEYYAPE 173
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 46/211 (21%), Positives = 65/211 (30%), Gaps = 49/211 (23%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNERVR 192
K F LG GA G + D V L + + E+ ++
Sbjct: 23 KISFCPKDVLGHGAEGTIVYRG-------MFDNRDVAVKRILPECFSFADREV----QLL 71
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
R N + RY R+F Y L +Q+
Sbjct: 72 RESDEH---------PN----------VIRYF------CTEKDRQFQYIAIELCAATLQE 106
Query: 253 L--PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE----GSRTFKIID 306
K T++ Q L LHS IVHRD+KP N++ S G I D
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 307 LGAAADLRVGINYIPKEFLLD--PRYAAPEQ 335
G L VG + + + + APE
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 43/243 (17%), Positives = 75/243 (30%), Gaps = 47/243 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY----------- 180
DF + +G G FGVV+ A + A K + +L +K
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 181 --GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGE-----ATLADLM 233
W+ + ++ + + +T +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 234 ISREFPYNVQTLI---LGEVQDLPKGI-------ERENRIIQTIMSQLLFALDGLHSTGI 283
+ V I L ++L + +RE+ + I Q+ A++ LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----------PRYAA 332
+HRD+KP N IF K+ D G + + Y +
Sbjct: 186 MHRDLKPSN-IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 333 PEQ 335
PEQ
Sbjct: 245 PEQ 247
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 69/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
D + + LG+G+FG V K G + K + E + R
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDK---ESLLR 75
Query: 194 ACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
N +Y FFE+ GGE L D +ISR+
Sbjct: 76 EVQLLKQLDHPNIMK--LYEFFEDKGYFYLVGEVYTGGE------------LFDEIISRK 121
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
++ E + I+ Q+L + +H IVHRD+KP+N++
Sbjct: 122 R-FS----------------EVD---AARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
S+ + +IID G + K+ + Y APE
Sbjct: 162 KSKDA-NIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE 198
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 46/219 (21%), Positives = 72/219 (32%), Gaps = 59/219 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWM-NERVRRAC- 195
DF + +G G FG V++A + DG V+K + NE+ R
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK------HRIDGKTYVIK--------RVKYNNEKAEREVK 56
Query: 196 --ANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
A + G ++ L M EF +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM---EF---------CDK 104
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L + IE+ + Q+ +D +HS +++RD+KP N IF ++ KI
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN-IFLVDTKQVKI 163
Query: 305 IDLGAAADLR--------VGINYIPKEFLLDPRYAAPEQ 335
D G L+ G RY +PEQ
Sbjct: 164 GDFGLVTSLKNDGKRTRSKG----------TLRYMSPEQ 192
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 40/183 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ + + +LG+GAFG VY+A +K G L K E +E ++ E
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAK------NKETGALAAAKVIETKSEEE---LEDYIVEIE 68
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ C + ++ + G+ W++ + + +M+ + L E
Sbjct: 69 ILATCDH---PYIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEP 117
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q IQ + Q+L AL+ LHS I+HRD+K NV+ + ++ D G +
Sbjct: 118 Q------------IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI-RLADFGVS 164
Query: 311 ADL 313
A
Sbjct: 165 AKN 167
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 51/233 (21%), Positives = 79/233 (33%), Gaps = 55/233 (23%)
Query: 120 FDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------ 173
F F L ++ +D++++ K LG GA G V A + V
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF------ERKTCKKVAIRIIS 169
Query: 174 LKKATEYGAVEIWMNERVRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRY-- 223
+K A E V + FF+ Y+++
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIK--IKNFFDAED-----YYIVLELME 222
Query: 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283
GE L D ++ + E + Q+L A+ LH GI
Sbjct: 223 GGE--LFDKVVGNKR-LK----------------EATCK---LYFYQMLLAVQYLHENGI 260
Query: 284 VHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+HRD+KP+NV+ S E KI D G + +G + + P Y APE
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPE 311
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 46/223 (20%), Positives = 78/223 (34%), Gaps = 65/223 (29%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
+ + +KLG GA+G V A K K+ + ++ +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQ--FDKGRYSDDNKNIEKFHEE 92
Query: 191 VRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMI 234
+ + N ++ FE+ +GGE L + +I
Sbjct: 93 IYNEISLLKSLDHPNIIK--LFDVFEDKKYFYLVTEFYEGGE------------LFEQII 138
Query: 235 SREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
+R ++ E + IM Q+L + LH IVHRDIKP+N++
Sbjct: 139 NRHK-FD----------------ECD---AANIMKQILSGICYLHKHNIVHRDIKPENIL 178
Query: 295 F---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+ KI+D G ++ Y ++ L Y APE
Sbjct: 179 LENKNSLL-NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 43/218 (19%), Positives = 78/218 (35%), Gaps = 69/218 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRR 193
D + + + +G G++ V R K ++ K+ EI E + R
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCI------HKATNMEFAVKIIDKSKRDPTEEI---EILLR 71
Query: 194 A--CANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
N + +++ KGGE L D ++ ++F ++
Sbjct: 72 YGQHPNIIT--LKDVYDDGKYVYVVTELMKGGE------------LLDKILRQKF-FS-- 114
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEGSR 300
ERE ++ + ++ LH+ G+VHRD+KP N+++ S
Sbjct: 115 --------------EREAS---AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPE 157
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ +I D G A LR L+ + APE
Sbjct: 158 SIRICDFGFAKQLRAE-----NGLLMTPCYTANFVAPE 190
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 44/212 (20%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKK----PSSKNDGDLVLKKATEYGAVEIW 186
+DD+ L + +G GA VV A +A K + D +LK EI
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK--------EIQ 65
Query: 187 MNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ C + ++ S E WL+ + ++ D++ ++ +
Sbjct: 66 A-------MSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
L E I TI+ ++L L+ LH G +HRD+K N++ E + +I D
Sbjct: 118 LDEST------------IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIAD 164
Query: 307 LGAAADLRVGINYIPKE----FLLDPRYAAPE 334
G +A L G + + F+ P + APE
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 53/216 (24%), Positives = 75/216 (34%), Gaps = 62/216 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA- 196
+ + KKLG GA+G V K K +V N ++ A
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCR------DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV 89
Query: 197 -------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
N +Y FFE+ KGGE L D +I R +N
Sbjct: 90 LKLLDHPNIMK--LYDFFEDKRNYYLVMECYKGGE------------LFDEIIHRMK-FN 134
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + I+ Q+L + LH IVHRD+KP+N++ +
Sbjct: 135 ----------------EVD---AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+ KI+D G +A KE L Y APE
Sbjct: 176 A-LIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 42/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ K+GEG+ G+V A K+ G V L+K E+ NE
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAR------EKHSGRQVAVKMMDLRKQQR---RELLFNEVV 94
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ R + V ++ S G E W++ + L D++ + L E
Sbjct: 95 IMRDYQH---FNVVEMYK-SYLVGEELWVLMEFLQGGALTDIV---------SQVRLNEE 141
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I T+ +L AL LH+ G++HRDIK +++ + R K+ D G
Sbjct: 142 Q------------IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRV-KLSDFGFC 188
Query: 311 ADL 313
A +
Sbjct: 189 AQI 191
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 42/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
K + +K+G+GA G VY A G V L++ + E+ +NE
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPK---KELIINEIL 69
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V R N + + + S G E W++ Y +L D++ + E
Sbjct: 70 VMRENKN---PNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTET---------CMDEG 116
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I + + L AL+ LHS ++HRDIK N++ K+ D G
Sbjct: 117 Q------------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV-KLTDFGFC 163
Query: 311 ADL 313
A +
Sbjct: 164 AQI 166
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 46/225 (20%), Positives = 74/225 (32%), Gaps = 82/225 (36%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
D + + ++LG GAFGVV+R K +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAK---------FINTPYPLDK------YT 94
Query: 191 VRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMI 234
V+ + ++ FE+ + GGE L D +
Sbjct: 95 VKNEISIMNQLHHPKLIN--LHDAFEDKYEMVLILEFLSGGE------------LFDRIA 140
Query: 235 SREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
+ ++ + E E + M Q L +H IVH DIKP+N++
Sbjct: 141 AEDYKMS----------------EAE---VINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 295 F-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++ + + KIID G A L P E + +AAPE
Sbjct: 182 CETKKASSVKIIDFGLATKLN------PDEIVKVTTATAEFAAPE 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-15
Identities = 48/218 (22%), Positives = 78/218 (35%), Gaps = 63/218 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNE-RVR 192
D F+ +KLG GAFG V+ ++ G + K +E E V
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVE------ERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 193 RAC--ANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYNV 242
++ N ++ FE+ +GGE L + ++S +
Sbjct: 75 KSLDHPNIIK--IFEVFEDYHNMYIVMETCEGGE------------LLERIVSAQARGKA 120
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSR 300
+ E + +M Q++ AL HS +VH+D+KP+N++F
Sbjct: 121 LS-------------EGY---VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G A + E + Y APE
Sbjct: 165 PIKIIDFGLA------ELFKSDEHSTNAAGTALYMAPE 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 44/227 (19%), Positives = 74/227 (32%), Gaps = 63/227 (27%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ ++ LG LG+G FG V+ + D V + + G + +
Sbjct: 29 FEAEYRLGPLLGKGGFGTVF---AGHR---LTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 193 R------------ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPY 240
+ +FE + L+ + E P
Sbjct: 83 LEVALLWKVGAGGGHPGVIR--LLDWFETQEG----FMLV------------L---ERPL 121
Query: 241 NVQTLILGEVQDL--PKG--IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
++ D KG E +R Q++ A+ HS G+VHRDIK +N++
Sbjct: 122 PA-----QDLFDYITEKGPLGEGPSR---CFFGQVVAAIQHCHSRGVVHRDIKDENILID 173
Query: 297 EGSRTFKIIDLGAAADLRVG--------INYIPKEFLLDPRYAAPEQ 335
K+ID G+ A L Y P E++ +Y A
Sbjct: 174 LRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 70/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
+ + + LG+G+FG V + + K + + + E +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK------DRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 192 RRAC--ANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
+ N ++ E+SS GGE L D +I R+ ++
Sbjct: 75 LKKLDHPNIMK--LFEILEDSSSFYIVGELYTGGE------------LFDEIIKRKR-FS 119
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + I+ Q+ + +H IVHRD+KP+N++ +
Sbjct: 120 ----------------EHD---AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G + + + D Y APE
Sbjct: 161 C-DIKIIDFGLS------TCFQQNTKMKDRIGTAYYIAPE 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 47/232 (20%), Positives = 74/232 (31%), Gaps = 77/232 (33%)
Query: 134 TTYRKDDF----VLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEI 185
T +R+++ G++LG G F VV + K+ G +KK +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCR------EKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 186 WMNERVRR--------ACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATL 229
E + R N ++ +EN + GGE L
Sbjct: 56 VSREDIEREVSILKEIQHPNVIT--LHEVYENKTDVILILELVAGGE------------L 101
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
D + +E E E + Q+L + LHS I H D+K
Sbjct: 102 FDFLAEKES-LT----------------EEE---ATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 290 PQNVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
P+N++ + KIID G A + P + APE
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLA------HKIDFGNEFKNIFGTPEFVAPE 187
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 47/216 (21%), Positives = 76/216 (35%), Gaps = 52/216 (24%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--E 184
Y D+ LG+G +G+VY ++ + + + + E
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGR------DLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 185 IWMNER------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
I +++ V+ G S + G + +L+ L+ S+
Sbjct: 70 IALHKHLKHKNIVQ----------YLG----SFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298
P ++ + I Q+L L LH IVHRDIK NV+ +
Sbjct: 116 P-----------------LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 158
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
S KI D G + L GIN + F +Y APE
Sbjct: 159 SGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE 193
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 42/219 (19%), Positives = 73/219 (33%), Gaps = 68/219 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
+ + + LG+G+FG V + + K + + + E +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK------DRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 192 RRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
+ N ++ E+SS GGE L D +I R+ ++
Sbjct: 75 LKKLDHPNIMK--LFEILEDSSSFYIVGELYTGGE------------LFDEIIKRKR-FS 119
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
E + I+ Q+ + +H IVHRD+KP+N++ E
Sbjct: 120 ----------------EHD---AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G + + + D Y APE
Sbjct: 161 CDIKIIDFGLSTCFQ------QNTKMKDRIGTAYYIAPE 193
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 45/224 (20%), Positives = 72/224 (32%), Gaps = 73/224 (32%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRR 193
+D + +G++LG G F +V + K G +KK + E + R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCR------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 194 ACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
N ++ FEN + GGE L D + +E
Sbjct: 58 EVNILREIRHPNIIT--LHDIFENKTDVVLILELVSGGE------------LFDFLAEKE 103
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
E E + Q+L + LHS I H D+KP+N++
Sbjct: 104 S-LT----------------EDE---ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ + K+ID G A + P + APE
Sbjct: 144 KNVPNPRIKLIDFGIA------HKIEAGNEFKNIFGTPEFVAPE 181
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 49/217 (22%), Positives = 79/217 (36%), Gaps = 66/217 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE- 189
D + + ++LG GAFGVV+R + A K E ++ M+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE---IQT-MSVL 211
Query: 190 ---RVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLMISREFPYNV 242
+ ++ FE+ + E +I YE GE L + + +
Sbjct: 212 RHPTLVN---------LHDAFEDDN----EMVMI--YEFMSGGE--LFEKVADEHNKMS- 253
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRT 301
E E M Q+ L +H VH D+KP+N++F ++ S
Sbjct: 254 ---------------EDE---AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 295
Query: 302 FKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G A L PK+ + +AAPE
Sbjct: 296 LKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPE 326
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 49/222 (22%), Positives = 71/222 (31%), Gaps = 69/222 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+D++++ K LG GA G V A + V +K A E V
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAF------ERKTCKKVAIKIISKRKFAIGSAREADPALNV 62
Query: 192 RRACANC------CADFVYGFFENSSK-------KGGEYWLIWRYEGEATLADLMISREF 238
C + FF+ +GGE L D ++ +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGE------------LFDKVVGNKR 110
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-- 296
E + Q+L A+ LH GI+HRD+KP+NV+ S
Sbjct: 111 -LK----------------EATCK---LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
E KI D G + L + P Y APE
Sbjct: 151 EEDCLIKITDFGHSKILG------ETSLMRTLCGTPTYLAPE 186
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 61/224 (27%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWM 187
F+ +D + +G++LG G F +V + K+ G +KK +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCR------EKSTGLEYAAKFIKKRQSRASRRGVS 58
Query: 188 NERVRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISRE 237
E + R + N ++ +EN + + LI GE L D + +E
Sbjct: 59 REEIEREVSILRQVLHHNVIT--LHDVYENRT----DVVLILELVSGGE--LFDFLAQKE 110
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
+ E E + + Q+L ++ LH+ I H D+KP+N++
Sbjct: 111 S-LS----------------EEE---ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ K+ID G A + P + APE
Sbjct: 151 KNIPIPHIKLIDFGLA------HEIEDGVEFKNIFGTPEFVAPE 188
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 47/218 (21%), Positives = 74/218 (33%), Gaps = 61/218 (27%)
Query: 138 KDDFVLGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNE- 189
+++ + LG G VV R A K G + + E + E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ-ELREATLKEV 74
Query: 190 RV-RRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPY 240
+ R+ + + +E ++ K GE L D + +
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE------------LFDYLTEKVT-L 121
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
+ E+E R IM LL + LH IVHRD+KP+N++ +
Sbjct: 122 S----------------EKETR---KIMRALLEVICALHKLNIVHRDLKPENILLDDDM- 161
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ D G + L P E L + P Y APE
Sbjct: 162 NIKLTDFGFSCQLD------PGEKLREVCGTPSYLAPE 193
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 40/182 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
++ F + +KLGEG++G VY+A K G +V ++ + EI +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI------HKETGQIVAIKQVPVESDLQEIIKEISI---- 77
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
C + V ++ S K + W++ Y G +++D++ R L E +
Sbjct: 78 ---MQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-------LTEDE 126
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
I TI+ L L+ LH +HRDIK N++ + K+ D G A
Sbjct: 127 ------------IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAG 173
Query: 312 DL 313
L
Sbjct: 174 QL 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 44/225 (19%), Positives = 67/225 (29%), Gaps = 62/225 (27%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNER-- 190
K+ V K LG G+ G V G V L + +EI +
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQG-------SFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 191 -----VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+R Y ++ L DL+ S+
Sbjct: 67 DHPNVIR----------YYCSETTDRF----LYIALELCN-LNLQDLVESKNVS------ 105
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF--- 302
++L E +++ Q+ + LHS I+HRD+KPQN++ S SR
Sbjct: 106 ----DENLKLQKEYN---PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 303 ---------KIIDLGAAADLRVGINYIPKEFLLD---PRYAAPEQ 335
I D G L G + + APE
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 73/230 (31%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWM 187
F+ +D + +G++LG G F +V + K+ G +KK +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCR------EKSTGLEYAAKFIKKRQSRASRRGVC 58
Query: 188 NERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLAD 231
E + R + N ++ +EN + GGE L D
Sbjct: 59 REEIEREVSILRQVLHPNIIT--LHDVYENRTDVVLILELVSGGE------------LFD 104
Query: 232 LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
+ +E + E E + + Q+L ++ LH+ I H D+KP+
Sbjct: 105 FLAQKES-LS----------------EEE---ATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 292 NVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
N++ + K+ID G A + P + APE
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLA------HEIEDGVEFKNIFGTPEFVAPE 188
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 38/184 (20%), Positives = 68/184 (36%), Gaps = 40/184 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ F +++G G+FG VY A + ++V + + E R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGE 249
+ + + + WL+ Y G + +DL+ + P L E
Sbjct: 107 FLQKLRH---PNTIQYRG-CYLREHTAWLVMEYCLG--SASDLLEVHKKP-------LQE 153
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
V+ I + L L LHS ++HRD+K N++ SE K+ D G+
Sbjct: 154 VE------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV-KLGDFGS 200
Query: 310 AADL 313
A+ +
Sbjct: 201 ASIM 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 45/222 (20%), Positives = 70/222 (31%), Gaps = 70/222 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+ +G G VV R + G + + E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCV------HRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 192 RRACANCCADF-------VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
RR + +E+SS + GE L D + +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE------------LFDYLTEK 194
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
+ E+E R +IM LL A+ LH+ IVHRD+KP+N++
Sbjct: 195 VA-LS----------------EKETR---SIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ ++ D G + L P E L + P Y APE
Sbjct: 235 DNM-QIRLSDFGFSCHLE------PGEKLRELCGTPGYLAPE 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 36/182 (19%), Positives = 60/182 (32%), Gaps = 45/182 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRR---A 194
++G G+FG V+R K G AV ++ + A
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMK------DKQTGFQC--------AVKKVRLEVFRVEELVA 103
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
CA + + YG ++G + +L L+ ++
Sbjct: 104 CAGLSSPRIVPLYGAV----REGPWVNIFMELLEGGSLGQLI--KQM------------- 144
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
G E+ + Q L L+ LH+ I+H D+K NV+ S + D G A
Sbjct: 145 ----GCLPED-RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 312 DL 313
L
Sbjct: 200 CL 201
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 49/183 (26%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
++ F +K+G+G+FG V++ +V L++A + +E E
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGI------DNRTQKVVAIKIIDLEEAED--EIEDIQQEIT 72
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V C + +V ++ S K + W+I Y G + DL+ L E
Sbjct: 73 VLSQCDS---PYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG---------PLDET 119
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A
Sbjct: 120 Q------------IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV-KLADFGVA 166
Query: 311 ADL 313
L
Sbjct: 167 GQL 169
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 48/249 (19%), Positives = 81/249 (32%), Gaps = 71/249 (28%)
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
+PG++ G + +A + LF Y L + +G+G F VV R ++ G
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYE-----LCEVIGKGPFSVVRRCI------NRETG 49
Query: 171 DL----VLKKATEYGAVEIWMNERVRRACANCCADF-------VYGFFENSSK------- 212
++ A ++ + E ++R A+ C + + +
Sbjct: 50 QQFAVKIVDVA-KFTSSPGLSTEDLKRE-ASICHMLKHPHIVELLETYSSDGMLYMVFEF 107
Query: 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQL 271
G + L ++ R V + E M Q+
Sbjct: 108 MDGAD------------LCFEIVKRADAGFVYS-------------EAVAS---HYMRQI 139
Query: 272 LFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
L AL H I+HRD+KP V+ + E S K+ G A L
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-----GESGLVAGGRV 194
Query: 328 --PRYAAPE 334
P + APE
Sbjct: 195 GTPHFMAPE 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 30/227 (13%), Positives = 65/227 (28%), Gaps = 68/227 (29%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKK----------PSSKNDGDLVLKKATEYGAVEIWMN 188
+D+ + + L +G F + L +K S + K+
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 189 ERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADL 232
+ + C G N + + +
Sbjct: 88 DDFKNELQIITDIKNEYCLT--CEGIITNYDEVYIIYEYMENDS---------------I 130
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291
++ +L + I+ II+ +L + +H+ I HRD+KP
Sbjct: 131 -----LKFDEYFFVLDKNYTCFIPIQVIKCIIK----SVLNSFSYIHNEKNICHRDVKPS 181
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
N++ + + K+ D G + Y+ + + + PE
Sbjct: 182 NILMDK-NGRVKLSDFGES-------EYMVDKKIKGSRGTYEFMPPE 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 42/224 (18%), Positives = 75/224 (33%), Gaps = 77/224 (34%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNERVR 192
+++ L ++LG+GAF VV R G K + E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCV------KVLAGQEYAAMIINTKKLSARDHQKLERE--- 60
Query: 193 RACANCCADF-------VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
A C ++ GGE L + +++RE
Sbjct: 61 ---ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE------------LFEDIVARE 105
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
+ Y+ E + + Q+L A+ H G+VHR++KP+N++
Sbjct: 106 Y-YS----------------EADAS---HCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+G+ K+ D G A ++ ++ P Y +PE
Sbjct: 146 KLKGA-AVKLADFGLAIEVEG-----EQQAWFGFAGTPGYLSPE 183
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 53/217 (24%), Positives = 74/217 (34%), Gaps = 58/217 (26%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK-----KATEYGAVEIWMNER 190
+ LG GAFG V+ A K V +K K E +E +
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAV------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 191 VRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
V A N V FEN + L+ G DL F +
Sbjct: 76 VTLEIAILSRVEHANIIK--VLDIFENQGF----FQLVMEKHGSG--LDL-----FAFID 122
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
+ P+ E I QL+ A+ L I+HRDIK +N++ +E T
Sbjct: 123 RH---------PRLDEPLAS---YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE-DFTI 169
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
K+ID G+A Y+ + L Y APE
Sbjct: 170 KLIDFGSA-------AYLERGKLFYTFCGTIEYCAPE 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 42/219 (19%), Positives = 71/219 (32%), Gaps = 70/219 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA- 196
+ L +G G++G V A K K VE +R ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAV------QKGTRIRRAAKKIPKYFVE--DVDRFKQEIEI 59
Query: 197 -------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
N +Y FE+++ GGE L + ++ + +
Sbjct: 60 MKSLDHPNIIR--LYETFEDNTDIYLVMELCTGGE------------LFERVVHKRV-FR 104
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
E + IM +L A+ H + HRD+KP+N +F
Sbjct: 105 ----------------ESDAA---RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G AA + P + + P Y +P+
Sbjct: 146 SPLKLIDFGLAARFK------PGKMMRTKVGTPYYVSPQ 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 70/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
D++ + ++LG+GAF VV R K G K + E R+
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCV------HKTTGLEFAAKIINTKKLSARDFQKLEREARI 58
Query: 192 RRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
R N ++ + S GGE L + +++REF Y+
Sbjct: 59 CRKLQHPNIVR--LHDSIQEESFHYLVFDLVTGGE------------LFEDIVAREF-YS 103
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + + Q+L ++ HS GIVHR++KP+N++ ++G
Sbjct: 104 ----------------EADAS---HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKG 144
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ K+ D G A ++ E P Y +PE
Sbjct: 145 A-AVKLADFGLAIEVN------DSEAWHGFAGTPGYLSPE 177
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 49/223 (21%), Positives = 79/223 (35%), Gaps = 67/223 (30%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWM 187
+TT + F+ + LG GAF V+ + G L +KK+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVK------QRLTGKLFALKCIKKSPA-FRDSSLE 54
Query: 188 NE-RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREF 238
NE V + + + +E+++ GGE L D ++ R
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE------------LFDRILERGV 102
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF--- 295
Y E++ ++ Q+L A+ LH GIVHRD+KP+N+++
Sbjct: 103 -YT----------------EKDAS---LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
E S I D G + + P Y APE
Sbjct: 143 EENS-KIMITDFGLSK-------MEQNGIMSTACGTPGYVAPE 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 48/226 (21%), Positives = 83/226 (36%), Gaps = 82/226 (36%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEI 185
D++ + ++LG+GAF VV R + K S D + + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER--------EA 79
Query: 186 WMNERVRRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
R+ R N ++ + S GGE L + +++
Sbjct: 80 ----RICRKLQHPNIVR--LHDSIQEESFHYLVFDLVTGGE------------LFEDIVA 121
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
REF Y+ E + + Q+L ++ HS GIVHR++KP+N++
Sbjct: 122 REF-YS----------------EADAS---HCIQQILESIAYCHSNGIVHRNLKPENLLL 161
Query: 296 ---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++G+ K+ D G A ++ E P Y +PE
Sbjct: 162 ASKAKGA-AVKLADFGLAIEVN------DSEAWHGFAGTPGYLSPE 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 43/188 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VEIWMNER 190
F L + +G G +G VY+ G L K + EI M
Sbjct: 23 AGIFELVELVGNGTYGQVYKGR------HVKTGQLAAIKVMDVTGDEEEEIKQEINM--- 73
Query: 191 VRRACANCCADFV---YGFF--ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+++ + + YG F +N + WL+ + G ++ DL+ N +
Sbjct: 74 LKKYSHH---RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI------KNTKGN 124
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
L E I I ++L L LH ++HRDIK QNV+ +E + K++
Sbjct: 125 TLKEEW------------IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLV 171
Query: 306 DLGAAADL 313
D G +A L
Sbjct: 172 DFGVSAQL 179
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 46/223 (20%), Positives = 75/223 (33%), Gaps = 76/223 (34%)
Query: 138 KDDFVLGKK--LGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMN 188
+ + K LG G FG V++ LA K + E + + MN
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE---ISV-MN 141
Query: 189 E----RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
+ + + +Y FE+ + GGE L D +I
Sbjct: 142 QLDHANLIQ---------LYDAFESKNDIVLVMEYVDGGE------------LFDRIIDE 180
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
+ E + M Q+ + +H I+H D+KP+N++
Sbjct: 181 SYNLT----------------ELD---TILFMKQICEGIRHMHQMYILHLDLKPENILCV 221
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ ++ KIID G A Y P+E L P + APE
Sbjct: 222 NRDAKQIKIIDFGLA------RRYKPREKLKVNFGTPEFLAPE 258
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 57/236 (24%)
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
A PG A D ++ D F + +LG GA +VYR +K + K
Sbjct: 30 AAPGTASLVPDYWIDGS-----NRDALSDFFEVESELGRGATSIVYRCK--QKGTQKPYA 82
Query: 171 DLVLKKATEYGAVEIWMNE-RVRRACANCCADFVYGFFENSSK--------KGGEYWLIW 221
VLKK + V E V ++ + FE ++ GGE
Sbjct: 83 LKVLKKTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----- 134
Query: 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281
L D ++ + + Y+ ER+ + Q+L A+ LH
Sbjct: 135 -------LFDRIVEKGY-YS----------------ERDAA---DAVKQILEAVAYLHEN 167
Query: 282 GIVHRDIKPQNVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
GIVHRD+KP+N+++ + + KI D G + + + K P Y APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPE 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 50/207 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR----- 193
DDF +LG G GVV++ S KPS + K + + + +R
Sbjct: 33 DDFEKISELGAGNGGVVFKVSH--KPSGLV---MARKL------IHLEIKPAIRNQIIRE 81
Query: 194 --ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
C + ++ YG F GE + + +L ++ + +
Sbjct: 82 LQVLHECNSPYIVGFYGAFY----SDGEISICMEHMDGGSLDQVLK--------KAGRIP 129
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIIDL 307
E +I+ + ++ L L I+HRD+KP N++ + K+ D
Sbjct: 130 E------------QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDF 176
Query: 308 GAAADLRVGINYIPKEFLLDPRYAAPE 334
G + L I+ + F+ Y +PE
Sbjct: 177 GVSGQL---IDSMANSFVGTRSYMSPE 200
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 50/231 (21%), Positives = 74/231 (32%), Gaps = 84/231 (36%)
Query: 138 KDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVEI------WMN 188
+D + L + LGEGA V T EY AV+I +
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCI---------------NLITSQEY-AVKIIEKQPGHIR 54
Query: 189 ERVRR---------ACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLAD 231
RV R N + FFE + +GG +
Sbjct: 55 SRVFREVEMLYQCQGHRNVLE--LIEFFEEEDRFYLVFEKMRGGS------------ILS 100
Query: 232 LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
+ R +N E E ++ + ALD LH+ GI HRD+KP+
Sbjct: 101 HIHKRRH-FN----------------ELEAS---VVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 292 NVIFS--EGSRTFKIIDLGAAADLRVGINYIP--KEFLLD----PRYAAPE 334
N++ KI D + +++ + P LL Y APE
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 46/228 (20%), Positives = 76/228 (33%), Gaps = 70/228 (30%)
Query: 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IW 186
++ + D V + LG G G V + K T ++ A++ +
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIF---------------NKRTQEKF-ALKMLQ 96
Query: 187 MNERVRR---------ACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLM 233
+ RR C + + +EN ++ E GE L +
Sbjct: 97 DCPKARREVELHWRASQCPHIVR--IVDVYENLYAGRKCLLIV--MECLDGGE--LFSRI 150
Query: 234 ISR-EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
R + + ERE IM + A+ LHS I HRD+KP+N
Sbjct: 151 QDRGDQAFT----------------EREAS---EIMKSIGEAIQYLHSINIAHRDVKPEN 191
Query: 293 VIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++++ + K+ D G A + L P Y APE
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETT------SHNSLTTPCYTPYYVAPE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 34/184 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA---TEYGAVEIWMNERVRRACANCCA 200
K +G G+FGVVY+A L + G+LV +KK + E+ + ++
Sbjct: 60 KVIGNGSFGVVYQAKL------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 201 DFVYGFFENSSKKGGEY-WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259
F F+ + KK Y L+ Y E T+ + R + QTL
Sbjct: 114 YF---FYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTL-------------- 153
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG--- 316
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 317 INYI 320
++YI
Sbjct: 214 VSYI 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 41/217 (18%), Positives = 63/217 (29%), Gaps = 49/217 (22%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK---KATEYGAVEIWMNERVRRACA 196
+ + L EG F VY A G LK E I + +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQ------DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 197 NC-----CADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEV 250
E S E+ L+ +G+ L + + E
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ--LVEFLKKME-----------SR 130
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHS--TGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
L + I Q A+ +H I+HRD+K +N++ S T K+ D G
Sbjct: 131 GPLS---CDT---VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFG 183
Query: 309 AAADLRVGINYIPKEFLLD-----------PRYAAPE 334
+A + +Y P Y PE
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 43/183 (23%), Positives = 66/183 (36%), Gaps = 23/183 (12%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATE---YGAVEIWMNERVRRACANCCA 200
K LG G+FG+V G LKK + Y E+ + + +
Sbjct: 13 KTLGTGSFGIVCEVFD------IESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ-----DLPK 255
D+ Y + K + G+ + Q L + L K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 256 GIERENRI--------IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
++ R I + QL A+ +HS GI HRDIKPQN++ + T K+ D
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 308 GAA 310
G+A
Sbjct: 187 GSA 189
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 44/224 (19%), Positives = 73/224 (32%), Gaps = 83/224 (37%)
Query: 142 VLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE 189
+ K+LG G F VV + L K+ ++ +L E + + +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH---E---IAV-LEL 84
Query: 190 -----RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
RV ++ +EN+S+ GGE + L +
Sbjct: 85 AKSCPRVIN---------LHEVYENTSEIILILEYAAGGE------------IFSLCLPE 123
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
+ E + ++ Q+L + LH IVH D+KPQN++ S
Sbjct: 124 LAEM------VSE------------NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 297 --EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KI+D G + L + P Y APE
Sbjct: 166 SIYPLGDIKIVDFGMS------RKIGHACELREIMGTPEYLAPE 203
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 40/234 (17%), Positives = 71/234 (30%), Gaps = 79/234 (33%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY 180
+ + + +V G+ LG+G F + A K ++ K+
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---------IVPKSL-- 52
Query: 181 GAVEIWMNERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYE 224
++ E++ + + +GFFE++ +
Sbjct: 53 -LLKPHQREKMSMEISIHRSLAHQHVVG--FHGFFEDNDFVFVVLELCRRRS-------- 101
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
L +L R + E E R + Q++ LH ++
Sbjct: 102 ----LLELHKRR-----------KALT------EPEAR---YYLRQIVLGCQYLHRNRVI 137
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
HRD+K N+ +E KI D G A + E P Y APE
Sbjct: 138 HRDLKLGNLFLNE-DLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPE 185
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 9/71 (12%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-RVGINYIPKEF 324
+ ++L AL LHS G+V+ D+KP+N++ +E K+IDLGA + + G
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGY------L 237
Query: 325 LLDPRYAAPEQ 335
P + APE
Sbjct: 238 YGTPGFQAPEI 248
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA---TEYGAVEIWMNERVRRACANCCAD 201
K +G G+FGVV++A L ++ +KK + E+ + V+
Sbjct: 46 KVIGNGSFGVVFQAKL------VESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 202 FVYGFFENSSKKGGEY-WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
F F+ N KK + L+ Y E T+ R + QT+
Sbjct: 100 F---FYSNGDKKDEVFLNLVLEYVPE-TVYRAS--RHYAKLKQTM--------------P 139
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---I 317
+I+ M QLL +L +HS GI HRDIKPQN++ S K+ID G+A L G +
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 318 NYI 320
+YI
Sbjct: 200 SYI 202
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 46/219 (21%), Positives = 74/219 (33%), Gaps = 68/219 (31%)
Query: 138 KDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IWMNERVRR 193
DD+ L K+ LG G G V + T + A++ ++ + + R+
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECF---------------HRRTGQKC-ALKLLYDSPKARQ 70
Query: 194 ---------ACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISR-EFPYN 241
+ + +EN +I GE L + R + +
Sbjct: 71 EVDHHWQASGGPHIVC--ILDVYENMHHGKRCLLIIMECMEGGE--LFSRIQERGDQAFT 126
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
ERE IM + A+ LHS I HRD+KP+N++++ E
Sbjct: 127 ----------------EREAA---EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ D G A + L P Y APE
Sbjct: 168 AVLKLTDFGFAK-------ETTQNALQTPCYTPYYVAPE 199
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 48/222 (21%), Positives = 79/222 (35%), Gaps = 67/222 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERV 191
+ + DDF +G+ LG+G FG VY LA++ +K L VL K+ + + ++
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQ---LEKEGVEHQL 61
Query: 192 RR---ACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISR 236
RR ++ + Y +F + + GE Y + +
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK------------HG 109
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
F E+ + T M +L AL H ++HRDIKP+N++
Sbjct: 110 RFD------------------EQRSA---TFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
KI D G + + P Y PE
Sbjct: 149 Y-KGELKIADFGWSV-------HAPSLRRRTMCGTLDYLPPE 182
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 34/214 (15%), Positives = 65/214 (30%), Gaps = 49/214 (22%)
Query: 138 KDDFVLGKKLGEGA--FGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE 189
+ L +G+G V A K G+ V L+ + + E
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLAR------YKPTGEYVTVRRINLEACSNEMVTFL-QGE 76
Query: 190 RVRRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ F E W++ + + DL+ +
Sbjct: 77 L--HVSKLFNHPNIVPYRATF----IADNELWVVTSFMAYGSAKDLICTH---------- 120
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
G+ I I+ +L ALD +H G VHR +K +++ S +
Sbjct: 121 ------FMDGMNEL--AIAYILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSG 171
Query: 307 LGAAADL------RVGINYIPKEFLLDPRYAAPE 334
L + + + ++ PK + + +PE
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 53/225 (23%), Positives = 84/225 (37%), Gaps = 78/225 (34%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE 189
+ +DF +G LG+G+F VYRA +A K K + KA M +
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA----MYKAG--------MVQ 56
Query: 190 RVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLM 233
RV+ + +Y +FE+S+ GE + +
Sbjct: 57 RVQNEVKIHCQLKHPSILE--LYNYFEDSNYVYLVLEMCHNGE------------MNRYL 102
Query: 234 ISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
+R P++ E E R M Q++ + LHS GI+HRD+ N+
Sbjct: 103 KNRVKPFS----------------ENEAR---HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
+ + + KI D G A L++ P E P Y +PE
Sbjct: 144 LLTR-NMNIKIADFGLATQLKM-----PHEKHYTLCGTPNYISPE 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 40/234 (17%), Positives = 71/234 (30%), Gaps = 79/234 (33%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY 180
+ + + +V G+ LG+G F + A K ++ K+
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---------IVPKSL-- 78
Query: 181 GAVEIWMNERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYE 224
++ E++ + + +GFFE++ +
Sbjct: 79 -LLKPHQREKMSMEISIHRSLAHQHVVG--FHGFFEDNDFVFVVLELCRRRS-------- 127
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
L +L R + E E R + Q++ LH ++
Sbjct: 128 ----LLELHKRR-----------KALT------EPEAR---YYLRQIVLGCQYLHRNRVI 163
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
HRD+K N+ +E KI D G A + E P Y APE
Sbjct: 164 HRDLKLGNLFLNE-DLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPE 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 73/225 (32%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMN 188
+ + +DF +G+ LG+G FG VY LA+ K ++ L KA + +
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVY---LAR---EKQSKFILALKVLFKAQ---LEKAGVE 53
Query: 189 ERVRR---ACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLM 233
++RR ++ + YG+F ++++ G Y + +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----------- 102
Query: 234 ISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
+F E+ T +++L AL HS ++HRDIKP+N+
Sbjct: 103 -LSKFD------------------EQRTA---TYITELANALSYCHSKRVIHRDIKPENL 140
Query: 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ KI D G + + P D Y PE
Sbjct: 141 LLGSAG-ELKIADFGWSV-------HAPSSRRTDLCGTLDYLPPE 177
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 47/222 (21%), Positives = 75/222 (33%), Gaps = 67/222 (30%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-----VLKKATEYGAVEIW 186
F Y D + K LGEG+F + + K + K+ EI
Sbjct: 6 FYQHY--DLDLKDKPLGEGSFSICRKCV------HKKSNQAFAVKIISKRMEANTQKEIT 57
Query: 187 MNERVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREF 238
+ N ++ F + GGE L + + ++
Sbjct: 58 ALKLCE-GHPNIVK--LHEVFHDQLHTFLVMELLNGGE------------LFERIKKKKH 102
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-- 296
++ E E IM +L+ A+ +H G+VHRD+KP+N++F+
Sbjct: 103 -FS----------------ETEAS---YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ KIID G A + L YAAPE
Sbjct: 143 NDNLEIKIIDFGFARLKPPD-----NQPLKTPCFTLHYAAPE 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 44/228 (19%), Positives = 78/228 (34%), Gaps = 69/228 (30%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
+ L ++G+G++GVV LA ++ND A+++ +++ R
Sbjct: 15 YTLKDEIGKGSYGVVK---LAY---NENDNTYY--------AMKVLSKKKLIRQAGFPRR 60
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF--------PYNVQT-------- 244
G I + + +E P V+
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQ-----------VYQEIAILKKLDHPNVVKLVEVLDDPN 109
Query: 245 -----LIL-----GEVQDLPKG---IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
++ G V ++P E + R L+ ++ LH I+HRDIKP
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLKPLSEDQAR---FYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
N++ E KI D G + + + + LL P + APE
Sbjct: 167 NLLVGE-DGHIKIADFGVSNEFK------GSDALLSNTVGTPAFMAPE 207
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 6e-11
Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 20/205 (9%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--------SKNDGDLVLKKATEYGAV 183
F + +K+GEG FG V++ P + + +K E
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 184 EI---WMNERVRRACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
EI + N F+ W + + F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 239 PYNVQTLIL-----GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQN 292
+ ++L G + + ++I+ QL +L ++ HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGI 317
V+ + S K+ +
Sbjct: 193 VLLKKTSLK-KLHYTLNGKSSTIPS 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 22/47 (46%), Positives = 30/47 (63%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ M ++L ALD HS GI+HRD+KP NV+ R ++ID G A
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 40/197 (20%), Positives = 67/197 (34%), Gaps = 60/197 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IWMNE 189
+ D V + LG G G V + K T ++ A++ +
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIF---------------NKRTQEKF-ALKMLQDCP 55
Query: 190 RVRR---------ACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLMISR 236
+ RR C + + +EN ++ E GE L + R
Sbjct: 56 KARREVELHWRASQCPHIVR--IVDVYENLYAGRKCLLIV--MECLDGGE--LFSRIQDR 109
Query: 237 -EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
+ + ERE IM + A+ LHS I HRD+KP+N+++
Sbjct: 110 GDQAFT----------------EREAS---EIMKSIGEAIQYLHSINIAHRDVKPENLLY 150
Query: 296 S--EGSRTFKIIDLGAA 310
+ + K+ D G A
Sbjct: 151 TSKRPNAILKLTDFGFA 167
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 37/187 (19%), Positives = 65/187 (34%), Gaps = 44/187 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+D ++G GA+G V + +A K + K ++ M+ V
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK--------QLLMDLDV 73
Query: 192 RRACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
++C ++ YG F + G+ W+ +
Sbjct: 74 VMRSSDC--PYIVQFYGALF-----REGDCWICMELMS-TSFDK--------------FY 111
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIID 306
V + + E I+ I + AL+ L I+HRDIKP N++ S K+ D
Sbjct: 112 KYVYSVLDDVIPEE-ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCD 169
Query: 307 LGAAADL 313
G + L
Sbjct: 170 FGISGQL 176
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 40/207 (19%), Positives = 73/207 (35%), Gaps = 48/207 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-----ATEYGAVEIWMNERVRR 193
+D ++G G G V++ + G ++ K + I M+ V
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRF------RKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 194 ACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+C ++ +G F + ++ G T A+ + R
Sbjct: 79 KSHDC--PYIVQCFGTFI-----TNTDVFIAMELMG--TCAEKLKKR------------- 116
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ I E I+ + ++ AL L G++HRD+KP N++ E K+ D G
Sbjct: 117 ---MQGPIP-ER-ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFG 170
Query: 309 AAADLRVGINYIPK-EFLLDPRYAAPE 334
+ L ++ K Y APE
Sbjct: 171 ISGRL---VDDKAKDRSAGCAAYMAPE 194
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 53/211 (25%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR----- 193
DD +LG GA+GVV + G ++ K + +N + ++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRH------VPSGQIMAVKR-----IRATVNSQEQKRLLMD 55
Query: 194 ---ACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ F YG F + G+ W+ +L
Sbjct: 56 LDISMRTVDCPFTVTFYGALF-----REGDVWICMELMD-TSLDK--------------F 95
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNV-IFSEGSRTFKI 304
+V D + I E+ I+ I ++ AL+ LHS ++HRD+KP NV I + G K+
Sbjct: 96 YKQVIDKGQTIP-ED-ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKM 151
Query: 305 IDLGAAADLRVGINYIPKE-FLLDPRYAAPE 334
D G + L ++ + K+ Y APE
Sbjct: 152 CDFGISGYL---VDDVAKDIDAGCKPYMAPE 179
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 32/217 (14%), Positives = 70/217 (32%), Gaps = 51/217 (23%)
Query: 141 FVLGKKLGEGAFGVVYRASL------------AKKPSSKNDGDL-----VLKKATEYGAV 183
+ +G +G+G FG +Y A + K ++G L ++A + +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 184 EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI--SREFPYN 241
+ W+ R + +G + ++I G L + ++ F
Sbjct: 97 QKWIRTRKLKYLGVPK---YWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFS-- 150
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG-SR 300
+T++ + ++L L+ +H VH DIK N++ +
Sbjct: 151 RKTVLQ-------------------LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191
Query: 301 TFKIIDLGAA-----ADLRVGINYIP-KEFLLDPRYA 331
++D G A + P + +
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 43/228 (18%), Positives = 81/228 (35%), Gaps = 61/228 (26%)
Query: 126 AFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--E 179
F ++ + ++DF + K +G GAFG V + K KN + +L K +
Sbjct: 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVA---VVKL---KNADKVFAMKILNKWEMLK 114
Query: 180 YGAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEA 227
+ ER + ++ + F++ + GG+ L+ ++E
Sbjct: 115 RAETACFREERDVLVNGDS--KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR- 171
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
P E + +++++ A+D +H VHRD
Sbjct: 172 ----------LP--------------------EEMA-RFYLAEMVIAIDSVHQLHYVHRD 200
Query: 288 IKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
IKP N++ G ++ D G+ L + P Y +PE
Sbjct: 201 IKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 43/133 (32%)
Query: 214 GGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272
G+ ++ R G LA + + R+ P + I+ Q+
Sbjct: 106 DGQLYVDMRLINGV-DLAAM-LRRQGPLAPPRAV-------------------AIVRQIG 144
Query: 273 FALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG---AAADLR-------VGINYIPK 322
ALD H+ G HRD+KP+N++ S ++D G A D + VG
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFA-YLVDFGIASATTDEKLTQLGNTVG------ 197
Query: 323 EFLLDPRYAAPEQ 335
Y APE+
Sbjct: 198 ----TLYYMAPER 206
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 33/211 (15%), Positives = 59/211 (27%), Gaps = 39/211 (18%)
Query: 141 FVLGKKLGEGAFGVVYRA---SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ L G++Y A S S LK + G + N R A
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI---LGEVQDLP 254
+ I G + Y L+ LG + L
Sbjct: 104 QVNKW-------KKLYSTPLLAIPTCMGFG-------VHQDKYRF--LVLPSLG--RSLQ 145
Query: 255 KGIERENR-------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR-TFKIID 306
++ + ++Q + +LL AL+ LH VH ++ +N+ + +
Sbjct: 146 SALDVSPKHVLSERSVLQ-VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 307 LGAA---ADLRVGINYIP---KEFLLDPRYA 331
G A + Y+ D +
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 34/214 (15%), Positives = 64/214 (29%), Gaps = 48/214 (22%)
Query: 141 FVLGKKLGEGAFGVVYR----------ASLAKKPSSKNDGDL-----VLKKATEYGAVEI 185
+VLGKK+G G FG++Y A K + +G L ++ + ++
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI-SREFPYNVQT 244
W+ + YG K +++ G L + + F T
Sbjct: 99 WIERKQLDYLGIPL---FYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFK--KST 152
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG-SRTFK 303
++ + ++L L+ +H VH DIK N++
Sbjct: 153 VLQ-------------------LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193
Query: 304 IIDLGAA---ADLRVGINYIPKE---FLLDPRYA 331
+ D G + Y +
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 26/70 (37%), Positives = 35/70 (50%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ L+ LHS GIVH+DIKP N++ + G T KI LG A L + +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEAL----HPFAADDTCRTS 171
Query: 328 ---PRYAAPE 334
P + PE
Sbjct: 172 QGSPAFQPPE 181
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 27/70 (38%), Positives = 34/70 (48%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ + LH GI HRDIKP+N++ E KI D G A R +E LL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN----NRERLLNKM 167
Query: 328 ---PRYAAPE 334
Y APE
Sbjct: 168 CGTLPYVAPE 177
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 42/222 (18%), Positives = 67/222 (30%), Gaps = 62/222 (27%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
D+ L + +G G +G VY+ SL K S N + E I+ +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNF----INE---KNIYRVPLME 65
Query: 193 RACANCCADFVYGFF----ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
N + F ++ EY L+ Y +L + +
Sbjct: 66 --HDN-----IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW-------- 110
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHST---------GIVHRDIKPQNVIFSEGS 299
R+ ++ L + LH+ I HRD+ +N + +
Sbjct: 111 ---------VSSCRLAHSVTRGLAY----LHTELPRGDHYKPAISHRDLNSRN-VLVKND 156
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD-------PRYAAPE 334
T I D G + L P E RY APE
Sbjct: 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 29/179 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA---TEYGAVEIWMNERVRRA 194
D F + + G+G FG V K+ G V +KK + E+ + + +
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKE------KSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL 76
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYE-GEATLADLMISREFPYNVQTLILGEVQDL 253
F+ + + +L E TL R +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC--RNYYRRQVAP-------- 126
Query: 254 PKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+I+ + QL+ ++ LH S + HRDIKP NV+ +E T K+ D G+A
Sbjct: 127 ------PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 14/81 (17%)
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E+E R + Q++ A+ H IVHRD+K +N++ KI D G +
Sbjct: 113 EKEAR---SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA-DMNIKIADFGFSN------ 162
Query: 318 NYIPKEFLL----DPRYAAPE 334
+ L P YAAPE
Sbjct: 163 EFTVGGKLDAFCGAPPYAAPE 183
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 27/70 (38%), Positives = 34/70 (48%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ + LH GI HRDIKP+N++ E KI D G A R +E LL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN----NRERLLNKM 167
Query: 328 ---PRYAAPE 334
Y APE
Sbjct: 168 CGTLPYVAPE 177
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 46/226 (20%), Positives = 82/226 (36%), Gaps = 61/226 (26%)
Query: 127 FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EY 180
+ ++ + +D+ + K +G GAFG V L + K+ + +L K +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ---LVRH---KSTRKVYAMKLLSKFEMIKR 110
Query: 181 GAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATL 229
+ ER A AN +V + F++ GG+ L
Sbjct: 111 SDSAFFWEERDIMAFANS--PWVVQLFYAFQDDRYLYMVMEYMPGGD------------L 156
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
+LM + + P E + ++++ ALD +HS G +HRD+K
Sbjct: 157 VNLMSNYDVP--------------------EKWA-RFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 290 PQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
P N++ G K+ D G + + P Y +PE
Sbjct: 196 PDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 18/44 (40%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+Q+L + H IVHRDIKPQN++ KI D G A
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTL-KIFDFGIA 158
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 61/228 (26%)
Query: 126 AFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--E 179
V RL ++DDF + K +G GAF V + K K G + ++ K +
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVA---VVKM---KQTGQVYAMKIMNKWDMLK 101
Query: 180 YGAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEA 227
G V + ER + ++ + F++ + GG+ L+ ++
Sbjct: 102 RGEVSCFREERDVLVNGDR--RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--- 156
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
P + +++++ A+D +H G VHRD
Sbjct: 157 --------ERIP--------------------AEMA-RFYLAEIVMAIDSVHRLGYVHRD 187
Query: 288 IKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
IKP N++ G ++ D G+ LR + P Y +PE
Sbjct: 188 IKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 7/75 (9%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT-FKIIDLGAAADLRVGI-NY 319
+++ +L LD LH I+H D+KP+N++ + R+ K+ID G++ + Y
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 320 IPKEFLLDPRYAAPE 334
I F Y APE
Sbjct: 260 IQSRF-----YRAPE 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 16/44 (36%), Positives = 27/44 (61%), Gaps = 1/44 (2%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+++ AL+ H GI+HRD+KP N++ S + K++D G A
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAV-KVMDFGIA 163
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 33/99 (33%), Positives = 45/99 (45%), Gaps = 18/99 (18%)
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL +++ I+ +M Q L LD LH+ IVHRD+KP+N+ + S G T K
Sbjct: 103 QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVK 160
Query: 304 IIDLGAAADLRVGINYIPK---------EFLLDPRYAAP 333
+ D G A + P E LL YA P
Sbjct: 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 13/70 (18%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
Q++ A++ H IVHRD+KP+N++ + + KI D G + N + L
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDD-NLNVKIADFGLS-------NIMTDGNFLKTS 167
Query: 328 ---PRYAAPE 334
P YAAPE
Sbjct: 168 CGSPNYAAPE 177
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+ ++R R ++++I Q L A++ H +HRD+KP+N+ I K+
Sbjct: 86 HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKL 143
Query: 305 IDLGAA 310
D G A
Sbjct: 144 CDFGFA 149
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 27/69 (39%), Positives = 35/69 (50%), Gaps = 11/69 (15%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL--- 326
Q+L A+D H +VHRD+KP+NV+ KI D G + + G EFL
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDG------EFLRTSC 171
Query: 327 -DPRYAAPE 334
P YAAPE
Sbjct: 172 GSPNYAAPE 180
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 43/205 (20%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-RVRRAC 195
++G G+F VY+ V +K T+ + + E + +
Sbjct: 30 FDIEIGRGSFKTVYKGL------DTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGL 82
Query: 196 ANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ + V Y +E++ K L+ TL + + F ++
Sbjct: 83 QH--PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFK------VMKI---- 128
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHS--TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
+++++ Q+L L LH+ I+HRD+K N+ + + + KI DLG A
Sbjct: 129 --------KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQY 336
R K + P + APE Y
Sbjct: 181 LKR---ASFAKAVIGTPEFMAPEMY 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 42/211 (19%), Positives = 74/211 (35%), Gaps = 57/211 (27%)
Query: 141 FVLGKKLGEGAFGVVYRAS--------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
+ +G+++GEG+FGV++ + K ++D + + Y ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY---------KLL 62
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI--SREFPYNVQTLILGEV 250
C VY F + G L+ G +L DL+ R+F + +
Sbjct: 63 AGCTGIPN--VYYFGQE----GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-VAMAAK- 113
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFK---IID 306
Q+L + +H +V+RDIKP N +I S+ ++D
Sbjct: 114 -------------------QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154
Query: 307 LGAAADLRVGINY--IP----KEFLLDPRYA 331
G R + IP K RY
Sbjct: 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 21/68 (30%), Positives = 36/68 (52%), Gaps = 8/68 (11%)
Query: 251 QDLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF---- 302
DL K +++ + I++ + QL+ ++ HS +HRD+KPQN++ S +
Sbjct: 117 NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 303 KIIDLGAA 310
KI D G A
Sbjct: 177 KIGDFGLA 184
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL +++ I+ +M QLL LD LHS +VHRD+KPQN+ + S G K
Sbjct: 103 QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIK 160
Query: 304 IIDLGAAADLRVGINYIPK---------EFLLDPRYAAP 333
+ D G A + E LL YA P
Sbjct: 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 27/80 (33%), Positives = 34/80 (42%), Gaps = 12/80 (15%)
Query: 262 RIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSR-----TFKIIDLGAAADLRV 315
++ I QLL LD +H GI+H DIKP+NV+ KI DLG A
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 316 GI-NYIPKEFLLDPRYAAPE 334
N I Y +PE
Sbjct: 191 HYTNSIQTRE-----YRSPE 205
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 21/66 (31%), Positives = 37/66 (56%), Gaps = 5/66 (7%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
IL +++ P G++ + +Q + Q++ + HS I+HRDIKP+N+ + G K+
Sbjct: 110 ILDDLELFPNGLDYQV--VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKL 165
Query: 305 IDLGAA 310
D G A
Sbjct: 166 CDFGFA 171
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 9/67 (13%)
Query: 251 QDLPKGIERENR------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL K ++ +I++ + QLL L HS ++HRD+KPQN+ I +EG K
Sbjct: 86 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIK 143
Query: 304 IIDLGAA 310
+ D G A
Sbjct: 144 LADFGLA 150
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 4e-08
Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
QDL K ++ ++ + QLL + H ++HRD+KPQN+ I EG KI
Sbjct: 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKI 141
Query: 305 IDLGAA 310
D G A
Sbjct: 142 ADFGLA 147
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 42/211 (19%), Positives = 70/211 (33%), Gaps = 60/211 (28%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
+ + + +G GAFGVV +A K+ S+++ + E+ RV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIV--------ELRQLSRVN 59
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
N +YG N L+ Y +L +++ E
Sbjct: 60 --HPNIVK--LYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPY----------- 98
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHS---TGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + Q + LHS ++HRD+KP N++ G KI D G
Sbjct: 99 ----YTAAHAMS--WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152
Query: 310 AADLR------VGINYIPKEFLLDPRYAAPE 334
A D++ G + APE
Sbjct: 153 ACDIQTHMTNNKG----------SAAWMAPE 173
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 24/70 (34%), Positives = 32/70 (45%), Gaps = 13/70 (18%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
Q+L +D H +VHRD+KP+NV+ KI D G + N + L
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLS-------NMMSDGEFLRTS 175
Query: 328 ---PRYAAPE 334
P YAAPE
Sbjct: 176 CGSPNYAAPE 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 46/215 (21%), Positives = 74/215 (34%), Gaps = 44/215 (20%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIW 186
RT R D L + +G+G +G V+R S K SS+++ + E++
Sbjct: 4 RTVAR--DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET-------ELY 54
Query: 187 MNERVRRACANCCADFVYGFF---ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
+R + GF S + WLI Y +L D +
Sbjct: 55 NTVMLRHEN-------ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 107
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTF 302
I+ + G ++ L + G I HRD+K +N++ + +
Sbjct: 108 LRIV---LSIASG-----------LAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQC 152
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD---PRYAAPE 334
I DLG A N + RY APE
Sbjct: 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 5e-08
Identities = 24/66 (36%), Positives = 35/66 (53%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
QDL K + N I+++ + QLL L HS ++HRD+KPQN+ I G K+
Sbjct: 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKL 142
Query: 305 IDLGAA 310
+ G A
Sbjct: 143 ANFGLA 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+DL K ++ I+ + QLL + H I+HRD+KPQN+ I S+G K+
Sbjct: 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKL 160
Query: 305 IDLGAA 310
D G A
Sbjct: 161 ADFGLA 166
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 262 RIIQTIMSQLLFALDGLHST--GIVHRDIKPQNVIFSEGSRTF-KIIDLGAAADLRVGIN 318
+ + Q+ AL L + I+H D+KP+N++ R+ KI+D G++ L I
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 319 -YIPKEFLLDPRYAAPE 334
YI F Y +PE
Sbjct: 217 QYIQSRF-----YRSPE 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+DL + ++ I ++ + QLL L H ++HRD+KPQN+ I G K+
Sbjct: 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKL 141
Query: 305 IDLGAA 310
D G A
Sbjct: 142 ADFGLA 147
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 22/66 (33%), Positives = 30/66 (45%), Gaps = 3/66 (4%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
QLL + HS I HRD+K +N + + KI D G + + PK + P
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTP 181
Query: 329 RYAAPE 334
Y APE
Sbjct: 182 AYIAPE 187
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 17/51 (33%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRT--FKIIDLGAA 310
++++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 42/203 (20%), Positives = 66/203 (32%), Gaps = 30/203 (14%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
VL + +G+G FG V+R G+ V K W E
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 199 CADFVYGFFENSSKKGG---EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ + GF +K G + WL+ Y +L D + +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA---LSTAS 150
Query: 256 GIERENRIIQTIMSQL-LFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
G ++ L + + I HRD+K +N++ + + T I DLG A
Sbjct: 151 G-----------LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHD 198
Query: 315 VGINYIPKEFLLD---PRYAAPE 334
+ I RY APE
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPE 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+ +M LL L +H I+HRD+K NV I +G K+ D G A
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLA 171
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 44/220 (20%), Positives = 77/220 (35%), Gaps = 35/220 (15%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+ L + G FG V++A L A K D + E++ +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNE------YEVYSLPGM 75
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ N F+ G + + + WLI + + +L+D + + +N I +
Sbjct: 76 K--HENILQ-FI-GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI---AE 128
Query: 252 DLPKGIERENRIIQTIMSQL---LFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ +G ++ L + L H I HRDIK +NV+ + T I D G
Sbjct: 129 TMARG-----------LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFG 176
Query: 309 AAADLRVGINYIPKEFLLD-PRYAAPEQYIMSTQTPSAPS 347
A G + + RY APE + +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDA 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
DL I+ + + I+ M L L+ LH I+HRD+KP N+ + G K+
Sbjct: 96 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKL 153
Query: 305 IDLGAA 310
D G A
Sbjct: 154 ADFGLA 159
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 14/41 (34%), Positives = 18/41 (43%), Gaps = 7/41 (17%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK 176
R + LGEG F VY+A KN +V +KK
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKA------RDKNTNQIVAIKK 42
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 18/47 (38%), Positives = 25/47 (53%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ M QLL L +HS ++HRD+KP N+ + KI D G A
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 13/71 (18%)
Query: 251 QDLPKGIERENR----------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGS 299
DL K ++ +++ QLL L H I+HRD+KPQN+ I G
Sbjct: 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG- 145
Query: 300 RTFKIIDLGAA 310
K+ D G A
Sbjct: 146 -QLKLGDFGLA 155
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 48/211 (22%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNE 189
+DF + + +G G FG VY +K + G + L K + +NE
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVY---GCRK---ADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 190 R-VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
R + + F+ + + + L + L+ G
Sbjct: 240 RIMLSLVSTGDCPFIVC-------------MSYAFHTPDKL----------SFILDLMNG 276
Query: 249 EVQDLPKGIERENRIIQTIM----SQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFK 303
DL + + + M ++++ L+ +H+ +V+RD+KP N++ G +
Sbjct: 277 --GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VR 332
Query: 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
I DLG A D P + Y APE
Sbjct: 333 ISDLGLACD---FSKKKPHASVGTHGYMAPE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 174
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 40/213 (18%), Positives = 68/213 (31%), Gaps = 61/213 (28%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR-RACANCC 199
F +GKK+G G FG + + + V A+++ E ++ RA
Sbjct: 11 FRVGKKIGCGNFGELRLG------KNLYTNEYV--------AIKL---EPMKSRAPQLHL 53
Query: 200 ADFVYGFFENSS---------KKGGEYWLIWRYEGEATLADLMI--SREFPYNVQTLILG 248
Y + G ++ G +L DL R F L++
Sbjct: 54 EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKT-VLMIA 111
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG----SRTFKI 304
QL+ ++ +HS +++RD+KP+N + + I
Sbjct: 112 I--------------------QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI 151
Query: 305 IDLGAAADLRVGINY--IP----KEFLLDPRYA 331
ID A + IP K RY
Sbjct: 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 12/53 (22%), Positives = 15/53 (28%), Gaps = 5/53 (9%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR----TFKII-DLGAAADLR 314
M L A D H G+ P V S + D D+R
Sbjct: 134 AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIR 186
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 19/48 (39%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+T++ LL + +HS GI+HRD+KP N + + S K+ D G A
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLA 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +HS G+VHRD+KP N+ +E KI+D G A
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 173
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 45/225 (20%), Positives = 76/225 (33%), Gaps = 67/225 (29%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R K+ F + LG+G FG V + + G + L+K + +
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVC---ACQV---RATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 187 MNERVRRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
+NE+ N FV +E GG DL
Sbjct: 232 LNEKQILEKVNS--RFVVSLAYAYETKDALCLVLTLMNGG---------------DLKF- 273
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
+ + + E R + +++ L+ LH IV+RD+KP+N++
Sbjct: 274 -------------HIYHMGQAGFPEARAVFYA-AEICCGLEDLHRERIVYRDLKPENILL 319
Query: 296 -SEGSRTFKIIDLGAAADLRVG---------INYIPKEFLLDPRY 330
G +I DLG A + G + Y+ E + + RY
Sbjct: 320 DDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+Q ++ Q+L L +HS I+HRD+KP N+ +E KI+D G A
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA 179
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 38/218 (17%), Positives = 67/218 (30%), Gaps = 60/218 (27%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
+ K++G+G +G V+ A K + ++ EI+ +R
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE------TEIYQTVLMRH 90
Query: 194 ACANCCADFVYGFF---ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ GF + + +LI Y +L D + S +
Sbjct: 91 EN-------ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLA--- 140
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRDIKPQNVIFSEGSRTF 302
G+ LH+ I HRD+K +N++ + + T
Sbjct: 141 YSSVSGLCH------------------LHTEIFSTQGKPAIAHRDLKSKNILVKK-NGTC 181
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD------PRYAAPE 334
I DLG A I+ + + RY PE
Sbjct: 182 CIADLGLA---VKFISDTNEVDIPPNTRVGTKRYMPPE 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 41/196 (20%), Positives = 69/196 (35%), Gaps = 60/196 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+ T + D F K LG G+FG V L K K G+ +L K + +E
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVM---LVKH---KESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 187 MNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
+NE+ N F+ F+++S GGE + R G
Sbjct: 89 LNEKRILQAVNF--PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--------- 137
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
F ++ + + LHS +++RD+KP+N++
Sbjct: 138 --FSEPHARFYAAQI---------------------VLTFEYLHSLDLIYRDLKPENLLI 174
Query: 296 -SEGSRTFKIIDLGAA 310
+G ++ D G A
Sbjct: 175 DQQGY--IQVTDFGFA 188
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 57/220 (25%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+D F+ + LG G FG V+ + K G L L K + +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVF---ACQM---KATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 187 MNERVRRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
M E+ A + F+ FE + GG D+
Sbjct: 233 MVEKKILAKVHS--RFIVSLAYAFETKTDLCLVMTIMNGG---------------DIR-- 273
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
Y++ + +E R I +Q++ L+ LH I++RD+KP+NV+
Sbjct: 274 ----YHIYNVDEDN------PGFQEPRAIFYT-AQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+G+ +I DLG A +L+ G K + P + APE
Sbjct: 323 DDDGN--VRISDLGLAVELKAG-QTKTKGYAGTPGFMAPE 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 18/47 (38%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+TI+ LL + +H +GI+HRD+KP N + ++ + K+ D G A
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLA 176
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ M +L L LH G+VHRD+ P N++ ++ + I D A
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLA 181
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 16/67 (23%), Positives = 31/67 (46%), Gaps = 18/67 (26%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF------------------K 303
I+ + Q+ +++ LHS + H D+KP+N++F + T K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 304 IIDLGAA 310
++D G+A
Sbjct: 178 VVDFGSA 184
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +H+ GI+HRD+KP N+ +E KI+D G A
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLA 175
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 52/257 (20%), Positives = 89/257 (34%), Gaps = 55/257 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRA---SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC 195
D LGK LG GAFG V A + K + + +LK+ + M+E ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE-LKILI 80
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE---FPYNVQTLILGEVQD 252
V +K GG +I + L+ + S+ PY + + +D
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 253 LPKGIERE--NRIIQTIMSQ-----------------------------------LLFAL 275
I + R+ SQ + ++
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 276 D------GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDP 328
L S +HRD+ +N++ SE KI D G A D+ +Y+ K + L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 329 RYAAPE---QYIMSTQT 342
++ APE + + Q+
Sbjct: 260 KWMAPETIFDRVYTIQS 276
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 8/73 (10%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI--IDLGAAADLRVGINY--IP- 321
+ Q++ ++ +HS +HRD+KP N + G + + ID G A R + IP
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 322 ---KEFLLDPRYA 331
K RYA
Sbjct: 170 RENKNLTGTARYA 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 18/67 (26%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF------------------K 303
++ + QL AL LH + H D+KP+N++F +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 304 IIDLGAA 310
+ D G+A
Sbjct: 183 VADFGSA 189
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 54/233 (23%), Positives = 74/233 (31%), Gaps = 86/233 (36%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R + DF LG+G+FG V L+++ K +L +LKK + VE
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVM---LSER---KGTDELYAVKILKKDVVIQDDDVECT 388
Query: 187 MNERVRRACANCCADFV--YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--I 234
M E+ A + F+ + GG DLM I
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHI 433
Query: 235 SRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
+ F E+ L L S GI++RD+K N
Sbjct: 434 QQVGRFKEPHAVFYAAEI---------------------AIGLFFLQSKGIIYRDLKLDN 472
Query: 293 VIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
V+ SEG KI D G KE + D P Y APE
Sbjct: 473 VMLDSEGH--IKIADFGMC-----------KENIWDGVTTKTFCGTPDYIAPE 512
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 16/47 (34%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q ++ QL+ + LHS G++HRD+KP N++ + K+ D G +
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLS 156
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ + Q L A+ LH + ++HRD+KP N++ + K+ D G A
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLA 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 14/59 (23%), Positives = 27/59 (45%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK 322
I+ ++L AL+ L + H D+KP+N++ + +I + D + Y K
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 8/73 (10%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG--SRTFKIIDLGAAADLRVGINY--IP- 321
+ Q++ ++ +HS +HRDIKP N + G + IID G A R + IP
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 322 ---KEFLLDPRYA 331
K RYA
Sbjct: 168 RENKNLTGTARYA 180
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 15/36 (41%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 262 RIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFS 296
++ I+ Q+L LD LH+ I+H DIKP+N++ S
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 15/73 (20%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
+ +L+ ALD L + I+HRD+KP N++ G I D AA +P+E +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAM-------LPRETQI 171
Query: 327 D-----PRYAAPE 334
Y APE
Sbjct: 172 TTMAGTKPYMAPE 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 12/101 (11%)
Query: 259 RENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
R+ +I+ + A + G LH+ GI+H+D+K +NV + G I D G +
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG--KVVITDFGLFSI 178
Query: 313 LRVGINYIPKEFLLDP----RYAAPEQYIMSTQTPSAPSAP 349
V ++ L + APE + P
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 49/227 (21%), Positives = 73/227 (32%), Gaps = 86/227 (37%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
DF L + +G G++ V L + K + V+KK + ++ E+
Sbjct: 52 QDFDLLRVIGRGSYAKVL---LVRL---KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV 105
Query: 193 RACANCCADFV--YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE--F 238
A+ V + F+ S+ GG DLM + R+
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---------------DLMFHMQRQRKL 150
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SE 297
P E+ AL+ LH GI++RD+K NV+ SE
Sbjct: 151 PEEHARFYSAEI---------------------SLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
G K+ D G KE L P Y APE
Sbjct: 190 GH--IKLTDYGMC-----------KEGLRPGDTTSTFCGTPNYIAPE 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 56/235 (23%), Positives = 77/235 (32%), Gaps = 90/235 (38%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+ + +DF+L K LG+G+FG V+ LA+ K LKK VE
Sbjct: 11 QIKLKIEDFILHKMLGKGSFGKVF---LAEF---KKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 187 MNER-VRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM- 233
M E+ V F+ + F+ GG DLM
Sbjct: 65 MVEKRVLSLAWEHP--FLTHMFCTFQTKENLFFVMEYLNGG---------------DLMY 107
Query: 234 -ISRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
I F + T E+ + L LHS GIV+RD+K
Sbjct: 108 HIQSCHKFDLSRATFYAAEI---------------------ILGLQFLHSKGIVYRDLKL 146
Query: 291 QNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
N++ +G KI D G KE +L P Y APE
Sbjct: 147 DNILLDKDGH--IKIADFGMC-----------KENMLGDAKTNTFCGTPDYIAPE 188
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 3e-05
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 59/176 (33%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNE 189
Y DF + + LG G+FG V+ L + +++G VLKK VE +E
Sbjct: 3 YSLQDFQILRTLGTGSFGRVH---LIRS---RHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 190 RVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISRE 237
R+ + F+ +G F+++ + +GGE + L+ + S+
Sbjct: 57 RLMLSIVTH--PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK------------SQR 102
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
FP V EV AL+ LHS I++RD+KP+N+
Sbjct: 103 FPNPVAKFYAAEV---------------------CLALEYLHSKDIIYRDLKPENI 137
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 56/229 (24%), Positives = 77/229 (33%), Gaps = 90/229 (39%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-V 191
D+F + LG+G+FG V LA+ K GDL VLKK + VE M E+ +
Sbjct: 23 DNFEFIRVLGKGSFGKVM---LARV---KETGDLYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 192 RRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE- 237
N F+ F+ + GG DLM I +
Sbjct: 77 LSLARNHP--FLTQLFCCFQTPDRLFFVMEFVNGG---------------DLMFHIQKSR 119
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
F E+ + AL LH GI++RD+K NV+
Sbjct: 120 RFDEARARFYAAEI---------------------ISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
EG K+ D G KE + + P Y APE
Sbjct: 159 HEGH--CKLADFGMC-----------KEGICNGVTTATFCGTPDYIAPE 194
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 55/234 (23%), Positives = 76/234 (32%), Gaps = 88/234 (37%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R + DF LG+G+FG V L+++ K +L +LKK + VE
Sbjct: 14 RDRMKLTDFNFLMVLGKGSFGKVM---LSER---KGTDELYAVKILKKDVVIQDDDVECT 67
Query: 187 MNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM-- 233
M E+ A F+ + F+ + GG DLM
Sbjct: 68 MVEKRVLALPGKPP-FLTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYH 111
Query: 234 ISRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
I + F E+ L L S GI++RD+K
Sbjct: 112 IQQVGRFKEPHAVFYAAEI---------------------AIGLFFLQSKGIIYRDLKLD 150
Query: 292 NVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
NV+ SEG KI D G KE + D P Y APE
Sbjct: 151 NVMLDSEGH--IKIADFGMC-----------KENIWDGVTTKTFCGTPDYIAPE 191
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 51/229 (22%), Positives = 75/229 (32%), Gaps = 90/229 (39%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-V 191
DF L + +G G++ V L + K + V+KK + ++ E+ V
Sbjct: 9 QDFDLLRVIGRGSYAKVL---LVRL---KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 192 RRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE- 237
+N F+ G F+ S+ GG DLM + R+
Sbjct: 63 FEQASNHP--FLVGLHSCFQTESRLFFVIEYVNGG---------------DLMFHMQRQR 105
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
P E+ AL+ LH GI++RD+K NV+
Sbjct: 106 KLPEEHARFYSAEI---------------------SLALNYLHERGIIYRDLKLDNVLLD 144
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
SEG K+ D G KE L P Y APE
Sbjct: 145 SEGH--IKLTDYGMC-----------KEGLRPGDTTSTFCGTPNYIAPE 180
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 48/223 (21%), Positives = 73/223 (32%), Gaps = 55/223 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
+ GK LG GAFG V A A + V LK + E M+E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE----- 76
Query: 195 CAN----------------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
C GG +I Y L + + +
Sbjct: 77 -LKVLSYLGNHMNIVNLLGACT------------IGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQN 292
+ ++D + + L F+ G L S +HRD+ +N
Sbjct: 124 SFICSKTSPAIMEDDELAL--------DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++ + G R KI D G A D++ NY+ K P ++ APE
Sbjct: 176 ILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 20/69 (28%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAA-ADLRVGINYIPKEFL 325
++++ AL+ LH GI+HRD+KP+N++ + +I D G A F+
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFV 193
Query: 326 LDPRYAAPE 334
+Y +PE
Sbjct: 194 GTAQYVSPE 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 38/210 (18%), Positives = 66/210 (31%), Gaps = 46/210 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKP----SSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
+ L + +G G FG VYRA ++++D D + + E E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH- 65
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N A K L+ + L ++ + P ++ +
Sbjct: 66 -PNIIA------LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA---VQIA 115
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTG---IVHRDIKPQNVIFSEGSR-------TFKI 304
+G M+ L H I+HRD+K N++ + KI
Sbjct: 116 RG-----------MNYL-------HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A R + APE
Sbjct: 158 TDFGLA---REWHRTTKMSAAGAYAWMAPE 184
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 18/61 (29%), Positives = 24/61 (39%), Gaps = 8/61 (13%)
Query: 278 LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAP 333
LH+ I+HRD+K N+ E T KI D G A + + AP
Sbjct: 136 LHAKSIIHRDLKSNNIFLHE-DNTVKIGDFGLA---TEKSRWSGSHQFEQLSGSILWMAP 191
Query: 334 E 334
E
Sbjct: 192 E 192
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 53/217 (24%), Positives = 79/217 (36%), Gaps = 66/217 (30%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
++F K LG+G FG V L K+ K G +LKK V + E
Sbjct: 148 NEFEYLKLLGKGTFGKVI---LVKE---KATGRYYAMKILKKEVIVAKDEVAHTLTEN-- 199
Query: 193 RACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--ISREFP 239
R N F+ F+ + GGE L +SRE
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---------------LFFHLSRE-- 242
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF-SE 297
+ E+R + ++++ ALD LHS +V+RD+K +N++ +
Sbjct: 243 ----------------RVFSEDRA-RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 285
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
G KI D G + + K F P Y APE
Sbjct: 286 GH--IKITDFGLCKE-GIKDGATMKTFCGTPEYLAPE 319
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 51/215 (23%), Positives = 73/215 (33%), Gaps = 40/215 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
D LGK LG GAFG V A A V LK+ + M+E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE----- 80
Query: 195 CANCCADFVYGFFEN-------SSKKGGEYWLIWRYEGEATLAD-LMISREFPYNVQTLI 246
G N +K GG +I + L+ L R
Sbjct: 81 -LKILIHI--GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------- 127
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSR 300
E E + T+ + ++ G L S +HRD+ +N++ SE
Sbjct: 128 -NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-N 185
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
KI D G A D+ +Y+ K P ++ APE
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 22/79 (27%), Positives = 36/79 (45%), Gaps = 25/79 (31%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
+ +++ AL+ LH GI++RDIK +N++ S G + D G + KEF+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLS-----------KEFVA 211
Query: 327 D-----------PRYAAPE 334
D Y AP+
Sbjct: 212 DETERAYDFCGTIEYMAPD 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 24/77 (31%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD 327
++++ AL+ LHS +V+RDIK +N++ +G KI D G KE + D
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLC-----------KEGISD 158
Query: 328 ----------PRYAAPE 334
P Y APE
Sbjct: 159 GATMKTFCGTPEYLAPE 175
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 48/196 (24%), Positives = 72/196 (36%), Gaps = 49/196 (25%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
K + LGEG FG V P++ G++V LK W E
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALKADAGPQHRSGWKQE---- 83
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEG---EATLADLMISREFPYNVQTLILGEV 250
+ + E+ I +Y+G +A A L + E+ + LG +
Sbjct: 84 --IDILRTLYH---EH----------IIKYKGCCEDAGAASLQLVMEY------VPLGSL 122
Query: 251 QD-LPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFK 303
+D L + I + LLFA G LH+ +HRD+ +NV+ R K
Sbjct: 123 RDYL-----PRHSI--GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVK 174
Query: 304 IIDLGAAADLRVGINY 319
I D G A + G Y
Sbjct: 175 IGDFGLAKAVPEGHEY 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 52/223 (23%), Positives = 82/223 (36%), Gaps = 50/223 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE----- 189
+ VLGK LGEG FG V +A A + V LK+ + ++E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 190 RVRRACAN------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF----- 238
+V + C+ + G LI Y A L R F
Sbjct: 82 QVN--HPHVIKLYGACS------------QDGPLLLIVEY---AKYGSL---RGFLRESR 121
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQN 292
L G ++ + R + T+ + FA G L +VHRD+ +N
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERAL-TMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++ +EG R KI D G + D+ +Y+ + P ++ A E
Sbjct: 181 ILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 14/26 (53%), Positives = 22/26 (84%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNV 293
+++L ALD LHS GI++RD+KP+N+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENI 157
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 6/46 (13%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATE 179
+ ++LG+G FG V P N G++V L+ +TE
Sbjct: 40 ERHLKFLQQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTE 83
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 11/26 (42%), Positives = 20/26 (76%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNV 293
++++ AL LH GI++RD+KP+N+
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENI 152
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 6/46 (13%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATE 179
+ ++LG+G FG V P N G++V L+ +TE
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTE 52
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 9/30 (30%), Positives = 14/30 (46%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKN 168
+D +GEG FG V +A + K +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMD 54
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 44/196 (22%), Positives = 66/196 (33%), Gaps = 47/196 (23%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
K + LGEG FG V P N G+ V LK + + E
Sbjct: 20 KRFLKRIRDLGEGHFGKVELCRY--DPEGDNTGEQVAVKSLKPESGGNHIADLKKE---- 73
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEG---EATLADLMISREFPYNVQTLILGEV 250
+ + EN I +Y+G E + + EF L G +
Sbjct: 74 --IEILRNLYH---EN----------IVKYKGICTEDGGNGIKLIMEF------LPSGSL 112
Query: 251 QD-LPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFK 303
++ L +N+ + QL +A+ G L S VHRD+ +NV+ K
Sbjct: 113 KEYL-----PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVK 166
Query: 304 IIDLGAAADLRVGINY 319
I D G + Y
Sbjct: 167 IGDFGLTKAIETDKEY 182
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 23/77 (29%), Positives = 34/77 (44%), Gaps = 24/77 (31%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD 327
+++ AL LHS IV+RD+KP+N+ + S+G + D G KE +
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLC-----------KENIEH 192
Query: 328 ----------PRYAAPE 334
P Y APE
Sbjct: 193 NSTTSTFCGTPEYLAPE 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 46/179 (25%), Positives = 57/179 (31%), Gaps = 67/179 (37%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGA-----VEIWMNE 189
D+F LG G FG VY+ LA DG LV LK+ G E+ M
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERTQGGELQFQTEVEMIS 82
Query: 190 RVR-RACAN------CCAD-----FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE 237
R N C VY + N S L R E + L
Sbjct: 83 MAVHR---NLLRLRGFCMTPTERLLVYPYMANGSV---ASCLRERPESQPPL-------- 128
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH---STGIVHRDIKPQNV 293
D PK R+ RI L + LH I+HRD+K N+
Sbjct: 129 --------------DWPK---RQ-RIALGSARGLAY----LHDHCDPKIIHRDVKAANI 165
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 55/228 (24%), Positives = 76/228 (33%), Gaps = 60/228 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
++ GK LG GAFG V A A S V LK+ + E M+E
Sbjct: 45 ENLEFGKVLGSGAFGKVMNA-TAYGISKTGVSIQVAVKMLKEKADSSEREALMSE----- 98
Query: 195 CAN----------------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
C G +LI+ Y DL +
Sbjct: 99 -LKMMTQLGSHENIVNLLGACT------------LSGPIYLIFEY---CCYGDL---LNY 139
Query: 239 -----PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRD 287
+ I E Q + E N + T L FA G L VHRD
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVL--TFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
+ +NV+ + G + KI D G A D+ NY+ + P ++ APE
Sbjct: 198 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 365 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 89.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.34 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 80.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 80.04 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=341.82 Aligned_cols=196 Identities=22% Similarity=0.332 Sum_probs=166.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++++.||+|+||+||+|++..++ +.||+|.+..... .......++...+...+|+||+.+++.+ .+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~ 103 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QD 103 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred CccccEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-Ee
Confidence 4578999999999999999999999998 8899998764322 1223344566777888999999999887 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI 163 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIG--------------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 163 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCEEEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 678999999999999999998765 468889999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+.++ .+||+|||+|+.+.... .....+.+||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 164 Ll~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~----~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 164 LLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK----SSDLWALGCIIYQLVA 229 (311)
T ss_dssp EECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH----HHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc----HHHHHHHHHHHHHHHh
Confidence 999988 99999999999875432 23456789999999999998877655 4569999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.44 Aligned_cols=197 Identities=22% Similarity=0.302 Sum_probs=159.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+++|+++++||+|+||+||+|++..++ +.||+|.+... ...+.....++...+...+|+||+.+++.+ .++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-~~~ 95 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDG-----RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-EEN 95 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTC-----CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EET
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-EEC
Confidence 4589999999999999999999999988 88999988643 233334455667778888999999999887 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
+.+|+||||+++|+|.+++...+ +..+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~------------------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 157 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQK------------------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTT------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence 78999999999999999997654 224578889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++++ .+||+|||+|+.+.... ....+.+||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 158 l~~~g-~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~----~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 158 LTKDG-TVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNN----KSDIWALGCVLYELCT 220 (350)
T ss_dssp ECTTC-CEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCH----HHHHHHHHHHHHHHHH
T ss_pred ECCCC-CEEEcccccceeecCCc-ccccccCCCccccCHHHHCCCCCCc----HHHHHHHHHHHHHHHH
Confidence 99988 99999999999765332 1234678999999999998876654 5669999999999854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=343.36 Aligned_cols=195 Identities=19% Similarity=0.255 Sum_probs=163.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
...+.|++.++||+|+||+||+|++..++ +.||+|++............++...+....|+||+.+++.+ ..++
T Consensus 71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~ 144 (346)
T 4fih_A 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGD 144 (346)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-EETT
T ss_pred ChhHhcEEeEEeecCcCeEEEEEEECCCC-----CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECC
Confidence 34468999999999999999999999988 78899887543332222334456677778899999999887 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+|+||||+++|+|.+++.... +++..++.++.||+.||+|||++|||||||||+||||
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~~---------------------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 203 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHTR---------------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 203 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEEeCCCCCcHHHHHHcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence 8999999999999999987643 4788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ ++||+|||+|+.+..... ...+.+||+.|||||++.+..++. .+|+||||+++|||-|
T Consensus 204 ~~~g-~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~----~~DiWSlGvilyeml~ 265 (346)
T 4fih_A 204 THDG-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGP----EVDIWSLGIMVIEMVD 265 (346)
T ss_dssp CTTC-CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred CCCC-CEEEecCcCceecCCCCC-cccccccCcCcCCHHHHCCCCCCc----HHHHHHHHHHHHHHHH
Confidence 9988 999999999998754432 345789999999999998777655 4559999999999843
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=336.71 Aligned_cols=215 Identities=20% Similarity=0.274 Sum_probs=168.2
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|.+.++||+|+||+||+|++...........||+|+++...........++...+...+|+||+.+++.+ .++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-VEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeC
Confidence 4566899999999999999999999875433333377999999876666555566778888889999999999987 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
+.+++||||+++|+|.+++...+..... .........+++..+..|+.||++||.|||+++||||||||+|||
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~-------~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVL-------MAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 160 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHH-------C----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCccccc-------ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence 7899999999999999999875410000 001112346788999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++++ .+||+|||+|+........ ......||+.|||||++.+..++.+ +|+||||++||||-
T Consensus 161 l~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k----~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 161 VGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWSLGVVLWEIF 224 (299)
T ss_dssp ECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH----HHHHHHHHHHHHHH
T ss_pred ECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch----hhHHHHHHHHHHHH
Confidence 99987 9999999999876544332 2334679999999999998877654 55999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=340.06 Aligned_cols=191 Identities=17% Similarity=0.118 Sum_probs=158.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.++||+|+||+||+|++..++ +.||+|+++..... .++...+...+|+||+.+++.+ .+++.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g-----~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~-~~~~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTG-----FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV-REGPW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEE-EETTE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCC-----CEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEE-EECCE
Confidence 3468999999999999999999999988 88999988643221 2355667788999999999887 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+|+||||+++|+|.++++..+ .+++..++.++.||+.||+|||+++||||||||+||||+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMG--------------------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC
T ss_pred EEEEEeccCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe
Confidence 999999999999999998765 467888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc----cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++.++||+|||+|+.+..... .....++||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~----~~DiwSlGvilyeml 250 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA----KVDIWSSCCMMLHML 250 (336)
T ss_dssp TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCT----HHHHHHHHHHHHHHH
T ss_pred CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCc----HHHHHHHHHHHHHHH
Confidence 8875799999999997754321 1234578999999999998876654 566999999999983
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.59 Aligned_cols=200 Identities=19% Similarity=0.250 Sum_probs=166.1
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
........+.|++.++||+|+||.||+|++..++ +.||+|++............++...+....|+||+.+++.+
T Consensus 143 ~~~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 217 (423)
T 4fie_A 143 VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217 (423)
T ss_dssp HSCSSCGGGTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCCCChhHhcEeeeEeccCcCcEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 3344445578999999999999999999999998 88899987643332223334456677778899999999887
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..++.+|+|||||++|+|.+++.... +++..++.++.||+.||+|||++|||||||||
T Consensus 218 -~~~~~~~iVmEy~~gG~L~~~i~~~~---------------------l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp 275 (423)
T 4fie_A 218 -LVGDELWVVMEFLEGGALTDIVTHTR---------------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275 (423)
T ss_dssp -EETTEEEEEEECCTTEEHHHHHHHSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCST
T ss_pred -EECCEEEEEEeCCCCCcHHHHHhccC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 45678999999999999999987543 47888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||||+.++ .+||+|||+|+.+..... ...+.+||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 276 ~NILl~~~g-~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~----~~DiWSlGvilyeml~ 342 (423)
T 4fie_A 276 DSILLTHDG-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGP----EVDIWSLGIMVIEMVD 342 (423)
T ss_dssp TTEEECTTC-CEEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCC-CEEEecCccceECCCCCc-cccccccCcCcCCHHHHCCCCCCc----HHHHHHHHHHHHHHHH
Confidence 999999988 999999999998754432 345789999999999998877755 4559999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=333.14 Aligned_cols=217 Identities=20% Similarity=0.248 Sum_probs=161.7
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|.+.++||+|+||+||+|++...........||+|+++...........++...+...+|+||+.+++.+ .++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~ 115 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-TEG 115 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EEC
Confidence 4456799999999999999999999865322222278999999876666555566778888889999999999987 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+++|+|.++++.......... .........+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLA-----GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC----------------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCccccccc-----ccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 789999999999999999987642111000 001112345788999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++++ ++||+|||+|+.+...... ......||+.|||||++.+..++. .+|+||||++||||-
T Consensus 191 l~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~----~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 191 VGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT----ESDVWSFGVVLWEIF 254 (329)
T ss_dssp EETTT-EEEECCCC----------------CCCCGGGCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred ECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc----cccccchHHHHHHHH
Confidence 99987 9999999999976544332 234578999999999998877655 456999999999973
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=339.13 Aligned_cols=220 Identities=20% Similarity=0.225 Sum_probs=171.6
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (365)
+|++..++|+++++||+|+||+||+|++..++...+.+.||+|.+...... +.....++...+... +|+||+.+++.+
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 356788999999999999999999999998887777788999998754432 222333344444444 568999999987
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
...+..+++|||||++|+|.++++.....+..... ..+......+++..+..++.||+.||.|||+++||||||||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV----APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccc----cchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 66677899999999999999999875421110000 00011234578899999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||+++++ ++||+|||+|+.+..+..+ ...+..||+.|||||++.+..++.+ +|+||||++||||
T Consensus 214 ~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k----sDVwS~Gv~l~El 280 (353)
T 4ase_A 214 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEI 280 (353)
T ss_dssp GGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH----HHHHHHHHHHHHH
T ss_pred cceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc----ccEeehHHHHHHH
Confidence 999999987 9999999999977554333 3345789999999999998777655 5599999999997
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=329.13 Aligned_cols=198 Identities=23% Similarity=0.256 Sum_probs=152.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
++|++.+.||+|+||+||+|++..++ +.||+|++..... .......++...+...+|+||+.+++.+...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTC-----CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 57999999999999999999999888 8899998864332 23334455677788889999999988764332
Q ss_pred --------CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 215 --------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 215 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
..+|+||||+.+|+|.+++..... ....++..++.++.||++||+|||++|||||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-----------------~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR 142 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-----------------IEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCS-----------------GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCC-----------------CChhHHHHHHHHHHHHHHHHHHHHHCcCccc
Confidence 347999999999999999986541 1133566788999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCcc-----------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
||||+|||++.++ .+||+|||+|+.+...... ...+.+||+.|||||++.+..++. .+|+||||
T Consensus 143 DlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~----~~DiwSlG 217 (299)
T 4g31_A 143 DLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH----KVDIFSLG 217 (299)
T ss_dssp CCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCT----HHHHHHHH
T ss_pred cCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCC----HHHHHHHH
Confidence 9999999999988 9999999999976543221 123468999999999998876654 55699999
Q ss_pred hhheeccc
Q 017820 356 PVLWQVQC 363 (365)
Q Consensus 356 ~vlw~lGc 363 (365)
+++|||-+
T Consensus 218 vilyell~ 225 (299)
T 4g31_A 218 LILFELLY 225 (299)
T ss_dssp HHHHHHHS
T ss_pred HHHHHHcc
Confidence 99999965
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.47 Aligned_cols=200 Identities=19% Similarity=0.209 Sum_probs=157.1
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.|++..+++++.++||+|+||+||+|++. ..||+|.++.. .........++...+...+|+||+.+++.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH--------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS--------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC--------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 46778899999999999999999999875 34777776532 233344455677888889999999999865
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
. ++.+++||||+++|+|.+++...+ ..+++..+..|+.||+.||.|||+++||||||||
T Consensus 102 ~--~~~~~iVmEy~~gGsL~~~l~~~~-------------------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp 160 (307)
T 3omv_A 102 T--KDNLAIVTQWCEGSSLYKHLHVQE-------------------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKS 160 (307)
T ss_dssp C--SSSCEEEEECCSSCBHHHHHHTSC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCS
T ss_pred E--CCeEEEEEEcCCCCCHHHHHhhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCH
Confidence 3 356899999999999999997654 2457788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||||++++ ++||+|||+|+...... .......+||+.|||||++.+.... ..+..+|+||||++||||-+
T Consensus 161 ~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~-~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 161 NNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN-PFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp SSEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC-CCCHHHHHHHHHHHHHHHHH
T ss_pred HHEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC-CCCcHHHhHhHHHHHHHHHH
Confidence 999999987 99999999998765432 2234567999999999999754322 23446779999999999843
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=323.28 Aligned_cols=192 Identities=19% Similarity=0.232 Sum_probs=157.0
Q ss_pred CCe-EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc---
Q 017820 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (365)
Q Consensus 139 ~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (365)
++| ++.++||+|+||+||+|.+..++ ..||+|++.... ..+.....++...+...+|+||+.+++.+..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 455 78889999999999999999988 788888876432 3333444566778888899999999887533
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCCCC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKP 290 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDIKp 290 (365)
.+..+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ ||||||||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp 159 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccCh
Confidence 2466899999999999999998754 4578889999999999999999998 99999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||||+..++.+||+|||+|+.... ....+.+||+.|||||++.+ .+ +..+|+||||+++|+|-|
T Consensus 160 ~NILl~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~-~y----~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 160 DNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KY----DESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CC----CTHHHHHHHHHHHHHHHH
T ss_pred hheeEECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHHHcCC-CC----CcHHHHHHHHHHHHHHHH
Confidence 9999985333999999999986432 23457899999999999864 33 456779999999999854
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=330.48 Aligned_cols=219 Identities=19% Similarity=0.210 Sum_probs=165.1
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..++..+++++.++||+|+||+||+|++.........+.||+|+++..... ......++...+...+|+||+.+++.+
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~- 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV- 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-
Confidence 345677899999999999999999999865332233378999998754322 122334456677778899999999987
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..++.+++||||+++|+|.+++........... ..........+++..+..|+.||+.||.|||+++||||||||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS----TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC---------CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccc----cccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 455688999999999999999976542110000 0001122346788999999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||++++ ++||+|||+|+.+..... .......||+.|||||++.+..++.+ +|+||||++||||
T Consensus 175 NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k----sDVwSfGvvl~El 240 (308)
T 4gt4_A 175 NVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEV 240 (308)
T ss_dssp GEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH----HHHHHHHHHHHHH
T ss_pred ceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc----chhhhHHHHHHHH
Confidence 99999987 999999999997654433 23456789999999999998877655 5599999999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.26 Aligned_cols=194 Identities=23% Similarity=0.294 Sum_probs=146.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||+||+|++..++ +.||+|.+....... .....++...+....|+||+.+++.+ ..
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~ 84 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTG-----QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-KS 84 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTC-----CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EE
Confidence 4589999999999999999999999888 889999876433211 22334556677778899999999887 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
++.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NI 143 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRD--------------------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 143 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHe
Confidence 67899999999 579999987654 468889999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ ++||+|||+|+...... ...+.+||+.|||||++.+..++ +..+|+||+|+++|+|-|
T Consensus 144 Ll~~~~-~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~---~~~~DiwSlGvily~llt 207 (275)
T 3hyh_A 144 LLDEHL-NVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYA---GPEVDVWSCGVILYVMLC 207 (275)
T ss_dssp EECTTC-CEEECCSSCC-----------------CTTSCHHHHSSSSCC---CTHHHHHHHHHHHHHHHH
T ss_pred EECCCC-CEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCC---CChhhhHHHHHHHHHHHH
Confidence 999987 99999999998765432 23568999999999999876542 345679999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.02 Aligned_cols=198 Identities=20% Similarity=0.263 Sum_probs=155.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||+||+|++..++... +.||+|.+..... .+.....++...+...+|+||+.+++.+ .++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~ 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDAR--QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-QTE 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTT--CEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-EET
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCC--EEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EEC
Confidence 3468999999999999999999875432211 6789998753321 1111223345567778899999999887 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--------------------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 158 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeE
Confidence 78999999999999999998764 4688899999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++++ ++||+|||+|+...... ....+.+||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 159 l~~~g-~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~----~~DiwSlGvilyemlt 221 (304)
T 3ubd_A 159 LDEEG-HIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQ----SADWWSFGVLMFEMLT 221 (304)
T ss_dssp ECTTS-CEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCT----HHHHHHHHHHHHHHHH
T ss_pred EcCCC-CEEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCC----CCcccchHHHHHHHHh
Confidence 99988 99999999998754332 2345689999999999998877665 4569999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=319.19 Aligned_cols=194 Identities=22% Similarity=0.321 Sum_probs=153.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC---C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (365)
++|.+.++||+|+||+||+|++.+ +.||+|++......+. ..+.+...+...+|+||+.+++.+...+ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g-------~~VAvK~l~~~~~~~~-~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-------EEEEEEEECGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccchhhH-HHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 479999999999999999999853 7799999876554433 3333445556678999999998875543 3
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC--------CCcccC
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRD 287 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~--------~IiHrD 287 (365)
.+++||||+++|+|.++++... ++++.+.+++.|++.||.|||++ +|||||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~---------------------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYT---------------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred EEEEEecCCCCCcHHHHHHhCC---------------------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 6899999999999999997653 46777889999999999999987 999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCC--CCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTP--SAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~--~~d~~s~~~slg~vlw~lG 362 (365)
|||+||||+.++ ++||+|||+|+........ .....+||+.|||||++.+..... ..+..+|+||||++||||-
T Consensus 134 lKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 134 LKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 999999999988 9999999999876544322 223568999999999997653222 2234678999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=337.24 Aligned_cols=196 Identities=18% Similarity=0.226 Sum_probs=162.9
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHH-HHHHHHHHhhccCCCceeeee
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIW-MNERVRRACANCCADFVYGFF 207 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~i~~~~ 207 (365)
..+..++|++++.||+|+||+||+|++..++ +.||+|.+.... ..... .+..+...+....|+||+.++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg-----~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 3567789999999999999999999999998 788888775322 22222 223345566777899999999
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
+.+ .+...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||||||
T Consensus 259 ~~f-~~~~~lylVmEy~~GGdL~~~l~~~~--------------------~l~E~~a~~y~~qIl~aL~yLH~~gIiHRD 317 (689)
T 3v5w_A 259 YAF-HTPDKLSFILDLMNGGDLHYHLSQHG--------------------VFSEADMRFYAAEIILGLEHMHNRFVVYRD 317 (689)
T ss_dssp EEE-ECSSEEEEEECCCCSCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred EEE-EECCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 887 55678999999999999999998765 468899999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||+||||+.++ ++||+|||+|+.+... ...+.+||+.|||||++.++ .++. .+|+||||++||+|-|
T Consensus 318 LKPeNILld~~G-~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~----~vDiWSLGvilYEmLt 386 (689)
T 3v5w_A 318 LKPANILLDEHG-HVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDS----SADWFSLGCMLFKLLR 386 (689)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred CchHHeEEeCCC-CEEecccceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCc----HHHHHHHHHHHHHHHh
Confidence 999999999988 9999999999876543 24568999999999999643 4444 5569999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=317.11 Aligned_cols=195 Identities=21% Similarity=0.270 Sum_probs=157.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
++|++++.||+|+||+||+|++..++ +.||+|++..... .......++...+....|+||+.+++.+..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTG-----QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 68999999999999999999999988 8899998864332 222333456677778889999999876532
Q ss_pred -CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 213 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
....+|+||||++ |+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~--------------------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 187 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQ--------------------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc
Confidence 3468999999996 68999987654 4688899999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCC---ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+.+.... .....+.+||+.|||||++.+..+ .+..+|+||+|+++|+|-|
T Consensus 188 NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~---~~~~~DiWSlG~il~ell~ 258 (398)
T 4b99_A 188 NLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE---YTQAIDLWSVGCIFGEMLA 258 (398)
T ss_dssp GEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC---CCTHHHHHHHHHHHHHHHH
T ss_pred ccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC---CCChhheehhHHHHHHHHH
Confidence 99999987 99999999998764432 223456899999999999876543 2345669999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.72 Aligned_cols=194 Identities=19% Similarity=0.217 Sum_probs=164.9
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++++.||+|+||+||+|++..++ +.||+|.+......+.....++...+...+|+||+.+++.+ .....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg-----~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-ECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEE
Confidence 478999999999999999999999998 88999988766555555555667778888999999999887 566899
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~-------------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEH-------------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTT-------------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEeecCCCcHHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 99999999999999986543 24688889999999999999999999999999999999986
Q ss_pred C-CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~-~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ .+.+||+|||+|+.+..... ....+||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 291 ~~~~~vKl~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~----~~DiWSlGvilyeml 350 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGY----YTDMWSVGVLSYILL 350 (573)
T ss_dssp SSCCCEEECCCSSCEECCTTSE--EEEECSSGGGCCHHHHTTCCBCH----HHHHHHHHHHHHHHH
T ss_pred CCCCCEEEeeccceeEccCCCc--eeeeEECccccCHHHhCCCCCCc----HHHHHHHHHHHHHHH
Confidence 4 23999999999998754432 35679999999999998877654 456999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.62 Aligned_cols=195 Identities=21% Similarity=0.258 Sum_probs=149.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHh-hccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.++||+|+||+||+|+++..... .+.||+|++.......... ++...+ ....|+||+.+++.+ ...+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~--~~~vAiK~i~~~~~~~~~~--~E~~~l~~~~~h~nIv~l~~~~-~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGP--EEKIALKHLIPTSHPIRIA--AELQCLTVAGGQDNVMGVKYCF-RKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSC--EEEEEEEEECTTSCHHHHH--HHHHHHHHTCSBTTBCCCSEEE-EETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCC--CCEEEEEEEccccCHHHHH--HHHHHHHHhcCCCCCceEEEEE-EECCE
Confidence 37899999999999999999987532111 1779999886554433222 223333 334789999988776 55679
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++.. +++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 95 ~~lvmE~~~g~~L~~~~~~-----------------------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS-----------------------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT-----------------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEEeCCCcccHHHHHcC-----------------------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence 9999999999999998842 36778999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc---------------------------cccccccCCCCcCCccccccCCCCCCCCCch
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN---------------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~---------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s 349 (365)
.+.+.+||+|||+|+....... ....+.+||+.|||||++.+... .+...
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---y~~~~ 228 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN---QTTAI 228 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSC---CCTHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC---CCCcc
Confidence 8745999999999986543211 11234689999999999976532 23355
Q ss_pred hhhhhhhhheeccc
Q 017820 350 VATALSPVLWQVQC 363 (365)
Q Consensus 350 ~~~slg~vlw~lGc 363 (365)
|+||+|+++|+|-|
T Consensus 229 DiWSlG~il~ell~ 242 (361)
T 4f9c_A 229 DMWSAGVIFLSLLS 242 (361)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHHH
Confidence 69999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=292.43 Aligned_cols=207 Identities=17% Similarity=0.223 Sum_probs=163.5
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++.+.||+|+||+||+|.+..+......+.||+|.+......+...+.++...+....|++++.+++.+ ..+
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-~~~ 139 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH-LFQ 139 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE-ECS
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee-ecC
Confidence 3456899999999999999999996544333333388999999887777766666666677777789999888876 445
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
+..++||||+++|+|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKN---------------TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHT---------------STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CCcEEEEeccCCCcHHHHHHHhhc---------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 678999999999999999976421 11235688899999999999999999999999999999999
Q ss_pred Eec-----------CCCcEEEEecccccccccC-CccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSE-----------GSRTFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~-----------~~~~ikL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++. ++ .+||+|||+|+.+... .........||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 205 l~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 279 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY----QIDYFGVAATVYCML 279 (365)
T ss_dssp ECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST----HHHHHHHHHHHHHHH
T ss_pred ecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc----cccHHHHHHHHHHHH
Confidence 988 66 9999999999865422 122334578999999999998876554 556999999999984
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=296.46 Aligned_cols=207 Identities=18% Similarity=0.271 Sum_probs=166.3
Q ss_pred HHHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH---HHHHHHHHHhhccCCCceee
Q 017820 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI---WMNERVRRACANCCADFVYG 205 (365)
Q Consensus 129 ~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~ 205 (365)
..........++|++.+.||+|+||.||+|++..++ +.+|+|.+........ ....++...+....|++++.
T Consensus 59 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred HHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCC-----cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344456677889999999999999999999999887 7888888754322111 11223345556678999999
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+++.+ ..+..+++||||+++|+|.+++.... +++..++.++.||+.||.|||++||+|
T Consensus 134 l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~~---------------------~~e~~~~~~~~qi~~aL~~LH~~givH 191 (410)
T 3v8s_A 134 LFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYD---------------------VPEKWARFYTAEVVLALDAIHSMGFIH 191 (410)
T ss_dssp EEEEE-ECSSEEEEEECCCTTEEHHHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEE-EECCEEEEEEeCCCCCcHHHHHHcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 98877 45678999999999999999987643 467788999999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||||+|||++.++ ++||+|||+|+.+.........+.+||+.|+|||++.+.......+..+|+||||+++|+|-+
T Consensus 192 rDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 192 RDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp CCCSGGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 99999999999988 999999999987755443344578999999999999876533334457789999999999843
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.28 Aligned_cols=195 Identities=22% Similarity=0.215 Sum_probs=159.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|++..++ +.+|+|.+..... .+.....++...+....|++++.+++.+ ..
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~ 76 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QT 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-EC
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-Ee
Confidence 5589999999999999999999999887 7889998764321 1122233345566677899999988877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 136 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence 578999999999999999987654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ ++||+|||+|+..... .......+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 137 ll~~~g-~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 137 MLDKDG-HIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGR----AVDWWGLGVVMYEMMC 200 (337)
T ss_dssp EECTTS-CEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCT----THHHHHHHHHHHHHHH
T ss_pred EECCCC-CEEEeeccchhhcccC-CCcccccccChhhCChhhhcCCCCCc----hhhcccchhHHHHHhc
Confidence 999988 9999999999864322 22345678999999999998776655 4559999999999843
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=296.25 Aligned_cols=206 Identities=18% Similarity=0.254 Sum_probs=162.8
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHH---HHHHHHHHHhhccCCCceeeeec
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI---WMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
....+..++|++.++||+|+||+||+|++..++ +.+|+|.+........ ....++...+....|++++.+++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCC-----cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345567789999999999999999999999887 7889998764322211 11223444556678999999888
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ ..+..+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 142 ~~-~~~~~~~lV~Ey~~gg~L~~~l~~~~-------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL 201 (437)
T 4aw2_A 142 AF-QDDNNLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201 (437)
T ss_dssp EE-ECSSEEEEEECCCTTCBHHHHHHTTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EE-eeCCEEEEEEecCCCCcHHHHHHHcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccc
Confidence 77 55678999999999999999997632 14578889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+|||++.++ ++||+|||+|+.+...........+||+.|||||++..... ....+..+|+||||+++|+|-+
T Consensus 202 Kp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt 276 (437)
T 4aw2_A 202 KPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276 (437)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred CHHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence 99999999988 99999999998766554444456789999999999873211 1122346679999999999843
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=288.77 Aligned_cols=196 Identities=19% Similarity=0.238 Sum_probs=151.5
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhc-cCCCceeeeeccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACAN-CCADFVYGFFENS 210 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~-~~~~~i~~~~~~~ 210 (365)
.+..++|++.+.||+|+||.||+|++..++ +.+|+|.+...... .......+...+.. ..|++++.+++.+
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETG-----DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCC-----CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 346689999999999999999999999887 78899987643211 11112222333333 3699999988877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 -~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 152 (353)
T 3txo_A 94 -QTPDRLFFVMEFVNGGDLMFHIQKSR--------------------RFDEARARFYAAEIISALMFLHDKGIIYRDLKL 152 (353)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred -EeCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCH
Confidence 55678999999999999999997754 457888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ ++||+|||+|+..... .......+||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 153 ~NILl~~~g-~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 218 (353)
T 3txo_A 153 DNVLLDHEG-HCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGP----AVDWWAMGVLLYEML 218 (353)
T ss_dssp GGEEECTTS-CEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTT----HHHHHHHHHHHHHHH
T ss_pred HHEEECCCC-CEEEccccceeecccC-CccccccCCCcCeEChhhcCCCCcCC----ccCCCcchHHHHHHH
Confidence 999999987 9999999999864322 22345678999999999998877655 455999999999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=289.86 Aligned_cols=198 Identities=18% Similarity=0.227 Sum_probs=157.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHh-hccCCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~-~~~~~~~i~~~~~~ 209 (365)
..+..++|++.++||+|+||.||+|++..++ +.+|+|.++..... .......+...+ ....|++++.+++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 3456789999999999999999999999887 77888887643211 111111222222 33478999998887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .....+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~-~~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLK 180 (396)
T 4dc2_A 122 F-QTESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLK 180 (396)
T ss_dssp E-ECSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred E-EECCEEEEEEEcCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 6 55678999999999999999998654 45788899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ ++||+|||+|+..... .....+.+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 181 p~NILl~~~g-~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~----~~DiwslGvllyell~ 248 (396)
T 4dc2_A 181 LDNVLLDSEG-HIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGF----SVDWWALGVLMFEMMA 248 (396)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred HHHEEECCCC-CEEEeecceeeecccC-CCccccccCCcccCCchhhcCCCCCh----HHHHHHHHHHHHHHHh
Confidence 9999999988 9999999999863322 22345689999999999998876654 5569999999999843
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=275.18 Aligned_cols=196 Identities=22% Similarity=0.268 Sum_probs=155.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...++|++.+.||+|+||.||+|.+..++ ..+++|.+... .........++...+....|++++.+++.+ .
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~ 81 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILN-----IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-E 81 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTC-----SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-E
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCC-----CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-e
Confidence 34579999999999999999999998887 78899987432 222233344556667777899999998876 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 141 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHG--------------------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN 141 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 5678999999999999999997654 35778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++..............||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 142 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 142 ILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE----CTDIYSIGIVLYEML 206 (294)
T ss_dssp EEECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCT----THHHHHHHHHHHHHH
T ss_pred EEECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCc----hHhHHHHHHHHHHHH
Confidence 9999987 9999999999876554433345578999999999998766544 456999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=277.38 Aligned_cols=198 Identities=18% Similarity=0.205 Sum_probs=162.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++++.||+|+||+||+|.+..++ +.+++|.+............++...+....|++++.+++.+ ..+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~ 79 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-YKD 79 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EET
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCC-----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-ecC
Confidence 346689999999999999999999999887 78899988665555555555667777888899999998877 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+.+++|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDS-------------------QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCT-------------------TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred CeeEEEEEecCCCcHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence 789999999999999999987431 3577888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccc-------------cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYI-------------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~-------------~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.++ .+||+|||+++......... .....||+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 141 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~~l~el 215 (310)
T 3s95_A 141 VRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE----KVDVFSFGIVLCEI 215 (310)
T ss_dssp ECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCT----HHHHHHHHHHHHHH
T ss_pred ECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCc----HHHHHHHHHHHHHH
Confidence 99987 99999999998764332211 11568999999999998766554 56699999999998
Q ss_pred c
Q 017820 362 Q 362 (365)
Q Consensus 362 G 362 (365)
-
T Consensus 216 ~ 216 (310)
T 3s95_A 216 I 216 (310)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=282.55 Aligned_cols=197 Identities=21% Similarity=0.309 Sum_probs=155.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhh-ccCCCceeeeeccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACA-NCCADFVYGFFENS 210 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~-~~~~~~i~~~~~~~ 210 (365)
.+..++|++.+.||+|+||.||+|++..++ +.||+|.+...... .......+...+. ...|++++.+++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 446789999999999999999999999887 78899987643211 1111111222222 34789999888876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||
T Consensus 88 -~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 146 (345)
T 1xjd_A 88 -QTKENLFFVMEYLNGGDLMYHIQSCH--------------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 146 (345)
T ss_dssp -ECSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred -EeCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCh
Confidence 45678999999999999999998654 357788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ ++||+|||+|+...... ......+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 147 ~NIll~~~g-~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 147 DNILLDKDG-HIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNH----SVDWWSFGVLLYEMLI 213 (345)
T ss_dssp GGEEECTTS-CEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred hhEEECCCC-CEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCC----hhhhHHHHHHHHHHhc
Confidence 999999988 99999999998653322 2245679999999999998766544 5669999999999743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=277.53 Aligned_cols=200 Identities=19% Similarity=0.273 Sum_probs=162.4
Q ss_pred HHhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 130 ~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.........++|++.+.||+|+||+||+|.+..++ +.||+|.+............++...+....|++++.+++.
T Consensus 11 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (297)
T 3fxz_A 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85 (297)
T ss_dssp HHSBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCcCChhhceeeeeeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEE
Confidence 33344456679999999999999999999998887 7889988754333222233344556667789999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+..+++||||+++++|.+++.... +++..++.++.|++.||.|||++||+|||||
T Consensus 86 ~-~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 143 (297)
T 3fxz_A 86 Y-LVGDELWVVMEYLAGGSLTDVVTETC---------------------MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143 (297)
T ss_dssp E-EETTEEEEEEECCTTCBHHHHHHHSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred E-EECCEEEEEEECCCCCCHHHHHhhcC---------------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence 6 44578999999999999999997643 4677899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+|+....... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 144 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 210 (297)
T 3fxz_A 144 SDNILLGMDG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGP----KVDIWSLGIMAIEMI 210 (297)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCT----HHHHHHHHHHHHHHH
T ss_pred HHHEEECCCC-CEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 9999999987 999999999987654332 234578999999999998776654 566999999999984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=289.48 Aligned_cols=206 Identities=20% Similarity=0.266 Sum_probs=163.6
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeee
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFF 207 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~ 207 (365)
+....+..++|++.+.||+|+||.||+|++..++ +.||+|.+....... .....++...+....|++++.++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~-----~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG-----QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 3455677789999999999999999999999887 889999876432211 11122344555667899999988
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
..+ .....+++||||+++|+|.+++...+ ..+++..++.++.||+.||.|||++||+|||
T Consensus 128 ~~~-~~~~~~~lVmE~~~gg~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~aL~~LH~~giiHrD 187 (412)
T 2vd5_A 128 FAF-QDENYLYLVMEYYVGGDLLTLLSKFG-------------------ERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187 (412)
T ss_dssp EEE-ECSSEEEEEECCCCSCBHHHHHHHHS-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEE-eeCCEEEEEEcCCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 876 45678999999999999999997653 1357788999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC---CCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST---QTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ ++||+|||+|+.+...........+||+.|+|||++.... .....+..+|+||||+++|+|-
T Consensus 188 LKp~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 188 IKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred cCHHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 999999999988 9999999999877654433344678999999999997421 1122345677999999999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=278.32 Aligned_cols=193 Identities=20% Similarity=0.294 Sum_probs=159.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+..++|++.+.||+|+||.||+|++..++ +.+|+|.+...... ......++...+....|++++.+++.+ .
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~ 76 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-Q 76 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-E
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-E
Confidence 45689999999999999999999999887 78888887643221 112223345566677899999998877 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 136 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ--------------------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 136 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhe
Confidence 5678999999999999999997654 35778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ .+||+|||+|+.... .....+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 137 Ill~~~g-~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 198 (318)
T 1fot_A 137 ILLDKNG-HIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNK----SIDWWSFGILIYEMLA 198 (318)
T ss_dssp EEECTTS-CEEECCCSSCEECSS----CBCCCCSCTTTCCHHHHTTCCBCT----THHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEEeecCcceecCC----ccccccCCccccCHhHhcCCCCCc----ccchhhhHHHHHHHHh
Confidence 9999987 999999999987543 234578999999999998776655 4559999999999843
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.72 Aligned_cols=196 Identities=19% Similarity=0.218 Sum_probs=157.8
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhc-cCCCceeeeecccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACAN-CCADFVYGFFENSS 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 211 (365)
+..++|++.+.||+|+||.||+|++..++ +.+|+|.+.... ........++...+.. ..|++++.+++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~- 79 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF- 79 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-
Confidence 45689999999999999999999999887 788888876432 2222222233333333 4799999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 45678999999999999999997654 3578889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ ++||+|||+|+...... ......+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 140 NIll~~~g-~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 140 NVLLDSEG-HIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGF----SVDWWALGVLMFEMMA 205 (345)
T ss_dssp GEEECTTS-CEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred HEEECCCC-CEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCCh----HHhHHHHHHHHHHHHh
Confidence 99999987 99999999998643222 2345679999999999998766544 5669999999999843
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=280.02 Aligned_cols=196 Identities=21% Similarity=0.278 Sum_probs=162.1
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
...++|++.+.||+|+||.||+|.+..++ +.||+|.+.... ........++...+....|++++.+++.+ ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTG-----REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-ET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EE
Confidence 35689999999999999999999998888 889999876432 22233334456667777899999998876 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG--------------------RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 678999999999999999997654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ .+||+|||+|+....+. ......||+.|+|||++.+..++ ...+|+||||+++|+|-|
T Consensus 146 ll~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~ 209 (328)
T 3fe3_A 146 LLDADM-NIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVS 209 (328)
T ss_dssp EECTTS-CEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCC---SHHHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcC---CchhhhhhhHHHHHHHHh
Confidence 999987 99999999998765433 23567899999999999876543 235779999999999844
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=283.88 Aligned_cols=197 Identities=19% Similarity=0.198 Sum_probs=155.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhc-cCCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACAN-CCADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~-~~~~~i~~~~~~ 209 (365)
..+..++|++.+.||+|+||.||+|++..++ +.+|+|.+...... .......+...+.. ..|++++.++..
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEE-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 3457789999999999999999999998877 78899987643221 11112223333433 378999888877
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .....+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+|||||
T Consensus 90 ~-~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 90 F-QTMDRLYFVMEYVNGGDLMYHIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148 (353)
T ss_dssp E-ECSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred E-EcCCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 6 45678999999999999999998654 35778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ ++||+|||+|+..... .......+||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 149 p~NIll~~~g-~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 215 (353)
T 2i0e_A 149 LDNVMLDSEG-HIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGK----SVDWWAFGVLLYEML 215 (353)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBST----HHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCC-cEEEEeCCcccccccC-CcccccccCCccccChhhhcCCCcCC----cccccchHHHHHHHH
Confidence 9999999988 9999999999864322 22345678999999999998766544 566999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=284.42 Aligned_cols=196 Identities=21% Similarity=0.227 Sum_probs=155.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHH-HhhccCCCceeeeecccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRR-ACANCCADFVYGFFENSS 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~-~~~~~~~~~i~~~~~~~~ 211 (365)
...++|++.+.||+|+||.||+|++..++ +.+|+|.+...... +......+.. .+....|++++.++..+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~- 108 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEE-----VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF- 108 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTC-----CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-
Confidence 45689999999999999999999999887 77888887644321 1111111222 24567899999998777
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 168 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER--------------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 168 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 45678999999999999999997654 3467888999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ ++||+|||+|+..... .......+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 169 NIll~~~g-~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 169 NILLDSQG-HIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDR----TVDWWCLGAVLYEMLY 234 (373)
T ss_dssp GEEECTTS-CEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred HEEECCCC-CEEEeeCccccccccC-CCccccccCCccccCHHHhCCCCCCc----hhhhHHHHHHHHHHHc
Confidence 99999988 9999999999864332 22345689999999999998766544 5669999999999843
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=280.82 Aligned_cols=199 Identities=18% Similarity=0.224 Sum_probs=160.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..+..++|++.+.||+|+||.||+|++..++ +.+|+|.+....... .....++...+....|++++.+++.+
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTK-----KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4456689999999999999999999999887 788999875433211 22233445666777899999998877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 143 (384)
T 4fr4_A 85 -QDEEDMFMVVDLLLGGDLRYHLQQNV--------------------HFKEETVKLFICELVMALDYLQNQRIIHRDMKP 143 (384)
T ss_dssp -ECSSEEEEEECCCTTEEHHHHHHTTC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -EeCCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcH
Confidence 45578999999999999999997653 457888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+|+.+.... ......||+.|+|||++.+.... ..+..+|+||||+++|+|-
T Consensus 144 ~NIll~~~g-~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~-~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 144 DNILLDEHG-HVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGA-GYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp GGEEECTTS-CEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSC-CBCTTHHHHHHHHHHHHHH
T ss_pred HHeEECCCC-CEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCC-CCCccceeechHHHHHHHH
Confidence 999999988 99999999998765432 23567899999999998643211 1233567999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=278.01 Aligned_cols=194 Identities=19% Similarity=0.237 Sum_probs=160.3
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
....++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 110 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF- 110 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 346689999999999999999999999887 78899987643321 122233445666777899999988776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRIG--------------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccc
Confidence 45678999999999999999998654 3577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+..... .....||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 171 NIll~~~g-~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 233 (350)
T 1rdq_E 171 NLLIDQQG-YIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNK----AVDWWALGVLIYEMAA 233 (350)
T ss_dssp GEEECTTS-CEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred eEEECCCC-CEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCC----cCCEecccHhHhHHhh
Confidence 99999987 9999999999876432 24578999999999998766544 5669999999999843
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=279.79 Aligned_cols=224 Identities=20% Similarity=0.195 Sum_probs=164.4
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+.+..++|++.+.||+|+||.||+|++.........+.||+|.+...... +.....++...+... +|+|++.+++.+.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 45677899999999999999999999765444444488999998754332 222233334444444 7899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchh----------------------------------------------hh
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQ----------------------------------------------TL 245 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----------------------------------------------~~ 245 (365)
..+..+++||||+.+|+|.+++.......... ..
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 76777999999999999999998764211000 00
Q ss_pred hccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCc-cccccc
Q 017820 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEF 324 (365)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~ 324 (365)
.............+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+..... ......
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcccc
Confidence 000000001122378899999999999999999999999999999999999887 999999999987644322 223456
Q ss_pred cCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 325 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 325 ~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 256 ~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 289 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIF 289 (359)
T ss_dssp EECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHT
T ss_pred CCCceeEChhhhcCCCCCc----hhhhhhHHHHHHHHH
Confidence 7899999999998766554 566999999999973
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=278.34 Aligned_cols=195 Identities=18% Similarity=0.245 Sum_probs=159.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..++|++.+.||+|+||.||+|.+..++ +.+|+|.+...... ......++...+....|++++.+++.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCC-----CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 3468999999999999999999999888 77888877643221 112333455667777899999998876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp 143 (361)
T 2yab_A 85 -ENRTDVVLILELVSGGELFDFLAQKE--------------------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP 143 (361)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTTCS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -EeCCEEEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 55678999999999999999997543 457888999999999999999999999999999
Q ss_pred CceEEecCCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++. .+||+|||+++.+.... ......||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslGvil~~ll~ 213 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLS 213 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCc----cccHHHHHHHHHHHHh
Confidence 9999987653 79999999998765432 234678999999999997765544 5669999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=274.44 Aligned_cols=205 Identities=16% Similarity=0.166 Sum_probs=159.7
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.+...+..++|++.+.||+|+||.||+|.+..++... ..|++|.+.... ........++...+....|++++.+++.
T Consensus 41 ~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRD--VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp --CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCC--EEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCC--ceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3455677789999999999999999999998766332 458999887543 2233334445667777789999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+..+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 119 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 178 (325)
T 3kul_A 119 V-TRGRLAMIVTEYMENGSLDTFLRTHD-------------------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178 (325)
T ss_dssp E-CGGGCCEEEEECCTTCBHHHHHHTTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred E-EeCCccEEEeeCCCCCcHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 6 45568899999999999999997543 135778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+++....... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 179 p~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 248 (325)
T 3kul_A 179 ARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS----ASDVWSFGVVMWEVL 248 (325)
T ss_dssp GGGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred cceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 9999999987 999999999987654322 1223345678899999998776655 556999999999973
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=272.83 Aligned_cols=198 Identities=22% Similarity=0.244 Sum_probs=155.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
++|++.+.||+|+||.||+|++..++ +.||+|.+..... .......++...+....|+|++.+++.+....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTC-----CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCC-----cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 68999999999999999999999887 7899998863322 22233445566777778999999887653222
Q ss_pred -----------------------------------------------------CeEEEEEEecCCCcHHHHHHhcCCCcc
Q 017820 215 -----------------------------------------------------GEYWLIWRYEGEATLADLMISREFPYN 241 (365)
Q Consensus 215 -----------------------------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~ 241 (365)
..+++||||+.+++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--- 157 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--- 157 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---
Confidence 248999999999999999987541
Q ss_pred hhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCc---
Q 017820 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN--- 318 (365)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~--- 318 (365)
....++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 158 --------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~ 222 (332)
T 3qd2_B 158 --------------LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQT 222 (332)
T ss_dssp --------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC-----
T ss_pred --------------ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhcc
Confidence 12345667889999999999999999999999999999999887 999999999987654421
Q ss_pred --------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 319 --------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 319 --------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~el~~ 271 (332)
T 3qd2_B 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH----KVDIFSLGLILFELLY 271 (332)
T ss_dssp ---------CCCSCC-CGGGSCHHHHHCCCCCT----HHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccCCCcCccChHHhcCCCCcc----hhhHHHHHHHHHHHHH
Confidence 1223467999999999998765544 5669999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=272.67 Aligned_cols=197 Identities=20% Similarity=0.280 Sum_probs=151.1
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEec---CCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhccCCCceeeee
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLA---KKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFF 207 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~~~ 207 (365)
.+..++|++.+.||+|+||.||+|++. .++ +.+++|.+..... .......++...+....|++++.++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 87 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTG-----KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI 87 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTT-----CEEEEEEECCC--------------HHHHHHHCCCTTBCCEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCC-----cEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence 446689999999999999999999985 344 7789998765421 1222233345556667899999988
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
+.+ ..+..+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+|||
T Consensus 88 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~D 146 (327)
T 3a62_A 88 YAF-QTGGKLYLILEYLSGGELFMQLEREG--------------------IFMEDTACFYLAEISMALGHLHQKGIIYRD 146 (327)
T ss_dssp EEE-ECSSCEEEEEECCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEE-EcCCEEEEEEeCCCCCcHHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence 776 45678999999999999999997654 346778889999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 147 lkp~Nill~~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~ 216 (327)
T 3a62_A 147 LKPENIMLNHQG-HVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHN----RAVDWWSLGALMYDMLT 216 (327)
T ss_dssp CCTTTEEECTTS-CEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCC----THHHHHHHHHHHHHHHH
T ss_pred CCHHHeEECCCC-cEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCC----CcccchhHHHHHHHHHH
Confidence 999999999987 99999999998643322 223457899999999999776554 46679999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.83 Aligned_cols=203 Identities=19% Similarity=0.242 Sum_probs=163.1
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
...+..++|++.+.||+|+||.||+|++..++ +.+|+|.+....... ......+...+....|++++.++..
T Consensus 179 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 253 (543)
T 3c4z_A 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATG-----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253 (543)
T ss_dssp TSCCCGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhheEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45667789999999999999999999999887 788888876433221 1222234455666789999988877
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .....+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 254 ~-~~~~~l~lVmE~~~gg~L~~~l~~~~~----------------~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK 316 (543)
T 3c4z_A 254 F-ETKTDLCLVMTIMNGGDIRYHIYNVDE----------------DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316 (543)
T ss_dssp E-ECSSEEEEEECCCTTCBHHHHHHTSST----------------TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred E-eeCCEEEEEEEeccCCCHHHHHHHhhc----------------ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence 6 456789999999999999999876431 12356888899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ ++||+|||+|+.+..... .....+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 317 P~NILl~~~g-~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~----~~DiwSlGvilyellt 384 (543)
T 3c4z_A 317 PENVLLDDDG-NVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDF----SVDYFALGVTLYEMIA 384 (543)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred hHHEEEeCCC-CEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCCh----HHhcCcchHHHHHHHh
Confidence 9999999988 999999999987654432 234568999999999998766554 5669999999999843
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=278.66 Aligned_cols=210 Identities=16% Similarity=0.182 Sum_probs=159.7
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.+.||+|+||.||+|++...........||+|.+.... ........++...+....|+|++.+++.+ ..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-ec
Confidence 34568999999999999999999997654333333789999986442 22222333445566667899999998877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+.+|+|.+++...... ......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 212 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPR-------------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCC-------------SSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccc-------------cCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 56789999999999999999876421 11223568888999999999999999999999999999999
Q ss_pred EEecCC--CcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGS--RTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~--~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ ..+||+|||+|+.+..... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~DvwslG~il~ell 280 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIF 280 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 998544 2699999999986543322 2234567899999999998776554 566999999999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=297.16 Aligned_cols=198 Identities=19% Similarity=0.200 Sum_probs=155.8
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhh-ccCCCceeeeec
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACA-NCCADFVYGFFE 208 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~-~~~~~~i~~~~~ 208 (365)
...+..++|++.+.||+|+||.||+|++..++ +.||+|.+...... .......+...+. ...|++++.++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSC-----CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34556789999999999999999999999887 77899887643211 1111122233333 346888888877
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ .....+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++|||||||
T Consensus 410 ~~-~~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDL 468 (674)
T 3pfq_A 410 CF-QTMDRLYFVMEYVNGGDLMYHIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468 (674)
T ss_dssp EC-BCSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTSEECCCC
T ss_pred EE-EeCCEEEEEEeCcCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeccC
Confidence 66 55678999999999999999998754 3578889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+||||+.++ ++||+|||+|+...... ....+.+||+.|||||++.+..++. .+|+||||++||+|-
T Consensus 469 Kp~NILl~~~g-~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~----~~DvwSlGvilyell 536 (674)
T 3pfq_A 469 KLDNVMLDSEG-HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGK----SVDWWAFGVLLYEML 536 (674)
T ss_dssp CSTTEEECSSS-CEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBST----HHHHHHHHHHHHHHH
T ss_pred ChhhEEEcCCC-cEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCc----cceEechHHHHHHHH
Confidence 99999999988 99999999998643322 2345689999999999998776654 556999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=276.66 Aligned_cols=219 Identities=20% Similarity=0.255 Sum_probs=160.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCC--CCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
+.+..++|++++.||+|+||.||+|++...+. ......|++|.+..... .......++...+... .|+|++.+++.
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34566899999999999999999999864321 11225689998875432 2223333444555555 79999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .....+++||||+.+|+|.+++.....+-....+- . .......+++..++.++.||+.||.|||++||+|||||
T Consensus 156 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 230 (370)
T 2psq_A 156 C-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD---I-NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230 (370)
T ss_dssp E-CSSSSCEEEEECCTTCBHHHHHHHTCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred E-ccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccc---c-cccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 6 45568999999999999999998764211000000 0 00112346788899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+|+.+...... ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 231 p~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~DvwslG~il~ell 299 (370)
T 2psq_A 231 ARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIF 299 (370)
T ss_dssp GGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH----HHHHHHHHHHHHHHH
T ss_pred hhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 9999999987 9999999999876543322 223456788999999998766554 566999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.45 Aligned_cols=196 Identities=21% Similarity=0.249 Sum_probs=153.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--------HHHHHHHHHHHHHhhccCCCceeeeec
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--------AVEIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
..++|++.++||+|+||+||+|++..++ +.||+|.+.... ......+.++...+....|+|++.+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTC-----CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 4579999999999999999999998887 788999876322 122223333444455556888888877
Q ss_pred ccccCCC----eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 209 NSSKKGG----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 209 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+..... .+++||||++ ++|.+++..... ..+++..++.++.|++.||.|||++||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~------------------~~~~~~~~~~i~~qi~~al~~lH~~~iv 142 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP------------------PGLPAETIKDLMRQFLRGLDFLHANCIV 142 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 6644332 5899999998 599999986541 2367888999999999999999999999
Q ss_pred ccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 285 HrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +|+||||+++|+|-+
T Consensus 143 H~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~----~DiwslG~il~~l~~ 214 (308)
T 3g33_A 143 HRDLKPENILVTSGG-TVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATP----VDMWSVGCIFAEMFR 214 (308)
T ss_dssp CSCCCTTTEEECTTS-CEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCST----HHHHHHHHHHHHTTT
T ss_pred cCCCCHHHEEEcCCC-CEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCch----HHHHHHHHHHHHHHh
Confidence 999999999999987 99999999998764332 2356789999999999987776554 569999999999843
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.37 Aligned_cols=193 Identities=22% Similarity=0.300 Sum_probs=158.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|++++.+++.+ ..+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCE
Confidence 68999999999999999999999887 788888875432 23333344556667777899999998876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred EEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 999999999999999987654 357788999999999999999999999999999999998
Q ss_pred cCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ ..+||+|||+++....... .....||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 163 ~~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~~ll~ 225 (362)
T 2bdw_A 163 SKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSK----PVDIWACGVILYILLV 225 (362)
T ss_dssp CSSTTCCEEECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred cCCCCCCEEEeecCcceEecCCcc--cccCCCCccccCHHHHccCCCCc----hhhHHHHHHHHHHHHH
Confidence 653 2699999999987654322 34578999999999998765544 5669999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=286.52 Aligned_cols=197 Identities=21% Similarity=0.205 Sum_probs=155.2
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+..++|++.+.||+|+||.||+|.+..++ +.||+|.+.... ..+.....++...+....|++++.+++.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~- 217 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF- 217 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCC-----CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-
Confidence 445689999999999999999999999887 789999876432 12222233445566777899999988877
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKP 290 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp 290 (365)
...+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+ +||+||||||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp 277 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCG
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCH
Confidence 45578999999999999999987654 35778899999999999999998 9999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+|+...... .......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 278 ~NIll~~~~-~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 278 ENLMLDKDG-HIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGR----AVDWWGLGVVMYEMMC 344 (446)
T ss_dssp GGEEECSSS-CEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCT----HHHHHHHHHHHHHHHH
T ss_pred HHEEECCCC-CEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCC----ccchhhhHHHHHHHhh
Confidence 999999987 99999999998643322 2235678999999999998776654 5569999999999843
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=265.91 Aligned_cols=201 Identities=19% Similarity=0.229 Sum_probs=146.7
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
...+..++|++.+.||+|+||.||+|.+..++... ..+++|....... .......++...+....|++++.+++..
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CC--EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCc--eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 34566789999999999999999999987654322 5688888765332 2223333455666777899999998775
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 145 (281)
T 1mp8_A 86 -TENPVWIIMELCTLGELRSFLQVRKY-------------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 145 (281)
T ss_dssp -CSSSCEEEEECCTTEEHHHHHHHTTT-------------------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -ccCccEEEEecCCCCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH
Confidence 34568999999999999999976542 3467788999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 146 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~el 210 (281)
T 1mp8_A 146 NVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEI 210 (281)
T ss_dssp GEEEEETT-EEEECC-------------------CCGGGCCHHHHHHCCCSH----HHHHHHHHHHHHHH
T ss_pred HEEECCCC-CEEECccccccccCcccccccccCCCcccccChhhcccCCCCC----ccCchHHHHHHHHH
Confidence 99999987 9999999999877554433344556788999999998765544 56699999999996
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.83 Aligned_cols=194 Identities=21% Similarity=0.264 Sum_probs=158.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.||+|.+....... .....++...+....|++++.+++.+ ..
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~ 80 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQ-----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-TT 80 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-Ee
Confidence 5589999999999999999999998887 788999876432221 12334456667778899999998877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+ +|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKK--------------------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred CCEEEEEEECC-CCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 57899999999 679999887654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ .+||+|||+++....+. .....+||+.|+|||++.+..+. +..+|+||||+++|+|-|
T Consensus 140 ll~~~~-~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~~ll~ 203 (336)
T 3h4j_B 140 LLDDNL-NVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYA---GPEVDVWSCGIVLYVMLV 203 (336)
T ss_dssp EECTTC-CEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGG---CHHHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCC---CCccchhHHHHHHHHHHh
Confidence 999987 99999999998765433 23557899999999999765542 346779999999999743
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=275.69 Aligned_cols=199 Identities=20% Similarity=0.263 Sum_probs=156.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-----HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.++|++.+.||+|+||.||+|.+..++ +.||+|.+...... ......++...+....|+||+.+++.+ .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~ 96 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETG-----QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-S 96 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-E
Confidence 368999999999999999999999888 78888876532211 122233345556666899999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+++++|.+++.... ..+..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N 160 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRA----------------DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence 4678999999999999998876542 012245788899999999999999999999999999999
Q ss_pred eEEecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ ..+||+|||+++...... .......||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~~ll~ 228 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYG----KPVDVWGCGVILFILLS 228 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCC----chHhhHHHHHHHHHHHH
Confidence 9998654 249999999998765432 223457899999999999876654 45669999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=272.33 Aligned_cols=194 Identities=23% Similarity=0.323 Sum_probs=158.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+....... ....++...+....|+|++.+++.+ .....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF-ESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTHHH-HHHHHHHHHHHHSCCTTBCCEEEEE-EETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCC-----cEEEEEEEecCcccH-HHHHHHHHHHHhCCCCCCCeEeEEE-ecCCEE
Confidence 479999999999999999999999887 788888876544333 2233455566677899999998877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-------------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEeCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 99999999999999997543 23577889999999999999999999999999999999987
Q ss_pred C-CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~-~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ +..+||+|||+++.+..+.. .....||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 138 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~~ll~ 198 (321)
T 1tki_A 138 RRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVST----ATDMWSLGTLVYVLLS 198 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECH----HHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEECCCCeECCCCCc--cccccCChhhcCcHHhcCCCCCc----hhhHHHHHHHHHHHHh
Confidence 2 23999999999987754332 24568999999999998765544 5669999999999854
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.64 Aligned_cols=191 Identities=21% Similarity=0.235 Sum_probs=150.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.++||+|+||+||+|.+..++ +.||+|++.... ........++........|++++.+++.+ ..+.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDG-----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-EEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTS-----CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCC-----eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-EeCC
Confidence 58999999999999999999999887 889999765322 22222223333444555799999888876 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+ +++|.+++...+ ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWG-------------------ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHC-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEEecc-CCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 899999999 568998887654 235788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++...... ......||+.|+|||++.+ . .+..+|+||||+++|+|-|
T Consensus 191 ~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~el~~ 250 (311)
T 3p1a_A 191 GPRG-RCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-S----YGTAADVFSLGLTILEVAC 250 (311)
T ss_dssp CGGG-CEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-C----CSTHHHHHHHHHHHHHHHH
T ss_pred CCCC-CEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-C----CCchhhHHHHHHHHHHHHh
Confidence 9987 99999999998764332 2345679999999999865 3 3446779999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=268.36 Aligned_cols=200 Identities=18% Similarity=0.171 Sum_probs=157.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEe----cCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASL----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.+..++|++.+.||+|+||.||+|++ ..++ +.||+|++............++...+....|++++.+++.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-----EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCC-----EEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCC-----cEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45668999999999999999999984 3444 78999998876665555555667777778899999988765
Q ss_pred ccC-CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 211 SKK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 211 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
... ...+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 141 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-------------------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc-------------------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 432 356899999999999999997654 135778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ .+||+|||+++....... .......+|..|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 142 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 142 TRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFT 212 (295)
T ss_dssp GGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHHH
T ss_pred HhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCCh----HHHHHHHHHHHHHHHh
Confidence 9999999987 999999999987654322 1223456777899999998776554 5669999999999843
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.03 Aligned_cols=193 Identities=17% Similarity=0.224 Sum_probs=154.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||+||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.+ ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC-----ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-EeCCE
Confidence 68999999999999999999999887 7889998764322 1222333456667777899999998876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 76 ~~lv~e~~~~-~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 76 LTLVFEFCDQ-DLKKYFDSCN-------------------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp EEEEEECCSE-EHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEecCCC-CHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 9999999986 5666555432 1457888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||+|+....... ......||+.|+|||++.+... .+..+|+||||+++|+|-
T Consensus 136 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~il~~l~ 196 (292)
T 3o0g_A 136 RNG-ELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp TTS-CEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSC---CCTHHHHHHHHHHHHHHT
T ss_pred CCC-CEEEeecccceecCCccc-cccCCccccCCcChHHHcCCCC---cCchHHHHHHHHHHHHHH
Confidence 987 999999999987643322 2345688999999999876541 234667999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=289.64 Aligned_cols=201 Identities=21% Similarity=0.207 Sum_probs=162.5
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeec
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
....+..++|++.+.||+|+||.||+|++..++ +.||+|.+...... ......++...+....|++++.+++
T Consensus 177 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 251 (576)
T 2acx_A 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251 (576)
T ss_dssp HTSCCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcCccccceEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 344577789999999999999999999999888 78888887543211 1122233455566678999999987
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ .....+++||||+++|+|.+++...+ ...+++..++.++.||+.||.|||++||+||||
T Consensus 252 ~~-~~~~~l~lVmEy~~gg~L~~~l~~~~------------------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDL 312 (576)
T 2acx_A 252 AY-ETKDALCLVLTLMNGGDLKFHIYHMG------------------QAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312 (576)
T ss_dssp EE-ECSSEEEEEECCCCSCBHHHHHHSSS------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EE-eeCCEEEEEEEcCCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCC
Confidence 76 45678999999999999999987653 123678889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+|||++.++ ++||+|||+|+.+..+.. ....+||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 313 KPeNILld~~g-~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~----~~DiwSLGvilyeLlt 380 (576)
T 2acx_A 313 KPENILLDDHG-HIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTF----SPDWWALGCLLYEMIA 380 (576)
T ss_dssp CGGGEEECTTS-CEEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESS----HHHHHHHHHHHHHHHH
T ss_pred chheEEEeCCC-CeEEEecccceecccCcc--ccccCCCccccCHHHHcCCCCCc----cchHHHHHHHHHHHHh
Confidence 99999999987 999999999987654332 24568999999999998766554 5569999999999843
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=270.56 Aligned_cols=198 Identities=21% Similarity=0.259 Sum_probs=150.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...++|++.+.||+|+||.||+|++..++ +.|++|.+..... .......++...+....|++++.+++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCC-----ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 35589999999999999999999998887 8899998865422 222233345556677789999988876543
Q ss_pred CC---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 213 KG---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 213 ~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
.. ...++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+|||||
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 143 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--------------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 32 34599999999999999997654 35778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ .+||+|||+++.+..... .......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 144 p~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~~l~~ll~ 214 (311)
T 3ork_A 144 PANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA----RSDVYSLGCVLYEVLT 214 (311)
T ss_dssp GGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHTCCCCH----HHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCc----hHhHHHHHHHHHHHHh
Confidence 9999999987 999999999987654322 2223467999999999998765544 5669999999999843
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.82 Aligned_cols=196 Identities=14% Similarity=0.200 Sum_probs=158.4
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.+.||+|+||.||+|.+..+ +.+++|.+......+.. ..++...+....|++++.+++.+ ..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~-~~~E~~~l~~l~h~~i~~~~~~~-~~ 76 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC-LE 76 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEEECTTSBCHHH-HHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCC------CeEEEEEecccccCHHH-HHHHHHHHHhCCCCCEeeEEEEE-ec
Confidence 445668999999999999999999998754 66899988754432222 23345566667799999998876 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRG-------------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTT-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCc-------------------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 5679999999999999999976541 357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 138 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~~l 200 (269)
T 4hcu_A 138 LVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS----KSDVWSFGVLMWEV 200 (269)
T ss_dssp EECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCc----hhhhHHHHHHHHHH
Confidence 999887 9999999999876544333334566788999999998766554 56699999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=280.90 Aligned_cols=195 Identities=22% Similarity=0.268 Sum_probs=157.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|+||+.+++.+ ..+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~-----~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAG-----QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-SEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTT-----EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-ECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCC-----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-EECC
Confidence 368999999999999999999999888 778888775433 22233344556667777899999998877 5667
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+.+|+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~--------------------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll 143 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE--------------------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLL 143 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEE
T ss_pred EEEEEEEeCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 8999999999999999988754 35788899999999999999999999999999999999
Q ss_pred ecC--CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEG--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~--~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.+ +..+||+|||+|+....... ......||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 144 ~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~----~~DIwSlGvilyell~ 208 (444)
T 3soa_A 144 ASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGK----PVDLWACGVILYILLV 208 (444)
T ss_dssp SBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred eccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCC----ccccHHHHHHHHHHHh
Confidence 852 34899999999987654322 234578999999999998766654 5669999999999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=266.89 Aligned_cols=199 Identities=19% Similarity=0.228 Sum_probs=149.3
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
...+..++|++.+.||+|+||+||+|++.+ ..+++|.+.... ........++...+....|++++.+++.+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECC-------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345567899999999999999999998753 678888876443 22223333455666777899999998877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDI 288 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDI 288 (365)
.....+++||||+.+++|.+++..... ...+++..++.++.|++.||.|||++| |+||||
T Consensus 104 -~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Di 165 (309)
T 3p86_A 104 -TQPPNLSIVTEYLSRGSLYRLLHKSGA-----------------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165 (309)
T ss_dssp -CSTTCCEEEEECCTTCBHHHHHHSTTH-----------------HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTC
T ss_pred -EECCceEEEEecCCCCcHHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCC
Confidence 455678999999999999999976431 123578889999999999999999999 999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 166 kp~NIll~~~~-~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 233 (309)
T 3p86_A 166 KSPNLLVDKKY-TVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNE----KSDVYSFGVILWELA 233 (309)
T ss_dssp CGGGEEECTTC-CEEECCCC------------------CCTTSCHHHHTTCCCCT----THHHHHHHHHHHHHH
T ss_pred ChhhEEEeCCC-cEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCc----hhhHHHHHHHHHHHH
Confidence 99999999987 99999999998643322 2234578999999999998776654 456999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.73 Aligned_cols=194 Identities=20% Similarity=0.255 Sum_probs=142.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|++.... ........++...+....|+||+.+++.+...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEK-----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCC-----cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 478999999999999999999999887 889999876432 22333344456667777899999988776433
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 214 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+++||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~ 185 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPV--------------------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA 185 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCceEEEEEeccc-cchhhhcccCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChh
Confidence 267899999986 68999887643 4578889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCc--------------------------cccccccCCCCcCCcccccc-CCCCCC
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGIN--------------------------YIPKEFLLDPRYAAPEQYIM-STQTPS 344 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~--------------------------~~~~~~~gt~~Y~APE~l~~-~~~~~~ 344 (365)
|||++.++ .+||+|||+|+....... ......+||+.|+|||++.. ..++
T Consensus 186 NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-- 262 (458)
T 3rp9_A 186 NCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-- 262 (458)
T ss_dssp GEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC--
T ss_pred hEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC--
Confidence 99999987 999999999987643211 12245688999999998743 3343
Q ss_pred CCCchhhhhhhhhheecc
Q 017820 345 APSAPVATALSPVLWQVQ 362 (365)
Q Consensus 345 ~d~~s~~~slg~vlw~lG 362 (365)
..+|+||||+++|||-
T Consensus 263 --~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 263 --EAIDVWSIGCIFAELL 278 (458)
T ss_dssp --THHHHHHHHHHHHHHH
T ss_pred --cHhHHHHHHHHHHHHH
Confidence 4567999999999984
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.97 Aligned_cols=195 Identities=22% Similarity=0.217 Sum_probs=161.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+......+.....++...+....|++++.+++.+ .....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCC-----CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-EeCCEE
Confidence 468999999999999999999999887 78899988766554444555667777888999999998877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-------------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-------------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEcCCCCcHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 99999999999999886543 23577889999999999999999999999999999999985
Q ss_pred C-CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~-~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ ...+||+|||+|+.+.... ......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~il~ellt 245 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF----YTDMWAIGVLGYVLLS 245 (387)
T ss_dssp TTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCH----HHHHHHHHHHHHHHHH
T ss_pred CCCCceEEEecccceecCCCc--ceeeeccCCCccCchhccCCCCCC----cccEeeHhHHHHHHHh
Confidence 3 2389999999998765432 224568999999999998765544 5679999999999854
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=273.65 Aligned_cols=202 Identities=14% Similarity=0.121 Sum_probs=154.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHH--------HHHHhhccCCCceee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNER--------VRRACANCCADFVYG 205 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~i~~ 205 (365)
..++|++.+.||+|+||.||+|.+..++.....+.||+|.+....... .....+ .........|++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 446999999999999999999999876555455789999876554321 111111 122345567899988
Q ss_pred eecccccC---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC
Q 017820 206 FFENSSKK---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (365)
Q Consensus 206 ~~~~~~~~---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~ 282 (365)
+++.+... ....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-------------------~~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-------------------KRFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 87765433 25689999999 899999997653 24577889999999999999999999
Q ss_pred CcccCCCCCceEEe--cCCCcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhh
Q 017820 283 IVHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (365)
Q Consensus 283 IiHrDIKp~NILl~--~~~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~sl 354 (365)
|+||||||+|||++ .++ .+||+|||+|+.+...... ......||+.|+|||++.+..++. .+|+|||
T Consensus 173 iiHrDlkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~sl 247 (364)
T 3op5_A 173 YVHGDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR----RGDLEIL 247 (364)
T ss_dssp EECCCCCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH----HHHHHHH
T ss_pred eEEecCCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc----hhhHHHH
Confidence 99999999999999 665 9999999999876543221 113456999999999998766544 5669999
Q ss_pred hhhheeccc
Q 017820 355 SPVLWQVQC 363 (365)
Q Consensus 355 g~vlw~lGc 363 (365)
|+++|+|-+
T Consensus 248 G~~l~el~~ 256 (364)
T 3op5_A 248 GYCMIQWLT 256 (364)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999999743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=261.24 Aligned_cols=195 Identities=17% Similarity=0.218 Sum_probs=157.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.+..++|++.+.||+|+||.||+|.+..+ ..+++|.+......... ..++...+....|++++.+++.+ ..+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~-~~~E~~~l~~l~h~~i~~~~~~~-~~~ 75 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ------YDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVC-SKE 75 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECBTTBCHHH-HHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCc------eeEEEEEeccCCCcHHH-HHHHHHHHHhCCCCCEeeEEEEE-ccC
Confidence 45678999999999999999999988754 56899988754432222 22344555556789999998876 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG-------------------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE
T ss_pred CceEEEEEccCCCcHHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE
Confidence 78999999999999999997653 13577889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.++ .+||+|||+++..............+|+.|+|||++.+..++.+ +|+||||+++|+|
T Consensus 137 ~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~~l 198 (268)
T 3sxs_A 137 VDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK----SDVWAFGILMWEV 198 (268)
T ss_dssp ECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETT----HHHHHHHHHHHHH
T ss_pred ECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchh----hhhHHHHHHHHHH
Confidence 99987 99999999998765544333344566788999999987776655 5599999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=267.07 Aligned_cols=202 Identities=17% Similarity=0.212 Sum_probs=156.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
...++|++.+.||+|+||+||+|.+..++ +.||+|.+...... ......++...+....|++++.+++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 35579999999999999999999999887 78999987643321 1122233455666667999999987664433
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...++||||+++++|.+++..... ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 143 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSN-----------------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGG-----------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhcc-----------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 478999999999999999986531 12367888999999999999999999999999999999
Q ss_pred EE----ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC----CCCCCCchhhhhhhhhheecc
Q 017820 294 IF----SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ----TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll----~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~----~~~~d~~s~~~slg~vlw~lG 362 (365)
|+ +.++ .+||+|||+|+....... .....||+.|+|||++..... ....+..+|+||||+++|+|-
T Consensus 144 ll~~~~~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 144 MRVIGEDGQS-VYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp EEEECTTSCE-EEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred EEeccCCCCc-eEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 98 5554 899999999987654432 245679999999999863211 223344667999999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=273.04 Aligned_cols=219 Identities=20% Similarity=0.227 Sum_probs=163.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCC--CCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
+++..++|++.+.||+|+||.||+|++..++.. .....+++|.+...... ......++...+... .|++++.+++.
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 455678999999999999999999998754421 22256899988654332 222333344444444 79999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..++..++||||+.+++|.+++......-....+ .........+++..++.++.|++.||.|||++||+|||||
T Consensus 144 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 144 C-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY----NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp E-CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC----CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred e-ccCCceEEEEEecCCCcHHHHHHHhccccccccc----ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 7 4556789999999999999999876521100000 0011123457889999999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+|+....... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 219 p~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 287 (382)
T 3tt0_A 219 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWEIF 287 (382)
T ss_dssp GGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH----HHHHHHHHHHHHHHH
T ss_pred cceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc----hhHHHHHHHHHHHHH
Confidence 9999999987 999999999987654322 2233456788999999998765554 556999999999973
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=268.06 Aligned_cols=193 Identities=21% Similarity=0.236 Sum_probs=155.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+++.+ .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~ 84 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-E 84 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cceEeceEEeeCCCeEEEEEEECCCC-----cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-E
Confidence 67999999999999999999999887 77888877543211 112233345556666799999988876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 144 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE--------------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC--------------------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHH
Confidence 5678999999999999999986543 45788899999999999999999999999999999
Q ss_pred eEEecCCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++. .+||+|||+|+.+..... .....||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 145 Ill~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 145 IMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLS 212 (326)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCc----HHHHHHHHHHHHHHHH
Confidence 99987652 799999999987654322 34568999999999997665544 5669999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=277.60 Aligned_cols=198 Identities=15% Similarity=0.236 Sum_probs=158.2
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+.+..++|++.+.||+|+||.||+|.+..++ +.||+|.++..... ......++...+....|++++.+++.+ .
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~ 182 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADN-----TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-T 182 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCC-----eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-e
Confidence 3456689999999999999999999998777 78999987754322 222233455667777899999998887 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+++++|.+++...+ ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 243 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEG-------------------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence 4567899999999999999997653 235778889999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCcccc-ccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||++.++ .+||+|||+|+....+..... ....+++.|+|||++.+..++. .+|+||||+++|+|
T Consensus 244 il~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~DvwslG~il~el 308 (377)
T 3cbl_A 244 CLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS----ESDVWSFGILLWET 308 (377)
T ss_dssp EEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEH----HHHHHHHHHHHHHH
T ss_pred EEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCc----hhhHHHHHHHHHHH
Confidence 9999987 999999999986543322111 1234577899999998776554 55699999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=279.21 Aligned_cols=190 Identities=19% Similarity=0.265 Sum_probs=147.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+....|+||+.+++.+....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCC-----CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 478999999999999999999999888 889999886542 222333334556677778999999887764332
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||++++ |.+.+.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~~----------------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp 192 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred cccCCeEEEEEeCCCCC-HHHHHhh----------------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 5689999999864 6665532 246778899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 193 ~NIll~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~il~ell 257 (464)
T 3ttj_A 193 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGEMV 257 (464)
T ss_dssp GGEEECTTS-CEEECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCT----THHHHHHHHHHHHHH
T ss_pred HhEEEeCCC-CEEEEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCH----HHHHHHHHHHHHHHH
Confidence 999999987 99999999998765432 235678999999999998876654 456999999999984
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.26 Aligned_cols=196 Identities=24% Similarity=0.242 Sum_probs=155.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||+||+|.+..++ +.|++|.+......+ .....++...+....|++++.+++.+ ..+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-ECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCC-----cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCC
Confidence 3489999999999999999999999887 788888875433221 12223345556667899999998876 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll 138 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eEEEEEEcCCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE
Confidence 8999999999999998876443 46788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++.+..... .......||+.|+|||++.+.... ...+|+||||+++|+|-
T Consensus 139 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~~ll 202 (323)
T 3tki_A 139 DERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH---AEPVDVWSCGIVLTAML 202 (323)
T ss_dssp CTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBC---HHHHHHHHHHHHHHHHH
T ss_pred eCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCC---CCcccHHHHHHHHHHHH
Confidence 9987 999999999987643322 223467899999999999765431 23567999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=268.70 Aligned_cols=193 Identities=17% Similarity=0.230 Sum_probs=152.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhc--cCCCceeeeecccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACAN--CCADFVYGFFENSS 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~--~~~~~i~~~~~~~~ 211 (365)
...++|++.++||+|+||.||+|++..++ +.||+|.+......... .+.++...+.. ..|++++.+++.+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~- 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNK-----KYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF- 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE-
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCC-----eEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee-
Confidence 45579999999999999999999998887 78999988643322221 12222222221 2489999988876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
......++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 166 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNY------------------NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcc
Confidence 4457899999999 8899999987542 23577889999999999999999999999999999
Q ss_pred ceEEec-------------------------CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCC
Q 017820 292 NVIFSE-------------------------GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346 (365)
Q Consensus 292 NILl~~-------------------------~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d 346 (365)
|||++. ++ .+||+|||+|+.... ......||+.|+|||++.+..++.
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~--- 238 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDV--- 238 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCC-CEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCT---
T ss_pred cEEEccccccccccchhcccccccccccccCCC-CEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCC---
Confidence 999975 44 999999999986432 234578999999999998876655
Q ss_pred Cchhhhhhhhhheecc
Q 017820 347 SAPVATALSPVLWQVQ 362 (365)
Q Consensus 347 ~~s~~~slg~vlw~lG 362 (365)
.+|+||||+++|+|-
T Consensus 239 -~~DiwslG~il~ell 253 (360)
T 3llt_A 239 -SSDMWSFGCVLAELY 253 (360)
T ss_dssp -THHHHHHHHHHHHHH
T ss_pred -ccchHHHHHHHHHHH
Confidence 456999999999984
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=263.62 Aligned_cols=198 Identities=17% Similarity=0.221 Sum_probs=156.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+.+..++|++.+.||+|+||.||+|.+..+ ..+++|.+......+.. ..++...+....|++++.+++.+ .
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~-~~~E~~~l~~l~h~~i~~~~~~~-~ 89 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC-T 89 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTT------EEEEEEEECTTSBCHHH-HHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCC------CeEEEEEecCCCCCHHH-HHHHHHHHhcCCCCCEeeEEEEE-e
Confidence 3456778999999999999999999988753 67899988754332222 23345566666799999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 150 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMR-------------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGG-------------------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccce
Confidence 5678999999999999999997643 135778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 151 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Dv~slG~~l~~l~ 215 (283)
T 3gen_A 151 CLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS----KSDIWAFGVLMWEIY 215 (283)
T ss_dssp EEECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH----HHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCc----hhhHHHHHHHHHHHH
Confidence 9999987 9999999999876543333334456788999999998776544 566999999999983
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=276.47 Aligned_cols=196 Identities=18% Similarity=0.313 Sum_probs=153.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+....|++++.+++.+....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTE-----KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3479999999999999999999999887 889999886432 223333445566677778999999887765443
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 157 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPI--------------------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKP 157 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 67999999988 59999987643 357888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCcc---------------------ccccccCCCCcCCccccccCCCCCCCCCch
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY---------------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~---------------------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s 349 (365)
+|||++.++ .+||+|||+|+........ .....+||+.|+|||++.... ..+..+
T Consensus 158 ~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~~~~~ 233 (432)
T 3n9x_A 158 ANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE---NYTKSI 233 (432)
T ss_dssp GGEEECTTC-CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS---CCCTHH
T ss_pred HHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC---CCCccc
Confidence 999999987 9999999999876543211 125678999999999874332 133466
Q ss_pred hhhhhhhhheecc
Q 017820 350 VATALSPVLWQVQ 362 (365)
Q Consensus 350 ~~~slg~vlw~lG 362 (365)
|+||||+++|+|-
T Consensus 234 DiwSlG~il~ell 246 (432)
T 3n9x_A 234 DIWSTGCIFAELL 246 (432)
T ss_dssp HHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHH
Confidence 7999999999984
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=274.30 Aligned_cols=193 Identities=19% Similarity=0.231 Sum_probs=144.0
Q ss_pred cCCCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc---c
Q 017820 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (365)
Q Consensus 137 ~~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (365)
..++|.+. +.||+|+||.||+|.+..++ +.||+|.+....... .++........|+|++.+++.+. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~~~----~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCC-----CEEEEEEeCcchhHH----HHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 34678887 78999999999999999887 889999886432211 11222233446777777665542 2
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 191 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcce
Confidence 3567899999999999999997643 1246788899999999999999999999999999999
Q ss_pred eEEec---CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~---~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++. ++ .+||+|||+|+...... .....+||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 192 ill~~~~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 192 LLYTSKRPNA-ILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDK----SCDMWSLGVIMYILLC 258 (400)
T ss_dssp EEESSSSTTC-CEEECCCTTCEECC-------------CTTCCGGGSCCCCSSS----HHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCc-cEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCC----cccHHHHHHHHHHHHh
Confidence 99997 44 99999999998654322 234678999999999997765544 5669999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=268.54 Aligned_cols=200 Identities=22% Similarity=0.260 Sum_probs=158.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..+..++|++.++||+|+||+||+|++.+ +.||+|.+........ ..+.+...+....|+|++.+++.+...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEETT-------EEEEEEEECGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccchhhchhhheecccCceEEEEEEECC-------CEEEEEEeecCchHHH-HHHHHHHHHhcCCCCCchhhcceeccC
Confidence 34566799999999999999999998863 7899998865543333 333345566777899999998876543
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC---------
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------- 281 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~--------- 281 (365)
...+++||||+++|+|.+++.... +++..++.++.|++.||.|||++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~ 149 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKANV---------------------VSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHhhccccccccC
Confidence 345899999999999999997643 46778999999999999999999
Q ss_pred -CCcccCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCC-CCCCchhhhhhhhhh
Q 017820 282 -GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTP-SAPSAPVATALSPVL 358 (365)
Q Consensus 282 -~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~-~~d~~s~~~slg~vl 358 (365)
+|+||||||+|||++.++ .+||+|||+|+.+...... ......||+.|+|||++.+..... ..+..+|+||||+++
T Consensus 150 ~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 150 PAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp CEEECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred CCEEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence 999999999999999987 9999999999876544322 233468999999999997643322 223366899999999
Q ss_pred eeccc
Q 017820 359 WQVQC 363 (365)
Q Consensus 359 w~lGc 363 (365)
|+|-+
T Consensus 229 ~el~t 233 (322)
T 3soc_A 229 WELAS 233 (322)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 99843
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=265.01 Aligned_cols=198 Identities=17% Similarity=0.237 Sum_probs=153.1
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--------------------------HHHHH
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--------------------------IWMNE 189 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~ 189 (365)
...++|++.+.||+|+||.||+|++..++ +.||+|.+....... .....
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDN-----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTT-----EEEEEEEEECC-------------------------------CHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 45689999999999999999999998887 788888875432111 12233
Q ss_pred HHHHHhhccCCCceeeeeccccc-CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHH
Q 017820 190 RVRRACANCCADFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (365)
Q Consensus 190 ~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 268 (365)
++...+....|++++.+++.+.. .+..+++||||+++++|.+++.. ..+++..++.++
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------------~~~~~~~~~~~~ 143 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---------------------KPLSEDQARFYF 143 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---------------------SCCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---------------------CCCCHHHHHHHH
Confidence 45566677789999999887654 35789999999999998764322 245788899999
Q ss_pred HHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCc
Q 017820 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (365)
Q Consensus 269 ~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~ 348 (365)
.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.+..... ......||+.|+|||++.+.... ..+..
T Consensus 144 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~~~ 220 (298)
T 2zv2_A 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKI-FSGKA 220 (298)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCC-EESHH
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCC-CCCch
Confidence 9999999999999999999999999999987 999999999987654322 23456899999999998654321 12346
Q ss_pred hhhhhhhhhheecc
Q 017820 349 PVATALSPVLWQVQ 362 (365)
Q Consensus 349 s~~~slg~vlw~lG 362 (365)
+|+||||+++|+|-
T Consensus 221 ~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 221 LDVWAMGVTLYCFV 234 (298)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred hhhHhHHHHHHHHH
Confidence 78999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=269.40 Aligned_cols=224 Identities=19% Similarity=0.257 Sum_probs=160.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (365)
.+++..++|++.+.||+|+||.||+|++...........|++|.+...... ......++...+... .|++++.+++.+
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 355677899999999999999999999855433333367999988744322 122223334444444 799999998876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccc---cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE---VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
...+..++||||+++++|.+++......+......... .........+++..++.++.||+.||.|||++||+|||
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 44568999999999999999998765332221111110 11111223568889999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~el~ 268 (344)
T 1rjb_A 198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGILLWEIF 268 (344)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHT
T ss_pred CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh----hHhHHHHHHHHHHHH
Confidence 999999999987 9999999999876544322 223456788999999998766544 566999999999984
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=268.10 Aligned_cols=226 Identities=18% Similarity=0.185 Sum_probs=165.3
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
....+..++|++.+.||+|+||.||+|++.........+.|++|.+...... ......++...+....|++++.+++.+
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456778999999999999999999999985443333377999988754332 233344556667777899999998877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcch----hhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNV----QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
..+...++||||+++++|.+++......... ................+++..++.++.||+.||.|||++||+||
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4467899999999999999999875311000 00000000001112467889999999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||+|||++.++ .+||+|||+++.+..... .......+|+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~el~t 271 (343)
T 1luf_A 199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT----ESDVWAYGVVLWEIFS 271 (343)
T ss_dssp CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc----ccccHHHHHHHHHHHh
Confidence 9999999999987 999999999987644322 2223567899999999998766544 5669999999999843
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=278.96 Aligned_cols=194 Identities=16% Similarity=0.226 Sum_probs=157.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+.+..++|++.+.||+|+||.||+|.+.+ +.||+|.++.....+. ..++...+....|+|++.+++....
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEESSCTTSHH--HHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecC-------CeEEEEEeCCchHHHH--HHHHHHHHHhccCCCEEEEEEEEEc
Confidence 456778899999999999999999999863 6799998876543322 2334556667789999999988766
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+++|+|.+++...+. ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGR------------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCT------------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 66689999999999999999987642 124677888999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++..... .....+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 320 ill~~~~-~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~----~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 320 VLVSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST----KSDVWSFGILLWEIY 380 (450)
T ss_dssp EEECTTS-CEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCH----HHHHHHHHHHHHHHH
T ss_pred EEECCCC-CEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 9999987 9999999999864322 23346788999999998766554 566999999999983
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=264.33 Aligned_cols=224 Identities=19% Similarity=0.230 Sum_probs=164.9
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+.+..++|++.+.||+|+||.||+|.+...........+++|.+.... ..+.....++...+....|++++.+++.+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC- 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-
Confidence 3455678999999999999999999998654333333678999887543 23333444556677777899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcch--h--hhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNV--Q--TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
..+...++||||+.+++|.+++......-.. . ...............+++..++.++.|++.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 4556799999999999999999875420000 0 00000000111234578889999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 176 ikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el~ 246 (314)
T 2ivs_A 176 LAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIV 246 (314)
T ss_dssp CSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred cchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc----hhhHHHHHHHHHHHH
Confidence 999999999987 9999999999876543222 223456788999999998766554 556999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=265.66 Aligned_cols=220 Identities=20% Similarity=0.202 Sum_probs=163.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+.+..++|++.+.||+|+||.||+|.+.........+.|++|.+...... ......++...+... +|++++.+++.+.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 45567899999999999999999999765443344478999988754332 222233334444444 6899999988876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+..+++||||+++++|.+++............. ........+++..++.++.|++.||.|||++||+||||||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA----PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhccccccccccc----chhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 66677999999999999999998765211100000 00001223688899999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+++.+..... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 178 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 244 (316)
T 2xir_A 178 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIF 244 (316)
T ss_dssp GEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred eEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccccccc----hhHHHHHHHHHHHHH
Confidence 99999887 999999999987644322 2233467789999999998766544 566999999999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=264.04 Aligned_cols=197 Identities=23% Similarity=0.287 Sum_probs=153.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc---cC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---KK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~ 213 (365)
..++|++.+.||+|+||+||+|++. + +.||+|.+.......... +..........|+|++.+++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~-----~~vavK~~~~~~~~~~~~-e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ--G-----ENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET--T-----EEEEEEEECGGGHHHHHH-HHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC--C-----EEEEEEEeccccchhhHH-HHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 4579999999999999999999884 3 779999887654433333 22233333367899888876543 23
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH--------HCCCcc
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--------STGIVH 285 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH--------~~~IiH 285 (365)
...+++||||+++|+|.++++.. .+++..++.++.|++.||.||| +++|+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 136 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQLT---------------------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTTC---------------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred CceeEEehhhccCCCHHHHHhhc---------------------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence 46789999999999999999643 3477888999999999999999 999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCC--CCCCchhhhhhhhhhee
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTP--SAPSAPVATALSPVLWQ 360 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~--~~d~~s~~~slg~vlw~ 360 (365)
|||||+|||++.++ .+||+|||+|+........ ......||+.|+|||++.+..... .....+|+||||+++|+
T Consensus 137 ~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~e 215 (301)
T 3q4u_A 137 RDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215 (301)
T ss_dssp SCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHH
Confidence 99999999999987 9999999999876544322 123458999999999997653322 11236789999999999
Q ss_pred ccc
Q 017820 361 VQC 363 (365)
Q Consensus 361 lGc 363 (365)
|-+
T Consensus 216 l~t 218 (301)
T 3q4u_A 216 VAR 218 (301)
T ss_dssp HHT
T ss_pred HHh
Confidence 853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=280.61 Aligned_cols=198 Identities=20% Similarity=0.276 Sum_probs=162.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.....++|.+++.||+|+||.||+|.+..++ +.||+|.+....... .....++...+....|++++.+++.+
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTG-----HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTC-----CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4456789999999999999999999999887 889999876443221 22334456667778899999998877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||
T Consensus 86 -~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp 144 (476)
T 2y94_A 86 -STPSDIFMVMEYVSGGELFDYICKNG--------------------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144 (476)
T ss_dssp -ECSSEEEEEEECCSSEEHHHHTTSSS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred -EECCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH
Confidence 45578999999999999999986543 457888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+++....+. ...+.+||+.|+|||++.+..+ .+..+|+||||+++|+|-|
T Consensus 145 ~NIll~~~~-~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlGvil~ellt 211 (476)
T 2y94_A 145 ENVLLDAHM-NAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY---AGPEVDIWSSGVILYALLC 211 (476)
T ss_dssp GGEEECTTC-CEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCB---CSHHHHHHHHHHHHHHHHH
T ss_pred HHEEEecCC-CeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCC---CCCcceehhhHHHHHHHhh
Confidence 999999987 99999999998765432 2345789999999999976543 2346779999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=271.08 Aligned_cols=195 Identities=19% Similarity=0.194 Sum_probs=148.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|.+......... ..++...+....|++++.+++.+ .....
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~-~~~E~~~l~~l~hpniv~~~~~~-~~~~~ 90 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTK-----ELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI-LTPTH 90 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTC-----CEEEEEEEESSTTSCHH-HHHHHHHHHHCCCTTBCCEEEEE-ECSSE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEecCccccHH-HHHHHHHHHhCCCCCCCcEEEEE-eeCCE
Confidence 4579999999999999999999999887 88999988654322221 22344555666799999998877 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~ 150 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG--------------------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 999999999999999987654 357888999999999999999999999999999999998
Q ss_pred cCCC-cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSR-TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~-~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++. .+||+|||+|+...... ......||+.|+|||++.+..++.+ .+|+||||+++|+|-+
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~---~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 151 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLV 213 (361)
T ss_dssp SSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHH---HHHHHHHHHHHHHHHH
T ss_pred CCCCceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCC---eeeeehhHHHHHHHHh
Confidence 7651 49999999998543222 2345689999999999977654322 3679999999999843
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=266.50 Aligned_cols=217 Identities=20% Similarity=0.243 Sum_probs=164.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
..+..++|++.+.||+|+||.||+|.+..++.....+.+++|.+...... ......++...+... .|++++.+++.+
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 119 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC- 119 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-
Confidence 45577899999999999999999999998887776778999988754322 222233344445555 799999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+..+++||||+++++|.+++........ ....-......+++..++.++.|++.||.|||++||+||||||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLE------TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHS------CC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhccccc------ccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence 455689999999999999999976531000 00000001234678889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++ ..+|+||||+++|+|-
T Consensus 194 NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 194 NVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT----VQSDVWSYGILLWEIF 260 (333)
T ss_dssp GCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC----HHHHHHHHHHHHHHHT
T ss_pred eEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC----hHHHHHHHHHHHHHHH
Confidence 99999987 9999999999876544322 22345678899999999876554 4566999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=284.98 Aligned_cols=200 Identities=16% Similarity=0.212 Sum_probs=161.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.+.||+|+||.||+|.+..++ ..||+|.+....... ....++...+....|+|++.+++.+ ..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~-~~ 287 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC-TR 287 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGT-----EEEEEEECCSSSSCH-HHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCC-----eEEEEEEecCcccch-HHHHHHHHHHHhcCCCCEeeEEEEE-ec
Confidence 4556679999999999999999999998876 789999887543221 1223345556666899999998877 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSC------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCcEEEEEEccCCCCHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 568899999999999999998643 12357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ .+||+|||+|+..............+|+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 350 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~sDvwSlG~~l~el~t 414 (495)
T 1opk_A 350 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIAT 414 (495)
T ss_dssp EECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECH----HHHHHHHHHHHHHHHT
T ss_pred EECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCc----HHhHHhHHHHHHHHHh
Confidence 999887 9999999999876544333333456678999999998776654 5569999999999843
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=272.55 Aligned_cols=195 Identities=22% Similarity=0.305 Sum_probs=142.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhcc-CCCceeeeecccccC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC-CADFVYGFFENSSKK- 213 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~- 213 (365)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+... .|++++.+++.+...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTG-----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTC-----CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 479999999999999999999999888 889999875332 22222222334444444 499999988876543
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||++ ++|.+++.... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~~---------------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 140 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRANI---------------------LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEecccC-cCHHHHHHcCC---------------------CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHe
Confidence 357899999998 58999887643 46677889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCC--------------------ccccccccCCCCcCCccccccCCCCCCCCCchhhhh
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGI--------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 353 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~--------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~s 353 (365)
|++.++ .+||+|||+|+.+.... .......+||+.|+|||++.+.. ..+..+|+||
T Consensus 141 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwS 216 (388)
T 3oz6_A 141 LLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST---KYTKGIDMWS 216 (388)
T ss_dssp EECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC---CCCTHHHHHH
T ss_pred EEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC---CCCChhhHHH
Confidence 999987 99999999998653210 11123468999999999987632 2234567999
Q ss_pred hhhhheeccc
Q 017820 354 LSPVLWQVQC 363 (365)
Q Consensus 354 lg~vlw~lGc 363 (365)
||+++|+|-+
T Consensus 217 lG~il~ell~ 226 (388)
T 3oz6_A 217 LGCILGEILC 226 (388)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=265.78 Aligned_cols=190 Identities=20% Similarity=0.240 Sum_probs=156.1
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEE
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (365)
.|...+.||+|+||.||+|++..++ +.||+|.+............++...+....|++++.+++.+ ..+...++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY-LVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCC-----cEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EECCEEEE
Confidence 5888999999999999999998877 78999987644333333334456667777899999988876 44568999
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~ 299 (365)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 120 v~e~~~~~~L~~~l~~~---------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---------------------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp EECCCCSCBHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEecCCCCCHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 99999999999988643 247788999999999999999999999999999999999987
Q ss_pred CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 300 ~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.+||+|||+++.+..... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 179 -~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~----~~Dv~slG~il~el~ 235 (321)
T 2c30_A 179 -RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYAT----EVDIWSLGIMVIEMV 235 (321)
T ss_dssp -CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHH
T ss_pred -cEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCc----hhhHHHHHHHHHHHH
Confidence 999999999987654322 234578999999999997765544 566999999999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=272.35 Aligned_cols=202 Identities=15% Similarity=0.171 Sum_probs=148.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
...+..++|++.+.||+|+||.||+|++..++... ..|++|.+.... ........++...+....|++++.+++.+
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~- 115 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE--ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV- 115 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCB--CCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCc--eeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 34556679999999999999999999987432221 679999886543 22333344556677777899999998877
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+...++||||+++++|.+++...+. .+++..++.++.||+.||.|||++||+||||||+
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 176 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDA-------------------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTT-------------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 455789999999999999999976532 3567788999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 177 NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Dv~SlG~il~el 243 (373)
T 2qol_A 177 NILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS----ASDVWSYGIVLWEV 243 (373)
T ss_dssp GEEECTTC-CEEECCC----------------------CTTSCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred eEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCc----hhcHHHHHHHHHHH
Confidence 99999987 9999999999876543221 122334578899999998766554 56699999999995
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=260.54 Aligned_cols=195 Identities=24% Similarity=0.250 Sum_probs=148.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|++..++ +.|++|.+..... .......++...+....|++++.+++.+ ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRE-----RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-EI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCC-----eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-ee
Confidence 5689999999999999999999998877 7899998765432 2223334456667777899999988876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++|+||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQG--------------------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCeEEEEEEecCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 678999999999999999998654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++..............||+.|+|||++.+..++.++ |+||||+++|+|-
T Consensus 166 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----Di~slG~il~~l~ 229 (309)
T 2h34_A 166 LVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA----DIYALTCVLYECL 229 (309)
T ss_dssp EECTTS-CEEECSCCC----------------CCGGGCCGGGTCC----CCC----HHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchH----hHHHHHHHHHHHH
Confidence 999987 999999999987654433333456899999999999877666555 5999999999984
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=262.51 Aligned_cols=201 Identities=16% Similarity=0.222 Sum_probs=163.1
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+.+..++|++.+.||+|+||.||+|.+..++ ..+++|.+........ ...++...+....|++++.+++.+ .
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~-~ 79 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC-T 79 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGT-----EEEEEEEECSCSTHHH-HHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCC-----EEEEEEecCcCHHHHH-HHHHHHHHHHhCCCCCEeeEEEEE-c
Confidence 35567789999999999999999999999877 7899998875543322 223345566666799999988876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N 141 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCC------------------TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGG
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcc------------------cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcce
Confidence 5677999999999999999997643 1235778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 142 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 142 CLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIAT 207 (288)
T ss_dssp EEECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred EEEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCc----hhhHHHHHHHHHHHHh
Confidence 9999887 9999999999876554433344566788999999998776544 5669999999999843
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=281.48 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=157.1
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.+.||+|+||.||+|.+..+ ..||+|.++..... .....++...+....|++++.+++...
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~-- 253 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-- 253 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTT------EEEEEEEECTTSBC-HHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCc------cEEEEEEecCCCcc-HHHHHHHHHHHhhCCCCCEeeEEEEEe--
Confidence 456778999999999999999999998653 67899988754322 222334456677778999999987753
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+.+|+|.+++.... +..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDE------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred CCccEEEEeecCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 457899999999999999997542 12346677889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+|+..............+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 316 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 316 LVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI----KSDVWSFGILLMEIV 379 (454)
T ss_dssp EECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCc----HHHHHhHHHHHHHHH
Confidence 999987 9999999999876543222223455678999999998766554 566999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=268.92 Aligned_cols=202 Identities=16% Similarity=0.180 Sum_probs=152.3
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
..+..++|++.+.||+|+||.||+|.+..++..++ .++++|.+..... .......++...+....|+|++.+++.+.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIK-IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCC-EEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEE-EEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567899999999999999999999988764332 2366665532221 11111223344556668999999988653
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+...++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 145 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR-------------------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 145 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG-------------------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTT
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc-------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchhe
Confidence 456899999999999999997643 134667788999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+|+.+...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 146 il~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~el~ 211 (325)
T 3kex_A 146 VLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH----QSDVWSYGVTVWELM 211 (325)
T ss_dssp EEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCCh----hhHhHHhHHHHHHHH
Confidence 9999987 9999999999977544322 234567788999999998776554 556999999999963
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=268.37 Aligned_cols=193 Identities=18% Similarity=0.170 Sum_probs=150.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|.+......+.. .++...+... .|++++.+++.. ..+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~--~~E~~~l~~l~~h~~i~~~~~~~-~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTN-----EYVAIKLEPMKSRAPQL--HLEYRFYKQLGSGDGIPQVYYFG-PCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTT-----EEEEEEEEETTCSSCCH--HHHHHHHHHHCSCTTSCCEEEEE-EETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCC-----cEEEEEEeccccchHHH--HHHHHHHHHhhCCCCCCEEEEEE-ecCC
Confidence 3478999999999999999999998887 78899987643322211 1122233333 678888777665 4467
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCD-------------------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccEEEEEeC-CCCHHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 899999999 899999998643 145778899999999999999999999999999999999
Q ss_pred ecCCCc-----EEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRT-----FKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~-----ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ . +||+|||+|+.+...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 139 ~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 211 (330)
T 2izr_A 139 GRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR----RDDLEALGHMFMYFL 211 (330)
T ss_dssp CCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred ccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCc----hhHHHHHHHHHHHHh
Confidence 9876 5 999999999876543221 124678999999999998766544 556999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.62 Aligned_cols=190 Identities=19% Similarity=0.249 Sum_probs=155.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
++|++.+.||+|+||.||+|.+..++ ..+++|++............++...+....|++++.+++.+ ..+...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTR-----IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-EDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCC-----cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCeEE
Confidence 68999999999999999999999887 77888887654333233334455666777899999998876 4567899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE---
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF--- 295 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl--- 295 (365)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--------------------VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred EEEeccCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 9999999999999987654 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||++....... ......||+.|+|||++.+. + +..+|+||||+++|+|-
T Consensus 143 ~~~~-~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~----~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 143 SPDS-PLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL-Y----GPECDEWSAGVMMYVLL 201 (277)
T ss_dssp STTC-CEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC-B----CTTHHHHHHHHHHHHHH
T ss_pred CCCC-cEEEEecccceeccCcc--chhccCCCCCccChHHhccc-C----CchhhehhHHHHHHHHH
Confidence 5555 99999999998765433 23456899999999998653 3 34567999999999984
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=257.44 Aligned_cols=194 Identities=21% Similarity=0.249 Sum_probs=155.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+..++|++.+.||+|+||.||+|.+..++ ..+++|.+....... .....++...+....|++++.+++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 78 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF- 78 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCC-----cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-
Confidence 456789999999999999999999999887 778888875433221 12233455666777899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
......++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~ 138 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLS--------------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGG
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 45578999999999999999997654 3577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||++...... ......||+.|+|||++.+...+. .+|+||||+++|+|-
T Consensus 139 Nili~~~~-~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 201 (279)
T 3fdn_A 139 NLLLGSAG-ELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDE----KVDLWSLGVLCYEFL 201 (279)
T ss_dssp GEEECTTS-CEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCT----THHHHHHHHHHHHHH
T ss_pred hEEEcCCC-CEEEEeccccccCCcc---cccccCCCCCccCHhHhccCCCCc----cchhHhHHHHHHHHH
Confidence 99999987 9999999998654432 224568999999999997765544 556999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=261.77 Aligned_cols=195 Identities=18% Similarity=0.246 Sum_probs=151.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
...++|++.++||+|+||+||+|.+.. + +.+|+|++......+ .....++...+....|++++.+++.+ ..
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~ 90 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-G-----RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-HS 90 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-S-----CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-CC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-C-----CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-cc
Confidence 356899999999999999999999854 3 779999886443222 12233455566667899999998877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENK-------------------TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEEcCCCC-CHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 6789999999995 8888876543 2357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+|+....... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 151 l~~~~~-~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll 214 (311)
T 3niz_A 151 LINSDG-ALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAEMI 214 (311)
T ss_dssp EECTTC-CEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHH
T ss_pred EECCCC-CEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCC---CCCchHHhHHHHHHHHHHH
Confidence 999987 999999999987643322 224468899999999987532 2344667999999999984
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=266.20 Aligned_cols=200 Identities=19% Similarity=0.177 Sum_probs=150.1
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.+.||+|+||.||+|++..++..++ .++++|.+..... .......++...+....|++++.+++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CC-EEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEE-EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 456799999999999999999999987764332 2357777654322 122233344556666789999999887644
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl 149 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREHKD-------------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHSTT-------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEE
Confidence 347899999999999999987542 3577888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .+||+|||+|+.+..... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 150 l~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 213 (327)
T 3poz_A 150 VKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH----QSDVWSYGVTVWELM 213 (327)
T ss_dssp EEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred ECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCc----hhhhhhhHHHHHHHH
Confidence 99987 999999999987654332 2223456688999999998776654 556999999999963
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=271.57 Aligned_cols=192 Identities=18% Similarity=0.252 Sum_probs=153.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|.+..++ +.+|+|.+........ +++........|++++.+++.+ ..+..+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~---~E~~~l~~~~~hp~iv~~~~~~-~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATN-----MEFAVKIIDKSKRDPT---EEIEILLRYGQHPNIITLKDVY-DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTTCCCH---HHHHHHHHHTTSTTBCCEEEEE-ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEcccCChH---HHHHHHHHhcCCCCcCeEEEEE-EcCCEE
Confidence 368999999999999999999999887 7889988764432111 1112222334689999888876 556789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK--------------------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred EEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 99999999999999987654 3578889999999999999999999999999999999965
Q ss_pred CCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++ .+||+|||+|+.+..... ......||+.|+|||++.+..++. .+|+||||+++|+|-|
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDA----ACDIWSLGVLLYTMLT 215 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHH----HHHHHHHHHHHHHHHH
T ss_pred CCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCC----ccCeeeHhHHHHHHhc
Confidence 432 599999999987654332 234678999999999998765554 5669999999999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=262.62 Aligned_cols=220 Identities=19% Similarity=0.220 Sum_probs=161.1
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
+++..++|++.+.||+|+||.||+|.+.........+.|++|.+..... .+.....++...+... .|++++.+++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~- 96 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC- 96 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-
Confidence 4567789999999999999999999975432223337899998875433 2222333344444444 799999998877
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..++..++||||+++++|.+++............... ........+++..++.++.|++.||.|||++||+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA--IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhccccccccccccc--ccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 4456789999999999999999876522111000000 00011234788999999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 175 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el 240 (313)
T 1t46_A 175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWEL 240 (313)
T ss_dssp GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred eEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh----HHHHHHHHHHHHHH
Confidence 99999987 9999999999876544332 223456788999999998765544 56699999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=269.21 Aligned_cols=192 Identities=23% Similarity=0.285 Sum_probs=143.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|++..++ +.|++|.+......+. ..++...+....|++++.+++.+ .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~-~~~~~ 122 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIF-ETPTE 122 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-ECSSE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCC-----cEEEEEEeccchhHHH--HHHHHHHHHhCCCCCCcceeeeE-ecCCe
Confidence 3468999999999999999999999887 7899998875543222 22344556666799999988876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+.+++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~ 182 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG--------------------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred EEEEEEeCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence 999999999999999987654 357788999999999999999999999999999999997
Q ss_pred c---CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 E---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~---~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
. ++ .+||+|||+++...... ......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 183 ~~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~ 245 (349)
T 2w4o_A 183 TPAPDA-PLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGP----EVDMWSVGIITYILLC 245 (349)
T ss_dssp SSSTTC-CEEECCCC------------------CGGGSCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred cCCCCC-CEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCc----ccchHHHHHHHHHHHh
Confidence 5 45 99999999998764322 234578999999999998765544 5669999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.05 Aligned_cols=202 Identities=20% Similarity=0.256 Sum_probs=148.0
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+..++|++.+.||+|+||.||+|.+..++ +.+|+|.+...... ......++........|++++.+++.+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~- 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSG-----QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF- 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCC-----eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-
Confidence 346689999999999999999999998887 88999988654322 2222333444567788999999988774
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~ 291 (365)
.+...++||||+++ +|.+++.... ..+..+++..++.++.|++.||.|||++ ||+||||||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVI----------------DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred ccCCEEEEEehhcc-chHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 55689999999984 8888776421 1123568888999999999999999998 9999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+|+....... .....||+.|+|||++.........+..+|+||||+++|+|-
T Consensus 140 Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 140 NVLINALG-QVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp GCEECTTC-CEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred HEEECCCC-CEEEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 99999987 999999999987654322 234579999999999754333344455778999999999973
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=269.22 Aligned_cols=199 Identities=14% Similarity=0.119 Sum_probs=159.0
Q ss_pred cCCCeEEeeeeecC--CCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 137 RKDDFVLGKKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
..++|++.++||+| +||.||+|++..++ +.||+|.+.... ........++...+....|+||+.+++.+ .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTG-----EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-I 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-E
Confidence 44799999999999 99999999999887 889999886443 22333344456677777899999998877 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHF------------------MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTC------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 5678999999999999999997653 1235788899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCC------ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||.+....... ........||+.|+|||++.+.. ...+..+|+||||+++|+|-
T Consensus 159 Ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 159 ILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL--QGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp EEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS--SCBCTHHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHhccC--CCCCcHhHHHHHHHHHHHHH
Confidence 9999987 99999999987543221 11223458899999999997631 11234667999999999984
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=261.50 Aligned_cols=199 Identities=13% Similarity=0.154 Sum_probs=157.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCC--CcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKN--DGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++..++|++.+.||+|+||.||+|.+..+++... ...+++|.+............++...+....|++++.+++.+.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV- 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-
Confidence 4566899999999999999999999987653211 1358888876544333334444566677778999999988774
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+...++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 143 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNK-------------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN 143 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcce
Confidence 4567899999999999999998654 135778889999999999999999999999999999
Q ss_pred eEEecCCCc--------EEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRT--------FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~--------ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ . +||+|||+++.... .....||+.|+|||++.+ ..++ ..+|+||||+++|+|-+
T Consensus 144 Ill~~~~-~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~----~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 144 ILLIREE-DRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLN----LATDKWSFGTTLWEICS 213 (289)
T ss_dssp EEEEECC-BGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCC----HHHHHHHHHHHHHHHHT
T ss_pred EEEecCC-cccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCC----chhHHHHHHHHHHHHHc
Confidence 9999877 5 99999999976532 234568899999999976 3333 35679999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=258.00 Aligned_cols=200 Identities=19% Similarity=0.203 Sum_probs=152.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.+.||+|+||.||+|.+....... ..+++|.+..... .......++...+....|++++.+++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEK--INVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-- 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCE--EEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCc--ceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--
Confidence 446689999999999999999999987543221 4588988775432 22223334455555667999998887753
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+..++||||+.+++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 144 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERNKN-------------------SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNI 144 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHTT-------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCCCEEEEecCCCCCHHHHHHhccc-------------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 3456899999999999999976542 356778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 145 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~ll 208 (281)
T 3cc6_A 145 LVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEIL 208 (281)
T ss_dssp EEEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCc----hhccHHHHHHHHHHH
Confidence 999987 9999999999876554433344567788999999997665544 566999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.54 Aligned_cols=200 Identities=19% Similarity=0.203 Sum_probs=162.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEe----cCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASL----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.-+..++|++.+.||+|+||.||+|++ ..++ +.|++|.+............++...+....|++++.+++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTG-----ALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCS-----EEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcc-----eEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 344568999999999999999999995 3444 7899999877665555555566677777789999998776
Q ss_pred ccc-CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 210 SSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 210 ~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
+.. ....+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Di 153 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHR-------------------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDL 153 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 543 4567899999999999999997643 13577889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 154 kp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~ll 224 (327)
T 3lxl_A 154 AARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR----QSDVWSFGVVLYELF 224 (327)
T ss_dssp SGGGEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEH----HHHHHHHHHHHHHHH
T ss_pred ChhhEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCCh----HHhHHHHHHHHHHHH
Confidence 99999999987 999999999987654322 1233457888999999998776554 556999999999984
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=263.86 Aligned_cols=199 Identities=20% Similarity=0.225 Sum_probs=142.7
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ......++...+....|++++.+++.+ ..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTG-----VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-HTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSC-----CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-CCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCC-----cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-EECCe
Confidence 368999999999999999999998887 78888887643321 112223445667777899999998877 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||++ ++|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~ 142 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVG--------------NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN 142 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSS--------------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred EEEEEEecC-CCHHHHHHhcccc--------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc
Confidence 999999999 5999998765311 1112467888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||+++....... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 143 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 143 KRG-QLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSR---TYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp TTC-CEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCC-CEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCC---CCCcHHHHHHHHHHHHHHH
Confidence 987 999999999987643322 224568899999999986532 2344677999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=266.75 Aligned_cols=199 Identities=21% Similarity=0.240 Sum_probs=152.5
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecc----
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN---- 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 209 (365)
+.+..++|++.+.||+|+||.||+|++.+ +.||+|.+.......... +..........|++++.+++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~-e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDE-------RPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETT-------EEEEEEEEEGGGHHHHHH-HHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECC-------eEEEEEEeeccchhhHHH-HHHHHHHHhccCcchhhheeccccc
Confidence 45677999999999999999999998743 789999887554443333 333444555789998888742
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC--------
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-------- 281 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-------- 281 (365)
.......+++||||+++|+|.+++.... .++..++.++.|++.||.|||++
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT---------------------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc---------------------cchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 2234457899999999999999997654 25677889999999999999999
Q ss_pred -CCcccCCCCCceEEecCCCcEEEEecccccccccCCc-------cccccccCCCCcCCccccccCCCCC---CCCCchh
Q 017820 282 -GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTP---SAPSAPV 350 (365)
Q Consensus 282 -~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~---~~d~~s~ 350 (365)
||+||||||+|||++.++ .+||+|||+|+.+..... .......||+.|+|||++.+..... ..+..+|
T Consensus 139 ~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp CCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred cceeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 999999999999999987 999999999987653321 1223467999999999987632211 1123577
Q ss_pred hhhhhhhheecc
Q 017820 351 ATALSPVLWQVQ 362 (365)
Q Consensus 351 ~~slg~vlw~lG 362 (365)
+||||+++|+|-
T Consensus 218 iwslG~il~ell 229 (336)
T 3g2f_A 218 MYALGLIYWEIF 229 (336)
T ss_dssp HHHHHHHHHHHH
T ss_pred hHHHHHHHHHHH
Confidence 999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=270.89 Aligned_cols=198 Identities=19% Similarity=0.244 Sum_probs=150.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecC---CCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhcc-CCCceeeeec
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAK---KPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANC-CADFVYGFFE 208 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~-~~~~i~~~~~ 208 (365)
..++|++.+.||+|+||.||+|++.. ++ +.||+|.++.... .......++...+... .|++++.++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTG-----KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTT-----CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCC-----eEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 45799999999999999999999853 44 7788888753210 0000001112222222 5788888777
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+ ..+..+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||
T Consensus 127 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 185 (355)
T 1vzo_A 127 AF-QTETKLHLILDYINGGELFTHLSQRE--------------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185 (355)
T ss_dssp EE-EETTEEEEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EE-eeCceEEEEeecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 66 44578999999999999999997654 3577889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+|||++.++ .+||+|||+++.+............||+.|+|||++.+.. ...+..+|+||||+++|+|-+
T Consensus 186 kp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 186 KLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD--SGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp CGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHH
T ss_pred CHHHEEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCC--CCCCchhhHHHHHHHHHHHHH
Confidence 99999999987 9999999999876544444445678999999999987532 123446789999999999843
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=266.80 Aligned_cols=198 Identities=21% Similarity=0.259 Sum_probs=159.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+.. + +.|++|+.............++...+....|++++.+++.+ ..+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 109 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRD-G-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-DERNE 109 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTT-C-----CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-CCTTC
T ss_pred HHhccCccceeecCCCeeEEEEEECC-C-----CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCe
Confidence 55799999999999999999999753 3 78999987755444444445566677788899999998876 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+.+++|.+++..... ....+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL----------------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC----------------CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCC----------------CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 8999999999999998865431 123467888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||+++....... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 174 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 235 (321)
T 2qkw_B 174 ENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE----KSDVYSFGVVLFEVL 235 (321)
T ss_dssp TTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCT----HHHHHHHHHHHHHHH
T ss_pred CCC-CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCc----ccchHhHHHHHHHHH
Confidence 987 999999999986543222 2234457899999999998776544 566999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=265.35 Aligned_cols=191 Identities=22% Similarity=0.272 Sum_probs=134.9
Q ss_pred CCeEEe---eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccccCC
Q 017820 139 DDFVLG---KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (365)
Q Consensus 139 ~~y~l~---~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (365)
++|++. +.||+|+||.||+|.+..++ +.+|+|.+.......... +...+... .|++|+.+++.+ ..+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~---e~~~l~~l~~h~niv~~~~~~-~~~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSN-----QAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF-HDQ 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTC-----CEEEEEEEEGGGHHHHHH---HHHHHHHTTTCTTBCCEEEEE-ECS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCC-----CEEEEEEEChhhhhhHHH---HHHHHHHhcCCCCeeEEEEEE-EcC
Confidence 457765 78999999999999999887 889999887554333222 22333333 489999988876 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKK--------------------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence 78999999999999999998754 4578889999999999999999999999999999999
Q ss_pred EecCCC--cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~--~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++.++. .+||+|||+++...... .......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 139 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~----~~DiwslG~il~~ll~ 204 (325)
T 3kn6_A 139 FTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDE----SCDLWSLGVILYTMLS 204 (325)
T ss_dssp EEC----CEEEECCCTTCEECCC-----------------------CCCCH----HHHHHHHHHHHHHHHH
T ss_pred EecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCC----ccchHHHHHHHHHHHh
Confidence 986542 79999999998654332 2234568899999999997766554 5669999999999843
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=268.97 Aligned_cols=193 Identities=18% Similarity=0.201 Sum_probs=151.4
Q ss_pred CeEE--eeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 140 DFVL--GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 140 ~y~l--~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.|.+ .+.||+|+||.||+|.+..++ ..|++|.+............++...+....|++++.+++.+ .....+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~ 161 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATG-----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-ESKNDI 161 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCC-----cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEE
Confidence 3444 678999999999999998887 88999988766544444455666777888999999998877 455789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 222 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDES-------------------YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred EEEEeCCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec
Confidence 99999999999999887543 23577788899999999999999999999999999999953
Q ss_pred -CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 -GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 -~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++..+||+|||+++.+..... .....||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 223 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ellt 283 (373)
T 2x4f_A 223 RDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSF----PTDMWSVGVIAYMLLS 283 (373)
T ss_dssp TTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCH----HHHHHHHHHHHHHHHH
T ss_pred CCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCc----HHhHHHHHHHHHHHHh
Confidence 233899999999987654332 24467999999999997665444 5669999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.03 Aligned_cols=210 Identities=19% Similarity=0.226 Sum_probs=144.2
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeec
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
.....+..++|++.+.||+|+||.||+|++..++... ..|++|.+.... ........++...+....|++++.+++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSF--VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcc--eeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 3345567789999999999999999999988765322 368899876542 222333445566677778999999887
Q ss_pred ccccCCC-----eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC
Q 017820 209 NSSKKGG-----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (365)
Q Consensus 209 ~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I 283 (365)
.+..... ..++||||+.+++|.+++...... .....+++..++.++.|++.||.|||++||
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG--------------ENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhcc--------------ccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 7644332 248999999999999999765310 112246788899999999999999999999
Q ss_pred cccCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+||||||+|||+++++ .+||+|||+|+........ ......+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 159 vH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el 232 (323)
T 3qup_A 159 IHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV----HSDVWAFGVTMWEI 232 (323)
T ss_dssp CCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCC----ccchhhHHHHHHHH
Confidence 9999999999999987 9999999999876544322 122456678999999998776554 55699999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=254.61 Aligned_cols=194 Identities=22% Similarity=0.293 Sum_probs=157.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|++++.+++.+ ..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCC-----ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-EcC
Confidence 4589999999999999999999999887 778888875432 22333344455666677899999988876 556
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+.+++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 137 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 137 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence 78899999999999999887654 3577889999999999999999999999999999999
Q ss_pred EecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ ..+||+|||++........ .....||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 138 LASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSK----PVDIWACGVILYILL 201 (284)
T ss_dssp ESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHH
T ss_pred EecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCc----ccchHHHHHHHHHHH
Confidence 98654 2499999999987654332 24568999999999998766544 566999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=261.99 Aligned_cols=194 Identities=18% Similarity=0.208 Sum_probs=158.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|.+.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+ ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-ED 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-EC
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ec
Confidence 4579999999999999999999999887 778888765432 22233334455666777899999998876 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRK--------------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CCeEEEEEecCCCCCHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 678999999999999999987654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++....... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 173 l~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 235 (335)
T 2owb_A 173 FLNEDL-EVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSF----EVDVWSIGCIMYTLL 235 (335)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCT----HHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCc----hhhHHHHHHHHHHHH
Confidence 999987 999999999987643322 234568999999999998766544 566999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=256.49 Aligned_cols=197 Identities=19% Similarity=0.227 Sum_probs=159.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
...+..++|++.+.||+|+||.||+|.+..++ ..+++|.+....... .....++...+....|++++.+++.
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 82 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNK-----FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCC-----cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 34567789999999999999999999998877 778888875432211 1223344556667789999998887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ..+...++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+|||||
T Consensus 83 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 141 (284)
T 2vgo_A 83 F-HDRKRIYLMLEFAPRGELYKELQKHG--------------------RFDEQRSATFMEELADALHYCHERKVIHRDIK 141 (284)
T ss_dssp E-ECSSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred E-EcCCEEEEEEEeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 6 45678999999999999999997654 35778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+||+++.++ .+||+|||++...... ......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 142 p~Nil~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~ 207 (284)
T 2vgo_A 142 PENLLMGYKG-ELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDE----KVDLWCAGVLCYEFLV 207 (284)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTTCCBCT----THHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCC-CEEEecccccccCccc---ccccccCCCCcCCHHHhccCCCCc----ccchhhHHHHHHHHHH
Confidence 9999999887 9999999999765432 234568999999999998766554 5669999999999743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.48 Aligned_cols=192 Identities=20% Similarity=0.249 Sum_probs=148.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|++ .++ +.+++|++......+ .....++...+....|++++.+++.+ ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYG-----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTS-----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCC-----CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-ccCCe
Confidence 6899999999999999999998 444 778888875433211 12233455667777899999998877 44578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 134 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCE-------------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTST-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred EEEEEEecCC-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 9999999996 9999887643 1356778899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||+|+....... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 135 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 135 REG-ELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSK---KYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp TTS-CEEECCTTHHHHHCC----------CCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHH
T ss_pred CCC-CEEEeECccccccCcccc-ccccccccccccCchheeCCC---CCCcHHHHHHHHHHHHHHH
Confidence 987 999999999987643221 223457899999999986532 2344677999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=257.88 Aligned_cols=190 Identities=22% Similarity=0.257 Sum_probs=150.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccccC-C
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKK-G 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~-~ 214 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+..........+. ..+... .|++++.+++..... .
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~E~---~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREI---KILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSCCHHHHHHHH---HHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCC-----cEEEEEEecccchHHHHHHH---HHHHHcCCCCCEEEeeeeeccCCC
Confidence 3479999999999999999999998887 88999988765544333222 223333 478888887766442 5
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|.+++.. +++..++.++.|++.||.|||++||+||||||+|||
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-----------------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 162 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-----------------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-----------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CceEEEEeccCchhHHHHHHh-----------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 678999999999999988743 356778899999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++..+||+|||+|+....... .....||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 163 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 163 IDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQ---MYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp EETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHH
T ss_pred EcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCC---cCCchhhHHHHHHHHHHHH
Confidence 997766899999999987654332 34568899999999986522 2334667999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=253.94 Aligned_cols=195 Identities=19% Similarity=0.286 Sum_probs=139.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|++..++ +.+++|.+......+ .....++...+....|++++.+++.+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 82 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTG-----LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-ED 82 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-EC
T ss_pred ccccceeeeeecCCCceEEEEEEEccCC-----ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-cc
Confidence 4578999999999999999999998877 788999876443221 12233445566777899999988876 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV-------------------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 678999999999999999997653 1357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++.++ .+||+|||++........ ......||+.|+|||++.+..++.+ +|+||||+++|+|-
T Consensus 144 li~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~----~Di~slG~il~~l~ 206 (278)
T 3cok_A 144 LLTRNM-NIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLE----SDVWSLGCMFYTLL 206 (278)
T ss_dssp EECTTC-CEEECCCTTCEECC-----------------------------C----THHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCch----hhHHHHHHHHHHHH
Confidence 999987 999999999987643322 2235678999999999987766555 45999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=269.90 Aligned_cols=198 Identities=18% Similarity=0.184 Sum_probs=146.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
..|++.+.||+|+||.||+|++..++... ..+++|.+..... .+.....++...+....|+|++.+++.+...++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEE--EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcE--EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 46889999999999999999986543221 4578887764332 23333344556677778999999998765666788
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 227 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETH-------------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 227 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTC-------------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEEEECCCCCCHHHHHhhccc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC
Confidence 999999999999999976532 3467778899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||+|+.+...... ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 228 ~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~DvwSlG~il~ell 290 (373)
T 3c1x_A 228 KF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELM 290 (373)
T ss_dssp TC-CEEECCC---------------------CCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred CC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 87 9999999999876443221 123456788999999998776654 566999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=261.91 Aligned_cols=193 Identities=19% Similarity=0.263 Sum_probs=155.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+++.+ .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 85 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-E 85 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCC-----eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-e
Confidence 68999999999999999999999887 77888877543211 112233344556666799999888876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~N 145 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE--------------------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS--------------------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHH
Confidence 5678999999999999999997643 45788899999999999999999999999999999
Q ss_pred eEEecCCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++. .+||+|||+++....... .....||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLS 213 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCC----CccccHHHHHHHHHHHH
Confidence 99998763 799999999987654322 2456799999999999776554 45669999999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=258.35 Aligned_cols=197 Identities=17% Similarity=0.223 Sum_probs=149.1
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHH-HHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWM-NERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.+.||+|+||.||+|.+..++ +.|++|.+......+... +.+....+ ..|+++..++... ..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~~~~l--~~~~~i~~~~~~~-~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLL--AGCTGIPNVYYFG-QE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHT--TTCTTCCCEEEEE-EE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeccCCccHHHHHHHHHHHHH--hcCCCCCeEEeec-CC
Confidence 345679999999999999999999998877 889999876443322111 11222222 2344444444433 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++||||+ +++|.+++...+. .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGR-------------------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-------------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CceeEEEEEec-CCCHHHHHHHhcc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 67899999999 8999999986541 357788999999999999999999999999999999
Q ss_pred EEecCCC----cEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSR----TFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~----~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++. .+||+|||+|+....... .......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~el~~ 213 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR----RDDLEALGHVFMYFLR 213 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH----HHHHHHHHHHHHHHHH
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCCh----HHHHHHHHHHHHHHHc
Confidence 9987651 399999999987654422 1234578999999999997766544 5669999999999743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=278.22 Aligned_cols=198 Identities=15% Similarity=0.197 Sum_probs=150.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.++||+|+||.||+|.+..+ ..||+|.+........ ...++...+....|++++.+++....
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCC------ceEEEEEeccCCCCHH-HHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 456678999999999999999999998764 5699998875432211 22334555666689999998877633
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...++||||+.+|+|.+++.... +..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred -CceEEEehhhcCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 56899999999999999997532 11357788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 312 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~sDvwslG~~l~el~t 376 (452)
T 1fmk_A 312 LVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELTT 376 (452)
T ss_dssp EECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred EECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCc----cccHHhHHHHHHHHHh
Confidence 999887 9999999999876544332233456788999999998776554 5669999999999843
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=259.76 Aligned_cols=194 Identities=21% Similarity=0.252 Sum_probs=150.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++|++.+.||+|+||.||+|.+..++ +.+++|++....... .....++...+....|++++.+++.+ ....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-RRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-ecCC
Confidence 378999999999999999999999887 789999875443322 22333455666777899999988876 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~ 135 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQR--------------------GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred eEEEEEEeCCCchHHHHHhhhc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE
Confidence 8999999999999999876543 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+++....... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 136 ~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 136 TKHS-VIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDT---QYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp CTTS-CEEECCCTTCEECC-------------GGGCCHHHHHTCS---CCCTHHHHHHHHHHHHHHH
T ss_pred cCCC-CEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCC---CCCcchhhHHHHHHHHHHH
Confidence 9987 999999999987653322 224568899999999987532 2234677999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.59 Aligned_cols=197 Identities=14% Similarity=0.187 Sum_probs=157.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.+.||+|+||.||+|.+..+ +.+++|.+........ ...++...+....|++++.+++.+ ..
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~-~~ 74 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC-LE 74 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTTBCHH-HHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCC------CeEEEEEccccCCCHH-HHHHHHHHHHhCCCCCEeeEEEEE-cc
Confidence 345668999999999999999999998743 6789998875433222 223345556666899999998876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRG-------------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTT-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCcc-------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 5679999999999999999976531 346788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++.++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 136 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 199 (267)
T 3t9t_A 136 LVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS----KSDVWSFGVLMWEVF 199 (267)
T ss_dssp EECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EECCCC-CEEEcccccccccccccccccccccccccccChhhhcCCCccc----hhchhhhHHHHHHHh
Confidence 999887 9999999999876443222234456788999999998765543 567999999999983
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=265.49 Aligned_cols=198 Identities=19% Similarity=0.160 Sum_probs=158.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.+.||+|+||.||+|.+.. + +.||+|.+....... .....++...+....|++++.+++.+ ....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLAD-G-----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSS-S-----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-CCSS
T ss_pred HhhccccceeEecCCCcEEEEEEecC-C-----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-ecCC
Confidence 56899999999999999999998643 3 779999886543321 11233445667777899999998877 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCc
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---GIVHRDIKPQN 292 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~---~IiHrDIKp~N 292 (365)
..++||||+.+++|.+++..... ....+++..++.++.|++.||.|||++ ||+||||||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPE----------------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCST----------------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred ceEEEEEeccCCCHHHHHHhccc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 78899999999999999986541 223467888999999999999999999 99999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++..............||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 165 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 229 (326)
T 3uim_A 165 ILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE----KTDVFGYGVMLLELI 229 (326)
T ss_dssp EEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECH----HHHHHHHHHHHHHHH
T ss_pred EEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCc----cccchhHHHHHHHHH
Confidence 9999987 9999999999877554444445567999999999998776654 556999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=254.26 Aligned_cols=194 Identities=18% Similarity=0.209 Sum_probs=157.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|.+.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+ ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 86 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-ED 86 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-EC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCC-----ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-cc
Confidence 4579999999999999999999999887 778888765432 22223333455666777899999998876 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+...++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRK--------------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 678999999999999999987654 357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++....... ......||+.|+|||++.+...+ ..+|+||||+++|+|-
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~~l~ 209 (294)
T 2rku_A 147 FLNEDL-EVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHS----FEVDVWSIGCIMYTLL 209 (294)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBC----THHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCC----chhhHHHHHHHHHHHH
Confidence 999987 999999999987643322 23456899999999999766554 4567999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=257.63 Aligned_cols=198 Identities=18% Similarity=0.186 Sum_probs=153.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.+|++.+.||+|+||.||+|.+..++... ..+++|.+..... .......++...+....|++++.+++.+...+...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----C--EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCce--eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 58999999999999999999986544222 4578887765433 23333444566677778999999998766677788
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~ 163 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET-------------------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEeCCCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC
Confidence 99999999999999997643 23467788899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||+|+....... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 164 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 226 (298)
T 3f66_A 164 KF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELM 226 (298)
T ss_dssp TC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred CC-CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCCh----HHHHHHHHHHHHHHH
Confidence 87 999999999987644322 1223456788999999998776554 556999999999973
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=262.45 Aligned_cols=202 Identities=18% Similarity=0.175 Sum_probs=149.5
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
..+..++|++.+.||+|+||.||+|.+..++..++. ++++|.+..... .......++...+....|++++.+++.+..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~-kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCE-EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEE-EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 345668999999999999999999999887744322 356666543221 112223344566677789999999887644
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
...++|++|+.+++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 89 --~~~~~v~~~~~~g~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 147 (327)
T 3lzb_A 89 --STVQLITQLMPFGCLLDYVREHKD-------------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147 (327)
T ss_dssp --SSEEEEECCCSSCBHHHHHHHTTT-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred --CCceEEEEecCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence 348899999999999999986542 35678889999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+|+....... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 148 Il~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 213 (327)
T 3lzb_A 148 VLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH----QSDVWSYGVTVWELM 213 (327)
T ss_dssp EEEEETT-EEEECCTTC----------------CCCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCCh----HHHHHHHHHHHHHHH
Confidence 9999987 999999999987644322 2223456688999999998776654 556999999999963
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=263.04 Aligned_cols=195 Identities=22% Similarity=0.250 Sum_probs=149.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.++||+|+||+||+|.+..++ +.|++|.+......+ .....++...+....|++++.+++.+ ..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 105 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTN-----ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-HHN 105 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-EET
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCC-----ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-ecC
Confidence 5589999999999999999999999887 889999886544332 22223456677778899999998876 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~--------------------~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl 164 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNP--------------------DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEecCCC-CHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence 789999999995 9999997654 3577889999999999999999999999999999999
Q ss_pred EecCC----CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGS----RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~----~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ ..+||+|||+|+.+..... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 165 LSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSR---HYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp EEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHH
T ss_pred EecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCC---CCCcHHHHHHHHHHHHHHH
Confidence 96332 2699999999987643322 234567899999999987643 1344667999999999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=262.12 Aligned_cols=195 Identities=22% Similarity=0.298 Sum_probs=152.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
.++|++.+.||+|+||.||+|.+.+ +.||+|.+.......... +..........|++++.+++......
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~-e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRG-------EKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEGGGHHHHHH-HHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECC-------ceEEEEEEeccccchhhh-HHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3689999999999999999999863 789999886554433322 22333334457999998887764433
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC--------CCccc
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHR 286 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~--------~IiHr 286 (365)
..+++||||+.+++|.++++... +++..++.++.|++.||.|||++ ||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT---------------------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred CceEEEEeccCCCcHHHHhhccC---------------------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 68899999999999999997643 46788899999999999999999 99999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCCCCC--chhhhhhhhhheec
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPS--APVATALSPVLWQV 361 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~d~--~s~~~slg~vlw~l 361 (365)
||||+|||++.++ .+||+|||+|+.+...... ......||+.|+|||++.+...+..... .+|+||||+++|+|
T Consensus 167 Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 167 DLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 9999999999987 9999999999876443221 1235689999999999977655544221 37899999999998
Q ss_pred c
Q 017820 362 Q 362 (365)
Q Consensus 362 G 362 (365)
-
T Consensus 246 ~ 246 (337)
T 3mdy_A 246 A 246 (337)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=271.41 Aligned_cols=196 Identities=21% Similarity=0.288 Sum_probs=144.9
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--------HHHHHHHHHHHHhhccCCCceeeeecc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
.++|.+.+.||+|+||.||+|.+..++ +.||+|.+..... .......++...+....|++++.+++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCC-----cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 479999999999999999999999988 7788887653321 111122344556666789999988876
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ....+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++|+|||||
T Consensus 209 ~--~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 266 (419)
T 3i6u_A 209 F--DAEDYYIVLELMEGGELFDKVVGNK--------------------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266 (419)
T ss_dssp E--ESSEEEEEEECCTTCBGGGGTSSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred E--ecCceEEEEEcCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 5 3456899999999999988775443 45788899999999999999999999999999
Q ss_pred CCceEEecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ ..+||+|||+|+...... ......||+.|+|||++.+... ...+..+|+||||+++|+|-+
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~~llt 339 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGT-AGYNRAVDCWSLGVILFICLS 339 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHHH
T ss_pred hHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCccCceeeecCCC-CCCCchhhhHhHHHHHHHHHH
Confidence 9999997543 269999999998765332 2346789999999999864221 122346789999999999843
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=255.39 Aligned_cols=190 Identities=22% Similarity=0.258 Sum_probs=152.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc------
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK------ 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~------ 212 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ..++...+....|++++.+++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDG-----KTYVIKRVKYNNEK----AEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTC-----CEEEEEEEECCSGG----GHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCC-----eEEEEEEeccccHH----HHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 58999999999999999999998777 78999988654321 1223444555678888877665421
Q ss_pred ---------CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC
Q 017820 213 ---------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (365)
Q Consensus 213 ---------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I 283 (365)
....+++||||+++++|.+++.... +..+++..++.++.|++.||.|||++||
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i 143 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR------------------GEKLDKVLALELFEQITKGVDYIHSKKL 143 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG------------------GSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 2356899999999999999997642 1245778899999999999999999999
Q ss_pred cccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||||||+|||+++++ .+||+|||+++....... .....||+.|+|||++.+..++ ..+|+||||+++|+|-
T Consensus 144 ~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 144 INRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYG----KEVDLYALGLILAELL 215 (284)
T ss_dssp ECSCCSGGGEEEEETT-EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCC----THHHHHHHHHHHHHHH
T ss_pred eeccCCHHHEEEcCCC-CEEECcchhheecccccc--ccccCCcccccChhhhccCCCc----chhhhHHHHHHHHHHH
Confidence 9999999999999987 999999999987654322 3456799999999999876554 4566999999999983
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=260.07 Aligned_cols=204 Identities=18% Similarity=0.204 Sum_probs=151.9
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
+..++..++|.+.+.||+|+||.||+|.+..++.. ....|++|.+..... .......++...+....|++++.+++.+
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---C-CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCC-ccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34566778999999999999999999998765421 113588888865432 2223334456667777899999998876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
......++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 116 -~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 116 -SKYKPMMIITEYMENGALDKFLREKD-------------------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp -CSSSSEEEEEECCTTEEHHHHHHHTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred -ecCCCcEEEEeCCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 45678999999999999999997653 1357788899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||++.++ .+||+|||+++....... .......+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 176 ~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el 243 (333)
T 1mqb_A 176 RNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS----ASDVWSFGIVMWEV 243 (333)
T ss_dssp GGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCH----HHHHHHHHHHHHHH
T ss_pred heEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCc----hhhhHHHHHHHHHH
Confidence 999999987 999999999987654322 1122345678999999997665544 56699999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=259.16 Aligned_cols=199 Identities=18% Similarity=0.158 Sum_probs=155.5
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEe----cCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASL----AKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
+..++|++.+.||+|+||.||+|++ ..++ +.|++|.+...... ......++...+....|++++.+++.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTG-----EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCS-----EEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccC-----eEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 3557899999999999999999994 3444 78999988744321 122333455666777899999988776
Q ss_pred ccCC-CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 211 SKKG-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 211 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
...+ ..+++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 153 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKN-------------------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTT-------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccc-------------------cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence 5443 668999999999999999966532 35778889999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.++ .+||+|||+++....... .......||..|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 154 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~ 224 (302)
T 4e5w_A 154 ARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI----ASDVWSFGVTLHELLT 224 (302)
T ss_dssp GGGEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHHHT
T ss_pred hheEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCc----chhHHHHHHHHHHHHH
Confidence 9999999987 999999999987654432 2234567888999999998776654 4569999999999843
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=273.01 Aligned_cols=197 Identities=12% Similarity=0.045 Sum_probs=146.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHH---HHhhccCCCceeeeeccc-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVR---RACANCCADFVYGFFENS- 210 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~---~~~~~~~~~~i~~~~~~~- 210 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|.+... .........++. ..+....|+|++.+++.+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCC-----CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCC-----cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 478999999999999999999998877 78999987632 111222222233 445556799998766322
Q ss_pred ------ccCC-----------C-----eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHH
Q 017820 211 ------SKKG-----------G-----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (365)
Q Consensus 211 ------~~~~-----------~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 268 (365)
...+ . ..++||||+ +|+|.+++...+.. -.....+++..++.++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~-------------~~~~~~l~~~~~~~i~ 212 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-------------SSTHKSLVHHARLQLT 212 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT-------------TTTTHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc-------------ccccccccHHHHHHHH
Confidence 1111 1 378999999 57999999865310 0012244567888899
Q ss_pred HHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC---------
Q 017820 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS--------- 339 (365)
Q Consensus 269 ~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--------- 339 (365)
.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 213 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccc
Confidence 9999999999999999999999999999987 999999999986432 2345677 999999999876
Q ss_pred --CCCCCCCCchhhhhhhhhheeccc
Q 017820 340 --TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 340 --~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ ..+|+||||+++|+|-|
T Consensus 287 ~~~~~----~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 287 RTLMT----FSFDAWALGLVIYWIWC 308 (377)
T ss_dssp EEECC----HHHHHHHHHHHHHHHHH
T ss_pred cccCC----hhhhHHHHHHHHHHHHH
Confidence 454 45669999999999844
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=263.84 Aligned_cols=190 Identities=22% Similarity=0.298 Sum_probs=147.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+....|+|++.+++.+...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 478999999999999999999998888 889999885432 222233334566667778999998887764432
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||+ +++|.+++.... +++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---------------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp 156 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHEK---------------------LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 156 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cccCceEEEEEecC-CCCHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCcCH
Confidence 4579999999 789999987643 46778899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+|+..... .....||+.|+|||++.+ ..++ ..+|+||+|+++|+|-+
T Consensus 157 ~NIll~~~~-~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~----~~~DiwslG~il~ell~ 221 (367)
T 1cm8_A 157 GNLAVNEDC-ELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT----QTVDIWSVGCIMAEMIT 221 (367)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCC----TTHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCC-CEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCC----hhhhHHHHHHHHHHHHh
Confidence 999999987 9999999999875422 345688999999999876 3343 35669999999999843
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=264.78 Aligned_cols=196 Identities=19% Similarity=0.251 Sum_probs=159.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
...+..++|++.+.||+|+||.||+|.+..++ ..+++|.+..... .......++...+....|++++.+++.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 100 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF- 100 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCC-----cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-
Confidence 34566789999999999999999999999887 7888888765432 2233344456667777899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKP 290 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp 290 (365)
..+..+++||||+++++|.+++.... .+++..+..++.|++.||.|||++ ||+||||||
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 160 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG
T ss_pred EECCEEEEEEECCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccH
Confidence 45678999999999999999997754 357788999999999999999996 999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+++..... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 161 ~Nil~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 161 SNILVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSV----QSDIWSMGLSLVEMA 224 (360)
T ss_dssp GGEEECTTC-CEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSH----HHHHHHHHHHHHHHH
T ss_pred HHEEECCCC-CEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCc----hhhHHHHHHHHHHHH
Confidence 999999987 9999999999765432 234568999999999998765544 566999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=269.61 Aligned_cols=194 Identities=20% Similarity=0.242 Sum_probs=152.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhh---ccCCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACA---NCCADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~---~~~~~~i~~~~~~~~ 211 (365)
..++|++.+.||+|+||.||+|.+..++ +.||+|.+......... .+.++...+. ...|++++.+++.+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~- 168 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVH-----QHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF- 168 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCC-----cEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-
Confidence 4468999999999999999999999887 88999988754432221 1222223332 33677888888776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++||||++ ++|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKF------------------QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 44578999999997 599999877542 13577889999999999999999999999999999
Q ss_pred ceEEecCCC-cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSR-TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~-~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++. .+||+|||+|+.... ...+..||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 230 NILl~~~~~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~il~ellt 294 (429)
T 3kvw_A 230 NILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILGARYGM----PIDMWSLGCILAELLT 294 (429)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHTBCCCT----HHHHHHHHHHHHHHHH
T ss_pred HeEEccCCCcceEEeecccceecCC----cccccCCCCCccChHHHhCCCCCc----hHHHHhHHHHHHHHHh
Confidence 999998772 299999999976432 234578999999999998876654 5669999999999843
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=260.69 Aligned_cols=219 Identities=20% Similarity=0.252 Sum_probs=158.3
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCC--CCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
+.+..++|++.+.||+|+||.||+|++..... ......|++|.+...... ......++...+... .|++++.+++.
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 45566899999999999999999999864321 112267899988754322 222233334444444 79999999887
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ .....+++||||+.+++|.+++......-..... .........+++..++.++.||+.||.|||++||+|||||
T Consensus 110 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 110 C-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY----DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp E-CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred E-ccCCceEEEEECCCCCcHHHHHHHhccccccccc----cccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 6 4456899999999999999999875421000000 0000112346788899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 185 p~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 253 (334)
T 2pvf_A 185 ARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIF 253 (334)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred cceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh----HHHHHHHHHHHHHHH
Confidence 9999999887 9999999999876543221 223456788999999998766554 566999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=261.91 Aligned_cols=198 Identities=15% Similarity=0.220 Sum_probs=144.5
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccC--CCceeeeecccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCC--ADFVYGFFENSS 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~--~~~i~~~~~~~~ 211 (365)
+..++|++.+.||+|+||.||+|.+.. + +.||+|.+.... ........++...+.... +++++.+++.+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~- 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE- 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTT-S-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCC-C-----CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-
Confidence 455789999999999999999998854 3 678999875332 222222233333333333 37888888776
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
..+..+++||| +.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~ 137 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 45678999999 56789999998754 3567788999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCC-------CCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQT-------PSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~-------~~~d~~s~~~slg~vlw~lGc 363 (365)
|||+++ + .+||+|||+|+.+...... ......||+.|+|||++.+.... ...+..+|+||||+++|+|-+
T Consensus 138 NIll~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 138 NFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GEEEET-T-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred eEEEEC-C-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 999974 5 8999999999876543322 23457899999999998763221 223446789999999999743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=257.68 Aligned_cols=193 Identities=19% Similarity=0.237 Sum_probs=143.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|++..++ +.|++|........+.... +...+....|++++..+......+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~--e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEC---CCCHHH--HHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCC-----ceEEEEeecccccchHHHH--HHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 378999999999999999999998887 7888887543322211111 122222233344344444444566789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE--
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl-- 295 (365)
++||||+ +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~ 140 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-------------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeec
Confidence 9999999 8999999975431 35778899999999999999999999999999999999
Q ss_pred -ecCCCcEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 -SEGSRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 -~~~~~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+|+....... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 141 ~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 141 GKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR----RDDLESLGYVLMYFN 209 (296)
T ss_dssp GGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred cCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCc----hhHHHHHHHHHHHHh
Confidence 5665 999999999987654432 1234578999999999998766544 566999999999973
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=254.36 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=151.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc------
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK------ 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~------ 212 (365)
++|++.+.||+|+||.||+|++..++ +.+++|.+..... ......++...+....|++++.+++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDS-----RYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEEEHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCC-----eEEEEEEEeccHH-HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 58999999999999999999998877 7899998865432 22333445566777789999888765432
Q ss_pred ------CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 213 ------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 213 ------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
....+++||||+++++|.+++.... ...++..++.++.|++.||.|||++||+||
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 140 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-------------------LNQQRDEYWRLFRQILEALSYIHSQGIIHR 140 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-------------------GGGCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-------------------cccchHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 2467899999999999999998653 234667788999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCC-------------ccccccccCCCCcCCccccccCCCCCCCCCchhhhh
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 353 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~s 353 (365)
||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+.. ..+..+|+||
T Consensus 141 dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~s 216 (303)
T 1zy4_A 141 DLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG---HYNEKIDMYS 216 (303)
T ss_dssp CCCGGGEEECTTS-CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS---CCCTHHHHHH
T ss_pred cCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC---CCcchhhHHH
Confidence 9999999999987 99999999998764321 11223567899999999987532 2345677999
Q ss_pred hhhhheeccc
Q 017820 354 LSPVLWQVQC 363 (365)
Q Consensus 354 lg~vlw~lGc 363 (365)
||+++|+|-+
T Consensus 217 lG~il~~l~~ 226 (303)
T 1zy4_A 217 LGIIFFEMIY 226 (303)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHHHh
Confidence 9999999866
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=260.58 Aligned_cols=197 Identities=19% Similarity=0.176 Sum_probs=147.6
Q ss_pred cCCCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHh-hccCCCceeeeecccccCC
Q 017820 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC-ANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~ 214 (365)
..+.|++. +.||+|+||.||+|.+..++ +.||+|.+............++...+ ....|++++.+++.+ ..+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-~~~ 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITS-----QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-EEE 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSC-----CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-EET
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCC-----cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-eeC
Confidence 34789995 78999999999999998887 78999988654322222222233333 335799999988876 455
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR--------------------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 78999999999999999997654 3577888999999999999999999999999999999
Q ss_pred EecCCC--cEEEEecccccccccCCc------cccccccCCCCcCCcccccc-----CCCCCCCCCchhhhhhhhhheec
Q 017820 295 FSEGSR--TFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIM-----STQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 295 l~~~~~--~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~-----~~~~~~~d~~s~~~slg~vlw~l 361 (365)
++.++. .+||+|||+++....... .......||+.|+|||++.+ ..++. .+|+||||+++|+|
T Consensus 144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~----~~DiwslG~il~~l 219 (316)
T 2ac3_A 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK----RCDLWSLGVILYIL 219 (316)
T ss_dssp ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTT----THHHHHHHHHHHHH
T ss_pred EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCc----ccccHhHHHHHHHH
Confidence 997662 399999999986543211 11224569999999999875 33343 56699999999998
Q ss_pred cc
Q 017820 362 QC 363 (365)
Q Consensus 362 Gc 363 (365)
-+
T Consensus 220 ~~ 221 (316)
T 2ac3_A 220 LS 221 (316)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=267.24 Aligned_cols=192 Identities=23% Similarity=0.274 Sum_probs=154.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--------HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--------EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
++|++.+.||+|+||.||+|++..++ +.|++|.+...... ......++...+....|++++.+++.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKN-----KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTT-----EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCC-----cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 68999999999999999999998887 78888877643211 111112244556666899999998876
Q ss_pred ccCCCeEEEEEEecCCC-cHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 211 SKKGGEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
.....+++||||+.+| +|.+++.... .+++..++.++.|++.||.|||++||+|||||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 157 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHP--------------------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK 157 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccC
Confidence 5567899999999777 9999997654 35788899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+++.+..... .....||+.|+|||++.+..+ .+..+|+||||+++|+|-
T Consensus 158 p~NIll~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 158 DENIVIAEDF-TIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPY---RGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCB---CSHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCC-cEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCC---CCCcccchhHHHHHHHHH
Confidence 9999999987 999999999987654332 345789999999999976544 234567999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=257.39 Aligned_cols=192 Identities=23% Similarity=0.308 Sum_probs=154.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|.+.+.||+|+||.||+|++..++ +.+++|.+............++...+....|++++.+++.+ .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTG-----KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-ESTTHY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-ECSSEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-ccCCEE
Confidence 368999999999999999999998877 78999988755433333344455666677899999888776 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE--
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl-- 295 (365)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERG--------------------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred EEEEEcCCCccHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 99999999999999987654 35778899999999999999999999999999999999
Q ss_pred -ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 -~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++..... ......||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 142 ~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~ 202 (304)
T 2jam_A 142 PEENS-KIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYS----KAVDCWSIGVITYILLC 202 (304)
T ss_dssp SSTTC-CEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCC----HHHHHHHHHHHHHHHHH
T ss_pred CCCCC-CEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCC----chhhHHHHHHHHHHHHH
Confidence 5555 9999999999764322 22456799999999999776554 45669999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=265.43 Aligned_cols=197 Identities=15% Similarity=0.226 Sum_probs=145.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhcc--CCCceeeeeccccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC--CADFVYGFFENSSK 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~ 212 (365)
..++|++.+.||+|+||.||+|.+.. + ..||+|.+.... ........++...+... +|++++.+++.. .
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-~ 126 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-I 126 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-E
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-C-----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-e
Confidence 34579999999999999999999865 4 778999875332 22222222333333333 368888888766 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N 185 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGG
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 4567999999 67789999998654 34667788999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCC-------CCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQT-------PSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~-------~~~d~~s~~~slg~vlw~lGc 363 (365)
||+++ + .+||+|||+|+.+..... .......||+.|+|||++.+.... ...+..+|+||||+++|+|-|
T Consensus 186 Ill~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 186 FLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp EEESS-S-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEC-C-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 99964 5 899999999987654332 123457899999999998763221 234557889999999999843
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=256.04 Aligned_cols=198 Identities=16% Similarity=0.195 Sum_probs=155.8
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+.+..++|++.+.||+|+||.||+|.+... +.+++|.+........ ...++...+....|++++.+++...
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCC------cEEEEEEecCCcccHH-HHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 3556678999999999999999999997643 5788988765432221 2233445556667899988887653
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..++||||+.+++|.+++.... +..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 -~~~~~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 139 (279)
T 1qpc_A 79 -QEPIYIITEYMENGSLVDFLKTPS------------------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139 (279)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -CCCcEEEEecCCCCCHHHHHhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhh
Confidence 346899999999999999986532 1235778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+++++ .+||+|||+++..............+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 140 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el~ 204 (279)
T 1qpc_A 140 ILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI----KSDVWSFGILLTEIV 204 (279)
T ss_dssp EEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCc----hhhhHHHHHHHHHHH
Confidence 9999887 9999999999877554333334556788999999998766544 566999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=261.94 Aligned_cols=190 Identities=19% Similarity=0.274 Sum_probs=143.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+....|++++.+++.+....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCC-----ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 479999999999999999999998887 789999876432 222233334556666778999998887764433
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
...++||||+++ +|.+++.. .+++..++.++.|++.||.|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHHS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cccccceEEEEEcCCC-CHHHHHhh----------------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 478999999985 78887753 236778889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 156 ~NIl~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~el~ 220 (371)
T 2xrw_A 156 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGEMI 220 (371)
T ss_dssp GGEEECTTS-CEEECCCCC------------------CTTCCHHHHTTCCCCT----THHHHHHHHHHHHHH
T ss_pred HHEEEcCCC-CEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCc----hHhHHHHHHHHHHHH
Confidence 999999987 99999999998754322 234568999999999998766554 556999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=255.67 Aligned_cols=194 Identities=19% Similarity=0.233 Sum_probs=147.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||.||+|++..++ +.|++|.+......+.... +...+....|++++..+......+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~--e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEESCSSCCHHHH--HHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC-----cEEEEEEecCCcchhHHHH--HHHHHHHhhcCCCCCccccccCCCCce
Confidence 479999999999999999999998887 7889997754433222111 222222233333333333333556788
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe-
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS- 296 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~- 296 (365)
++||||+ +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSR-------------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred EEEEEec-CCCHHHHHHhhcc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEec
Confidence 9999999 8999999975431 357788999999999999999999999999999999995
Q ss_pred --cCCCcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 --EGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 --~~~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||+++........ ......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 141 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 141 GKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR----RDDLESLGYVLMYFNL 210 (296)
T ss_dssp GGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH----HHHHHHHHHHHHHHHH
T ss_pred CCCCC-eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCc----chhhHHHHHHHHHHHh
Confidence 555 9999999999876554321 134578999999999998766544 5669999999999843
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=260.20 Aligned_cols=213 Identities=18% Similarity=0.234 Sum_probs=161.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+.+..++|++.+.||+|+||.||+|.+.........+.+++|.+...... ......++...+....|++++.+++.+ .
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 98 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-S 98 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-C
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-c
Confidence 34466899999999999999999999874222222277999988754332 233344556677788899999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+...++||||+.+++|.+++....... ........+++..++.++.|++.||.|||++||+||||||+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAM----------ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHH----------HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhh----------ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 5568899999999999999997643100 000111234778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 169 Ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el~ 234 (322)
T 1p4o_A 169 CMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT----YSDVWSFGVVLWEIA 234 (322)
T ss_dssp EEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc----hhhHHHHHHHHHHHH
Confidence 9999987 9999999999876443221 223456788999999998766544 566999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=282.06 Aligned_cols=198 Identities=15% Similarity=0.197 Sum_probs=156.0
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.++||+|+||.||+|.+..+ ..|++|.+........ ...++...+....|++++.+++.+..
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCC------ceEEEEEeCCCCCCHH-HHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 445667899999999999999999998764 5689998875432211 22334555666679999998877633
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
..+++||||+.+|+|.+++.... +..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred -ccceEeeehhcCCcHHHHHhhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 57899999999999999997532 11356788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ .+||+|||+++.+............+|..|+|||++.+..++. .+|+||||++||+|-+
T Consensus 395 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~sDvwSlGv~l~el~t 459 (535)
T 2h8h_A 395 LVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELTT 459 (535)
T ss_dssp EECGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHTT
T ss_pred EEcCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCc----hhhHHHHHHHHHHHHh
Confidence 999887 9999999999876533222223456788999999998766554 5669999999999843
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=255.27 Aligned_cols=195 Identities=22% Similarity=0.282 Sum_probs=150.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.++||+|+||.||+|.+..++ ..+++|.+..... .......++...+....|++++.+++.+ ......
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG-----LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCC-----ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-ecCCeE
Confidence 68999999999999999999998887 7788888764432 1222333455666777899999998877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++++|.+++.... ..+..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ----------------ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred EEEEEeCCCCcHHHHHHhhh----------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 99999999999999986542 11234678889999999999999999999999999999999954
Q ss_pred C--CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 G--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~--~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ ...+||+|||+++...... ......||+.|+|||++.+ . .+..+|+||||+++|+|-
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~-~----~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 160 TSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFKR-D----VTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp SSTTCCEEECCCCCCCC------------CTTGGGCCHHHHTT-C----CCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhcc-C----CCcccCeehHHHHHHHHH
Confidence 2 2389999999998765432 2345689999999999753 2 344678999999999973
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=260.67 Aligned_cols=195 Identities=21% Similarity=0.294 Sum_probs=154.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HH-H--HHHHHHHHHHhhcc-CCCceeeeecc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AV-E--IWMNERVRRACANC-CADFVYGFFEN 209 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~-~--~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (365)
++|++.+.||+|+||.||+|.+..++ +.||+|.+.... .. + .....++...+... .|++++.+++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATG-----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCC-----cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 57999999999999999999998877 789999775332 11 1 11122233334443 68898888876
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ......++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 169 ~-~~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk 227 (365)
T 2y7j_A 169 Y-ESSSFMFLVFDLMRKGELFDYLTEKV--------------------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227 (365)
T ss_dssp E-EBSSEEEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred E-eeCCEEEEEEEeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6 45678999999999999999997653 35778899999999999999999999999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC--CCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ--TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||++..+..... .....||+.|+|||++.+... ....+..+|+||||+++|+|-
T Consensus 228 p~NIl~~~~~-~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell 299 (365)
T 2y7j_A 228 PENILLDDNM-QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299 (365)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred HHHEEECCCC-CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence 9999999987 999999999987654332 345789999999999875532 223445778999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=261.62 Aligned_cols=192 Identities=21% Similarity=0.238 Sum_probs=153.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+.|++.+.||+|+||.||+|++..++ +.|++|++.... ........++...+....|++++.+++.+ ..+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC-----eEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECC
Confidence 56999999999999999999998887 889999886432 22222333455666777899999998876 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+. |+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 187 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKK-------------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTS-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred eEEEEEecCC-CCHHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 8999999998 688888865431 35778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++.... .....||+.|+|||++.+... ...+..+|+||||+++|+|-+
T Consensus 188 ~~~~-~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~ell~ 248 (348)
T 1u5q_A 188 SEPG-LVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAE 248 (348)
T ss_dssp ETTT-EEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSS-CCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCC-CEEEeeccCceecCC-----CCcccCCcceeCHhhhccccC-CCCCcHHHHHHHHHHHHHHHh
Confidence 9987 999999999986542 235689999999999863221 123446789999999999843
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=253.18 Aligned_cols=194 Identities=21% Similarity=0.184 Sum_probs=150.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+... .........++........|++++.+++.+ ....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDG-----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-AEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-EETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCC-----ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-ecCC
Confidence 68999999999999999999998887 88999987643 222222233333333334899999998876 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYR----------------IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHH----------------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eEEEEEEecCCCcHHHHHHhhcc----------------cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 89999999999999999976420 11245788899999999999999999999999999999999
Q ss_pred ecC------------------CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhh
Q 017820 296 SEG------------------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357 (365)
Q Consensus 296 ~~~------------------~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~v 357 (365)
+.+ ...+||+|||.++..... ....||+.|+|||++.+.. ..+..+|+||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~i 220 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENY---THLPKADIFALALT 220 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCC---TTHHHHHHHHHHHH
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCC---CCCchhhHHHHHHH
Confidence 843 237999999999876432 2346899999999987541 22246789999999
Q ss_pred heecc
Q 017820 358 LWQVQ 362 (365)
Q Consensus 358 lw~lG 362 (365)
+|+|-
T Consensus 221 l~~l~ 225 (289)
T 1x8b_A 221 VVCAA 225 (289)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 99884
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=259.90 Aligned_cols=202 Identities=19% Similarity=0.199 Sum_probs=159.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEe----cCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeec
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASL----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 208 (365)
...+..++|++.+.||+|+||.||+|++ ..++ +.|++|.+............++...+....|++++.+++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-----EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCC-----EEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCc-----eEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3455667999999999999999999985 3344 789999987665554445555666777778999999887
Q ss_pred ccccCC-CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 209 NSSKKG-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 209 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
.....+ ..+++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+|||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 170 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------------------RIDHIKLLQYTSQICKGMEYLGTKRYIHRD 170 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTT-------------------SSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccC
Confidence 654433 478999999999999999986531 356778899999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||+|||++.++ .+||+|||+++........ ......+|..|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 171 ikp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el~t 243 (326)
T 2w1i_A 171 LATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFT 243 (326)
T ss_dssp CCGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHHHH
T ss_pred CCcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCc----hhhHHHHHHHHHHHHh
Confidence 999999999987 9999999999876544321 123356778899999998766544 5669999999999853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=255.72 Aligned_cols=190 Identities=21% Similarity=0.265 Sum_probs=146.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+..++|++.+.||+|+||.||+|.+.. +.+++|.+......+. ..++...+....|+|++.+++.+. +
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~hp~iv~~~~~~~---~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL---N 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSSTTHHHH--HHHHHHHHHHCCCTTBCCEEEBCT---T
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecChhHHHH--HHHHHHHHhcCCCCCcCeEEEEEc---C
Confidence 345799999999999999999999863 6799998875544332 233455566678999999988763 3
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH---CCCcccCCCCCc
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS---TGIVHRDIKPQN 292 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~---~~IiHrDIKp~N 292 (365)
..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+ +||+||||||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEP-----------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSS-----------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred CcEEEEEcCCCCCHHHHHhccCC-----------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 47899999999999999976541 1234677888999999999999999 899999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++..+||+|||+++..... .....||+.|+|||++.+..++ ..+|+||||+++|+|-
T Consensus 136 Ill~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG~il~el~ 197 (307)
T 2eva_A 136 LLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYS----EKCDVFSWGIILWEVI 197 (307)
T ss_dssp EEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCC----THHHHHHHHHHHHHHH
T ss_pred EEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCC----cHHHHHHHHHHHHHHH
Confidence 999988745899999999865432 2345799999999999876554 4566999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=270.50 Aligned_cols=202 Identities=17% Similarity=0.214 Sum_probs=156.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|.+...... ......++...+....|++++.+++.+....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 4579999999999999999999999887 78999987643321 1122233455666677999999987764443
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+.+++|.+++..... ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 144 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSN-----------------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGG-----------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CeeEEEEecCCCCCHHHHHHhhhc-----------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEE
Confidence 478999999999999999876431 123678889999999999999999999999999999999
Q ss_pred E----ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCC----CCCCchhhhhhhhhheeccc
Q 017820 295 F----SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP----SAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l----~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~----~~d~~s~~~slg~vlw~lGc 363 (365)
+ +.++ .+||+|||+|+....... .....||+.|+|||++.+..... ..+..+|+||||+++|+|-+
T Consensus 145 l~~~~~~~~-~~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 145 RVIGEDGQS-VYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp EEECTTSCE-EEEECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeecCCCce-eEEEecCCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 8 5544 899999999987654332 24568999999999987532211 12235679999999999843
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=252.70 Aligned_cols=196 Identities=15% Similarity=0.215 Sum_probs=153.6
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HH----HHHHHHHHHhhccCCCceee
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EI----WMNERVRRACANCCADFVYG 205 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~~~~~~~~~~~~i~~ 205 (365)
.+.+..++|++.+.||+|+||.||+|++..++ +.+++|.+...... .. ....++...+....|++++.
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 87 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDK-----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTC-----CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCc-----eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence 34556789999999999999999999998887 78899987532211 11 23344566677778999999
Q ss_pred eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--C
Q 017820 206 FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--I 283 (365)
Q Consensus 206 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--I 283 (365)
+++.+... .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |
T Consensus 88 ~~~~~~~~---~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 88 LYGLMHNP---PRMVMEFVPCGDLYHRLLDKA-------------------HPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp EEEEETTT---TEEEEECCTTCBHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred hheeecCC---CeEEEEecCCCCHHHHHhccc-------------------CCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 98876332 269999999999999886544 24577888999999999999999999 9
Q ss_pred cccCCCCCceEEecCCCc-----EEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhh
Q 017820 284 VHRDIKPQNVIFSEGSRT-----FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~-----ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vl 358 (365)
+||||||+|||++.++ . +||+|||+|+.... ......||+.|+|||++.+.. ...+..+|+||||+++
T Consensus 146 vH~dikp~Nil~~~~~-~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~--~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLD-ENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEE--ESYTEKADTYSFAMIL 218 (287)
T ss_dssp BCSCCSGGGEEESCCC-TTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSS--CEECHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccC-CCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCC--CCcCchhhHHHHHHHH
Confidence 9999999999998766 4 99999999985432 234578999999999984321 1123367799999999
Q ss_pred eecc
Q 017820 359 WQVQ 362 (365)
Q Consensus 359 w~lG 362 (365)
|+|-
T Consensus 219 ~~l~ 222 (287)
T 4f0f_A 219 YTIL 222 (287)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=262.38 Aligned_cols=216 Identities=21% Similarity=0.223 Sum_probs=153.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+ ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~ 99 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTR-----AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-ED 99 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred hheeecceeeecCCeEEEEEEECCCC-----ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-cc
Confidence 68999999999999999999998887 778888765332 12223333455566667799999998877 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCC------------------cchhhhhccccccCc--ccccccHHHHHHHHHHHHH
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFP------------------YNVQTLILGEVQDLP--KGIERENRIIQTIMSQLLF 273 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qi~~ 273 (365)
....++||||+++++|.+++...... .+......+...... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 67899999999999999998532100 000000001111111 1234467889999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCC-cEEEEecccccccccCC---ccccccccCCCCcCCccccccCCCCCCCCCch
Q 017820 274 ALDGLHSTGIVHRDIKPQNVIFSEGSR-TFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (365)
Q Consensus 274 aL~yLH~~~IiHrDIKp~NILl~~~~~-~ikL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s 349 (365)
||.|||+++|+||||||+|||++.++. .+||+|||+|+.+.... ........||+.|+|||++.+.. ...+..+
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~ 257 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--ESYGPKC 257 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS--SCCCTHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC--CCCCcHH
Confidence 999999999999999999999986542 89999999998764322 22234678999999999986521 2234467
Q ss_pred hhhhhhhhheecc
Q 017820 350 VATALSPVLWQVQ 362 (365)
Q Consensus 350 ~~~slg~vlw~lG 362 (365)
|+||||+++|+|-
T Consensus 258 DiwslG~il~el~ 270 (345)
T 3hko_A 258 DAWSAGVLLHLLL 270 (345)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 7999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=249.82 Aligned_cols=198 Identities=21% Similarity=0.285 Sum_probs=150.9
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..+..++|++.+.||+|+||.||+|.+..++ +.+++|.+....... .....++...+....|++++.+++..
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG-----HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCC-----ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3456689999999999999999999998877 788999876433221 12233445566677899999988876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
......++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||
T Consensus 81 -~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 139 (276)
T 2h6d_A 81 -STPTDFFMVMEYVSGGELFDYICKHG--------------------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139 (276)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCG
T ss_pred -ecCCeEEEEEeccCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 45678999999999999999997654 346788899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+||+++.++ .+||+|||++....... ......||+.|+|||++.+... .+..+|+||||+++|+|-+
T Consensus 140 ~Nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 140 ENVLLDAHM-NAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY---AGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp GGEEECTTS-CEEECCCCGGGCCCC---------------CCTGGGTTSCC---CHHHHHHHHHHHHHHHHHH
T ss_pred hhEEECCCC-CEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCC---CCccchHHHHHHHHHHHHh
Confidence 999999987 99999999998765432 2235678999999999876533 2346789999999999854
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=256.51 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=146.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+............++........|++++.+++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC-----CeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 5579999999999999999999998877 78899987644322222222222222233688888887776443
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 214 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+++||||+++++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 158 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK------------------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence 468999999999999999997642 124577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||++........ ......||+.|+|||++.+... ....+..+|+||||+++|+|-
T Consensus 159 NIl~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 159 NVLLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp GEEECTTC-CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred HEEEcCCC-CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 99999887 999999999987643221 2345689999999999874321 222344677999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=254.21 Aligned_cols=193 Identities=17% Similarity=0.229 Sum_probs=148.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+.+..++|++.+.||+|+||.||+|.+.+ +.+++|.+......+. ..++...+....|++++.+++.....
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HH--HHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcC-------CEEEEEEecchhHHHH--HHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 45567899999999999999999998753 6799998876553332 23345566677899999998876566
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR------------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 148 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH------------------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred CCceEEEEecCCCCCHHHHHHhccc------------------ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceE
Confidence 6789999999999999999976531 1246788899999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++.++ .+||+|||+++..... .....+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 149 l~~~~~-~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 208 (278)
T 1byg_A 149 LVSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST----KSDVWSFGILLWEIY 208 (278)
T ss_dssp EECTTS-CEEECCCCC----------------CCTTTSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEeCCC-cEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCc----hhcHHHHHHHHHHHH
Confidence 999887 9999999999865432 23346789999999998765544 566999999999983
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=261.88 Aligned_cols=194 Identities=18% Similarity=0.216 Sum_probs=146.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH-HHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW-MNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.||+|.+......... ...++...+....|++++.+++.+ ..+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-ECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC-----cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-eeCCEE
Confidence 78999999999999999999999887 78999987643322111 111345566777899999998876 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||++ ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCG-------------------NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred EEEecccc-cCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 99999998 58999887654 13577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .+||+|||+++....... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 136 ~~-~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~ 196 (324)
T 3mtl_A 136 RG-ELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMAT 196 (324)
T ss_dssp TC-CEEECSSSEEECC-------------CGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHH
T ss_pred CC-CEEEccCcccccccCCcc-ccccccCcccccChhhhcCCC---CCCcHHHHHHHHHHHHHHHh
Confidence 87 999999999986543322 234567899999999986532 23346779999999999843
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=267.58 Aligned_cols=195 Identities=19% Similarity=0.134 Sum_probs=134.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHH---HHHHhhccCCCceeeeecccc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNER---VRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..+|++.+.||+|+||.||+|++..++ +.||+|.+..... .......+ ....+.. .|++++.++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~ 134 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERL-----EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCC-----ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence 346999999999999999999998887 8899998876432 11111111 2345555 7888665432221
Q ss_pred -------cCC----------------CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHH-HHH
Q 017820 212 -------KKG----------------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII-QTI 267 (365)
Q Consensus 212 -------~~~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-~~i 267 (365)
..+ ..+++||||++ ++|.+++...+.... ........+ ..+
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~--------------~~~~~~~~vk~~i 199 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYV--------------FRGDEGILALHIL 199 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCC--------------CCHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccc--------------hhhhhhhhhHHHH
Confidence 111 45899999999 899999987531110 001111122 466
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc--CCCCCCC
Q 017820 268 MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM--STQTPSA 345 (365)
Q Consensus 268 ~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~ 345 (365)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..... .....+|+.|+|||++.+ ..++
T Consensus 200 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~--- 271 (371)
T 3q60_A 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFT--- 271 (371)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECC---
T ss_pred HHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcC---
Confidence 69999999999999999999999999999987 9999999999875422 124567799999999976 4444
Q ss_pred CCchhhhhhhhhheecc
Q 017820 346 PSAPVATALSPVLWQVQ 362 (365)
Q Consensus 346 d~~s~~~slg~vlw~lG 362 (365)
..+|+||||+++|+|-
T Consensus 272 -~~~DiwSlG~il~ell 287 (371)
T 3q60_A 272 -HALNAWQLGLSIYRVW 287 (371)
T ss_dssp -HHHHHHHHHHHHHHHH
T ss_pred -ccccHHHHHHHHHHHH
Confidence 4566999999999983
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-33 Score=262.42 Aligned_cols=199 Identities=16% Similarity=0.149 Sum_probs=146.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHH--------HHHHHHhhccCCCceee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMN--------ERVRRACANCCADFVYG 205 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~--------~~~~~~~~~~~~~~i~~ 205 (365)
..++|++.+.||+|+||.||+|.+..++... ..+++|........ +.... .++........|++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD--ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGG--CCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCcc--ceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 4579999999999999999999998733222 67888887644321 11111 12233456668899888
Q ss_pred eeccccc---CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC
Q 017820 206 FFENSSK---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (365)
Q Consensus 206 ~~~~~~~---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~ 282 (365)
+++.+.. .....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--------------------TFKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--------------------BCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 8776544 257899999999 899999987543 4578889999999999999999999
Q ss_pred CcccCCCCCceEEecCC-CcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 283 IVHRDIKPQNVIFSEGS-RTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 283 IiHrDIKp~NILl~~~~-~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
|+||||||+|||++.++ ..+||+|||+|+.+...... ......||+.|+|||++.+..++ ..+|+||||
T Consensus 172 ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG 247 (345)
T 2v62_A 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS----RRSDVEILG 247 (345)
T ss_dssp EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC----HHHHHHHHH
T ss_pred eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC----chhhHHHHH
Confidence 99999999999998753 38999999999876543211 11456899999999999876544 456699999
Q ss_pred hhheecc
Q 017820 356 PVLWQVQ 362 (365)
Q Consensus 356 ~vlw~lG 362 (365)
+++|+|-
T Consensus 248 ~il~ell 254 (345)
T 2v62_A 248 YCMLRWL 254 (345)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-33 Score=266.18 Aligned_cols=196 Identities=24% Similarity=0.278 Sum_probs=150.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|++....... .++...+....|+|++.+++.+..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~~~~----~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESG-----KRFALKKVLQDPRYK----NRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTC-----CEEEEEEEECCTTSC----CHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEecCcchH----HHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4579999999999999999999999888 889999876443211 134555666789999888776532
Q ss_pred ---------------------------------CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccc
Q 017820 213 ---------------------------------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259 (365)
Q Consensus 213 ---------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (365)
.+..+++||||++ ++|.+.+.... ..+..+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~~~~~l 138 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI----------------RSGRSI 138 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHH----------------HTTCCC
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH----------------hcCCCC
Confidence 2345889999999 58888776421 112356
Q ss_pred cHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccC
Q 017820 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 339 (365)
Q Consensus 260 ~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 339 (365)
++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||+|+.+..... .....||+.|+|||++.+.
T Consensus 139 ~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 139 PMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCC
Confidence 78889999999999999999999999999999999985444999999999987654332 3456889999999998764
Q ss_pred CCCCCCCCchhhhhhhhhheeccc
Q 017820 340 TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 340 ~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.. .+..+|+||+|+++|+|-+
T Consensus 217 ~~---~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 217 TE---YTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp SS---CCTHHHHHHHHHHHHHHHH
T ss_pred CC---CCcchhhhhHHHHHHHHHh
Confidence 31 2345679999999999854
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=258.31 Aligned_cols=202 Identities=19% Similarity=0.198 Sum_probs=140.3
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccc---
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSS--- 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--- 211 (365)
+...+|++.+.||+|+||.||+|++..++ +.|++|.+............++...+... .|++++.+++.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSG-----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCC-----cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 34569999999999999999999998887 88999988655544333333334444444 5899988876652
Q ss_pred ----cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 017820 212 ----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVH 285 (365)
Q Consensus 212 ----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiH 285 (365)
.....+++||||++ |+|.+++.... ....+++..++.++.||+.||.|||+++ |+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 161 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKME-----------------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHH-----------------TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBC
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhh-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEE
Confidence 34466899999997 69999886532 1124678889999999999999999999 999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCcc-----------ccccccCCCCcCCccccccCCCCCCCCCchhhhhh
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~sl 354 (365)
|||||+|||++.++ .+||+|||+++........ ......||+.|+|||++.... ....+..+|+|||
T Consensus 162 ~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 162 RDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWAL 239 (337)
T ss_dssp CCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------------------CCT-TSCSSHHHHHHHH
T ss_pred ccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc-cCCCChHHhHHHH
Confidence 99999999999987 9999999999876543221 112456899999999984221 1223346779999
Q ss_pred hhhheecc
Q 017820 355 SPVLWQVQ 362 (365)
Q Consensus 355 g~vlw~lG 362 (365)
|+++|+|-
T Consensus 240 G~il~el~ 247 (337)
T 3ll6_A 240 GCILYLLC 247 (337)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=258.04 Aligned_cols=196 Identities=20% Similarity=0.276 Sum_probs=152.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|++..++ +.|++|.+...... ......++...+....|++++.+++.+ ...
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-KKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTC-----CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCC-----ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-ecC
Confidence 4579999999999999999999999887 78999987543322 222233455566667799999998877 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...++||||+++++|.++..... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN--------------------GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CEEEEEEecCCcchHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 78999999999999988865443 3578889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++.++ .+||+|||+++.+..... ......||+.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 157 ~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 157 VSQSG-VVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDV---KYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp ECTTS-CEEECCCTTC-------------CCCCCTTCCHHHHTTCT---TCCTHHHHHHHHHHHHHHHH
T ss_pred EcCCC-cEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCC---CcchHHHHHHHHHHHHHHHh
Confidence 99987 999999999987643322 234568999999999986541 23446779999999999843
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=252.53 Aligned_cols=198 Identities=17% Similarity=0.179 Sum_probs=156.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
-.|.+.++||+|+||+||+|.+..+.... ..+++|.+..... .......++...+....|++++.+++.+...+...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNR--IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCE--EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCce--eeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 36778899999999999999987655322 4688888765433 22333344566677778999999998876666666
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~ 159 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ-------------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT-------------------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEecccCCCHHHHHhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 99999999999999997643 23467788899999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||+++.+..... .......+|+.|+|||.+.+..++. .+|+||||+++|+|-
T Consensus 160 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 222 (298)
T 3pls_A 160 SF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT----KSDVWSFGVLLWELL 222 (298)
T ss_dssp TC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred CC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh----hhchhhHHHHHHHHh
Confidence 87 999999999986544321 1223467788999999997766554 566999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-32 Score=248.35 Aligned_cols=194 Identities=19% Similarity=0.219 Sum_probs=154.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccc---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSS--- 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--- 211 (365)
..+.|++.+.||+|+||.||+|.+..++ ..+++|.+.... ..+.....++...+....|++++.+++.+.
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCc-----eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3457999999999999999999999887 778888775432 233334445566677778999998877543
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIK 289 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDIK 289 (365)
.....+++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|||||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik 158 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc--------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence 23567899999999999999997654 3577889999999999999999999 9999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++.+.+.+||+|||++...... ......||+.|+|||++.+. .+..+|+||||+++|+|-+
T Consensus 159 p~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~ 224 (290)
T 1t4h_A 159 CDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp GGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGTC-----CCTHHHHHHHHHHHHHHHH
T ss_pred HHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHHHHhcc-----CCCcchHHHHHHHHHHHHh
Confidence 999999843349999999999764432 23456899999999987632 3456789999999999843
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=273.26 Aligned_cols=192 Identities=21% Similarity=0.214 Sum_probs=151.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.++||+|+||.||+|++..++ ..+|+|.+...... ......++...+....|+||+.+++.+ .....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTH-----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTC-----CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCE
Confidence 57999999999999999999999887 77888887643211 122233456667778899999998887 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM--------------------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred EEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence 999999999999999887654 357788999999999999999999999999999999997
Q ss_pred cCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ ..+||+|||+|+...... ......||+.|+|||++.+ .+ +..+|+||+|+++|+|-|
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~----~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRK-KY----DEKCDVWSIGVILFILLA 232 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHTT-CB----CTHHHHHHHHHHHHHHHH
T ss_pred CCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHcc-cC----CCchhHHHHHHHHHHHHh
Confidence 643 269999999998765432 2345789999999999853 33 446779999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=280.28 Aligned_cols=200 Identities=20% Similarity=0.234 Sum_probs=154.2
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
..+..++|++.+.||+|+||.||+|.+..++... ..+++|........ ......++...+....|+|++.+++.+.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCC--EEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCcc--EEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3455679999999999999999999987654332 56888887643322 2223334455666778999999988762
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~N 521 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKF-------------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTT-------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHh
Confidence 3568999999999999999986542 34677888999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||++.++ .+||+|||+|+..............+|+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 522 ILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~~DiwSlG~il~el 585 (656)
T 2j0j_A 522 VLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEI 585 (656)
T ss_dssp EEEEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred EEEeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc----hhhHHHHHHHHHHH
Confidence 9999987 9999999999877554444344566788999999998765544 56699999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=260.06 Aligned_cols=193 Identities=20% Similarity=0.241 Sum_probs=153.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
++|++.+.||+|+||.||+|.+..++ ..||+|++...... ......++...+....|++++.+++.+....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCC-----eEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 68999999999999999999998887 78999988643322 2233344566667778999988877654322
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 215 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...++|+||+++ +|.+++.... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~~~---------------------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 159 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKTQH---------------------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cceEEEEEcccCc-CHHHHHHhCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhE
Confidence 578999999985 9999887643 46788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++........ ......||+.|+|||++.+... .+..+|+||||+++|+|-
T Consensus 160 l~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 160 LLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG---YTKSIDIWSVGCILAEML 226 (364)
T ss_dssp EECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCS---CSTHHHHHHHHHHHHHHH
T ss_pred EECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCC---CCcchhHHHHHHHHHHHH
Confidence 999987 9999999999876543222 1245689999999998765431 234667999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-33 Score=258.53 Aligned_cols=210 Identities=16% Similarity=0.186 Sum_probs=153.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
.+..++|++.+.||+|+||.||+|++...........|++|.+.... ........++...+....|++++.+++.+ ..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-cC
Confidence 34568999999999999999999996543222223789999886432 22223333445556666899999998877 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+++++|.+++...... ......+++..++.++.|++.||.|||++||+||||||+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NI 171 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPR-------------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCC-------------SSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhccc-------------ccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHE
Confidence 56789999999999999999876421 11223467888999999999999999999999999999999
Q ss_pred EEecCC--CcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGS--RTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~--~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ ..+||+|||+++....... .......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 239 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIF 239 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCc----hhhHHHHHHHHHHHH
Confidence 998432 3799999999986543322 2223467899999999998765544 566999999999973
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=269.35 Aligned_cols=194 Identities=24% Similarity=0.248 Sum_probs=148.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc-----C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-----K 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~ 213 (365)
.+|++.+.||+|+||.||+|++..++ +.||+|++...... ..++...+....|+|++.+++.+.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCC-----cEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 58999999999999999999998887 78899987643221 1123455566678998887655422 1
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||+++ +|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 187 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYS----------------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred ceeEEeehhcccc-cHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhE
Confidence 2346799999996 6766665321 0123467788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++..+||+|||+|+.+..+.. .....||+.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 188 Ll~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 188 LLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCC---CCCchhhhHHHHHHHHHHHh
Confidence 9997665899999999987654332 24568899999999987542 23346679999999999854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=256.53 Aligned_cols=204 Identities=18% Similarity=0.206 Sum_probs=158.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc---C
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---K 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~ 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+............++...+....|++++.+++.+.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDG-----HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCC-----cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 4579999999999999999999998887 8899998866555444445556667777789999988776542 3
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++|+||+.+++|.+++.... ..+..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NI 165 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLK----------------DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNI 165 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHH----------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CceeEEEEEeCCCCcHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 458899999999999999997632 1123567888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc--------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY--------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ .+||+|||+++........ ......||+.|+|||++.+.... ..+..+|+||||+++|+|-+
T Consensus 166 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~il~el~~ 241 (317)
T 2buj_A 166 LLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMF 241 (317)
T ss_dssp EECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEE-EECTHHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCc-CCCchhhHHHHHHHHHHHHh
Confidence 999987 9999999998765321110 01235679999999998654321 12346779999999999843
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=270.57 Aligned_cols=193 Identities=20% Similarity=0.243 Sum_probs=154.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-------------HHHHHHHHHHHhhccCCCcee
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-------------EIWMNERVRRACANCCADFVY 204 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~i~ 204 (365)
.++|++.++||+|+||+||+|.+..++ ..+|+|.+...... ......++...+....|++|+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGH-----SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCC-----cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 478999999999999999999999887 77888887643211 112233455666777899999
Q ss_pred eeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCc
Q 017820 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (365)
Q Consensus 205 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~Ii 284 (365)
.+++.+ ..+..+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+
T Consensus 110 ~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~iv 168 (504)
T 3q5i_A 110 KLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH--------------------KFDECDAANIMKQILSGICYLHKHNIV 168 (504)
T ss_dssp CEEEEE-ECSSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eEEEEE-EcCCEEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 998887 55678999999999999999987654 357888999999999999999999999
Q ss_pred ccCCCCCceEEecCCC--cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 285 HRDIKPQNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 285 HrDIKp~NILl~~~~~--~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||||||+|||++.++. .+||+|||+|+...... ......||+.|+|||++.+ .+ +..+|+||+|+++|+|-
T Consensus 169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~----~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KY----NEKCDVWSCGVIMYILL 241 (504)
T ss_dssp CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CB----CTHHHHHHHHHHHHHHH
T ss_pred eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CC----CchHHHHHHHHHHHHHH
Confidence 9999999999997653 69999999998765432 2345789999999999863 33 34677999999999985
Q ss_pred c
Q 017820 363 C 363 (365)
Q Consensus 363 c 363 (365)
|
T Consensus 242 ~ 242 (504)
T 3q5i_A 242 C 242 (504)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=250.92 Aligned_cols=193 Identities=19% Similarity=0.258 Sum_probs=150.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+++.+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 78 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG-----KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-E 78 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC-----CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-c
Confidence 57999999999999999999999887 77888876533211 112223344555666789999888776 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 138 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKE--------------------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHH
Confidence 5578999999999999999997653 35778899999999999999999999999999999
Q ss_pred eEEecCCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++.++. .+||+|||+++....... .....||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 139 il~~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLS 206 (283)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCC----cchhhhhHHHHHHHHHH
Confidence 99987642 799999999987654322 2456799999999999766554 45679999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-33 Score=272.77 Aligned_cols=192 Identities=19% Similarity=0.252 Sum_probs=152.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||+||+|.+..++ +.||+|.+..... .......++...+....|++++.+++.+ .....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTC-----CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-EcCCE
Confidence 68999999999999999999999887 7788888753211 1122233445566667899999998876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+.+++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~ 155 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK--------------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred EEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 999999999999999887654 357788999999999999999999999999999999996
Q ss_pred cCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ ..+||+|||+|+.+.... ......||+.|+|||++.+. .+..+|+||||+++|+|-|
T Consensus 156 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~ 217 (486)
T 3mwu_A 156 SKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILLS 217 (486)
T ss_dssp SSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGSC-----CCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCCC-----CCchhhHHHHHHHHHHHHh
Confidence 432 379999999998765432 23456899999999998653 3446789999999999843
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=251.95 Aligned_cols=200 Identities=20% Similarity=0.248 Sum_probs=145.3
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..++..++|++.++||+|+||.||+|.+. ..+++|.+... .........++...+....|++++.+++..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 35667789999999999999999999875 34777776533 233333444566777888899999888753
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 90 --~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp 148 (289)
T 3og7_A 90 --TAPQLAIVTQWCEGSSLYHHLHASE-------------------TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148 (289)
T ss_dssp --CSSSCEEEEECCCEEEHHHHHTTC----------------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred --cCCccEEEEEecCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 4567899999999999999986543 2357788899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+++...... ........||+.|+|||++...... ..+..+|+||||+++|+|-+
T Consensus 149 ~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 149 NNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN-PYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp GGEEEETTT-EEEECCCC------------------CCCTTCCHHHHC----C-CSCHHHHHHHHHHHHHHHHH
T ss_pred ceEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCC-CCCcccchHHHHHHHHHHHH
Confidence 999999987 99999999998654321 1223456899999999998632221 22336779999999999743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-33 Score=260.73 Aligned_cols=196 Identities=20% Similarity=0.225 Sum_probs=148.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-----HHHHHHHHHHhhccCCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----IWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+......+ .....++...+....|++++.+++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 81 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF- 81 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-
Confidence 4579999999999999999999998887 789999886432211 11223345556667899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
......++||||+++ +|.+++..... .+++..++.++.|++.||.|||++||+||||||+
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 141 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKDNSL-------------------VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 141 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTTCCS-------------------SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeCCceEEEEEcCCC-CHHHHHHhcCc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHH
Confidence 455789999999996 88888876542 3455678899999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+.+.... .......||+.|+|||++.+.. ..+..+|+||||+++|+|-+
T Consensus 142 Nil~~~~~-~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~ 208 (346)
T 1ua2_A 142 NLLLDENG-VLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLL 208 (346)
T ss_dssp GEEECTTC-CEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCS---CCCHHHHHHHHHHHHHHHHH
T ss_pred HEEEcCCC-CEEEEecccceeccCCc-ccCCcccccccccCchHhhCCC---CCCchhhhHhHHHHHHHHHH
Confidence 99999987 99999999998764332 2234568899999999986543 13346779999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=253.33 Aligned_cols=210 Identities=16% Similarity=0.217 Sum_probs=150.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
...+..++|.+.+.||+|+||.||+|.+....... ..+++|.+.... ........++...+....|++++.+++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTS--LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCE--EEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCce--eEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 33456679999999999999999999887643221 578999876432 22333344456667777899999988776
Q ss_pred ccCC----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 211 SKKG----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 211 ~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
.... ...++||||+.+++|.+++...... .....+++..++.++.|++.||.|||++||+||
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 171 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE--------------TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHR 171 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBT--------------TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhh--------------cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 4433 2469999999999999998654310 122356888999999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCccc-cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||+|||++.++ .+||+|||+++.+....... .....+++.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 172 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~el~~ 244 (313)
T 3brb_A 172 DLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS----KSDVWAFGVTMWEIAT 244 (313)
T ss_dssp CCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHSSCCCH----HHHHHHHHHHHHHHHT
T ss_pred CCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccc----hhhhHHHHHHHHHHHh
Confidence 9999999999987 99999999998765443222 23456788999999998765544 5669999999999843
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=249.18 Aligned_cols=192 Identities=19% Similarity=0.247 Sum_probs=142.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH----HHHHHHHHHHhhccCCCceeeeecccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE----IWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
+..++|++.+.||+|+||.||+|.+.+ ..+++|.+....... .....++...+....|++++.+++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 75 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC- 75 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETT-------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcC-------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence 466899999999999999999999863 678888876443221 22233445566667899999988876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC---CcccCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG---IVHRDI 288 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~---IiHrDI 288 (365)
..+...++||||+++++|.+++... .+++..++.++.|++.||.|||++| |+||||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSGK---------------------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTSS---------------------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred ecCCceEEEEEcCCCCCHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 4556789999999999999998643 3467889999999999999999999 899999
Q ss_pred CCCceEEecC-------CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 289 KPQNVIFSEG-------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 289 Kp~NILl~~~-------~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+|||++.+ +..+||+|||+++...... .....||+.|+|||++.+..++. .+|+||||+++|+|
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~~l~~l 207 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSK----GSDVWSYGVLLWEL 207 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSH----HHHHHHHHHHHHHH
T ss_pred chHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCc----hhhHHHHHHHHHHH
Confidence 9999999862 3389999999998664332 23467899999999998766544 56699999999997
Q ss_pred cc
Q 017820 362 QC 363 (365)
Q Consensus 362 Gc 363 (365)
-+
T Consensus 208 ~~ 209 (271)
T 3dtc_A 208 LT 209 (271)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=273.23 Aligned_cols=192 Identities=21% Similarity=0.249 Sum_probs=155.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
.++|++.+.||+|+||.||+|.+..++ +.+|+|.+.... ........++...+....|++++.+++.+ ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~ 98 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITG-----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDK 98 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCC-----CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence 368999999999999999999999888 788888764321 11222333445667777899999998877 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 158 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRK--------------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 78999999999999999987654 3578889999999999999999999999999999999
Q ss_pred Ee---cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 FS---EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l~---~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .++ .+||+|||+|+.+.... ......||+.|+|||++.+ .+ +..+|+||||+++|+|-|
T Consensus 159 ~~~~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~----~~~~DiwslG~il~~ll~ 222 (484)
T 3nyv_A 159 LESKSKDA-NIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TY----DEKCDVWSTGVILYILLS 222 (484)
T ss_dssp ESSSSTTC-CEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CC----CTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCC-cEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CC----CCcceeHHHHHHHHHHHH
Confidence 95 444 99999999998765432 2345689999999999865 33 446779999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=252.94 Aligned_cols=199 Identities=21% Similarity=0.260 Sum_probs=146.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+... .........++...+....|++++.+++.+. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-E 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTC-----CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCC-----ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-c
Confidence 4478999999999999999999998877 78899987632 2223333344556667778999999888764 4
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+.+++|.+++.... .....+++..++.++.|++.||.|||++||+||||||+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCcEEEEEecCCCCCHHHHHHHhc----------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence 568999999999999999987532 0122457788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++.++ .+||+|||+++....... ......||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 168 l~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~~l~~ 231 (310)
T 2wqm_A 168 FITATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYN----FKSDIWSLGCLLYEMAA 231 (310)
T ss_dssp EECTTS-CEEECCC-------------------CCSSCCHHHHTTCCCC----HHHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCC----chhhHHHHHHHHHHHHh
Confidence 999887 999999999987643322 22356789999999999776544 45679999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=260.41 Aligned_cols=197 Identities=21% Similarity=0.257 Sum_probs=151.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|++......+ .....++...+....|++++.+++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTC-----CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCC-----CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4579999999999999999999998887 788888775332211 11122344555566788888887765433
Q ss_pred ------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 214 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
++.+++||||+++ +|.+.+.... ..+++..++.++.|++.||.|||++||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D 149 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-------------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 4578999999996 7777776543 1357788999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+|+.+..... .......||+.|+|||++.+... .+..+|+||||+++|+|-
T Consensus 150 lkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~ell 223 (351)
T 3mi9_A 150 MKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD---YGPPIDLWGAGCIMAEMW 223 (351)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCS---CCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCC---CCcHhHHHHHHHHHHHHH
Confidence 999999999987 999999999987653222 22345688999999999865321 234677999999999983
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=260.92 Aligned_cols=198 Identities=12% Similarity=0.079 Sum_probs=146.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCC---CCcceeehhhccccHHHHHHHHHHHHHhhccCCCceee---------
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSK---NDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYG--------- 205 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------- 205 (365)
.++|++.+.||+|+||.||+|++..+.... ..+.+|+|.+...... .++...+....|++++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~-----~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL-----FNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTH-----HHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchH-----HHHHHHHHHhcccchhhhhhhhccCC
Confidence 479999999999999999999998752110 0178999988754221 11222223334555544
Q ss_pred ------eecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH
Q 017820 206 ------FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (365)
Q Consensus 206 ------~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH 279 (365)
+++.....+...++||||+ +++|.+++.... +..+++..++.++.||+.||.|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------------------~~~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP------------------KHVLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG------------------GGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3444434467899999999 899999998652 124678889999999999999999
Q ss_pred HCCCcccCCCCCceEEecCC-CcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhh
Q 017820 280 STGIVHRDIKPQNVIFSEGS-RTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (365)
Q Consensus 280 ~~~IiHrDIKp~NILl~~~~-~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~ 352 (365)
++||+||||||+|||++.++ ..+||+|||+|+.+...... ......||+.|+|||++.+..++. .+|+|
T Consensus 177 ~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~Di~ 252 (352)
T 2jii_A 177 ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR----RSDLQ 252 (352)
T ss_dssp HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH----HHHHH
T ss_pred hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc----hhhHH
Confidence 99999999999999999864 28999999999876543221 123458999999999998765443 56699
Q ss_pred hhhhhheeccc
Q 017820 353 ALSPVLWQVQC 363 (365)
Q Consensus 353 slg~vlw~lGc 363 (365)
|||+++|+|-+
T Consensus 253 slG~il~el~~ 263 (352)
T 2jii_A 253 SLGYCMLKWLY 263 (352)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999999743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=252.11 Aligned_cols=193 Identities=26% Similarity=0.352 Sum_probs=156.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.+.|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.+ .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-LKDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCC-----cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-ecCCe
Confidence 368999999999999999999998877 7888888754321 1222333445556667889999888876 44578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG---------------------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEEeCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 99999999999999998643 246788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||++..+.... .......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 154 ~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~ 214 (303)
T 3a7i_A 154 EHG-EVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDS----KADIWSLGITAIELAR 214 (303)
T ss_dssp TTS-CEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred CCC-CEEEeecccceecCccc-cccCccCCCcCccCHHHHhcCCCCc----hhhhHHHHHHHHHHcc
Confidence 987 99999999998765432 2234568999999999997765544 5679999999999854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=256.68 Aligned_cols=195 Identities=23% Similarity=0.293 Sum_probs=150.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--------HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
++|++.+.||+|+||.||+|.+..++ +.|++|.+..... .......++...+....|++++.+++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCC-----cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 68999999999999999999999887 7889998754321 1111223445566667899999888775
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.. ..+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 85 ~~--~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 142 (322)
T 2ycf_A 85 DA--EDYYIVLELMEGGELFDKVVGNK--------------------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142 (322)
T ss_dssp ES--SSEEEEEECCTTEETHHHHSTTC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cC--CceEEEEecCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 33 34899999999999999886543 457788999999999999999999999999999
Q ss_pred CceEEecCCC--cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~--~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++. .+||+|||+++...... ......||+.|+|||++.+.. ....+..+|+||||+++|+|-+
T Consensus 143 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~~ 214 (322)
T 2ycf_A 143 ENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICLS 214 (322)
T ss_dssp GGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHHH
T ss_pred HHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHHh
Confidence 9999987652 49999999998764322 123567999999999975321 1223457789999999998743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=252.02 Aligned_cols=197 Identities=20% Similarity=0.199 Sum_probs=149.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc-----
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS----- 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----- 211 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+............++...+....|++++.+++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD-----KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTT-----EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCC-----eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 4479999999999999999999999887 889999887655544444455666777778999998876542
Q ss_pred --------cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCC
Q 017820 212 --------KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (365)
Q Consensus 212 --------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~I 283 (365)
......++||||++ ++|.+++... .+++..++.++.|++.||.|||++||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~l~~lH~~~i 141 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---------------------PLLEEHARLFMYQLLRGLKYIHSANV 141 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhcC---------------------CccHHHHHHHHHHHHHHHHHHHhCCE
Confidence 33478899999998 5999998643 24677888999999999999999999
Q ss_pred cccCCCCCceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 284 iHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+||||||+|||++.++..+||+|||+++....... .......+|+.|+|||++.+.. ..+..+|+||||+++|+|
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT---CCCHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc---cCCchhhhHhHHHHHHHH
Confidence 99999999999986555999999999987643211 1223457799999999886532 234467799999999998
Q ss_pred cc
Q 017820 362 QC 363 (365)
Q Consensus 362 Gc 363 (365)
-+
T Consensus 219 ~~ 220 (320)
T 2i6l_A 219 LT 220 (320)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=261.43 Aligned_cols=194 Identities=21% Similarity=0.238 Sum_probs=148.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhcc-----CCCceeeeecc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANC-----CADFVYGFFEN 209 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~i~~~~~~ 209 (365)
..++|++.++||+|+||.||+|++..++ +.||+|.+......... .+.++...+.+. +|++++.+++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGK-----KFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCC-----eEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 4579999999999999999999998887 88999988754332211 222223333322 37778888776
Q ss_pred ccc---CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 017820 210 SSK---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVH 285 (365)
Q Consensus 210 ~~~---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiH 285 (365)
+.. .+..+++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++ ||+|
T Consensus 110 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~givH 170 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLG-HHLLKWIIKSN------------------YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIH 170 (397)
T ss_dssp EEEEETTEEEEEEEECCCC-CBHHHHHHHTT------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred eeecCCCCceEEEEEeccC-ccHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 542 4568999999995 56666555432 12357788999999999999999999 9999
Q ss_pred cCCCCCceEEecCC------------------------------------------------CcEEEEecccccccccCC
Q 017820 286 RDIKPQNVIFSEGS------------------------------------------------RTFKIIDLGAAADLRVGI 317 (365)
Q Consensus 286 rDIKp~NILl~~~~------------------------------------------------~~ikL~DFGla~~~~~~~ 317 (365)
|||||+|||++.++ ..+||+|||+|+.....
T Consensus 171 rDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~- 249 (397)
T 1wak_A 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH- 249 (397)
T ss_dssp CCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-
T ss_pred CCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-
Confidence 99999999998764 27999999999876432
Q ss_pred ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 318 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.....||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 250 ---~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell 287 (397)
T 1wak_A 250 ---FTEDIQTRQYRSLEVLIGSGYNT----PADIWSTACMAFELA 287 (397)
T ss_dssp ---SCSCCSCGGGCCHHHHHTSCCCT----HHHHHHHHHHHHHHH
T ss_pred ---CccCCCCCcccCChhhcCCCCCc----HHHHHHHHHHHHHHh
Confidence 24568999999999998876554 556999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=248.66 Aligned_cols=198 Identities=20% Similarity=0.253 Sum_probs=155.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----H----HHHHHHHHHHHHhhcc-CCCceeee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----A----VEIWMNERVRRACANC-CADFVYGF 206 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~~~~~~~~~-~~~~i~~~ 206 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+.... . .......++...+... .|++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcC-----ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 5589999999999999999999998887 788999875332 1 1111122233334444 58999988
Q ss_pred ecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCccc
Q 017820 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHr 286 (365)
++.+ ..+...++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||
T Consensus 90 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 148 (298)
T 1phk_A 90 KDTY-ETNTFFFLVFDLMKKGELFDYLTEKV--------------------TLSEKETRKIMRALLEVICALHKLNIVHR 148 (298)
T ss_dssp EEEE-ECSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeee-ccCCeEEEEEeccCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 8876 55678999999999999999997653 35778899999999999999999999999
Q ss_pred CCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC--CCCCCCchhhhhhhhhheeccc
Q 017820 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ--TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 287 DIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~d~~s~~~slg~vlw~lGc 363 (365)
||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+... ....+..+|+||||+++|+|-+
T Consensus 149 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 149 DLKPENILLDDDM-NIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp CCSGGGEEECTTC-CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEcCCC-cEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 9999999999987 99999999998765432 2345689999999999864321 2223457789999999999843
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=250.78 Aligned_cols=194 Identities=24% Similarity=0.232 Sum_probs=155.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.. ..+...
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-EETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCC-----cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-EcCCEE
Confidence 68999999999999999999998887 7888888754322 1222333445566667899999988876 456788
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++|+||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred EEEEEecCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 99999999999988875432 4577889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 GSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++ .+||+|||++..+..... .......||+.|+|||++.+... ....+|+||||+++|+|-
T Consensus 141 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~il~~l~ 202 (276)
T 2yex_A 141 RD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAML 202 (276)
T ss_dssp TC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB---CHHHHHHHHHHHHHHHHH
T ss_pred CC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC---CCCcchHHHHHHHHHHHH
Confidence 87 999999999987643322 22345689999999999876543 223577999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=260.45 Aligned_cols=189 Identities=21% Similarity=0.260 Sum_probs=134.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
++|++.+.||+|+||.||+|.+..++ +.||+|++.... ........++...+....|+|++.+++.+...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTT-----EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 79999999999999999999998887 889999886432 22223333455666777899999887765432
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 214 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+++|+|++ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 161 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKCQ---------------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161 (367)
T ss_dssp GGCCCCEEEEECC-CEECC-----C---------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred ccCCeEEEEeccc-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh
Confidence 25689999999 57898887653 3577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+..... .....||+.|+|||++.+ ..++ ..+|+||||+++|+|-+
T Consensus 162 NIll~~~~-~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~----~~~DiwslG~il~ell~ 225 (367)
T 2fst_X 162 NLAVNEDC-ELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYN----QTVDIWSVGCIMAELLT 225 (367)
T ss_dssp GEEECTTC-CEEECC-------------------CCCTTCCHHHHTTCCSCC----TTHHHHHHHHHHHHHHH
T ss_pred hEEECCCC-CEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCC----chhhHHHHHHHHHHHHh
Confidence 99999987 9999999999875422 245689999999999876 3333 45669999999999843
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=246.70 Aligned_cols=196 Identities=12% Similarity=0.120 Sum_probs=156.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
..+..++|++.+.||+|+||.||+|++.+ +.+++|.+.... ........++...+....|++++.+++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECC-------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 45567899999999999999999999863 678888876432 222333444556677778999999988765
Q ss_pred cC-CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCC
Q 017820 212 KK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDI 288 (365)
Q Consensus 212 ~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDI 288 (365)
.. ...+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGT------------------NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCS------------------SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcc------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 44 367899999999999999998654 123578889999999999999999999 999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++.++ .++|+|||++.... .....||+.|+|||++.+...+..+ ..+|+||||+++|+|-
T Consensus 140 kp~Nil~~~~~-~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 140 NSRSVMIDEDM-TARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNR-RSADMWSFAVLLWELV 205 (271)
T ss_dssp SGGGEEECTTS-CEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGSCH-HHHHHHHHHHHHHHHH
T ss_pred ccceEEEcCCc-ceeEEeccceeeec------ccCccCCccccChhhhccCCCCCCC-chhhHHHHHHHHHHHH
Confidence 99999999887 99999999876532 2345789999999999865444321 2577999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=252.93 Aligned_cols=205 Identities=17% Similarity=0.218 Sum_probs=139.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
+.+..++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ......++........|++++.+++.+.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG-----QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTT-----EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCC-----CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4567789999999999999999999998887 88999988754322 2222233344567778999999988774
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKP 290 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp 290 (365)
..+..++||||+++ +|.+++..... .....+++..+..++.|++.||.|||++ ||+||||||
T Consensus 92 -~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp 154 (327)
T 3aln_A 92 -REGDCWICMELMST-SFDKFYKYVYS---------------VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154 (327)
T ss_dssp -CSSEEEEEECCCSE-EHHHHHHHHHH---------------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCG
T ss_pred -eCCceEEEEeecCC-ChHHHHHHHHh---------------hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCH
Confidence 45789999999995 88887764210 0112457788999999999999999999 999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+++....... .....||+.|+|||++.........+..+|+||||+++|+|-+
T Consensus 155 ~NIll~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (327)
T 3aln_A 155 SNILLDRSG-NIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224 (327)
T ss_dssp GGEEEETTT-EEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCC-CEEEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence 999999987 999999999987654322 2345799999999998543333344557789999999999853
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=251.44 Aligned_cols=199 Identities=20% Similarity=0.284 Sum_probs=155.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccc-cC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSS-KK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~ 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+. ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCC-----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 3479999999999999999999998887 788888876432 223333344555666678999999887653 34
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC-----CcccCC
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDI 288 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~-----IiHrDI 288 (365)
+..+++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+||||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl 142 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTK----------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHH----------------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcc----------------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEecc
Confidence 5789999999999999999976431 1223678889999999999999999999 999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+..++ ..+|+||||+++|+|-
T Consensus 143 ~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~ 210 (279)
T 2w5a_A 143 KPANVFLDGKQ-NVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYN----EKSDIWSLGCLLYELC 210 (279)
T ss_dssp SGGGEEECSSS-CEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CC----HHHHHHHHHHHHHHHH
T ss_pred chhhEEEcCCC-CEEEecCchheeeccccc-cccccCCCccccChHHhccCCCC----chhhHHHHHHHHHHHH
Confidence 99999999887 999999999987643322 12346789999999999876544 4567999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=270.27 Aligned_cols=193 Identities=21% Similarity=0.263 Sum_probs=146.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
..++|++.++||+|+||.||+|++..++ +.||+|.+......+ ...+.++...+.+..+...+.. +...+.
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~---~~~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRW---FGVEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTC-----CEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEE---EEEETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCC-----cEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEE---EEeeCC
Confidence 3479999999999999999999998887 788888765333222 2222223333333222222222 224567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~-------------------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCS-------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred EEEEEEECC-CCCHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 889999999 889999997543 135778899999999999999999999999999999999
Q ss_pred ---ecCCCcEEEEecccccccccCCcc------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 ---SEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ---~~~~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+|+.+...... ......||+.|+|||++.+..++. .+|+||||++||+|-
T Consensus 137 ~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~----~sDvwSlGvil~ell 207 (483)
T 3sv0_A 137 GLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSR----RDDLESLGYVLMYFL 207 (483)
T ss_dssp CCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred ecCCCCC-eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCCh----HHHHHHHHHHHHHHH
Confidence 4555 9999999999876554321 123678999999999998776654 556999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=257.95 Aligned_cols=193 Identities=21% Similarity=0.262 Sum_probs=146.6
Q ss_pred CCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 139 DDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 139 ~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
++|.+. +.||+|+||.||+|.+..++ +.||+|.+...... ......++........|++++.+++.+ ...
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTG-----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-ENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-EeC
Confidence 578887 89999999999999999887 78888877643211 112222222233334578888888776 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL------------------AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 78999999999999998875432 124678889999999999999999999999999999999
Q ss_pred Eec---CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~---~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++. ++ .+||+|||+++....... .....||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 164 ~~~~~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~~ll 227 (327)
T 3lm5_A 164 LSSIYPLG-DIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITT----ATDMWNIGIIAYMLL 227 (327)
T ss_dssp ESCBTTBC-CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCT----HHHHHHHHHHHHHHH
T ss_pred EecCCCCC-cEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCc----hhhHHHHHHHHHHHH
Confidence 987 45 999999999987653322 24568999999999997766554 566999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=256.95 Aligned_cols=195 Identities=22% Similarity=0.318 Sum_probs=152.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC---C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (365)
++|++.+.||+|+||.||+|.+. + +.|++|.+..........+.+ ........|++++.+++...... .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~-----~~vavK~~~~~~~~~~~~e~~-~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--G-----EEVAVKIFSSREERSWFREAE-IYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--T-----EEEEEEEECGGGHHHHHHHHH-HHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--C-----ccEEEEEeCchhHHHHHHHHH-HHHHhhcCCCcEEEEEeeecccCCccc
Confidence 58999999999999999999984 3 789999887654433322222 22222367899998887765444 3
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH--------HCCCcccC
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--------STGIVHRD 287 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH--------~~~IiHrD 287 (365)
..++||||+++++|.+++.... +++..++.++.|++.||.||| +++|+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 172 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYT---------------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred eeEEEEeecCCCcHHHHHhccC---------------------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCC
Confidence 7899999999999999997643 467788999999999999999 89999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCC--CCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPS--APSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~--~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+++........ ......||+.|+|||++.+...... ....+|+||||+++|+|-
T Consensus 173 lkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 173 LKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999999987 9999999999876544321 2345689999999999876533221 114678999999999985
Q ss_pred c
Q 017820 363 C 363 (365)
Q Consensus 363 c 363 (365)
+
T Consensus 252 t 252 (342)
T 1b6c_B 252 R 252 (342)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=251.20 Aligned_cols=194 Identities=22% Similarity=0.310 Sum_probs=152.0
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+......+. ..++...+....|++++.+++.+ .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~--~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETG-----QIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVVKYYGSY-FKNTD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTC-----CEEEEEEEETTSCCHH--HHHHHHHHHTCCCTTBCCEEEEE-EETTE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCC-----CEEEEEecCchHHHHH--HHHHHHHHHhCCCCCCccEEEEE-EeCCE
Confidence 4579999999999999999999998877 7899998865443222 22334556667899999888876 34578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 159 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-------------------KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEeecCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC
Confidence 999999999999999987433 2357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||++........ ......||+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 160 ~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~ 220 (314)
T 3com_A 160 TEG-HAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNC----VADIWSLGITAIEMAE 220 (314)
T ss_dssp TTC-CEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCT----THHHHHHHHHHHHHHH
T ss_pred CCC-CEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCc----cccHHHHHHHHHHHHh
Confidence 987 999999999987654322 234568999999999998766554 4569999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=249.60 Aligned_cols=198 Identities=16% Similarity=0.257 Sum_probs=153.9
Q ss_pred ccCCCeEEee-eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+..++|.+.+ .||+|+||.||+|.+..+... ..|++|.+..... .......++...+....|++++.+++.+ .
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~ 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--Q 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CC---EEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCc---ceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--c
Confidence 4557888887 999999999999987543211 6788998875432 2333334455666667899999998876 3
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 141 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 141 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheE
Confidence 456899999999999999996543 2357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 142 li~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 207 (287)
T 1u59_A 142 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS----RSDVWSYGVTMWEAL 207 (287)
T ss_dssp EEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCc----hhhHHHHHHHHHHHH
Confidence 999987 9999999999876543221 123456688999999997766554 566999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=253.39 Aligned_cols=199 Identities=22% Similarity=0.303 Sum_probs=150.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+............++...+....|++++.+++.+. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-HDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTC-----CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CC-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-eCCe
Confidence 4479999999999999999999999877 778888876443322223333445556668999999888764 4568
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDR-------------------GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhhcc-------------------CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 9999999999999999876431 357788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC-CCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ .+||+|||++....... .......||+.|+|||++.... .....+..+|+||||+++|+|-
T Consensus 152 ~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 152 LEG-DIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216 (302)
T ss_dssp TTS-CEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred CCC-CEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence 887 99999999986432211 1123467999999999985321 1222345778999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=257.01 Aligned_cols=213 Identities=18% Similarity=0.229 Sum_probs=153.4
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (365)
.+..++|++.+.||+|+||.||+|++..++.. ..+++|.+...... ......++...+... .|++++.+++.+ .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~ 96 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-E 96 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-E
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcc---cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-e
Confidence 34568999999999999999999999877621 13477777643222 222233344455555 899999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.....++||||+++++|.+++.............. .......+++..++.++.|++.||.|||++||+||||||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI----ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHH----HTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccc----cccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 55789999999999999999986541000000000 00112356888999999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+++..... .......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 173 Il~~~~~-~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~ell 235 (327)
T 1fvr_A 173 ILVGENY-VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIV 235 (327)
T ss_dssp EEECGGG-CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred EEEcCCC-eEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCc----hhcchHHHHHHHHHH
Confidence 9999987 9999999999754322 1223456788999999997766554 566999999999973
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=251.79 Aligned_cols=198 Identities=16% Similarity=0.204 Sum_probs=151.9
Q ss_pred cccCCCeEEee-eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+..++|.+.+ .||+|+||.||+|.+..... .+.+++|.+...... ......++...+....|++++.+++.+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSS---EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCc---eeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 44557999998 99999999999996643221 167889887654322 122333455666677899999998876
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
....+++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~ 146 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 146 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcc
Confidence 4467899999999999999998654 3577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccc--cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+++......... .....+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 147 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 214 (291)
T 1xbb_A 147 NVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS----KSDVWSFGVLMWEAF 214 (291)
T ss_dssp GEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHHH
T ss_pred eEEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCCh----hhhHHHHHHHHHHHH
Confidence 99999987 99999999998765443221 22345678999999998766544 566999999999973
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=253.31 Aligned_cols=207 Identities=22% Similarity=0.295 Sum_probs=143.2
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+.+..++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ......++...+....|++++.+++.+ .
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 83 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKK-----EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-V 83 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCCCTTBCCEEEEE-E
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCC-----cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-e
Confidence 4557789999999999999999999998777 78999987643321 122223345556667899999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.....++||||+.+++|.+++..... ........+++..++.++.|++.||.|||++||+||||||+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVA------------KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHH------------TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred ecCCcEEEehhccCCchHHHHHHHhh------------ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 45679999999999999999875310 001122346888999999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc----cccccccCCCCcCCccccccC-CCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMS-TQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~-~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++.++ .+||+|||+++....... .......||+.|+|||++.+. .+ +..+|+||||+++|+|-+
T Consensus 152 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 152 ILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELAT 222 (303)
T ss_dssp EEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCC----CTHHHHHHHHHHHHHHHH
T ss_pred EEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCC----CchhhHHHHHHHHHHHHh
Confidence 9999987 999999999986643321 122356899999999998652 33 346779999999999843
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=252.09 Aligned_cols=195 Identities=17% Similarity=0.208 Sum_probs=146.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEec-CCCCCCCCcceeehhhccccHHHH--HHHHHHHHHhhc---cCCCceeeeecc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACAN---CCADFVYGFFEN 209 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~---~~~~~i~~~~~~ 209 (365)
...++|++.+.||+|+||.||+|.+. .++ +.|++|.+........ ..+.++...+.+ ..+.+++.+++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGG-----RHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCC-----cEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 34579999999999999999999984 444 6789998865432211 111122222222 223446666665
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIK 289 (365)
+ ...+.+++||||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 86 ~-~~~~~~~lv~e~~-~~~l~~~l~~~~~------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 145 (339)
T 1z57_A 86 F-EHHGHICIVFELL-GLSTYDFIKENGF------------------LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145 (339)
T ss_dssp E-EETTEEEEEEECC-CCBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred c-ccCCcEEEEEcCC-CCCHHHHHHhcCC------------------CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 5 4457899999999 7899999876541 235678899999999999999999999999999
Q ss_pred CCceEEecC------------------CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhh
Q 017820 290 PQNVIFSEG------------------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA 351 (365)
Q Consensus 290 p~NILl~~~------------------~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~ 351 (365)
|+|||++.+ ...+||+|||+++..... .....||+.|+|||++.+..++. .+|+
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~----~~Di 217 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQ----PCDV 217 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCT----HHHH
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCc----chhh
Confidence 999999873 227999999999864322 24568999999999998765544 5669
Q ss_pred hhhhhhheeccc
Q 017820 352 TALSPVLWQVQC 363 (365)
Q Consensus 352 ~slg~vlw~lGc 363 (365)
||||+++|+|-+
T Consensus 218 ~slG~il~el~~ 229 (339)
T 1z57_A 218 WSIGCILIEYYL 229 (339)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999999743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=274.94 Aligned_cols=198 Identities=16% Similarity=0.250 Sum_probs=149.6
Q ss_pred ccCCCeEEee-eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+..+++.+.+ .||+|+||.||+|.+..++.. ..||+|.++.... .......++...+....|+|++.+++.+..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCE---EEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCc---EEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 3456777777 899999999999988754311 5689998875421 122233345566677789999999887643
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 467 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHE
Confidence 46899999999999999996543 2357788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccc--cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+|+.+....... .....+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 468 Ll~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~----~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 468 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS----RSDVWSYGVTMWEAL 533 (613)
T ss_dssp EEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred EEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 999987 99999999998765432221 12345578999999998776654 556999999999963
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=256.07 Aligned_cols=192 Identities=20% Similarity=0.235 Sum_probs=132.4
Q ss_pred cCCCeEEee-eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc---c
Q 017820 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (365)
Q Consensus 137 ~~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (365)
..++|.+.+ .||+|+||.||+|.+..++ +.||+|.+....... .++........|++++.+++.+. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~----~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTG-----QKCALKLLYDSPKAR----QEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCC-----CEEEEEEecCcHHHH----HHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 447999965 6999999999999999887 889999886543222 12223334445666666655442 2
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERG------------------DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-------------------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEeccCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3456899999999999999998653 1246788899999999999999999999999999999
Q ss_pred eEEecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ ..+||+|||+++..... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDK----SCDMWSLGVIMYILL 223 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-------------------------CHHHH----HHHHHHHHHHHHHHH
T ss_pred EEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCc----hhhHHHHHHHHHHHH
Confidence 9998643 26999999999865432 224568899999999987666554 556999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=259.10 Aligned_cols=182 Identities=16% Similarity=0.157 Sum_probs=134.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----------HHHHHHHHHHHHhhc------cC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----------VEIWMNERVRRACAN------CC 199 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~~~~~------~~ 199 (365)
..++|++.+.||+|+||+||+|++ ++ +.||+|.+..... .....+.++...+.. ..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~ 90 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DH-----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TT-----EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred ccccchheeeecccCceEEEEEEe--CC-----ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence 447899999999999999999998 33 7899998864421 222222222222221 12
Q ss_pred C-----------------Cceeeeeccccc------------CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhcccc
Q 017820 200 A-----------------DFVYGFFENSSK------------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250 (365)
Q Consensus 200 ~-----------------~~i~~~~~~~~~------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~ 250 (365)
| ++++.+++.+.. ....+++||||+.+|++.+.+...
T Consensus 91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------------- 156 (336)
T 2vuw_A 91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------------- 156 (336)
T ss_dssp CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT--------------
T ss_pred CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc--------------
Confidence 4 444444444322 267899999999999766655332
Q ss_pred ccCcccccccHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCceEEecCC-------------------CcEEEEecccc
Q 017820 251 QDLPKGIERENRIIQTIMSQLLFALDGLH-STGIVHRDIKPQNVIFSEGS-------------------RTFKIIDLGAA 310 (365)
Q Consensus 251 ~~~~~~~~~~~~~i~~i~~qi~~aL~yLH-~~~IiHrDIKp~NILl~~~~-------------------~~ikL~DFGla 310 (365)
.+++..++.++.||+.||.||| ++||+||||||+|||++.++ ..+||+|||+|
T Consensus 157 -------~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a 229 (336)
T 2vuw_A 157 -------LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS 229 (336)
T ss_dssp -------CCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTC
T ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecccc
Confidence 2477889999999999999999 99999999999999999864 28999999999
Q ss_pred cccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhh
Q 017820 311 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357 (365)
Q Consensus 311 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~v 357 (365)
+.... ....||+.|||||++.+.. +..+|+||++..
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~g~~-----~~~~Diwsl~~~ 265 (336)
T 2vuw_A 230 RLERD------GIVVFCDVSMDEDLFTGDG-----DYQFDIYRLMKK 265 (336)
T ss_dssp BEEET------TEEECCCCTTCSGGGCCCS-----SHHHHHHHHHHH
T ss_pred EecCC------CcEEEeecccChhhhcCCC-----ccceehhhhhCC
Confidence 87653 2458999999999997654 457789997655
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=250.26 Aligned_cols=200 Identities=18% Similarity=0.154 Sum_probs=145.6
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.+..++|++.+.||+|+||.||+|++..+.... ..|++|.+..... .......++...+....|++++.+++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCE--EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCce--eEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 345579999999999999999999976543211 3588888764321 22233334455566668999999988764
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.. ..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 92 ~~--~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 150 (291)
T 1u46_A 92 TP--PMKMVTELAPLGSLLDRLRKHQ-------------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 150 (291)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHHG-------------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred cC--CceeeEecccCCCHHHHHHhcc-------------------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence 43 4889999999999999997653 13577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+++........ ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 151 Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 218 (291)
T 1u46_A 151 NLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH----ASDTWMFGVTLWEMF 218 (291)
T ss_dssp GEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHHH
T ss_pred eEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCc----hhhHHHHHHHHHHHH
Confidence 99999987 9999999999876543221 223456788999999998765543 566999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=250.83 Aligned_cols=194 Identities=22% Similarity=0.267 Sum_probs=151.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEec-CCCCCCCCcceeehhhccccHH-----HHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.++|++.+.||+|+||.||+|++. .++ +.|++|.+...... ....+..+...+....|++++.+++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCC-----EEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 379999999999999999999985 444 67888877533211 1222223334444457888888877653
Q ss_pred ----cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 212 ----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 212 ----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
.....+++||||++ ++|.+++..... ..+++..++.++.|++.||.|||++||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~d 145 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPE------------------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCT------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhccc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 24577899999999 599999876531 2357788999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 146 lkp~Nili~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~ 213 (326)
T 1blx_A 146 LKPQNILVTSSG-QIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYAT----PVDLWSVGCIFAEMF 213 (326)
T ss_dssp CCGGGEEECTTC-CEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCT----HHHHHHHHHHHHHHH
T ss_pred CCHHHeEEcCCC-CEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCc----chhHHHHHHHHHHHH
Confidence 999999999987 99999999998764322 234568899999999998765544 567999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=250.09 Aligned_cols=204 Identities=21% Similarity=0.188 Sum_probs=156.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..+..++|.....||+|+||.||+|.+..++ ..|++|.+............++...+....|++++.+++.+ ..
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 90 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQ-----VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-SE 90 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTC-----CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-EE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCC-----eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-Ee
Confidence 3444555656669999999999999998887 78999988765444344444556667777899999998877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+..++||||+++++|.+++..... ....++..++.++.|++.||.|||++||+||||||+||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWG-----------------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTC-----------------CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhcc-----------------CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 5789999999999999999976531 12346778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++.+++.+||+|||+++....... ......||+.|+|||++.+... ..+..+|+||||+++|+|-+
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~ 220 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPR--GYGKAADIWSLGCTIIEMAT 220 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGG--GCSHHHHHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEeecccccccCCCCC-cccccCCCccccChhhhcCCCC--CCCcHHHHHHHHHHHHHHHH
Confidence 9998334999999999987643221 2345689999999999876431 12346779999999999843
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.34 Aligned_cols=195 Identities=23% Similarity=0.276 Sum_probs=151.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccC--
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ......++...+....|++++.+++.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCC-----cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3479999999999999999999998887 78999988643322 222333455666677899999888765332
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 214 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
....++||||++ ++|.+++.... +++..++.++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~~---------------------~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQM---------------------LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CccceEEEEEeccC-ccHHHHHhhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 367899999998 58999887642 467888999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc---------ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY---------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+|+.+...... ......||+.|+|||++.+. ...+..+|+||||+++|+|-
T Consensus 142 Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 142 NLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS---AKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp GEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSC---CCCCHHHHHHHHHHHHHHHH
T ss_pred HeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccC---CCccchhhHHHHHHHHHHHH
Confidence 99999987 9999999999876532211 12245789999999987642 22344677999999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=257.18 Aligned_cols=194 Identities=19% Similarity=0.233 Sum_probs=146.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhh---ccCCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACA---NCCADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~---~~~~~~i~~~~~~~~ 211 (365)
..++|++.+.||+|+||+||+|.+..++ +.||+|.+....... ...+.++...+. ...+.+++.+.+.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~- 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQ-----EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF- 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCC-----cEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee-
Confidence 4579999999999999999999998887 789999887543221 111222222222 22233466666555
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH--HCCCcccCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDIK 289 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH--~~~IiHrDIK 289 (365)
.....+++||||+++ +|.+++..... ..+++..++.++.|++.||.||| +.||+|||||
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk 186 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNF------------------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK 186 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTT------------------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCc------------------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC
Confidence 345789999999975 99999987541 13577889999999999999999 5799999999
Q ss_pred CCceEEec-CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 290 PQNVIFSE-GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 290 p~NILl~~-~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+|||++. +...+||+|||+|+..... .....||+.|+|||++.+..++ ..+|+||||+++|+|-+
T Consensus 187 p~NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~----~~~DiwSlG~il~ellt 253 (382)
T 2vx3_A 187 PENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYD----LAIDMWSLGCILVEMHT 253 (382)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHH
T ss_pred cccEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCC----cHHHHHHHHHHHHHHHh
Confidence 99999964 2238999999999876432 2457899999999999877654 45669999999999843
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=276.49 Aligned_cols=194 Identities=17% Similarity=0.213 Sum_probs=145.3
Q ss_pred CCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+.+.+. ++||+|+||.||+|.+...... +.||+|.++..... ......++...+....|++|+.+++.+. ..
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~ 442 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVV---KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AE 442 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCE---EEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SS
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcc---eEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cC
Confidence 345554 4899999999999976533211 67899987654321 1222333455566667999999988763 34
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl 502 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 502 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CEEEEEEccCCCCHHHHHhhCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE
Confidence 5889999999999999997654 35778899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+|+.+...... ......+|+.|+|||++.+..++. .+|+||||+++|+|-
T Consensus 503 ~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~----~sDvwSlGv~l~ell 566 (635)
T 4fl3_A 503 VTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS----KSDVWSFGVLMWEAF 566 (635)
T ss_dssp EETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred eCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCc----HHHHHHHHHHHHHHH
Confidence 9987 9999999999877544321 123345688999999998776655 556999999999963
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=254.68 Aligned_cols=188 Identities=22% Similarity=0.309 Sum_probs=146.4
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCC-
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGG- 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~- 215 (365)
++|.+.+.||+|+||.||+|.+..++ +.||+|++..... .......++...+....|++++.+++.+...+.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCC-----CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 79999999999999999999999887 8899998865322 222333345566677789999988877644332
Q ss_pred ----eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 216 ----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 216 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.+++||||++ ++|.+++.. .+++..++.++.|++.||.|||++||+||||||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMGM----------------------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ccceeEEEEEcccc-ccHHHHhhc----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 3499999998 588777632 2477889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+..... .....||+.|+|||++.+ ..++ ..+|+||||+++|+|-+
T Consensus 174 NIll~~~~-~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~----~~~DiwslG~il~el~~ 237 (371)
T 4exu_A 174 NLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYN----QTVDIWSVGCIMAEMLT 237 (371)
T ss_dssp GEEECTTC-CEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCC----TTHHHHHHHHHHHHHHH
T ss_pred HeEECCCC-CEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCC----cHHhHHHHHHHHHHHHh
Confidence 99999987 9999999999865422 245688999999999876 3444 35669999999999843
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=260.98 Aligned_cols=194 Identities=25% Similarity=0.274 Sum_probs=144.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
...+|++.+.||+|+||.||+|++..+ +.+++|++....... .++...+....|+|++.+++.+...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~------~~~aikk~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVES------DEVAIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTT------EEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCC------CeEEEEEEecCcchH----HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 346899999999999999999998876 447887775432211 1234555666789988887665332
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 214 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+++||||++++.+........ ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAK-----------------LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHH-----------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCceEEEEEeeccCccHHHHHHHHHh-----------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 234789999999754433332111 1124577889999999999999999999999999999
Q ss_pred ceEEe-cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~-~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++ .++ .+||+|||+|+.+..+.. .....||+.|+|||++.+... .+..+|+||||+++|+|-+
T Consensus 171 Nill~~~~~-~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 171 NLLLDPPSG-VLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATN---YTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp GEEEETTTT-EEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSS---CCTHHHHHHHHHHHHHHHH
T ss_pred HEEEcCCCC-cEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCC---CCcHHHHHHHHHHHHHHHh
Confidence 99999 555 999999999987644332 245688999999999866431 2346679999999999843
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=252.92 Aligned_cols=198 Identities=16% Similarity=0.121 Sum_probs=153.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC-CCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-GGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~ 216 (365)
+.|++.+.||+|+||.||++.+..... ...+.||+|.+..... .......++...+....|++++.+++.+... ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345999999999999999887543211 0117799998875432 2233344456666777799999988877554 468
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++++|.+++.... +++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~ 168 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS---------------------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC---------------------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc
Confidence 899999999999999987643 46778899999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.++ .+||+|||+++....... .......+|+.|+|||++.+..++. .+|+||||+++|+|-+
T Consensus 169 ~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~ll~ 232 (318)
T 3lxp_A 169 NDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY----ASDVWSFGVTLYELLT 232 (318)
T ss_dssp TTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHHHT
T ss_pred CCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc----HHHHHHHHHHHHHHHh
Confidence 987 999999999987754432 1233467888999999998776654 5569999999999843
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=254.17 Aligned_cols=194 Identities=17% Similarity=0.221 Sum_probs=142.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----------HHHHHHHHHHHHhhccCCCceee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----------VEIWMNERVRRACANCCADFVYG 205 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~i~~ 205 (365)
..++|++.+.||+|+||.||+|.+.. + +.||+|++..... .......++...+....|++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-G-----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-S-----CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-C-----CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 56899999999999999999999865 4 7789997753221 11123334455666667999988
Q ss_pred eeccccc----CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC
Q 017820 206 FFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (365)
Q Consensus 206 ~~~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~ 281 (365)
+++.+.. ....+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-------------------IVISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 8766532 3357899999999 58888887543 2357788999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+.. ..+..+|+||||+++|+|
T Consensus 154 ~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 154 GVVHRDLHPGNILLADNN-DITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFK---GFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp TCCCCCCCGGGEEECTTC-CEEECCTTC-----------------CGGGCCHHHHTTCT---TCCTHHHHHHHHHHHHHH
T ss_pred cCEecCCChHHEEEcCCC-CEEEEecCccccccccc--ccceecccceecCcHHhcCCC---CCCcHhHHHhHHHHHHHH
Confidence 999999999999999887 99999999998644332 234568899999999987622 234467799999999998
Q ss_pred c
Q 017820 362 Q 362 (365)
Q Consensus 362 G 362 (365)
-
T Consensus 228 ~ 228 (362)
T 3pg1_A 228 F 228 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=247.33 Aligned_cols=193 Identities=22% Similarity=0.269 Sum_probs=149.7
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.|..++.||+|+||.||+|.+.+ +.+++|++.... ........++...+....|++++.+++.+ ....
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 103 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGD 103 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSS-------CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSS
T ss_pred ccccCCccccCCCeEEEEEEECC-------ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-ecCC
Confidence 34456899999999999998743 678888775321 11222333445566667899999988876 4456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++||||+++++|.+++.... ....+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCLD-----------------GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL 166 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTGG-----------------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ceEEEEEecCCCcHHHHHHhcc-----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 8899999999999999987543 12245788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+++....... .......||+.|+|||++.+. .+..+|+||||+++|+|-+
T Consensus 167 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~Dv~slG~il~~l~~ 229 (307)
T 2nru_A 167 DEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-----ITPKSDIYSFGVVLLEIIT 229 (307)
T ss_dssp CTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-----ECTHHHHHHHHHHHHHHHH
T ss_pred cCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcCC-----CCccchhHHHHHHHHHHHH
Confidence 9987 999999999987643322 123346899999999988653 3457789999999999843
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.41 Aligned_cols=187 Identities=21% Similarity=0.254 Sum_probs=148.7
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecC-CCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAK-KPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
..++|++.+.||+|+||.||+|.+.. ++ +.|++|.+..... .......++...+....|++|+.+++.+...+
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNG-----RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTT-----EEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCC-----cEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 44899999999999999999999975 45 7799998764433 22233344566677778999998887765433
Q ss_pred C----eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 G----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
. ..++||||+++++|.+++.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----------------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp 210 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----------------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP 210 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh
Confidence 2 27999999999999886643 247788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +..+|+||||+++|+|-
T Consensus 211 ~NIll~~~--~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~sDi~slG~~l~~l~ 270 (681)
T 2pzi_A 211 ENIMLTEE--QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-----TVATDIYTVGRTLAALT 270 (681)
T ss_dssp GGEEECSS--CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-----CHHHHHHHHHHHHHHHH
T ss_pred HHeEEeCC--cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-----CCceehhhhHHHHHHHH
Confidence 99999873 8999999999876432 4568999999999987643 45788999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=255.32 Aligned_cols=197 Identities=20% Similarity=0.266 Sum_probs=148.8
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHH--HHHHHHHhhc--------cCCCcee
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWM--NERVRRACAN--------CCADFVY 204 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~--------~~~~~i~ 204 (365)
.+..++|++.+.||+|+||.||+|.+..++ +.||+|.+.......... +.++...+.. ..|++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCC-----cEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 345689999999999999999999998887 889999887443222211 1122222221 2267777
Q ss_pred eeeccccc---CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC
Q 017820 205 GFFENSSK---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (365)
Q Consensus 205 ~~~~~~~~---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~ 281 (365)
.+++.+.. .+..+++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~ 150 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE------------------HRGIPLIYVKQISKQLLLGLDYMHRR 150 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT------------------TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh------------------ccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 77665533 224789999999 789999997643 12357788999999999999999998
Q ss_pred -CCcccCCCCCceEEecCC-----CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhh
Q 017820 282 -GIVHRDIKPQNVIFSEGS-----RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (365)
Q Consensus 282 -~IiHrDIKp~NILl~~~~-----~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg 355 (365)
||+||||||+|||++.++ ..+||+|||+|+..... .....||+.|+|||++.+..++. .+|+||||
T Consensus 151 ~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~----~~Di~slG 222 (373)
T 1q8y_A 151 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGC----GADIWSTA 222 (373)
T ss_dssp TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCT----HHHHHHHH
T ss_pred CCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCc----hHhHHHHH
Confidence 999999999999996322 27999999999876432 23468899999999998766544 56699999
Q ss_pred hhheeccc
Q 017820 356 PVLWQVQC 363 (365)
Q Consensus 356 ~vlw~lGc 363 (365)
+++|+|-+
T Consensus 223 ~il~el~~ 230 (373)
T 1q8y_A 223 CLIFELIT 230 (373)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999743
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=255.00 Aligned_cols=198 Identities=20% Similarity=0.233 Sum_probs=136.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|++........ ...++...+....|+|++.+++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~-~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTG-----MSVAIKKVIQDPRFRN-RELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTC-----CEEEEEEEECCTTCCC-HHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEecCccccH-HHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 4489999999999999999999999887 7889987754322111 112233334445688888877665332
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHH--HCCCcccCC
Q 017820 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDI 288 (365)
Q Consensus 214 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH--~~~IiHrDI 288 (365)
...+++||||+++ +|.+.+.... .....+++..++.++.|++.||.||| ++||+||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dl 157 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY----------------RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH----------------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCC
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh----------------hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcC
Confidence 2247899999997 5554443211 11234577888999999999999999 999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||++.+++.+||+|||+|+.+..... .....||+.|+|||++.+.. ..+..+|+||||+++|+|-
T Consensus 158 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~ell 226 (360)
T 3e3p_A 158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQ---HYTTAVDIWSVGCIFAEMM 226 (360)
T ss_dssp CGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCC---CCCcHHHHHHHHHHHHHHH
Confidence 999999997334999999999987654332 24567899999999986543 1344667999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=247.25 Aligned_cols=199 Identities=19% Similarity=0.189 Sum_probs=153.0
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhccCCCceeeeecccc-c
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSS-K 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 212 (365)
.++|++.+.||+|+||.||+|.+..++ ..+++|.+..... .......++...+....|++++.+++.+. .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETL-----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTC-----CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCC-----cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 478999999999999999999998887 7788887764321 12233344556677778999999888764 3
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.....++||||++++ |.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N 139 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVP------------------EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHST------------------TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeEEEEehhccCC-HHHHHHhCc------------------ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 346789999999976 777776532 1245778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ .+||+|||++....... ........||+.|+|||++.+... ..+..+|+||||+++|+|-+
T Consensus 140 Il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 140 LLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT--FSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp EEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC--EESHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCccc--CCcchhhHHHHHHHHHHHHh
Confidence 9999987 99999999998764322 222345679999999999865322 12346789999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=244.34 Aligned_cols=191 Identities=19% Similarity=0.258 Sum_probs=152.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH--HHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.+++.+ .....
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 95 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSS 95 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-eCCCe
Confidence 68999999999999999999998877 7788888753321 1122233345556667899999988876 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++|+||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK--------------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred EEEEEEccCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 999999999999999887654 357788999999999999999999999999999999997
Q ss_pred cCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ ..+||+|||+++....... .....||+.|+|||++.+. .+..+|+||||+++|+|-
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILL 216 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTTC-----CCTHHHHHHHHHHHHHHH
T ss_pred cCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHhcCC-----CCCchhhHhHHHHHHHHH
Confidence 643 2799999999987654322 2345689999999998653 345778999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=248.92 Aligned_cols=194 Identities=16% Similarity=0.211 Sum_probs=142.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHH--HHHHHHHHhhccC---CCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCC---ADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~---~~~i~~~~~~~~ 211 (365)
..++|++.+.||+|+||.||+|.+..++. ..|++|.+......... .+.++...+.+.. +..++.+.+.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~- 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF- 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCc----eEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-
Confidence 45899999999999999999999976641 46888887654332221 1112222332222 22244444443
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
...+.+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~------------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~ 152 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNF------------------QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPE 152 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 4457899999999 5567777665431 23577889999999999999999999999999999
Q ss_pred ceEE-------------------ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhh
Q 017820 292 NVIF-------------------SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (365)
Q Consensus 292 NILl-------------------~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~ 352 (365)
|||+ +.++ .+||+|||+++..... .....||+.|+|||++.+..++. .+|+|
T Consensus 153 NIll~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~----~~Di~ 223 (355)
T 2eu9_A 153 NILFVNSEFETLYNEHKSCEEKSVKNT-SIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQ----PCDVW 223 (355)
T ss_dssp GEEESCCCEEEEECCC-CCCEEEESCC-CEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCT----HHHHH
T ss_pred HEEEecccccccccccccccccccCCC-cEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCC----ccchH
Confidence 9999 4555 9999999999864322 24568999999999998766544 56699
Q ss_pred hhhhhheeccc
Q 017820 353 ALSPVLWQVQC 363 (365)
Q Consensus 353 slg~vlw~lGc 363 (365)
|||+++|+|-+
T Consensus 224 slG~il~el~~ 234 (355)
T 2eu9_A 224 SIGCILFEYYR 234 (355)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999999743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=250.63 Aligned_cols=189 Identities=21% Similarity=0.291 Sum_probs=146.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|.+.+.||+|+||.||+|.+..++ +.|++|.+.... ........++...+....|++++.+++.+...+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCC-----CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 378999999999999999999998887 889999876432 222223334555666778999998887764443
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||++ ++|.+++.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~----------------------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 154 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMGL----------------------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 154 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred cccceeEEEEecccc-CCHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 24699999998 577665532 257788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc-CCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM-STQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+++..... .....||+.|+|||++.+ ..+ +..+|+||||+++|+|-+
T Consensus 155 ~NIl~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~----~~~~Di~slG~il~el~~ 219 (353)
T 3coi_A 155 GNLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHY----NQTVDIWSVGCIMAEMLT 219 (353)
T ss_dssp GGEEECTTC-CEEECSTTCTTC------------CCSBCCSCHHHHSCCSCC----CTTHHHHHHHHHHHHHHH
T ss_pred HHEeECCCC-cEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCC----CchhhHHHHHHHHHHHHh
Confidence 999999987 9999999999865422 235688999999999876 333 345679999999999843
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=251.40 Aligned_cols=195 Identities=21% Similarity=0.313 Sum_probs=149.8
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---------HHHHHHHHHHHhhccCCCceeee
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---------EIWMNERVRRACANCCADFVYGF 206 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~~ 206 (365)
...++|++.+.||+|+||.||+|.+..++ +.|++|.+...... ....+..+...+. ..|++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~i~~~ 113 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS-SGFSGVIRL 113 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTT-----EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC-SSSCSBCCE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc-cCCCCceEE
Confidence 35689999999999999999999998887 78888887543211 0011111112221 146888888
Q ss_pred ecccccCCCeEEEEEEecCC-CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 207 FENSSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
++.+ ......++|+|++.+ ++|.+++.... .+++..++.++.|++.||.|||++||+|
T Consensus 114 ~~~~-~~~~~~~lv~e~~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH 172 (320)
T 3a99_A 114 LDWF-ERPDSFVLILERPEPVQDLFDFITERG--------------------ALQEELARSFFWQVLEAVRHCHNCGVLH 172 (320)
T ss_dssp EEEE-ECSSEEEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEE-ecCCcEEEEEEcCCCCccHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 7776 455789999999986 89999997654 3577889999999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||||+|||++.+++.+||+|||+++...... .....||+.|+|||++.+... .+..+|+||||+++|+|-+
T Consensus 173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~---~~~~~Di~slG~il~el~~ 244 (320)
T 3a99_A 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVC 244 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCB---CHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCC---CCccchHHhHHHHHHHHHH
Confidence 99999999999433499999999998765332 245679999999999876543 2335679999999999843
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=244.91 Aligned_cols=200 Identities=18% Similarity=0.216 Sum_probs=138.8
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
....++|++.+.||+|+||.||+|.+..++ +.|++|.+......+ .....++........|++++.+++.+ .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~ 94 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-I 94 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTC-----CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-E
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCC-----eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-e
Confidence 335679999999999999999999998887 789999886543322 22223334456667899999998876 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCC
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~-~IiHrDIKp~ 291 (365)
.+..+++||||+ ++.+..+..... ..+++..++.++.|++.||.|||++ ||+||||||+
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~ 154 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ-------------------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGG
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHH
Confidence 557899999999 456665554432 1357788999999999999999995 9999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+++.+..... .....||+.|+|||++..... ....+..+|+||||+++|+|-+
T Consensus 155 Nil~~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (318)
T 2dyl_A 155 NILLDERG-QIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224 (318)
T ss_dssp GEEECTTS-CEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH
T ss_pred HEEECCCC-CEEEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh
Confidence 99999987 999999999987644322 235679999999999864321 2234457889999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=250.32 Aligned_cols=194 Identities=20% Similarity=0.242 Sum_probs=145.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH------HHHHHHHHHHhh----ccCCCceeee
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE------IWMNERVRRACA----NCCADFVYGF 206 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~~~----~~~~~~i~~~ 206 (365)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+....... .....++...+. ...|++++.+
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDR-----LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTC-----CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCC-----eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4579999999999999999999998887 788999875432211 111111222222 2278999998
Q ss_pred ecccccCCCeEEEEEEe-cCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 207 FENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 207 ~~~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
++.+ ......++|+|+ +.+++|.+++.... .+++..++.++.|++.||.|||++||+|
T Consensus 104 ~~~~-~~~~~~~~v~e~~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H 162 (312)
T 2iwi_A 104 LDWF-ETQEGFMLVLERPLPAQDLFDYITEKG--------------------PLGEGPSRCFFGQVVAAIQHCHSRGVVH 162 (312)
T ss_dssp EEEC------CEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHTEEC
T ss_pred EEEE-ecCCeEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 8876 445678899999 78999999998654 3577889999999999999999999999
Q ss_pred cCCCCCceEEe-cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 286 RDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 286 rDIKp~NILl~-~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||||+||+++ .++ .+||+|||+++...... .....||+.|+|||++.+.... ...+|+||||+++|+|-+
T Consensus 163 ~dlkp~Nil~~~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~---~~~~Di~slG~il~~l~~ 234 (312)
T 2iwi_A 163 RDIKDENILIDLRRG-CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYH---ALPATVWSLGILLYDMVC 234 (312)
T ss_dssp CCCSGGGEEEETTTT-EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBC---HHHHHHHHHHHHHHHHHH
T ss_pred cCCChhhEEEeCCCC-eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCC---CccchHHHHHHHHHHHHH
Confidence 99999999999 555 99999999998765432 2456799999999998765432 235779999999999843
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=257.96 Aligned_cols=202 Identities=21% Similarity=0.282 Sum_probs=137.5
Q ss_pred CCeEE-eeeeecCCCeeEEEEEecC--CCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc-cCC
Q 017820 139 DDFVL-GKKLGEGAFGVVYRASLAK--KPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-KKG 214 (365)
Q Consensus 139 ~~y~l-~~~LG~G~fG~Vy~a~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~ 214 (365)
+.|++ +++||+|+||.||+|++.. ++ +.||+|.+......+.. .++...+....|++++.+++.+. ..+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~-----~~vaiK~~~~~~~~~~~--~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDD-----KDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCC-----CCEEEEECSSSSCCHHH--HHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCC-----eEEEEEEECCCCCCHHH--HHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 56877 5689999999999999763 34 77999988754433222 23455566667999998877764 345
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+++ +|.+++...... ........+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIl 160 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRAS-----------KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 160 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHH-----------C-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccc-----------cccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeE
Confidence 789999999985 888887643210 00111224688899999999999999999999999999999999
Q ss_pred E----ecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 295 F----SEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 295 l----~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ +.++ .+||+|||+|+.+..... .......||+.|+|||++.+... .+..+|+||||+++|+|-+
T Consensus 161 l~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlG~il~ell~ 231 (405)
T 3rgf_A 161 VMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 231 (405)
T ss_dssp ECCSSTTTT-CEEECCTTCCC----------------CCCTTCCHHHHTTCCS---CCHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCC-cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCc---ccchhhhHHHHHHHHHHHh
Confidence 9 4545 999999999987653321 22345789999999999876431 2345679999999999843
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=243.75 Aligned_cols=198 Identities=15% Similarity=0.227 Sum_probs=142.9
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhcc--CCCceeeeeccc
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC--CADFVYGFFENS 210 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~ 210 (365)
.+..++|++.+.||+|+||.||+|.+.. + +.+++|.+.... ........++...+... .|++++.+++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCC-C-----cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3455789999999999999999999864 3 678888875332 22222222233333332 257888887766
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+...++||| +.+++|.+++.... .+++..++.++.|++.||.|||+++|+||||||
T Consensus 98 -~~~~~~~lv~e-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 155 (313)
T 3cek_A 98 -ITDQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155 (313)
T ss_dssp -ECSSEEEEEEC-CCSEEHHHHHHHCS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred -ecCCEEEEEEe-cCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc
Confidence 44568999999 67789999998654 346778889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCC-------CCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQT-------PSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~-------~~~d~~s~~~slg~vlw~lG 362 (365)
+|||+++ + .+||+|||+++.+..... .......||+.|+|||++.+.... ...+..+|+||||+++|+|-
T Consensus 156 ~NIl~~~-~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 233 (313)
T 3cek_A 156 ANFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233 (313)
T ss_dssp GGEEEET-T-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred ccEEEEC-C-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence 9999975 5 999999999987654322 122356799999999998763221 23455788999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=252.29 Aligned_cols=201 Identities=15% Similarity=0.139 Sum_probs=154.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-----------------HHHHHHHHHHhhcc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----------------IWMNERVRRACANC 198 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~~~~~~~~ 198 (365)
...++|++.+.||+|+||.||+|.+ ++ +.|++|.+....... .....++...+...
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DN-----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TT-----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CC-----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 3458999999999999999999999 44 789999876432211 02333445666777
Q ss_pred CCCceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHH
Q 017820 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL 278 (365)
Q Consensus 199 ~~~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yL 278 (365)
.|++++.+++.+ ...+..++||||+++++|.+++...... .......+++..++.++.|++.||.||
T Consensus 101 ~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~l------------~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 101 KNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVL------------DKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp CCTTBCCCSEEE-ESSSEEEEEEECCTTCBSSEESSSEESS------------CSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcceEEEEE-eeCCeEEEEEeccCCCcHHHHHHHhhhh------------hhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 899999988876 4457899999999999998873221000 000134568889999999999999999
Q ss_pred HH-CCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCC-chhhhhhhh
Q 017820 279 HS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS-APVATALSP 356 (365)
Q Consensus 279 H~-~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~-~s~~~slg~ 356 (365)
|+ +||+||||||+|||++.++ .+||+|||+++..... ......||+.|+|||++.+.. ..+. .+|+||||+
T Consensus 168 H~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~ 240 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNES---SYNGAKVDIWSLGI 240 (348)
T ss_dssp HHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCC---CEEHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEEcCCC-cEEEeccccccccccc---cccCCCCCcCccCchhhcCCC---CCCcchhhHHHHHH
Confidence 99 9999999999999999987 9999999999876433 234568999999999987652 1122 677999999
Q ss_pred hheeccc
Q 017820 357 VLWQVQC 363 (365)
Q Consensus 357 vlw~lGc 363 (365)
++|+|-+
T Consensus 241 il~~l~~ 247 (348)
T 2pml_X 241 CLYVMFY 247 (348)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=264.80 Aligned_cols=199 Identities=23% Similarity=0.233 Sum_probs=154.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeeccccc---
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (365)
..++|++.+.||+|+||.||+|.+..++ +.||+|.+.... ........++...+....|+|++.+++....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg-----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTG-----EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTT-----CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 4479999999999999999999998887 789999886542 2223333445566666789999888766432
Q ss_pred --CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 213 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
.+...++||||+++++|.+++..... ...+++..++.++.|++.||.|||++||+||||||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~-----------------~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP 149 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFEN-----------------CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKP 149 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSC-----------------TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCS
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhccc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 25778999999999999999986431 12356677889999999999999999999999999
Q ss_pred CceEEecCCC--cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~--~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++. .+||+|||+++...... ......||+.|+|||++.+..++.+ +|+||||+++|+|-+
T Consensus 150 ~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~k----sDIwSLGviLyeLlt 218 (676)
T 3qa8_A 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVT----VDYWSFGTLAFECIT 218 (676)
T ss_dssp TTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTT----HHHHHHHHHHHHHHS
T ss_pred HHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCch----hHHHHHHHHHHHHHH
Confidence 9999997652 49999999998765433 2345789999999999987766554 559999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=252.92 Aligned_cols=202 Identities=18% Similarity=0.139 Sum_probs=139.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhh-ccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA-NCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~ 215 (365)
..+.|.+.+.||+|+||+||.+.. .++ +.||+|++......... ++...+. ...|+|++.+++.. ..+.
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~-~~g-----~~vAvK~~~~~~~~~~~---~E~~~l~~l~~HpnIv~~~~~~-~~~~ 82 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGS-FQG-----RPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSE-TTDR 82 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEE-SSS-----SEEEEEEEEGGGHHHHH---HHHHHHHHHTTSTTBCCEEEEE-ECSS
T ss_pred hhheeeccCeEeeCCCeEEEEEEE-ECC-----eEEEEEEEcHHHHHHHH---HHHHHHHhccCCCCcCeEEEEE-ecCC
Confidence 335677789999999999986543 344 78999988654432221 2223333 34799999998776 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||++ |+|.+++......... ....++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl 148 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDEN-------------LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC-------------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchh-------------hhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 8999999997 5999999876421000 0011223457899999999999999999999999999999
Q ss_pred ecC------------CCcEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCC---CCCCCCchhhhhhhhh
Q 017820 296 SEG------------SRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQ---TPSAPSAPVATALSPV 357 (365)
Q Consensus 296 ~~~------------~~~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~---~~~~d~~s~~~slg~v 357 (365)
+.+ ...+||+|||+|+.+...... ......||+.|+|||++.+... ....+..+|+||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i 228 (434)
T 2rio_A 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228 (434)
T ss_dssp ECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred ecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence 753 238999999999976543221 1235689999999999976321 2344567889999999
Q ss_pred heecc
Q 017820 358 LWQVQ 362 (365)
Q Consensus 358 lw~lG 362 (365)
+|+|-
T Consensus 229 l~ell 233 (434)
T 2rio_A 229 FYYIL 233 (434)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99973
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=252.87 Aligned_cols=198 Identities=22% Similarity=0.198 Sum_probs=138.7
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhcc-CCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~ 213 (365)
.+...+|.+.+.||+|+||+||... ..++ +.||+|++........ .++...+... .|+||+.+++.. ..
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~-~~~~-----~~vAvK~~~~~~~~~~---~~E~~~l~~l~~HpnIv~l~~~~-~~ 89 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRG-MFDN-----RDVAVKRILPECFSFA---DREVQLLRESDEHPNVIRYFCTE-KD 89 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEE-ESSS-----SEEEEEEECTTTEEEC---HHHHHHHHHSCCCTTBCCEEEEE-EE
T ss_pred EEccEEEecCCeeecCcCEEEEEEE-EeCC-----eEEEEEEECHHHHHHH---HHHHHHHHhccCCCCcCeEEEEE-ec
Confidence 3455679999999999999965332 2333 7799998764322111 1223333333 799999998776 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||++ ++|.+++....... .+..++.++.||+.||.|||++||+||||||+||
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~-------------------~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI 149 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAH-------------------LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCC-------------------CSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSE
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCc-------------------cchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHE
Confidence 678999999997 59999998765321 1223567999999999999999999999999999
Q ss_pred EEecCC----CcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGS----RTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~----~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ ..+||+|||+|+.+..... .......||+.|+|||++.+... ...+..+|+||||+++|+|-+
T Consensus 150 ll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK-ENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp EECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred EEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc-cCCCcHHHHHHHHHHHHHHHc
Confidence 996322 2688999999987654321 22345789999999999874322 222346789999999999843
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-31 Score=244.92 Aligned_cols=201 Identities=16% Similarity=0.152 Sum_probs=148.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
.+.+..++|++.+.||+|+||.||+|.+.. .+++|.+...... ......++...+....|++++.+++.+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 456677899999999999999999998853 4677766532211 111112234455666899999988876
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
. ....+++||||+.+++|.+++...+. .+++..++.++.|++.||.|||++||+||||||
T Consensus 99 ~-~~~~~~iv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp 158 (319)
T 2y4i_B 99 M-SPPHLAIITSLCKGRTLYSVVRDAKI-------------------VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS 158 (319)
T ss_dssp E-CSSCEEEECBCCCSEEHHHHTTSSCC-------------------CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCS
T ss_pred e-cCCceEEEeecccCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCh
Confidence 4 45679999999999999999876431 346677889999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCC----ccccccccCCCCcCCccccccCCCC-----CCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQT-----PSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~-----~~~d~~s~~~slg~vlw~l 361 (365)
+|||++ ++ .+||+|||+++...... ........||+.|+|||++.+.... ...+..+|+||||+++|+|
T Consensus 159 ~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 236 (319)
T 2y4i_B 159 KNVFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236 (319)
T ss_dssp TTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHH
T ss_pred hhEEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHH
Confidence 999998 45 99999999987653211 1122345689999999998764321 2234578899999999998
Q ss_pred cc
Q 017820 362 QC 363 (365)
Q Consensus 362 Gc 363 (365)
-+
T Consensus 237 ~~ 238 (319)
T 2y4i_B 237 HA 238 (319)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=249.23 Aligned_cols=202 Identities=11% Similarity=0.023 Sum_probs=135.9
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCC-Cc----------
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCA-DF---------- 202 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~-~~---------- 202 (365)
...+|.+.+.||+|+||+||+|++..++ +.||+|.+....... .....++........| .+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CceeEEEecccccCCCEEEEEEEecCCC-----CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3356999999999999999999999888 789999876322211 1122222222333322 10
Q ss_pred -----eeee------ecccc----cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHH
Q 017820 203 -----VYGF------FENSS----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTI 267 (365)
Q Consensus 203 -----i~~~------~~~~~----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i 267 (365)
+... ..... .....++++|+++ +++|.++++.... ....+..+++..+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~-------------~~~~~~~l~~~~~~~i 216 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-------------HSSTHKSLVHHARLQL 216 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH-------------HTTTSHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc-------------ccccCCCCCHHHHHHH
Confidence 0000 00000 0023456666655 5799998853210 0011234577888899
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCC------C
Q 017820 268 MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST------Q 341 (365)
Q Consensus 268 ~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~------~ 341 (365)
+.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+..... .....| +.|+|||++.+.. .
T Consensus 217 ~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~ 290 (413)
T 3dzo_A 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHH 290 (413)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGC
T ss_pred HHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccceeecCCc----cccCCC-CceeCchhhhcccccccccc
Confidence 99999999999999999999999999999988 8999999999865432 345677 9999999994332 2
Q ss_pred CCCCCCchhhhhhhhhheeccc
Q 017820 342 TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 342 ~~~~d~~s~~~slg~vlw~lGc 363 (365)
....+..+|+||||+++|+|-|
T Consensus 291 ~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 291 PTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CEEECHHHHHHHHHHHHHHHHH
T ss_pred CcCCCchhhHHHHHHHHHHHHH
Confidence 2233446779999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=226.06 Aligned_cols=165 Identities=11% Similarity=-0.015 Sum_probs=132.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||.||+|++..++ +.|++|.+..... .......++...+....|+|++.+++.+ ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~ 102 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALD-----RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-HT 102 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTT-----EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-EE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCC-----ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-EE
Confidence 4478999999999999999999998877 8899998875432 2222333445556777899999998876 44
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
++..|+||||+++++|.++++... ....+..++.|++.||.|||++||+||||||+||
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~~----------------------~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI 160 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTSP----------------------SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTCC----------------------CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCcEEEEEEecCCCCHHHHHhcCC----------------------ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence 578999999999999999985421 3345778999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+++| |++| .+..+|+||||+++|+|-
T Consensus 161 ll~~~g-~~kl~~~~---------------------~~~~-----------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 161 RVSIDG-DVVLAYPA---------------------TMPD-----------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp EEETTS-CEEECSCC---------------------CCTT-----------CCHHHHHHHHHHHHHHHH
T ss_pred EEcCCC-CEEEEecc---------------------ccCC-----------CCchhHHHHHHHHHHHHH
Confidence 999987 99987443 4433 345778999999999973
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=254.72 Aligned_cols=180 Identities=16% Similarity=0.117 Sum_probs=114.5
Q ss_pred eecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--------HHH--HHHHHHHHHHhhcc-CCCceeeeecccccCCC
Q 017820 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--------AVE--IWMNERVRRACANC-CADFVYGFFENSSKKGG 215 (365)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~~--~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 215 (365)
.+.|++|.+..++....+ ..+++|.+.... ..+ .....++...+... .|+++..++..+ .++.
T Consensus 242 ~~~~~~~~h~~~rr~~fg-----~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-ed~~ 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFG-----EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-ENAQ 315 (569)
T ss_dssp -C--------CCEEEEEC-----SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-ECSS
T ss_pred cccCCccccccccccccc-----ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EECC
Confidence 445666666555555555 566777664321 111 12223344555554 688888888776 5668
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+||||||++|++|.+++...+ .+++. .|+.||+.||+|+|++|||||||||+||||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~--------------------~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL 372 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE--------------------EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV 372 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC--------------------CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE
T ss_pred EEEEEEecCCCCcHHHHHHhCC--------------------CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE
Confidence 9999999999999999998765 22333 488999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++++ .+||+|||+|+....... ...+.+||+.|||||++.+. . +..+|+|++|+++|++-
T Consensus 373 ~~dg-~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g~-~----~~~~d~~s~g~~~~~l~ 432 (569)
T 4azs_A 373 DARQ-HARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAEN-K----SWNGFWRSAPVHPFNLP 432 (569)
T ss_dssp CTTS-CEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC----------------------CCCC
T ss_pred CCCC-CEEEeecccCeeCCCCCc-cccCceechhhccHHHhCCC-C----CCcccccccccchhhhc
Confidence 9988 999999999987654432 34568999999999998764 2 23455888888877763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=221.53 Aligned_cols=171 Identities=18% Similarity=0.225 Sum_probs=133.2
Q ss_pred cCCCeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc---
Q 017820 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (365)
Q Consensus 137 ~~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (365)
..++|.+. +.||+|+||.||+|.+..++ +.||+|.+....... .++........|++++.+++.+..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~----~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCC-----cEEEEEEecccHHHH----HHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 44688887 78999999999999998887 889999886543221 122222344567777777665432
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+++++|.+++.... +..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCT------------------TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCceEEEEEeecCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3567899999999999999998753 1245788899999999999999999999999999999
Q ss_pred eEEec---CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~---~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++. ++ .+||+|||+|..... .. .+..+|+||||+++|+|-
T Consensus 148 il~~~~~~~~-~~kl~Dfg~a~~~~~-----------------------~~----~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 148 LLYTSKRPNA-ILKLTDFGFAKETTG-----------------------EK----YDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp EEESSSSTTC-CEEECCCTTCEECTT-----------------------CG----GGGHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCC-cEEEecccccccccc-----------------------cc----CCchhhHHHHHHHHHHHH
Confidence 99997 44 899999999975431 11 233577999999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-26 Score=229.04 Aligned_cols=164 Identities=18% Similarity=0.142 Sum_probs=112.6
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcc-----ccHHH---HHHHHHHHHHhhccCCCcee--eeecccc
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVE---IWMNERVRRACANCCADFVY--GFFENSS 211 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~~---~~~~~~~~~~~~~~~~~~i~--~~~~~~~ 211 (365)
...+.||+|+||+||+|.... +.+++|+... ....+ .....++...+....|+|++ .++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-- 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD-------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-- 409 (540)
T ss_dssp ---------CCEEEEEEECSS-------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE--
T ss_pred CCCCEEeeCCCEEEEEEEECC-------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE--
Confidence 345689999999999995544 4455554321 11111 12233455566667888888 44333
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....++||||+++++|.+++.. +..++.|+++||.|||+++|+||||||+
T Consensus 410 -~~~~~~lVmE~~~ggsL~~~l~~----------------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~ 460 (540)
T 3en9_A 410 -DLDNKRIMMSYINGKLAKDVIED----------------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTS 460 (540)
T ss_dssp -ETTTTEEEEECCCSEEHHHHSTT----------------------------CTHHHHHHHHHHHHHHHTTEECTTCCTT
T ss_pred -eCCccEEEEECCCCCCHHHHHHH----------------------------HHHHHHHHHHHHHHHHHCcCccCCCCHH
Confidence 34556999999999999999864 2368999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCcc------ccccccCCCCcCCcccccc--CCCCCCCC
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIM--STQTPSAP 346 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~--~~~~~~~d 346 (365)
|||+++ ++||+|||+|+........ ......||+.|||||++.. ..++...|
T Consensus 461 NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d 520 (540)
T 3en9_A 461 NFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYD 520 (540)
T ss_dssp SEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCT
T ss_pred HEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHh
Confidence 999998 8999999999987543221 1246789999999999976 34444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=193.90 Aligned_cols=146 Identities=19% Similarity=0.132 Sum_probs=104.2
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------------------HHHHHHHHHHHhhccCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------------------EIWMNERVRRACANCCA 200 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~~~~~~~ 200 (365)
..|.+++.||+|+||.||+|.+ .++ +.+|+|.++..... ......++...+....|
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g-----~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKF-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTT-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEEecCEeccCCCceEEEEEe-CCC-----CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 3455669999999999999999 665 78999988532210 11111222222222222
Q ss_pred CceeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH
Q 017820 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280 (365)
Q Consensus 201 ~~i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~ 280 (365)
..+..++. .+..++||||+++++|.+ +... ....++.|++.||.|||+
T Consensus 164 ~~v~~~~~-----~~~~~lvmE~~~g~~L~~-l~~~--------------------------~~~~i~~qi~~~l~~lH~ 211 (282)
T 1zar_A 164 LAVPKVYA-----WEGNAVLMELIDAKELYR-VRVE--------------------------NPDEVLDMILEEVAKFYH 211 (282)
T ss_dssp SSSCCEEE-----EETTEEEEECCCCEEGGG-CCCS--------------------------CHHHHHHHHHHHHHHHHH
T ss_pred CCcCeEEe-----ccceEEEEEecCCCcHHH-cchh--------------------------hHHHHHHHHHHHHHHHHH
Confidence 44444432 245699999999999988 4211 134699999999999999
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCcccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 338 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 338 (365)
+||+||||||+|||++ ++ .+||+|||+|+. +..|+|||++..
T Consensus 212 ~giiHrDlkp~NILl~-~~-~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 212 RGIVHGDLSQYNVLVS-EE-GIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TTEECSCCSTTSEEEE-TT-EEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCEeCCCCHHHEEEE-CC-cEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999999999999999 66 999999999963 345789998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-20 Score=168.36 Aligned_cols=135 Identities=19% Similarity=0.234 Sum_probs=92.4
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcc--eeehhhccccHH------------------------HHHHHHHHHH
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGD--LVLKKATEYGAV------------------------EIWMNERVRR 193 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~~~~ 193 (365)
-|.+.+.||+|+||.||+|.+..++ +. +|+|..+..... ......++..
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDG-----KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETT-----EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCC-----cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 4789999999999999999986555 66 888865322100 0001111222
Q ss_pred H---hhcc--CCCceeeeecccccCCCeEEEEEEecCC-C----cHHHHHHhcCCCcchhhhhccccccCcccccccHHH
Q 017820 194 A---CANC--CADFVYGFFENSSKKGGEYWLIWRYEGE-A----TLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263 (365)
Q Consensus 194 ~---~~~~--~~~~i~~~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (365)
. +.+. .++.++.+ ...++||||+++ | +|.++.... ++..
T Consensus 123 ~l~~l~~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~~-----------------------~~~~ 171 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGREL-----------------------KELD 171 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGGG-----------------------GGSC
T ss_pred HHHHHHhCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhcc-----------------------ChHH
Confidence 2 2222 23333221 246899999953 4 666653221 1233
Q ss_pred HHHHHHHHHHHHHHHH-HCCCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 264 IQTIMSQLLFALDGLH-STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 264 i~~i~~qi~~aL~yLH-~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
+..++.|++.+|.||| ++||+||||||+|||+++ .++|+|||+|...
T Consensus 172 ~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 172 VEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 6679999999999999 999999999999999987 8999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=165.17 Aligned_cols=140 Identities=16% Similarity=0.202 Sum_probs=88.8
Q ss_pred CeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc----------------HHHHHHHHHHHHHhhccCCCce
Q 017820 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----------------AVEIWMNERVRRACANCCADFV 203 (365)
Q Consensus 140 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~i 203 (365)
=|.++++||+|+||.||+|.+.. + +.||+|..+... ....+.. +.+......|+++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~-G-----~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~--~~rl~A~kE~~nL 167 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK-G-----KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMY--LSRLAAIKEFAFM 167 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT-C-----CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHH--HHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC-C-----CEEEEEEEecccccHHHHHHHHHHHHhhccccHHH--HHHHHHHHHHHHH
Confidence 49999999999999999999864 4 678888643110 0000000 0000000011111
Q ss_pred eeeecccccC-----CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHH
Q 017820 204 YGFFENSSKK-----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL 278 (365)
Q Consensus 204 ~~~~~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yL 278 (365)
..+....... ....++||||+++++|.++... .....++.|++.+|.||
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~--------------------------~~~~~l~~qll~~l~~l 221 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV--------------------------PDPASLYADLIALILRL 221 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC--------------------------SCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc--------------------------HHHHHHHHHHHHHHHHH
Confidence 1111110000 0123799999999887554221 11346789999999999
Q ss_pred HHCCCcccCCCCCceEEecCCC---------cEEEEeccccccc
Q 017820 279 HSTGIVHRDIKPQNVIFSEGSR---------TFKIIDLGAAADL 313 (365)
Q Consensus 279 H~~~IiHrDIKp~NILl~~~~~---------~ikL~DFGla~~~ 313 (365)
|++|||||||||.|||+++++. .+.|+||+-+...
T Consensus 222 H~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 222 AKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999999999987652 3899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-11 Score=108.39 Aligned_cols=137 Identities=15% Similarity=0.123 Sum_probs=93.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc---cHHHHHHHHHHHHHhh-ccCCCceeeeecccccCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACA-NCCADFVYGFFENSSKKG 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~ 214 (365)
+.|++...++.|+++.||++...+ +.+++|..... .......+.+....+. ....+.++.+. ...
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~-------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~----~~~ 82 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----RHD 82 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE----EET
T ss_pred ccceeEeeccCCCCCeEEEEECCC-------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE----ecC
Confidence 578999999999999999997542 67888887642 1111222222223332 23344444433 234
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH--------------
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-------------- 280 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-------------- 280 (365)
+..|+||||++|.+|.+.+.... ....++.+++++|..||+
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~~~-------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~ 137 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYEDEQ-------------------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCTTT-------------------------CHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHH
T ss_pred CceEEEEEecCCeehhhccCCcc-------------------------cHHHHHHHHHHHHHHHhCCCcccCCCcchHHH
Confidence 67899999999999877531110 122567888888888888
Q ss_pred ---------------------------------------------CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 ---------------------------------------------TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ---------------------------------------------~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|++|.|||+++++ .+.|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 4589999999999998743 667999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.7e-10 Score=103.03 Aligned_cols=31 Identities=23% Similarity=0.257 Sum_probs=26.1
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
+++|+|++|.|||+++++ .+.|+|||.|...
T Consensus 185 ~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~g 215 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGR-FSGFIDCGRLGVA 215 (264)
T ss_dssp EEECSSCCGGGEEEETTE-EEEECCCTTCEEE
T ss_pred EEECCCCCCCcEEEECCc-EEEEEcchhcccC
Confidence 399999999999998754 6679999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.3e-09 Score=102.51 Aligned_cols=140 Identities=17% Similarity=0.184 Sum_probs=88.1
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhc--ccc----HHHHHHHHHHHHHhhc--cCCCceeeeecccccCC
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYG----AVEIWMNERVRRACAN--CCADFVYGFFENSSKKG 214 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~--~~~----~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~ 214 (365)
-.+.|+.|.++.||+....+ +.+++|+.. ... ......+.++...+.. ...+.++.+.... ...
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~-~~~ 113 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE-SVI 113 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT-TTT
T ss_pred eEEEcCCcccceEEEEEECC-------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC-Ccc
Confidence 46778999999999998653 567787765 322 1112222223333332 2244444443321 112
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH--------------
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-------------- 280 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-------------- 280 (365)
+..|+||||++|.++.+.. ...++......++.++++.|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~~----------------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~ 171 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQS----------------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKP 171 (359)
T ss_dssp SSCEEEEECCCCBCCCCTT----------------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCC
T ss_pred CCeEEEEEecCCeecCCCc----------------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCC
Confidence 4678999999987763310 0122445566778888888888886
Q ss_pred --------------------------------------------CCCcccCCCCCceEEecCCC-cEEEEecccccc
Q 017820 281 --------------------------------------------TGIVHRDIKPQNVIFSEGSR-TFKIIDLGAAAD 312 (365)
Q Consensus 281 --------------------------------------------~~IiHrDIKp~NILl~~~~~-~ikL~DFGla~~ 312 (365)
..++|+|++|.|||++.++. .+.|+||+.|..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 172 GNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997652 469999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=3.8e-09 Score=96.99 Aligned_cols=32 Identities=28% Similarity=0.512 Sum_probs=27.0
Q ss_pred CCcccCCCCCceEEecC-CCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSEG-SRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~-~~~ikL~DFGla~~~ 313 (365)
.++|+|++|.||+++++ +..+.|+||+.+...
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 48999999999999984 337899999998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=3.1e-06 Score=77.61 Aligned_cols=32 Identities=28% Similarity=0.427 Sum_probs=26.4
Q ss_pred CCcccCCCCCceEEec---CCCcEEEEeccccccc
Q 017820 282 GIVHRDIKPQNVIFSE---GSRTFKIIDLGAAADL 313 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~---~~~~ikL~DFGla~~~ 313 (365)
.++|+|++|.|||++. ++..+.|+||+.+..-
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 5899999999999987 3435689999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.5e-06 Score=75.43 Aligned_cols=80 Identities=15% Similarity=0.101 Sum_probs=47.0
Q ss_pred eeecCCCe-eEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc-cCCCceeeeecccccCCCeEEEEEEe
Q 017820 146 KLGEGAFG-VVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKKGGEYWLIWRY 223 (365)
Q Consensus 146 ~LG~G~fG-~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~lV~e~ 223 (365)
.+..|..| .||+......+ ..+++|........+...+....+.+.. .-.|.++.+. ..++..|+|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~-----~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~----~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNA-----PELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI----RTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTC-----CCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE----EETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCC-----eEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE----EECCeEEEEEEe
Confidence 34455554 69998876655 6788887665443333333332333222 2234444333 234678999999
Q ss_pred cCCCcHHHHHH
Q 017820 224 EGEATLADLMI 234 (365)
Q Consensus 224 ~~~gsL~~~l~ 234 (365)
+++.++.+...
T Consensus 102 l~G~~~~~~~~ 112 (272)
T 4gkh_A 102 IPGKTAFQVLE 112 (272)
T ss_dssp CCSEEHHHHHH
T ss_pred eCCcccccccc
Confidence 99988877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=7.6e-05 Score=68.76 Aligned_cols=31 Identities=23% Similarity=0.396 Sum_probs=27.4
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.+++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 5799999999999998766 899999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4e-05 Score=72.70 Aligned_cols=31 Identities=26% Similarity=0.321 Sum_probs=26.2
Q ss_pred HCCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 280 ~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
...++|+|+.+.|||++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence 3579999999999999874 589999987763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=2.7e-05 Score=72.64 Aligned_cols=31 Identities=16% Similarity=0.286 Sum_probs=26.2
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|+++.|||+++ +..+.|+||+.|..
T Consensus 222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEET-TEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeC-CcEEEEEccccccc
Confidence 46999999999999996 42679999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00017 Score=68.90 Aligned_cols=33 Identities=18% Similarity=0.304 Sum_probs=27.9
Q ss_pred HHCCCcccCCCCCceEEecCCCcEEEEeccccccc
Q 017820 279 HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (365)
Q Consensus 279 H~~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~~ 313 (365)
+...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccC
Confidence 456799999999999998753 999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0011 Score=60.66 Aligned_cols=31 Identities=29% Similarity=0.468 Sum_probs=26.1
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.+++|+|+++.|||+++++ .+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 3699999999999999754 568999998853
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00075 Score=61.26 Aligned_cols=29 Identities=21% Similarity=0.239 Sum_probs=24.4
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.+.||| ..++ .+.|+||..|..
T Consensus 174 ~l~HgDl~~~Nil-~~~~-~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGE-RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSS-CEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCC-CEEEEecccccC
Confidence 4899999999999 4445 789999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0042 Score=56.82 Aligned_cols=77 Identities=13% Similarity=0.079 Sum_probs=46.0
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc---cCCCceeeeecccccCCCeEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN---CCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 218 (365)
.-.+.|+.|.+..+|+..... +.+++|............+.+....+.. ...|.++.+. ...+..+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~-------~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~----~~~g~~~ 107 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEV-------QTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG----NSQGHSF 107 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSS-------CEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE----ECSSEEE
T ss_pred eeeEEeCCccceeeeEEEECC-------CeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe----ecCCceE
Confidence 345779999999999998632 6788887654432222222222333322 2234444332 2236789
Q ss_pred EEEEecCCCcH
Q 017820 219 LIWRYEGEATL 229 (365)
Q Consensus 219 lV~e~~~~gsL 229 (365)
+||||+++..+
T Consensus 108 lvme~l~G~~~ 118 (312)
T 3jr1_A 108 LLLEALNKSKN 118 (312)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeccCCCC
Confidence 99999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0014 Score=60.21 Aligned_cols=33 Identities=27% Similarity=0.318 Sum_probs=27.5
Q ss_pred CCCcccCCCCCceEEecC---CCcEEEEeccccccc
Q 017820 281 TGIVHRDIKPQNVIFSEG---SRTFKIIDLGAAADL 313 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~---~~~ikL~DFGla~~~ 313 (365)
..++|+|+.+.|||++.+ ...+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 138999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0066 Score=55.42 Aligned_cols=29 Identities=21% Similarity=0.312 Sum_probs=25.2
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 4589999999999998 3 799999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0061 Score=57.32 Aligned_cols=31 Identities=16% Similarity=0.363 Sum_probs=26.5
Q ss_pred CCcccCCCCCceEEecC---CCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEG---SRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~---~~~ikL~DFGla~~ 312 (365)
.++|+|+.+.|||++.+ ...+.|+||..|..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999976 23899999999864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.011 Score=54.50 Aligned_cols=31 Identities=26% Similarity=0.334 Sum_probs=27.2
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
..++|+|+.+.|||+++++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 3689999999999998766 899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0038 Score=56.10 Aligned_cols=35 Identities=20% Similarity=0.221 Sum_probs=27.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcc
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE 179 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~ 179 (365)
.+..-.+.+|.|..+.||+.+..+. +.+++|....
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG------~~~~vK~~~~ 49 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADG------TPLFVKALPD 49 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTS------CEEEEEECCT
T ss_pred CCeEEEEecCCCCCeEEEEEEECCC------CEEEEEEeCC
Confidence 4566788999999999999987653 6788887543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.19 E-value=0.012 Score=56.27 Aligned_cols=31 Identities=19% Similarity=0.414 Sum_probs=25.2
Q ss_pred CCcccCCCCCceEEecC---------------------------CCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEG---------------------------SRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~---------------------------~~~ikL~DFGla~~ 312 (365)
.++|+|+.+.|||++++ ...+.|+||..|..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 58999999999999885 13799999988863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.024 Score=54.62 Aligned_cols=33 Identities=9% Similarity=0.158 Sum_probs=21.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhh
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA 177 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~ 177 (365)
+... .+.|+.|-...+|++.....+ +.+++|..
T Consensus 109 ~~~~-i~~lsgG~tN~~y~v~~~~~~-----~~~vLRi~ 141 (458)
T 2qg7_A 109 DSLE-FQIINGGITNILIKVKDMSKQ-----AKYLIRLY 141 (458)
T ss_dssp TTEE-EEEECC--CEEEEEEEETTTT-----EEEEEEEE
T ss_pred cCeE-EEEcCCCeEeEEEEEEECCCC-----ceEEEEEC
Confidence 4444 467888888999999876533 55777754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.68 E-value=0.17 Score=46.88 Aligned_cols=28 Identities=21% Similarity=0.461 Sum_probs=24.2
Q ss_pred CCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
.++|+|+++.|||++++ .+.|+||..|.
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCC
Confidence 58999999999999763 58999999876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=89.79 E-value=0.96 Score=38.71 Aligned_cols=96 Identities=10% Similarity=0.046 Sum_probs=57.2
Q ss_pred CCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEecCCCcEEE
Q 017820 226 EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKI 304 (365)
Q Consensus 226 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NILl~~~~~~ikL 304 (365)
..+|.++++..+. .++++++|.++.|.+..|.-+-. +.-..+=+-|..|+|..+| .+..
T Consensus 32 ~vSL~eIL~~~~~-------------------PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f 91 (229)
T 2yle_A 32 ALSLEEILRLYNQ-------------------PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTL 91 (229)
T ss_dssp EEEHHHHHHHHTS-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEE
T ss_pred cccHHHHHHHcCC-------------------CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceec
Confidence 3489999988764 56889999999999999877622 1111222346888898887 6665
Q ss_pred EecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhhee
Q 017820 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (365)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~ 360 (365)
.+ +.+. .....+.|||... .......-+|+||++||.
T Consensus 92 ~~-~~s~-------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ 128 (229)
T 2yle_A 92 AP-AADD-------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYK 128 (229)
T ss_dssp CC-C-------------------------CCSS-----SSSCHHHHHHHHHHHHHH
T ss_pred cc-cccc-------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHH
Confidence 53 1110 1122466888752 112235569999999985
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.34 E-value=0.47 Score=44.58 Aligned_cols=30 Identities=20% Similarity=0.396 Sum_probs=24.7
Q ss_pred CcccCCCCCceEEec-----CCCcEEEEecccccc
Q 017820 283 IVHRDIKPQNVIFSE-----GSRTFKIIDLGAAAD 312 (365)
Q Consensus 283 IiHrDIKp~NILl~~-----~~~~ikL~DFGla~~ 312 (365)
++|+|+.+.|||+.+ ++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999943 234899999999864
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=80.56 E-value=5.3 Score=40.18 Aligned_cols=84 Identities=14% Similarity=0.200 Sum_probs=47.7
Q ss_pred EEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHH--HHHHHHHCCCcccCCCCCceEEec
Q 017820 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF--ALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 220 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~--aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
+.|++++.+|.+++...+ .+.+++.....+..............++.+++- -+.|+= || +|=.++||||+.
T Consensus 490 LIE~V~s~tl~~i~~~~~---~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--Gl--GDRH~~NILid~ 562 (696)
T 2x6h_A 490 FLQYVDSCTVAEVLAREG---NIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--GV--GDRHLDNLLLTT 562 (696)
T ss_dssp EEECCCCEEHHHHHHHSS---SHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--TC--CCCCTTTEEECT
T ss_pred eeeeCCCccHHHHHHhcC---hHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--cC--CCCCCcceEEeC
Confidence 568888889999887654 233333222111111111112333444444432 233332 22 588899999998
Q ss_pred CCCcEEEEeccccc
Q 017820 298 GSRTFKIIDLGAAA 311 (365)
Q Consensus 298 ~~~~ikL~DFGla~ 311 (365)
+| ++.=+|||.+-
T Consensus 563 tG-~v~HIDFG~~f 575 (696)
T 2x6h_A 563 NG-KLFHIDFGYIL 575 (696)
T ss_dssp TS-CEEECCCCSCT
T ss_pred CC-CEEEEeehhhh
Confidence 66 99999999874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=80.04 E-value=0.6 Score=44.28 Aligned_cols=29 Identities=21% Similarity=0.390 Sum_probs=25.1
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.+.||| +.++ .+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~-~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQN-NIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSS-CEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCC-cEEEEecccCCc
Confidence 4899999999999 6555 999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 365 | ||||
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-19 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-19 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-19 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-19 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-19 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-18 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-18 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-18 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-17 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-17 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-17 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-16 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-16 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-16 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-16 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-16 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-15 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-14 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-14 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-14 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-14 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-12 |
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 8e-23
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 16/219 (7%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+++ GK LG GAFG V A+ S V LK+ + E M+E
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 194 ACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ V G S G +LI+ Y L + + S+ ++ + +
Sbjct: 95 TQLGSHENIVNLLGACTLS----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 252 DLPKGIEREN---RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
L + + + Q+ ++ L VHRD+ +NV+ + G + KI D G
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFG 209
Query: 309 AAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAP 346
A D+ NY + L ++ APE T +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 5e-22
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 19/218 (8%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVR 192
++ GK LG GAFG V A+ + V LK + E M+E +V
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
N + G GG +I Y L + + + +
Sbjct: 81 SYLGNH--MNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
++D ++ E+ + + Q+ + L S +HRD+ +N++ + G R KI D G
Sbjct: 135 MEDDELALDLEDLL--SFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGL 191
Query: 310 AADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAP 346
A D++ NY+ K L ++ APE T +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 1e-21
Identities = 49/240 (20%), Positives = 85/240 (35%), Gaps = 36/240 (15%)
Query: 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVE 184
E + R +D + + +LG+GAFG VY+A K L + +E +
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQN------KETSVLAAAKVIDTKSEEELED 55
Query: 185 IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQT 244
+ + +C + + F W++ + + +M+ E P
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLELERPLTESQ 111
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
IQ + Q L AL+ LH I+HRD+K N++F+ K+
Sbjct: 112 -------------------IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL-DGDIKL 151
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT-ALSPVLWQVQC 363
D G +A I F+ P + APE + T +L L ++
Sbjct: 152 ADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 1e-20
Identities = 39/211 (18%), Positives = 68/211 (32%), Gaps = 35/211 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRR---A 194
+DF +G+ LG+G FG VY A K ++ LK + + + ++RR
Sbjct: 6 EDFEIGRPLGKGKFGNVYLARE------KQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
++ + + Y ++ +L +F
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR------------ 107
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
T +++L AL HS ++HRDIKP+N++ KI D G +
Sbjct: 108 ---------TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS---V 154
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ Y PE
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.8 bits (214), Expect = 5e-20
Identities = 38/220 (17%), Positives = 68/220 (30%), Gaps = 16/220 (7%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-R 190
Y +++ + +GEGAFG V++A +V LK+ + E
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ N + G G L++ Y L + + S
Sbjct: 69 LMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 251 QDLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
+ I Q+ + L VHRD+ +N + E + KI D
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIAD 183
Query: 307 LGAAADLRVGINYIPKE-FLLDPRYAAPEQYIMSTQTPSA 345
G + ++ Y + R+ PE + T +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 223
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 86.7 bits (214), Expect = 1e-19
Identities = 39/212 (18%), Positives = 71/212 (33%), Gaps = 36/212 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D + + ++LG GAFGVV+R + + G+ K + + + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVT------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + FE+ E +I+ + L + + +
Sbjct: 80 LRHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEHNKMSEDE---------- 125
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADL 313
M Q+ L +H VH D+KP+N++F ++ S K+ID G A L
Sbjct: 126 ---------AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ +AAPE
Sbjct: 177 DPKQSVKVTTG--TAEFAAPEVAEGKPVGYYT 206
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.5 bits (211), Expect = 1e-19
Identities = 44/217 (20%), Positives = 73/217 (33%), Gaps = 39/217 (17%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
R +DF GK LGEG+F V A L+K ++ R R
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ F Y F++ + + Y L + E
Sbjct: 60 DVMSRLDHPFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKIG--------SFDE 107
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG- 308
+ ++++ AL+ LH GI+HRD+KP+N++ +E +I D G
Sbjct: 108 TC------------TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGT 154
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
A F+ +Y +PE + S+
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 2e-19
Identities = 43/213 (20%), Positives = 72/213 (33%), Gaps = 35/213 (16%)
Query: 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK--KATEYGAVEIWMNERVRRA 194
DD+ V + LG G G V + +K + LK + E+ ++ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIF------NKRTQEKFALKMLQDCPKARREVELHWRASQ- 63
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
C + + +EN ++ L + R E
Sbjct: 64 CPHIVR--IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA------FTE----- 110
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE--GSRTFKIIDLGAAAD 312
R IM + A+ LHS I HRD+KP+N++++ + K+ D G A +
Sbjct: 111 -------REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ + P Y APE S
Sbjct: 164 TTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSC 194
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 2e-19
Identities = 45/204 (22%), Positives = 65/204 (31%), Gaps = 37/204 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
+D+ L + LGEGA+G V A ++ + V + E E + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLA------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ YG G +L Y L D +
Sbjct: 59 MLNHENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGM-------------- 100
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
Q QL+ + LH GI HRDIKP+N++ E KI D G A
Sbjct: 101 ------PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVF 153
Query: 314 RVGINY-IPKEFLLDPRYAAPEQY 336
R + + Y APE
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELL 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.3 bits (208), Expect = 5e-19
Identities = 39/217 (17%), Positives = 78/217 (35%), Gaps = 44/217 (20%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ DDF +LG G GVV++ S K G ++ + + + E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSH------KPSGLVMARKLIHLEIKPAIRNQIIRE--L 55
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ C + ++ YG F + GE + + +L ++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKAGRI---------- 101
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+I+ + ++ L L I+HRD+KP N++ + K+ D G
Sbjct: 102 ----------PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFG 150
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ L I+ + F+ Y +PE+ + + +
Sbjct: 151 VSGQL---IDSMANSFVGTRSYMSPERLQGTHYSVQS 184
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 5e-19
Identities = 41/220 (18%), Positives = 84/220 (38%), Gaps = 37/220 (16%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR--- 193
R +D+ + +G G++G + K+DG +++ K +YG++ + +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKI------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ Y + + +++ Y LA ++
Sbjct: 56 LLRELKHPNIVRYYDRIID--RTNTTLYIVMEYCEGGDLASVI----------------T 97
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDIKPQNVIFSEGSRTFKII 305
+ + + + +M+QL AL H ++HRD+KP N +F +G + K+
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQNVKLG 156
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
D G A L ++ K F+ P Y +PEQ + +
Sbjct: 157 DFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKS 195
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 8e-19
Identities = 45/206 (21%), Positives = 71/206 (34%), Gaps = 37/206 (17%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
++ LG+ +GEG FG V++ S +N V K T E ++ E
Sbjct: 6 RERIELGRCIGEGQFGDVHQ---GIYMSPENPALAVAIKTCKNCTSDSVREKFLQE--AL 60
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ G W+I L + R++ ++ +LIL
Sbjct: 61 TMRQFDHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL--- 112
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
QL AL L S VHRDI +NV+ S + K+ D G +
Sbjct: 113 ----------------YAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLS 155
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQY 336
+ Y + L ++ APE
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESI 181
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 1e-18
Identities = 36/202 (17%), Positives = 69/202 (34%), Gaps = 37/202 (18%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVRRACA 196
++G G+F VY+ V + + + E + +
Sbjct: 13 FDIEIGRGSFKTVYKGLD------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ Y +E++ K L+ TL + +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM----------------- 109
Query: 257 IERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ +++++ Q+L L LH+ I+HRD+K N+ + + + KI DLG A
Sbjct: 110 ---KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---T 163
Query: 315 VGINYIPKEFLLDPRYAAPEQY 336
+ K + P + APE Y
Sbjct: 164 LKRASFAKAVIGTPEFMAPEMY 185
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 1e-18
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 49/243 (20%)
Query: 104 SAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
S ++ + ATPG P ++ + K +G G+FGVVY+A L
Sbjct: 1 SKVTTVVATPGQGPD----------------RPQEVSYTDTKVIGNGSFGVVYQAKL--- 41
Query: 164 PSSKNDGDLV----LKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219
+ G+LV + + + E+ + ++ N + FF +S +K E +L
Sbjct: 42 ---CDSGELVAIKKVLQDKRFKNRELQIMRKLD--HCNIVR--LRYFFYSSGEKKDEVYL 94
Query: 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER-ENRIIQTIMSQLLFALDGL 278
+ V + + + + ++ M QL +L +
Sbjct: 95 NLVLD----------------YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 279 HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 338
HS GI HRDIKPQN++ + K+ D G+A L G + ++ Y APE
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFG 196
Query: 339 STQ 341
+T
Sbjct: 197 ATD 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 82.5 bits (203), Expect = 2e-18
Identities = 38/218 (17%), Positives = 74/218 (33%), Gaps = 43/218 (19%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNE--RVRRACAN 197
+ +G+++GEG+FGV++ + + + V +K +E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGT------NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC 60
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
VY F + G L+ G +L DL+ ++V+T
Sbjct: 61 TGIPNVYYFGQE----GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT------------- 102
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG----SRTFKIIDLGAAADL 313
+ Q+L + +H +V+RDIKP N + + ++D G
Sbjct: 103 ------VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 314 RVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSA 345
R + K RY + ++ Q+
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 194
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 83.2 bits (205), Expect = 2e-18
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 36/212 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D + + ++LG GAFGVV+R K G + K ++ + +
Sbjct: 29 DYYDILEELGSGAFGVVHRCV------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 82
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + FE+ E LI + L D + + ++ +
Sbjct: 83 LHHPKLINLHDAFED----KYEMVLILEFLSGGELFDRIAAEDYKMSEAE---------- 128
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADL 313
+ M Q L +H IVH DIKP+N++ + + + KIID G A L
Sbjct: 129 ---------VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ I K +AAPE
Sbjct: 180 NP--DEIVKVTTATAEFAAPEIVDREPVGFYT 209
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 3e-18
Identities = 40/213 (18%), Positives = 74/213 (34%), Gaps = 22/213 (10%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVR 192
++ + ++LG+G+FG+VY +AK V + +A ++NE V
Sbjct: 19 REKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + G G +I L + S + +
Sbjct: 78 KEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLR----------PAMAN 123
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
P + + ++ + L++ VHRD+ +N + +E T KI D G D
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRD 182
Query: 313 LRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPS 344
+ Y + LL R+ +PE T
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 215
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 4e-18
Identities = 38/213 (17%), Positives = 70/213 (32%), Gaps = 29/213 (13%)
Query: 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRA 194
++D+ ++ +LG G FG V + + + VLK+ TE E M E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N + G + L+ G L ++ + V
Sbjct: 66 LDNPYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLVGKREEIPVSN---------- 110
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ ++ Q+ + L VHRD+ +NV+ KI D G + L
Sbjct: 111 ---------VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALG 160
Query: 315 VGINYIPKE--FLLDPRYAAPEQYIMSTQTPSA 345
+Y ++ APE + +
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.6 bits (201), Expect = 4e-18
Identities = 44/211 (20%), Positives = 82/211 (38%), Gaps = 35/211 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ +++ + LG G FG+V+R + + K + + + ++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCV------ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 199 CADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ + FE+ E +I+ + + + + + F N
Sbjct: 59 RHRNILHLHESFES----MEELVMIFEFISGLDIFERINTSAFELN-------------- 100
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLR 314
R I + + Q+ AL LHS I H DI+P+N+I+ S T KII+ G A L+
Sbjct: 101 -----EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
G N+ + P Y APE + + +
Sbjct: 156 PGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 5e-18
Identities = 47/206 (22%), Positives = 74/206 (35%), Gaps = 11/206 (5%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+D LGK LG GAFG V A V LK+ + M+E
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ V +K GG +I + L+ + S+ + + +DL
Sbjct: 71 IHIGHHLNVVN-LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP---EDL 126
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
K +I Q+ ++ L S +HRD+ +N++ SE KI D G A D+
Sbjct: 127 YKDFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDI 184
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMS 339
+Y+ K P + I
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (199), Expect = 5e-18
Identities = 42/207 (20%), Positives = 77/207 (37%), Gaps = 31/207 (14%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACAN 197
+G+++G G+FG VY+ + K ++ A ++ + NE V R +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVK----MLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
G+ + ++ ++ ++L + E + + LI
Sbjct: 64 VNILLFMGYST-----APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI----------- 107
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-RVG 316
I Q +D LH+ I+HRD+K N+ E T KI D G A R
Sbjct: 108 --------DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWS 158
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTP 343
++ ++ + APE M + P
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNP 185
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 8e-18
Identities = 35/211 (16%), Positives = 70/211 (33%), Gaps = 34/211 (16%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
++ L ++LG G FG V+ N V K+ + G++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ Y ++I Y +L D + + P
Sbjct: 65 LQHQRLVRLYAVVTQ-----EPIYIITEYMENGSLVDFLKT------------------P 101
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
GI+ + + +Q+ + + +HRD++ N++ S+ + + KI D G A +
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ ++ APE T T +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (196), Expect = 2e-17
Identities = 37/209 (17%), Positives = 68/209 (32%), Gaps = 13/209 (6%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+D +GEG FG V +A + K + +K+ + E
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 199 CADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ + G E+ G +L Y L D + R+
Sbjct: 70 HPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTAST 123
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+ + + + + +D L +HRD+ +N++ E + KI D G + V
Sbjct: 124 LSSQQLL--HFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVY 180
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ L R+ A E S T ++
Sbjct: 181 VKK--TMGRLPVRWMAIESLNYSVYTTNS 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 45/214 (21%), Positives = 78/214 (36%), Gaps = 13/214 (6%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-----VLKKATEYGAVEIWMNERVR 192
+D VLGK LGEGAFG V A K + +LK + ++E
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + + G ++I Y + L + + +R P L
Sbjct: 72 MKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPP----GLEYSYNPS 125
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ ++ + + Q+ ++ L S +HRD+ +NV+ +E KI D G A D
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARD 184
Query: 313 L-RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ + L ++ APE T +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 36/214 (16%), Positives = 71/214 (33%), Gaps = 35/214 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
+ +GEGA+G+V A + V + + + E ++
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAY------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ + + + + + + A L L+ ++
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS-------------- 107
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
N I + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 108 -------NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVA 159
Query: 314 RVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSA 345
++ E++ Y APE + S +
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 193
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.4 bits (195), Expect = 2e-17
Identities = 45/214 (21%), Positives = 77/214 (35%), Gaps = 36/214 (16%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERV 191
Y DF + + LG G+FG V+ S+++G LKK ++
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIR------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
R + F+ + + ++ EG + L S+ FP
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP------------ 102
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
N + + +++ AL+ LHS I++RD+KP+N++ + KI D G A
Sbjct: 103 ---------NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAK 152
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ + P Y APE S
Sbjct: 153 Y----VPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 3e-17
Identities = 42/214 (19%), Positives = 71/214 (33%), Gaps = 41/214 (19%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK--ATEYGAVEIWMNERVRRA 194
K + +K+G+GA G VY A G V +++ + E+ +NE
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEI--LV 70
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ + G E W++ Y +L D++
Sbjct: 71 MRENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQ--------- 117
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
I + + L AL+ LHS ++HRDIK N++ + K+ D G A
Sbjct: 118 ------------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 164
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ + P + APE P
Sbjct: 165 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 3e-17
Identities = 35/208 (16%), Positives = 68/208 (32%), Gaps = 34/208 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
+ L + +G+G FG V G+ V +K + ++ E
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATAQAFLAEA--SVMTQ 56
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ ++ G +++ Y + +L D + SR +LG
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGG-------- 102
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
+ + A++ L VHRD+ +NV+ SE K+ D G +
Sbjct: 103 ----DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKE----A 153
Query: 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ L ++ APE + +
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKS 181
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.6 bits (193), Expect = 4e-17
Identities = 32/210 (15%), Positives = 70/210 (33%), Gaps = 32/210 (15%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNE-RVRRAC 195
++ L KLG+G FG V+ + + +K + E ++ E +V +
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTW------NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL 69
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ +Y +++ Y + +L D + Y ++
Sbjct: 70 RHEKLVQLYAVVSE-----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-------- 116
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
+ +Q+ + + VHRD++ N++ E K+ D G A +
Sbjct: 117 ----------DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC-KVADFGLARLIED 165
Query: 316 GINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ ++ APE + T +
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 4e-17
Identities = 43/208 (20%), Positives = 74/208 (35%), Gaps = 38/208 (18%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+ + +G LG G FG VY +D V ++K E+ RV
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGI------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 194 -----ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
+ V + + ++ R E L D + R L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQ 108
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
E + ++ Q+L A+ H+ G++HRDIK +N++ K+ID G
Sbjct: 109 E------------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQY 336
+ A L+ + + +F Y+ PE
Sbjct: 157 SGALLK---DTVYTDFDGTRVYSPPEWI 181
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 5e-17
Identities = 45/233 (19%), Positives = 73/233 (31%), Gaps = 34/233 (14%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
VL + +G+G FG V+R A K S + ++A EI+ +R
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA------EIYQTVMLR- 55
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
N + + WL+ Y +L D + +
Sbjct: 56 -HENILG--FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS---- 108
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ + + I HRD+K +N++ + I DLG A
Sbjct: 109 ---------TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRH 158
Query: 314 RVGINYI---PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA--TALSPVLWQV 361
+ I P + RY APE S S A A+ V W++
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 77.8 bits (191), Expect = 6e-17
Identities = 43/207 (20%), Positives = 75/207 (36%), Gaps = 37/207 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER- 190
+++ + LG G VV R A K G + + E + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ-ELREATLKEVD 61
Query: 191 -VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+R+ + + +E ++ ++L++ + L D + + L E
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEKV--------TLSE 109
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + IM LL + LH IVHRD+KP+N++ + K+ D G
Sbjct: 110 KE------------TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGF 156
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQY 336
+ L G +E P Y APE
Sbjct: 157 SCQLDPGEKL--REVCGTPSYLAPEII 181
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 33/211 (15%), Positives = 68/211 (32%), Gaps = 36/211 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNERVRRACAN 197
D K+LG G FGVV + D+ +K + + ++ E + N
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW------RGQYDVAIKMIKEGSMSEDEFIEE--AKVMMN 55
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + YG ++I Y L + + + Q
Sbjct: 56 LSHEKLVQLYGVCTK----QRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------- 101
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ + + A++ L S +HRD+ +N + ++ K+ D G + +
Sbjct: 102 ---------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVL 151
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
R++ PE + S + +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 30/209 (14%), Positives = 62/209 (29%), Gaps = 26/209 (12%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ D + KLG G +G VY K V K + +E+ +
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVW------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ +++ Y + L L + L+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL----------- 118
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
+ +Q+ A++ L +HRD+ +N + E + K+ D G + +
Sbjct: 119 --------YMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT 169
Query: 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346
++ APE + + +
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 2e-16
Identities = 30/210 (14%), Positives = 67/210 (31%), Gaps = 34/210 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ +++G G FG+V+ + D V K GA+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 57
Query: 199 CADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ YG L++ + L+D + ++ + +TL+
Sbjct: 58 SHPKLVQLYGVCLE----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL--------- 104
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
+ + + L ++HRD+ +N + E ++ K+ D G +
Sbjct: 105 ----------GMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153
Query: 316 GINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
++A+PE + S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.5 bits (190), Expect = 2e-16
Identities = 37/208 (17%), Positives = 67/208 (32%), Gaps = 44/208 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNER-V 191
+DF + + +G G FG VY + G + K+ + +NER +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRK------ADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 192 RRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
+ F+ F + I L +
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQHGVFSEAD----- 108
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++ ++++ L+ +H+ +V+RD+KP N++ E +I DLG
Sbjct: 109 ---------------MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLG 152
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQY 336
A D P + Y APE
Sbjct: 153 LACDFS---KKKPHASVGTHGYMAPEVL 177
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 76.3 bits (187), Expect = 2e-16
Identities = 43/216 (19%), Positives = 76/216 (35%), Gaps = 36/216 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
D + LG+ LG G V+ A V L+ R +
Sbjct: 7 DRYELGEILGFGGMSEVHLA------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
A + Y E + G +++ Y TL D++ +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------------- 105
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
G R I+ +++ AL+ H GI+HRD+KP N++ S + K++D G A
Sbjct: 106 ----GPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIAR 159
Query: 312 DLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSA 345
+ N + + + +Y +PEQ + +
Sbjct: 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.8 bits (188), Expect = 3e-16
Identities = 39/223 (17%), Positives = 70/223 (31%), Gaps = 40/223 (17%)
Query: 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGA 182
E + T + D F K LG G+FG V K G+ +K +
Sbjct: 31 ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK------HKESGNHYAMKILDKQKVVKLKQ 84
Query: 183 VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
+E +NE+ R F+ + Y ++ G + L F
Sbjct: 85 IEHTLNEK--RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-- 140
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
+ +Q++ + LHS +++RD+KP+N++ +
Sbjct: 141 -------------------PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ D G A + P APE + +
Sbjct: 182 -VTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNKAV 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.0 bits (186), Expect = 3e-16
Identities = 37/218 (16%), Positives = 71/218 (32%), Gaps = 41/218 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNER--VRRAC 195
+ + LG+K+G G+FG +Y + G+ V +K E +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGT------DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ G ++ G +L DL +++
Sbjct: 61 GGVGIPTIRWCGAE----GDYNVMVMELLGP-SLEDLFNFCSRKFSL------------- 102
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI--IDLGAAADL 313
+ + + Q++ ++ +HS +HRD+KP N + G + + ID G A
Sbjct: 103 ------KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 314 RVG------INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
R K RYA+ ++ Q+
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 5e-16
Identities = 43/213 (20%), Positives = 82/213 (38%), Gaps = 37/213 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEY-GAVEIWMNE-RVR 192
++F +K+GEG +GVVY+A +K G++V ++ TE G + E +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKAR------NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + + + +L++ + + + S
Sbjct: 56 KELNHPNIVKLLDVIHT----ENKLYLVFEFLHQDLKKFMDASALTGIP----------- 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+I++ + QLL L HS ++HRD+KPQN++ + K+ D G A
Sbjct: 101 --------LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARA 151
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
V + ++ Y APE + +A
Sbjct: 152 FGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTA 183
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 75.4 bits (185), Expect = 5e-16
Identities = 41/219 (18%), Positives = 76/219 (34%), Gaps = 47/219 (21%)
Query: 136 YRKDD----FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWM 187
+ KDD F +++G G+FG VY A + ++V + + + +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 188 NERVRRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQT 244
+ R G + WL+ Y + +DL+ + P
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLR----EHTAWLVMEYC-LGSASDLLEVHKKPLQEVE 116
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
I + L L LHS ++HRD+K N++ SE K+
Sbjct: 117 -------------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKL 156
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP 343
D G+A+ + +++ P + APE + +
Sbjct: 157 GDFGSASIMAPANSFVG-----TPYWMAPEVILAMDEGQ 190
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 5e-16
Identities = 44/215 (20%), Positives = 73/215 (33%), Gaps = 33/215 (15%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RV 191
++ +F K LG GAFG VY+ P + V L++AT A + ++E V
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ N + G LI + L D + + Q L+
Sbjct: 65 MASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLL----- 114
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
Q+ ++ L +VHRD+ +NV+ KI D G A
Sbjct: 115 --------------NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAK 159
Query: 312 DLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
L Y + + ++ A E + T +
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 74.9 bits (183), Expect = 9e-16
Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 35/209 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
DD+ L +KLG G + V+ A + + + V+ K + + E
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAI------NITNNEKVVVKILKPVKKKKIKREIKILENLRG 88
Query: 199 CADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ + ++ + L++ + L +
Sbjct: 89 GPNIITLADIVKDPVSR--TPALVFEHVNNTDFKQLY--QTLT----------------- 127
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+ I+ M ++L ALD HS GI+HRD+KP NV+ R ++ID G A G
Sbjct: 128 ----DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
Y + + PE + +
Sbjct: 184 QEY--NVRVASRYFKGPELLVDYQMYDYS 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 1e-15
Identities = 45/215 (20%), Positives = 71/215 (33%), Gaps = 40/215 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERVR 192
+DF+L K LG+G+FG V+ A K VE M E+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEF------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 193 RACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ A + F+ + + Y L + S
Sbjct: 56 LSLAWEHPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC-------------- 97
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+R ++++ L LHS GIV+RD+K N++ + KI D G
Sbjct: 98 -----HKFDLSRATF-YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMC 150
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ +G + F P Y APE + S
Sbjct: 151 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSV 184
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 2e-15
Identities = 46/216 (21%), Positives = 71/216 (32%), Gaps = 35/216 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERVR 192
+ ++GEGA+G V++A KN G V ++ E + V
Sbjct: 7 QQYECVAEIGEGAYGKVFKAR-----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
R V + S + + L + P
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------- 112
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
I+ +M QLL LD LHS +VHRD+KPQN++ + S K+ D G
Sbjct: 113 ---------VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGL 162
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
A ++ Y APE + S+
Sbjct: 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPV 196
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 3e-15
Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 22/172 (12%)
Query: 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCAD 201
+GK +GEG V+ V+ D
Sbjct: 3 AIGKLMGEGKESAVFNCYSE-------KFGEC--------VVKFHKVGHTSFKKVKEKRD 47
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
+ F + + + L L + + + + +L E+ D +
Sbjct: 48 YGDLHFSVLAIR----SARNEFRALQKLQGLAVPKVYAWE-GNAVLMELIDAKELYRVRV 102
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ +L + + GIVH D+ NV+ SE IID + ++
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV 152
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 3e-15
Identities = 35/208 (16%), Positives = 71/208 (34%), Gaps = 34/208 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-----ATEYGAVEIWMNE-RVR 192
D L +KLG+G+FGVV R S + +K ++ A++ ++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + +YG ++ +L D + + + + T
Sbjct: 66 HSLDHRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGHFLLGT-------- 112
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ Q+ + L S +HRD+ +N++ + KI D G
Sbjct: 113 -----------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRA 160
Query: 313 LRVGI-NYIPKEFLLDPRYAAPEQYIMS 339
L +Y+ +E P + + +
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT 188
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 4e-15
Identities = 39/207 (18%), Positives = 66/207 (31%), Gaps = 26/207 (12%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRACANCCAD 201
+ +G G FG VY +L K + L + T+ G V ++ E +
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE--GIIMKDFSHP 88
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
V + G ++ Y L + + + V+ LI
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--------------- 133
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---IN 318
Q+ + L S VHRD+ +N + E T K+ D G A D+
Sbjct: 134 ----GFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 188
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ L ++ A E T +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKS 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 5e-15
Identities = 43/211 (20%), Positives = 69/211 (32%), Gaps = 33/211 (15%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
+DF K LG+G FG V K G L+K E+ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVR------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N F+ +++ G +SRE + +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER---------- 106
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ ++++ AL+ LHS +V+RDIK +N++ + KI D G +
Sbjct: 107 ---------ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGI 156
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
K F P Y APE + +
Sbjct: 157 -SDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.8 bits (172), Expect = 2e-14
Identities = 30/213 (14%), Positives = 73/213 (34%), Gaps = 38/213 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVR 192
+ +K+GEG +G V++A ++ ++V + G + E +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK------NRETHEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + ++ + + L++ + +
Sbjct: 56 KELKHKNIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCNGDLDP----------- 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
I+++ + QLL L HS ++HRD+KPQN++ + K+ + G A
Sbjct: 101 ---------EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARA 150
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ + ++ Y P+ + ++
Sbjct: 151 FGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTS 182
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 2e-14
Identities = 36/203 (17%), Positives = 66/203 (32%), Gaps = 33/203 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
K +G G FG VY+ L K SS V LK ++ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
++ + G +I Y L + ++ ++V L+
Sbjct: 65 QFSHHNIIRLEGVISK----YKPMMIITEYMENGALDKFLREKDGEFSVLQLV------- 113
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ + + L + VHRD+ +N++ + + K+ D G + L
Sbjct: 114 ------------GMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVL 160
Query: 314 RVGIN--YIPKEFLLDPRYAAPE 334
Y + R+ APE
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPE 183
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.7 bits (172), Expect = 2e-14
Identities = 40/210 (19%), Positives = 75/210 (35%), Gaps = 36/210 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL--------AKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
+ K+G+G FG V++A KK +N+ + A EI + +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQL 65
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
++ + ++ G +L++ + E LA L+ + + +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSE------ 118
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ +M LL L +H I+HRD+K NV+ + K+ D G A
Sbjct: 119 -------------IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLA 164
Query: 311 ADLRVGIN---YIPKEFLLDPRYAAPEQYI 337
+ N ++ Y PE +
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 4e-14
Identities = 46/218 (21%), Positives = 76/218 (34%), Gaps = 37/218 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKAT---EYGAVEIWMNER- 190
++F L K LG GA+G V+ L +K S + G L LKKAT + E ER
Sbjct: 24 ENFELLKVLGTGAYGKVF---LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 191 -VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ + ++ F+ + LI Y L
Sbjct: 81 VLEHIRQSPFLVTLHYAFQT----ETKLHLILDYINGGELFTH----------------- 119
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
L + +Q + +++ AL+ LH GI++RDIK +N++ + D G
Sbjct: 120 ---LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGL 175
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347
+ + +F Y AP+
Sbjct: 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (170), Expect = 4e-14
Identities = 38/207 (18%), Positives = 66/207 (31%), Gaps = 34/207 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNERVRRACANCCADFV 203
K+LG G FG V + K K +LK A + + + E ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA--NVMQQLDNPYI 70
Query: 204 ---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
G E + L+ L L + +
Sbjct: 71 VRMIGICEA-----ESWMLVMEMAELGPLNKY--------------------LQQNRHVK 105
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI 320
++ I ++ Q+ + L + VHRD+ +NV+ KI D G + LR NY
Sbjct: 106 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYY 164
Query: 321 PKE--FLLDPRYAAPEQYIMSTQTPSA 345
+ ++ APE + +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKS 191
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.4 bits (169), Expect = 5e-14
Identities = 31/215 (14%), Positives = 59/215 (27%), Gaps = 34/215 (15%)
Query: 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEI 185
R F + + +G G FG V V LK
Sbjct: 17 REFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+++E V K +I + +L + + + V L
Sbjct: 74 FLSEA--SIMGQFDHPNVIHLE-GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 130
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+ ++ + + L VHRD+ +N++ + + K+
Sbjct: 131 V-------------------GMLRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVS 170
Query: 306 DLGAAADLRVGINYI----PKEFLLDPRYAAPEQY 336
D G + L + + R+ APE
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 69.1 bits (168), Expect = 6e-14
Identities = 36/204 (17%), Positives = 71/204 (34%), Gaps = 39/204 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVR 192
+ + +K+GEG +GVVY+A N G+ + + G + E +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-------NNYGETFALKKIRLEKEDEGIPSTTIREISIL 54
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + +Y L++ + + L + +V
Sbjct: 55 KELKHSNIVKLYDVIHT----KKRLVLVFEHLDQDLKKLLDVCEGGLESVT--------- 101
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
++ + QLL + H ++HRD+KPQN++ + KI D G A
Sbjct: 102 -----------AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARA 149
Query: 313 LRVGINYIPKEFLLDPRYAAPEQY 336
+ + ++ Y AP+
Sbjct: 150 FGIPVRKYTH-EIVTLWYRAPDVL 172
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 8e-14
Identities = 47/230 (20%), Positives = 81/230 (35%), Gaps = 33/230 (14%)
Query: 117 PGFFDMFVLAFVERLFRTTYR-KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLK 175
P F+ + L +T + + + +G GA+G V A G V
Sbjct: 2 PTFYR-------QELNKTIWEVPERYQNLSPVGSGAYGSVCAA------FDTKTGLRVAV 48
Query: 176 KATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMIS 235
K I +R R E K ++ + T A +
Sbjct: 49 KKLSRPFQSIIHAKRTYR--------------ELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
Y V L+ ++ ++ K + + +Q ++ Q+L L +HS I+HRD+KP N+
Sbjct: 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+E KI+D G A + ++ Y APE +
Sbjct: 155 NEDCE-LKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.5 bits (166), Expect = 2e-13
Identities = 45/235 (19%), Positives = 76/235 (32%), Gaps = 41/235 (17%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK------ATEYGAVEIWMNERVRR 193
++L +KLG G F V+ A + V +K TE EI + +RV
Sbjct: 15 YILVRKLGWGHFSTVWLA------KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVND 68
Query: 194 ACANCCADF-------VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
A + F + G +++ GE LA + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-- 126
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGL-HSTGIVHRDIKPQNVIFSEGSRTFKII 305
++ I QLL LD + GI+H DIKP+NV+ +I
Sbjct: 127 -----------------VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169
Query: 306 DLG-AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
+ A + + Y +PE + + A A + ++
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.4 bits (164), Expect = 3e-13
Identities = 47/217 (21%), Positives = 71/217 (32%), Gaps = 43/217 (19%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+D + LG GAF V A K LV + K G NE
Sbjct: 8 RDIYDFRDVLGTGAFSEVILA------EDKRTQKLVAIKCIAKKALEGKEGSMENE--IA 59
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ +E+ GG +LI + L D ++ + F
Sbjct: 60 VLHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEKGFY----------- 104
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLG 308
R ++ Q+L A+ LH GIVHRD+KP+N+++ + I D G
Sbjct: 105 ---------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ G P Y APE + +
Sbjct: 156 LSKMEDPGSVL--STACGTPGYVAPEVLAQKPYSKAV 190
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (163), Expect = 3e-13
Identities = 47/219 (21%), Positives = 72/219 (32%), Gaps = 45/219 (20%)
Query: 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIW 186
+FR D + G++LG G F VV + K+ G +KK +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 187 MNERVRR---ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPY 240
E + R V + +EN + LI L D + +E
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEKESLT 111
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE--- 297
+ Q+L + LHS I H D+KP+N++ +
Sbjct: 112 --------------------EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 336
KIID G A + G + K P + APE
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIV 188
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (163), Expect = 4e-13
Identities = 42/207 (20%), Positives = 71/207 (34%), Gaps = 24/207 (11%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ K +G GA G+V A V K +R R
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYR----- 65
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
E K + I T + + Y V L+ + + +
Sbjct: 66 ---------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 116
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
R+ ++ Q+L + LHS GI+HRD+KP N++ KI+D G A G +
Sbjct: 117 DHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLART--AGTS 172
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSA 345
++ +++ Y APE + +
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENV 199
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 2e-12
Identities = 42/229 (18%), Positives = 80/229 (34%), Gaps = 49/229 (21%)
Query: 117 PGFFDMFVLAFVERLFRTTYR-KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-- 173
GF+ + + +T + + + + +G GA+G V A G V
Sbjct: 2 SGFYR-------QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV------DGRTGAKVAI 48
Query: 174 ---LKKATEYGAVEIWMNE-RVRRACANCCADFVYGFF--ENSSKKGGEYWLIWRYEGEA 227
+ + E R+ + + + F + + +++L+ + G
Sbjct: 49 KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD 108
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
LM + IQ ++ Q+L L +H+ GI+HRD
Sbjct: 109 LG-KLMKHEKLG---------------------EDRIQFLVYQMLKGLRYIHAAGIIHRD 146
Query: 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 336
+KP N+ +E KI+D G A + +++ Y APE
Sbjct: 147 LKPGNLAVNEDCE-LKILDFGLARQ----ADSEMTGYVVTRWYRAPEVI 190
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 7e-12
Identities = 38/198 (19%), Positives = 61/198 (30%), Gaps = 35/198 (17%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR--RACANC 198
LGEG F VY+A KN +V +K A + +R +
Sbjct: 4 DFLGEGQFATVYKARD------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ G + + L++ + + +
Sbjct: 58 SHPNIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH--------------- 101
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
I+ M L L+ LH I+HRD+KP N++ E K+ D G A
Sbjct: 102 -----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNR 155
Query: 319 YIPKEFLLDPRYAAPEQY 336
++ Y APE
Sbjct: 156 A-YTHQVVTRWYRAPELL 172
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 365 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.86 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=324.51 Aligned_cols=193 Identities=20% Similarity=0.285 Sum_probs=161.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.++||+|+||+||+|++..++ +.||+|++............++...+....|+||+.+++.+ ..+..
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~ 91 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDE 91 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-EECCE
Confidence 4568999999999999999999999888 78899987644332233344556677788899999999887 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+|+||||+++|+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~~---------------------l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTETC---------------------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEEecCCCcHHHHhhccC---------------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC
Confidence 999999999999999876543 47788999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
.++ ++||+|||+|+.+..+.. .....+||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 151 ~~~-~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~----~~DiwSlGvilyeml 210 (293)
T d1yhwa1 151 MDG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGP----KVDIWSLGIMAIEMI 210 (293)
T ss_dssp TTC-CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCT----HHHHHHHHHHHHHHH
T ss_pred CCC-cEeeccchhheeeccccc-cccccccCCCccChhhhcCCCCCc----hhceehHhHHHHHHh
Confidence 987 999999999998754432 335678999999999998876654 566999999999983
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=316.21 Aligned_cols=194 Identities=21% Similarity=0.244 Sum_probs=161.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+..++|++++.||+|+||+||+|++..++ +.||+|.+......+ .....++...+...+|+||+.+++.+ .
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~ 76 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-H 76 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCC-----cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-E
Confidence 34689999999999999999999999887 788998875432211 22233456677788899999999887 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+++||||+++|+|.+++...+ .+++..++.++.||++||+|||++||+||||||+|
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~--------------------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~N 136 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS--------------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccc
Confidence 5678999999999999999998754 45788899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ .+||+|||+|+..... ......||+.|||||++.+..++. .+|+||||+++|+|-+
T Consensus 137 ill~~~~-~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~----~~DiwSlGvilyell~ 199 (263)
T d2j4za1 137 LLLGSAG-ELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDE----KVDLWSLGVLCYEFLV 199 (263)
T ss_dssp EEECTTS-CEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTTCCCCT----THHHHHHHHHHHHHHH
T ss_pred ceecCCC-CEeecccceeeecCCC---cccccCCCCcccCHHHHcCCCCCc----hhhhhhHhHHHHHHhc
Confidence 9999987 9999999999876533 234678999999999998876654 4569999999999843
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=319.77 Aligned_cols=196 Identities=24% Similarity=0.249 Sum_probs=160.2
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|.+......+ .....++...+....|+||+.+++.+ ..+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-EETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-ccCce
Confidence 479999999999999999999999888 788999876443221 22334456677888999999999887 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred eEEEEeccCCCcHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 999999999999999886543 468889999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+++ .+||+|||+|+.+..... ......+||+.|||||++.+..+. +..+|+||||+++|+|-+
T Consensus 138 ~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~---~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 138 ERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH---AEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp TTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBC---HHHHHHHHHHHHHHHHHH
T ss_pred CCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCC---CCceeeeHhHHHHHHHHh
Confidence 987 999999999998754432 234567899999999999876542 224679999999999743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=317.04 Aligned_cols=198 Identities=20% Similarity=0.278 Sum_probs=151.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc-CC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK-KG 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~ 214 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|.+.... ..+.....++...+....|+||+.+++.+.. .+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 479999999999999999999999988 789999875432 3334444556777888899999999987654 34
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC-----CcccCCC
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDIK 289 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~-----IiHrDIK 289 (365)
..+|+||||+++|+|.+++.... ..+..+++..++.++.||+.||.|||+++ |||||||
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~----------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK 141 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGT----------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred CEEEEEEecCCCCcHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence 67899999999999999987532 11235688999999999999999999976 9999999
Q ss_pred CCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 290 p~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+|||++.++ .+||+|||+|+.+..... ......||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 142 p~NIll~~~~-~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~----~~DIwSlGvilyel~ 208 (269)
T d2java1 142 PANVFLDGKQ-NVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNE----KSDIWSLGCLLYELC 208 (269)
T ss_dssp GGGEEECTTS-CEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred hhhcCcCCCC-cEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCCh----HHHHHhhCHHHHHHh
Confidence 9999999987 999999999998754432 235679999999999998776654 566999999999983
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=323.81 Aligned_cols=194 Identities=19% Similarity=0.260 Sum_probs=161.0
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (365)
+..++|++.++||+|+||+||+|++..++ ..||+|.++.... .......++...+...+|+||+.+++.+ ...
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTT-----EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-ECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EEC
Confidence 45689999999999999999999999887 7889998764322 2222334456677888999999999887 456
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCce
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNV 293 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHrDIKp~NI 293 (365)
..+++||||+.+|+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHe
Confidence 78999999999999999998764 35788899999999999999997 5999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|+++++ ++||+|||+|+.+... ...+.+||+.|||||++.+..++.++ |+||+|+++|+|-+
T Consensus 137 Ll~~~~-~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~----DiWSlGvil~ell~ 198 (322)
T d1s9ja_ 137 LVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS----DIWSMGLSLVEMAV 198 (322)
T ss_dssp EECTTC-CEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTH----HHHHHHHHHHHHHH
T ss_pred eECCCC-CEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHH----HHHHHHHHHHHHHH
Confidence 999988 9999999999976532 23567999999999999988776654 59999999999843
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-43 Score=319.92 Aligned_cols=201 Identities=16% Similarity=0.222 Sum_probs=166.4
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
++++..++|++.++||+|+||+||+|++..++ +.||+|+++....... ...++...+...+|+||+.+++.+ .
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~-~~~~E~~il~~l~HpnIv~~~~~~-~ 83 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC-T 83 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGT-----EEEEEEECCTTCSCHH-HHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCC-----eEEEEEEECCccchHH-HHHHHHHHHHhCCCCCEecCCccE-e
Confidence 35667789999999999999999999999887 7899998865433222 233456667778899999999987 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.++.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~N 145 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSC------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eCCeeEEEeecccCcchHHHhhhcc------------------ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCe
Confidence 5678899999999999999997653 1245778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+++++ .+||+|||+|+..............||+.|||||++.+..++. .+|+||||+++|||-+
T Consensus 146 ILl~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~----k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 146 CLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIAT 211 (287)
T ss_dssp EEECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSH----HHHHHHHHHHHHHHHT
T ss_pred EEECCCC-cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCc----hhhhhhHHHHHHHHHh
Confidence 9999987 9999999999987655444344567899999999998877654 5569999999999843
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=319.88 Aligned_cols=196 Identities=21% Similarity=0.215 Sum_probs=164.4
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+..++|++++.||+|+||.||+|++..++ +.||+|.+...... ......++...+...+|++|+.+++.+ .
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~ 75 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-Q 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-E
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-c
Confidence 35689999999999999999999999988 88898887643211 122233456677788899999999887 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+...+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~--------------------~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred cccccccceeccCCCchhhhhhccc--------------------CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence 5678999999999999999998765 45788899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++.++ .+||+|||+|+...... ......+||+.|||||++.+..++.++ |+||||+++|+|-|
T Consensus 136 ILl~~~g-~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~----DiwSlGvilyeml~ 200 (337)
T d1o6la_ 136 LMLDKDG-HIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMC 200 (337)
T ss_dssp EEECTTS-CEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTH----HHHHHHHHHHHHHH
T ss_pred eEecCCC-CEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhh----cccchhhHHHHHHH
Confidence 9999988 99999999998764332 234568999999999999988776655 59999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=316.32 Aligned_cols=195 Identities=22% Similarity=0.342 Sum_probs=158.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++++.||+|+||+||+|++..++ +.||+|.+...... ......++...+...+|+||+.+++.+ ..
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~ 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QD 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-EC
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-EE
Confidence 4478999999999999999999999888 78899987543211 122333455666777899999998877 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+|+||||+++|+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+||
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIG--------------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCEEEEEEEccCCCCHHHhhhccC--------------------CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence 678999999999999999988765 467888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCC-ccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|+++++ .+||+|||+|+.+.... .......+||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 140 ll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~----~~DiwSlGvilyell 204 (288)
T d1uu3a_ 140 LLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK----SSDLWALGCIIYQLV 204 (288)
T ss_dssp EECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH----HHHHHHHHHHHHHHH
T ss_pred ccCCCc-eEEecccccceecccCCcccccccccCCccccCceeeccCCCCc----ccceehhhHHHHHHh
Confidence 999988 99999999999875432 22334678999999999998776654 566999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=321.31 Aligned_cols=223 Identities=19% Similarity=0.262 Sum_probs=163.8
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhc-cCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACAN-CCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~-~~~~~i~~~~~~~ 210 (365)
+|++..++|+++++||+|+||+||+|++..++.......|++|.+...... ......++...+.. .+|+||+.+++.+
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 355677899999999999999999999988776555567888887644322 22222333344433 4799999999887
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccc---cccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE---VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
...+.+++||||+++|+|.+++......+......... .........+++..++.++.||+.||.|||+++|||||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45568999999999999999998765433222211111 11122234678899999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|||+|||++.++ ++||+|||+|+........ ...+..||+.|||||++.+..++. .+|+||||+++|||
T Consensus 190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~----~~DiwS~Gvil~em 259 (325)
T d1rjba_ 190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGILLWEI 259 (325)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc----ceeccchhHHHHHH
Confidence 999999999987 9999999999876554332 233567899999999998877655 45699999999997
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=315.91 Aligned_cols=198 Identities=23% Similarity=0.281 Sum_probs=161.6
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
+.|++.+.||+|+||+||+|++..++ ..||+|.+......+.....++...+....|+||+.+++.+ ..++.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-EETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCC-----eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCeEE
Confidence 57999999999999999999999888 78899987654433333334456667778899999999887 4567899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecC
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~ 298 (365)
+||||+++|+|.+++.+... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-------------------~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-------------------PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEEecCCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 99999999999999876431 35788899999999999999999999999999999999998
Q ss_pred CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCC-CCCCCCchhhhhhhhhheeccc
Q 017820 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 299 ~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~d~~s~~~slg~vlw~lGc 363 (365)
+ .+||+|||+|+...... ....+..||+.|||||++..... ....+..+|+||||+++|+|-+
T Consensus 147 ~-~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 147 G-DIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210 (288)
T ss_dssp S-CEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred C-CEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence 8 99999999998654322 12346789999999999865433 2233567889999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=315.69 Aligned_cols=221 Identities=19% Similarity=0.206 Sum_probs=161.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
++++..++|+++++||+|+||.||+|++..++...+.+.||+|++....... .....++.......+|++++.+++..
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3566778999999999999999999999887766666889999987543222 22222333445556788898888887
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
...+..+++||||+++|+|.+++......+..... .........+++..++.++.||++||.|||+++||||||||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV----APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC---------------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcccccccccc----chhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 67778899999999999999999876422111110 00111234578899999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+||||++++ ++||+|||+|+....... .......||+.|||||++.+..++. .+|+||||+++|||-
T Consensus 163 ~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~----~sDiwS~Gvil~ell 230 (299)
T d1ywna1 163 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIF 230 (299)
T ss_dssp GGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred cceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc----ccceeehHHHHHHHH
Confidence 999999987 999999999987654433 2334678999999999998876655 456999999999973
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=311.47 Aligned_cols=198 Identities=21% Similarity=0.235 Sum_probs=155.1
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
|++..++|+++++||+|+||+||+|++. ..||+|.++.. ...+.....++...+...+|+||+.+++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~- 73 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-
Confidence 5677789999999999999999999864 34888887533 222333444567778888999999998864
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.++.+++||||+++|+|.+++...+ ..+++..+..++.||+.||+|||+++||||||||+
T Consensus 74 -~~~~~~lv~Ey~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~ 133 (276)
T d1uwha_ 74 -TAPQLAIVTQWCEGSSLYHHLHIIE-------------------TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133 (276)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHHTSC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -eccEEEEEEecCCCCCHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHH
Confidence 3456899999999999999997654 13577889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+||+|||+|+....... .......||+.|||||++.+..... .+..+|+||||+++|||-
T Consensus 134 NiLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 134 NIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-YSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp GEEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCC-CCHHHHHHHHHHHHHHHH
T ss_pred HEEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCC-CCchhhhhhhHHHHHHHH
Confidence 99999987 999999999987654322 2345678999999999987543332 245778999999999984
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-41 Score=313.53 Aligned_cols=192 Identities=20% Similarity=0.273 Sum_probs=161.2
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++++.||+|+||+||+|++..++ +.||+|.+...... ......++...+....|+||+.+++.+ ..
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~ 75 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-QD 75 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-EC
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-ee
Confidence 4578999999999999999999999888 78999987643221 122333456677888999999999887 55
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
+..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQ--------------------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CCeeeeEeeecCCccccccccccc--------------------cccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 679999999999999999988765 346778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++ .+||+|||+|+..... ..+.+||+.|||||++.+..++.+ +|+||||+++|+|-+
T Consensus 136 Ll~~~g-~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~----~DiwSlGvilyemlt 196 (316)
T d1fota_ 136 LLDKNG-HIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKS----IDWWSFGILIYEMLA 196 (316)
T ss_dssp EECTTS-CEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTT----HHHHHHHHHHHHHHH
T ss_pred eEcCCC-CEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCch----hhccccchhHHHHHh
Confidence 999987 9999999999876432 346799999999999988777654 559999999999743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=305.09 Aligned_cols=190 Identities=18% Similarity=0.230 Sum_probs=155.3
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc--cHHHHHHHHHHHHHhhccCCCceeeeeccccc---CCC
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSK---KGG 215 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~ 215 (365)
|++.++||+|+||+||+|++..++ ..||+|++... ...+.....++...+...+|+||+.+++.+.. .+.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~-----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 478889999999999999999887 77888887543 23333445566777888899999999876532 346
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCce
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKPQNV 293 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~--IiHrDIKp~NI 293 (365)
.+++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred EEEEEEeCCCCCcHHHHHhccc--------------------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 7899999999999999998754 4577889999999999999999998 99999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++++++.+||+|||+|+..... ...+..||+.|||||++.+. + +..+|+||||+++|+|-+
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~~-~----~~~~DIwSlGvilyel~~ 207 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEEK-Y----DESVDVYAFGMCMLEMAT 207 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGTC-C----CTHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCCC-C----CCcCchhhHHHHHHHHHH
Confidence 99754349999999999864332 23567999999999998642 3 456789999999999854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=308.12 Aligned_cols=194 Identities=14% Similarity=0.205 Sum_probs=148.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.+.||+|+||+||+|.+..+ ..||+|++......+.. ..++...+...+|+||+.+++.+ ..++.
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~-~~~E~~~l~~l~HpnIv~~~g~~-~~~~~ 74 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC-LEQAP 74 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTT------EEEEEEECCSSSSCHHH-HHHHHHHHHHCCCTTBCCEEEEE-CSSSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCC------CEEEEEEECCCcCcHHH-HHHHHHHHHhcCCCCccccccee-ccCCc
Confidence 457999999999999999999998754 56999998754433322 33455666777899999999987 44567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++..... .++++.+..++.||+.||.|||+++|+||||||+|||++
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~-------------------~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~ 135 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRG-------------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 135 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT-------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC
T ss_pred eEEEEEecCCCcHHHHhhcccc-------------------CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec
Confidence 8999999999999999876542 346778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+++ .+||+|||+|+..............||+.|||||++.+..++. .+|+||||+++|||-
T Consensus 136 ~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~----k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 136 ENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS----KSDVWSFGVLMWEVF 196 (263)
T ss_dssp GGG-CEEECSCC------------------CTTSCCHHHHTTCCCCH----HHHHHHHHHHHHHHH
T ss_pred CCC-CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCc----hhhhcchHHHHHHHH
Confidence 987 9999999999877655444445578999999999998776654 566999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-41 Score=319.21 Aligned_cols=194 Identities=19% Similarity=0.212 Sum_probs=163.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|++......+.....++...+....|+||+.+++.+ ..++.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-EETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEE
Confidence 468999999999999999999999888 88999998766655555555667777888899999999877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-------------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-------------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-------------------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEcCCCCCHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 99999999999999986443 24688899999999999999999999999999999999974
Q ss_pred C-CCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 298 ~-~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+ ++.+||+|||+|+.+.... ......||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~----~~DiwSlGvilyell 219 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGY----YTDMWSVGVLSYILL 219 (350)
T ss_dssp TTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCH----HHHHHHHHHHHHHHH
T ss_pred CCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCCh----hHhhhhhhHHHHHHH
Confidence 3 2389999999998765433 235679999999999998876654 566999999999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=310.74 Aligned_cols=199 Identities=16% Similarity=0.193 Sum_probs=162.0
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.+++..++|++.++||+|+||+||+|++..+ +.||+|++........ ...++...+....|+||+.+++.+.
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~~~~~-~~~~E~~~l~~l~HpnIv~~~g~~~- 78 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCC------CEEEEEEEccCcCCHH-HHHHHHHHHHhCCCCCEeEEEeeec-
Confidence 3556778999999999999999999998643 6799998875433222 2334456667778999999998653
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+.+++||||+++|+|.+++.... +..+++..+..++.||++||.|||+++|+||||||+|
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~------------------~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~N 139 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPS------------------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhh
Confidence 356789999999999999775432 2246888899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++++ .+||+|||+|+.+..+.........||+.|||||++.+..++. .+|+||||+++|||-+
T Consensus 140 Ill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~----~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 140 ILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI----KSDVWSFGILLTEIVT 205 (272)
T ss_dssp EEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH----HHHHHHHHHHHHHHHT
T ss_pred eeeeccc-ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCc----hhhhhhhHHHHHHHHh
Confidence 9999987 9999999999987665544455678999999999998776654 5569999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.7e-41 Score=316.50 Aligned_cols=192 Identities=19% Similarity=0.237 Sum_probs=158.6
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc------HHHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
..++|++.+.||+|+||.||+|++..++ +.||+|.+.... ......+.++...+....|++|+.+++.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCC-----CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 4689999999999999999999999988 788888765322 12222333445667778899999998877
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
...+.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++|||||||||
T Consensus 77 -~~~~~~~ivmE~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP 135 (364)
T d1omwa3 77 -HTPDKLSFILDLMNGGDLHYHLSQHG--------------------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 135 (364)
T ss_dssp -ECSSEEEEEECCCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -EECCEEEEEEEecCCCcHHHHHHhcc--------------------cccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence 45678999999999999999998764 347788999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+|||++.++ .+||+|||+|+.+... ......||+.|||||++.+.. ..+..+|+||||+++|+|
T Consensus 136 ~NILl~~~g-~iKl~DFGla~~~~~~---~~~~~~GT~~y~APE~~~~~~---~~~~~~DiwSlGvilyem 199 (364)
T d1omwa3 136 ANILLDEHG-HVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGV---AYDSSADWFSLGCMLFKL 199 (364)
T ss_dssp GGEEECSSS-CEEECCCTTCEECSSS---CCCSCCSCGGGCCHHHHSTTC---CCCTHHHHHHHHHHHHHH
T ss_pred ceeEEcCCC-cEEEeeeceeeecCCC---cccccccccccchhHHhhcCC---CCCcccchhHHHHHHHHH
Confidence 999999987 9999999999976543 235678999999999986532 223456799999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=307.82 Aligned_cols=192 Identities=20% Similarity=0.231 Sum_probs=158.0
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+.|++.++||+|+||+||+|++..++ +.||+|.+.... ........++...+....|+||+.+++.+ ..+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCC-----cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-EECC
Confidence 35999999999999999999999887 789999876433 22223344567778888999999999887 4567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.+|+|..++.... .+++..++.++.||+.||.|||++|||||||||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~--------------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 148 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK--------------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred EEEEEEEecCCCchHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 8999999999999987765543 45788899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||+|+.... .....||+.|||||++.+.... ..+..+|+||||+++|+|-+
T Consensus 149 ~~~~-~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~-~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 149 SEPG-LVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp ETTT-EEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSC-CBCTHHHHHHHHHHHHHHHH
T ss_pred CCCC-CEEEeecccccccCC-----CCccccCccccCHHHHhccCCC-CcCchhhhhhHHHHHHHHHH
Confidence 9987 999999999986543 2456899999999998654322 23446789999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-41 Score=308.11 Aligned_cols=204 Identities=15% Similarity=0.126 Sum_probs=152.2
Q ss_pred hhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccc
Q 017820 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENS 210 (365)
Q Consensus 132 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (365)
+...+..++|++.++||+|+||+||+|++..++... ..|++|++..... .......++...+...+|+||+.+++.+
T Consensus 19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CC--EEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEE--EEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 445667789999999999999999999998765332 3578888765433 3333445567778888999999999987
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..++.+++||||+++|+|.+++.... ..+++..+..++.||++||.|||+++|+||||||
T Consensus 97 -~~~~~~~iv~Ey~~~g~L~~~~~~~~-------------------~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp 156 (299)
T d1jpaa_ 97 -TKSTPVMIITEFMENGSLDSFLRQND-------------------GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156 (299)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHTTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred -eeCCEEEEEEEecCCCcceeeecccc-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc
Confidence 55578999999999999999887643 2357788899999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccc----cccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI----PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ ++||+|||+|+.+....... .....||+.|||||++.+..++. .+|+||||+++|||-
T Consensus 157 ~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----~sDvwS~Gvvl~el~ 227 (299)
T d1jpaa_ 157 RNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS----ASDVWSYGIVMWEVM 227 (299)
T ss_dssp GGEEECTTC-CEEECCC-----------------------CGGGSCHHHHHSCCCCH----HHHHHHHHHHHHHHH
T ss_pred ceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc----ccccccchHHHHHHH
Confidence 999999987 99999999999775443211 12346799999999998776654 456999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-41 Score=315.85 Aligned_cols=194 Identities=22% Similarity=0.222 Sum_probs=164.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
++|++.+.||+|+||+||+|++..++ +.||+|.+......+....+++...+....|+||+.+++.+ ..+..++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEE
Confidence 68999999999999999999999888 88999998766655555555677788888999999999887 5667899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec-
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE- 297 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~- 297 (365)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 103 ivmE~~~gg~L~~~~~~~~-------------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~ 163 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-------------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 163 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-------------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEEEcCCCChHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc
Confidence 9999999999998876543 24688899999999999999999999999999999999983
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.+.+||+|||+|+.+.... ......||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 164 ~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlGvilyellt 223 (352)
T d1koba_ 164 KASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF----YTDMWAIGVLGYVLLS 223 (352)
T ss_dssp TCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCH----HHHHHHHHHHHHHHHH
T ss_pred CCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCC----ccchHHHHHHHHHHHh
Confidence 23499999999999875433 235678999999999998776654 5569999999999854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-41 Score=311.59 Aligned_cols=194 Identities=22% Similarity=0.264 Sum_probs=145.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.+.|++.+.||+|+||+||+|++..++ +.||+|.+...... ......++...+...+|+||+.+++.+ ..++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-ESGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTC-----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-ECSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCE
Confidence 467999999999999999999999887 78999987644322 122233456677788999999999877 55678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG--------------------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred EEEEEeccCCCcHHHhhhccc--------------------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence 999999999999999997654 468888999999999999999999999999999999996
Q ss_pred c--CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 297 E--GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 297 ~--~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
. +++.+||+|||+|+....+. ...+.+||+.|||||++.+..++. .+|+||||+++|+|-+
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~----~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSK----AVDCWSIGVIAYILLC 204 (307)
T ss_dssp SSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCT----HHHHHHHHHHHHHHHH
T ss_pred ccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCc----HHHhhhhhHHHHHHHh
Confidence 3 23399999999998765432 234678999999999998776544 5669999999999843
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=302.70 Aligned_cols=200 Identities=19% Similarity=0.233 Sum_probs=149.3
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+++..++|++++.||+|+||+||+|++..++... ..|++|.+..... .......++...+...+|+||+.+++.+.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~--~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CC--EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCcee--EEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4566789999999999999999999987665333 4578887764332 23334445666777789999999998763
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+.+++||||+++|+|.+++..... .+++..++.++.||++||.|||+++|+||||||+|
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~-------------------~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~N 138 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKY-------------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTT-------------------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCC-------------------CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhh
Confidence 4578999999999999998876542 35778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|++++++ .+||+|||+|+.+............||+.|+|||++.+..++. .+|+||||+++|||
T Consensus 139 Ill~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~----~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 139 VLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEI 202 (273)
T ss_dssp EEEEETT-EEEECC-------------------CCGGGCCHHHHHHCCCSH----HHHHHHHHHHHHHH
T ss_pred eeecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCC----ccccccchHHHHHH
Confidence 9999988 9999999999987655444455678899999999998776665 45699999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-40 Score=311.20 Aligned_cols=192 Identities=18% Similarity=0.234 Sum_probs=161.2
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH---HHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
...++|++.+.||+|+||.||+|++..++ +.||+|.+...... ......++...+....|+||+.+++.+ .
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g-----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~ 111 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-K 111 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-E
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-c
Confidence 34589999999999999999999999888 78899987543221 122233456677888999999998877 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
....+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++||||||||+|
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~--------------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~N 171 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG--------------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cccccccccccccccchhhhHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHH
Confidence 5678999999999999999997764 45788899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ ++||+|||+|+.+... ..+..||+.|||||++.+..++. .+|+||||+++|+|-
T Consensus 172 ILl~~~g-~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~----~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 172 LLIDQQG-YIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNK----AVDWWALGVLIYEMA 232 (350)
T ss_dssp EEECTTS-CEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHH
T ss_pred cccCCCC-CEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCc----cccccchhHHHHHHH
Confidence 9999987 9999999999976432 34678999999999998876654 566999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=305.94 Aligned_cols=198 Identities=15% Similarity=0.193 Sum_probs=154.7
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
|++..++|++++.||+|+||+||+|++.++ +.||+|++........ ...++...+...+|+||+.+++.+.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~------~~vAiK~l~~~~~~~~-~~~~E~~~l~~l~h~nIv~~~g~~~-- 82 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS-- 82 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC------CEEEEEEECcccCCHH-HHHHHHHHHHhcccCCEeEEEEEEe--
Confidence 456678999999999999999999999766 5699999875443222 2334566677788999999998763
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+.+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cCCeEEEEEecCCCchhhhhhhcc------------------cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 346889999999999999886543 12357888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||++++ ++||+|||+|+.+..+.........||+.|+|||++.+..++. .+|+||||+++|||-|
T Consensus 145 ll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----ksDI~S~Giil~el~t 209 (285)
T d1fmka3 145 LVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELTT 209 (285)
T ss_dssp EECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred EECCCC-cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCc----HHhhhcchHHHHHHHh
Confidence 999987 9999999999877655444445578999999999998877665 4569999999999843
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=305.42 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=158.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-----HHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
.++|++++.||+|+||+||+|.+..++ +.||+|.+.... ..+....+ +........|++|+.+++.+ .
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~-----~~vAvK~i~k~~~~~~~~~~~~~~e-~~~l~~~~~hp~Iv~~~~~~-~ 73 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVE-KRVLSLAWEHPFLTHMFCTF-Q 73 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHH-HHHHHHHTTCTTBCCEEEEE-E
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCC-----CEEEEEEEchhhccChHHHHHHHHH-HHHHHHhCCCCcEEEEEEEE-c
Confidence 378999999999999999999999988 888999886432 11222222 22233457899999999887 5
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~~--------------------~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~N 133 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSCH--------------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred cCCceeEEEeecCCCcHHHHhhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccc
Confidence 5678999999999999999998765 35778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+++++ .+||+|||+|+....... ......||+.|+|||++.+..++.+ +|+||||+++|+|-+
T Consensus 134 iL~~~~~-~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~----~DiwSlGvilyemlt 198 (320)
T d1xjda_ 134 ILLDKDG-HIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHS----VDWWSFGVLLYEMLI 198 (320)
T ss_dssp EEECTTS-CEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTH----HHHHHHHHHHHHHHH
T ss_pred eeecCCC-ceeccccchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCch----hhhhhhhHHHHHHHh
Confidence 9999987 999999999987654332 3355789999999999988776554 559999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=302.35 Aligned_cols=194 Identities=22% Similarity=0.244 Sum_probs=159.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH------HHHHHHHHHHHHhhccCCCceeeeecccc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA------VEIWMNERVRRACANCCADFVYGFFENSS 211 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (365)
.++|++++.||+|+||+||+|++..++ +.||+|.+..... .......++...+...+|+||+.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~- 82 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY- 82 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-
Confidence 367999999999999999999999888 7888887643211 1122333455666777899999999887
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+++|+||||||+
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--------------------~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~ 142 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKE--------------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EECCEEEEEEEcCCCccccchhcccc--------------------ccchhHHHHHHHHHHHHHHhhhhcceeecccccc
Confidence 55678999999999999999997754 4578889999999999999999999999999999
Q ss_pred ceEEecCCC---cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~---~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++. .+||+|||+|+.+..+.. ..+..||+.|||||++.+..++. .+|+||+|+++|+|-|
T Consensus 143 Nill~~~~~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~----~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLS 211 (293)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCT----HHHHHHHHHHHHHHHH
T ss_pred eEEEecCCCcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCC----cccchhhhHHHHHHHc
Confidence 999987653 599999999987654332 34678999999999998766654 5569999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=297.00 Aligned_cols=193 Identities=18% Similarity=0.235 Sum_probs=160.3
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
..++|++.++||+|+||+||+|+++. + +.||+|+++.....+.. ..++...+....|+||+.+++.+ .+...
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~-----~~vAvK~l~~~~~~~~~-~~~Ev~~~~~l~HpnIv~~~g~~-~~~~~ 73 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRG-Q-----YDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC-TKQRP 73 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETT-T-----EEEEEEEEESSSSCHHH-HHHHHHHHHTCCCTTBCCEEEEE-CCSSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECC-C-----CEEEEEEECcCcCCHHH-HHHHHHHHHhcCCCceeeEEEEE-eeCCc
Confidence 34799999999999999999999853 3 67999988754433322 33456677777899999999987 45578
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++.... ..+++..+++++.|+++||.|||++||+||||||+|||++
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-------------------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-------------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-------------------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC
T ss_pred eEEEEEccCCCcHHHhhhccc-------------------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc
Confidence 999999999999999976654 2356778889999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
+++ .+||+|||+|+.+............||+.|+|||.+.+..++. .+|+||||+++|||
T Consensus 135 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~----ksDiwS~G~~l~el 194 (258)
T d1k2pa_ 135 DQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS----KSDIWAFGVLMWEI 194 (258)
T ss_dssp TTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred CCC-cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCc----ceeecccchhhHhH
Confidence 987 9999999999887665554455678999999999998877654 55699999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-40 Score=299.29 Aligned_cols=197 Identities=16% Similarity=0.237 Sum_probs=155.9
Q ss_pred ccCCCeEEeee-eecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 136 YRKDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~-LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
+..++|.+.+. ||+|+||+||+|.+..++.. ..||+|.+..... .......++...+....|+||+.+++.+.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-- 79 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-- 79 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CC---EEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCc---EEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--
Confidence 34578999985 99999999999988655421 4688998865433 22333445666777788999999998763
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
.+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 80 ~~~~~lvmE~~~~g~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 80 AEALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140 (285)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCeEEEEEEeCCCCcHHHHhhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhe
Confidence 346899999999999999986543 2457788999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
|++.++ .+||+|||+|+.+..... .......||+.|||||++.+..++. .+|+||||+++|||
T Consensus 141 ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 141 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS----RSDVWSYGVTMWEA 205 (285)
T ss_dssp EEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECH----HHHHHHHHHHHHHH
T ss_pred eeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCc----cchhhcchHHHHHH
Confidence 999987 999999999997754432 2223467899999999998777655 45699999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-40 Score=301.64 Aligned_cols=227 Identities=19% Similarity=0.199 Sum_probs=169.3
Q ss_pred HhhccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecc
Q 017820 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFEN 209 (365)
Q Consensus 131 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (365)
+...++..++|++.+.||+|+||+||+|++.........+.||+|++......+ .....++...+....|+|++.+++.
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345667788999999999999999999998765444444789999987544332 3334456677788899999999988
Q ss_pred cccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhc----cccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcc
Q 017820 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL----GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiH 285 (365)
+ ......+++|||+.+|+|.+++.............. ...........+++..+..++.|++.||+|||+++|||
T Consensus 85 ~-~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 85 C-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp E-CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred e-ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 7 456789999999999999999986543111111000 00112223445788999999999999999999999999
Q ss_pred cCCCCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 286 rDIKp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||||+|||++.++ ++||+|||+|+.+...... ...+..||+.|||||++.+..++. .+|+||||+++|||-|
T Consensus 164 rDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~----ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 164 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT----ESDVWAYGVVLWEIFS 237 (301)
T ss_dssp SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred eEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh----hhhhccchhhHHHHHc
Confidence 99999999999987 9999999999876544332 234578899999999998877665 4569999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-39 Score=293.35 Aligned_cols=197 Identities=19% Similarity=0.242 Sum_probs=160.3
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-----H----HHHHHHHHHHHhhcc-CCCceeeee
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----V----EIWMNERVRRACANC-CADFVYGFF 207 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~~~~~-~~~~i~~~~ 207 (365)
.++|++.+.||+|+||+||+|++..++ +.+|+|.+..... . ......++...+... .|+|++.++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCC-----CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 379999999999999999999998887 7888888753211 1 111222344455554 489999998
Q ss_pred cccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 208 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
+.+ .+++.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+|||
T Consensus 77 ~~~-~~~~~~~ivmE~~~~g~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~~lH~~~ivHrD 135 (277)
T d1phka_ 77 DTY-ETNTFFFLVFDLMKKGELFDYLTEKV--------------------TLSEKETRKIMRALLEVICALHKLNIVHRD 135 (277)
T ss_dssp EEE-ECSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eec-ccCcceEEEEEcCCCchHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Confidence 887 56789999999999999999998765 468899999999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCC--CCCCchhhhhhhhhheeccc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP--SAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~--~~d~~s~~~slg~vlw~lGc 363 (365)
|||+|||++.++ .+||+|||+|+.+..+. ......||+.|+|||++.+..... ..+..+|+||+|+++|+|-+
T Consensus 136 lkp~Nill~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~ 210 (277)
T d1phka_ 136 LKPENILLDDDM-NIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210 (277)
T ss_dssp CSGGGEEECTTC-CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred cccceEEEcCCC-CeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence 999999999987 99999999999775433 235678999999999998665433 23557899999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=296.41 Aligned_cols=203 Identities=17% Similarity=0.186 Sum_probs=153.3
Q ss_pred cccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 135 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
++..++|++.++||+|+||+||+|.+..++.. ....||+|++...... ......++...+...+|+||+.+++.+ ..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---C-CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCE-EEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-ec
Confidence 45667899999999999999999998765422 1246889988644332 222334566777888999999999887 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
....++||||+.++++.+++..... .+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~-------------------~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDG-------------------EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTT-------------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCceEEEEEecccCcchhhhhcccc-------------------cccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence 5678999999999999998876542 357778889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+.++ .+||+|||+|+.+..... .......||+.|||||++.+..++. .+|+||||+++|||-+
T Consensus 142 Ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~----~sDI~S~Gvil~el~t 208 (283)
T d1mqba_ 142 LVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS----ASDVWSFGIVMWEVMT 208 (283)
T ss_dssp EECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCH----HHHHHHHHHHHHHHHT
T ss_pred EECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCC----cccccccHHHHHHHHh
Confidence 999987 999999999987654322 2233467899999999998776655 4569999999999843
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=296.77 Aligned_cols=192 Identities=17% Similarity=0.216 Sum_probs=149.0
Q ss_pred CeEEe-eeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 140 DFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 140 ~y~l~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
.+.+. ++||+|+||+||+|.+..++. .+.||+|.++..... ......++...+...+|+||+.+++.+. .+.
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~~~ 81 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AES 81 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSS---EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSS
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCc---CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--cCC
Confidence 44554 479999999999998765331 167899988643322 1223344566677789999999998763 345
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~ 141 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEEEcCCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc
Confidence 789999999999999998654 457888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc--ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~~~~ikL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.++ .+||+|||+|+.+...... ......||+.|||||++.+..++. .+|+||||+++|||
T Consensus 142 ~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~----~sDiwS~Gv~l~el 203 (277)
T d1xbba_ 142 TQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS----KSDVWSFGVLMWEA 203 (277)
T ss_dssp ETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH----HHHHHHHHHHHHHH
T ss_pred ccC-cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCc----hhhhccchhhhhHH
Confidence 988 9999999999876544322 223467899999999998877655 45699999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-39 Score=295.10 Aligned_cols=197 Identities=21% Similarity=0.256 Sum_probs=153.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc---HHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
..++|++.+.||+|+||+||+|++..++ +.||+|.+.... ........++...+...+|+|++.+++.....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 3478999999999999999999999888 889999876432 22223344566677888999999988776543
Q ss_pred C---CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 214 G---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 214 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
. ..+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEG--------------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCceEEEEEECCCCCEehhhhcccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 3 45899999999999999987765 457888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ ..+|+|||.++....... .......||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 140 ~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~----~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 140 ANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA----RSDVYSLGCVLYEVLT 209 (277)
T ss_dssp GGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTTCCCCH----HHHHHHHHHHHHHHHH
T ss_pred cccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCc----ceecccchHHHHHHHh
Confidence 999999988 999999999986544322 2344678999999999998766544 5669999999999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-39 Score=298.54 Aligned_cols=194 Identities=19% Similarity=0.222 Sum_probs=154.9
Q ss_pred cCCCeEEee-eeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccc---c
Q 017820 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (365)
Q Consensus 137 ~~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (365)
..++|.+.+ .||+|+||.||+|++..++ +.||+|.+....... .++........|+|++.+++.+. .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~----~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCC-----CEEEEEEECCcHHHH----HHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 347899875 6999999999999999888 889999886543221 12222334457888888876653 2
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+..+|+||||+++|+|.+++...+ ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~------------------~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCS------------------CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcC------------------CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccc
Confidence 3577899999999999999997653 1246889999999999999999999999999999999
Q ss_pred eEEecCC--CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 293 ILl~~~~--~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+++++ ..+||+|||+|+...... ......||+.|||||++.+..++. .+|+||||+++|+|-|
T Consensus 142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~----~~DiwSlGvily~llt 208 (335)
T d2ozaa1 142 LLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDK----SCDMWSLGVIMYILLC 208 (335)
T ss_dssp EEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSH----HHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCH----HHHHHhhchhHHHHhh
Confidence 9998632 379999999998765433 235678999999999998877765 4569999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=298.59 Aligned_cols=194 Identities=23% Similarity=0.327 Sum_probs=161.6
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.++|++++.||+|+||+||+|.+..++ +.||+|.+......+. ...++...+....|+||+.+++.+ ..+..+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~-----~~~AiK~i~~~~~~~~-~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF-ESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTHHHH-HHHHHHHHHHHSCCTTBCCEEEEE-EETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEcCCcccHH-HHHHHHHHHHhCCCCCCCeEEEEE-EECCEE
Confidence 478999999999999999999999988 7899998876554433 334456677788899999999877 456789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
|+||||+++|+|.+++...+. .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~-------------------~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAF-------------------ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSC-------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEecCCCCcHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 999999999999999976542 4578889999999999999999999999999999999985
Q ss_pred CC-CcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GS-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~-~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ ..+||+|||+++...... ......||+.|+|||.+.+..++. .+|+||||+++|+|-+
T Consensus 138 ~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~----~~DiWSlGvily~ll~ 198 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVST----ATDMWSLGTLVYVLLS 198 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECH----HHHHHHHHHHHHHHHH
T ss_pred CCceEEEEcccchhhccccCC--cccccccccccccchhccCCCCCc----hhhcccHHHHHHHHHh
Confidence 42 389999999998765432 234578999999999998777655 4559999999999743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=297.14 Aligned_cols=200 Identities=18% Similarity=0.159 Sum_probs=152.8
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
+.++|+++++||+|+||+||+|.+..+++..+ .+||+|++...... ......++...+...+|+||+.+++.+.. +
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~ 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CC-EEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEE-EEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 44689999999999999999999988764433 25788877543222 12223345566677789999999988743 4
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+.+++|.+++..... .+++..++.++.||+.||.|||+++||||||||+|||+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~-------------------~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll 144 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKD-------------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 144 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSS-------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CeeEEEEeccCCccccccccccc-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee
Confidence 57888999999999998876542 45778889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ ++||+|||+|+.+...... ......||+.|||||++.+..++. .+|+||||+++|||-|
T Consensus 145 ~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~----~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 145 KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH----QSDVWSYGVTVWELMT 208 (317)
T ss_dssp EETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH----HHHHHHHHHHHHHHHT
T ss_pred CCCC-CeEeeccccceecccccccccccccccCccccChHHHhcCCCCh----hhhhhhHHHHHHHHHH
Confidence 9987 9999999999977544332 233467899999999998877654 5569999999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=290.70 Aligned_cols=193 Identities=17% Similarity=0.244 Sum_probs=152.8
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccC
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (365)
|++..++|+++++||+|+||.||+|++.+ ..||+|+++.....+.. .++...+...+|+||+.+++.+...
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~~~~~~--~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQAF--LAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HHH--HHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHHHHHHH--HHHHHHHHhCCCCCEeeEEEEEEec
Confidence 56677899999999999999999999854 67999999766554433 3456677788999999999987665
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Ni 134 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 134 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHH------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred CCcEEEEEeccCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhh
Confidence 667899999999999999997643 12357888999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+++..... .....+|+.|+|||++.+..++. .+|+||||+++|||-
T Consensus 135 l~~~~~-~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~----~sDIwSfG~il~el~ 194 (262)
T d1byga_ 135 LVSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST----KSDVWSFGILLWEIY 194 (262)
T ss_dssp EECTTS-CEEECCCCC----------------CCTTTSCHHHHHHCCCCH----HHHHHHHHHHHHHHH
T ss_pred eecCCC-CEeecccccceecCCC----CccccccccCCChHHHhCCCCCh----HHHHHhHHHHHHHHH
Confidence 999988 9999999999875432 23457899999999998876654 556999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=293.29 Aligned_cols=222 Identities=18% Similarity=0.204 Sum_probs=166.2
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhh-ccCCCceeeeeccc
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACA-NCCADFVYGFFENS 210 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~-~~~~~~i~~~~~~~ 210 (365)
.|.+..++|+++++||+|+||.||+|++.........+.||+|+++..... +.....++...+. ..+|+||+.+++.+
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 456777999999999999999999999876544445578999998754332 2222223333333 34799999999987
Q ss_pred ccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 211 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+..+++||||+++|+|.+++................ .......+++..+..++.||+.||.|||+++|+||||||
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI--MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhcccccccccccccc--ccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 45567999999999999999998765322222111110 112234678899999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+|||++.++ .+||+|||+++....... .......||+.|+|||++.+..++.+ +|+||||+++|+|-
T Consensus 174 ~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----~DIwS~G~~l~ell 241 (311)
T d1t46a_ 174 RNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE----SDVWSYGIFLWELF 241 (311)
T ss_dssp GGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH----HHHHHHHHHHHHHH
T ss_pred ccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc----ccccchHHHHHHHH
Confidence 999999987 999999999997765433 22345788999999999987766555 55999999999983
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=291.74 Aligned_cols=194 Identities=20% Similarity=0.283 Sum_probs=150.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH------HHHHHHHHHHHhh--ccCCCceeeeecc
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACA--NCCADFVYGFFEN 209 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~~--~~~~~~i~~~~~~ 209 (365)
.++|++++.||+|+||+||+|++..++ +.||+|.+...... ......++...+. ...|+|++.+++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 368999999999999999999999888 78888877532110 0000011122222 2348899999887
Q ss_pred cccCCCeEEEEEEecCC-CcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 210 SSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 210 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
+ .....+++||||+.+ +++.+++.... .+++..++.++.||+.||.|||++||+||||
T Consensus 78 ~-~~~~~~~lv~e~~~~~~~l~~~~~~~~--------------------~l~e~~~~~~~~qi~~al~~lH~~~iiHrDi 136 (273)
T d1xwsa_ 78 F-ERPDSFVLILERPEPVQDLFDFITERG--------------------ALQEELARSFFWQVLEAVRHCHNCGVLHRDI 136 (273)
T ss_dssp E-ECSSEEEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred E-eeCCeEEEEEEeccCcchHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Confidence 6 556789999999975 68888887654 4578889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+|||++.++..+||+|||+|+..... ...+..||+.|||||++.+..+. +..+|+||||+++|+|-+
T Consensus 137 Kp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~---~~~~DiwSlGvilyell~ 205 (273)
T d1xwsa_ 137 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH---GRSAAVWSLGILLYDMVC 205 (273)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBC---HHHHHHHHHHHHHHHHHH
T ss_pred cccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCC---CcccccccceeeehhHhh
Confidence 9999999976559999999999865432 23567899999999999876543 234679999999999843
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=291.90 Aligned_cols=221 Identities=21% Similarity=0.252 Sum_probs=159.5
Q ss_pred hccccCCCeEEeeeeecCCCeeEEEEEecCCCCCC--CCcceeehhhccccHHH-HHH-HHHHHHHhhccCCCceeeeec
Q 017820 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSK--NDGDLVLKKATEYGAVE-IWM-NERVRRACANCCADFVYGFFE 208 (365)
Q Consensus 133 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~--~~~~vavK~~~~~~~~~-~~~-~~~~~~~~~~~~~~~i~~~~~ 208 (365)
++.+..++|++++.||+|+||.||+|+...+++.. ....||+|++....... ... ..+.........|+||+.+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 35667799999999999999999999987665322 22468999887554322 222 222333444457999999998
Q ss_pred ccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 209 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.+. +++..++||||+.+|+|.+++.............. .......+++..++.++.||+.||+|||+++||||||
T Consensus 87 ~~~-~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 87 ACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP----SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp EEC-SSSSCEEEECCCTTCBHHHHHHTTSCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ccc-cCCeEEEEEEccCCCcHHHHHHhhcCCcccccccc----ccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 874 56789999999999999999987653221111100 1112346789999999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCcc-ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
||+|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.+ +|+||||+++|||-|
T Consensus 162 Kp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k----~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 162 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ----SDVWSFGVLLWEIFT 232 (299)
T ss_dssp SGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH----HHHHHHHHHHHHHHT
T ss_pred cccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch----hhhHHhHHHHHHhcc
Confidence 99999999988 9999999999977654332 2344678999999999988776554 569999999999843
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=290.90 Aligned_cols=194 Identities=23% Similarity=0.350 Sum_probs=153.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCC---C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (365)
++|.+.+.||+|+||.||+|++.+ +.||+|++......+ ...+.+.......+|+||+.+++.+..++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g-------~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 579999999999999999999743 789999887654433 33333444555678999999988876544 3
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH--------CCCcccC
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS--------TGIVHRD 287 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~--------~~IiHrD 287 (365)
.+|+||||+++|+|.+++++.. +++..+..++.|++.||.|||+ ++|||||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~---------------------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYT---------------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred EEEEEEecccCCCHHHHHhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 6899999999999999998653 4677788999999999999996 5999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCC--CCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPS--APSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~--~d~~s~~~slg~vlw~lG 362 (365)
|||+||||+.++ ++||+|||+++....... .......||+.|||||++.+...... .+..+|+||||++||||-
T Consensus 134 lKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 134 LKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 999999999987 999999999997755432 12345789999999999876533221 234678999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-38 Score=288.14 Aligned_cols=195 Identities=22% Similarity=0.268 Sum_probs=154.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++|++.+.||+|+||+||+|++..++ +.||+|.+......+ .....++...+...+|++|+.+++.+ ..+.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-EETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-cccc
Confidence 379999999999999999999999888 789999886443222 22333456777888999999999887 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
.+++||||+.++ +.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 75 ~~~iv~e~~~~~-~~~~~~~~~------------------~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~ 135 (298)
T d1gz8a_ 75 KLYLVFEFLHQD-LKKFMDASA------------------LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135 (298)
T ss_dssp EEEEEEECCSEE-HHHHHHHTT------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ceeEEEeecCCc-hhhhhhhhc------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee
Confidence 899999999865 444443322 2246889999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ .+||+|||+|+...... .......||+.|+|||++..... .+..+|+||+|+++|+|-
T Consensus 136 ~~~~-~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~---~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 136 NTEG-AIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp CTTS-CEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSS---CCTHHHHHHHHHHHHHHH
T ss_pred cccC-cceeccCCcceeccCCc-ccceeecccceeeehhhhccccC---CCccccccccchhhhHHh
Confidence 9987 99999999998764432 23455789999999999866543 344678999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=293.31 Aligned_cols=212 Identities=18% Similarity=0.215 Sum_probs=167.6
Q ss_pred ccccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc-HHHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 134 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
|++..++|+++++||+|+||+||+|++..+........||+|+++... ..+.....++...+...+|+|++.+++.+ .
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-S 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-C
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-e
Confidence 566779999999999999999999998754333333679999987543 33334445667788888999999999987 4
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
.+...++||||+.+|+|.+++...... .........+++..+.+++.|+++||.|||+++|+||||||+|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPA----------MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHH----------HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccc----------cccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 556889999999999999998764310 0011112345778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc-cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||+++++ ++||+|||+|+.+..... .......||+.|+|||.+.+..++. .+|+||||+++|||
T Consensus 164 iLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~----~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 164 CMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT----YSDVWSFGVVLWEI 228 (308)
T ss_dssp EEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH----HHHHHHHHHHHHHH
T ss_pred eeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCc----ccccccHHHHHHHH
Confidence 9999987 999999999987654433 2233457899999999998876655 45599999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=290.99 Aligned_cols=190 Identities=20% Similarity=0.188 Sum_probs=148.3
Q ss_pred EeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-----HHHHHHHHHHhhccCCCceeeeecccccCCCeE
Q 017820 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (365)
Q Consensus 143 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (365)
.+++||+|+||+||+|++..++ +.||+|++......+ .....++...+...+|+||+.+++.+ ..++.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCC-----cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCce
Confidence 4689999999999999999888 789999876433221 11233456667778899999999887 555789
Q ss_pred EEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 017820 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (365)
Q Consensus 218 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~ 297 (365)
++||||+.++++..+..... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~~--------------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNSL--------------------VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135 (299)
T ss_dssp EEEEECCSEEHHHHHTTCCS--------------------SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred eehhhhhcchHHhhhhhccc--------------------CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC
Confidence 99999999887766654332 3566778999999999999999999999999999999999
Q ss_pred CCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 ~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++ .+||+|||+|+....... .....+||+.|||||++.+... .+..+|+||+|+++|+|-+
T Consensus 136 ~~-~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlGvil~el~~ 196 (299)
T d1ua2a_ 136 NG-VLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARM---YGVGVDMWAVGCILAELLL 196 (299)
T ss_dssp TC-CEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSC---CCHHHHHHHHHHHHHHHHH
T ss_pred CC-ccccccCccccccCCCcc-cccceecChhhccHHHHccCCC---CChhhhhhhcchHHHHHHh
Confidence 87 999999999987654322 2345789999999999865432 2346679999999999843
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=286.18 Aligned_cols=196 Identities=18% Similarity=0.200 Sum_probs=155.6
Q ss_pred EEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccc-cHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEEEE
Q 017820 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (365)
Q Consensus 142 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lV 220 (365)
.+.++||+|+||+||+|++..++... ..||+|++... ...+.....++...+....|+|++.+++.+...+..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----C--EEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEE--EEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34789999999999999987754222 35788888643 3334444555667778889999999999876667789999
Q ss_pred EEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 017820 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (365)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~~~~ 300 (365)
|||+++++|.+++..... ..++..+..++.|++.||.|||+++|+||||||+|||+++++
T Consensus 108 ~E~~~~g~l~~~~~~~~~-------------------~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~- 167 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-------------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF- 167 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-------------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-
T ss_pred EEEeecCchhhhhccccc-------------------cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-
Confidence 999999999999876542 335667889999999999999999999999999999999987
Q ss_pred cEEEEecccccccccCCcc---ccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 301 TFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 301 ~ikL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
.+||+|||+++........ ......||+.|+|||.+.+..++.+ +|+||||+++|||-|
T Consensus 168 ~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k----sDI~SfGivl~El~t 229 (311)
T d1r0pa_ 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK----SDVWSFGVLLWELMT 229 (311)
T ss_dssp CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH----HHHHHHHHHHHHHHT
T ss_pred CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCCh----hHhhhhHHHHHHHHH
Confidence 9999999999876544222 2234678999999999988766554 569999999999843
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=285.76 Aligned_cols=199 Identities=17% Similarity=0.155 Sum_probs=147.7
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH---HHHHHHHHHHHHhhccCCCceeeeeccccc
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (365)
+..++|++.+.||+|+||+||+|++....... ..||+|++..... .......++...+...+|+||+.+++.+..
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~--~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCE--EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcE--EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34578999999999999999999976543222 4688888764322 112223345566777789999999988743
Q ss_pred CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 017820 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~N 292 (365)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N 141 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQ-------------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 141 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG-------------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred --cchheeeeeecCcchhhhhhccc-------------------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence 46789999999999999887653 245778899999999999999999999999999999
Q ss_pred eEEecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 293 ILl~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||++.++ .+||+|||+|+.+..... .......||..|+|||++.+..++.+ +|+||||+++|||-
T Consensus 142 Ill~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~----~Di~S~Gvil~eml 208 (273)
T d1u46a_ 142 LLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA----SDTWMFGVTLWEMF 208 (273)
T ss_dssp EEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH----HHHHHHHHHHHHHH
T ss_pred hcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcc----hhhhhhHHHHHHHH
Confidence 9999987 999999999998754432 12234567889999999988766554 56999999999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-37 Score=284.32 Aligned_cols=192 Identities=18% Similarity=0.253 Sum_probs=145.5
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH-HHHHHHHHHHhhccCCCceeeeecccccCCCe
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (365)
-++|+++++||+|+||+||+|++..++ +.||+|.+......+ ...+.++...+.+ ++++..++... ..+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~e~~~~~~l~~--~~~i~~~~~~~-~~~~~ 75 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLLAG--CTGIPNVYYFG-QEGLH 75 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHTTT--CTTCCCEEEEE-EETTE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEccccCcHHHHHHHHHHHHhcC--CCCCCEEEEEe-ecCCc
Confidence 378999999999999999999999887 889999775433221 1222222333332 34444444333 45678
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 017820 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (365)
Q Consensus 217 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~ 296 (365)
.++||||+ +++|.+++...+. .++...+..++.|++.||+|||++||+||||||+|||++
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~-------------------~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGR-------------------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-------------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred cEEEEEec-CCCHHHHHHhhcc-------------------chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 99999999 4799999876542 346777889999999999999999999999999999997
Q ss_pred cC----CCcEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 297 EG----SRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 297 ~~----~~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
.+ ...+||+|||+|+.+..... .......||+.|||||++.+..++. .+|+||||+++|+|
T Consensus 136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~----~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR----RDDLEALGHVFMYF 206 (293)
T ss_dssp CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH----HHHHHHHHHHHHHH
T ss_pred CcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCCh----HHHHHHhhHHHHHH
Confidence 42 23899999999997654322 1234578999999999998766554 45599999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=285.22 Aligned_cols=195 Identities=23% Similarity=0.274 Sum_probs=151.8
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-----HHHHHHHHHHHhhccCCCceeeeecccc-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSS- 211 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~- 211 (365)
.++|++.++||+|+||+||+|++..++. +.||+|+++..... ....+..+.+.+....|+|++.+++.+.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCC----EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 3799999999999999999999976531 45788887533211 1222233445556668999988876653
Q ss_pred ---cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 017820 212 ---KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (365)
Q Consensus 212 ---~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDI 288 (365)
.....+++++||++++.+........ ..+++..++.++.|++.||+|||+++|+||||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPE-------------------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 23467899999999887765544332 24577889999999999999999999999999
Q ss_pred CCCceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 289 Kp~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
||+|||+++++ .+||+|||+++...... ......||+.|||||++.+..++. .+|+||+|+++|+|-
T Consensus 143 Kp~NILi~~~~-~~kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~----~~DiwSlG~il~ell 209 (305)
T d1blxa_ 143 KPQNILVTSSG-QIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYAT----PVDLWSVGCIFAEMF 209 (305)
T ss_dssp CGGGEEECTTC-CEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCT----HHHHHHHHHHHHHHH
T ss_pred CccEEEEcCCC-Ceeecchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCCh----hehhhchHHHHHHHH
Confidence 99999999988 99999999998654332 235679999999999998877655 556999999999984
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=289.17 Aligned_cols=212 Identities=18% Similarity=0.231 Sum_probs=157.6
Q ss_pred ccCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH-HHHHHHHHHHHhhcc-CCCceeeeecccccC
Q 017820 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSSKK 213 (365)
Q Consensus 136 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~ 213 (365)
+..++|++.++||+|+||+||+|++..++.. ..|++|++...... ......++...+... .|+||+.+++.+ ..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-~~ 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EH 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-EE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeE---EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-ec
Confidence 3557999999999999999999999887622 24677776543322 222333445555554 799999999987 45
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
++.+++||||+++|+|.++++........... .........+++..+.+++.||+.||.|||+++|+||||||+||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF----AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHH----HHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhh----hccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence 67899999999999999999865311000000 00112345678899999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|++.++ .+||+|||+|+...... ......||+.|+|||.+.+..++. .+|+||||+++|||-
T Consensus 159 L~~~~~-~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~----~sDvwSfGvil~ell 220 (309)
T d1fvra_ 159 LVGENY-VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIV 220 (309)
T ss_dssp EECGGG-CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECH----HHHHHHHHHHHHHHH
T ss_pred EEcCCC-ceEEccccccccccccc--cccceecCCcccchHHhccCCCCc----cceeehhHHHHHHHH
Confidence 999987 99999999998654332 224567899999999998877655 455999999999973
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-37 Score=283.22 Aligned_cols=194 Identities=19% Similarity=0.229 Sum_probs=145.8
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeecccccCCCeEE
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (365)
++|++.+.||+|+||+||+|++..++ +.||+|.+......+... .+...+....|++++..+......+...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~--~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLH--IESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEESCTTSCCHH--HHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC-----CEEEEEEEchhccCHHHH--HHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 57999999999999999999999887 788898765433222211 22333334444444444444446678899
Q ss_pred EEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec-
Q 017820 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE- 297 (365)
Q Consensus 219 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl~~- 297 (365)
+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++|||||||||+|||++.
T Consensus 80 ivme~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCS-------------------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139 (299)
T ss_dssp EEEECCCC-BHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG
T ss_pred EEEEEcCC-chhhhhhhcc-------------------CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc
Confidence 99999965 5666554433 24577889999999999999999999999999999999864
Q ss_pred -CCCcEEEEecccccccccCCc------cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 298 -GSRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 298 -~~~~ikL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
++..+||+|||+|+.+..... .......||+.|||||++.+..++. .+|+||||+++|+|-+
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~~l~el~t 208 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR----RDDLESLGYVLMYFNL 208 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH----HHHHHHHHHHHHHHHH
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCC----hhhEEecCHHHHHHHh
Confidence 233799999999998754432 1234578999999999998877655 4559999999999843
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.1e-37 Score=278.61 Aligned_cols=194 Identities=19% Similarity=0.225 Sum_probs=152.1
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH--HHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++|++.++||+|+||+||+|++. ++ +.||+|++......+ .....++...+....|+||+.++..+ ..+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YG-----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TS-----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CC-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-ccCC
Confidence 379999999999999999999986 44 779999886443221 22333456677788899999998887 4557
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..++++||+.++.+..+....+ .+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll 133 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCEG--------------------GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTSTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ceeEEEEeehhhhHHHHHhhcC--------------------CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE
Confidence 8899999999887777765443 56889999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+.++ .+||+|||.|....... .......|++.|+|||.+.+... .+..+|+||||+++|+|-|
T Consensus 134 ~~~~-~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~---~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 134 NREG-ELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKK---YSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp CTTS-CEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCS---CCTHHHHHHHHHHHHHHHH
T ss_pred cCCC-CEEecccccceecccCc-cccceecccchhhhHHHHhCCCC---CCcceeehhcCcHHHHHHH
Confidence 9987 99999999998764432 22345678999999999875432 3456779999999999854
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-37 Score=286.58 Aligned_cols=194 Identities=24% Similarity=0.236 Sum_probs=149.5
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhccCCCceeeeeccccc-----C
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-----K 213 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~ 213 (365)
-+|+..++||+|+||+||+|++..++ +.||+|++....... .++...+...+|+|++.+++.+.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRFK----NRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSSC----CHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCC-----CEEEEEEECccchHH----HHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 37999999999999999999999888 788999886543211 123445556678898888766532 2
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 017820 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (365)
Q Consensus 214 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NI 293 (365)
...+++||||++++.+..+..... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~-----------------~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSR-----------------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHH-----------------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ceEEEEEEeccCCccHHHHHhhhh-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 356799999999765444432211 123568889999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 294 Ll~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|++.++..+||+|||+|+.+..... ..+..||+.|+|||.+.+.. ..+..+|+||+|+++|+|-+
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHH
T ss_pred EEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhccc---CCCcceeecccceEEEehhh
Confidence 9998766999999999987654432 34578999999999986542 23446679999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-36 Score=279.55 Aligned_cols=190 Identities=22% Similarity=0.241 Sum_probs=151.5
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHHHHHHHhhc-cCCCceeeeeccccc-CC
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSK-KG 214 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~-~~ 214 (365)
..++|++.++||+|+||+||+|++..++ +.||+|++.......... +...+.. ..|++++.+++.+.. ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~---Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSSCHHHHHH---HHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEECHHHHHHHHH---HHHHHHhccCCCCCcEEEEEEEecCC
Confidence 3468999999999999999999999888 889999887655433322 2333333 358899888876643 34
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
..+++||||+.+++|.++.+ .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~-----------------------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQ-----------------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTT-----------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CceeEEEeecCCCcHHHHhc-----------------------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 67999999999999866532 3577889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++..+||+|||+|+...... ......||+.|+|||.+.+... .+..+|+||+|+++|+|-
T Consensus 162 i~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 162 IDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQM---YDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp EETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCC---CCTHHHHHHHHHHHHHHH
T ss_pred EcCCCCeeeecccccceeccCCC--cccccccCccccCcccccCCCC---CCcccchhhhhhhhHHhc
Confidence 99776579999999998765443 2356789999999999876542 234667999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=279.85 Aligned_cols=194 Identities=20% Similarity=0.207 Sum_probs=149.3
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH-HHHHHHHHHHHHhhccCCCceeeeecccccCC---
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (365)
++|+++++||+|+||+||+|++..++ +.||+|++..... .......++...+...+|++++.+++.+....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTC-----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCC-----cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 57999999999999999999999888 7899998864432 22333344566677778999888776653322
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 017820 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NIL 294 (365)
...+++++|+.+|+|.+++.... +++..++.++.|++.||+|||++|||||||||+|||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~~---------------------l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL 141 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQH---------------------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cceEEEEEeecCCchhhhhhcCC---------------------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence 23455556777899999997643 477889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecccccccccCCc--cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 295 FSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 295 l~~~~~~ikL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
++.++ .+||+|||+|+....... ......+||+.|+|||++..... ....+|+||+|+++|+|-
T Consensus 142 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 142 LNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG---YTKSIDIWSVGCILAEML 207 (345)
T ss_dssp ECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCS---CSTHHHHHHHHHHHHHHH
T ss_pred ECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCC---CCchhhhhccCceehHHh
Confidence 99987 999999999987644322 22345789999999999855432 234567999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-36 Score=279.99 Aligned_cols=191 Identities=21% Similarity=0.290 Sum_probs=147.9
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCC-
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (365)
.++|++.++||+|+||+||+|.+..++ +.||+|++.... ........++...+....|++++.+++.+...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 479999999999999999999999888 889999886432 222333345566677788999998887764433
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 017820 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (365)
Q Consensus 215 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp 290 (365)
..+++||||+ +.+|.++++.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~~---------------------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp 149 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKHE---------------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ccccceEEEEEecc-cccHHHHHHhc---------------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence 4679999999 45787776543 357888999999999999999999999999999
Q ss_pred CceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 291 ~NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
+|||++.++ .+||+|||+|+..... .....||+.|+|||++.+... .+..+|+||+|+++|+|-+
T Consensus 150 ~NIL~~~~~-~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwSlGvil~ell~ 214 (346)
T d1cm8a_ 150 GNLAVNEDC-ELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMIT 214 (346)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTC---CCTTHHHHHHHHHHHHHHH
T ss_pred chhhccccc-ccccccccceeccCCc----cccccccccccCHHHHcCCCC---CCccchhhcchHHHHHHHH
Confidence 999999988 9999999999876432 345789999999999876432 2345669999999999843
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=278.96 Aligned_cols=197 Identities=20% Similarity=0.216 Sum_probs=147.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHH--HHHHHHHHHHHhhccCCCceeeeecccccC-
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK- 213 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (365)
..++|++.++||+|+||+||+|++..++ +.||+|++...... ......++...+....|++++.+++.+...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4589999999999999999999999887 78899987533221 112222345556666788888776654332
Q ss_pred ------CCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 017820 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (365)
Q Consensus 214 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrD 287 (365)
+..+++||||++++.+..+.... ..+++..++.++.|++.||.|||++||+|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrD 142 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 142 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTT--------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ccccccCceEEEEEeccCCCccchhhhcc--------------------cccccHHHHHHHHHHHHHHHHhccCCEEecC
Confidence 35689999999987765543322 2457788899999999999999999999999
Q ss_pred CCCCceEEecCCCcEEEEecccccccccCCc---cccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 288 IKp~NILl~~~~~~ikL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||+|||++.++ .+||+|||+|+.+..... ......+||+.|+|||++.+... .+..+|+||+|+++|+|-
T Consensus 143 lKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~---~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 143 MKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD---YGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSS---CCTHHHHHHHHHHHHHHH
T ss_pred cCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCC---CCcHHHcccCCceeeeHh
Confidence 999999999988 999999999987653321 22334689999999999876421 234567999999999983
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=269.88 Aligned_cols=194 Identities=15% Similarity=0.208 Sum_probs=157.9
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeecccccCCC
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (365)
.++|++.++||+|+||+||+|++..++ +.||+|.++... ........++...+....|+|++.+.+.+ ....
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCC-----cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-cccc
Confidence 378999999999999999999999887 788999875332 22233344556677888999999988877 5567
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 017820 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (365)
Q Consensus 216 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~NILl 295 (365)
..+++++++.+++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli 134 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSCNG--------------------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ceeEEeeecccccccccccccc--------------------ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc
Confidence 8899999999999988876654 45678899999999999999999999999999999999
Q ss_pred ecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 296 ~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
+.++ ++||+|||.|+........ .....+++.|+|||++.+... .+..+|+||+|+++|+|-
T Consensus 135 ~~~~-~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~---~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 135 NRNG-ELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp CTTC-CEEECCCTTCEECCSCCSC-CCSCCSCGGGCCHHHHTTCSC---CCTHHHHHHHHHHHHHHT
T ss_pred ccCC-ceeeeecchhhcccCCCcc-ceeeccccchhhhhHhccCCC---CCchhhccccchHHHHHh
Confidence 9987 9999999999876544332 334567889999999876543 234567999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=277.29 Aligned_cols=201 Identities=19% Similarity=0.238 Sum_probs=152.4
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH----HHHHHHHHHHHHhhcc-CCCceeeeecccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANC-CADFVYGFFENSS 211 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (365)
..++|++++.||+|+||+||+|.+....... +.||+|.+..... .......++...+... ++++|+.++..+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~- 98 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTG--KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF- 98 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTT--CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCC--cEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-
Confidence 4588999999999999999999874432111 6788887643210 1111111223333333 346788777665
Q ss_pred cCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 212 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....++++|||+.+++|.+++...+ ...+..++.++.||+.||.|||+++|+||||||+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--------------------~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~ 158 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--------------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--------------------cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcc
Confidence 55578999999999999999998775 3466778899999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+||+|||+|+.+............||+.|+|||.+.+.... .+..+|+||||++||+|-+
T Consensus 159 Nill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~--~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 159 NILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp GEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHH
T ss_pred ceeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcC--CCchhhhHHHHHHHHHHHh
Confidence 99999987 999999999987765544445677899999999999764332 3446789999999999843
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=272.69 Aligned_cols=189 Identities=19% Similarity=0.252 Sum_probs=141.7
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc----
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (365)
++|++.++||+|+||+||+|++..++ +.||+|++.... ........++...+...+|++++.+++.+..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTT-----EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCC-----CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 78999999999999999999999888 889999886432 2222334455666777789999998877643
Q ss_pred -CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 213 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
....+|+||||+.++.+ +.+.. .+++..++.++.||+.||.|||++||+||||||+
T Consensus 92 ~~~~~~~iv~Ey~~~~l~-~~~~~----------------------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLC-QVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp TTCCEEEEEEECCSEEHH-HHHTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ccCceeEEEEeccchHHH-Hhhhc----------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc
Confidence 34789999999987554 44321 2477889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheecc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQ 362 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lG 362 (365)
|||++.++ .+|++|||+++...... ......||+.|+|||++.+..++++ +|+||+|+++|+|-
T Consensus 149 Nil~~~~~-~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~----~DiwSlG~~l~ell 212 (355)
T d2b1pa1 149 NIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKEN----VDIWSVGCIMGEMV 212 (355)
T ss_dssp GEEECTTC-CEEECCCCC-----------------CCTTCCHHHHTTCCCCTT----HHHHHHHHHHHHHH
T ss_pred cccccccc-ceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCC----cccccccchHHHHh
Confidence 99999987 99999999998765433 3356789999999999988766555 55999999999963
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-35 Score=273.26 Aligned_cols=192 Identities=20% Similarity=0.212 Sum_probs=149.4
Q ss_pred CCCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhcccc--HHHHHHHHHHHHHhhccCCCceeeeeccccc---
Q 017820 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (365)
Q Consensus 138 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (365)
.++|++.++||+|+||+||+|++..++ +.||+|++.... ........++...+....|++++.++..+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTT-----EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 378999999999999999999999888 889999886432 2233334455667777789999887766532
Q ss_pred -CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 017820 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (365)
Q Consensus 213 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~IiHrDIKp~ 291 (365)
.....+++++|+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~---------------------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~ 150 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ---------------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cccCceEEEEEeecCCchhhhcccc---------------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCc
Confidence 234456677888899999998654 3578889999999999999999999999999999
Q ss_pred ceEEecCCCcEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheeccc
Q 017820 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQVQC 363 (365)
Q Consensus 292 NILl~~~~~~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~lGc 363 (365)
|||++.++ .+|++|||+|..... ...+..||+.|+|||++.+... .+..+|+||||+++|+|-+
T Consensus 151 NILi~~~~-~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~---~~~~~DiwSlGv~l~~ll~ 214 (348)
T d2gfsa1 151 NLAVNEDC-ELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLT 214 (348)
T ss_dssp GEEECTTC-CEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSC---CCTTHHHHHHHHHHHHHHH
T ss_pred cccccccc-cccccccchhcccCc----ccccccccccccCchhhcCCcc---CCcccchhhhhHHHHHHHh
Confidence 99999987 999999999976532 2345788999999998766533 2345669999999999843
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=3.6e-31 Score=248.91 Aligned_cols=194 Identities=19% Similarity=0.232 Sum_probs=140.9
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHHHHHHH--HHHHHhh--------ccCCCceeeeec
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE--RVRRACA--------NCCADFVYGFFE 208 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~~--------~~~~~~i~~~~~ 208 (365)
++|+++++||+|+||+||+|++..++ +.||+|+++........... ++.+.+. ...|++++.++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g-----~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 57999999999999999999999888 88999988755332111111 1222222 224667777766
Q ss_pred cccc-CCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 017820 209 NSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHR 286 (365)
Q Consensus 209 ~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~-~~IiHr 286 (365)
.... .....+++++++..+.......... ....+++..++.++.||+.||.|||+ +||+||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr 150 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKY-----------------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHT-----------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred Eeeeccccceeeeeeecccccccccccccc-----------------cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence 5533 2355667777766554433332221 12345778899999999999999998 899999
Q ss_pred CCCCCceEEecCCC-----cEEEEecccccccccCCccccccccCCCCcCCccccccCCCCCCCCCchhhhhhhhhheec
Q 017820 287 DIKPQNVIFSEGSR-----TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQV 361 (365)
Q Consensus 287 DIKp~NILl~~~~~-----~ikL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~d~~s~~~slg~vlw~l 361 (365)
||||+|||++.++. .++++|||.|..... ......||+.|+|||++.+..++. .+|+||+|+++|+|
T Consensus 151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~il~el 222 (362)
T d1q8ya_ 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGC----GADIWSTACLIFEL 222 (362)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCT----HHHHHHHHHHHHHH
T ss_pred cCChhHeeeeccCcccccceeeEeeccccccccc----ccccccccccccChhhccccCCCc----cccccchHHHHHHH
Confidence 99999999987552 499999999986532 235678999999999998776554 45699999999987
Q ss_pred c
Q 017820 362 Q 362 (365)
Q Consensus 362 G 362 (365)
-
T Consensus 223 ~ 223 (362)
T d1q8ya_ 223 I 223 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=7.1e-23 Score=174.70 Aligned_cols=134 Identities=21% Similarity=0.206 Sum_probs=91.5
Q ss_pred eEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccH------------------HHHHHHHHHHHHhhccCCCc
Q 017820 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA------------------VEIWMNERVRRACANCCADF 202 (365)
Q Consensus 141 y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~ 202 (365)
+.++++||+|+||+||+|++.. + +.||+|.++.... ......+.+...+....+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g-----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-F-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-T-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECCC-C-----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 4689999999999999999854 4 7788886532110 00111112222333334444
Q ss_pred eeeeecccccCCCeEEEEEEecCCCcHHHHHHhcCCCcchhhhhccccccCcccccccHHHHHHHHHHHHHHHHHHHHCC
Q 017820 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (365)
Q Consensus 203 i~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qi~~aL~yLH~~~ 282 (365)
+...+... ..+++|||+++..+.++ +...+..++.|++.+|.|||++|
T Consensus 76 v~~~~~~~-----~~~lvme~~~~~~~~~l---------------------------~~~~~~~i~~ql~~~l~~lH~~g 123 (191)
T d1zara2 76 VPKVYAWE-----GNAVLMELIDAKELYRV---------------------------RVENPDEVLDMILEEVAKFYHRG 123 (191)
T ss_dssp SCCEEEEE-----TTEEEEECCCCEEGGGC---------------------------CCSCHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEec-----CCEEEEEeeccccccch---------------------------hhHHHHHHHHHHHHHHHHHhhCC
Confidence 44433321 23699999997654321 12224578999999999999999
Q ss_pred CcccCCCCCceEEecCCCcEEEEecccccccc
Q 017820 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (365)
Q Consensus 283 IiHrDIKp~NILl~~~~~~ikL~DFGla~~~~ 314 (365)
|+||||||+|||++++ .++|+|||+|+...
T Consensus 124 iiHrDiKP~NILv~~~--~~~liDFG~a~~~~ 153 (191)
T d1zara2 124 IVHGDLSQYNVLVSEE--GIWIIDFPQSVEVG 153 (191)
T ss_dssp EECSCCSTTSEEEETT--EEEECCCTTCEETT
T ss_pred EEEccCChhheeeeCC--CEEEEECCCcccCC
Confidence 9999999999999974 68999999997653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=1.3e-06 Score=75.73 Aligned_cols=84 Identities=12% Similarity=-0.022 Sum_probs=47.1
Q ss_pred CCeEEeeeeecCCCeeEEEEEecCCCCCCCCcceeehhhccccHHH---HHHHHHHHHHhh-ccCCCceeeeecccccCC
Q 017820 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACA-NCCADFVYGFFENSSKKG 214 (365)
Q Consensus 139 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~ 214 (365)
+.|++.+..+.++.+.||+....+ +.+++|......... ...+......+. ....|.++.+. ..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~-------~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----~~~ 82 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----RHD 82 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE----EET
T ss_pred hceEEEEcCCCCCCCcEEEEEeCC-------CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE----ecC
Confidence 567777766556667899987543 557777664332211 111111222222 22234444332 234
Q ss_pred CeEEEEEEecCCCcHHHHH
Q 017820 215 GEYWLIWRYEGEATLADLM 233 (365)
Q Consensus 215 ~~~~lV~e~~~~gsL~~~l 233 (365)
+..++||+++++.++.+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp TEEEEEEECCSSEEHHHHT
T ss_pred CceEEEEEecccccccccc
Confidence 6789999999998876543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=1.3e-05 Score=68.84 Aligned_cols=30 Identities=23% Similarity=0.278 Sum_probs=25.9
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.|.|||++++. .+.|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~-~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGR-FSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCc-eEEEEEchhccc
Confidence 389999999999999864 678999999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.54 E-value=8e-05 Score=68.37 Aligned_cols=29 Identities=28% Similarity=0.331 Sum_probs=25.5
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
.++|+|+.|.|||++++ .++|+||-.|..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 59999999999999875 589999988864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.71 E-value=0.0023 Score=56.60 Aligned_cols=28 Identities=21% Similarity=0.372 Sum_probs=23.4
Q ss_pred CCcccCCCCCceEEecCCCcEEEEecccccc
Q 017820 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (365)
Q Consensus 282 ~IiHrDIKp~NILl~~~~~~ikL~DFGla~~ 312 (365)
++||+|+.+.|||+++ + ..++||+-|..
T Consensus 193 ~liHgDlh~~NvL~~~-~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C--ceEEechhccc
Confidence 6899999999999974 3 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0036 Score=54.81 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=26.6
Q ss_pred CCCcccCCCCCceEEecCCCcEEEEeccccc
Q 017820 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (365)
Q Consensus 281 ~~IiHrDIKp~NILl~~~~~~ikL~DFGla~ 311 (365)
.|+||+|+.++||+++.+. ..-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-ceeEecccccc
Confidence 3799999999999999865 67899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.86 E-value=0.039 Score=49.68 Aligned_cols=84 Identities=10% Similarity=0.143 Sum_probs=42.1
Q ss_pred cCCCeEEeeeeecCCCeeEEEEEecCCCCC--CCCcceeehhhccc-cHHHHHHHHHHHHHh-hccCCCceeeeeccccc
Q 017820 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEY-GAVEIWMNERVRRAC-ANCCADFVYGFFENSSK 212 (365)
Q Consensus 137 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~ 212 (365)
..+++++ +.|+.|-.-.+|++........ ...+.++++..-.. .......+.++.+.+ .....|.++.++..
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 4456665 5677788889999987653211 11133444433211 112222222222222 22234555555421
Q ss_pred CCCeEEEEEEecCCCcH
Q 017820 213 KGGEYWLIWRYEGEATL 229 (365)
Q Consensus 213 ~~~~~~lV~e~~~~gsL 229 (365)
++|+||+++.+|
T Consensus 117 -----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -----GRLEEYIPSRPL 128 (395)
T ss_dssp -----EEEECCCCEEEC
T ss_pred -----ceEEEEeccccC
Confidence 578999987554
|